data_2mzs_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mzs _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.66 157.87 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 O-C-N 121.257 -0.902 . . . . 0.0 111.495 172.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 3.7 mp -131.86 132.81 61.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 126.166 1.787 . . . . 0.0 107.235 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 36.0 m -104.43 137.27 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.212 1.005 . . . . 0.0 109.254 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -140.15 35.59 1.91 Allowed 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -157.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -160.58 -22.43 0.06 Allowed 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 12.7 mt -47.41 130.67 10.22 Favored Pre-proline 0 CA--C 1.557 1.243 0 O-C-N 120.77 -1.206 . . . . 0.0 111.341 160.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -88.44 170.29 5.66 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 124.82 3.68 . . . . 0.0 111.791 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -61.13 -8.36 3.43 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 9.1 m -68.89 -22.87 64.16 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.474 1.11 . . . . 0.0 113.121 171.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.5 p -108.6 136.69 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 126.882 2.073 . . . . 0.0 109.247 173.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -141.7 174.2 10.79 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.498 1.519 . . . . 0.0 111.447 -167.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -43.48 -50.8 6.95 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -168.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -69.14 -28.47 66.48 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 119.315 0.961 . . . . 0.0 113.014 -175.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -77.48 -40.13 44.06 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 167.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 3.9 tt -53.16 -46.03 68.72 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.993 1.317 . . . . 0.0 109.743 175.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -46.15 -54.17 9.13 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.932 0.893 . . . . 0.0 111.586 172.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -61.75 -27.89 69.05 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.881 1.272 . . . . 0.0 113.891 -175.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 23.8 mt -53.79 -27.38 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 124.587 1.155 . . . . 0.0 112.125 172.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -118.26 -29.46 5.53 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.357 1.463 . . . . 0.0 112.309 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.8 -13.61 62.36 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.571 1.548 . . . . 0.0 113.709 176.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -57.9 -17.74 18.57 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 172.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 75.8 m -71.72 -1.85 15.34 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 173.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 89.11 14.25 60.84 Favored Glycine 0 N--CA 1.476 1.334 0 C-N-CA 124.973 1.273 . . . . 0.0 114.63 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -138.54 -178.82 5.47 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 126.811 2.044 . . . . 0.0 109.755 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.36 147.05 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 120.476 -1.39 . . . . 0.0 112.896 169.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -109.31 -114.5 0.3 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.481 1.513 . . . . 0.0 110.205 169.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -158.44 155.11 27.97 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.174 1.39 . . . . 0.0 113.081 175.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.34 171.52 20.02 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.573 1.149 . . . . 0.0 112.54 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -161.63 168.27 23.73 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.559 1.143 . . . . 0.0 113.197 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 11.7 m -140.66 158.74 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 127.951 2.5 . . . . 0.0 109.52 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -128.1 108.14 10.39 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.517 0.727 . . . . 0.0 110.521 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 8.3 mp -70.44 145.6 50.9 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.945 1.298 . . . . 0.0 111.74 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -65.14 159.11 24.19 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.747 0.819 . . . . 0.0 111.269 164.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -62.81 -17.63 58.36 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 124.333 0.968 . . . . 0.0 115.391 -177.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -81.83 -3.25 53.54 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 118.992 1.396 . . . . 0.0 113.675 170.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 84.07 21.91 56.12 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 125.106 1.336 . . . . 0.0 114.928 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 19.9 m -99.43 -6.1 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 -164.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 4.8 t 66.76 -177.11 0.2 Allowed 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 38.1 p -142.87 -35.46 0.41 Allowed 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -164.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 75.02 -57.63 2.71 Favored Glycine 0 N--CA 1.475 1.256 0 C-N-CA 124.547 1.07 . . . . 0.0 111.936 -168.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 19.2 t -40.74 118.1 0.92 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.397 1.879 . . . . 0.0 111.381 158.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -169.98 177.62 43.26 Favored Glycine 0 N--CA 1.473 1.121 0 C-N-CA 124.722 1.153 . . . . 0.0 115.193 -169.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 25.4 p -106.41 142.06 36.7 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.392 1.877 . . . . 0.0 111.497 -169.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 1.7 t -128.3 121.7 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.398 1.479 . . . . 0.0 108.789 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 42.7 m -93.82 109.82 21.49 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.962 1.305 . . . . 0.0 108.572 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.4 162.1 28.14 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -163.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -51.69 -54.86 23.62 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.42 1.088 . . . . 0.0 111.699 173.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -172.56 163.69 5.41 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 129.139 2.976 . . . . 0.0 108.551 171.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 87.8 mt -58.26 -30.74 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.048 0.939 . . . . 0.0 111.74 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.06 -40.21 57.79 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 172.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -102.25 -20.78 14.52 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.377 0.535 . . . . 0.0 112.365 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -55.08 -52.35 63.5 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.22 1.408 . . . . 0.0 110.381 174.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -64.04 -30.46 71.53 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 32.4 mtp-105 -70.33 -46.67 63.74 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.557 1.143 . . . . 0.0 111.383 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -69.18 -32.08 71.13 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.31 1.444 . . . . 0.0 113.032 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -57.92 -38.96 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.438 1.095 . . . . 0.0 112.418 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -82.49 -18.79 40.37 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -84.23 -45.91 12.39 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.224 1.01 . . . . 0.0 112.572 -177.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -100.94 -21.14 15.16 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.644 1.349 . . . . 0.0 114.644 -170.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -67.33 111.96 4.3 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.386 0.993 . . . . 0.0 109.919 171.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 99.04 0.34 57.29 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 124.59 1.09 . . . . 0.0 114.88 -171.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -94.22 168.1 11.13 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 118.938 1.369 . . . . 0.0 111.668 173.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 45.6 p -138.42 129.2 26.61 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 120.181 -1.575 . . . . 0.0 112.615 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 11.5 mt -144.63 111.3 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 124.308 1.043 . . . . 0.0 110.099 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 63.07 16.77 9.59 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.771 1.628 . . . . 0.0 114.048 173.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . -159.42 -132.84 1.42 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.969 1.271 . . . . 0.0 113.319 -171.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -95.97 -176.55 3.73 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.933 0.893 . . . . 0.0 110.279 176.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 12.1 p -55.39 131.88 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 121.259 -0.9 . . . . 0.0 108.784 152.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 1.2 pp -103.53 143.22 33.01 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.144 0.978 . . . . 0.0 110.687 -176.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -128.36 141.22 51.49 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.623 1.569 . . . . 0.0 109.33 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 17.3 t -126.66 129.88 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.068 1.347 . . . . 0.0 110.174 -164.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -129.14 169.96 14.12 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.061 1.744 . . . . 0.0 110.822 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 94.5 p -138.38 169.43 17.8 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.885 1.274 . . . . 0.0 111.833 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -176.399 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 . . . . . 0 CA--C 1.554 1.116 0 N-CA-C 112.494 0.554 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 34.2 m -137.37 151.37 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 120.977 -1.077 . . . . 0.0 112.243 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 3.2 mp -102.04 143.68 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 127.865 2.466 . . . . 0.0 108.305 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 18.9 m -126.83 140.38 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 125.695 1.598 . . . . 0.0 108.622 168.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -145.61 24.99 1.36 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -145.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -161.55 -22.54 0.05 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 84.5 mt -47.7 119.37 6.74 Favored Pre-proline 0 CA--C 1.563 1.453 0 C-N-CA 127.023 2.129 . . . . 0.0 111.585 168.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -89.33 -172.71 0.67 Allowed 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 124.986 3.791 . . . . 0.0 113.375 -176.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -54.27 -29.53 47.38 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -173.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 30.6 m -71.09 -18.06 62.56 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.374 -0.829 . . . . 0.0 112.987 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . 0.263 2.4 p -113.6 60.58 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 127.53 2.332 . . . . 0.0 109.948 176.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -62.52 175.6 0.76 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.733 1.613 . . . . 0.0 111.969 176.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -45.63 -42.25 11.13 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.803 1.641 . . . . 0.0 114.952 -174.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -68.72 -40.03 80.12 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.272 0.942 . . . . 0.0 111.696 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.66 -35.73 75.44 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 172.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 2.2 tt -54.74 -51.55 65.29 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.18 0.9 . . . . 0.0 109.229 168.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 4.6 tmmm? -57.2 -35.96 70.26 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.575 0.75 . . . . 0.0 111.905 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -67.57 -23.89 65.45 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 175.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 18.3 mt -58.83 -51.44 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-N 119.38 0.991 . . . . 0.0 110.86 173.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -79.03 -27.5 43.21 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.226 0.61 . . . . 0.0 111.5 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -51.86 -23.27 4.59 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.177 1.391 . . . . 0.0 113.927 173.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -61.59 -13.43 21.87 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 175.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 97.5 m -73.13 -5.58 40.07 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 168.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 96.69 -12.23 66.14 Favored Glycine 0 N--CA 1.476 1.366 0 C-N-CA 126.118 1.818 . . . . 0.0 114.608 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -138.33 172.84 12.3 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.305 2.242 . . . . 0.0 108.98 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 4.8 p -145.3 145.16 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -91.8 -125.39 0.08 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 126.238 1.815 . . . . 0.0 111.807 176.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -153.31 158.01 40.95 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.787 1.635 . . . . 0.0 113.232 -175.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.57 175.96 13.0 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -172.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -159.05 168.19 27.33 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.9 2.08 . . . . 0.0 111.312 176.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 28.7 m -151.01 170.99 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 126.72 2.008 . . . . 0.0 112.722 -171.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -103.71 153.52 20.58 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.489 1.516 . . . . 0.0 112.424 174.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.8 mp -126.71 144.18 51.01 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.115 1.366 . . . . 0.0 111.902 174.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -71.14 160.49 32.77 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.946 0.898 . . . . 0.0 111.304 162.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -66.95 -12.61 60.33 Favored Glycine 0 CA--C 1.534 1.276 0 N-CA-C 115.926 1.13 . . . . 0.0 115.926 -169.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -85.67 -1.36 57.09 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.688 1.195 . . . . 0.0 113.062 172.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.86 15.31 73.18 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.146 1.355 . . . . 0.0 115.131 175.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 97.7 t -81.22 -17.72 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -168.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.4 p 75.98 171.68 0.25 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 127.319 2.248 . . . . 0.0 114.943 176.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 30.3 p -146.26 164.05 33.55 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 127.672 2.389 . . . . 0.0 107.518 172.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -94.7 -16.2 43.24 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.137 0.875 . . . . 0.0 113.862 170.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 8.7 t -55.45 121.7 9.58 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.578 1.151 . . . . 0.0 110.852 166.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 174.86 -160.39 29.43 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.211 0.91 . . . . 0.0 114.46 -171.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 20.1 p -123.55 148.19 46.56 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.845 1.658 . . . . 0.0 110.537 -172.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.9 123.48 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.134 1.774 . . . . 0.0 106.851 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 8.1 t -99.32 110.56 23.06 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.733 1.213 . . . . 0.0 108.255 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.18 165.23 16.71 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -149.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -52.12 -51.57 57.01 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.086 1.354 . . . . 0.0 111.89 174.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -172.55 166.44 5.58 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 129.813 3.245 . . . . 0.0 108.059 171.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.55 -26.82 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 123.863 0.865 . . . . 0.0 111.81 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -30.89 64.85 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 171.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -91.14 -14.48 31.05 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -168.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 10.6 mp -49.52 -49.07 47.48 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.958 0.903 . . . . 0.0 109.311 161.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -61.52 -31.77 71.78 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -172.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -75.21 -56.65 4.52 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.064 1.345 . . . . 0.0 112.039 168.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -65.92 -33.04 74.91 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.967 1.307 . . . . 0.0 114.01 -170.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.18 -27.08 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.594 1.158 . . . . 0.0 111.599 177.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -82.61 -38.82 23.06 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.788 0.835 . . . . 0.0 111.569 170.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -77.32 -41.19 41.56 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -170.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -106.35 -17.33 14.32 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -172.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -54.92 126.24 23.62 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.407 1.003 . . . . 0.0 111.025 167.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 82.77 0.31 90.05 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 119.258 -0.745 . . . . 0.0 114.383 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -97.66 162.59 13.21 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.985 1.314 . . . . 0.0 112.034 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 47.5 p -138.27 128.26 25.53 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.547 1.139 . . . . 0.0 111.468 -176.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 12.2 mt -136.05 112.85 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.038 0.935 . . . . 0.0 109.858 -177.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 56.61 27.54 12.62 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.935 1.694 . . . . 0.0 112.961 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . -176.76 -143.44 4.8 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.428 1.014 . . . . 0.0 113.754 -166.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -93.23 174.96 6.95 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.971 0.908 . . . . 0.0 111.054 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 11.4 p -58.39 141.28 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 121.645 -0.66 . . . . 0.0 110.182 163.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 1.7 pp -122.81 156.26 34.9 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 122.429 1.109 . . . . 0.0 112.804 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -122.83 166.1 15.55 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.707 1.603 . . . . 0.0 110.172 163.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.03 125.64 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 126.824 2.05 . . . . 0.0 107.466 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -141.86 133.7 27.24 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.146 0.578 . . . . 0.0 112.389 -169.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 20.0 p -110.47 153.82 24.51 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.542 1.537 . . . . 0.0 111.997 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp . . . . . 0 CA--C 1.546 0.813 0 O-C-N 121.208 -0.933 . . . . 0.0 110.908 173.728 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 31.1 m -130.99 147.37 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.978 1.711 . . . . 0.0 110.553 173.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.7 mp -97.84 140.91 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 127.461 2.305 . . . . 0.0 107.232 175.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 30.0 m -131.48 120.64 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.608 0.763 . . . . 0.0 110.388 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -147.66 77.93 1.44 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.972 0.909 . . . . 0.0 110.9 -162.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -174.36 -42.21 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 126.383 1.873 . . . . 0.0 110.732 177.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 71.3 mt -34.75 116.97 0.54 Allowed Pre-proline 0 CA--C 1.558 1.271 0 C-N-CA 127.377 2.271 . . . . 0.0 111.582 160.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -89.64 177.92 2.54 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 125.121 3.881 . . . . 0.0 112.641 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -51.36 -26.94 8.54 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 -171.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 5.5 t -76.85 -14.85 59.85 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . 0.259 1.6 p -108.28 79.88 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.938 1.695 . . . . 0.0 108.863 174.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -69.81 179.14 2.32 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.965 2.106 . . . . 0.0 112.546 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -57.05 -37.76 72.27 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 120.6 -1.313 . . . . 0.0 112.689 177.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -65.5 -37.33 86.49 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.239 -0.913 . . . . 0.0 111.321 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -71.12 -38.2 72.31 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 168.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 5.4 tt -53.79 -45.67 70.8 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.819 1.248 . . . . 0.0 110.517 176.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -47.76 -51.77 21.1 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.483 0.713 . . . . 0.0 111.706 172.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -64.99 -22.55 67.02 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -174.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 45.0 mt -55.73 -44.98 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.271 1.028 . . . . 0.0 111.509 171.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -104.89 -22.34 13.17 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.181 0.993 . . . . 0.0 113.047 -173.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -64.93 0.15 1.32 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.426 1.89 . . . . 0.0 115.138 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -55.45 -19.05 8.24 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 120.501 -1.374 . . . . 0.0 113.834 168.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 21.8 t -56.54 -20.48 20.76 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.624 1.57 . . . . 0.0 114.072 169.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 92.3 -7.46 78.12 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.919 1.724 . . . . 0.0 113.454 -173.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -138.46 175.87 9.19 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.362 2.665 . . . . 0.0 109.116 174.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.4 p -145.12 145.24 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 120.705 -1.247 . . . . 0.0 113.136 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -79.44 -104.75 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.656 1.582 . . . . 0.0 111.877 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -152.04 146.03 25.25 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.995 1.718 . . . . 0.0 112.253 -175.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.35 166.83 31.33 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.798 0.839 . . . . 0.0 113.254 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -159.82 172.83 16.94 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.942 1.697 . . . . 0.0 111.153 -177.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 4.2 m -142.32 152.07 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.471 1.909 . . . . 0.0 111.753 -177.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -111.18 99.05 7.96 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.108 0.963 . . . . 0.0 109.765 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 8.9 mt -91.33 160.11 15.66 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.943 0.897 . . . . 0.0 112.074 -172.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -80.7 147.18 30.72 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.437 1.095 . . . . 0.0 112.445 -173.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -67.61 -13.12 62.82 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.0 1.286 . . . . 0.0 115.963 -172.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -82.36 -0.13 44.45 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 119.175 1.487 . . . . 0.0 113.152 169.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.84 61.59 1.93 Allowed Glycine 0 C--N 1.341 0.849 0 C-N-CA 125.132 1.349 . . . . 0.0 112.161 176.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 13.6 p -154.29 146.48 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.36 1.064 . . . . 0.0 111.839 -174.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 26.6 t -62.79 161.45 12.56 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.44 1.096 . . . . 0.0 113.932 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 35.9 p -146.09 -27.24 0.43 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 126.846 2.058 . . . . 0.0 114.082 -169.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 78.46 -41.07 2.04 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 126.545 2.022 . . . . 0.0 114.82 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 5.3 p -50.14 132.89 23.75 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.388 1.875 . . . . 0.0 112.828 166.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -172.59 -159.99 20.25 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 124.49 1.043 . . . . 0.0 115.475 -172.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 46.0 p -137.46 155.01 49.8 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.668 1.587 . . . . 0.0 110.638 -173.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.48 119.2 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.593 1.557 . . . . 0.0 107.44 -176.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 44.1 t -108.9 124.81 51.23 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.677 1.191 . . . . 0.0 109.128 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.18 165.63 12.52 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 -144.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -52.75 -53.9 41.43 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.081 170.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -172.91 168.43 4.95 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 129.01 2.924 . . . . 0.0 108.205 165.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 19.5 tt -57.58 -28.3 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.2 -41.38 68.54 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 172.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -94.48 -28.56 15.4 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.179 0.445 . . . . 0.0 111.44 -176.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.1 tt -52.56 -49.01 65.79 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.526 1.531 . . . . 0.0 110.089 169.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -56.69 -35.35 68.37 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -70.71 -55.98 7.43 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.324 0.65 . . . . 0.0 111.381 169.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.72 -35.26 72.4 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.568 1.547 . . . . 0.0 113.712 -174.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.71 -33.43 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.123 0.969 . . . . 0.0 112.291 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -82.58 -42.29 18.48 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.754 0.822 . . . . 0.0 111.711 172.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -64.91 -40.56 95.26 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -174.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -105.95 -10.13 16.76 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -169.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -69.13 116.26 9.37 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 121.096 -1.002 . . . . 0.0 110.542 169.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 93.46 -0.14 67.87 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.817 1.675 . . . . 0.0 114.774 -175.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -80.55 133.98 35.87 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.139 1.375 . . . . 0.0 111.279 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 16.0 p -99.6 126.7 45.64 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.072 -1.643 . . . . 0.0 111.989 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.45 96.84 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.908 0.883 . . . . 0.0 110.058 -171.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 56.84 30.12 17.28 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.279 1.432 . . . . 0.0 113.211 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 178.8 -130.86 1.61 Allowed Glycine 0 C--N 1.342 0.9 0 O-C-N 121.162 -0.961 . . . . 0.0 113.468 -171.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -90.07 178.96 6.05 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.427 0.691 . . . . 0.0 110.562 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 35.2 m -63.6 137.28 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 O-C-N 121.403 -0.811 . . . . 0.0 109.634 162.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 22.7 tp -83.02 118.95 23.87 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.402 1.481 . . . . 0.0 110.181 -175.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -94.43 143.39 26.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.749 0.82 . . . . 0.0 109.721 165.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 19.8 t -136.42 124.9 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.646 1.579 . . . . 0.0 108.418 -171.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -132.75 133.85 43.99 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.545 1.138 . . . . 0.0 111.249 -170.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 34.8 p -83.83 155.95 22.71 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.859 -1.151 . . . . 0.0 111.983 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 85.3 tttt . . . . . 0 CA--C 1.549 0.932 0 O-C-N 121.288 -0.882 . . . . 0.0 111.599 179.544 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 . . . . . 0 CA--C 1.54 0.575 0 N-CA-C 111.335 0.124 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 21.2 m -133.52 156.39 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.605 1.162 . . . . 0.0 110.324 166.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 76.4 mt -106.97 139.17 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 127.276 2.23 . . . . 0.0 107.252 -178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 19.0 m -125.54 118.36 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.317 1.047 . . . . 0.0 108.838 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -143.78 62.41 1.36 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 121.897 0.856 . . . . 0.0 112.33 -151.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -168.21 -25.64 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.533 1.133 . . . . 0.0 113.697 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 23.5 mt -61.13 136.86 94.04 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 125.741 1.616 . . . . 0.0 111.83 175.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -88.52 171.02 5.36 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 124.484 3.456 . . . . 0.0 110.758 173.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -59.98 -5.78 1.11 Allowed 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 6.3 t -59.06 -30.56 68.15 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.824 1.25 . . . . 0.0 112.938 169.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 9.0 p -89.37 123.99 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 170.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -77.92 157.05 29.92 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.724 0.81 . . . . 0.0 110.655 172.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -51.43 -37.72 50.03 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.722 -1.236 . . . . 0.0 113.285 176.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -73.72 -31.09 63.2 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.007 -1.058 . . . . 0.0 112.188 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.85 -32.56 71.02 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.184 -0.947 . . . . 0.0 112.635 167.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 3.1 tt -61.06 -42.44 98.49 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.218 0.917 . . . . 0.0 111.406 169.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -57.17 -46.75 82.52 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 118.785 0.721 . . . . 0.0 110.312 171.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -61.44 -23.1 65.62 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 18.7 mt -51.74 -30.23 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 124.73 1.212 . . . . 0.0 111.83 172.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -116.73 -38.33 3.48 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.275 1.43 . . . . 0.0 110.913 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -5.4 4.43 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.008 1.323 . . . . 0.0 114.142 176.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -55.53 -17.33 5.14 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 120.432 -1.418 . . . . 0.0 113.767 160.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 65.2 m -70.87 -0.72 9.73 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.032 1.333 . . . . 0.0 114.264 168.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 88.31 -58.49 4.18 Favored Glycine 0 N--CA 1.471 1.0 0 C-N-CA 126.589 2.043 . . . . 0.0 111.729 -176.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -70.14 165.21 22.52 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.857 1.263 . . . . 0.0 111.921 175.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.9 p -142.03 142.5 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 120.911 -1.118 . . . . 0.0 112.475 178.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -89.35 -96.01 0.1 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.85 1.26 . . . . 0.0 110.203 167.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -165.31 157.85 15.67 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 127.133 2.173 . . . . 0.0 111.208 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.72 159.61 35.45 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.083 -1.011 . . . . 0.0 113.667 -173.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -161.22 171.67 18.02 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.284 1.434 . . . . 0.0 113.21 -176.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 16.8 m -144.03 160.17 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 128.009 2.523 . . . . 0.0 110.244 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -132.15 99.63 4.78 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.51 0.724 . . . . 0.0 111.428 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.69 170.77 7.74 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.065 1.346 . . . . 0.0 113.338 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -74.85 153.7 38.58 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 122.766 0.426 . . . . 0.0 111.391 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -64.99 -10.84 48.73 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 124.121 0.867 . . . . 0.0 114.873 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 44.5 p30 -74.14 -12.65 60.65 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.859 1.263 . . . . 0.0 114.289 169.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 88.15 12.62 65.32 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 117.226 -1.874 . . . . 0.0 116.613 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 14.6 m -67.73 -17.18 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-N 121.408 2.604 . . . . 0.0 116.297 -172.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 3.7 t 73.54 163.65 0.27 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 126.025 1.73 . . . . 0.0 113.687 -176.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 29.1 p -151.65 136.89 17.52 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.44 1.896 . . . . 0.0 110.089 -171.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -79.98 -35.71 26.93 Favored Glycine 0 N--CA 1.47 0.93 0 O-C-N 123.246 0.341 . . . . 0.0 112.823 173.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 33.9 p -57.05 124.46 18.8 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.057 1.343 . . . . 0.0 111.878 167.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -161.53 -165.83 19.13 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.952 1.263 . . . . 0.0 113.788 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 99.1 m -130.53 138.83 50.4 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.943 1.297 . . . . 0.0 108.656 -175.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 8.4 m -128.45 128.11 67.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 124.442 1.097 . . . . 0.0 109.374 -175.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 36.8 m -79.87 146.93 31.94 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.669 173.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.39 146.89 35.05 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -173.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -49.65 -49.05 48.76 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.148 1.779 . . . . 0.0 112.552 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -172.24 173.31 4.27 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 128.13 2.572 . . . . 0.0 108.466 159.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 15.1 tt -62.27 -24.06 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -177.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.7 -42.69 65.04 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.267 1.427 . . . . 0.0 114.161 168.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -98.32 -20.34 17.25 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -175.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 6.7 tt -60.26 -52.63 64.47 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.838 1.255 . . . . 0.0 111.109 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -73.3 -20.78 60.73 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.017 -1.052 . . . . 0.0 113.247 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -70.66 -44.98 65.95 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.198 0.999 . . . . 0.0 111.682 166.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -73.16 -38.62 66.14 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.783 1.633 . . . . 0.0 113.284 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 2.5 pp -64.09 -22.21 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 121.147 -0.971 . . . . 0.0 113.556 176.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -82.31 -23.23 35.26 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.958 0.903 . . . . 0.0 112.951 169.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -89.44 -47.17 8.18 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.153 1.381 . . . . 0.0 112.968 -175.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -90.56 -30.01 17.5 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -172.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -65.85 118.18 9.31 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 121.245 -0.909 . . . . 0.0 110.28 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 96.69 -1.98 62.04 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.269 0.937 . . . . 0.0 115.265 -173.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -92.16 173.89 7.59 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.05 1.425 . . . . 0.0 111.097 169.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 60.0 p -138.57 129.7 26.99 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 119.83 -1.793 . . . . 0.0 112.395 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 18.9 mt -143.21 116.73 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 124.305 1.042 . . . . 0.0 109.58 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 59.49 18.96 7.39 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 125.633 1.573 . . . . 0.0 114.357 175.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . -177.55 -131.47 1.53 Allowed Glycine 0 CA--C 1.527 0.83 0 O-C-N 120.98 -1.075 . . . . 0.0 114.301 -173.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -94.96 -178.81 4.62 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.448 1.099 . . . . 0.0 110.929 -176.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 10.4 p -61.44 125.52 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 121.513 -0.742 . . . . 0.0 110.714 169.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 88.4 mt -62.9 132.85 53.49 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.174 1.79 . . . . 0.0 111.753 176.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -132.81 120.94 22.24 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.027 1.731 . . . . 0.0 108.19 174.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 15.1 t -129.31 125.38 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.72 1.208 . . . . 0.0 109.915 -160.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -142.94 171.19 14.38 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.447 1.499 . . . . 0.0 111.476 -171.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 90.3 p -145.29 152.75 40.42 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.147 -1.596 . . . . 0.0 112.842 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 62.8 tttm . . . . . 0 CA--C 1.549 0.914 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.501 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 . . . . . 0 CA--C 1.538 0.51 0 CA-C-O 121.415 0.626 . . . . 0.0 111.79 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 35.7 m -132.05 159.94 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 126.262 1.825 . . . . 0.0 110.052 170.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 5.0 mp -124.08 130.67 73.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.184 1.794 . . . . 0.0 106.95 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 29.3 m -99.48 138.11 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 170.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -150.01 78.37 1.34 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.053 0.541 . . . . 0.0 112.281 -165.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -176.71 -34.83 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.227 1.411 . . . . 0.0 113.649 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 74.2 mt -62.99 140.5 97.63 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 125.613 1.565 . . . . 0.0 111.711 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -83.1 177.17 6.84 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 124.8 3.667 . . . . 0.0 112.013 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -57.89 -7.42 0.74 Allowed 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 -176.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 4.0 t -62.65 -31.5 72.39 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.217 -0.927 . . . . 0.0 112.318 170.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 3.7 p -84.05 133.06 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.651 0.739 . . . . 0.0 109.915 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -137.71 167.11 22.37 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.53 1.932 . . . . 0.0 109.144 -176.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -43.74 -50.63 7.6 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -168.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -68.5 -36.17 78.52 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.635 -0.666 . . . . 0.0 111.987 -175.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.83 -38.36 76.5 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.483 -0.761 . . . . 0.0 112.977 169.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 8.1 tt -63.08 -37.41 87.09 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.129 0.972 . . . . 0.0 111.531 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -53.3 -53.5 50.0 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.483 0.713 . . . . 0.0 110.606 168.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -60.93 -25.26 66.66 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.139 1.376 . . . . 0.0 113.672 -173.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 29.8 mt -49.83 -40.32 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 124.351 1.06 . . . . 0.0 111.686 171.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -111.5 -31.63 6.96 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.009 1.323 . . . . 0.0 112.215 -175.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -63.24 -2.99 1.6 Allowed 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.698 1.599 . . . . 0.0 113.493 170.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -51.79 -27.7 13.1 Favored 'General case' 0 CA--C 1.55 0.979 0 O-C-N 120.699 -1.251 . . . . 0.0 112.449 160.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 96.5 m -66.95 -1.69 4.36 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 169.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 86.71 -51.03 4.28 Favored Glycine 0 N--CA 1.473 1.148 0 C-N-CA 126.303 1.906 . . . . 0.0 113.059 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -71.79 169.88 14.79 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.65 1.18 . . . . 0.0 111.16 171.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.0 p -139.88 144.14 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 120.59 -1.319 . . . . 0.0 112.925 174.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -101.01 -108.72 0.22 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.671 1.589 . . . . 0.0 110.608 172.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -158.47 149.42 20.55 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.582 1.553 . . . . 0.0 112.267 -176.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.43 175.42 13.72 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.107 -0.996 . . . . 0.0 112.964 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -154.39 153.62 31.9 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -174.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 50.7 t -158.0 135.82 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 129.055 2.942 . . . . 0.0 106.893 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -132.53 146.43 51.9 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.657 0.783 . . . . 0.0 110.667 171.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 4.7 mt -92.75 142.98 26.75 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.458 0.647 . . . . 0.0 111.587 -171.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -72.73 144.06 47.79 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.967 1.307 . . . . 0.0 111.036 171.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -66.91 -9.98 54.57 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.15 1.357 . . . . 0.0 116.209 -171.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -75.4 -2.13 27.14 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 119.321 1.561 . . . . 0.0 113.045 165.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 86.9 44.49 5.71 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.58 1.562 . . . . 0.0 112.48 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 53.9 t -136.47 129.1 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.384 1.073 . . . . 0.0 110.656 -169.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 22.1 m -81.28 141.14 34.38 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -177.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 67.9 p -78.93 104.49 9.6 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.604 0.762 . . . . 0.0 109.102 171.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -69.82 -36.83 74.97 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 111.952 -0.459 . . . . 0.0 111.952 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 27.4 m -66.46 111.22 3.46 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.148 0.979 . . . . 0.0 110.76 161.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -131.65 165.31 23.36 Favored Glycine 0 N--CA 1.474 1.21 0 C-N-CA 124.765 1.174 . . . . 0.0 114.892 -173.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.74 146.02 24.46 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 126.562 1.945 . . . . 0.0 110.902 178.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -140.68 138.91 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.821 1.648 . . . . 0.0 108.259 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 26.9 t -116.33 132.4 56.68 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.127 0.971 . . . . 0.0 110.888 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.63 156.8 16.85 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 -158.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -55.73 -52.72 62.94 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 113.934 -1.484 . . . . 0.0 111.179 171.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -172.9 170.31 4.57 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 129.061 2.944 . . . . 0.0 108.623 170.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 10.7 tp -57.7 -30.87 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.954 0.901 . . . . 0.0 113.323 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -46.66 78.94 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.831 0.852 . . . . 0.0 113.11 171.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -84.43 -25.04 29.29 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 119.581 -0.247 . . . . 0.0 110.819 -175.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 4.9 tt -60.14 -45.64 92.35 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.845 1.258 . . . . 0.0 109.725 171.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -67.27 -25.54 66.11 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 171.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 21.3 mmm-85 -70.33 -43.1 70.97 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.962 1.255 . . . . 0.0 111.649 166.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -68.84 -38.42 79.81 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.675 1.59 . . . . 0.0 113.073 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 2.6 pp -69.56 -19.94 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 171.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -82.41 -42.59 18.4 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.62 1.168 . . . . 0.0 111.879 170.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -76.51 -53.4 8.14 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -105.62 -19.99 13.6 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -159.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -67.43 113.69 5.5 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 119.269 0.94 . . . . 0.0 109.423 172.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 97.65 -0.26 59.47 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.692 1.615 . . . . 0.0 114.962 -171.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -100.38 149.58 23.49 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.966 1.383 . . . . 0.0 111.472 176.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 23.1 p -113.42 128.29 56.4 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.108 0.963 . . . . 0.0 113.269 -173.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 15.2 mt -147.95 122.65 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.754 1.622 . . . . 0.0 107.943 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 59.18 37.66 23.83 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.364 1.065 . . . . 0.0 113.133 -177.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 140.36 -111.13 0.72 Allowed Glycine 0 N--CA 1.47 0.942 0 C-N-CA 124.449 1.023 . . . . 0.0 114.085 171.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -84.58 177.03 8.23 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.52 0.728 . . . . 0.0 111.008 -170.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 17.9 m -63.77 142.59 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 159.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 3.1 pp -99.52 144.86 28.13 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.74 0.781 . . . . 0.0 111.922 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -105.61 165.58 11.06 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.117 1.767 . . . . 0.0 109.205 162.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 26.6 t -136.16 120.3 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.718 1.607 . . . . 0.0 109.204 -174.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -122.69 170.39 10.1 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.239 1.815 . . . . 0.0 110.841 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 32.2 t -145.19 155.63 43.38 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 120.218 -1.551 . . . . 0.0 112.058 177.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 15.3 tptm . . . . . 0 CA--C 1.552 1.054 0 C-N-CA 125.0 1.32 . . . . 0.0 113.215 179.493 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 . . . . . 0 N--CA 1.47 0.544 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 30.1 m -143.26 164.7 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 126.166 1.787 . . . . 0.0 110.624 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.6 mp -116.97 145.85 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 127.437 2.295 . . . . 0.0 107.446 173.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 19.2 m -118.62 146.19 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.43 1.092 . . . . 0.0 110.488 171.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -150.52 153.63 36.17 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.289 1.036 . . . . 0.0 113.135 -163.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 28.1 t30 83.91 -23.03 0.2 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 128.999 2.919 . . . . 0.0 114.259 176.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 47.8 mt -28.91 116.58 0.28 Allowed Pre-proline 0 CA--C 1.563 1.454 0 C-N-CA 126.495 1.918 . . . . 0.0 111.285 144.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -81.81 -175.52 2.61 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 125.107 3.871 . . . . 0.0 112.95 -173.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -61.92 -12.91 20.36 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 -176.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 16.1 m -85.27 -10.04 56.97 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.96 1.304 . . . . 0.0 114.12 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -108.72 127.43 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 126.704 2.002 . . . . 0.0 109.609 177.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -136.74 -177.26 4.66 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.175 2.19 . . . . 0.0 110.407 -173.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -43.76 -51.15 7.46 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.426 1.49 . . . . 0.0 114.595 -176.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -63.47 -38.04 89.61 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.076 0.853 . . . . 0.0 112.293 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.31 -41.66 73.02 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 170.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 5.8 tt -55.65 -43.31 76.12 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.89 1.276 . . . . 0.0 110.719 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -46.8 -58.46 3.88 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.321 1.049 . . . . 0.0 111.643 171.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -61.19 -24.19 66.14 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.489 1.515 . . . . 0.0 113.293 -175.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 34.9 mt -52.14 -40.41 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 119.861 1.209 . . . . 0.0 111.185 172.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -102.02 -29.58 11.7 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.867 1.267 . . . . 0.0 111.718 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 23.7 tptt -70.16 -18.09 63.2 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.148 1.379 . . . . 0.0 113.553 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -61.07 -18.73 59.45 Favored 'General case' 0 CA--C 1.551 1.011 0 O-C-N 120.323 -1.486 . . . . 0.0 113.281 168.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 10.4 t -66.18 -11.03 47.04 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 124.709 1.203 . . . . 0.0 113.837 171.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 100.45 -8.94 58.85 Favored Glycine 0 N--CA 1.475 1.272 0 C-N-CA 125.973 1.749 . . . . 0.0 114.099 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -138.47 143.12 39.47 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.943 1.697 . . . . 0.0 109.936 172.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.9 p -89.54 141.26 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.176 0.99 . . . . 0.0 111.301 -177.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -83.52 -128.84 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.206 1.402 . . . . 0.0 110.583 170.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -157.64 162.22 38.67 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 127.457 2.303 . . . . 0.0 110.327 169.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -155.43 165.79 35.54 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.936 -1.103 . . . . 0.0 113.651 -170.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -147.69 137.26 22.58 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.609 1.564 . . . . 0.0 111.822 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 22.6 t -154.9 137.76 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.771 2.028 . . . . 0.0 108.375 -174.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -132.49 123.01 25.77 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.09 0.956 . . . . 0.0 110.097 170.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 18.8 mt -89.63 161.73 15.98 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.677 0.791 . . . . 0.0 112.948 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -74.03 139.04 44.46 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.481 1.112 . . . . 0.0 110.728 177.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -68.8 -8.99 58.46 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 116.59 1.396 . . . . 0.0 116.59 -163.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -78.53 -2.07 36.96 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 118.879 1.34 . . . . 0.0 112.791 166.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 89.03 46.63 4.41 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 125.519 1.533 . . . . 0.0 112.133 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.06 128.81 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.508 1.123 . . . . 0.0 110.896 -168.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 51.8 m -61.22 146.34 48.09 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.026 1.73 . . . . 0.0 114.449 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 29.4 p -84.79 -32.02 23.59 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.12 1.368 . . . . 0.0 112.895 172.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 77.78 -60.81 3.73 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.911 1.243 . . . . 0.0 111.433 -171.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 59.3 p -67.3 154.99 40.02 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.16 1.784 . . . . 0.0 113.393 167.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -167.05 171.31 41.81 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.802 1.192 . . . . 0.0 114.773 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 94.8 m -106.85 146.18 31.25 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.833 1.653 . . . . 0.0 110.092 -174.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 1.1 t -134.6 135.0 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.143 1.777 . . . . 0.0 109.292 -175.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 8.2 m -109.39 119.76 40.45 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.17 1.788 . . . . 0.0 108.347 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.45 164.49 25.4 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -157.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -56.09 -47.0 78.84 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.784 173.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -172.39 162.07 5.32 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 129.746 3.218 . . . . 0.0 108.921 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 4.5 mp -62.19 -31.4 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.99 0.916 . . . . 0.0 111.823 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.62 -43.4 62.56 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 177.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -97.91 -14.97 20.36 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -176.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.8 tt -55.41 -51.6 66.32 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.178 1.391 . . . . 0.0 110.828 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -66.91 -29.33 69.18 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 39.1 mtp85 -70.16 -51.05 34.3 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.653 1.181 . . . . 0.0 111.126 170.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -63.07 -32.98 74.48 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.982 1.713 . . . . 0.0 113.524 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -54.83 -39.17 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.213 1.405 . . . . 0.0 112.051 177.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -82.67 -39.19 22.39 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.217 0.607 . . . . 0.0 112.055 174.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -65.51 -49.05 70.41 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -171.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -85.87 -20.84 28.48 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -176.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -67.19 113.69 5.33 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.415 -0.803 . . . . 0.0 110.03 173.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 101.03 0.07 54.86 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.29 0.947 . . . . 0.0 114.864 -173.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -94.21 168.83 10.67 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 118.962 1.381 . . . . 0.0 111.742 172.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 55.3 p -138.22 127.06 23.83 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 120.399 -1.438 . . . . 0.0 112.671 -175.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 22.6 mt -143.53 125.13 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.688 1.195 . . . . 0.0 109.487 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 59.49 20.73 9.16 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.7 1.6 . . . . 0.0 114.217 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 170.78 -118.49 0.75 Allowed Glycine 0 C--N 1.342 0.893 0 O-C-N 121.004 -1.06 . . . . 0.0 114.935 -178.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -96.48 178.13 5.45 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.8 0.84 . . . . 0.0 111.081 -171.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 12.6 p -52.64 137.49 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 O-C-N 121.879 -0.513 . . . . 0.0 109.948 157.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 2.1 pp -112.98 147.53 36.95 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.475 1.11 . . . . 0.0 112.195 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -104.56 157.45 17.16 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.176 1.39 . . . . 0.0 110.475 170.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 16.6 t -133.91 135.64 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.242 1.417 . . . . 0.0 109.313 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -149.29 159.57 44.15 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.819 1.248 . . . . 0.0 111.515 -171.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 23.0 t -144.39 151.7 39.65 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 120.59 -1.319 . . . . 0.0 111.099 172.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt . . . . . 0 N--CA 1.478 0.948 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -174.397 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 35.3 m -134.28 157.72 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.197 0.999 . . . . 0.0 111.454 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 3.8 mp -131.82 140.29 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 126.258 1.823 . . . . 0.0 107.485 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 28.0 m -123.74 125.79 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.796 0.838 . . . . 0.0 109.984 -177.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -142.08 66.84 1.33 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.301 1.44 . . . . 0.0 111.82 -160.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -170.61 -44.67 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.957 1.703 . . . . 0.0 111.069 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 33.1 mt -40.09 119.26 1.45 Allowed Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 126.98 2.112 . . . . 0.0 112.327 165.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -94.06 -174.54 0.39 Allowed 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 124.505 3.47 . . . . 0.0 111.593 -176.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -51.32 -18.23 0.93 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.449 1.9 . . . . 0.0 115.379 177.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 15.8 m -64.68 -21.5 66.75 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.324 1.45 . . . . 0.0 113.879 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 5.4 p -105.72 148.54 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.742 1.217 . . . . 0.0 109.816 169.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -127.26 168.13 15.17 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.171 1.389 . . . . 0.0 111.549 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -54.1 -40.87 67.68 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -167.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -68.98 -37.75 78.94 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.482 -0.761 . . . . 0.0 111.687 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.47 -33.52 73.03 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 171.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 7.2 tt -60.48 -43.39 97.0 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.939 0.79 . . . . 0.0 110.962 172.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.49 -36.44 78.33 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.766 -0.584 . . . . 0.0 111.928 174.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -69.2 -20.06 63.97 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 23.7 mt -54.48 -45.53 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-N 119.604 1.093 . . . . 0.0 112.484 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -103.17 -3.97 25.06 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.662 1.185 . . . . 0.0 112.496 -174.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -61.8 -23.95 66.55 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.818 2.047 . . . . 0.0 115.217 -169.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -76.2 -10.87 59.75 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 14.0 t -79.03 -23.82 44.05 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 174.08 -165.99 37.88 Favored Glycine 0 N--CA 1.473 1.158 0 C-N-CA 124.346 0.974 . . . . 0.0 114.543 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -64.03 105.5 0.88 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.428 1.091 . . . . 0.0 110.087 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 5.3 p -52.94 137.2 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -153.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -73.43 -111.05 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.469 1.508 . . . . 0.0 112.397 -176.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -162.86 161.66 26.04 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.434 1.894 . . . . 0.0 111.091 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.3 168.39 27.14 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.076 -1.015 . . . . 0.0 112.386 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -156.86 153.62 28.52 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.313 1.045 . . . . 0.0 112.118 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 20.1 t -151.66 142.46 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.752 2.021 . . . . 0.0 108.302 -172.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -127.87 152.18 48.15 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.924 0.889 . . . . 0.0 110.861 172.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 15.4 mt -103.62 -157.06 0.59 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.762 1.225 . . . . 0.0 110.655 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -149.9 151.12 32.91 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.026 0.93 . . . . 0.0 111.273 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -63.26 -20.94 63.62 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-O 118.784 -1.009 . . . . 0.0 115.604 -174.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -117.55 -9.8 10.74 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 118.924 1.362 . . . . 0.0 113.962 165.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -70.27 -51.58 21.62 Favored Glycine 0 N--CA 1.47 0.92 0 C-N-CA 124.362 0.982 . . . . 0.0 112.267 169.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 2.8 t 58.94 10.46 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 C-N-CA 127.145 2.178 . . . . 0.0 112.016 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 86.4 p -179.57 153.45 0.56 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 127.94 2.496 . . . . 0.0 110.652 -168.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 5.0 p -152.97 -54.81 0.12 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 125.385 1.474 . . . . 0.0 112.774 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 78.3 -62.9 3.7 Favored Glycine 0 N--CA 1.473 1.111 0 C-N-CA 125.186 1.374 . . . . 0.0 112.023 -176.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 38.3 m -49.48 120.8 4.41 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.73 1.612 . . . . 0.0 112.451 165.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -157.25 -160.82 10.39 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.114 1.34 . . . . 0.0 114.522 -177.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 22.0 p -108.96 145.74 34.97 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.615 1.966 . . . . 0.0 111.149 -173.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.68 127.14 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.915 1.286 . . . . 0.0 109.047 -177.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 19.4 m -85.21 151.84 23.78 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.036 0.934 . . . . 0.0 110.138 171.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.33 157.74 27.51 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 -169.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -57.91 -55.66 32.01 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.608 1.563 . . . . 0.0 111.52 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -172.26 175.35 3.69 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 128.184 2.594 . . . . 0.0 108.975 161.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 74.2 mt -57.05 -35.9 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.241 1.416 . . . . 0.0 111.77 -176.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.39 -50.16 9.34 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.957 1.703 . . . . 0.0 114.874 172.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -95.76 -21.67 18.0 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.333 0.653 . . . . 0.0 112.129 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.0 tt -56.01 -49.4 73.78 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.549 1.14 . . . . 0.0 109.881 170.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -59.87 -33.64 72.08 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -70.51 -53.79 14.8 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.236 0.614 . . . . 0.0 111.267 170.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.52 -37.06 74.85 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.331 1.452 . . . . 0.0 113.602 -176.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.16 -40.17 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.306 1.042 . . . . 0.0 112.071 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -82.54 -38.94 23.04 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.487 0.715 . . . . 0.0 111.776 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -64.46 -47.72 77.94 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.519 1.128 . . . . 0.0 113.403 -173.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -92.54 -18.48 23.08 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -172.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -70.0 116.36 10.28 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.023 -1.048 . . . . 0.0 110.479 175.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 97.72 -5.84 62.29 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.628 1.585 . . . . 0.0 115.139 -174.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -80.09 172.79 13.31 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 118.824 1.312 . . . . 0.0 111.164 170.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 53.8 m -134.56 130.86 37.18 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 120.703 1.592 . . . . 0.0 111.697 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 39.0 mt -145.63 114.62 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.297 1.039 . . . . 0.0 109.159 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 57.1 28.52 15.06 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.439 1.096 . . . . 0.0 113.897 172.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 168.87 -125.52 1.28 Allowed Glycine 0 C--N 1.342 0.909 0 O-C-N 120.825 -1.172 . . . . 0.0 114.33 -177.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -87.35 -178.94 6.3 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.193 0.997 . . . . 0.0 110.824 -176.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 35.1 m -59.87 137.19 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 121.9 -0.5 . . . . 0.0 109.655 161.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 11.1 mp -71.34 128.31 35.47 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.135 1.374 . . . . 0.0 109.476 173.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -106.05 146.28 30.33 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 154.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 14.4 t -136.7 128.76 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.561 1.544 . . . . 0.0 108.938 -172.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -130.03 169.69 14.96 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.77 2.028 . . . . 0.0 110.512 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 32.9 t -138.5 151.66 47.58 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 120.537 -1.352 . . . . 0.0 111.833 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 40.6 tttm . . . . . 0 CA--C 1.552 1.022 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 -168.225 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 120.02 -0.038 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 32.6 m -133.24 147.14 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.142 0.977 . . . . 0.0 111.056 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.7 mp -91.57 141.23 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 126.675 1.99 . . . . 0.0 108.606 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 34.7 m -132.84 129.07 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.577 1.151 . . . . 0.0 109.036 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.3 tptm -150.5 50.46 0.88 Allowed 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 -148.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -160.94 -17.68 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 170.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 39.3 mt -54.35 131.96 61.93 Favored Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 125.713 1.605 . . . . 0.0 111.598 168.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -86.09 169.5 8.75 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.312 3.341 . . . . 0.0 111.276 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -55.81 -10.66 0.78 Allowed 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 6.2 t -59.32 -31.21 68.95 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.696 1.198 . . . . 0.0 113.006 171.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.62 116.33 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 169.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -69.36 153.28 43.85 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.562 0.745 . . . . 0.0 110.097 171.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -55.46 -32.67 62.99 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 120.538 -1.351 . . . . 0.0 113.108 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -69.11 -39.57 78.85 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.021 0.929 . . . . 0.0 111.033 175.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.53 -25.51 64.06 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.078 -1.014 . . . . 0.0 113.065 170.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.74 -49.05 64.63 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.258 0.935 . . . . 0.0 111.343 170.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -25.89 68.25 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 119.762 1.165 . . . . 0.0 111.852 174.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -68.93 -21.66 64.19 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 171.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 30.1 mt -56.97 -51.35 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 CA-C-N 119.696 1.134 . . . . 0.0 111.269 173.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -85.84 -19.55 30.46 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.678 0.791 . . . . 0.0 111.824 -174.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -57.62 -13.98 4.71 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.103 1.761 . . . . 0.0 114.808 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -59.48 -15.32 16.84 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 168.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 83.9 m -68.79 -5.62 21.86 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 168.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.39 -8.58 60.5 Favored Glycine 0 N--CA 1.48 1.575 0 C-N-CA 125.789 1.662 . . . . 0.0 115.666 172.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -138.69 -174.65 3.89 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.823 2.049 . . . . 0.0 108.634 170.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 6.8 p -144.06 144.22 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 121.159 1.799 . . . . 0.0 113.618 172.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -94.81 -121.04 0.1 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.184 1.793 . . . . 0.0 111.189 177.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -143.82 158.55 43.61 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.538 1.935 . . . . 0.0 111.567 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.96 -179.72 8.3 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 120.974 -1.079 . . . . 0.0 113.855 -177.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 8.2 p30 -155.54 173.7 16.32 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.656 1.583 . . . . 0.0 113.781 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 17.2 m -149.92 173.86 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 127.69 2.396 . . . . 0.0 110.075 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -108.22 159.54 16.54 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.674 1.19 . . . . 0.0 111.318 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.3 mp -132.96 134.17 44.15 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.542 1.137 . . . . 0.0 111.347 173.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -66.77 164.27 17.5 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.691 1.196 . . . . 0.0 111.221 165.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -61.97 -19.93 59.5 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.019 0.819 . . . . 0.0 114.669 176.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -79.14 -6.16 55.86 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.917 1.287 . . . . 0.0 113.47 171.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 80.87 14.13 80.12 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.034 1.302 . . . . 0.0 115.135 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 3.7 p -91.11 4.66 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 -165.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 10.9 p 64.87 -179.39 0.18 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 126.992 2.117 . . . . 0.0 116.159 175.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 68.6 p -141.99 156.3 45.45 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 128.368 2.667 . . . . 0.0 108.229 172.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -88.01 -34.31 10.0 Favored Glycine 0 N--CA 1.47 0.947 0 C-N-CA 123.245 0.45 . . . . 0.0 112.203 169.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 18.7 p -56.81 143.04 38.58 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.762 1.625 . . . . 0.0 111.922 163.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 169.55 -153.59 22.09 Favored Glycine 0 N--CA 1.471 0.985 0 C-N-CA 126.172 1.844 . . . . 0.0 112.253 -175.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 17.8 p -125.09 154.97 40.57 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 117.994 0.897 . . . . 0.0 111.357 173.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 13.4 m -123.82 121.96 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 125.222 1.409 . . . . 0.0 107.782 172.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 4.5 m -91.09 120.79 32.34 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.013 1.725 . . . . 0.0 109.356 -175.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.85 157.47 21.99 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -158.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -54.38 -54.03 46.0 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 113.56 -1.655 . . . . 0.0 111.793 172.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -172.68 170.24 4.78 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 129.366 3.067 . . . . 0.0 108.676 171.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 89.5 mt -57.49 -34.32 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 124.864 1.266 . . . . 0.0 112.054 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.14 -40.2 64.07 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.138 1.375 . . . . 0.0 114.433 172.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -89.39 -33.15 16.96 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 119.328 -0.368 . . . . 0.0 110.418 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 6.2 tt -56.64 -52.16 65.94 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.854 1.262 . . . . 0.0 111.378 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -62.3 -47.58 83.66 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.67 -0.644 . . . . 0.0 112.541 -177.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 28.1 ptt85 -70.44 -28.83 65.34 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -74.12 -33.78 63.68 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.502 1.121 . . . . 0.0 112.997 173.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -53.71 -44.04 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.156 1.382 . . . . 0.0 112.3 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -82.75 -17.37 44.47 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -89.07 -48.51 7.36 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.913 0.885 . . . . 0.0 112.671 -171.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -85.32 -21.55 28.89 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -49.8 125.26 11.37 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.885 0.874 . . . . 0.0 110.761 159.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 86.93 0.34 85.74 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 119.141 -0.811 . . . . 0.0 114.757 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -103.69 163.43 12.33 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.139 1.375 . . . . 0.0 112.045 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 34.1 p -138.03 129.35 27.66 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 120.684 -1.26 . . . . 0.0 111.897 -175.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 11.0 mt -146.71 116.86 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.49 1.116 . . . . 0.0 109.104 -177.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 60.86 25.95 15.84 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.695 1.198 . . . . 0.0 112.792 176.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 178.2 -140.01 4.42 Favored Glycine 0 C--N 1.342 0.888 0 O-C-N 120.931 -1.106 . . . . 0.0 114.474 -170.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -91.42 178.26 6.0 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.399 1.08 . . . . 0.0 110.644 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 11.7 p -59.92 129.19 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 O-C-N 121.642 -0.661 . . . . 0.0 109.308 160.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 1.8 pp -104.37 149.09 25.69 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 122.406 1.098 . . . . 0.0 111.533 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -113.37 163.54 14.72 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.017 1.327 . . . . 0.0 110.092 166.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 24.3 t -135.93 130.52 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 126.561 1.945 . . . . 0.0 107.51 -175.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -135.28 133.94 39.41 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.234 1.014 . . . . 0.0 111.46 -173.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 77.3 p -118.0 167.54 11.35 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.186 1.394 . . . . 0.0 112.894 -171.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt . . . . . 0 N--CA 1.474 0.736 0 C-N-CA 125.081 1.352 . . . . 0.0 110.718 175.72 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 34.7 m -132.86 157.43 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.687 1.195 . . . . 0.0 111.109 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.0 mp -125.17 136.91 59.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 127.044 2.137 . . . . 0.0 107.033 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.93 128.89 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.116 0.967 . . . . 0.0 109.427 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 60.2 mmtt -138.76 73.84 1.45 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.034 1.334 . . . . 0.0 110.784 -161.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -179.13 -32.21 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.554 1.942 . . . . 0.0 113.3 -173.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 89.1 mt -74.07 131.35 81.29 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-O 117.917 -1.04 . . . . 0.0 109.834 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -94.83 -168.88 0.16 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 124.272 3.315 . . . . 0.0 110.759 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -55.59 -13.62 1.68 Allowed 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 50.0 m -60.26 -24.19 64.71 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.386 1.474 . . . . 0.0 113.872 170.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.3 p -103.5 144.57 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.43 1.092 . . . . 0.0 109.893 170.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -135.91 173.56 11.58 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.944 1.698 . . . . 0.0 109.775 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -44.35 -51.28 8.65 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.959 1.303 . . . . 0.0 113.777 -170.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -70.07 -40.82 74.8 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.917 -0.49 . . . . 0.0 111.618 -175.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.25 -33.56 73.45 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.789 0.722 . . . . 0.0 112.82 176.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 8.2 tt -63.1 -45.2 93.2 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.98 0.809 . . . . 0.0 110.409 172.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 3.7 tmmm? -60.69 -37.63 82.27 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.864 -0.523 . . . . 0.0 111.161 174.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -63.68 -25.32 68.16 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 176.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 28.1 mt -55.92 -51.37 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 124.112 0.965 . . . . 0.0 110.609 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -89.0 -26.26 21.56 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.666 0.786 . . . . 0.0 112.343 -175.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 2.9 ttpt -52.7 -22.03 4.71 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.292 1.437 . . . . 0.0 114.356 173.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -61.8 -13.75 26.7 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 120.77 -1.206 . . . . 0.0 113.79 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 79.3 m -71.54 -0.37 10.42 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.968 1.307 . . . . 0.0 114.403 167.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.58 -73.57 0.25 Allowed Glycine 0 N--CA 1.471 1.001 0 C-N-CA 126.393 1.949 . . . . 0.0 111.449 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -73.08 172.3 11.3 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.19 0.996 . . . . 0.0 111.136 170.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.29 142.05 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 O-C-N 120.635 -1.29 . . . . 0.0 113.827 172.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -85.36 -125.56 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.733 1.613 . . . . 0.0 111.415 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -152.1 162.0 41.77 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.4 1.48 . . . . 0.0 112.89 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.6 173.72 16.16 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.11 -0.994 . . . . 0.0 113.641 -173.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -154.87 158.42 39.33 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.799 1.24 . . . . 0.0 113.398 -177.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 21.8 m -151.53 163.45 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 127.486 2.314 . . . . 0.0 110.914 -172.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -131.97 167.46 19.61 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.77 1.228 . . . . 0.0 111.84 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 4.0 mp -129.05 152.68 48.39 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.228 1.411 . . . . 0.0 112.203 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -92.84 153.17 19.0 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.066 1.746 . . . . 0.0 111.487 173.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -68.5 -7.08 52.25 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.801 1.191 . . . . 0.0 114.989 -178.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -74.08 -4.77 37.57 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.31 1.444 . . . . 0.0 112.953 168.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 86.45 38.29 8.37 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.035 1.302 . . . . 0.0 113.392 176.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 30.6 m -142.05 148.41 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.678 1.591 . . . . 0.0 111.143 -174.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 75.0 p -81.1 152.74 27.67 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.924 0.89 . . . . 0.0 113.039 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 39.1 p -76.25 -29.4 57.48 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.858 0.863 . . . . 0.0 112.881 176.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 74.49 -64.26 2.16 Favored Glycine 0 N--CA 1.47 0.926 0 C-N-CA 125.724 1.63 . . . . 0.0 112.207 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 58.1 m -55.0 110.61 0.69 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.427 1.891 . . . . 0.0 111.435 166.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -146.67 -160.11 8.61 Favored Glycine 0 N--CA 1.469 0.851 0 C-N-CA 124.695 1.14 . . . . 0.0 113.897 -173.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 98.0 m -114.89 136.67 52.85 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.526 1.53 . . . . 0.0 109.625 -170.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 1.3 t -120.41 120.23 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 125.751 1.621 . . . . 0.0 107.622 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 42.9 m -88.46 108.04 19.18 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.416 1.086 . . . . 0.0 108.426 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -79.6 162.91 25.02 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 -160.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -53.21 -55.58 23.21 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.625 1.17 . . . . 0.0 111.35 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -172.39 178.82 2.69 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.039 2.535 . . . . 0.0 109.007 154.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 16.7 tt -53.51 -33.31 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.101 1.36 . . . . 0.0 113.488 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.69 -42.72 68.28 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.207 1.403 . . . . 0.0 113.956 173.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -95.26 -24.58 16.72 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.5 tt -58.35 -51.97 67.57 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 125.434 1.493 . . . . 0.0 110.221 175.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -62.21 -33.43 74.54 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -70.33 -42.39 71.97 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.695 1.198 . . . . 0.0 112.036 174.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -72.92 -33.55 66.05 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.432 1.493 . . . . 0.0 113.134 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.44 -37.01 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.833 0.853 . . . . 0.0 112.6 -176.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -82.17 -19.59 39.6 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.855 0.862 . . . . 0.0 113.206 175.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -89.01 -46.09 9.13 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.68 1.192 . . . . 0.0 112.645 -175.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -87.71 -30.71 20.14 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -171.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -65.09 118.84 9.75 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 119.011 0.823 . . . . 0.0 110.324 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 103.42 -7.07 50.45 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 125.644 1.592 . . . . 0.0 115.629 -172.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -93.88 142.92 26.82 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 119.451 1.625 . . . . 0.0 111.78 176.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 11.0 p -111.96 126.64 55.35 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.793 1.237 . . . . 0.0 112.234 -174.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -148.58 103.16 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.113 0.965 . . . . 0.0 109.517 -166.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 57.06 35.89 26.96 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 121.932 0.872 . . . . 0.0 111.462 -172.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 163.31 -148.69 15.47 Favored Glycine 0 C--N 1.343 0.952 0 O-C-N 121.152 -0.968 . . . . 0.0 114.787 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -80.93 174.55 11.51 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.804 1.642 . . . . 0.0 111.066 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 32.8 m -63.37 136.18 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 121.213 -0.929 . . . . 0.0 111.301 175.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 14.6 mt -63.41 122.28 15.86 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.674 0.79 . . . . 0.0 113.001 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -106.04 102.37 11.8 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.36 1.864 . . . . 0.0 107.599 160.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.45 131.69 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.286 1.435 . . . . 0.0 109.698 -171.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -130.0 135.13 47.94 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.978 1.311 . . . . 0.0 110.806 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 50.1 p -97.05 159.0 15.16 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.874 -1.141 . . . . 0.0 112.005 175.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 23.6 tptm . . . . . 0 CA--C 1.548 0.866 0 O-C-N 121.286 -0.883 . . . . 0.0 111.079 178.664 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.54 0.576 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 31.3 m -138.59 147.26 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.45 1.5 . . . . 0.0 111.126 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.4 mp -92.05 137.83 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 126.01 1.724 . . . . 0.0 107.683 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 5.4 m -117.75 118.5 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -139.37 44.75 1.97 Allowed 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -148.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -168.51 -6.65 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 116.623 2.083 . . . . 0.0 116.623 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 68.0 mt -69.84 144.17 93.04 Favored Pre-proline 0 CA--C 1.553 1.079 0 O-C-N 120.532 -1.355 . . . . 0.0 110.103 174.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -90.62 -175.24 0.83 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.3 3.333 . . . . 0.0 110.905 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -56.37 -12.47 1.68 Allowed 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 20.4 m -60.48 -31.05 70.1 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.78 1.232 . . . . 0.0 113.266 171.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.6 p -93.73 142.49 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.503 0.721 . . . . 0.0 109.697 172.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -137.26 168.41 19.69 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.004 1.722 . . . . 0.0 109.09 176.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -50.56 -40.92 53.43 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -167.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -68.64 -39.01 80.94 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.761 -0.587 . . . . 0.0 111.895 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.58 -36.25 76.09 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.382 -0.824 . . . . 0.0 112.715 170.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 3.3 tt -61.03 -38.27 85.51 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.189 0.996 . . . . 0.0 112.138 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -57.84 -46.94 84.02 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 121.537 -0.727 . . . . 0.0 110.947 169.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.29 -17.82 64.82 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 29.3 mt -54.41 -33.45 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.344 1.058 . . . . 0.0 111.803 169.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -118.05 -27.7 6.05 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.171 1.389 . . . . 0.0 112.183 -176.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -64.31 -6.66 7.39 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -52.72 -25.29 10.65 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.198 1.399 . . . . 0.0 113.06 167.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 70.8 m -67.66 -5.17 14.52 Favored 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 172.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 97.06 -12.17 65.59 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 126.436 1.969 . . . . 0.0 115.017 175.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -138.67 172.47 12.83 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.394 1.878 . . . . 0.0 109.659 174.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.1 p -145.34 144.35 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 120.341 -1.474 . . . . 0.0 112.318 173.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -72.57 -79.4 0.08 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.473 1.109 . . . . 0.0 112.077 178.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -178.45 147.01 0.39 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 127.947 2.499 . . . . 0.0 109.813 -167.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.59 166.56 31.79 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.11 -0.994 . . . . 0.0 112.658 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -157.46 165.8 34.71 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.898 1.279 . . . . 0.0 112.496 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 22.7 m -146.37 155.4 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 126.838 2.055 . . . . 0.0 110.793 -174.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -132.0 115.21 15.54 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.875 1.27 . . . . 0.0 108.848 174.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 17.2 mt -96.13 169.1 10.19 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.466 1.106 . . . . 0.0 111.376 -173.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -78.16 144.76 36.11 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.009 0.923 . . . . 0.0 112.119 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -68.44 -12.35 63.58 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.88 1.229 . . . . 0.0 115.795 -173.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -80.81 0.01 36.77 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 119.301 1.551 . . . . 0.0 113.22 168.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 85.81 43.35 6.44 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.575 1.083 . . . . 0.0 113.172 175.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.19 148.9 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.08 1.352 . . . . 0.0 111.89 -177.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 58.5 m -77.79 139.32 39.32 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -169.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 7.9 p -89.22 -26.66 21.1 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.69 1.996 . . . . 0.0 113.529 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 80.27 -54.27 4.52 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.103 1.811 . . . . 0.0 113.067 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 23.4 p -52.34 139.75 23.63 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 122.998 1.38 . . . . 0.0 113.28 163.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -161.23 -171.73 27.63 Favored Glycine 0 N--CA 1.468 0.832 0 C-N-CA 124.831 1.205 . . . . 0.0 114.682 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 26.6 p -123.39 122.41 38.22 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.48 1.512 . . . . 0.0 109.493 -176.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 19.6 m -112.58 129.73 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 175.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 5.1 m -87.88 150.03 23.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.709 172.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.74 157.44 19.76 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -165.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -53.82 -52.57 59.92 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.743 1.617 . . . . 0.0 111.88 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -172.66 170.36 4.77 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.351 2.66 . . . . 0.0 108.532 162.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.466 HD13 ' H ' ' A' ' 311' ' ' ILE . 4.3 mp -47.1 -38.23 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 125.121 1.368 . . . . 0.0 112.11 175.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.67 -48.99 19.98 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.878 1.671 . . . . 0.0 115.111 173.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -96.39 -21.44 17.77 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 118.749 -0.643 . . . . 0.0 111.993 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.3 tt -57.87 -52.33 65.91 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.234 1.013 . . . . 0.0 110.191 173.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -68.87 -26.61 65.21 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -70.29 -43.36 70.56 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.043 0.937 . . . . 0.0 111.594 169.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -75.24 -30.6 60.57 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.511 1.525 . . . . 0.0 113.675 -177.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.01 -42.28 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.179 0.991 . . . . 0.0 113.12 -172.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -82.77 -37.79 24.09 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.688 0.795 . . . . 0.0 112.449 175.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -57.46 -38.15 74.01 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.198 -0.939 . . . . 0.0 111.997 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -106.31 28.53 7.65 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.322 1.849 . . . . 0.0 112.616 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -89.94 118.75 29.74 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.421 -1.424 . . . . 0.0 110.866 161.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 84.41 -8.67 67.15 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.975 1.274 . . . . 0.0 115.523 172.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.43 171.55 1.06 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.282 1.833 . . . . 0.0 113.78 168.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 73.4 p -138.52 122.25 17.55 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.077 -1.015 . . . . 0.0 112.048 175.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 13.4 mt -135.54 111.3 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.714 1.206 . . . . 0.0 108.878 177.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 65.09 26.6 12.52 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.359 1.464 . . . . 0.0 112.939 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . -179.07 -131.83 1.65 Allowed Glycine 0 CA--C 1.53 1.014 0 N-CA-C 115.707 1.043 . . . . 0.0 115.707 -176.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -98.61 179.28 4.74 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.481 1.513 . . . . 0.0 111.077 -172.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 30.8 m -60.29 132.28 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 162.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 59.7 tp -126.21 117.16 22.5 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.553 0.741 . . . . 0.0 111.147 -165.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -75.67 148.74 38.45 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.147 160.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 96.6 t -136.89 137.69 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 126.074 1.75 . . . . 0.0 108.998 -176.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -144.13 135.74 25.92 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.994 0.918 . . . . 0.0 111.952 -170.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 82.5 p -89.37 161.74 16.17 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 45.0 tttm . . . . . 0 CA--C 1.557 1.214 0 C-N-CA 124.826 1.25 . . . . 0.0 113.219 -179.826 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 . . . . . 0 N--CA 1.476 0.852 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 12.1 m -133.94 161.46 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 124.976 1.311 . . . . 0.0 110.963 169.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.97 139.57 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 127.343 2.257 . . . . 0.0 108.368 178.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.57 126.6 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.329 1.051 . . . . 0.0 108.961 175.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -140.15 42.5 1.93 Allowed 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -153.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -158.34 -15.31 0.07 Allowed 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 171.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 16.2 mt -52.29 133.47 42.36 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 125.641 1.577 . . . . 0.0 112.969 173.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -88.24 166.55 6.71 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.929 3.753 . . . . 0.0 110.931 172.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -60.32 -12.48 9.23 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -174.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 16.0 m -61.76 -23.47 66.2 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.289 1.036 . . . . 0.0 112.789 171.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.5 p -115.32 131.51 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 126.936 2.094 . . . . 0.0 108.958 167.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -148.5 178.2 8.82 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.109 1.764 . . . . 0.0 109.224 -171.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -38.87 -50.67 1.73 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.284 1.834 . . . . 0.0 115.932 -162.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -67.35 -44.51 78.86 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.234 0.925 . . . . 0.0 111.886 -176.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.84 -32.0 70.17 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 172.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 4.1 tt -58.64 -45.31 89.59 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.257 1.023 . . . . 0.0 109.91 174.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -56.08 -38.3 70.49 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.577 -0.702 . . . . 0.0 112.376 173.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -69.04 -19.95 64.11 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 178.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 29.7 mt -58.19 -30.47 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 124.157 0.983 . . . . 0.0 111.707 170.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -114.19 -26.46 8.03 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.666 1.186 . . . . 0.0 113.434 -175.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 1.8 tmmt? -63.54 -20.73 65.87 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -176.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -75.0 -13.54 60.52 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 171.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 11.2 t -107.08 -33.55 7.43 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.185 1.394 . . . . 0.0 113.301 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -138.03 153.52 22.32 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.843 1.211 . . . . 0.0 114.84 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -69.45 115.25 8.49 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.707 1.203 . . . . 0.0 110.751 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 4.8 p -41.14 132.9 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 -154.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -99.09 -111.76 0.17 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.971 1.708 . . . . 0.0 110.274 174.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 -159.58 155.23 25.91 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.667 1.587 . . . . 0.0 112.456 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.23 171.31 20.44 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.132 -0.98 . . . . 0.0 112.621 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -157.59 165.6 35.1 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.828 1.251 . . . . 0.0 112.814 -173.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 23.1 t -151.01 142.78 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 127.421 2.288 . . . . 0.0 107.387 -177.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -119.52 133.09 55.83 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.224 0.61 . . . . 0.0 110.921 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 11.8 mt -86.34 164.99 16.76 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.981 0.912 . . . . 0.0 111.471 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -64.72 133.33 51.88 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 155.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -67.51 -11.88 60.47 Favored Glycine 0 N--CA 1.475 1.265 0 N-CA-C 117.385 1.714 . . . . 0.0 117.385 -153.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -79.73 0.4 30.7 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 118.556 1.178 . . . . 0.0 112.736 168.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 93.75 33.91 6.83 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 126.356 1.931 . . . . 0.0 113.584 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.32 15.38 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -157.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 21.0 p 73.27 148.0 0.09 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 127.532 2.333 . . . . 0.0 115.484 171.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 11.9 p -159.75 158.05 30.53 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 128.183 2.593 . . . . 0.0 109.022 -177.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -112.82 -50.22 0.56 Allowed Glycine 0 N--CA 1.473 1.137 0 C-N-CA 124.187 0.898 . . . . 0.0 112.844 169.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 69.1 m -44.19 120.82 2.27 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.901 1.68 . . . . 0.0 113.093 170.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -152.01 -168.22 16.05 Favored Glycine 0 N--CA 1.468 0.826 0 C-N-CA 125.047 1.308 . . . . 0.0 114.288 -173.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 30.0 p -122.65 152.75 40.19 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.101 1.76 . . . . 0.0 110.314 -174.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 1.7 t -139.46 126.19 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.353 1.061 . . . . 0.0 108.474 -170.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 19.4 t -92.57 121.0 33.58 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.819 0.847 . . . . 0.0 108.757 172.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.94 155.54 18.65 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -165.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -55.02 -53.83 50.81 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.844 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -172.85 -170.62 0.68 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 128.519 2.728 . . . . 0.0 108.805 145.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.4 mp -55.96 -34.18 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.426 1.49 . . . . 0.0 113.284 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.36 -35.61 60.46 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.293 1.219 . . . . 0.0 114.293 174.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -98.82 -35.57 10.08 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 123.703 0.627 . . . . 0.0 110.127 -173.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.5 tt -51.21 -52.32 45.59 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 126.971 2.108 . . . . 0.0 110.659 174.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -65.15 -25.27 67.67 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 119.13 0.877 . . . . 0.0 113.21 -176.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -70.64 -55.96 7.57 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.917 1.287 . . . . 0.0 110.427 169.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -63.88 -37.2 86.52 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.124 1.37 . . . . 0.0 113.351 -175.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.15 -34.01 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.446 1.098 . . . . 0.0 112.031 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -82.53 -40.82 20.47 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.054 0.942 . . . . 0.0 111.901 173.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.07 -41.69 85.99 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.224 1.01 . . . . 0.0 113.501 -175.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -106.13 -17.53 14.29 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -169.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -66.78 121.05 14.6 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.977 1.262 . . . . 0.0 109.836 168.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 91.41 -1.2 75.89 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 124.193 0.901 . . . . 0.0 114.693 -171.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -97.49 166.75 11.38 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.318 1.447 . . . . 0.0 111.446 175.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 61.7 p -138.43 127.21 23.66 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 120.11 -1.619 . . . . 0.0 112.358 -177.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 16.9 mt -137.47 106.91 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.991 0.917 . . . . 0.0 109.72 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 59.03 25.18 13.54 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.402 1.481 . . . . 0.0 112.996 175.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . -167.29 -140.61 2.94 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.807 1.194 . . . . 0.0 113.808 -169.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -96.2 179.94 4.87 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.891 0.876 . . . . 0.0 111.101 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.53 128.2 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 165.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 16.3 mt -72.37 129.46 38.42 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.042 1.337 . . . . 0.0 112.111 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -112.79 118.84 36.08 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.021 1.728 . . . . 0.0 107.3 163.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 18.0 t -127.25 138.49 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.18 1.392 . . . . 0.0 109.436 -166.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -140.37 139.96 35.44 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.622 1.169 . . . . 0.0 111.521 -177.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 32.4 t -91.15 146.98 23.38 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.27 -0.894 . . . . 0.0 112.594 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 79.8 tttt . . . . . 0 CA--C 1.553 1.066 0 C-N-CA 124.121 0.968 . . . . 0.0 112.877 170.477 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 . . . . . 0 N--CA 1.467 0.406 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.37 149.47 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 126.3 1.84 . . . . 0.0 110.957 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.79 126.41 62.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 126.842 2.057 . . . . 0.0 106.277 172.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 29.5 m -91.44 144.74 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 167.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -144.94 138.21 26.72 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.6 0.76 . . . . 0.0 112.647 -167.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 50.2 t30 96.97 -3.03 0.05 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 129.461 3.104 . . . . 0.0 114.051 175.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 82.6 mt -70.62 133.62 86.68 Favored Pre-proline 0 CA--C 1.556 1.173 0 O-C-N 120.954 -1.091 . . . . 0.0 109.491 165.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -88.95 -168.58 0.35 Allowed 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 124.396 3.397 . . . . 0.0 111.471 -174.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -52.71 -17.09 1.16 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.908 1.683 . . . . 0.0 115.249 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 7.6 t -63.47 -31.25 72.36 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.567 1.147 . . . . 0.0 113.135 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.23 137.32 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 118.712 0.687 . . . . 0.0 110.74 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -145.24 173.0 12.33 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.35 2.26 . . . . 0.0 108.554 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -48.61 -44.38 37.04 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 120.156 1.344 . . . . 0.0 114.135 -166.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -74.7 -23.75 58.65 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -79.85 -37.26 35.37 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.852 1.206 . . . . 0.0 113.166 164.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.48 -48.54 76.91 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.835 0.854 . . . . 0.0 111.044 177.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.28 -30.86 71.43 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.773 -0.579 . . . . 0.0 111.344 -178.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.47 -18.91 63.75 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.011 1.724 . . . . 0.0 114.699 172.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 56.3 mt -56.78 -42.91 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 119.52 1.055 . . . . 0.0 110.27 168.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -104.96 -9.71 17.73 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -173.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -61.95 -8.56 5.32 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -175.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -57.9 -21.07 41.61 Favored 'General case' 0 CA--C 1.55 0.955 0 O-C-N 120.818 -1.176 . . . . 0.0 112.873 168.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 34.2 t -56.87 -21.85 32.52 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.505 1.522 . . . . 0.0 114.074 167.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.1 -17.37 58.16 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 126.907 2.194 . . . . 0.0 113.794 -176.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -139.35 -172.9 3.46 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.624 1.97 . . . . 0.0 109.875 173.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.41 134.56 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 120.544 -1.348 . . . . 0.0 111.294 167.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -74.25 -72.69 0.26 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.591 1.156 . . . . 0.0 112.674 -172.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -159.13 136.54 9.94 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.049 1.74 . . . . 0.0 110.888 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.45 137.89 11.75 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.326 -0.859 . . . . 0.0 112.459 -154.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -162.53 175.37 11.52 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.399 1.48 . . . . 0.0 112.499 -174.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 17.6 m -145.68 167.03 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 126.59 1.956 . . . . 0.0 110.821 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -132.12 148.11 52.46 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.643 1.577 . . . . 0.0 109.684 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.1 mp -134.88 142.05 46.49 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.642 1.177 . . . . 0.0 111.746 -177.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -79.92 179.75 7.41 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.0 0.92 . . . . 0.0 111.072 170.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -67.68 -17.8 69.46 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 121.105 -0.997 . . . . 0.0 114.589 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -88.61 -0.42 57.25 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.184 1.394 . . . . 0.0 113.569 175.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 72.65 25.07 74.99 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.066 0.841 . . . . 0.0 114.238 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 4.8 p -96.18 12.06 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -163.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 22.7 p 59.97 10.85 2.34 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 127.336 2.254 . . . . 0.0 115.132 -176.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . 0.27 1.1 t 50.47 10.07 0.05 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 129.389 3.075 . . . . 0.0 115.752 176.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 86.44 20.23 55.02 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.552 1.548 . . . . 0.0 114.531 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 95.1 p -164.37 167.99 19.08 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 120.103 1.951 . . . . 0.0 116.027 -172.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -153.78 163.6 30.91 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.303 1.906 . . . . 0.0 112.082 173.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 55.1 m -125.71 130.96 52.56 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 118.367 1.083 . . . . 0.0 110.779 -165.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 21.7 t -135.83 123.77 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.789 0.836 . . . . 0.0 109.455 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 66.2 m -104.07 128.26 51.67 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.077 1.351 . . . . 0.0 109.914 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.27 163.38 13.46 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 -141.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -54.21 -51.45 64.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.324 1.45 . . . . 0.0 111.688 175.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -172.86 167.33 5.16 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 128.7 2.8 . . . . 0.0 108.507 164.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.27 -30.62 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.92 0.888 . . . . 0.0 111.306 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.59 -43.7 46.54 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 171.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -95.72 -26.43 15.7 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 118.13 0.423 . . . . 0.0 111.581 -176.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 4.6 tt -53.87 -48.25 70.24 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.507 1.523 . . . . 0.0 109.973 172.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -57.81 -37.57 74.0 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -70.67 -52.43 21.19 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.515 0.726 . . . . 0.0 111.462 171.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -59.64 -34.72 73.15 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.32 1.448 . . . . 0.0 113.452 -175.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.89 -36.81 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.336 1.055 . . . . 0.0 112.382 176.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -83.66 -43.13 15.91 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.753 0.821 . . . . 0.0 112.268 173.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -58.65 -48.51 80.78 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.337 1.455 . . . . 0.0 113.898 -171.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -93.17 -18.51 22.47 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -174.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -73.74 111.89 9.32 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.598 -0.689 . . . . 0.0 110.558 177.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 101.07 -0.05 54.73 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.731 1.157 . . . . 0.0 114.414 -170.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -103.87 173.81 6.14 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.532 1.533 . . . . 0.0 111.446 174.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 30.5 p -138.03 122.94 18.94 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 120.412 -1.43 . . . . 0.0 111.933 -175.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 11.7 mt -145.02 115.09 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.636 1.174 . . . . 0.0 108.34 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 63.95 34.88 11.18 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.27 1.028 . . . . 0.0 112.565 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 167.45 -132.24 2.55 Favored Glycine 0 C--N 1.341 0.823 0 O-C-N 121.305 -0.872 . . . . 0.0 115.24 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -97.75 -174.64 2.95 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.516 1.526 . . . . 0.0 110.215 -173.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 55.1 t -58.76 126.12 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 159.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 2.2 pp -103.85 144.16 31.87 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 122.419 1.104 . . . . 0.0 112.006 -177.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -94.05 158.62 15.53 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.497 1.919 . . . . 0.0 109.931 165.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 26.3 t -136.2 132.03 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.303 1.441 . . . . 0.0 108.567 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -132.2 133.81 44.62 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.307 1.443 . . . . 0.0 109.98 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 78.0 p -94.73 154.4 17.32 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.973 -1.079 . . . . 0.0 112.154 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 84.2 tttt . . . . . 0 CA--C 1.546 0.803 0 C-N-CA 123.864 0.866 . . . . 0.0 110.955 178.378 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 110.801 -0.074 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 29.9 m -135.24 149.97 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 125.15 1.38 . . . . 0.0 111.249 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.74 144.34 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 126.606 1.962 . . . . 0.0 107.848 169.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 17.4 m -138.57 128.63 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.452 1.501 . . . . 0.0 109.432 -177.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -141.3 158.01 44.46 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -159.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 82.35 -26.25 0.14 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 129.847 3.259 . . . . 0.0 113.938 173.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 92.2 mt -28.71 108.67 0.23 Allowed Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 126.664 1.986 . . . . 0.0 111.482 145.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -87.56 -175.64 1.54 Allowed 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.89 3.06 . . . . 0.0 111.692 177.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -56.29 -25.2 47.55 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 16.8 m -67.47 -16.8 64.41 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . 0.262 2.7 p -108.6 85.36 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 126.407 1.883 . . . . 0.0 109.671 176.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -68.19 174.48 3.88 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.877 2.071 . . . . 0.0 113.39 -174.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -54.31 -43.31 71.02 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.85 -1.156 . . . . 0.0 113.573 -177.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -59.5 -45.12 92.61 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.373 0.669 . . . . 0.0 111.388 176.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.37 -32.98 72.39 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 176.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 2.6 tt -62.19 -42.13 98.99 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.299 1.04 . . . . 0.0 111.258 170.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -64.55 -38.67 91.83 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.415 -0.803 . . . . 0.0 111.036 173.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -62.7 -25.21 68.05 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 177.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 30.8 mt -50.34 -51.18 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 124.667 1.187 . . . . 0.0 111.432 175.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -94.33 -29.92 14.78 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.999 0.92 . . . . 0.0 111.19 -176.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -58.35 -20.53 44.32 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -177.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -61.73 -11.42 12.01 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 172.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 7.8 t -65.95 -14.08 60.93 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 124.358 1.063 . . . . 0.0 113.606 168.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.89 -10.1 60.33 Favored Glycine 0 N--CA 1.476 1.363 0 C-N-CA 126.337 1.922 . . . . 0.0 113.718 -177.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 34.5 p-10 -138.63 166.32 24.64 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 128.312 2.645 . . . . 0.0 110.028 173.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.5 p -145.28 140.92 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 120.936 -1.102 . . . . 0.0 111.733 168.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -69.98 -79.61 0.06 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.421 1.088 . . . . 0.0 111.828 -177.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -168.16 149.41 5.11 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 127.433 2.293 . . . . 0.0 110.66 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.14 150.07 21.75 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.95 0.9 . . . . 0.0 112.027 -168.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -170.14 179.84 3.38 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 126.37 1.868 . . . . 0.0 110.731 -176.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -165.21 138.51 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 127.246 2.219 . . . . 0.0 109.78 170.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -76.86 131.25 38.51 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 163.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 14.2 mt -103.25 170.5 7.92 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.633 0.773 . . . . 0.0 112.996 -168.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -51.09 154.67 1.48 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.149 1.779 . . . . 0.0 112.701 165.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -65.41 -15.78 61.86 Favored Glycine 0 CA--C 1.536 1.361 0 N-CA-C 115.983 1.153 . . . . 0.0 115.983 -173.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -88.48 -0.01 56.76 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 119.27 1.535 . . . . 0.0 113.15 169.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.07 21.18 61.47 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.409 1.48 . . . . 0.0 114.566 173.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 63.5 t -86.89 -62.53 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 117.939 0.87 . . . . 0.0 111.938 -167.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 10.3 t -175.05 -174.13 0.74 Allowed 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.051 1.34 . . . . 0.0 111.584 -171.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -161.71 -51.71 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 127.54 2.336 . . . . 0.0 112.106 174.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 87.51 -68.14 3.16 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.807 1.194 . . . . 0.0 112.241 -178.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 34.4 p -61.97 122.54 15.73 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.52 1.128 . . . . 0.0 112.665 172.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -177.54 -141.06 3.95 Favored Glycine 0 N--CA 1.471 1.021 0 C-N-CA 125.41 1.481 . . . . 0.0 113.856 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 8.0 p -130.77 148.81 52.59 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.911 1.685 . . . . 0.0 111.624 -175.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 13.4 m -130.25 147.9 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.004 1.322 . . . . 0.0 110.376 169.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 38.4 m -80.15 155.97 27.2 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.469 169.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.2 159.21 29.13 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 -172.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -58.06 -51.79 68.21 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.781 1.632 . . . . 0.0 112.237 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -172.16 -178.3 2.05 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.8 2.44 . . . . 0.0 109.398 159.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 17.9 tt -56.09 -33.21 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.095 1.358 . . . . 0.0 114.29 -175.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.31 -34.19 72.02 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 175.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.47 -22.2 25.07 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 119.208 -0.425 . . . . 0.0 111.674 -161.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 7.9 mp -50.09 -50.42 48.29 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.636 1.174 . . . . 0.0 109.848 163.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -62.92 -36.05 82.11 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -172.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.34 -51.73 27.86 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.465 1.106 . . . . 0.0 111.839 170.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -67.17 -32.41 73.48 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.48 1.512 . . . . 0.0 113.548 -172.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -62.65 -31.3 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 120.949 -1.094 . . . . 0.0 112.531 -178.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -82.33 -16.16 50.27 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.204 1.002 . . . . 0.0 113.308 174.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -89.0 -42.05 12.0 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.851 1.26 . . . . 0.0 112.438 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -101.48 -21.51 14.75 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -166.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -67.27 115.13 6.59 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 119.145 0.884 . . . . 0.0 110.999 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 91.67 0.3 72.66 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.03 1.3 . . . . 0.0 114.55 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -90.75 130.59 36.72 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.687 1.243 . . . . 0.0 111.23 -178.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 22.5 p -92.26 134.51 34.82 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 120.341 -1.474 . . . . 0.0 113.261 -175.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 49.1 mt -138.16 101.78 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.416 1.087 . . . . 0.0 109.68 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 53.34 38.84 28.79 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.913 1.685 . . . . 0.0 113.224 170.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 168.56 -128.82 1.76 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.017 0.818 . . . . 0.0 112.953 -169.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -90.63 -168.46 2.1 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.62 0.768 . . . . 0.0 110.372 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 34.4 m -68.46 145.89 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 O-C-N 120.896 -1.128 . . . . 0.0 109.587 164.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 42.7 tp -83.84 141.91 31.0 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.281 1.433 . . . . 0.0 109.309 167.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -126.64 154.31 44.17 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.976 0.911 . . . . 0.0 109.376 159.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 41.1 t -136.35 127.94 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.582 1.553 . . . . 0.0 108.838 -169.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -136.04 153.21 51.42 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.901 1.28 . . . . 0.0 112.817 -167.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 89.8 p -82.78 173.97 11.39 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.216 -0.927 . . . . 0.0 112.193 172.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 67.1 mttm . . . . . 0 CA--C 1.552 1.022 0 O-C-N 121.629 -0.669 . . . . 0.0 111.996 157.803 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 . . . . . 0 N--CA 1.47 0.545 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 25.7 m -125.47 154.35 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.183 1.393 . . . . 0.0 110.341 165.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.1 mp -115.1 134.24 58.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.998 1.719 . . . . 0.0 107.434 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 20.5 m -105.78 129.65 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.233 1.013 . . . . 0.0 109.968 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -138.95 64.27 1.48 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.318 1.447 . . . . 0.0 111.257 -162.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -169.12 -40.48 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.179 1.792 . . . . 0.0 113.07 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 48.9 mt -57.19 116.58 14.03 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 127.16 2.184 . . . . 0.0 110.221 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -91.25 -170.17 0.33 Allowed 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 124.669 3.579 . . . . 0.0 112.342 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -56.56 -25.77 53.19 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -175.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 15.7 m -72.81 -16.58 61.61 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.441 1.096 . . . . 0.0 113.958 -177.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 1.3 p -108.34 105.67 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.926 2.09 . . . . 0.0 108.047 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -79.63 168.26 19.62 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.537 1.135 . . . . 0.0 111.912 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.7 -36.29 73.99 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 120.894 -1.129 . . . . 0.0 112.62 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -68.77 -32.93 73.03 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.333 -0.854 . . . . 0.0 112.233 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.53 -39.93 77.22 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.461 -0.781 . . . . 0.0 112.438 170.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 4.2 tt -54.33 -48.3 71.53 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.938 0.895 . . . . 0.0 109.856 170.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.83 -39.85 68.96 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.387 0.675 . . . . 0.0 112.161 175.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -68.88 -20.73 64.27 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 27.5 mt -60.13 -46.96 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 120.04 1.291 . . . . 0.0 112.259 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -98.43 -9.43 25.18 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.188 0.995 . . . . 0.0 113.429 -173.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -71.58 -0.74 11.38 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 128.23 2.612 . . . . 0.0 115.086 -177.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -61.56 -15.42 38.53 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 120.43 -1.419 . . . . 0.0 114.011 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 63.3 m -68.98 -3.35 12.59 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.678 1.591 . . . . 0.0 114.398 172.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 87.25 -52.99 4.39 Favored Glycine 0 N--CA 1.473 1.103 0 C-N-CA 126.074 1.797 . . . . 0.0 111.456 -176.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -72.16 170.23 14.44 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.31 1.044 . . . . 0.0 111.044 162.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.6 p -145.72 146.35 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.03 0.932 . . . . 0.0 111.827 164.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -77.53 -107.72 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.221 1.408 . . . . 0.0 112.158 177.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -158.38 149.25 20.55 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.3 1.84 . . . . 0.0 111.354 -171.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.31 165.65 34.26 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.478 1.111 . . . . 0.0 111.514 177.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -161.34 166.93 26.74 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.113 1.365 . . . . 0.0 111.619 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 14.8 m -145.48 153.82 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 126.516 1.926 . . . . 0.0 110.97 -171.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -106.45 117.63 34.53 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.344 1.057 . . . . 0.0 108.716 170.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 12.9 mt -89.77 160.22 16.65 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.642 0.734 . . . . 0.0 112.497 -175.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -78.77 137.46 37.75 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.753 1.221 . . . . 0.0 110.616 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -70.2 -8.03 61.14 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 116.488 1.355 . . . . 0.0 116.488 -162.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -79.78 -0.43 34.39 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 118.797 1.299 . . . . 0.0 112.699 166.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 88.55 48.48 3.95 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.429 1.49 . . . . 0.0 111.789 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 39.5 t -132.15 140.54 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.377 1.071 . . . . 0.0 110.78 -170.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 22.2 p -65.28 158.01 27.49 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.457 1.503 . . . . 0.0 114.021 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 21.7 p -139.15 -16.82 1.06 Allowed 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -168.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 67.85 -71.8 0.28 Allowed Glycine 0 N--CA 1.476 1.3 0 C-N-CA 126.26 1.886 . . . . 0.0 113.611 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 49.9 p -36.7 126.94 0.87 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.915 2.486 . . . . 0.0 113.881 167.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 176.34 -165.22 35.49 Favored Glycine 0 N--CA 1.471 1.027 0 N-CA-C 115.256 0.862 . . . . 0.0 115.256 -175.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 16.6 p -100.46 137.53 38.75 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.621 1.968 . . . . 0.0 110.893 -174.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.3 t -119.85 119.52 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.626 1.57 . . . . 0.0 107.111 172.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 53.7 m -93.81 110.16 21.82 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.774 1.229 . . . . 0.0 108.208 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.51 158.28 24.54 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -159.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -51.83 -54.17 31.9 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.675 1.19 . . . . 0.0 111.147 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -172.97 169.3 4.74 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 128.641 2.776 . . . . 0.0 109.272 161.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 19.5 tt -54.35 -29.02 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.325 1.05 . . . . 0.0 113.719 177.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.38 -37.91 62.87 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.17 1.388 . . . . 0.0 114.736 171.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -104.49 -20.88 13.56 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 7.0 tt -55.08 -51.55 66.01 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.332 1.453 . . . . 0.0 111.332 177.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -69.02 -24.16 64.16 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 33.6 mtp-105 -70.36 -44.28 68.45 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.135 0.974 . . . . 0.0 110.773 168.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -68.4 -43.26 77.67 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.215 1.406 . . . . 0.0 113.349 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 2.6 pt -70.96 -16.67 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 177.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -82.05 -40.91 21.35 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.84 0.856 . . . . 0.0 110.831 168.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -70.3 -53.74 15.56 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.451 1.1 . . . . 0.0 113.605 -178.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -90.18 -24.26 21.08 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -163.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -62.72 121.53 13.62 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 119.364 0.984 . . . . 0.0 110.244 173.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 101.82 0.32 52.23 Favored Glycine 0 CA--C 1.538 1.499 0 CA-C-O 118.833 -0.982 . . . . 0.0 115.098 -174.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -108.1 145.34 34.21 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.998 1.399 . . . . 0.0 112.032 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 62.1 m -112.59 129.15 56.47 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 120.779 -1.201 . . . . 0.0 111.974 -174.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 55.5 mt -137.33 106.95 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.298 1.039 . . . . 0.0 109.915 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 56.19 33.31 21.87 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.463 1.505 . . . . 0.0 112.95 170.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 171.78 -135.63 3.5 Favored Glycine 0 C--N 1.341 0.843 0 O-C-N 121.122 -0.986 . . . . 0.0 113.94 -168.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -99.8 165.31 11.64 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.164 0.986 . . . . 0.0 110.78 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 9.0 p -60.12 130.09 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.8 0.84 . . . . 0.0 112.771 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 35.9 mt -57.37 127.97 34.65 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.661 1.584 . . . . 0.0 113.923 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -134.02 122.57 23.2 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.527 2.731 . . . . 0.0 107.33 173.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 13.6 t -136.59 126.57 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.726 1.21 . . . . 0.0 109.476 -162.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -135.33 134.05 39.43 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.729 0.812 . . . . 0.0 111.532 -170.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 95.9 p -82.38 155.28 24.79 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.824 -1.173 . . . . 0.0 113.589 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 54.7 tptt . . . . . 0 CA--C 1.555 1.137 0 C-N-CA 125.386 1.474 . . . . 0.0 111.579 178.061 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.541 0.628 0 N-CA-C 111.544 0.201 . . . . 0.0 111.544 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 31.0 m -138.49 153.88 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.568 1.147 . . . . 0.0 110.919 175.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 2.7 mp -103.93 134.32 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 30.7 m -107.36 132.26 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.916 1.286 . . . . 0.0 108.134 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -149.71 55.33 0.95 Allowed 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -154.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -167.58 -24.46 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.337 1.055 . . . . 0.0 113.728 172.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 52.6 mt -47.39 127.02 9.93 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 126.205 1.802 . . . . 0.0 111.311 165.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -82.78 173.28 10.45 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.879 3.053 . . . . 0.0 110.154 172.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -62.61 0.3 0.52 Allowed 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 8.3 t -65.67 -31.11 71.94 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.435 1.094 . . . . 0.0 113.089 171.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 8.0 p -83.24 130.0 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 118.457 0.571 . . . . 0.0 109.801 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -94.08 159.84 14.97 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.753 1.221 . . . . 0.0 111.16 177.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -48.62 -40.88 29.21 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -68.21 -39.35 82.43 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.458 -0.776 . . . . 0.0 111.727 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.42 -32.55 71.59 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.438 -0.789 . . . . 0.0 112.491 172.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 1.9 tt -62.26 -38.96 91.31 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.312 1.045 . . . . 0.0 112.0 171.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -60.5 -48.7 80.62 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.549 -0.719 . . . . 0.0 110.012 171.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -59.7 -24.43 63.96 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.26 1.424 . . . . 0.0 114.171 -175.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 9.1 mt -49.56 -39.86 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 125.117 1.367 . . . . 0.0 111.687 171.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -110.52 -35.19 6.09 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.051 1.34 . . . . 0.0 111.592 -176.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -61.31 -7.17 2.66 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.596 1.558 . . . . 0.0 113.915 174.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -44.95 -31.04 1.14 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.017 1.327 . . . . 0.0 112.955 159.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 83.5 m -64.37 -7.09 8.46 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 176.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 91.18 -3.01 79.74 Favored Glycine 0 N--CA 1.477 1.424 0 C-N-CA 125.678 1.609 . . . . 0.0 114.958 177.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -138.36 178.3 7.24 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.207 2.203 . . . . 0.0 109.496 176.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.11 142.03 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 120.458 -1.402 . . . . 0.0 112.912 177.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -83.65 -106.42 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.256 1.422 . . . . 0.0 110.161 167.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -148.69 147.0 28.39 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.848 1.659 . . . . 0.0 111.834 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.08 148.66 20.58 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.577 1.151 . . . . 0.0 111.628 -176.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -168.27 160.04 11.2 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.843 1.657 . . . . 0.0 110.943 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.68 131.71 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 126.827 2.051 . . . . 0.0 110.271 177.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -75.29 130.33 38.9 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.659 0.783 . . . . 0.0 110.534 167.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 10.4 mt -87.43 153.48 21.4 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.303 0.641 . . . . 0.0 111.392 -178.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -76.81 149.83 36.18 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.867 0.867 . . . . 0.0 112.537 -177.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -67.29 -15.74 66.07 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.801 1.191 . . . . 0.0 115.483 -176.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -81.68 0.16 39.99 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 119.059 1.429 . . . . 0.0 113.193 168.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 85.45 47.35 5.19 Favored Glycine 0 N--CA 1.469 0.889 0 C-N-CA 124.944 1.259 . . . . 0.0 113.402 171.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 35.5 m -137.54 151.18 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.658 1.183 . . . . 0.0 112.24 -176.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 10.9 m -90.04 11.69 19.94 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 -150.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 18.2 p 45.59 80.53 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 127.263 2.225 . . . . 0.0 114.16 167.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -69.36 -47.09 53.67 Favored Glycine 0 N--CA 1.472 1.069 0 O-C-N 121.692 -0.63 . . . . 0.0 113.481 -175.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 5.9 p -60.26 117.69 5.48 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.849 1.259 . . . . 0.0 110.932 164.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -179.13 -160.87 25.7 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.394 0.997 . . . . 0.0 115.336 -173.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 14.2 p -104.77 146.64 28.69 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.152 1.781 . . . . 0.0 112.867 -169.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.71 137.23 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.314 1.446 . . . . 0.0 109.912 169.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 8.7 t -102.29 144.55 30.66 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.86 0.864 . . . . 0.0 110.993 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -104.01 158.76 16.2 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -165.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -57.34 -55.93 28.45 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.145 -1.388 . . . . 0.0 111.152 175.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -172.64 179.78 2.34 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 128.46 2.704 . . . . 0.0 108.521 161.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.23 -25.37 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.637 1.175 . . . . 0.0 112.075 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.18 -33.56 41.28 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 168.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.56 -26.07 9.66 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.315 0.646 . . . . 0.0 112.514 -174.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 6.5 tt -55.05 -49.25 72.07 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.534 1.534 . . . . 0.0 111.041 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -68.82 -30.76 69.38 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.404 -0.81 . . . . 0.0 113.042 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 33.9 mtm180 -69.62 -37.4 76.82 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 121.52 -0.737 . . . . 0.0 111.107 174.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -70.48 -47.89 58.36 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.2 1.4 . . . . 0.0 112.284 174.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 3.5 pt -68.87 -21.65 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -75.38 -31.6 60.54 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 118.822 0.737 . . . . 0.0 112.205 170.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -88.91 -53.1 4.76 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.792 0.837 . . . . 0.0 113.081 -176.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -90.14 -16.98 28.47 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -164.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -71.49 110.2 5.94 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 121.102 -0.999 . . . . 0.0 110.013 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 99.21 0.12 57.14 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 125.193 1.377 . . . . 0.0 114.537 -170.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -98.55 145.67 26.58 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.193 1.397 . . . . 0.0 111.312 175.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 18.7 p -110.19 128.43 55.48 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.25 1.02 . . . . 0.0 113.155 -173.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 18.6 mt -143.9 115.48 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.883 1.273 . . . . 0.0 109.042 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 61.73 25.81 15.6 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.924 1.29 . . . . 0.0 113.449 173.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 173.87 -134.43 2.86 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 120.996 -1.065 . . . . 0.0 114.076 -171.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -86.39 -176.14 5.76 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.824 0.849 . . . . 0.0 109.751 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 19.9 m -58.94 142.84 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 O-C-N 120.981 -1.074 . . . . 0.0 108.687 155.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 3.0 pp -98.43 143.03 29.31 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.773 0.797 . . . . 0.0 111.006 175.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -125.58 137.06 53.9 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.779 1.632 . . . . 0.0 108.953 173.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 12.5 t -118.44 137.19 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.574 1.549 . . . . 0.0 110.026 -165.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -134.81 159.25 41.97 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.755 1.622 . . . . 0.0 112.328 -171.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 35.0 t -114.9 148.25 38.88 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.412 1.085 . . . . 0.0 112.101 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 77.0 tttt . . . . . 0 CA--C 1.554 1.104 0 C-N-CA 124.749 1.22 . . . . 0.0 112.946 172.404 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 . . . . . 0 CA--C 1.54 0.589 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 15.6 m -135.91 156.82 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 125.159 1.384 . . . . 0.0 111.584 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 5.4 mp -116.13 138.32 46.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 126.858 2.063 . . . . 0.0 107.129 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 34.3 m -120.22 129.76 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.28 1.032 . . . . 0.0 109.338 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -146.17 58.5 1.22 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.779 0.8 . . . . 0.0 111.907 -157.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -164.36 -45.14 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.798 1.239 . . . . 0.0 111.471 -176.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 27.7 mt -40.12 117.53 1.32 Allowed Pre-proline 0 CA--C 1.557 1.242 0 C-N-CA 126.099 1.76 . . . . 0.0 111.496 158.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -95.33 -177.95 0.47 Allowed 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.633 3.555 . . . . 0.0 111.703 -176.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -54.44 -14.19 1.16 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.577 1.551 . . . . 0.0 115.16 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 17.1 m -65.91 -21.12 66.42 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.111 1.364 . . . . 0.0 113.987 172.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 8.2 p -101.4 132.84 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 119.428 1.013 . . . . 0.0 110.643 172.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -90.59 157.1 17.68 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.271 1.428 . . . . 0.0 111.373 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -59.59 -31.62 69.63 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 120.478 -1.389 . . . . 0.0 113.213 178.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -68.24 -34.59 76.5 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.282 -0.886 . . . . 0.0 111.042 176.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.94 -38.8 76.27 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 117.733 -1.127 . . . . 0.0 113.098 168.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 3.9 tt -53.37 -51.25 63.11 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.84 1.2 . . . . 0.0 109.883 172.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -48.84 -44.52 39.61 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.138 0.975 . . . . 0.0 111.953 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -68.71 -25.49 64.79 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 21.1 mt -53.32 -45.05 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 124.627 1.171 . . . . 0.0 111.377 176.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -98.09 -34.15 10.88 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.449 1.1 . . . . 0.0 111.627 -175.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -61.17 -10.33 6.35 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.611 1.164 . . . . 0.0 113.803 173.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 15.4 tm-20 -52.23 -24.71 7.69 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.638 1.575 . . . . 0.0 113.484 165.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 87.0 m -63.82 -8.21 10.15 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 172.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 88.8 2.28 78.83 Favored Glycine 0 N--CA 1.479 1.516 0 C-N-CA 124.663 1.125 . . . . 0.0 114.777 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -138.39 -177.92 5.06 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 127.237 2.215 . . . . 0.0 108.227 172.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.6 p -132.01 146.75 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 120.828 1.649 . . . . 0.0 114.063 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -106.48 -120.03 0.24 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.27 1.828 . . . . 0.0 110.821 171.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -161.08 156.69 24.92 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.602 1.961 . . . . 0.0 112.733 -174.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.39 164.85 35.9 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.487 1.115 . . . . 0.0 113.174 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -156.64 160.03 39.01 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.279 1.832 . . . . 0.0 110.995 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 3.5 t -151.63 141.58 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.354 1.462 . . . . 0.0 109.555 -172.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -113.06 134.49 54.5 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.463 1.105 . . . . 0.0 109.515 168.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 13.9 mt -98.69 172.59 7.37 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.182 0.993 . . . . 0.0 113.037 -170.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.25 153.72 0.68 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.094 2.158 . . . . 0.0 113.277 165.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -72.09 -3.92 57.87 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.911 1.243 . . . . 0.0 115.808 -172.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -114.65 0.62 13.97 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 126.267 1.827 . . . . 0.0 111.709 168.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 94.84 8.93 58.93 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 126.345 1.926 . . . . 0.0 114.476 176.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 4.8 t -87.58 58.28 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 118.819 1.31 . . . . 0.0 111.074 -171.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 75.6 m 61.1 -168.08 0.18 Allowed 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 126.325 1.85 . . . . 0.0 114.501 170.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -167.04 -45.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 127.249 2.22 . . . . 0.0 112.276 175.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 82.08 -57.14 4.98 Favored Glycine 0 N--CA 1.472 1.042 0 C-N-CA 125.252 1.406 . . . . 0.0 112.051 -176.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 61.9 p -55.57 111.04 0.8 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.715 1.606 . . . . 0.0 112.459 169.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -139.37 -166.35 10.59 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.008 1.29 . . . . 0.0 113.996 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 93.7 m -115.99 141.63 47.87 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.528 1.931 . . . . 0.0 108.934 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 t -129.9 116.11 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 125.446 1.498 . . . . 0.0 107.412 -173.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 46.2 m -101.52 110.25 22.22 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.223 1.409 . . . . 0.0 108.176 -174.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.28 168.65 12.53 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -151.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -53.68 -65.31 0.59 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.847 1.259 . . . . 0.0 111.024 175.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -172.65 -175.73 1.37 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 129.153 2.981 . . . . 0.0 108.005 162.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 16.3 tt -55.14 -37.03 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -175.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -49.63 67.76 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -92.05 -18.82 23.06 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.439 0.296 . . . . 0.0 110.836 -174.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 57.5 tp -66.25 -47.36 73.97 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.462 0.705 . . . . 0.0 111.093 171.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -68.32 -20.87 64.78 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.342 -0.848 . . . . 0.0 113.037 178.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 35.5 mtp85 -70.61 -54.57 11.51 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.36 1.064 . . . . 0.0 111.621 162.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.03 -43.99 82.48 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.026 1.33 . . . . 0.0 113.752 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 2.6 pp -65.38 -21.35 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 177.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -82.6 -46.32 13.46 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.438 1.095 . . . . 0.0 111.199 172.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -71.57 -47.99 51.32 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -176.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -98.39 -22.26 16.16 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -163.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -67.15 120.47 13.78 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.872 -1.142 . . . . 0.0 110.494 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 92.37 -1.0 72.18 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.071 1.319 . . . . 0.0 114.95 -173.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -98.59 139.76 33.83 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.126 1.463 . . . . 0.0 111.328 177.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 23.7 p -103.15 133.99 47.33 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.136 0.975 . . . . 0.0 113.155 -174.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 56.3 mt -144.17 113.59 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.953 1.301 . . . . 0.0 108.763 -176.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 58.07 25.84 12.87 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.806 1.242 . . . . 0.0 113.832 176.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 166.37 -129.63 1.97 Allowed Glycine 0 C--N 1.342 0.905 0 C-N-CA 124.424 1.012 . . . . 0.0 113.194 -176.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -83.76 177.7 8.25 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.889 0.876 . . . . 0.0 111.099 -177.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 32.9 m -62.69 149.83 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 O-C-N 121.55 -0.718 . . . . 0.0 110.739 166.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 10.9 mt -73.35 137.18 44.59 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.186 0.994 . . . . 0.0 111.489 170.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -125.37 108.48 11.72 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.667 1.587 . . . . 0.0 107.747 167.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.84 120.96 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.27 1.428 . . . . 0.0 109.798 -165.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -139.54 162.5 34.93 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.391 1.477 . . . . 0.0 111.859 -171.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 77.8 p -145.19 159.18 43.39 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 120.869 -1.145 . . . . 0.0 113.078 -176.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? . . . . . 0 CA--C 1.551 1.006 0 C-N-CA 124.393 1.077 . . . . 0.0 111.981 179.378 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 . . . . . 0 CA--C 1.549 0.937 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 16.1 m -137.03 159.76 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.248 1.019 . . . . 0.0 111.069 173.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.4 mp -131.66 141.47 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 127.249 2.22 . . . . 0.0 107.469 -175.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 19.4 m -129.68 133.43 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.834 0.854 . . . . 0.0 111.086 -174.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -148.57 73.23 1.22 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.863 1.265 . . . . 0.0 112.772 -164.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -169.12 -41.68 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.627 1.571 . . . . 0.0 111.237 171.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 49.6 mt -28.17 110.92 0.24 Allowed Pre-proline 0 CA--C 1.561 1.396 0 C-N-CA 127.159 2.183 . . . . 0.0 111.415 153.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -95.64 -170.64 0.18 Allowed 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 125.238 3.959 . . . . 0.0 112.658 -175.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -58.1 -20.25 38.55 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -173.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 58.8 m -76.93 -11.6 59.83 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 176.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 1.4 p -108.51 145.56 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 126.969 2.107 . . . . 0.0 108.227 167.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -155.59 174.63 14.99 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.678 1.591 . . . . 0.0 109.638 -176.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -41.99 -49.41 4.65 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.817 1.647 . . . . 0.0 114.853 -170.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -68.52 -35.71 77.86 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 118.916 0.78 . . . . 0.0 112.18 -175.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.37 -37.75 74.64 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 168.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 7.8 tt -61.79 -35.3 77.77 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.233 0.613 . . . . 0.0 111.727 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -53.03 -52.39 58.63 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.686 0.676 . . . . 0.0 110.641 170.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -59.63 -27.99 66.82 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.041 1.336 . . . . 0.0 113.331 -175.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 32.9 mt -51.7 -45.7 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.782 1.233 . . . . 0.0 112.082 173.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -106.17 -24.6 12.29 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.164 0.986 . . . . 0.0 112.548 -174.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -64.03 -2.93 2.21 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 126.626 1.97 . . . . 0.0 114.713 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -57.82 -20.76 38.22 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 120.567 -1.333 . . . . 0.0 113.307 168.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 72.0 m -69.02 0.32 4.71 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 125.436 1.494 . . . . 0.0 114.451 170.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 100.32 -76.69 0.44 Allowed Glycine 0 C--N 1.342 0.875 0 C-N-CA 126.36 1.933 . . . . 0.0 110.876 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -73.46 175.53 6.91 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.286 1.034 . . . . 0.0 111.173 172.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.01 142.08 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 120.65 -1.281 . . . . 0.0 111.442 172.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -76.95 -96.28 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.749 1.22 . . . . 0.0 111.142 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -160.66 147.07 15.24 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.633 1.573 . . . . 0.0 111.978 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.48 172.01 19.11 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.968 -1.082 . . . . 0.0 112.185 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -158.26 153.22 25.23 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -178.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 27.2 t -157.28 136.25 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 129.476 3.11 . . . . 0.0 105.674 176.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -132.24 144.27 50.51 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.02 0.528 . . . . 0.0 111.892 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 9.1 mp -64.77 144.07 57.5 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.6 1.16 . . . . 0.0 111.755 175.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -69.79 151.41 45.8 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.864 1.266 . . . . 0.0 111.339 169.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -64.86 -11.31 49.85 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.949 1.261 . . . . 0.0 115.348 -176.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -70.49 -6.45 36.19 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 118.782 1.291 . . . . 0.0 113.151 166.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 85.74 49.19 4.42 Favored Glycine 0 C--N 1.343 0.918 0 C-N-CA 125.481 1.515 . . . . 0.0 112.367 176.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 9.5 p -155.13 143.83 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.922 0.889 . . . . 0.0 112.135 -170.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 38.3 t -68.15 170.34 8.72 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.414 1.086 . . . . 0.0 113.209 176.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 12.1 t -144.15 -25.02 0.54 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -173.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 73.98 -48.25 1.67 Allowed Glycine 0 N--CA 1.475 1.246 0 C-N-CA 125.624 1.583 . . . . 0.0 114.589 177.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 7.8 p -51.07 123.12 8.67 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.542 1.937 . . . . 0.0 112.411 168.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -168.74 -168.6 31.04 Favored Glycine 0 N--CA 1.469 0.894 0 C-N-CA 124.075 0.845 . . . . 0.0 115.177 -174.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 18.7 p -115.56 152.54 32.86 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.259 1.824 . . . . 0.0 111.073 -170.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.5 t -138.99 120.53 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.177 1.391 . . . . 0.0 108.095 -177.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 4.5 t -100.12 108.22 20.31 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.398 1.079 . . . . 0.0 108.849 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.25 162.09 22.45 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -158.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -53.91 -63.51 1.13 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.906 1.282 . . . . 0.0 111.052 174.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -172.32 -176.34 1.57 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.995 2.518 . . . . 0.0 109.533 159.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.5 mp -49.11 -39.08 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 125.605 1.562 . . . . 0.0 113.569 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.25 -42.03 66.06 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 177.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -95.21 -31.43 13.5 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 123.321 0.388 . . . . 0.0 110.617 -174.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.5 tt -55.93 -51.32 68.08 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 125.469 1.508 . . . . 0.0 110.755 175.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -61.92 -46.59 88.69 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.056 0.844 . . . . 0.0 112.516 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -70.45 -32.74 70.43 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 176.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -65.87 -38.37 88.61 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.18 0.992 . . . . 0.0 112.045 171.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -57.74 -40.86 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.653 1.181 . . . . 0.0 112.168 176.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -81.99 -24.57 35.38 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -79.27 -45.09 20.42 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.355 1.062 . . . . 0.0 112.959 -177.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -103.68 -26.18 12.86 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -167.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -65.32 116.26 6.46 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 119.682 1.128 . . . . 0.0 110.023 173.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 99.61 0.55 56.58 Favored Glycine 0 CA--C 1.538 1.486 0 CA-C-O 119.101 -0.833 . . . . 0.0 114.962 -174.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -104.27 151.7 23.09 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.795 1.638 . . . . 0.0 111.63 175.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 26.9 p -111.92 134.11 53.69 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 120.433 -1.417 . . . . 0.0 113.09 -177.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 59.3 mt -145.27 118.71 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.898 1.279 . . . . 0.0 109.604 -176.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 57.15 23.27 8.39 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.636 1.574 . . . . 0.0 114.32 173.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 170.17 -119.84 0.83 Allowed Glycine 0 C--N 1.341 0.839 0 O-C-N 120.992 -1.067 . . . . 0.0 113.029 -177.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -86.03 176.66 7.9 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.355 0.662 . . . . 0.0 111.079 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 9.4 p -57.1 138.45 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 121.655 -0.653 . . . . 0.0 109.335 155.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 1.5 pp -100.48 145.03 28.76 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.831 0.824 . . . . 0.0 111.432 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -126.28 137.9 53.55 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.038 1.735 . . . . 0.0 109.374 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 18.5 t -120.54 132.19 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.36 1.464 . . . . 0.0 109.996 -170.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -131.41 154.72 48.36 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.377 1.871 . . . . 0.0 110.652 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 79.3 p -145.14 167.37 22.9 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 120.599 -1.313 . . . . 0.0 112.754 -172.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt . . . . . 0 CA--C 1.547 0.831 0 C-N-CA 123.904 0.882 . . . . 0.0 111.945 176.319 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 . . . . . 0 N--CA 1.469 0.511 0 CA-C-O 121.148 0.499 . . . . 0.0 112.289 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 21.2 t -126.96 140.01 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 127.33 2.252 . . . . 0.0 108.499 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.4 mp -106.79 131.04 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.736 1.614 . . . . 0.0 107.057 175.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 23.0 m -110.59 126.39 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.617 0.767 . . . . 0.0 109.232 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -148.69 59.64 1.07 Allowed 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 121.64 0.733 . . . . 0.0 112.127 -155.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -171.42 -38.26 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 126.116 1.767 . . . . 0.0 111.285 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -34.29 122.52 0.53 Allowed Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 126.637 1.975 . . . . 0.0 111.517 162.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -86.18 167.13 9.39 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.46 3.44 . . . . 0.0 110.671 175.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -60.53 -4.6 0.94 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -174.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 8.3 t -60.58 -31.05 70.2 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.606 1.163 . . . . 0.0 113.205 169.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 8.8 p -79.73 121.63 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 121.639 0.733 . . . . 0.0 111.511 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -79.15 156.68 28.14 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.965 1.306 . . . . 0.0 110.6 170.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -52.04 -37.92 55.28 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 120.804 -1.185 . . . . 0.0 113.087 178.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -71.42 -38.24 71.41 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.502 -0.749 . . . . 0.0 111.354 178.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.98 -26.36 64.99 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.05 -1.031 . . . . 0.0 112.651 171.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 1.8 tt -66.95 -46.93 73.22 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.623 0.769 . . . . 0.0 111.367 170.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -28.56 66.42 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.808 1.186 . . . . 0.0 111.218 177.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -64.99 -23.17 67.14 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.675 1.19 . . . . 0.0 113.258 173.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 41.3 mt -55.02 -51.33 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 119.226 0.921 . . . . 0.0 110.315 171.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -91.09 -18.73 24.06 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.267 1.027 . . . . 0.0 112.508 -173.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -57.17 -17.86 12.98 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.863 1.665 . . . . 0.0 114.146 176.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -57.17 -14.86 4.56 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.343 1.457 . . . . 0.0 114.146 173.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 9.3 t -66.15 -11.38 48.98 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 171.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 91.23 -3.29 79.79 Favored Glycine 0 N--CA 1.479 1.537 0 C-N-CA 125.488 1.518 . . . . 0.0 114.219 -177.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -138.53 -179.6 5.91 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.971 2.509 . . . . 0.0 108.189 171.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 5.0 p -145.78 143.3 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 120.158 1.345 . . . . 0.0 112.68 164.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -78.77 -94.73 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.529 1.532 . . . . 0.0 112.183 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -170.6 153.47 4.18 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 127.717 2.407 . . . . 0.0 110.072 -167.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.56 170.15 22.82 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.156 -0.965 . . . . 0.0 112.626 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -149.65 143.27 25.4 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.43 1.092 . . . . 0.0 113.314 -177.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 32.2 t -158.66 136.82 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 127.498 2.319 . . . . 0.0 107.999 -171.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -132.67 128.06 36.2 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.998 0.919 . . . . 0.0 110.322 170.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 12.1 mt -75.49 167.68 21.45 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 122.206 1.003 . . . . 0.0 113.631 -169.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.96 151.97 0.86 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 127.842 2.457 . . . . 0.0 113.804 167.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -70.9 -6.93 60.99 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.938 1.256 . . . . 0.0 116.082 -172.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -109.72 0.43 18.92 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.101 1.76 . . . . 0.0 111.83 169.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 95.26 8.6 58.66 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.735 2.112 . . . . 0.0 114.393 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 6.2 t -90.19 58.74 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 118.804 1.302 . . . . 0.0 111.019 -166.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 7.6 t 60.36 -163.48 0.24 Allowed 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 125.598 1.559 . . . . 0.0 114.096 172.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -166.47 143.53 5.02 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 129.041 2.937 . . . . 0.0 108.631 173.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -89.11 -76.9 1.3 Allowed Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.148 0.88 . . . . 0.0 112.086 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 32.2 p -54.92 149.34 11.74 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.372 1.469 . . . . 0.0 113.676 169.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -163.32 -177.46 36.26 Favored Glycine 0 N--CA 1.471 1.028 0 C-N-CA 125.045 1.307 . . . . 0.0 114.664 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 40.6 m -116.38 135.3 53.98 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.503 1.521 . . . . 0.0 108.623 -177.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 13.2 m -129.93 130.73 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.066 0.946 . . . . 0.0 109.181 178.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 33.0 m -90.52 115.51 27.72 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.953 0.901 . . . . 0.0 108.715 -175.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -83.59 147.54 27.67 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -163.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -49.78 -55.62 13.38 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.95 1.3 . . . . 0.0 112.573 -175.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.59 172.84 4.15 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.85 2.06 . . . . 0.0 110.039 162.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.42 -24.84 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.3 1.04 . . . . 0.0 112.422 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -45.54 69.72 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 169.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -98.18 -20.04 17.52 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.35 0.523 . . . . 0.0 111.947 -175.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -49.3 -52.15 29.5 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.066 1.747 . . . . 0.0 111.117 174.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -67.32 -29.67 69.3 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -70.49 -52.25 23.32 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.314 0.645 . . . . 0.0 110.888 170.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -59.65 -35.9 75.33 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.276 1.43 . . . . 0.0 113.004 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -50.67 -44.38 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.639 1.176 . . . . 0.0 112.393 176.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -90.39 -34.35 15.68 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 177.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -62.43 -40.08 95.4 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.994 -1.066 . . . . 0.0 113.025 -176.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -92.98 -13.39 28.82 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -62.71 115.28 4.17 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.532 -0.73 . . . . 0.0 110.189 169.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 91.93 0.18 72.01 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-O 118.935 -0.925 . . . . 0.0 114.898 -175.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -103.42 135.54 44.85 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.011 1.405 . . . . 0.0 111.5 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 30.1 p -112.82 133.48 54.79 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.411 1.084 . . . . 0.0 112.563 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -144.0 119.65 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.579 1.151 . . . . 0.0 109.015 -170.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 56.94 28.35 14.54 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.447 1.099 . . . . 0.0 113.44 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 149.18 -119.67 1.08 Allowed Glycine 0 C--N 1.343 0.964 0 C-N-CA 124.433 1.016 . . . . 0.0 113.09 -174.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -89.67 175.32 7.3 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.112 0.965 . . . . 0.0 112.239 -169.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.94 137.06 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.161 0.984 . . . . 0.0 110.014 169.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.56 124.57 24.97 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.726 0.81 . . . . 0.0 111.832 -177.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.5 113.43 24.81 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 158.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 91.4 t -105.83 121.22 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.648 1.179 . . . . 0.0 108.609 177.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -140.98 133.69 28.79 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.239 1.416 . . . . 0.0 110.042 175.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 65.2 p -82.9 166.61 18.76 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.377 -0.827 . . . . 0.0 111.811 173.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 86.1 tttt . . . . . 0 CA--C 1.547 0.863 0 O-C-N 121.244 -0.91 . . . . 0.0 111.001 174.712 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.538 0.507 0 CA-C-O 120.999 0.428 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 65.5 t -151.32 146.35 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 126.642 1.977 . . . . 0.0 108.898 -165.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 2.0 mp -131.29 136.99 56.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.026 1.731 . . . . 0.0 107.835 176.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 31.5 m -120.3 124.64 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.809 1.244 . . . . 0.0 108.797 -176.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -143.85 80.0 1.64 Allowed 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -156.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -172.27 -38.82 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.245 1.818 . . . . 0.0 111.105 169.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 59.0 mt -34.82 123.26 0.56 Allowed Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 128.362 2.665 . . . . 0.0 113.132 167.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -85.44 174.89 6.6 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.102 3.201 . . . . 0.0 111.459 173.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -53.87 -12.73 0.59 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.248 1.819 . . . . 0.0 115.832 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 41.2 t -55.3 -30.99 61.26 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.731 1.612 . . . . 0.0 113.746 171.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 8.8 p -91.57 122.62 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 119.318 0.963 . . . . 0.0 110.712 176.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -84.48 158.4 21.02 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.625 1.57 . . . . 0.0 111.147 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -49.85 -34.51 20.19 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 175.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -67.31 -38.31 84.75 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.97 -1.081 . . . . 0.0 111.04 177.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -76.8 -27.42 55.21 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 173.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 3.7 tp -53.6 -51.58 62.57 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 120.218 1.372 . . . . 0.0 109.491 166.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -55.22 -43.97 74.99 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 122.971 0.508 . . . . 0.0 111.067 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.45 -19.83 62.43 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.056 1.343 . . . . 0.0 114.505 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 66.0 mt -58.73 -29.67 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 119.293 0.951 . . . . 0.0 111.526 171.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -123.27 -23.05 4.96 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.54 1.136 . . . . 0.0 113.716 -175.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -65.97 -12.39 54.63 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.34 1.456 . . . . 0.0 113.892 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -60.51 -12.18 9.04 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 177.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 23.6 p -72.62 -8.62 56.16 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 170.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 93.13 13.37 56.28 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.203 1.382 . . . . 0.0 114.509 -177.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -138.45 176.51 8.63 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.417 1.887 . . . . 0.0 111.116 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 6.8 p -145.47 140.58 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 O-C-N 121.184 -0.948 . . . . 0.0 112.633 168.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -95.06 -99.15 0.16 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.103 1.361 . . . . 0.0 110.295 167.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -160.72 154.5 22.48 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.975 1.71 . . . . 0.0 111.959 176.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.04 149.85 21.73 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.119 -0.988 . . . . 0.0 111.894 -170.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -157.32 165.11 36.7 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.539 1.136 . . . . 0.0 113.881 -174.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 8.1 m -141.02 144.93 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 127.222 2.209 . . . . 0.0 110.525 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -108.94 129.3 55.43 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.471 1.109 . . . . 0.0 109.476 171.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -134.66 171.85 13.77 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.602 1.161 . . . . 0.0 113.098 -171.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -68.88 152.6 45.08 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.956 1.302 . . . . 0.0 113.144 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -70.61 -18.31 75.55 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.616 1.103 . . . . 0.0 115.252 -175.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -88.96 0.25 56.8 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 118.824 1.312 . . . . 0.0 112.67 169.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 92.61 10.77 60.04 Favored Glycine 0 N--CA 1.471 1.019 0 C-N-CA 125.004 1.287 . . . . 0.0 115.008 173.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 57.9 t -70.75 116.06 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 118.386 1.093 . . . . 0.0 108.613 172.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 68.5 p -76.69 177.35 7.62 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.063 1.345 . . . . 0.0 114.555 -170.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 21.0 p -145.28 139.48 27.12 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 127.03 2.132 . . . . 0.0 109.884 -170.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -94.74 -34.99 6.02 Favored Glycine 0 N--CA 1.472 1.045 0 C-N-CA 123.391 0.52 . . . . 0.0 113.822 175.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 17.6 t -55.73 111.96 1.04 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.825 1.25 . . . . 0.0 110.293 167.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -142.89 169.22 25.72 Favored Glycine 0 N--CA 1.471 0.981 0 C-N-CA 124.789 1.185 . . . . 0.0 114.919 -165.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 85.7 m -115.73 141.31 48.26 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.414 1.886 . . . . 0.0 109.086 -173.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.34 113.04 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 124.829 1.252 . . . . 0.0 109.613 -170.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 13.6 t -74.34 147.88 41.83 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 113.911 -1.495 . . . . 0.0 110.159 170.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.72 157.46 19.72 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 -169.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -59.2 -53.9 52.99 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 113.974 -1.466 . . . . 0.0 111.519 176.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -172.67 166.19 5.44 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.814 2.846 . . . . 0.0 108.498 171.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 67.5 mt -60.25 -30.57 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.027 0.931 . . . . 0.0 111.603 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.56 -43.38 45.95 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.935 1.294 . . . . 0.0 114.273 171.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -96.33 -22.34 17.26 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 6.0 tt -58.4 -52.19 66.67 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.708 1.203 . . . . 0.0 110.524 177.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -65.79 -28.88 69.34 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -70.16 -51.65 29.63 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.267 1.027 . . . . 0.0 110.978 172.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -61.73 -33.99 75.03 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.785 1.634 . . . . 0.0 113.191 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -56.92 -41.55 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.817 1.247 . . . . 0.0 112.72 177.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -82.61 -29.24 30.29 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 175.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -75.03 -45.44 41.7 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -171.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -100.26 -16.7 17.63 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -172.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -70.35 118.62 13.39 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.437 -0.789 . . . . 0.0 110.754 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 102.24 0.11 50.77 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.68 1.61 . . . . 0.0 114.726 -176.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -105.47 144.24 32.52 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.941 1.371 . . . . 0.0 112.441 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 67.3 m -94.06 125.6 38.79 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.184 -0.948 . . . . 0.0 112.54 -176.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 46.5 mt -138.32 108.36 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.403 1.081 . . . . 0.0 109.427 176.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 59.48 20.31 8.72 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.77 1.628 . . . . 0.0 114.314 177.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . -168.59 -133.21 1.53 Allowed Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.157 1.36 . . . . 0.0 112.406 -176.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 49.4 p30 -98.01 -172.94 2.47 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.599 1.16 . . . . 0.0 110.282 172.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 20.4 m -58.31 131.38 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-N 119.163 0.892 . . . . 0.0 109.353 172.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 2.4 pp -91.26 138.15 31.81 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 122.378 1.085 . . . . 0.0 111.126 178.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -91.48 156.0 18.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 113.925 -1.489 . . . . 0.0 109.998 166.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 18.6 t -136.93 131.68 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.953 1.701 . . . . 0.0 108.977 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -148.11 143.34 27.07 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.116 1.367 . . . . 0.0 111.366 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 83.5 p -119.09 171.7 8.08 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 120.919 -1.113 . . . . 0.0 112.503 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 52.6 tttm . . . . . 0 CA--C 1.552 1.043 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -164.497 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 . . . . . 0 CA--C 1.551 1.01 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 35.5 m -139.01 152.4 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 120.906 -1.121 . . . . 0.0 110.95 163.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 5.1 mp -118.72 138.84 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 126.024 1.729 . . . . 0.0 108.355 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 20.8 m -112.73 125.57 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.643 1.177 . . . . 0.0 107.95 172.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -142.95 46.47 1.55 Allowed 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -148.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -168.99 -26.36 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 88.1 mt -51.85 144.79 18.51 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 124.338 1.055 . . . . 0.0 111.583 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -79.74 -179.16 5.09 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.497 3.465 . . . . 0.0 111.017 178.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -62.54 -7.49 4.75 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 115.216 1.561 . . . . 0.0 115.216 -176.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 16.4 m -68.96 -17.08 63.89 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.86 1.664 . . . . 0.0 114.589 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 9.9 p -98.98 142.79 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.458 1.103 . . . . 0.0 110.482 175.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -142.53 168.33 19.99 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.722 2.009 . . . . 0.0 110.219 -177.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -46.31 -51.03 15.46 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -171.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -63.59 -36.37 83.59 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.793 0.724 . . . . 0.0 112.226 -178.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.89 -39.95 75.93 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 169.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 6.8 tt -60.06 -35.57 75.44 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.863 0.865 . . . . 0.0 111.698 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -53.79 -52.86 58.94 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.508 0.723 . . . . 0.0 111.306 169.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -62.42 -21.18 65.2 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.605 1.562 . . . . 0.0 113.561 -176.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 28.2 mt -54.9 -29.82 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 124.654 1.182 . . . . 0.0 111.992 171.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -121.29 -27.55 4.84 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.142 1.377 . . . . 0.0 112.577 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.6 -8.93 30.51 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.6 1.56 . . . . 0.0 115.005 -177.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -60.38 -15.48 26.39 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 120.348 -1.47 . . . . 0.0 114.139 172.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 71.3 m -66.37 -5.62 11.43 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 171.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 91.26 5.28 67.65 Favored Glycine 0 N--CA 1.477 1.43 0 C-N-CA 125.35 1.453 . . . . 0.0 114.54 177.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -138.43 179.3 6.55 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.904 2.481 . . . . 0.0 110.719 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.41 144.27 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 121.118 -0.989 . . . . 0.0 112.439 177.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -100.63 -114.0 0.18 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.518 1.527 . . . . 0.0 110.528 172.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -156.59 143.38 18.62 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.645 1.178 . . . . 0.0 113.475 -178.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.3 174.07 15.71 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.594 1.158 . . . . 0.0 112.06 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -159.25 152.0 21.77 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.143 1.377 . . . . 0.0 112.608 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 20.4 t -150.04 140.09 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.225 1.81 . . . . 0.0 108.203 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -132.19 135.75 46.56 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.289 1.035 . . . . 0.0 109.939 173.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 8.7 mt -91.34 158.09 16.74 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.759 0.824 . . . . 0.0 111.705 -169.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -77.86 146.43 35.68 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.706 1.203 . . . . 0.0 112.129 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -66.55 -12.67 59.42 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.095 1.331 . . . . 0.0 115.792 -174.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -74.97 -1.12 21.18 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 119.157 1.478 . . . . 0.0 113.237 166.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 87.85 38.63 7.37 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.094 1.33 . . . . 0.0 113.308 174.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 23.9 m -142.49 143.79 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 125.158 1.383 . . . . 0.0 111.732 -174.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.71 154.46 40.69 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.218 1.007 . . . . 0.0 113.114 -178.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 37.1 p -69.54 -32.14 70.79 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.076 0.951 . . . . 0.0 112.874 173.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 78.29 -61.37 3.86 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.932 1.253 . . . . 0.0 111.641 -176.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 52.2 p -60.07 146.63 42.25 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 122.471 1.129 . . . . 0.0 112.243 161.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -159.37 170.08 35.61 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.569 1.557 . . . . 0.0 113.924 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 99.0 m -119.9 142.49 48.64 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.751 1.62 . . . . 0.0 109.492 -175.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.0 t -133.54 127.62 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.689 1.596 . . . . 0.0 109.059 -170.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 14.9 t -92.92 127.85 38.57 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.916 0.886 . . . . 0.0 109.24 172.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -85.3 163.53 18.55 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -164.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -52.4 -54.44 31.94 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.776 1.23 . . . . 0.0 112.108 175.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -172.35 161.88 5.33 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 129.081 2.952 . . . . 0.0 108.375 170.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.78 -28.01 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.99 0.916 . . . . 0.0 112.02 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.54 -43.44 56.1 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 171.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -102.44 -17.55 15.76 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -176.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 4.1 tt -58.6 -50.66 73.01 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.318 1.047 . . . . 0.0 110.021 174.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -64.98 -28.12 69.3 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 45.4 mtp85 -70.01 -53.33 18.11 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.349 1.06 . . . . 0.0 111.071 169.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -60.02 -36.28 76.9 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.703 1.601 . . . . 0.0 113.264 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -53.34 -46.54 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.826 1.25 . . . . 0.0 112.482 -178.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -85.82 -37.27 19.41 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.168 0.587 . . . . 0.0 112.339 175.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -61.05 -34.42 74.85 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.193 -0.942 . . . . 0.0 113.324 -175.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -97.61 -1.51 43.61 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 175.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -60.03 111.51 1.52 Allowed 'General case' 0 CA--C 1.552 1.038 0 O-C-N 119.576 -1.952 . . . . 0.0 111.891 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 96.44 -0.01 61.36 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.462 1.506 . . . . 0.0 115.499 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.2 169.31 15.38 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 119.137 1.469 . . . . 0.0 114.576 179.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 56.0 p -138.5 124.3 19.86 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.262 1.025 . . . . 0.0 111.833 172.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 10.1 mt -138.28 116.66 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 125.147 1.379 . . . . 0.0 108.77 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 61.98 30.34 17.98 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.42 1.488 . . . . 0.0 113.271 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 173.68 -127.94 1.42 Allowed Glycine 0 C--N 1.342 0.864 0 N-CA-C 115.116 0.806 . . . . 0.0 115.116 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 42.7 p30 -110.27 -177.2 3.19 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.397 1.879 . . . . 0.0 111.376 -171.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 26.6 m -66.12 139.65 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 121.476 -0.765 . . . . 0.0 111.315 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.83 130.22 56.75 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.453 1.501 . . . . 0.0 112.29 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -72.24 154.66 40.88 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.86 148.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 47.1 t -136.45 124.34 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.295 1.438 . . . . 0.0 108.79 -174.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 58.2 mttt -146.28 141.93 27.81 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.613 1.565 . . . . 0.0 111.742 -170.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 30.2 p -89.61 167.34 13.01 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.11 1.364 . . . . 0.0 112.369 173.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 77.9 tttt . . . . . 0 CA--C 1.552 1.023 0 C-N-CA 125.332 1.453 . . . . 0.0 112.351 -173.963 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.913 0 N-CA-C 112.099 -0.4 . . . . 0.0 112.099 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 53.9 p -169.89 152.7 4.52 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.472 1.509 . . . . 0.0 111.403 -175.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 67.99 168.34 0.26 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 127.068 2.147 . . . . 0.0 113.52 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.66 157.87 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 O-C-N 121.257 -0.902 . . . . 0.0 111.495 172.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 3.7 mp -131.86 132.81 61.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 126.166 1.787 . . . . 0.0 107.235 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 36.0 m -104.43 137.27 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.212 1.005 . . . . 0.0 109.254 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -140.15 35.59 1.91 Allowed 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -157.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -160.58 -22.43 0.06 Allowed 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 12.7 mt -47.41 130.67 10.22 Favored Pre-proline 0 CA--C 1.557 1.243 0 O-C-N 120.77 -1.206 . . . . 0.0 111.341 160.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -88.44 170.29 5.66 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 124.82 3.68 . . . . 0.0 111.791 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -61.13 -8.36 3.43 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 9.1 m -68.89 -22.87 64.16 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.474 1.11 . . . . 0.0 113.121 171.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.5 p -108.6 136.69 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 126.882 2.073 . . . . 0.0 109.247 173.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -141.7 174.2 10.79 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.498 1.519 . . . . 0.0 111.447 -167.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -43.48 -50.8 6.95 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -168.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -69.14 -28.47 66.48 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 119.315 0.961 . . . . 0.0 113.014 -175.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -77.48 -40.13 44.06 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 167.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 3.9 tt -53.16 -46.03 68.72 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.993 1.317 . . . . 0.0 109.743 175.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -46.15 -54.17 9.13 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.932 0.893 . . . . 0.0 111.586 172.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -61.75 -27.89 69.05 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.881 1.272 . . . . 0.0 113.891 -175.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 23.8 mt -53.79 -27.38 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 124.587 1.155 . . . . 0.0 112.125 172.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -118.26 -29.46 5.53 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.357 1.463 . . . . 0.0 112.309 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.8 -13.61 62.36 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.571 1.548 . . . . 0.0 113.709 176.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -57.9 -17.74 18.57 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 172.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 75.8 m -71.72 -1.85 15.34 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 173.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 89.11 14.25 60.84 Favored Glycine 0 N--CA 1.476 1.334 0 C-N-CA 124.973 1.273 . . . . 0.0 114.63 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -138.54 -178.82 5.47 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 126.811 2.044 . . . . 0.0 109.755 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.36 147.05 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 120.476 -1.39 . . . . 0.0 112.896 169.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -109.31 -114.5 0.3 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.481 1.513 . . . . 0.0 110.205 169.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -158.44 155.11 27.97 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.174 1.39 . . . . 0.0 113.081 175.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.34 171.52 20.02 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.573 1.149 . . . . 0.0 112.54 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -161.63 168.27 23.73 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.559 1.143 . . . . 0.0 113.197 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 11.7 m -140.66 158.74 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 127.951 2.5 . . . . 0.0 109.52 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -128.1 108.14 10.39 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.517 0.727 . . . . 0.0 110.521 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 8.3 mp -70.44 145.6 50.9 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.945 1.298 . . . . 0.0 111.74 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -65.14 159.11 24.19 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.747 0.819 . . . . 0.0 111.269 164.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -62.81 -17.63 58.36 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 124.333 0.968 . . . . 0.0 115.391 -177.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -81.83 -3.25 53.54 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 118.992 1.396 . . . . 0.0 113.675 170.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 84.07 21.91 56.12 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 125.106 1.336 . . . . 0.0 114.928 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 19.9 m -99.43 -6.1 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 -164.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 4.8 t 66.76 -177.11 0.2 Allowed 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 38.1 p -142.87 -35.46 0.41 Allowed 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -164.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 75.02 -57.63 2.71 Favored Glycine 0 N--CA 1.475 1.256 0 C-N-CA 124.547 1.07 . . . . 0.0 111.936 -168.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 19.2 t -40.74 118.1 0.92 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.397 1.879 . . . . 0.0 111.381 158.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -169.98 177.62 43.26 Favored Glycine 0 N--CA 1.473 1.121 0 C-N-CA 124.722 1.153 . . . . 0.0 115.193 -169.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 25.4 p -106.41 142.06 36.7 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.392 1.877 . . . . 0.0 111.497 -169.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 1.7 t -128.3 121.7 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.398 1.479 . . . . 0.0 108.789 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 42.7 m -93.82 109.82 21.49 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.962 1.305 . . . . 0.0 108.572 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.4 162.1 28.14 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -163.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -51.69 -54.86 23.62 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.42 1.088 . . . . 0.0 111.699 173.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -172.56 163.69 5.41 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 129.139 2.976 . . . . 0.0 108.551 171.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 87.8 mt -58.26 -30.74 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.048 0.939 . . . . 0.0 111.74 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.06 -40.21 57.79 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 172.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -102.25 -20.78 14.52 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.377 0.535 . . . . 0.0 112.365 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -55.08 -52.35 63.5 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.22 1.408 . . . . 0.0 110.381 174.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -64.04 -30.46 71.53 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 32.4 mtp-105 -70.33 -46.67 63.74 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.557 1.143 . . . . 0.0 111.383 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -69.18 -32.08 71.13 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.31 1.444 . . . . 0.0 113.032 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -57.92 -38.96 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.438 1.095 . . . . 0.0 112.418 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -82.49 -18.79 40.37 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -84.23 -45.91 12.39 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.224 1.01 . . . . 0.0 112.572 -177.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -100.94 -21.14 15.16 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.644 1.349 . . . . 0.0 114.644 -170.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -67.33 111.96 4.3 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.386 0.993 . . . . 0.0 109.919 171.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 99.04 0.34 57.29 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 124.59 1.09 . . . . 0.0 114.88 -171.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -94.22 168.1 11.13 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 118.938 1.369 . . . . 0.0 111.668 173.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 45.6 p -138.42 129.2 26.61 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 120.181 -1.575 . . . . 0.0 112.615 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 11.5 mt -144.63 111.3 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 124.308 1.043 . . . . 0.0 110.099 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 63.07 16.77 9.59 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.771 1.628 . . . . 0.0 114.048 173.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . -159.42 -132.84 1.42 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.969 1.271 . . . . 0.0 113.319 -171.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -95.97 -176.55 3.73 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.933 0.893 . . . . 0.0 110.279 176.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 12.1 p -55.39 131.88 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 121.259 -0.9 . . . . 0.0 108.784 152.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 1.2 pp -103.53 143.22 33.01 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.144 0.978 . . . . 0.0 110.687 -176.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -128.36 141.22 51.49 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.623 1.569 . . . . 0.0 109.33 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 17.3 t -126.66 129.88 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.068 1.347 . . . . 0.0 110.174 -164.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -129.14 169.96 14.12 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.061 1.744 . . . . 0.0 110.822 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 94.5 p -138.38 169.43 17.8 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.885 1.274 . . . . 0.0 111.833 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -74.39 -13.0 60.67 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -176.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 61.68 -144.89 0.43 Allowed 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 126.045 1.738 . . . . 0.0 112.357 170.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 9.5 t -165.85 173.79 10.23 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.379 1.872 . . . . 0.0 111.067 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 59.2 t -145.53 122.24 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 126.22 1.808 . . . . 0.0 108.817 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -160.09 2.32 0.08 Allowed 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -171.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -78.81 -22.29 46.45 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -161.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' HIS . . . . . 0.488 ' CG ' ' H ' ' A' ' 343' ' ' SER . 18.6 t60 61.86 -179.25 0.12 Allowed 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 126.327 1.851 . . . . 0.0 114.268 177.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' SER . . . . . 0.488 ' H ' ' CG ' ' A' ' 342' ' ' HIS . 29.4 m -163.23 114.53 1.45 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.478 2.311 . . . . 0.0 108.763 170.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -115.55 0.07 13.2 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.119 1.367 . . . . 0.0 114.244 -166.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 98.09 63.73 0.87 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.171 1.367 . . . . 0.0 110.234 -165.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -98.25 12.37 34.92 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.441 1.496 . . . . 0.0 113.558 -167.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -157.46 164.24 37.65 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.068 2.147 . . . . 0.0 109.875 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 28.4 m -146.7 166.22 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 127.675 2.39 . . . . 0.0 111.489 -170.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -142.65 45.88 1.6 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.913 1.285 . . . . 0.0 111.631 -173.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 40.4 pt -133.12 149.34 72.45 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 126.054 1.742 . . . . 0.0 111.622 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -75.06 163.99 34.13 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.792 2.995 . . . . 0.0 112.048 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 27.4 ttt -157.22 129.47 7.31 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.097 1.359 . . . . 0.0 110.677 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -165.86 168.47 15.85 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.241 1.816 . . . . 0.0 111.015 -176.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -147.34 113.81 5.97 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.565 1.546 . . . . 0.0 110.5 171.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 56.7 p -115.28 148.38 40.65 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 125.59 1.556 . . . . 0.0 112.241 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.19 139.74 39.45 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.213 2.609 . . . . 0.0 110.926 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 13.0 p -165.55 144.14 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.024 1.33 . . . . 0.0 110.648 -174.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 29.0 m120 . . . . . 0 C--O 1.253 1.27 0 C-N-CA 126.166 1.786 . . . . 0.0 111.726 -178.078 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.818 0 CA-C-O 119.267 -0.74 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 15.5 m 76.38 154.73 0.16 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 127.091 2.156 . . . . 0.0 114.296 175.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 68.68 170.92 0.29 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 126.939 2.096 . . . . 0.0 112.494 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 34.2 m -137.37 151.37 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 120.977 -1.077 . . . . 0.0 112.243 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 3.2 mp -102.04 143.68 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 127.865 2.466 . . . . 0.0 108.305 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 18.9 m -126.83 140.38 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 125.695 1.598 . . . . 0.0 108.622 168.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -145.61 24.99 1.36 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -145.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -161.55 -22.54 0.05 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 84.5 mt -47.7 119.37 6.74 Favored Pre-proline 0 CA--C 1.563 1.453 0 C-N-CA 127.023 2.129 . . . . 0.0 111.585 168.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -89.33 -172.71 0.67 Allowed 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 124.986 3.791 . . . . 0.0 113.375 -176.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -54.27 -29.53 47.38 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -173.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 30.6 m -71.09 -18.06 62.56 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.374 -0.829 . . . . 0.0 112.987 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . 0.263 2.4 p -113.6 60.58 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 127.53 2.332 . . . . 0.0 109.948 176.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -62.52 175.6 0.76 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.733 1.613 . . . . 0.0 111.969 176.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -45.63 -42.25 11.13 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.803 1.641 . . . . 0.0 114.952 -174.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -68.72 -40.03 80.12 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.272 0.942 . . . . 0.0 111.696 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.66 -35.73 75.44 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 172.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 2.2 tt -54.74 -51.55 65.29 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.18 0.9 . . . . 0.0 109.229 168.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 4.6 tmmm? -57.2 -35.96 70.26 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.575 0.75 . . . . 0.0 111.905 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -67.57 -23.89 65.45 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 175.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 18.3 mt -58.83 -51.44 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-N 119.38 0.991 . . . . 0.0 110.86 173.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -79.03 -27.5 43.21 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.226 0.61 . . . . 0.0 111.5 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -51.86 -23.27 4.59 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.177 1.391 . . . . 0.0 113.927 173.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -61.59 -13.43 21.87 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 175.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 97.5 m -73.13 -5.58 40.07 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 168.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 96.69 -12.23 66.14 Favored Glycine 0 N--CA 1.476 1.366 0 C-N-CA 126.118 1.818 . . . . 0.0 114.608 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -138.33 172.84 12.3 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.305 2.242 . . . . 0.0 108.98 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 4.8 p -145.3 145.16 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -91.8 -125.39 0.08 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 126.238 1.815 . . . . 0.0 111.807 176.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -153.31 158.01 40.95 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.787 1.635 . . . . 0.0 113.232 -175.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.57 175.96 13.0 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -172.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -159.05 168.19 27.33 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.9 2.08 . . . . 0.0 111.312 176.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 28.7 m -151.01 170.99 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 126.72 2.008 . . . . 0.0 112.722 -171.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -103.71 153.52 20.58 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.489 1.516 . . . . 0.0 112.424 174.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.8 mp -126.71 144.18 51.01 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.115 1.366 . . . . 0.0 111.902 174.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -71.14 160.49 32.77 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.946 0.898 . . . . 0.0 111.304 162.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -66.95 -12.61 60.33 Favored Glycine 0 CA--C 1.534 1.276 0 N-CA-C 115.926 1.13 . . . . 0.0 115.926 -169.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -85.67 -1.36 57.09 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.688 1.195 . . . . 0.0 113.062 172.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.86 15.31 73.18 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.146 1.355 . . . . 0.0 115.131 175.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 97.7 t -81.22 -17.72 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -168.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.4 p 75.98 171.68 0.25 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 127.319 2.248 . . . . 0.0 114.943 176.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 30.3 p -146.26 164.05 33.55 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 127.672 2.389 . . . . 0.0 107.518 172.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -94.7 -16.2 43.24 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.137 0.875 . . . . 0.0 113.862 170.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 8.7 t -55.45 121.7 9.58 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.578 1.151 . . . . 0.0 110.852 166.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 174.86 -160.39 29.43 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.211 0.91 . . . . 0.0 114.46 -171.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 20.1 p -123.55 148.19 46.56 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.845 1.658 . . . . 0.0 110.537 -172.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.9 123.48 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.134 1.774 . . . . 0.0 106.851 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 8.1 t -99.32 110.56 23.06 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.733 1.213 . . . . 0.0 108.255 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.18 165.23 16.71 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -149.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -52.12 -51.57 57.01 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.086 1.354 . . . . 0.0 111.89 174.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -172.55 166.44 5.58 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 129.813 3.245 . . . . 0.0 108.059 171.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.55 -26.82 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 123.863 0.865 . . . . 0.0 111.81 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -30.89 64.85 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 171.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -91.14 -14.48 31.05 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -168.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 10.6 mp -49.52 -49.07 47.48 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.958 0.903 . . . . 0.0 109.311 161.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -61.52 -31.77 71.78 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -172.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -75.21 -56.65 4.52 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.064 1.345 . . . . 0.0 112.039 168.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -65.92 -33.04 74.91 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.967 1.307 . . . . 0.0 114.01 -170.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.18 -27.08 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.594 1.158 . . . . 0.0 111.599 177.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -82.61 -38.82 23.06 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.788 0.835 . . . . 0.0 111.569 170.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -77.32 -41.19 41.56 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -170.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -106.35 -17.33 14.32 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -172.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -54.92 126.24 23.62 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.407 1.003 . . . . 0.0 111.025 167.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 82.77 0.31 90.05 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 119.258 -0.745 . . . . 0.0 114.383 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -97.66 162.59 13.21 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.985 1.314 . . . . 0.0 112.034 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 47.5 p -138.27 128.26 25.53 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.547 1.139 . . . . 0.0 111.468 -176.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 12.2 mt -136.05 112.85 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.038 0.935 . . . . 0.0 109.858 -177.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 56.61 27.54 12.62 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.935 1.694 . . . . 0.0 112.961 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . -176.76 -143.44 4.8 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.428 1.014 . . . . 0.0 113.754 -166.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -93.23 174.96 6.95 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.971 0.908 . . . . 0.0 111.054 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 11.4 p -58.39 141.28 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 121.645 -0.66 . . . . 0.0 110.182 163.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 1.7 pp -122.81 156.26 34.9 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 122.429 1.109 . . . . 0.0 112.804 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -122.83 166.1 15.55 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.707 1.603 . . . . 0.0 110.172 163.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.03 125.64 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 126.824 2.05 . . . . 0.0 107.466 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -141.86 133.7 27.24 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.146 0.578 . . . . 0.0 112.389 -169.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 20.0 p -110.47 153.82 24.51 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.542 1.537 . . . . 0.0 111.997 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -75.82 103.86 6.1 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.208 -0.933 . . . . 0.0 110.908 173.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -166.87 144.42 4.89 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.925 1.69 . . . . 0.0 110.224 -177.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 23.2 t -166.08 153.62 10.18 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.092 0.957 . . . . 0.0 112.217 173.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 14.8 p -170.82 144.88 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 126.93 2.092 . . . . 0.0 109.543 -174.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -155.45 161.79 40.89 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.711 1.204 . . . . 0.0 113.273 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -158.89 137.11 10.64 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.772 1.629 . . . . 0.0 110.664 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -72.56 -31.12 65.0 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -174.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 27.2 t -171.43 143.57 1.83 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.192 1.397 . . . . 0.0 111.837 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -80.0 -10.22 59.75 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.136 0.975 . . . . 0.0 112.866 171.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 88.24 161.19 36.81 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.578 1.561 . . . . 0.0 113.707 -178.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -166.85 138.48 3.38 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.161 1.785 . . . . 0.0 110.731 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -163.59 155.56 17.38 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.999 1.719 . . . . 0.0 110.546 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 10.1 p -170.27 135.42 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 127.977 2.511 . . . . 0.0 109.556 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -156.44 39.64 0.34 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.431 1.093 . . . . 0.0 112.086 -172.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 6.4 pt -129.51 96.9 26.14 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 125.239 1.416 . . . . 0.0 111.529 -172.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -81.36 164.03 19.3 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.895 3.064 . . . . 0.0 111.597 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -157.01 124.62 5.37 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.94 1.296 . . . . 0.0 110.423 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -153.76 146.07 23.9 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.258 1.823 . . . . 0.0 111.226 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -150.53 126.68 10.57 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.036 1.735 . . . . 0.0 109.905 172.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 39.4 m -115.22 146.6 36.71 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 125.018 1.327 . . . . 0.0 111.964 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -72.61 153.45 54.53 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.455 2.77 . . . . 0.0 111.518 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 10.1 p -161.76 143.4 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 125.028 1.331 . . . . 0.0 110.736 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 . . . . . 0 C--O 1.255 1.343 0 C-N-CA 126.83 2.052 . . . . 0.0 112.553 -178.141 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.957 0 CA-C-O 121.029 0.239 . . . . 0.0 112.699 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 18.7 m -169.43 164.27 10.58 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 127.196 2.198 . . . . 0.0 110.155 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -156.75 160.21 39.06 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.042 -1.037 . . . . 0.0 112.923 -171.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 31.1 m -130.99 147.37 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.978 1.711 . . . . 0.0 110.553 173.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.7 mp -97.84 140.91 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 127.461 2.305 . . . . 0.0 107.232 175.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 30.0 m -131.48 120.64 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.608 0.763 . . . . 0.0 110.388 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -147.66 77.93 1.44 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.972 0.909 . . . . 0.0 110.9 -162.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -174.36 -42.21 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 126.383 1.873 . . . . 0.0 110.732 177.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 71.3 mt -34.75 116.97 0.54 Allowed Pre-proline 0 CA--C 1.558 1.271 0 C-N-CA 127.377 2.271 . . . . 0.0 111.582 160.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -89.64 177.92 2.54 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 125.121 3.881 . . . . 0.0 112.641 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -51.36 -26.94 8.54 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 -171.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 5.5 t -76.85 -14.85 59.85 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . 0.259 1.6 p -108.28 79.88 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.938 1.695 . . . . 0.0 108.863 174.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -69.81 179.14 2.32 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.965 2.106 . . . . 0.0 112.546 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -57.05 -37.76 72.27 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 120.6 -1.313 . . . . 0.0 112.689 177.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -65.5 -37.33 86.49 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.239 -0.913 . . . . 0.0 111.321 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -71.12 -38.2 72.31 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 168.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 5.4 tt -53.79 -45.67 70.8 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.819 1.248 . . . . 0.0 110.517 176.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -47.76 -51.77 21.1 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.483 0.713 . . . . 0.0 111.706 172.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -64.99 -22.55 67.02 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -174.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 45.0 mt -55.73 -44.98 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.271 1.028 . . . . 0.0 111.509 171.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -104.89 -22.34 13.17 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.181 0.993 . . . . 0.0 113.047 -173.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -64.93 0.15 1.32 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.426 1.89 . . . . 0.0 115.138 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -55.45 -19.05 8.24 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 120.501 -1.374 . . . . 0.0 113.834 168.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 21.8 t -56.54 -20.48 20.76 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.624 1.57 . . . . 0.0 114.072 169.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 92.3 -7.46 78.12 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.919 1.724 . . . . 0.0 113.454 -173.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -138.46 175.87 9.19 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.362 2.665 . . . . 0.0 109.116 174.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.4 p -145.12 145.24 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 120.705 -1.247 . . . . 0.0 113.136 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -79.44 -104.75 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.656 1.582 . . . . 0.0 111.877 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -152.04 146.03 25.25 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.995 1.718 . . . . 0.0 112.253 -175.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.35 166.83 31.33 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.798 0.839 . . . . 0.0 113.254 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -159.82 172.83 16.94 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.942 1.697 . . . . 0.0 111.153 -177.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 4.2 m -142.32 152.07 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.471 1.909 . . . . 0.0 111.753 -177.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -111.18 99.05 7.96 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.108 0.963 . . . . 0.0 109.765 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 8.9 mt -91.33 160.11 15.66 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.943 0.897 . . . . 0.0 112.074 -172.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -80.7 147.18 30.72 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.437 1.095 . . . . 0.0 112.445 -173.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -67.61 -13.12 62.82 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.0 1.286 . . . . 0.0 115.963 -172.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -82.36 -0.13 44.45 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 119.175 1.487 . . . . 0.0 113.152 169.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.84 61.59 1.93 Allowed Glycine 0 C--N 1.341 0.849 0 C-N-CA 125.132 1.349 . . . . 0.0 112.161 176.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 13.6 p -154.29 146.48 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.36 1.064 . . . . 0.0 111.839 -174.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 26.6 t -62.79 161.45 12.56 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.44 1.096 . . . . 0.0 113.932 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 35.9 p -146.09 -27.24 0.43 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 126.846 2.058 . . . . 0.0 114.082 -169.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 78.46 -41.07 2.04 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 126.545 2.022 . . . . 0.0 114.82 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 5.3 p -50.14 132.89 23.75 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.388 1.875 . . . . 0.0 112.828 166.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -172.59 -159.99 20.25 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 124.49 1.043 . . . . 0.0 115.475 -172.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 46.0 p -137.46 155.01 49.8 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.668 1.587 . . . . 0.0 110.638 -173.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.48 119.2 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.593 1.557 . . . . 0.0 107.44 -176.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 44.1 t -108.9 124.81 51.23 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.677 1.191 . . . . 0.0 109.128 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.18 165.63 12.52 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 -144.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -52.75 -53.9 41.43 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.081 170.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -172.91 168.43 4.95 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 129.01 2.924 . . . . 0.0 108.205 165.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 19.5 tt -57.58 -28.3 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.2 -41.38 68.54 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 172.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -94.48 -28.56 15.4 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.179 0.445 . . . . 0.0 111.44 -176.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.1 tt -52.56 -49.01 65.79 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.526 1.531 . . . . 0.0 110.089 169.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -56.69 -35.35 68.37 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -70.71 -55.98 7.43 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.324 0.65 . . . . 0.0 111.381 169.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.72 -35.26 72.4 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.568 1.547 . . . . 0.0 113.712 -174.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.71 -33.43 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.123 0.969 . . . . 0.0 112.291 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -82.58 -42.29 18.48 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.754 0.822 . . . . 0.0 111.711 172.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -64.91 -40.56 95.26 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -174.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -105.95 -10.13 16.76 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -169.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -69.13 116.26 9.37 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 121.096 -1.002 . . . . 0.0 110.542 169.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 93.46 -0.14 67.87 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.817 1.675 . . . . 0.0 114.774 -175.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -80.55 133.98 35.87 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.139 1.375 . . . . 0.0 111.279 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 16.0 p -99.6 126.7 45.64 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.072 -1.643 . . . . 0.0 111.989 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.45 96.84 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.908 0.883 . . . . 0.0 110.058 -171.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 56.84 30.12 17.28 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.279 1.432 . . . . 0.0 113.211 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 178.8 -130.86 1.61 Allowed Glycine 0 C--N 1.342 0.9 0 O-C-N 121.162 -0.961 . . . . 0.0 113.468 -171.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -90.07 178.96 6.05 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.427 0.691 . . . . 0.0 110.562 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 35.2 m -63.6 137.28 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 O-C-N 121.403 -0.811 . . . . 0.0 109.634 162.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 22.7 tp -83.02 118.95 23.87 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.402 1.481 . . . . 0.0 110.181 -175.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -94.43 143.39 26.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.749 0.82 . . . . 0.0 109.721 165.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 19.8 t -136.42 124.9 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.646 1.579 . . . . 0.0 108.418 -171.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -132.75 133.85 43.99 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.545 1.138 . . . . 0.0 111.249 -170.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 34.8 p -83.83 155.95 22.71 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.859 -1.151 . . . . 0.0 111.983 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -72.42 129.94 39.54 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 121.288 -0.882 . . . . 0.0 111.599 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -72.18 137.49 46.96 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.767 0.827 . . . . 0.0 111.166 176.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 12.8 t -167.41 -169.86 1.32 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.683 1.593 . . . . 0.0 111.151 -177.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 16.3 m -143.27 145.41 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 126.975 2.11 . . . . 0.0 110.041 178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -148.61 151.63 35.35 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.168 1.387 . . . . 0.0 112.654 -171.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -142.73 140.69 31.56 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.917 1.687 . . . . 0.0 110.729 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 30.4 p80 -160.41 168.75 24.51 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.261 1.425 . . . . 0.0 113.224 -173.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 1.4 p 77.89 155.8 0.16 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 128.526 2.73 . . . . 0.0 113.619 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -115.19 -0.34 13.3 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.966 1.306 . . . . 0.0 113.842 -170.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 72.08 -137.97 26.05 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.419 1.009 . . . . 0.0 112.747 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -156.69 135.52 11.74 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.843 1.657 . . . . 0.0 111.146 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -164.46 157.03 16.85 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.843 2.057 . . . . 0.0 109.83 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 12.1 p -165.78 136.15 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 126.933 2.093 . . . . 0.0 110.162 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -166.75 115.1 0.86 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.318 1.847 . . . . 0.0 109.415 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 17.5 tt -69.73 129.69 91.0 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.812 0.845 . . . . 0.0 111.545 -176.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -75.08 158.04 42.11 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.203 2.602 . . . . 0.0 111.693 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 57.6 ttp -159.36 148.14 18.04 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.315 1.446 . . . . 0.0 111.001 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -119.2 146.25 45.35 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.524 1.53 . . . . 0.0 111.433 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -80.32 115.72 20.02 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.602 1.161 . . . . 0.0 111.673 174.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 41.8 p -82.5 153.15 68.06 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 124.925 1.29 . . . . 0.0 112.926 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -72.23 151.71 55.03 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.516 2.811 . . . . 0.0 111.383 177.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 14.6 p -162.79 140.55 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.821 1.249 . . . . 0.0 111.09 -177.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.19 0 C-N-CA 126.007 1.723 . . . . 0.0 110.994 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.895 0 N-CA-C 112.534 -0.227 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 29.1 t -159.71 94.7 1.16 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.643 1.177 . . . . 0.0 110.077 -177.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -166.24 142.91 5.04 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.065 0.946 . . . . 0.0 111.335 -165.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 21.2 m -133.52 156.39 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.605 1.162 . . . . 0.0 110.324 166.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 76.4 mt -106.97 139.17 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 127.276 2.23 . . . . 0.0 107.252 -178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 19.0 m -125.54 118.36 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.317 1.047 . . . . 0.0 108.838 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -143.78 62.41 1.36 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 121.897 0.856 . . . . 0.0 112.33 -151.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -168.21 -25.64 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.533 1.133 . . . . 0.0 113.697 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 23.5 mt -61.13 136.86 94.04 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 125.741 1.616 . . . . 0.0 111.83 175.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -88.52 171.02 5.36 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 124.484 3.456 . . . . 0.0 110.758 173.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -59.98 -5.78 1.11 Allowed 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 6.3 t -59.06 -30.56 68.15 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.824 1.25 . . . . 0.0 112.938 169.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 9.0 p -89.37 123.99 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 170.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -77.92 157.05 29.92 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.724 0.81 . . . . 0.0 110.655 172.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -51.43 -37.72 50.03 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.722 -1.236 . . . . 0.0 113.285 176.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -73.72 -31.09 63.2 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.007 -1.058 . . . . 0.0 112.188 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.85 -32.56 71.02 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.184 -0.947 . . . . 0.0 112.635 167.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 3.1 tt -61.06 -42.44 98.49 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.218 0.917 . . . . 0.0 111.406 169.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -57.17 -46.75 82.52 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 118.785 0.721 . . . . 0.0 110.312 171.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -61.44 -23.1 65.62 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 18.7 mt -51.74 -30.23 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 124.73 1.212 . . . . 0.0 111.83 172.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -116.73 -38.33 3.48 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.275 1.43 . . . . 0.0 110.913 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -5.4 4.43 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.008 1.323 . . . . 0.0 114.142 176.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -55.53 -17.33 5.14 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 120.432 -1.418 . . . . 0.0 113.767 160.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 65.2 m -70.87 -0.72 9.73 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.032 1.333 . . . . 0.0 114.264 168.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 88.31 -58.49 4.18 Favored Glycine 0 N--CA 1.471 1.0 0 C-N-CA 126.589 2.043 . . . . 0.0 111.729 -176.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -70.14 165.21 22.52 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.857 1.263 . . . . 0.0 111.921 175.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.9 p -142.03 142.5 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 120.911 -1.118 . . . . 0.0 112.475 178.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -89.35 -96.01 0.1 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.85 1.26 . . . . 0.0 110.203 167.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -165.31 157.85 15.67 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 127.133 2.173 . . . . 0.0 111.208 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.72 159.61 35.45 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.083 -1.011 . . . . 0.0 113.667 -173.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -161.22 171.67 18.02 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.284 1.434 . . . . 0.0 113.21 -176.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 16.8 m -144.03 160.17 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 128.009 2.523 . . . . 0.0 110.244 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -132.15 99.63 4.78 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.51 0.724 . . . . 0.0 111.428 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.69 170.77 7.74 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.065 1.346 . . . . 0.0 113.338 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -74.85 153.7 38.58 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 122.766 0.426 . . . . 0.0 111.391 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -64.99 -10.84 48.73 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 124.121 0.867 . . . . 0.0 114.873 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 44.5 p30 -74.14 -12.65 60.65 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.859 1.263 . . . . 0.0 114.289 169.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 88.15 12.62 65.32 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 117.226 -1.874 . . . . 0.0 116.613 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 14.6 m -67.73 -17.18 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-N 121.408 2.604 . . . . 0.0 116.297 -172.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 3.7 t 73.54 163.65 0.27 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 126.025 1.73 . . . . 0.0 113.687 -176.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 29.1 p -151.65 136.89 17.52 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.44 1.896 . . . . 0.0 110.089 -171.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -79.98 -35.71 26.93 Favored Glycine 0 N--CA 1.47 0.93 0 O-C-N 123.246 0.341 . . . . 0.0 112.823 173.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 33.9 p -57.05 124.46 18.8 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.057 1.343 . . . . 0.0 111.878 167.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -161.53 -165.83 19.13 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.952 1.263 . . . . 0.0 113.788 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 99.1 m -130.53 138.83 50.4 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.943 1.297 . . . . 0.0 108.656 -175.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 8.4 m -128.45 128.11 67.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 124.442 1.097 . . . . 0.0 109.374 -175.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 36.8 m -79.87 146.93 31.94 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.669 173.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.39 146.89 35.05 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -173.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -49.65 -49.05 48.76 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.148 1.779 . . . . 0.0 112.552 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -172.24 173.31 4.27 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 128.13 2.572 . . . . 0.0 108.466 159.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 15.1 tt -62.27 -24.06 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -177.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.7 -42.69 65.04 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.267 1.427 . . . . 0.0 114.161 168.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -98.32 -20.34 17.25 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -175.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 6.7 tt -60.26 -52.63 64.47 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.838 1.255 . . . . 0.0 111.109 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -73.3 -20.78 60.73 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.017 -1.052 . . . . 0.0 113.247 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -70.66 -44.98 65.95 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.198 0.999 . . . . 0.0 111.682 166.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -73.16 -38.62 66.14 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.783 1.633 . . . . 0.0 113.284 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 2.5 pp -64.09 -22.21 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 121.147 -0.971 . . . . 0.0 113.556 176.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -82.31 -23.23 35.26 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.958 0.903 . . . . 0.0 112.951 169.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -89.44 -47.17 8.18 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.153 1.381 . . . . 0.0 112.968 -175.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -90.56 -30.01 17.5 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -172.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -65.85 118.18 9.31 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 121.245 -0.909 . . . . 0.0 110.28 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 96.69 -1.98 62.04 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.269 0.937 . . . . 0.0 115.265 -173.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -92.16 173.89 7.59 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.05 1.425 . . . . 0.0 111.097 169.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 60.0 p -138.57 129.7 26.99 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 119.83 -1.793 . . . . 0.0 112.395 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 18.9 mt -143.21 116.73 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 124.305 1.042 . . . . 0.0 109.58 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 59.49 18.96 7.39 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 125.633 1.573 . . . . 0.0 114.357 175.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . -177.55 -131.47 1.53 Allowed Glycine 0 CA--C 1.527 0.83 0 O-C-N 120.98 -1.075 . . . . 0.0 114.301 -173.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -94.96 -178.81 4.62 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.448 1.099 . . . . 0.0 110.929 -176.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 10.4 p -61.44 125.52 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 121.513 -0.742 . . . . 0.0 110.714 169.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 88.4 mt -62.9 132.85 53.49 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.174 1.79 . . . . 0.0 111.753 176.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -132.81 120.94 22.24 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.027 1.731 . . . . 0.0 108.19 174.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 15.1 t -129.31 125.38 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.72 1.208 . . . . 0.0 109.915 -160.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -142.94 171.19 14.38 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.447 1.499 . . . . 0.0 111.476 -171.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 90.3 p -145.29 152.75 40.42 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.147 -1.596 . . . . 0.0 112.842 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -78.26 -19.13 54.31 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -142.2 167.81 21.24 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.549 2.34 . . . . 0.0 109.686 175.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 16.9 t -160.04 -170.73 2.96 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.177 1.391 . . . . 0.0 111.379 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 26.2 m -144.49 147.14 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 126.658 1.983 . . . . 0.0 110.701 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -162.87 148.8 12.23 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.36 1.464 . . . . 0.0 112.433 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -158.65 152.26 23.2 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.778 1.631 . . . . 0.0 111.739 175.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -159.33 143.38 15.04 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.328 1.451 . . . . 0.0 112.225 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 19.9 m -155.44 150.05 26.25 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.585 1.554 . . . . 0.0 110.955 -177.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -75.34 -19.12 59.79 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 87.96 170.78 46.31 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.336 1.446 . . . . 0.0 114.464 175.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -164.06 134.12 4.12 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.286 1.835 . . . . 0.0 110.64 -178.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -165.37 162.84 19.8 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.515 1.926 . . . . 0.0 109.957 -177.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 11.8 p -165.24 139.87 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 127.13 2.172 . . . . 0.0 110.318 -177.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -166.03 120.74 1.19 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.483 1.913 . . . . 0.0 109.92 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 7.8 tp -133.46 133.68 22.96 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 125.713 1.605 . . . . 0.0 110.843 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -81.88 174.11 10.53 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.602 2.868 . . . . 0.0 111.897 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 13.0 tpt -153.56 129.3 10.11 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.836 1.254 . . . . 0.0 111.418 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -159.51 8.31 0.11 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.267 2.227 . . . . 0.0 112.18 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -85.92 31.72 0.62 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.422 2.289 . . . . 0.0 113.824 -158.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 25.3 p -63.34 130.24 94.11 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 125.05 1.34 . . . . 0.0 112.348 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.31 156.01 50.95 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.52 2.813 . . . . 0.0 112.162 -176.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 22.1 t 74.49 115.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 127.733 2.413 . . . . 0.0 111.356 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.912 1.685 . . . . 0.0 112.07 -178.024 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.797 0 N-CA-C 112.127 -0.389 . . . . 0.0 112.127 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 59.0 p -143.26 17.98 1.9 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.678 1.191 . . . . 0.0 113.211 -174.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -148.38 141.44 24.91 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.993 -1.067 . . . . 0.0 111.79 -169.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 35.7 m -132.05 159.94 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 126.262 1.825 . . . . 0.0 110.052 170.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 5.0 mp -124.08 130.67 73.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.184 1.794 . . . . 0.0 106.95 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 29.3 m -99.48 138.11 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 170.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -150.01 78.37 1.34 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.053 0.541 . . . . 0.0 112.281 -165.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -176.71 -34.83 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.227 1.411 . . . . 0.0 113.649 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 74.2 mt -62.99 140.5 97.63 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 125.613 1.565 . . . . 0.0 111.711 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -83.1 177.17 6.84 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 124.8 3.667 . . . . 0.0 112.013 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -57.89 -7.42 0.74 Allowed 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 -176.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 4.0 t -62.65 -31.5 72.39 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.217 -0.927 . . . . 0.0 112.318 170.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 3.7 p -84.05 133.06 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.651 0.739 . . . . 0.0 109.915 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -137.71 167.11 22.37 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.53 1.932 . . . . 0.0 109.144 -176.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -43.74 -50.63 7.6 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -168.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -68.5 -36.17 78.52 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.635 -0.666 . . . . 0.0 111.987 -175.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.83 -38.36 76.5 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.483 -0.761 . . . . 0.0 112.977 169.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 8.1 tt -63.08 -37.41 87.09 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.129 0.972 . . . . 0.0 111.531 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -53.3 -53.5 50.0 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.483 0.713 . . . . 0.0 110.606 168.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -60.93 -25.26 66.66 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.139 1.376 . . . . 0.0 113.672 -173.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 29.8 mt -49.83 -40.32 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 124.351 1.06 . . . . 0.0 111.686 171.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -111.5 -31.63 6.96 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.009 1.323 . . . . 0.0 112.215 -175.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -63.24 -2.99 1.6 Allowed 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.698 1.599 . . . . 0.0 113.493 170.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -51.79 -27.7 13.1 Favored 'General case' 0 CA--C 1.55 0.979 0 O-C-N 120.699 -1.251 . . . . 0.0 112.449 160.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 96.5 m -66.95 -1.69 4.36 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 169.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 86.71 -51.03 4.28 Favored Glycine 0 N--CA 1.473 1.148 0 C-N-CA 126.303 1.906 . . . . 0.0 113.059 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -71.79 169.88 14.79 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.65 1.18 . . . . 0.0 111.16 171.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.0 p -139.88 144.14 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 120.59 -1.319 . . . . 0.0 112.925 174.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -101.01 -108.72 0.22 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.671 1.589 . . . . 0.0 110.608 172.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -158.47 149.42 20.55 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.582 1.553 . . . . 0.0 112.267 -176.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.43 175.42 13.72 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.107 -0.996 . . . . 0.0 112.964 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -154.39 153.62 31.9 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -174.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 50.7 t -158.0 135.82 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 129.055 2.942 . . . . 0.0 106.893 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -132.53 146.43 51.9 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.657 0.783 . . . . 0.0 110.667 171.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 4.7 mt -92.75 142.98 26.75 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.458 0.647 . . . . 0.0 111.587 -171.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -72.73 144.06 47.79 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.967 1.307 . . . . 0.0 111.036 171.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -66.91 -9.98 54.57 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.15 1.357 . . . . 0.0 116.209 -171.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -75.4 -2.13 27.14 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 119.321 1.561 . . . . 0.0 113.045 165.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 86.9 44.49 5.71 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.58 1.562 . . . . 0.0 112.48 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 53.9 t -136.47 129.1 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.384 1.073 . . . . 0.0 110.656 -169.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 22.1 m -81.28 141.14 34.38 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -177.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 67.9 p -78.93 104.49 9.6 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.604 0.762 . . . . 0.0 109.102 171.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -69.82 -36.83 74.97 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 111.952 -0.459 . . . . 0.0 111.952 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 27.4 m -66.46 111.22 3.46 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.148 0.979 . . . . 0.0 110.76 161.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -131.65 165.31 23.36 Favored Glycine 0 N--CA 1.474 1.21 0 C-N-CA 124.765 1.174 . . . . 0.0 114.892 -173.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.74 146.02 24.46 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 126.562 1.945 . . . . 0.0 110.902 178.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -140.68 138.91 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.821 1.648 . . . . 0.0 108.259 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 26.9 t -116.33 132.4 56.68 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.127 0.971 . . . . 0.0 110.888 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.63 156.8 16.85 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 -158.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -55.73 -52.72 62.94 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 113.934 -1.484 . . . . 0.0 111.179 171.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -172.9 170.31 4.57 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 129.061 2.944 . . . . 0.0 108.623 170.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 10.7 tp -57.7 -30.87 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.954 0.901 . . . . 0.0 113.323 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -46.66 78.94 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.831 0.852 . . . . 0.0 113.11 171.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -84.43 -25.04 29.29 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 119.581 -0.247 . . . . 0.0 110.819 -175.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 4.9 tt -60.14 -45.64 92.35 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.845 1.258 . . . . 0.0 109.725 171.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -67.27 -25.54 66.11 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 171.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 21.3 mmm-85 -70.33 -43.1 70.97 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.962 1.255 . . . . 0.0 111.649 166.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -68.84 -38.42 79.81 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.675 1.59 . . . . 0.0 113.073 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 2.6 pp -69.56 -19.94 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 171.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -82.41 -42.59 18.4 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.62 1.168 . . . . 0.0 111.879 170.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -76.51 -53.4 8.14 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -105.62 -19.99 13.6 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -159.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -67.43 113.69 5.5 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 119.269 0.94 . . . . 0.0 109.423 172.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 97.65 -0.26 59.47 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.692 1.615 . . . . 0.0 114.962 -171.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -100.38 149.58 23.49 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.966 1.383 . . . . 0.0 111.472 176.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 23.1 p -113.42 128.29 56.4 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.108 0.963 . . . . 0.0 113.269 -173.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 15.2 mt -147.95 122.65 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.754 1.622 . . . . 0.0 107.943 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 59.18 37.66 23.83 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.364 1.065 . . . . 0.0 113.133 -177.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 140.36 -111.13 0.72 Allowed Glycine 0 N--CA 1.47 0.942 0 C-N-CA 124.449 1.023 . . . . 0.0 114.085 171.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -84.58 177.03 8.23 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.52 0.728 . . . . 0.0 111.008 -170.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 17.9 m -63.77 142.59 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 159.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 3.1 pp -99.52 144.86 28.13 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.74 0.781 . . . . 0.0 111.922 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -105.61 165.58 11.06 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.117 1.767 . . . . 0.0 109.205 162.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 26.6 t -136.16 120.3 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.718 1.607 . . . . 0.0 109.204 -174.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -122.69 170.39 10.1 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.239 1.815 . . . . 0.0 110.841 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 32.2 t -145.19 155.63 43.38 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 120.218 -1.551 . . . . 0.0 112.058 177.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -84.69 3.46 37.11 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 125.0 1.32 . . . . 0.0 113.215 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -150.9 177.79 9.78 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.696 1.999 . . . . 0.0 109.622 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 14.9 t -67.86 152.24 45.88 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 120.703 -1.248 . . . . 0.0 113.08 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 45.9 t -142.05 118.74 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 126.635 1.974 . . . . 0.0 107.959 -175.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -162.63 152.27 15.81 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.857 1.263 . . . . 0.0 113.01 -169.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -159.96 127.38 4.6 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.633 1.573 . . . . 0.0 110.155 -177.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 29.4 p80 -169.13 172.56 7.34 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.539 1.536 . . . . 0.0 112.794 -166.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 88.7 p -158.88 165.01 35.16 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.218 1.407 . . . . 0.0 111.758 176.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -79.9 -13.01 59.69 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 79.23 -131.74 10.89 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.47 1.033 . . . . 0.0 111.967 -176.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -158.7 173.64 16.25 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.755 1.622 . . . . 0.0 112.676 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -125.46 25.74 6.97 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.245 1.818 . . . . 0.0 113.912 -174.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 31.2 m -135.04 156.01 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -171.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -132.92 17.77 4.18 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.126 1.77 . . . . 0.0 113.597 -174.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 18.9 tt -60.94 130.19 90.89 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 124.804 1.242 . . . . 0.0 111.939 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.13 128.41 12.99 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.952 2.434 . . . . 0.0 110.237 175.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 53.7 ttm -164.55 139.05 5.4 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.196 1.398 . . . . 0.0 110.695 -173.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -159.37 142.34 14.23 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.99 1.316 . . . . 0.0 111.791 -177.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -80.27 53.34 1.76 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.733 1.613 . . . . 0.0 111.647 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 57.4 p -68.33 149.07 98.2 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.15 1.38 . . . . 0.0 113.631 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -73.2 150.59 47.83 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.581 2.854 . . . . 0.0 111.747 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 8.2 p -149.14 22.36 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 124.331 1.052 . . . . 0.0 112.861 -175.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 . . . . . 0 C--O 1.255 1.343 0 C-N-CA 126.499 1.919 . . . . 0.0 111.552 -177.905 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.921 0 N-CA-C 112.385 -0.286 . . . . 0.0 112.385 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 18.0 t -153.29 33.45 0.46 Allowed 'General case' 0 N--CA 1.48 1.069 0 O-C-N 121.718 -0.872 . . . . 0.0 112.496 -174.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -140.19 157.15 46.05 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.134 0.974 . . . . 0.0 112.017 -172.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 30.1 m -143.26 164.7 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 126.166 1.787 . . . . 0.0 110.624 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.6 mp -116.97 145.85 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 127.437 2.295 . . . . 0.0 107.446 173.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 19.2 m -118.62 146.19 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.43 1.092 . . . . 0.0 110.488 171.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -150.52 153.63 36.17 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.289 1.036 . . . . 0.0 113.135 -163.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 28.1 t30 83.91 -23.03 0.2 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 128.999 2.919 . . . . 0.0 114.259 176.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 47.8 mt -28.91 116.58 0.28 Allowed Pre-proline 0 CA--C 1.563 1.454 0 C-N-CA 126.495 1.918 . . . . 0.0 111.285 144.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -81.81 -175.52 2.61 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 125.107 3.871 . . . . 0.0 112.95 -173.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -61.92 -12.91 20.36 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 -176.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 16.1 m -85.27 -10.04 56.97 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.96 1.304 . . . . 0.0 114.12 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -108.72 127.43 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 126.704 2.002 . . . . 0.0 109.609 177.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -136.74 -177.26 4.66 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.175 2.19 . . . . 0.0 110.407 -173.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -43.76 -51.15 7.46 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.426 1.49 . . . . 0.0 114.595 -176.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -63.47 -38.04 89.61 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.076 0.853 . . . . 0.0 112.293 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.31 -41.66 73.02 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 170.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 5.8 tt -55.65 -43.31 76.12 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.89 1.276 . . . . 0.0 110.719 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -46.8 -58.46 3.88 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.321 1.049 . . . . 0.0 111.643 171.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -61.19 -24.19 66.14 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.489 1.515 . . . . 0.0 113.293 -175.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 34.9 mt -52.14 -40.41 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 119.861 1.209 . . . . 0.0 111.185 172.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -102.02 -29.58 11.7 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.867 1.267 . . . . 0.0 111.718 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 23.7 tptt -70.16 -18.09 63.2 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.148 1.379 . . . . 0.0 113.553 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -61.07 -18.73 59.45 Favored 'General case' 0 CA--C 1.551 1.011 0 O-C-N 120.323 -1.486 . . . . 0.0 113.281 168.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 10.4 t -66.18 -11.03 47.04 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 124.709 1.203 . . . . 0.0 113.837 171.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 100.45 -8.94 58.85 Favored Glycine 0 N--CA 1.475 1.272 0 C-N-CA 125.973 1.749 . . . . 0.0 114.099 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -138.47 143.12 39.47 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.943 1.697 . . . . 0.0 109.936 172.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.9 p -89.54 141.26 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.176 0.99 . . . . 0.0 111.301 -177.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -83.52 -128.84 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.206 1.402 . . . . 0.0 110.583 170.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -157.64 162.22 38.67 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 127.457 2.303 . . . . 0.0 110.327 169.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -155.43 165.79 35.54 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.936 -1.103 . . . . 0.0 113.651 -170.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -147.69 137.26 22.58 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.609 1.564 . . . . 0.0 111.822 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 22.6 t -154.9 137.76 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.771 2.028 . . . . 0.0 108.375 -174.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -132.49 123.01 25.77 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.09 0.956 . . . . 0.0 110.097 170.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 18.8 mt -89.63 161.73 15.98 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.677 0.791 . . . . 0.0 112.948 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -74.03 139.04 44.46 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.481 1.112 . . . . 0.0 110.728 177.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -68.8 -8.99 58.46 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 116.59 1.396 . . . . 0.0 116.59 -163.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -78.53 -2.07 36.96 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 118.879 1.34 . . . . 0.0 112.791 166.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 89.03 46.63 4.41 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 125.519 1.533 . . . . 0.0 112.133 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.06 128.81 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.508 1.123 . . . . 0.0 110.896 -168.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 51.8 m -61.22 146.34 48.09 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.026 1.73 . . . . 0.0 114.449 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 29.4 p -84.79 -32.02 23.59 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.12 1.368 . . . . 0.0 112.895 172.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 77.78 -60.81 3.73 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.911 1.243 . . . . 0.0 111.433 -171.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 59.3 p -67.3 154.99 40.02 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.16 1.784 . . . . 0.0 113.393 167.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -167.05 171.31 41.81 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.802 1.192 . . . . 0.0 114.773 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 94.8 m -106.85 146.18 31.25 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.833 1.653 . . . . 0.0 110.092 -174.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 1.1 t -134.6 135.0 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.143 1.777 . . . . 0.0 109.292 -175.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 8.2 m -109.39 119.76 40.45 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.17 1.788 . . . . 0.0 108.347 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.45 164.49 25.4 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -157.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -56.09 -47.0 78.84 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.784 173.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -172.39 162.07 5.32 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 129.746 3.218 . . . . 0.0 108.921 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 4.5 mp -62.19 -31.4 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.99 0.916 . . . . 0.0 111.823 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.62 -43.4 62.56 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 177.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -97.91 -14.97 20.36 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -176.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.8 tt -55.41 -51.6 66.32 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.178 1.391 . . . . 0.0 110.828 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -66.91 -29.33 69.18 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 39.1 mtp85 -70.16 -51.05 34.3 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.653 1.181 . . . . 0.0 111.126 170.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -63.07 -32.98 74.48 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.982 1.713 . . . . 0.0 113.524 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -54.83 -39.17 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.213 1.405 . . . . 0.0 112.051 177.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -82.67 -39.19 22.39 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.217 0.607 . . . . 0.0 112.055 174.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -65.51 -49.05 70.41 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -171.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -85.87 -20.84 28.48 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -176.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -67.19 113.69 5.33 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.415 -0.803 . . . . 0.0 110.03 173.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 101.03 0.07 54.86 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.29 0.947 . . . . 0.0 114.864 -173.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -94.21 168.83 10.67 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 118.962 1.381 . . . . 0.0 111.742 172.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 55.3 p -138.22 127.06 23.83 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 120.399 -1.438 . . . . 0.0 112.671 -175.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 22.6 mt -143.53 125.13 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.688 1.195 . . . . 0.0 109.487 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 59.49 20.73 9.16 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.7 1.6 . . . . 0.0 114.217 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 170.78 -118.49 0.75 Allowed Glycine 0 C--N 1.342 0.893 0 O-C-N 121.004 -1.06 . . . . 0.0 114.935 -178.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -96.48 178.13 5.45 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.8 0.84 . . . . 0.0 111.081 -171.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 12.6 p -52.64 137.49 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 O-C-N 121.879 -0.513 . . . . 0.0 109.948 157.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 2.1 pp -112.98 147.53 36.95 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.475 1.11 . . . . 0.0 112.195 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -104.56 157.45 17.16 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.176 1.39 . . . . 0.0 110.475 170.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 16.6 t -133.91 135.64 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.242 1.417 . . . . 0.0 109.313 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -149.29 159.57 44.15 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.819 1.248 . . . . 0.0 111.515 -171.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 23.0 t -144.39 151.7 39.65 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 120.59 -1.319 . . . . 0.0 111.099 172.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -72.73 -28.82 62.88 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -174.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 59.1 -167.12 0.16 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 126.809 2.044 . . . . 0.0 113.004 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 24.9 t -164.75 126.48 2.16 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.712 1.605 . . . . 0.0 110.23 174.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 11.6 p -169.46 141.2 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 125.299 1.44 . . . . 0.0 111.162 -174.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -157.58 129.05 6.82 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.317 1.447 . . . . 0.0 111.718 171.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -165.92 150.09 8.07 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.77 1.628 . . . . 0.0 111.939 -176.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -152.42 152.72 32.35 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.019 1.328 . . . . 0.0 112.66 172.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 34.4 p -163.76 127.71 2.74 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.144 1.778 . . . . 0.0 109.496 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -77.38 -16.76 58.7 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -173.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 79.23 -179.25 53.1 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.205 1.383 . . . . 0.0 115.06 171.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -163.64 132.21 3.78 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.83 2.052 . . . . 0.0 110.071 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -158.23 149.81 21.34 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.674 1.989 . . . . 0.0 110.241 -172.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 14.7 p -159.23 139.65 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 126.164 1.786 . . . . 0.0 110.356 176.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -170.63 128.84 0.8 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.507 2.323 . . . . 0.0 108.873 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 44.6 pt -133.06 151.08 77.25 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 126.018 1.727 . . . . 0.0 111.977 -176.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -73.82 158.24 46.84 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.597 2.865 . . . . 0.0 111.743 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 59.7 ttm -159.55 134.46 8.02 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.276 1.43 . . . . 0.0 110.754 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -80.05 155.32 27.62 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.207 1.403 . . . . 0.0 113.524 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -157.62 115.66 3.11 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.58 1.552 . . . . 0.0 110.447 175.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 73.2 m -115.32 147.26 38.23 Favored Pre-proline 0 N--CA 1.477 0.882 0 C-N-CA 124.979 1.312 . . . . 0.0 112.157 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.35 147.17 52.34 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.467 2.778 . . . . 0.0 111.414 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 14.6 p -164.01 143.18 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 125.172 1.389 . . . . 0.0 110.804 -176.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 5.9 p30 . . . . . 0 C--O 1.254 1.311 0 C-N-CA 126.281 1.832 . . . . 0.0 112.682 -179.48 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.925 0 N-CA-C 112.253 -0.339 . . . . 0.0 112.253 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 5.0 m 66.22 -156.14 0.25 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.392 1.477 . . . . 0.0 112.966 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 71.96 166.8 0.3 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 127.515 2.326 . . . . 0.0 114.016 176.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 35.3 m -134.28 157.72 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.197 0.999 . . . . 0.0 111.454 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 3.8 mp -131.82 140.29 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 126.258 1.823 . . . . 0.0 107.485 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 28.0 m -123.74 125.79 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.796 0.838 . . . . 0.0 109.984 -177.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -142.08 66.84 1.33 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.301 1.44 . . . . 0.0 111.82 -160.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -170.61 -44.67 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.957 1.703 . . . . 0.0 111.069 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 33.1 mt -40.09 119.26 1.45 Allowed Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 126.98 2.112 . . . . 0.0 112.327 165.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -94.06 -174.54 0.39 Allowed 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 124.505 3.47 . . . . 0.0 111.593 -176.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -51.32 -18.23 0.93 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.449 1.9 . . . . 0.0 115.379 177.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 15.8 m -64.68 -21.5 66.75 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.324 1.45 . . . . 0.0 113.879 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 5.4 p -105.72 148.54 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.742 1.217 . . . . 0.0 109.816 169.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -127.26 168.13 15.17 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.171 1.389 . . . . 0.0 111.549 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -54.1 -40.87 67.68 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -167.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -68.98 -37.75 78.94 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.482 -0.761 . . . . 0.0 111.687 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.47 -33.52 73.03 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 171.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 7.2 tt -60.48 -43.39 97.0 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.939 0.79 . . . . 0.0 110.962 172.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.49 -36.44 78.33 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.766 -0.584 . . . . 0.0 111.928 174.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -69.2 -20.06 63.97 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 23.7 mt -54.48 -45.53 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-N 119.604 1.093 . . . . 0.0 112.484 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -103.17 -3.97 25.06 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.662 1.185 . . . . 0.0 112.496 -174.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -61.8 -23.95 66.55 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.818 2.047 . . . . 0.0 115.217 -169.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -76.2 -10.87 59.75 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 14.0 t -79.03 -23.82 44.05 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 174.08 -165.99 37.88 Favored Glycine 0 N--CA 1.473 1.158 0 C-N-CA 124.346 0.974 . . . . 0.0 114.543 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -64.03 105.5 0.88 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.428 1.091 . . . . 0.0 110.087 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 5.3 p -52.94 137.2 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -153.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -73.43 -111.05 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.469 1.508 . . . . 0.0 112.397 -176.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -162.86 161.66 26.04 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.434 1.894 . . . . 0.0 111.091 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.3 168.39 27.14 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.076 -1.015 . . . . 0.0 112.386 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -156.86 153.62 28.52 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.313 1.045 . . . . 0.0 112.118 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 20.1 t -151.66 142.46 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.752 2.021 . . . . 0.0 108.302 -172.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -127.87 152.18 48.15 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.924 0.889 . . . . 0.0 110.861 172.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 15.4 mt -103.62 -157.06 0.59 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.762 1.225 . . . . 0.0 110.655 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -149.9 151.12 32.91 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.026 0.93 . . . . 0.0 111.273 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -63.26 -20.94 63.62 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-O 118.784 -1.009 . . . . 0.0 115.604 -174.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -117.55 -9.8 10.74 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 118.924 1.362 . . . . 0.0 113.962 165.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -70.27 -51.58 21.62 Favored Glycine 0 N--CA 1.47 0.92 0 C-N-CA 124.362 0.982 . . . . 0.0 112.267 169.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 2.8 t 58.94 10.46 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 C-N-CA 127.145 2.178 . . . . 0.0 112.016 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 86.4 p -179.57 153.45 0.56 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 127.94 2.496 . . . . 0.0 110.652 -168.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 5.0 p -152.97 -54.81 0.12 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 125.385 1.474 . . . . 0.0 112.774 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 78.3 -62.9 3.7 Favored Glycine 0 N--CA 1.473 1.111 0 C-N-CA 125.186 1.374 . . . . 0.0 112.023 -176.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 38.3 m -49.48 120.8 4.41 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.73 1.612 . . . . 0.0 112.451 165.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -157.25 -160.82 10.39 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.114 1.34 . . . . 0.0 114.522 -177.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 22.0 p -108.96 145.74 34.97 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.615 1.966 . . . . 0.0 111.149 -173.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.68 127.14 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.915 1.286 . . . . 0.0 109.047 -177.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 19.4 m -85.21 151.84 23.78 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.036 0.934 . . . . 0.0 110.138 171.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.33 157.74 27.51 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 -169.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -57.91 -55.66 32.01 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.608 1.563 . . . . 0.0 111.52 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -172.26 175.35 3.69 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 128.184 2.594 . . . . 0.0 108.975 161.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 74.2 mt -57.05 -35.9 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.241 1.416 . . . . 0.0 111.77 -176.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.39 -50.16 9.34 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.957 1.703 . . . . 0.0 114.874 172.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -95.76 -21.67 18.0 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.333 0.653 . . . . 0.0 112.129 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.0 tt -56.01 -49.4 73.78 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.549 1.14 . . . . 0.0 109.881 170.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -59.87 -33.64 72.08 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -70.51 -53.79 14.8 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.236 0.614 . . . . 0.0 111.267 170.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.52 -37.06 74.85 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.331 1.452 . . . . 0.0 113.602 -176.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.16 -40.17 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.306 1.042 . . . . 0.0 112.071 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -82.54 -38.94 23.04 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.487 0.715 . . . . 0.0 111.776 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -64.46 -47.72 77.94 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.519 1.128 . . . . 0.0 113.403 -173.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -92.54 -18.48 23.08 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -172.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -70.0 116.36 10.28 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.023 -1.048 . . . . 0.0 110.479 175.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 97.72 -5.84 62.29 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.628 1.585 . . . . 0.0 115.139 -174.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -80.09 172.79 13.31 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 118.824 1.312 . . . . 0.0 111.164 170.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 53.8 m -134.56 130.86 37.18 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 120.703 1.592 . . . . 0.0 111.697 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 39.0 mt -145.63 114.62 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.297 1.039 . . . . 0.0 109.159 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 57.1 28.52 15.06 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.439 1.096 . . . . 0.0 113.897 172.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 168.87 -125.52 1.28 Allowed Glycine 0 C--N 1.342 0.909 0 O-C-N 120.825 -1.172 . . . . 0.0 114.33 -177.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -87.35 -178.94 6.3 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.193 0.997 . . . . 0.0 110.824 -176.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 35.1 m -59.87 137.19 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 121.9 -0.5 . . . . 0.0 109.655 161.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 11.1 mp -71.34 128.31 35.47 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.135 1.374 . . . . 0.0 109.476 173.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -106.05 146.28 30.33 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 154.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 14.4 t -136.7 128.76 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.561 1.544 . . . . 0.0 108.938 -172.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -130.03 169.69 14.96 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.77 2.028 . . . . 0.0 110.512 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 32.9 t -138.5 151.66 47.58 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 120.537 -1.352 . . . . 0.0 111.833 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 40.6 tttm -80.13 2.11 25.43 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 -168.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -152.88 121.98 6.6 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.671 1.189 . . . . 0.0 110.91 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 23.3 t -172.93 165.41 5.11 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.679 1.992 . . . . 0.0 110.977 173.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 14.9 p -168.91 -40.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 125.043 1.337 . . . . 0.0 113.871 -176.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -141.63 157.17 45.42 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.495 1.118 . . . . 0.0 113.41 -174.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -120.51 3.38 10.73 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.318 1.447 . . . . 0.0 113.844 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 23.5 t60 58.83 34.35 23.64 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.912 1.685 . . . . 0.0 113.713 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 16.0 m -67.72 -15.92 63.88 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -171.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -83.31 -10.8 58.29 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.741 1.216 . . . . 0.0 113.307 175.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -87.52 141.14 17.14 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.147 1.356 . . . . 0.0 112.63 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -163.34 133.95 4.56 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.61 1.564 . . . . 0.0 111.432 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -166.23 156.81 12.69 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.105 2.162 . . . . 0.0 109.83 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 16.2 m -151.35 149.89 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 127.197 2.199 . . . . 0.0 111.037 -175.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -166.75 118.0 0.94 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.926 1.69 . . . . 0.0 110.222 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 5.3 mp -130.2 108.04 16.37 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 125.259 1.424 . . . . 0.0 108.699 178.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.47 152.69 13.64 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.568 2.845 . . . . 0.0 112.235 -176.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 42.3 tpp 73.38 146.08 0.08 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 128.103 2.561 . . . . 0.0 114.228 174.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -163.3 -41.73 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.007 1.323 . . . . 0.0 114.012 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -118.84 -11.17 9.79 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -160.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 66.0 m -115.52 152.05 46.71 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 124.491 1.116 . . . . 0.0 112.997 -166.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.24 150.84 53.93 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.234 2.623 . . . . 0.0 111.08 174.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 59.9 t -142.68 128.54 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.397 1.479 . . . . 0.0 108.798 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 32.9 m120 . . . . . 0 C--O 1.254 1.291 0 C-N-CA 125.939 1.696 . . . . 0.0 111.61 -174.878 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.938 0 N-CA-C 112.389 -0.284 . . . . 0.0 112.389 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 92.5 p -157.25 33.6 0.28 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.129 0.972 . . . . 0.0 112.723 -171.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -159.74 145.94 16.03 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.771 -1.206 . . . . 0.0 110.972 -170.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 32.6 m -133.24 147.14 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.142 0.977 . . . . 0.0 111.056 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.7 mp -91.57 141.23 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 126.675 1.99 . . . . 0.0 108.606 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 34.7 m -132.84 129.07 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.577 1.151 . . . . 0.0 109.036 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.3 tptm -150.5 50.46 0.88 Allowed 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 -148.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -160.94 -17.68 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 170.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 39.3 mt -54.35 131.96 61.93 Favored Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 125.713 1.605 . . . . 0.0 111.598 168.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -86.09 169.5 8.75 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.312 3.341 . . . . 0.0 111.276 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -55.81 -10.66 0.78 Allowed 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 6.2 t -59.32 -31.21 68.95 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.696 1.198 . . . . 0.0 113.006 171.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.62 116.33 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 169.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -69.36 153.28 43.85 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.562 0.745 . . . . 0.0 110.097 171.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -55.46 -32.67 62.99 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 120.538 -1.351 . . . . 0.0 113.108 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -69.11 -39.57 78.85 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.021 0.929 . . . . 0.0 111.033 175.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.53 -25.51 64.06 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.078 -1.014 . . . . 0.0 113.065 170.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.74 -49.05 64.63 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.258 0.935 . . . . 0.0 111.343 170.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -25.89 68.25 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 119.762 1.165 . . . . 0.0 111.852 174.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -68.93 -21.66 64.19 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 171.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 30.1 mt -56.97 -51.35 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 CA-C-N 119.696 1.134 . . . . 0.0 111.269 173.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -85.84 -19.55 30.46 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.678 0.791 . . . . 0.0 111.824 -174.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -57.62 -13.98 4.71 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.103 1.761 . . . . 0.0 114.808 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -59.48 -15.32 16.84 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 168.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 83.9 m -68.79 -5.62 21.86 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 168.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.39 -8.58 60.5 Favored Glycine 0 N--CA 1.48 1.575 0 C-N-CA 125.789 1.662 . . . . 0.0 115.666 172.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -138.69 -174.65 3.89 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.823 2.049 . . . . 0.0 108.634 170.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 6.8 p -144.06 144.22 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 121.159 1.799 . . . . 0.0 113.618 172.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -94.81 -121.04 0.1 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.184 1.793 . . . . 0.0 111.189 177.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -143.82 158.55 43.61 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.538 1.935 . . . . 0.0 111.567 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.96 -179.72 8.3 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 120.974 -1.079 . . . . 0.0 113.855 -177.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 8.2 p30 -155.54 173.7 16.32 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.656 1.583 . . . . 0.0 113.781 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 17.2 m -149.92 173.86 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 127.69 2.396 . . . . 0.0 110.075 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -108.22 159.54 16.54 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.674 1.19 . . . . 0.0 111.318 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.3 mp -132.96 134.17 44.15 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.542 1.137 . . . . 0.0 111.347 173.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -66.77 164.27 17.5 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.691 1.196 . . . . 0.0 111.221 165.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -61.97 -19.93 59.5 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.019 0.819 . . . . 0.0 114.669 176.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -79.14 -6.16 55.86 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.917 1.287 . . . . 0.0 113.47 171.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 80.87 14.13 80.12 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.034 1.302 . . . . 0.0 115.135 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 3.7 p -91.11 4.66 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 -165.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 10.9 p 64.87 -179.39 0.18 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 126.992 2.117 . . . . 0.0 116.159 175.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 68.6 p -141.99 156.3 45.45 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 128.368 2.667 . . . . 0.0 108.229 172.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -88.01 -34.31 10.0 Favored Glycine 0 N--CA 1.47 0.947 0 C-N-CA 123.245 0.45 . . . . 0.0 112.203 169.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 18.7 p -56.81 143.04 38.58 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.762 1.625 . . . . 0.0 111.922 163.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 169.55 -153.59 22.09 Favored Glycine 0 N--CA 1.471 0.985 0 C-N-CA 126.172 1.844 . . . . 0.0 112.253 -175.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 17.8 p -125.09 154.97 40.57 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 117.994 0.897 . . . . 0.0 111.357 173.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 13.4 m -123.82 121.96 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 125.222 1.409 . . . . 0.0 107.782 172.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 4.5 m -91.09 120.79 32.34 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.013 1.725 . . . . 0.0 109.356 -175.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.85 157.47 21.99 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -158.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -54.38 -54.03 46.0 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 113.56 -1.655 . . . . 0.0 111.793 172.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -172.68 170.24 4.78 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 129.366 3.067 . . . . 0.0 108.676 171.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 89.5 mt -57.49 -34.32 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 124.864 1.266 . . . . 0.0 112.054 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.14 -40.2 64.07 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.138 1.375 . . . . 0.0 114.433 172.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -89.39 -33.15 16.96 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 119.328 -0.368 . . . . 0.0 110.418 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 6.2 tt -56.64 -52.16 65.94 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.854 1.262 . . . . 0.0 111.378 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -62.3 -47.58 83.66 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.67 -0.644 . . . . 0.0 112.541 -177.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 28.1 ptt85 -70.44 -28.83 65.34 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -74.12 -33.78 63.68 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.502 1.121 . . . . 0.0 112.997 173.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -53.71 -44.04 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.156 1.382 . . . . 0.0 112.3 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -82.75 -17.37 44.47 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -89.07 -48.51 7.36 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.913 0.885 . . . . 0.0 112.671 -171.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -85.32 -21.55 28.89 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -49.8 125.26 11.37 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.885 0.874 . . . . 0.0 110.761 159.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 86.93 0.34 85.74 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 119.141 -0.811 . . . . 0.0 114.757 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -103.69 163.43 12.33 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.139 1.375 . . . . 0.0 112.045 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 34.1 p -138.03 129.35 27.66 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 120.684 -1.26 . . . . 0.0 111.897 -175.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 11.0 mt -146.71 116.86 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.49 1.116 . . . . 0.0 109.104 -177.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 60.86 25.95 15.84 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.695 1.198 . . . . 0.0 112.792 176.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 178.2 -140.01 4.42 Favored Glycine 0 C--N 1.342 0.888 0 O-C-N 120.931 -1.106 . . . . 0.0 114.474 -170.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -91.42 178.26 6.0 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.399 1.08 . . . . 0.0 110.644 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 11.7 p -59.92 129.19 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 O-C-N 121.642 -0.661 . . . . 0.0 109.308 160.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 1.8 pp -104.37 149.09 25.69 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 122.406 1.098 . . . . 0.0 111.533 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -113.37 163.54 14.72 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.017 1.327 . . . . 0.0 110.092 166.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 24.3 t -135.93 130.52 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 126.561 1.945 . . . . 0.0 107.51 -175.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -135.28 133.94 39.41 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.234 1.014 . . . . 0.0 111.46 -173.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 77.3 p -118.0 167.54 11.35 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.186 1.394 . . . . 0.0 112.894 -171.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -122.22 124.01 42.82 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.081 1.352 . . . . 0.0 110.718 175.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -161.05 -59.8 0.05 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.64 1.176 . . . . 0.0 110.997 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 12.1 t -163.77 -169.8 2.0 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.026 1.33 . . . . 0.0 111.865 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 21.7 m -143.56 149.81 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 127.307 2.243 . . . . 0.0 110.535 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -146.73 156.74 43.4 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.133 1.373 . . . . 0.0 112.749 -170.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -159.48 177.35 11.04 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.901 1.68 . . . . 0.0 112.08 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -116.35 21.13 13.81 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.505 1.522 . . . . 0.0 112.825 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 20.1 m -79.58 71.64 6.19 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.326 1.45 . . . . 0.0 111.674 -176.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -75.42 -10.65 59.64 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.021 1.328 . . . . 0.0 114.214 -175.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 92.04 -2.86 76.26 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.29 1.424 . . . . 0.0 115.107 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -151.51 138.98 19.51 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.257 1.823 . . . . 0.0 110.897 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -164.62 134.18 3.77 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.934 1.693 . . . . 0.0 110.938 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 17.1 m -153.8 154.27 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 126.212 1.805 . . . . 0.0 111.232 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -148.61 106.11 3.66 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.86 1.664 . . . . 0.0 109.652 174.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 7.4 pt -133.33 96.56 17.08 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 125.172 1.389 . . . . 0.0 110.596 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -83.13 147.53 13.02 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.238 2.625 . . . . 0.0 111.806 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -73.39 149.27 42.63 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.558 1.143 . . . . 0.0 111.411 172.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -71.56 133.77 45.99 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.359 0.664 . . . . 0.0 111.994 173.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -151.94 26.46 0.63 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.009 1.724 . . . . 0.0 111.4 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 21.3 t -63.43 128.75 92.97 Favored Pre-proline 0 CA--C 1.55 0.978 0 O-C-N 120.994 -1.066 . . . . 0.0 112.347 -176.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.43 151.31 33.13 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.585 2.857 . . . . 0.0 111.742 -177.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 15.9 m -148.58 144.98 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 125.432 1.493 . . . . 0.0 111.095 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 . . . . . 0 C--O 1.254 1.339 0 C-N-CA 126.291 1.836 . . . . 0.0 111.56 -178.942 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.719 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 73.0 m -146.8 164.79 31.69 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.198 1.399 . . . . 0.0 111.229 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -142.56 160.07 41.0 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.156 0.982 . . . . 0.0 112.156 -170.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 34.7 m -132.86 157.43 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.687 1.195 . . . . 0.0 111.109 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.0 mp -125.17 136.91 59.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 127.044 2.137 . . . . 0.0 107.033 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.93 128.89 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.116 0.967 . . . . 0.0 109.427 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 60.2 mmtt -138.76 73.84 1.45 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.034 1.334 . . . . 0.0 110.784 -161.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -179.13 -32.21 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.554 1.942 . . . . 0.0 113.3 -173.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 89.1 mt -74.07 131.35 81.29 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-O 117.917 -1.04 . . . . 0.0 109.834 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -94.83 -168.88 0.16 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 124.272 3.315 . . . . 0.0 110.759 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -55.59 -13.62 1.68 Allowed 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 50.0 m -60.26 -24.19 64.71 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.386 1.474 . . . . 0.0 113.872 170.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.3 p -103.5 144.57 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.43 1.092 . . . . 0.0 109.893 170.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -135.91 173.56 11.58 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.944 1.698 . . . . 0.0 109.775 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -44.35 -51.28 8.65 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.959 1.303 . . . . 0.0 113.777 -170.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -70.07 -40.82 74.8 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.917 -0.49 . . . . 0.0 111.618 -175.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.25 -33.56 73.45 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.789 0.722 . . . . 0.0 112.82 176.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 8.2 tt -63.1 -45.2 93.2 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.98 0.809 . . . . 0.0 110.409 172.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 3.7 tmmm? -60.69 -37.63 82.27 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.864 -0.523 . . . . 0.0 111.161 174.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -63.68 -25.32 68.16 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 176.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 28.1 mt -55.92 -51.37 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 124.112 0.965 . . . . 0.0 110.609 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -89.0 -26.26 21.56 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.666 0.786 . . . . 0.0 112.343 -175.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 2.9 ttpt -52.7 -22.03 4.71 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.292 1.437 . . . . 0.0 114.356 173.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -61.8 -13.75 26.7 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 120.77 -1.206 . . . . 0.0 113.79 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 79.3 m -71.54 -0.37 10.42 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.968 1.307 . . . . 0.0 114.403 167.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.58 -73.57 0.25 Allowed Glycine 0 N--CA 1.471 1.001 0 C-N-CA 126.393 1.949 . . . . 0.0 111.449 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -73.08 172.3 11.3 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.19 0.996 . . . . 0.0 111.136 170.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.29 142.05 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 O-C-N 120.635 -1.29 . . . . 0.0 113.827 172.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -85.36 -125.56 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.733 1.613 . . . . 0.0 111.415 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -152.1 162.0 41.77 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.4 1.48 . . . . 0.0 112.89 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.6 173.72 16.16 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.11 -0.994 . . . . 0.0 113.641 -173.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -154.87 158.42 39.33 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.799 1.24 . . . . 0.0 113.398 -177.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 21.8 m -151.53 163.45 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 127.486 2.314 . . . . 0.0 110.914 -172.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -131.97 167.46 19.61 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.77 1.228 . . . . 0.0 111.84 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 4.0 mp -129.05 152.68 48.39 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.228 1.411 . . . . 0.0 112.203 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -92.84 153.17 19.0 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.066 1.746 . . . . 0.0 111.487 173.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -68.5 -7.08 52.25 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.801 1.191 . . . . 0.0 114.989 -178.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -74.08 -4.77 37.57 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.31 1.444 . . . . 0.0 112.953 168.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 86.45 38.29 8.37 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.035 1.302 . . . . 0.0 113.392 176.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 30.6 m -142.05 148.41 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.678 1.591 . . . . 0.0 111.143 -174.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 75.0 p -81.1 152.74 27.67 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.924 0.89 . . . . 0.0 113.039 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 39.1 p -76.25 -29.4 57.48 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.858 0.863 . . . . 0.0 112.881 176.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 74.49 -64.26 2.16 Favored Glycine 0 N--CA 1.47 0.926 0 C-N-CA 125.724 1.63 . . . . 0.0 112.207 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 58.1 m -55.0 110.61 0.69 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.427 1.891 . . . . 0.0 111.435 166.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -146.67 -160.11 8.61 Favored Glycine 0 N--CA 1.469 0.851 0 C-N-CA 124.695 1.14 . . . . 0.0 113.897 -173.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 98.0 m -114.89 136.67 52.85 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.526 1.53 . . . . 0.0 109.625 -170.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 1.3 t -120.41 120.23 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 125.751 1.621 . . . . 0.0 107.622 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 42.9 m -88.46 108.04 19.18 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.416 1.086 . . . . 0.0 108.426 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -79.6 162.91 25.02 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 -160.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -53.21 -55.58 23.21 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.625 1.17 . . . . 0.0 111.35 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -172.39 178.82 2.69 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.039 2.535 . . . . 0.0 109.007 154.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 16.7 tt -53.51 -33.31 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.101 1.36 . . . . 0.0 113.488 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.69 -42.72 68.28 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.207 1.403 . . . . 0.0 113.956 173.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -95.26 -24.58 16.72 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.5 tt -58.35 -51.97 67.57 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 125.434 1.493 . . . . 0.0 110.221 175.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -62.21 -33.43 74.54 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -70.33 -42.39 71.97 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.695 1.198 . . . . 0.0 112.036 174.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -72.92 -33.55 66.05 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.432 1.493 . . . . 0.0 113.134 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.44 -37.01 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.833 0.853 . . . . 0.0 112.6 -176.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -82.17 -19.59 39.6 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.855 0.862 . . . . 0.0 113.206 175.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -89.01 -46.09 9.13 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.68 1.192 . . . . 0.0 112.645 -175.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -87.71 -30.71 20.14 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -171.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -65.09 118.84 9.75 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 119.011 0.823 . . . . 0.0 110.324 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 103.42 -7.07 50.45 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 125.644 1.592 . . . . 0.0 115.629 -172.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -93.88 142.92 26.82 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 119.451 1.625 . . . . 0.0 111.78 176.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 11.0 p -111.96 126.64 55.35 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.793 1.237 . . . . 0.0 112.234 -174.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -148.58 103.16 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.113 0.965 . . . . 0.0 109.517 -166.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 57.06 35.89 26.96 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 121.932 0.872 . . . . 0.0 111.462 -172.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 163.31 -148.69 15.47 Favored Glycine 0 C--N 1.343 0.952 0 O-C-N 121.152 -0.968 . . . . 0.0 114.787 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -80.93 174.55 11.51 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.804 1.642 . . . . 0.0 111.066 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 32.8 m -63.37 136.18 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 121.213 -0.929 . . . . 0.0 111.301 175.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 14.6 mt -63.41 122.28 15.86 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.674 0.79 . . . . 0.0 113.001 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -106.04 102.37 11.8 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.36 1.864 . . . . 0.0 107.599 160.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.45 131.69 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.286 1.435 . . . . 0.0 109.698 -171.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -130.0 135.13 47.94 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.978 1.311 . . . . 0.0 110.806 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 50.1 p -97.05 159.0 15.16 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.874 -1.141 . . . . 0.0 112.005 175.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -82.07 97.85 8.36 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 121.286 -0.883 . . . . 0.0 111.079 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.04 174.24 12.53 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.987 1.715 . . . . 0.0 112.087 -175.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 20.3 t -160.94 163.63 31.71 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.478 1.511 . . . . 0.0 111.293 174.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 9.9 p -91.82 -24.23 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.442 1.097 . . . . 0.0 113.614 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 57.27 26.96 12.96 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 125.535 1.534 . . . . 0.0 114.538 174.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -71.18 -21.97 62.09 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -167.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' HIS . . . . . 0.406 ' CG ' ' H ' ' A' ' 343' ' ' SER . 22.0 t-80 63.94 175.88 0.17 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 126.473 1.909 . . . . 0.0 114.356 177.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' SER . . . . . 0.406 ' H ' ' CG ' ' A' ' 342' ' ' HIS . 33.5 t -163.41 140.16 7.17 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.465 1.506 . . . . 0.0 111.152 177.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -84.68 -8.11 58.98 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.401 1.08 . . . . 0.0 113.107 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 84.21 -171.24 47.98 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.177 1.37 . . . . 0.0 114.045 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -150.07 146.63 27.06 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.177 1.791 . . . . 0.0 111.153 -176.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -164.49 158.74 18.61 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.994 2.117 . . . . 0.0 109.697 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 14.9 p -165.36 143.45 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 126.86 2.064 . . . . 0.0 110.606 -175.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -161.83 114.24 1.77 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.311 1.844 . . . . 0.0 109.167 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 40.5 mm -99.1 119.99 59.39 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 124.325 1.05 . . . . 0.0 110.0 -175.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -79.42 163.67 24.42 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.684 2.923 . . . . 0.0 112.106 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 27.8 ttt -158.12 132.92 8.43 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.257 1.423 . . . . 0.0 110.53 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -161.07 158.37 27.64 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.142 1.377 . . . . 0.0 112.171 -178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -149.05 9.65 0.77 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 128.115 2.566 . . . . 0.0 112.547 177.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 12.7 t -64.3 147.56 96.91 Favored Pre-proline 0 CA--C 1.552 1.023 0 O-C-N 120.663 -1.273 . . . . 0.0 112.304 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.28 -14.16 41.98 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.957 2.438 . . . . 0.0 113.289 164.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 21.6 t 73.49 95.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 126.4 1.88 . . . . 0.0 110.9 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 . . . . . 0 C--O 1.254 1.316 0 C-N-CA 126.653 1.981 . . . . 0.0 111.163 179.346 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.913 0 CA-C-O 121.151 0.306 . . . . 0.0 112.608 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 8.3 m -176.6 98.04 0.05 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 128.288 2.635 . . . . 0.0 109.122 175.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -167.47 153.35 7.63 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.218 -0.926 . . . . 0.0 112.853 -173.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 31.3 m -138.59 147.26 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.45 1.5 . . . . 0.0 111.126 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.4 mp -92.05 137.83 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 126.01 1.724 . . . . 0.0 107.683 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 5.4 m -117.75 118.5 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -139.37 44.75 1.97 Allowed 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -148.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -168.51 -6.65 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 116.623 2.083 . . . . 0.0 116.623 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 68.0 mt -69.84 144.17 93.04 Favored Pre-proline 0 CA--C 1.553 1.079 0 O-C-N 120.532 -1.355 . . . . 0.0 110.103 174.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -90.62 -175.24 0.83 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.3 3.333 . . . . 0.0 110.905 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -56.37 -12.47 1.68 Allowed 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 20.4 m -60.48 -31.05 70.1 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.78 1.232 . . . . 0.0 113.266 171.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.6 p -93.73 142.49 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.503 0.721 . . . . 0.0 109.697 172.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -137.26 168.41 19.69 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.004 1.722 . . . . 0.0 109.09 176.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -50.56 -40.92 53.43 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -167.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -68.64 -39.01 80.94 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.761 -0.587 . . . . 0.0 111.895 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.58 -36.25 76.09 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.382 -0.824 . . . . 0.0 112.715 170.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 3.3 tt -61.03 -38.27 85.51 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.189 0.996 . . . . 0.0 112.138 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -57.84 -46.94 84.02 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 121.537 -0.727 . . . . 0.0 110.947 169.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.29 -17.82 64.82 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 29.3 mt -54.41 -33.45 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.344 1.058 . . . . 0.0 111.803 169.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -118.05 -27.7 6.05 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.171 1.389 . . . . 0.0 112.183 -176.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -64.31 -6.66 7.39 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -52.72 -25.29 10.65 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.198 1.399 . . . . 0.0 113.06 167.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 70.8 m -67.66 -5.17 14.52 Favored 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 172.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 97.06 -12.17 65.59 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 126.436 1.969 . . . . 0.0 115.017 175.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -138.67 172.47 12.83 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.394 1.878 . . . . 0.0 109.659 174.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.1 p -145.34 144.35 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 120.341 -1.474 . . . . 0.0 112.318 173.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -72.57 -79.4 0.08 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.473 1.109 . . . . 0.0 112.077 178.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -178.45 147.01 0.39 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 127.947 2.499 . . . . 0.0 109.813 -167.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.59 166.56 31.79 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.11 -0.994 . . . . 0.0 112.658 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -157.46 165.8 34.71 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.898 1.279 . . . . 0.0 112.496 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 22.7 m -146.37 155.4 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 126.838 2.055 . . . . 0.0 110.793 -174.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -132.0 115.21 15.54 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.875 1.27 . . . . 0.0 108.848 174.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 17.2 mt -96.13 169.1 10.19 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.466 1.106 . . . . 0.0 111.376 -173.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -78.16 144.76 36.11 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.009 0.923 . . . . 0.0 112.119 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -68.44 -12.35 63.58 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.88 1.229 . . . . 0.0 115.795 -173.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -80.81 0.01 36.77 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 119.301 1.551 . . . . 0.0 113.22 168.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 85.81 43.35 6.44 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.575 1.083 . . . . 0.0 113.172 175.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.19 148.9 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.08 1.352 . . . . 0.0 111.89 -177.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 58.5 m -77.79 139.32 39.32 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -169.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 7.9 p -89.22 -26.66 21.1 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.69 1.996 . . . . 0.0 113.529 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 80.27 -54.27 4.52 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.103 1.811 . . . . 0.0 113.067 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 23.4 p -52.34 139.75 23.63 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 122.998 1.38 . . . . 0.0 113.28 163.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -161.23 -171.73 27.63 Favored Glycine 0 N--CA 1.468 0.832 0 C-N-CA 124.831 1.205 . . . . 0.0 114.682 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 26.6 p -123.39 122.41 38.22 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.48 1.512 . . . . 0.0 109.493 -176.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 19.6 m -112.58 129.73 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 175.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 5.1 m -87.88 150.03 23.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.709 172.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.74 157.44 19.76 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -165.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -53.82 -52.57 59.92 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.743 1.617 . . . . 0.0 111.88 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -172.66 170.36 4.77 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.351 2.66 . . . . 0.0 108.532 162.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.466 HD13 ' H ' ' A' ' 311' ' ' ILE . 4.3 mp -47.1 -38.23 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 125.121 1.368 . . . . 0.0 112.11 175.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.67 -48.99 19.98 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.878 1.671 . . . . 0.0 115.111 173.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -96.39 -21.44 17.77 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 118.749 -0.643 . . . . 0.0 111.993 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.3 tt -57.87 -52.33 65.91 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.234 1.013 . . . . 0.0 110.191 173.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -68.87 -26.61 65.21 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -70.29 -43.36 70.56 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.043 0.937 . . . . 0.0 111.594 169.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -75.24 -30.6 60.57 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.511 1.525 . . . . 0.0 113.675 -177.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.01 -42.28 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.179 0.991 . . . . 0.0 113.12 -172.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -82.77 -37.79 24.09 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.688 0.795 . . . . 0.0 112.449 175.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -57.46 -38.15 74.01 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.198 -0.939 . . . . 0.0 111.997 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -106.31 28.53 7.65 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.322 1.849 . . . . 0.0 112.616 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -89.94 118.75 29.74 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.421 -1.424 . . . . 0.0 110.866 161.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 84.41 -8.67 67.15 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.975 1.274 . . . . 0.0 115.523 172.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.43 171.55 1.06 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.282 1.833 . . . . 0.0 113.78 168.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 73.4 p -138.52 122.25 17.55 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.077 -1.015 . . . . 0.0 112.048 175.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 13.4 mt -135.54 111.3 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.714 1.206 . . . . 0.0 108.878 177.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 65.09 26.6 12.52 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.359 1.464 . . . . 0.0 112.939 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . -179.07 -131.83 1.65 Allowed Glycine 0 CA--C 1.53 1.014 0 N-CA-C 115.707 1.043 . . . . 0.0 115.707 -176.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -98.61 179.28 4.74 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.481 1.513 . . . . 0.0 111.077 -172.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 30.8 m -60.29 132.28 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 162.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 59.7 tp -126.21 117.16 22.5 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.553 0.741 . . . . 0.0 111.147 -165.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -75.67 148.74 38.45 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.147 160.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 96.6 t -136.89 137.69 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 126.074 1.75 . . . . 0.0 108.998 -176.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -144.13 135.74 25.92 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.994 0.918 . . . . 0.0 111.952 -170.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 82.5 p -89.37 161.74 16.17 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 45.0 tttm -86.87 16.36 4.95 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 124.826 1.25 . . . . 0.0 113.219 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -82.02 -26.08 34.1 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -168.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 53.7 m 69.66 164.62 0.26 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 126.647 1.979 . . . . 0.0 114.155 -176.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 15.8 m -148.01 150.95 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 125.794 1.638 . . . . 0.0 111.358 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -147.34 -13.67 0.4 Allowed 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -72.92 128.09 34.46 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.203 -0.936 . . . . 0.0 111.367 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -109.56 -17.15 13.8 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 -170.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 22.9 t -169.73 155.62 5.98 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.622 1.569 . . . . 0.0 111.392 -173.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -88.86 -12.31 42.2 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.671 1.188 . . . . 0.0 113.02 173.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 147.34 173.03 18.12 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.485 1.517 . . . . 0.0 114.237 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -85.62 -8.07 58.47 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.022 1.329 . . . . 0.0 114.141 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -163.71 156.98 18.62 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.916 2.487 . . . . 0.0 109.262 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 15.3 m -152.62 144.77 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 127.022 2.129 . . . . 0.0 111.116 -170.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -81.55 -14.85 56.36 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.941 0.896 . . . . 0.0 113.343 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 5.3 mp -133.06 125.46 19.06 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.456 1.903 . . . . 0.0 107.721 172.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.4 133.31 27.84 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.036 2.49 . . . . 0.0 111.518 -174.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 28.0 ttt -165.21 140.45 5.2 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.041 1.736 . . . . 0.0 110.255 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -159.56 153.21 22.77 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.419 1.487 . . . . 0.0 112.328 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -150.21 18.27 0.85 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.085 1.354 . . . . 0.0 112.718 -175.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 32.5 p -87.33 152.96 53.31 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 125.319 1.448 . . . . 0.0 112.808 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -72.39 149.1 49.97 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.517 2.812 . . . . 0.0 111.315 177.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 11.0 p -163.47 142.77 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.017 1.327 . . . . 0.0 110.75 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 . . . . . 0 C--O 1.253 1.275 0 C-N-CA 124.987 1.315 . . . . 0.0 113.885 -179.095 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.916 0 N-CA-C 112.411 -0.276 . . . . 0.0 112.411 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 57.2 m -137.75 75.89 1.55 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.717 1.207 . . . . 0.0 110.367 -174.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -147.25 154.73 41.36 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.436 1.094 . . . . 0.0 112.084 -173.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 12.1 m -133.94 161.46 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 124.976 1.311 . . . . 0.0 110.963 169.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.97 139.57 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 127.343 2.257 . . . . 0.0 108.368 178.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.57 126.6 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.329 1.051 . . . . 0.0 108.961 175.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -140.15 42.5 1.93 Allowed 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -153.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -158.34 -15.31 0.07 Allowed 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 171.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 16.2 mt -52.29 133.47 42.36 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 125.641 1.577 . . . . 0.0 112.969 173.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -88.24 166.55 6.71 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.929 3.753 . . . . 0.0 110.931 172.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -60.32 -12.48 9.23 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -174.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 16.0 m -61.76 -23.47 66.2 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.289 1.036 . . . . 0.0 112.789 171.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.5 p -115.32 131.51 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 126.936 2.094 . . . . 0.0 108.958 167.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -148.5 178.2 8.82 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.109 1.764 . . . . 0.0 109.224 -171.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -38.87 -50.67 1.73 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.284 1.834 . . . . 0.0 115.932 -162.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -67.35 -44.51 78.86 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.234 0.925 . . . . 0.0 111.886 -176.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.84 -32.0 70.17 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 172.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 4.1 tt -58.64 -45.31 89.59 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.257 1.023 . . . . 0.0 109.91 174.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -56.08 -38.3 70.49 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.577 -0.702 . . . . 0.0 112.376 173.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -69.04 -19.95 64.11 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 178.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 29.7 mt -58.19 -30.47 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 124.157 0.983 . . . . 0.0 111.707 170.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -114.19 -26.46 8.03 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.666 1.186 . . . . 0.0 113.434 -175.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 1.8 tmmt? -63.54 -20.73 65.87 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -176.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -75.0 -13.54 60.52 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 171.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 11.2 t -107.08 -33.55 7.43 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.185 1.394 . . . . 0.0 113.301 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -138.03 153.52 22.32 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.843 1.211 . . . . 0.0 114.84 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -69.45 115.25 8.49 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.707 1.203 . . . . 0.0 110.751 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 4.8 p -41.14 132.9 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 -154.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -99.09 -111.76 0.17 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.971 1.708 . . . . 0.0 110.274 174.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 -159.58 155.23 25.91 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.667 1.587 . . . . 0.0 112.456 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.23 171.31 20.44 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.132 -0.98 . . . . 0.0 112.621 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -157.59 165.6 35.1 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.828 1.251 . . . . 0.0 112.814 -173.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 23.1 t -151.01 142.78 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 127.421 2.288 . . . . 0.0 107.387 -177.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -119.52 133.09 55.83 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.224 0.61 . . . . 0.0 110.921 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 11.8 mt -86.34 164.99 16.76 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.981 0.912 . . . . 0.0 111.471 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -64.72 133.33 51.88 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 155.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -67.51 -11.88 60.47 Favored Glycine 0 N--CA 1.475 1.265 0 N-CA-C 117.385 1.714 . . . . 0.0 117.385 -153.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -79.73 0.4 30.7 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 118.556 1.178 . . . . 0.0 112.736 168.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 93.75 33.91 6.83 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 126.356 1.931 . . . . 0.0 113.584 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.32 15.38 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -157.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 21.0 p 73.27 148.0 0.09 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 127.532 2.333 . . . . 0.0 115.484 171.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 11.9 p -159.75 158.05 30.53 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 128.183 2.593 . . . . 0.0 109.022 -177.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -112.82 -50.22 0.56 Allowed Glycine 0 N--CA 1.473 1.137 0 C-N-CA 124.187 0.898 . . . . 0.0 112.844 169.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 69.1 m -44.19 120.82 2.27 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.901 1.68 . . . . 0.0 113.093 170.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -152.01 -168.22 16.05 Favored Glycine 0 N--CA 1.468 0.826 0 C-N-CA 125.047 1.308 . . . . 0.0 114.288 -173.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 30.0 p -122.65 152.75 40.19 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.101 1.76 . . . . 0.0 110.314 -174.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 1.7 t -139.46 126.19 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.353 1.061 . . . . 0.0 108.474 -170.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 19.4 t -92.57 121.0 33.58 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.819 0.847 . . . . 0.0 108.757 172.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.94 155.54 18.65 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -165.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -55.02 -53.83 50.81 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.844 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -172.85 -170.62 0.68 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 128.519 2.728 . . . . 0.0 108.805 145.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.4 mp -55.96 -34.18 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.426 1.49 . . . . 0.0 113.284 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.36 -35.61 60.46 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.293 1.219 . . . . 0.0 114.293 174.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -98.82 -35.57 10.08 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 123.703 0.627 . . . . 0.0 110.127 -173.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.5 tt -51.21 -52.32 45.59 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 126.971 2.108 . . . . 0.0 110.659 174.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -65.15 -25.27 67.67 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 119.13 0.877 . . . . 0.0 113.21 -176.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -70.64 -55.96 7.57 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.917 1.287 . . . . 0.0 110.427 169.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -63.88 -37.2 86.52 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.124 1.37 . . . . 0.0 113.351 -175.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.15 -34.01 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.446 1.098 . . . . 0.0 112.031 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -82.53 -40.82 20.47 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.054 0.942 . . . . 0.0 111.901 173.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.07 -41.69 85.99 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.224 1.01 . . . . 0.0 113.501 -175.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -106.13 -17.53 14.29 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -169.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -66.78 121.05 14.6 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.977 1.262 . . . . 0.0 109.836 168.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 91.41 -1.2 75.89 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 124.193 0.901 . . . . 0.0 114.693 -171.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -97.49 166.75 11.38 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.318 1.447 . . . . 0.0 111.446 175.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 61.7 p -138.43 127.21 23.66 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 120.11 -1.619 . . . . 0.0 112.358 -177.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 16.9 mt -137.47 106.91 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.991 0.917 . . . . 0.0 109.72 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 59.03 25.18 13.54 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.402 1.481 . . . . 0.0 112.996 175.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . -167.29 -140.61 2.94 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.807 1.194 . . . . 0.0 113.808 -169.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -96.2 179.94 4.87 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.891 0.876 . . . . 0.0 111.101 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.53 128.2 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 165.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 16.3 mt -72.37 129.46 38.42 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.042 1.337 . . . . 0.0 112.111 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -112.79 118.84 36.08 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.021 1.728 . . . . 0.0 107.3 163.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 18.0 t -127.25 138.49 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.18 1.392 . . . . 0.0 109.436 -166.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -140.37 139.96 35.44 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.622 1.169 . . . . 0.0 111.521 -177.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 32.4 t -91.15 146.98 23.38 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.27 -0.894 . . . . 0.0 112.594 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -81.09 -6.96 59.42 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.121 0.968 . . . . 0.0 112.877 170.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -144.91 132.65 21.08 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.423 1.489 . . . . 0.0 111.126 -176.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 21.7 t -168.57 161.87 11.73 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.17 0.988 . . . . 0.0 112.273 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 12.9 p -170.99 147.48 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 127.14 2.176 . . . . 0.0 109.565 -172.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -151.82 137.77 18.13 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.271 1.028 . . . . 0.0 113.349 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -163.89 143.79 8.22 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.542 2.337 . . . . 0.0 109.606 174.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -154.35 143.69 21.35 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.166 0.986 . . . . 0.0 113.348 -176.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 13.6 t -164.21 164.13 22.64 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.995 2.118 . . . . 0.0 109.523 174.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -115.11 -61.21 1.78 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.469 1.108 . . . . 0.0 112.197 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 72.92 3.42 59.93 Favored Glycine 0 CA--C 1.536 1.404 0 N-CA-C 116.552 1.381 . . . . 0.0 116.552 170.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -89.13 118.95 29.21 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.661 1.731 . . . . 0.0 112.484 -174.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -165.85 136.87 3.72 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.486 1.914 . . . . 0.0 110.391 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 13.3 p -167.95 141.77 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 125.405 1.482 . . . . 0.0 111.389 -175.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -149.77 106.22 3.51 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.362 1.865 . . . . 0.0 109.186 172.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 39.0 pt -133.63 153.02 79.99 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 125.598 1.559 . . . . 0.0 112.048 -176.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -72.32 157.42 53.49 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.55 2.833 . . . . 0.0 111.263 172.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 97.8 mtp -79.39 143.35 35.14 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.934 0.893 . . . . 0.0 112.498 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -99.77 20.56 13.93 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.004 2.122 . . . . 0.0 113.098 -178.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -78.01 -1.38 31.85 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.207 1.803 . . . . 0.0 115.577 -169.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 19.9 t -63.16 125.6 87.3 Favored Pre-proline 0 CA--C 1.55 0.978 0 O-C-N 121.276 -0.89 . . . . 0.0 111.867 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.39 158.39 32.93 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.552 2.835 . . . . 0.0 112.35 -174.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 14.9 p -162.98 140.05 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.42 1.488 . . . . 0.0 110.397 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 . . . . . 0 C--O 1.254 1.295 0 C-N-CA 125.974 1.71 . . . . 0.0 111.68 -177.783 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.158 0 CA-C-O 119.67 -0.517 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 83.6 p 62.41 5.09 1.48 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 117.869 2.544 . . . . 0.0 117.869 164.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -156.81 159.58 38.39 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 120.338 -1.477 . . . . 0.0 113.286 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.37 149.47 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 126.3 1.84 . . . . 0.0 110.957 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.79 126.41 62.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 126.842 2.057 . . . . 0.0 106.277 172.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 29.5 m -91.44 144.74 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 167.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -144.94 138.21 26.72 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.6 0.76 . . . . 0.0 112.647 -167.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 50.2 t30 96.97 -3.03 0.05 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 129.461 3.104 . . . . 0.0 114.051 175.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 82.6 mt -70.62 133.62 86.68 Favored Pre-proline 0 CA--C 1.556 1.173 0 O-C-N 120.954 -1.091 . . . . 0.0 109.491 165.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -88.95 -168.58 0.35 Allowed 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 124.396 3.397 . . . . 0.0 111.471 -174.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -52.71 -17.09 1.16 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.908 1.683 . . . . 0.0 115.249 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 7.6 t -63.47 -31.25 72.36 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.567 1.147 . . . . 0.0 113.135 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.23 137.32 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 118.712 0.687 . . . . 0.0 110.74 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -145.24 173.0 12.33 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.35 2.26 . . . . 0.0 108.554 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -48.61 -44.38 37.04 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 120.156 1.344 . . . . 0.0 114.135 -166.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -74.7 -23.75 58.65 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -79.85 -37.26 35.37 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.852 1.206 . . . . 0.0 113.166 164.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.48 -48.54 76.91 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.835 0.854 . . . . 0.0 111.044 177.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.28 -30.86 71.43 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.773 -0.579 . . . . 0.0 111.344 -178.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.47 -18.91 63.75 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.011 1.724 . . . . 0.0 114.699 172.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 56.3 mt -56.78 -42.91 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 119.52 1.055 . . . . 0.0 110.27 168.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -104.96 -9.71 17.73 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -173.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -61.95 -8.56 5.32 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -175.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -57.9 -21.07 41.61 Favored 'General case' 0 CA--C 1.55 0.955 0 O-C-N 120.818 -1.176 . . . . 0.0 112.873 168.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 34.2 t -56.87 -21.85 32.52 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.505 1.522 . . . . 0.0 114.074 167.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.1 -17.37 58.16 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 126.907 2.194 . . . . 0.0 113.794 -176.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -139.35 -172.9 3.46 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.624 1.97 . . . . 0.0 109.875 173.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.41 134.56 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 120.544 -1.348 . . . . 0.0 111.294 167.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -74.25 -72.69 0.26 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.591 1.156 . . . . 0.0 112.674 -172.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -159.13 136.54 9.94 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.049 1.74 . . . . 0.0 110.888 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.45 137.89 11.75 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.326 -0.859 . . . . 0.0 112.459 -154.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -162.53 175.37 11.52 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.399 1.48 . . . . 0.0 112.499 -174.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 17.6 m -145.68 167.03 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 126.59 1.956 . . . . 0.0 110.821 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -132.12 148.11 52.46 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.643 1.577 . . . . 0.0 109.684 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.1 mp -134.88 142.05 46.49 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.642 1.177 . . . . 0.0 111.746 -177.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -79.92 179.75 7.41 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.0 0.92 . . . . 0.0 111.072 170.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -67.68 -17.8 69.46 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 121.105 -0.997 . . . . 0.0 114.589 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -88.61 -0.42 57.25 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.184 1.394 . . . . 0.0 113.569 175.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 72.65 25.07 74.99 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.066 0.841 . . . . 0.0 114.238 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 4.8 p -96.18 12.06 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -163.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 22.7 p 59.97 10.85 2.34 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 127.336 2.254 . . . . 0.0 115.132 -176.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . 0.27 1.1 t 50.47 10.07 0.05 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 129.389 3.075 . . . . 0.0 115.752 176.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 86.44 20.23 55.02 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.552 1.548 . . . . 0.0 114.531 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 95.1 p -164.37 167.99 19.08 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 120.103 1.951 . . . . 0.0 116.027 -172.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -153.78 163.6 30.91 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.303 1.906 . . . . 0.0 112.082 173.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 55.1 m -125.71 130.96 52.56 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 118.367 1.083 . . . . 0.0 110.779 -165.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 21.7 t -135.83 123.77 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.789 0.836 . . . . 0.0 109.455 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 66.2 m -104.07 128.26 51.67 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.077 1.351 . . . . 0.0 109.914 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.27 163.38 13.46 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 -141.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -54.21 -51.45 64.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.324 1.45 . . . . 0.0 111.688 175.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -172.86 167.33 5.16 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 128.7 2.8 . . . . 0.0 108.507 164.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.27 -30.62 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.92 0.888 . . . . 0.0 111.306 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.59 -43.7 46.54 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 171.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -95.72 -26.43 15.7 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 118.13 0.423 . . . . 0.0 111.581 -176.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 4.6 tt -53.87 -48.25 70.24 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.507 1.523 . . . . 0.0 109.973 172.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -57.81 -37.57 74.0 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -70.67 -52.43 21.19 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.515 0.726 . . . . 0.0 111.462 171.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -59.64 -34.72 73.15 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.32 1.448 . . . . 0.0 113.452 -175.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.89 -36.81 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.336 1.055 . . . . 0.0 112.382 176.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -83.66 -43.13 15.91 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.753 0.821 . . . . 0.0 112.268 173.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -58.65 -48.51 80.78 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.337 1.455 . . . . 0.0 113.898 -171.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -93.17 -18.51 22.47 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -174.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -73.74 111.89 9.32 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.598 -0.689 . . . . 0.0 110.558 177.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 101.07 -0.05 54.73 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.731 1.157 . . . . 0.0 114.414 -170.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -103.87 173.81 6.14 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.532 1.533 . . . . 0.0 111.446 174.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 30.5 p -138.03 122.94 18.94 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 120.412 -1.43 . . . . 0.0 111.933 -175.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 11.7 mt -145.02 115.09 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.636 1.174 . . . . 0.0 108.34 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 63.95 34.88 11.18 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.27 1.028 . . . . 0.0 112.565 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 167.45 -132.24 2.55 Favored Glycine 0 C--N 1.341 0.823 0 O-C-N 121.305 -0.872 . . . . 0.0 115.24 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -97.75 -174.64 2.95 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.516 1.526 . . . . 0.0 110.215 -173.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 55.1 t -58.76 126.12 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 159.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 2.2 pp -103.85 144.16 31.87 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 122.419 1.104 . . . . 0.0 112.006 -177.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -94.05 158.62 15.53 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.497 1.919 . . . . 0.0 109.931 165.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 26.3 t -136.2 132.03 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.303 1.441 . . . . 0.0 108.567 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -132.2 133.81 44.62 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.307 1.443 . . . . 0.0 109.98 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 78.0 p -94.73 154.4 17.32 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.973 -1.079 . . . . 0.0 112.154 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -80.21 70.06 6.76 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.864 0.866 . . . . 0.0 110.955 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -141.03 147.31 38.44 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.955 1.702 . . . . 0.0 111.283 -171.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 23.0 t -160.48 96.16 1.15 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.737 1.215 . . . . 0.0 109.916 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 27.6 m -142.32 14.84 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 124.887 1.275 . . . . 0.0 113.53 -172.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . 0.403 ' HE2' ' CE1' ' A' ' 342' ' ' HIS . 85.1 t60 -70.32 149.75 47.05 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -173.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -152.16 129.89 11.61 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.11 1.764 . . . . 0.0 110.622 173.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' HIS . . . . . 0.403 ' CE1' ' HE2' ' A' ' 340' ' ' HIS . 98.7 m-70 -77.05 121.76 23.99 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.833 0.853 . . . . 0.0 112.207 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 32.8 t -165.58 141.0 5.05 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.336 1.454 . . . . 0.0 111.03 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -89.12 -14.38 36.34 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.413 1.085 . . . . 0.0 113.219 177.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 74.52 -172.75 52.21 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.987 1.28 . . . . 0.0 113.801 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -162.48 121.74 2.28 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.403 1.481 . . . . 0.0 111.244 178.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -168.64 159.05 9.72 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.261 2.224 . . . . 0.0 109.743 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 11.3 m -150.24 137.67 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 127.21 2.204 . . . . 0.0 110.648 -178.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -170.19 118.17 0.56 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.67 1.988 . . . . 0.0 109.886 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 18.0 tt -133.72 132.98 21.91 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 125.06 1.344 . . . . 0.0 111.255 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.5 154.91 35.94 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 123.217 2.611 . . . . 0.0 111.557 176.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 25.1 ptp -163.99 153.2 13.99 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.396 1.478 . . . . 0.0 112.045 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -162.49 149.69 13.58 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.651 1.58 . . . . 0.0 111.752 -176.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -154.15 66.58 0.72 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.555 1.542 . . . . 0.0 110.233 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 21.9 t -114.88 137.35 22.79 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.824 1.25 . . . . 0.0 112.577 -171.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -78.92 174.31 12.37 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 124.261 3.308 . . . . 0.0 112.515 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 25.1 m -141.28 154.19 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.564 1.546 . . . . 0.0 111.56 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.158 0 C-N-CA 125.854 1.662 . . . . 0.0 111.418 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.004 0 N-CA-C 111.905 -0.478 . . . . 0.0 111.905 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 55.9 p -148.95 26.0 0.9 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.126 0.97 . . . . 0.0 113.165 -169.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -156.15 142.48 18.4 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.765 1.226 . . . . 0.0 110.801 -175.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 29.9 m -135.24 149.97 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 125.15 1.38 . . . . 0.0 111.249 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.74 144.34 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 126.606 1.962 . . . . 0.0 107.848 169.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 17.4 m -138.57 128.63 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.452 1.501 . . . . 0.0 109.432 -177.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -141.3 158.01 44.46 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -159.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 82.35 -26.25 0.14 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 129.847 3.259 . . . . 0.0 113.938 173.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 92.2 mt -28.71 108.67 0.23 Allowed Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 126.664 1.986 . . . . 0.0 111.482 145.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -87.56 -175.64 1.54 Allowed 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.89 3.06 . . . . 0.0 111.692 177.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -56.29 -25.2 47.55 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 16.8 m -67.47 -16.8 64.41 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . 0.262 2.7 p -108.6 85.36 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 126.407 1.883 . . . . 0.0 109.671 176.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -68.19 174.48 3.88 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.877 2.071 . . . . 0.0 113.39 -174.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -54.31 -43.31 71.02 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.85 -1.156 . . . . 0.0 113.573 -177.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -59.5 -45.12 92.61 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.373 0.669 . . . . 0.0 111.388 176.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.37 -32.98 72.39 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 176.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 2.6 tt -62.19 -42.13 98.99 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.299 1.04 . . . . 0.0 111.258 170.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -64.55 -38.67 91.83 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.415 -0.803 . . . . 0.0 111.036 173.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -62.7 -25.21 68.05 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 177.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 30.8 mt -50.34 -51.18 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 124.667 1.187 . . . . 0.0 111.432 175.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -94.33 -29.92 14.78 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.999 0.92 . . . . 0.0 111.19 -176.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -58.35 -20.53 44.32 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -177.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -61.73 -11.42 12.01 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 172.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 7.8 t -65.95 -14.08 60.93 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 124.358 1.063 . . . . 0.0 113.606 168.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.89 -10.1 60.33 Favored Glycine 0 N--CA 1.476 1.363 0 C-N-CA 126.337 1.922 . . . . 0.0 113.718 -177.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 34.5 p-10 -138.63 166.32 24.64 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 128.312 2.645 . . . . 0.0 110.028 173.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.5 p -145.28 140.92 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 120.936 -1.102 . . . . 0.0 111.733 168.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -69.98 -79.61 0.06 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.421 1.088 . . . . 0.0 111.828 -177.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -168.16 149.41 5.11 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 127.433 2.293 . . . . 0.0 110.66 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.14 150.07 21.75 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.95 0.9 . . . . 0.0 112.027 -168.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -170.14 179.84 3.38 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 126.37 1.868 . . . . 0.0 110.731 -176.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -165.21 138.51 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 127.246 2.219 . . . . 0.0 109.78 170.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -76.86 131.25 38.51 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 163.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 14.2 mt -103.25 170.5 7.92 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.633 0.773 . . . . 0.0 112.996 -168.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -51.09 154.67 1.48 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.149 1.779 . . . . 0.0 112.701 165.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -65.41 -15.78 61.86 Favored Glycine 0 CA--C 1.536 1.361 0 N-CA-C 115.983 1.153 . . . . 0.0 115.983 -173.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -88.48 -0.01 56.76 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 119.27 1.535 . . . . 0.0 113.15 169.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.07 21.18 61.47 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.409 1.48 . . . . 0.0 114.566 173.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 63.5 t -86.89 -62.53 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 117.939 0.87 . . . . 0.0 111.938 -167.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 10.3 t -175.05 -174.13 0.74 Allowed 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.051 1.34 . . . . 0.0 111.584 -171.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -161.71 -51.71 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 127.54 2.336 . . . . 0.0 112.106 174.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 87.51 -68.14 3.16 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.807 1.194 . . . . 0.0 112.241 -178.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 34.4 p -61.97 122.54 15.73 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.52 1.128 . . . . 0.0 112.665 172.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -177.54 -141.06 3.95 Favored Glycine 0 N--CA 1.471 1.021 0 C-N-CA 125.41 1.481 . . . . 0.0 113.856 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 8.0 p -130.77 148.81 52.59 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.911 1.685 . . . . 0.0 111.624 -175.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 13.4 m -130.25 147.9 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.004 1.322 . . . . 0.0 110.376 169.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 38.4 m -80.15 155.97 27.2 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.469 169.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.2 159.21 29.13 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 -172.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -58.06 -51.79 68.21 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.781 1.632 . . . . 0.0 112.237 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -172.16 -178.3 2.05 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.8 2.44 . . . . 0.0 109.398 159.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 17.9 tt -56.09 -33.21 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.095 1.358 . . . . 0.0 114.29 -175.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.31 -34.19 72.02 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 175.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.47 -22.2 25.07 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 119.208 -0.425 . . . . 0.0 111.674 -161.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 7.9 mp -50.09 -50.42 48.29 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.636 1.174 . . . . 0.0 109.848 163.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -62.92 -36.05 82.11 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -172.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.34 -51.73 27.86 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.465 1.106 . . . . 0.0 111.839 170.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -67.17 -32.41 73.48 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.48 1.512 . . . . 0.0 113.548 -172.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -62.65 -31.3 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 120.949 -1.094 . . . . 0.0 112.531 -178.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -82.33 -16.16 50.27 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.204 1.002 . . . . 0.0 113.308 174.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -89.0 -42.05 12.0 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.851 1.26 . . . . 0.0 112.438 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -101.48 -21.51 14.75 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -166.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -67.27 115.13 6.59 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 119.145 0.884 . . . . 0.0 110.999 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 91.67 0.3 72.66 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.03 1.3 . . . . 0.0 114.55 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -90.75 130.59 36.72 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.687 1.243 . . . . 0.0 111.23 -178.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 22.5 p -92.26 134.51 34.82 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 120.341 -1.474 . . . . 0.0 113.261 -175.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 49.1 mt -138.16 101.78 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.416 1.087 . . . . 0.0 109.68 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 53.34 38.84 28.79 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.913 1.685 . . . . 0.0 113.224 170.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 168.56 -128.82 1.76 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.017 0.818 . . . . 0.0 112.953 -169.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -90.63 -168.46 2.1 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.62 0.768 . . . . 0.0 110.372 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 34.4 m -68.46 145.89 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 O-C-N 120.896 -1.128 . . . . 0.0 109.587 164.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 42.7 tp -83.84 141.91 31.0 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.281 1.433 . . . . 0.0 109.309 167.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -126.64 154.31 44.17 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.976 0.911 . . . . 0.0 109.376 159.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 41.1 t -136.35 127.94 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.582 1.553 . . . . 0.0 108.838 -169.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -136.04 153.21 51.42 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.901 1.28 . . . . 0.0 112.817 -167.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 89.8 p -82.78 173.97 11.39 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.216 -0.927 . . . . 0.0 112.193 172.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -59.45 165.18 2.95 Favored 'General case' 0 CA--C 1.552 1.022 0 O-C-N 121.629 -0.669 . . . . 0.0 111.996 157.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -64.43 -33.5 76.02 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -170.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 9.4 t -164.23 172.97 12.9 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.502 1.121 . . . . 0.0 112.172 178.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 57.6 t -148.34 126.83 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 127.088 2.155 . . . . 0.0 108.236 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -67.35 131.78 46.39 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.371 0.668 . . . . 0.0 112.639 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -158.25 144.6 17.35 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.301 1.441 . . . . 0.0 111.559 -174.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -158.91 161.0 36.73 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.978 1.311 . . . . 0.0 113.18 -174.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 95.9 p -167.29 -159.72 0.34 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.873 2.069 . . . . 0.0 108.872 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -64.79 -13.75 56.56 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 120.91 -1.119 . . . . 0.0 113.756 167.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 91.81 -6.4 79.58 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.525 1.536 . . . . 0.0 114.689 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -164.21 175.83 9.77 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.774 2.03 . . . . 0.0 111.918 177.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -131.91 28.07 4.54 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.111 1.765 . . . . 0.0 113.247 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 3.5 p -60.48 138.21 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.01 0.924 . . . . 0.0 112.885 -173.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -163.17 112.51 1.32 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.277 1.831 . . . . 0.0 109.668 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 7.7 tp -74.52 131.32 80.24 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.788 0.835 . . . . 0.0 111.413 -175.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.73 161.93 30.26 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 123.197 2.598 . . . . 0.0 111.461 177.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 15.5 tpt -157.57 146.43 19.6 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.887 1.275 . . . . 0.0 111.472 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -163.22 156.23 18.99 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.765 2.026 . . . . 0.0 111.805 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -155.74 111.53 3.05 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.152 1.381 . . . . 0.0 110.742 177.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 69.2 m -115.42 146.8 37.32 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 124.946 1.298 . . . . 0.0 111.627 174.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -77.0 64.4 7.75 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 124.3 3.334 . . . . 0.0 111.652 -176.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 12.9 p -69.71 138.42 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.255 1.422 . . . . 0.0 111.728 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 9.0 t30 . . . . . 0 C--O 1.252 1.228 0 C-N-CA 125.754 1.622 . . . . 0.0 111.921 -177.649 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.914 0 N-CA-C 112.375 -0.29 . . . . 0.0 112.375 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 25.4 m -169.01 170.69 8.75 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 127.135 2.174 . . . . 0.0 110.2 178.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -151.25 137.09 18.07 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 120.719 -1.238 . . . . 0.0 112.683 -175.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 25.7 m -125.47 154.35 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.183 1.393 . . . . 0.0 110.341 165.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.1 mp -115.1 134.24 58.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.998 1.719 . . . . 0.0 107.434 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 20.5 m -105.78 129.65 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.233 1.013 . . . . 0.0 109.968 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -138.95 64.27 1.48 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.318 1.447 . . . . 0.0 111.257 -162.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -169.12 -40.48 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.179 1.792 . . . . 0.0 113.07 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 48.9 mt -57.19 116.58 14.03 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 127.16 2.184 . . . . 0.0 110.221 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -91.25 -170.17 0.33 Allowed 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 124.669 3.579 . . . . 0.0 112.342 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -56.56 -25.77 53.19 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -175.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 15.7 m -72.81 -16.58 61.61 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.441 1.096 . . . . 0.0 113.958 -177.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 1.3 p -108.34 105.67 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.926 2.09 . . . . 0.0 108.047 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -79.63 168.26 19.62 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.537 1.135 . . . . 0.0 111.912 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.7 -36.29 73.99 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 120.894 -1.129 . . . . 0.0 112.62 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -68.77 -32.93 73.03 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.333 -0.854 . . . . 0.0 112.233 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.53 -39.93 77.22 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.461 -0.781 . . . . 0.0 112.438 170.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 4.2 tt -54.33 -48.3 71.53 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.938 0.895 . . . . 0.0 109.856 170.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.83 -39.85 68.96 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.387 0.675 . . . . 0.0 112.161 175.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -68.88 -20.73 64.27 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 27.5 mt -60.13 -46.96 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 120.04 1.291 . . . . 0.0 112.259 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -98.43 -9.43 25.18 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.188 0.995 . . . . 0.0 113.429 -173.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -71.58 -0.74 11.38 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 128.23 2.612 . . . . 0.0 115.086 -177.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -61.56 -15.42 38.53 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 120.43 -1.419 . . . . 0.0 114.011 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 63.3 m -68.98 -3.35 12.59 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.678 1.591 . . . . 0.0 114.398 172.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 87.25 -52.99 4.39 Favored Glycine 0 N--CA 1.473 1.103 0 C-N-CA 126.074 1.797 . . . . 0.0 111.456 -176.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -72.16 170.23 14.44 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.31 1.044 . . . . 0.0 111.044 162.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.6 p -145.72 146.35 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.03 0.932 . . . . 0.0 111.827 164.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -77.53 -107.72 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.221 1.408 . . . . 0.0 112.158 177.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -158.38 149.25 20.55 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.3 1.84 . . . . 0.0 111.354 -171.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.31 165.65 34.26 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.478 1.111 . . . . 0.0 111.514 177.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -161.34 166.93 26.74 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.113 1.365 . . . . 0.0 111.619 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 14.8 m -145.48 153.82 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 126.516 1.926 . . . . 0.0 110.97 -171.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -106.45 117.63 34.53 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.344 1.057 . . . . 0.0 108.716 170.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 12.9 mt -89.77 160.22 16.65 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.642 0.734 . . . . 0.0 112.497 -175.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -78.77 137.46 37.75 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.753 1.221 . . . . 0.0 110.616 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -70.2 -8.03 61.14 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 116.488 1.355 . . . . 0.0 116.488 -162.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -79.78 -0.43 34.39 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 118.797 1.299 . . . . 0.0 112.699 166.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 88.55 48.48 3.95 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.429 1.49 . . . . 0.0 111.789 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 39.5 t -132.15 140.54 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.377 1.071 . . . . 0.0 110.78 -170.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 22.2 p -65.28 158.01 27.49 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.457 1.503 . . . . 0.0 114.021 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 21.7 p -139.15 -16.82 1.06 Allowed 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -168.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 67.85 -71.8 0.28 Allowed Glycine 0 N--CA 1.476 1.3 0 C-N-CA 126.26 1.886 . . . . 0.0 113.611 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 49.9 p -36.7 126.94 0.87 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.915 2.486 . . . . 0.0 113.881 167.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 176.34 -165.22 35.49 Favored Glycine 0 N--CA 1.471 1.027 0 N-CA-C 115.256 0.862 . . . . 0.0 115.256 -175.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 16.6 p -100.46 137.53 38.75 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.621 1.968 . . . . 0.0 110.893 -174.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.3 t -119.85 119.52 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.626 1.57 . . . . 0.0 107.111 172.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 53.7 m -93.81 110.16 21.82 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.774 1.229 . . . . 0.0 108.208 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.51 158.28 24.54 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -159.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -51.83 -54.17 31.9 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.675 1.19 . . . . 0.0 111.147 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -172.97 169.3 4.74 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 128.641 2.776 . . . . 0.0 109.272 161.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 19.5 tt -54.35 -29.02 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.325 1.05 . . . . 0.0 113.719 177.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.38 -37.91 62.87 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.17 1.388 . . . . 0.0 114.736 171.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -104.49 -20.88 13.56 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 7.0 tt -55.08 -51.55 66.01 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.332 1.453 . . . . 0.0 111.332 177.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -69.02 -24.16 64.16 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 33.6 mtp-105 -70.36 -44.28 68.45 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.135 0.974 . . . . 0.0 110.773 168.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -68.4 -43.26 77.67 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.215 1.406 . . . . 0.0 113.349 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 2.6 pt -70.96 -16.67 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 177.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -82.05 -40.91 21.35 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.84 0.856 . . . . 0.0 110.831 168.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -70.3 -53.74 15.56 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.451 1.1 . . . . 0.0 113.605 -178.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -90.18 -24.26 21.08 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -163.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -62.72 121.53 13.62 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 119.364 0.984 . . . . 0.0 110.244 173.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 101.82 0.32 52.23 Favored Glycine 0 CA--C 1.538 1.499 0 CA-C-O 118.833 -0.982 . . . . 0.0 115.098 -174.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -108.1 145.34 34.21 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.998 1.399 . . . . 0.0 112.032 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 62.1 m -112.59 129.15 56.47 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 120.779 -1.201 . . . . 0.0 111.974 -174.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 55.5 mt -137.33 106.95 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.298 1.039 . . . . 0.0 109.915 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 56.19 33.31 21.87 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.463 1.505 . . . . 0.0 112.95 170.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 171.78 -135.63 3.5 Favored Glycine 0 C--N 1.341 0.843 0 O-C-N 121.122 -0.986 . . . . 0.0 113.94 -168.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -99.8 165.31 11.64 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.164 0.986 . . . . 0.0 110.78 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 9.0 p -60.12 130.09 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.8 0.84 . . . . 0.0 112.771 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 35.9 mt -57.37 127.97 34.65 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.661 1.584 . . . . 0.0 113.923 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -134.02 122.57 23.2 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.527 2.731 . . . . 0.0 107.33 173.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 13.6 t -136.59 126.57 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.726 1.21 . . . . 0.0 109.476 -162.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -135.33 134.05 39.43 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.729 0.812 . . . . 0.0 111.532 -170.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 95.9 p -82.38 155.28 24.79 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.824 -1.173 . . . . 0.0 113.589 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -78.2 57.69 1.9 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.386 1.474 . . . . 0.0 111.579 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -138.37 -42.02 0.51 Allowed 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -171.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 42.9 m 66.59 20.55 10.78 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 172.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 89.0 t -87.89 125.7 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.149 1.38 . . . . 0.0 109.876 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -148.5 142.25 25.63 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.516 1.526 . . . . 0.0 112.141 -176.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 19.0 m120 65.65 99.23 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 127.734 2.414 . . . . 0.0 112.483 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -157.6 153.45 26.88 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.927 1.291 . . . . 0.0 113.079 -173.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 61.0 p -165.68 154.25 11.47 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.565 1.946 . . . . 0.0 110.845 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -77.9 -28.13 49.72 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -175.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 76.53 175.78 41.25 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.117 1.341 . . . . 0.0 115.003 175.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 33.6 t70 71.24 146.1 0.07 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 128.44 2.696 . . . . 0.0 114.78 175.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -163.48 142.28 8.09 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.669 1.987 . . . . 0.0 110.853 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 14.9 p -167.01 141.58 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.854 1.662 . . . . 0.0 110.655 -176.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 25.7 t70 75.41 123.75 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 128.213 2.605 . . . . 0.0 113.651 175.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 46.2 pt -133.25 148.99 71.31 Favored Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 125.678 1.591 . . . . 0.0 111.593 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.25 141.91 32.98 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.301 2.668 . . . . 0.0 111.235 178.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.86 166.31 15.66 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.607 1.963 . . . . 0.0 111.437 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -162.92 157.32 20.99 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.677 1.591 . . . . 0.0 112.378 -176.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -158.58 111.2 2.29 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.455 1.502 . . . . 0.0 110.445 176.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 66.2 m -115.57 146.4 36.58 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 124.813 1.245 . . . . 0.0 112.151 176.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -72.07 146.75 47.33 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.413 2.742 . . . . 0.0 111.184 177.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 14.6 p -164.26 142.4 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.086 1.354 . . . . 0.0 110.809 -177.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 . . . . . 0 C--O 1.252 1.219 0 C-N-CA 126.244 1.817 . . . . 0.0 111.683 -178.294 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.733 0 N-CA-C 112.323 -0.311 . . . . 0.0 112.323 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 69.2 p -162.13 13.88 0.08 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.553 1.541 . . . . 0.0 113.517 -177.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -139.4 166.68 23.91 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.826 2.05 . . . . 0.0 111.544 -172.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 31.0 m -138.49 153.88 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.568 1.147 . . . . 0.0 110.919 175.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 2.7 mp -103.93 134.32 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 30.7 m -107.36 132.26 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.916 1.286 . . . . 0.0 108.134 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -149.71 55.33 0.95 Allowed 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -154.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -167.58 -24.46 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.337 1.055 . . . . 0.0 113.728 172.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 52.6 mt -47.39 127.02 9.93 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 126.205 1.802 . . . . 0.0 111.311 165.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -82.78 173.28 10.45 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.879 3.053 . . . . 0.0 110.154 172.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -62.61 0.3 0.52 Allowed 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 8.3 t -65.67 -31.11 71.94 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.435 1.094 . . . . 0.0 113.089 171.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 8.0 p -83.24 130.0 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 118.457 0.571 . . . . 0.0 109.801 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -94.08 159.84 14.97 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.753 1.221 . . . . 0.0 111.16 177.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -48.62 -40.88 29.21 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -68.21 -39.35 82.43 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.458 -0.776 . . . . 0.0 111.727 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.42 -32.55 71.59 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.438 -0.789 . . . . 0.0 112.491 172.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 1.9 tt -62.26 -38.96 91.31 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.312 1.045 . . . . 0.0 112.0 171.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -60.5 -48.7 80.62 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.549 -0.719 . . . . 0.0 110.012 171.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -59.7 -24.43 63.96 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.26 1.424 . . . . 0.0 114.171 -175.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 9.1 mt -49.56 -39.86 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 125.117 1.367 . . . . 0.0 111.687 171.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -110.52 -35.19 6.09 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.051 1.34 . . . . 0.0 111.592 -176.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -61.31 -7.17 2.66 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.596 1.558 . . . . 0.0 113.915 174.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -44.95 -31.04 1.14 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.017 1.327 . . . . 0.0 112.955 159.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 83.5 m -64.37 -7.09 8.46 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 176.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 91.18 -3.01 79.74 Favored Glycine 0 N--CA 1.477 1.424 0 C-N-CA 125.678 1.609 . . . . 0.0 114.958 177.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -138.36 178.3 7.24 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.207 2.203 . . . . 0.0 109.496 176.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.11 142.03 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 120.458 -1.402 . . . . 0.0 112.912 177.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -83.65 -106.42 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.256 1.422 . . . . 0.0 110.161 167.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -148.69 147.0 28.39 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.848 1.659 . . . . 0.0 111.834 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.08 148.66 20.58 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.577 1.151 . . . . 0.0 111.628 -176.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -168.27 160.04 11.2 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.843 1.657 . . . . 0.0 110.943 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.68 131.71 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 126.827 2.051 . . . . 0.0 110.271 177.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -75.29 130.33 38.9 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.659 0.783 . . . . 0.0 110.534 167.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 10.4 mt -87.43 153.48 21.4 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.303 0.641 . . . . 0.0 111.392 -178.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -76.81 149.83 36.18 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.867 0.867 . . . . 0.0 112.537 -177.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -67.29 -15.74 66.07 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.801 1.191 . . . . 0.0 115.483 -176.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -81.68 0.16 39.99 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 119.059 1.429 . . . . 0.0 113.193 168.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 85.45 47.35 5.19 Favored Glycine 0 N--CA 1.469 0.889 0 C-N-CA 124.944 1.259 . . . . 0.0 113.402 171.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 35.5 m -137.54 151.18 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.658 1.183 . . . . 0.0 112.24 -176.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 10.9 m -90.04 11.69 19.94 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 -150.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 18.2 p 45.59 80.53 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 127.263 2.225 . . . . 0.0 114.16 167.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -69.36 -47.09 53.67 Favored Glycine 0 N--CA 1.472 1.069 0 O-C-N 121.692 -0.63 . . . . 0.0 113.481 -175.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 5.9 p -60.26 117.69 5.48 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.849 1.259 . . . . 0.0 110.932 164.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -179.13 -160.87 25.7 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.394 0.997 . . . . 0.0 115.336 -173.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 14.2 p -104.77 146.64 28.69 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.152 1.781 . . . . 0.0 112.867 -169.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.71 137.23 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.314 1.446 . . . . 0.0 109.912 169.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 8.7 t -102.29 144.55 30.66 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.86 0.864 . . . . 0.0 110.993 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -104.01 158.76 16.2 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -165.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -57.34 -55.93 28.45 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.145 -1.388 . . . . 0.0 111.152 175.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -172.64 179.78 2.34 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 128.46 2.704 . . . . 0.0 108.521 161.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.23 -25.37 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.637 1.175 . . . . 0.0 112.075 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.18 -33.56 41.28 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 168.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.56 -26.07 9.66 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.315 0.646 . . . . 0.0 112.514 -174.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 6.5 tt -55.05 -49.25 72.07 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.534 1.534 . . . . 0.0 111.041 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -68.82 -30.76 69.38 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.404 -0.81 . . . . 0.0 113.042 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 33.9 mtm180 -69.62 -37.4 76.82 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 121.52 -0.737 . . . . 0.0 111.107 174.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -70.48 -47.89 58.36 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.2 1.4 . . . . 0.0 112.284 174.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 3.5 pt -68.87 -21.65 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -75.38 -31.6 60.54 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 118.822 0.737 . . . . 0.0 112.205 170.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -88.91 -53.1 4.76 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.792 0.837 . . . . 0.0 113.081 -176.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -90.14 -16.98 28.47 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -164.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -71.49 110.2 5.94 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 121.102 -0.999 . . . . 0.0 110.013 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 99.21 0.12 57.14 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 125.193 1.377 . . . . 0.0 114.537 -170.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -98.55 145.67 26.58 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.193 1.397 . . . . 0.0 111.312 175.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 18.7 p -110.19 128.43 55.48 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.25 1.02 . . . . 0.0 113.155 -173.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 18.6 mt -143.9 115.48 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.883 1.273 . . . . 0.0 109.042 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 61.73 25.81 15.6 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.924 1.29 . . . . 0.0 113.449 173.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 173.87 -134.43 2.86 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 120.996 -1.065 . . . . 0.0 114.076 -171.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -86.39 -176.14 5.76 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.824 0.849 . . . . 0.0 109.751 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 19.9 m -58.94 142.84 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 O-C-N 120.981 -1.074 . . . . 0.0 108.687 155.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 3.0 pp -98.43 143.03 29.31 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.773 0.797 . . . . 0.0 111.006 175.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -125.58 137.06 53.9 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.779 1.632 . . . . 0.0 108.953 173.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 12.5 t -118.44 137.19 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.574 1.549 . . . . 0.0 110.026 -165.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -134.81 159.25 41.97 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.755 1.622 . . . . 0.0 112.328 -171.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 35.0 t -114.9 148.25 38.88 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.412 1.085 . . . . 0.0 112.101 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -86.86 -1.06 57.5 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.749 1.22 . . . . 0.0 112.946 172.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -149.72 136.54 19.44 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.708 1.603 . . . . 0.0 111.539 -171.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 98.3 p -169.72 159.56 8.21 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.942 1.297 . . . . 0.0 112.061 172.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 20.1 m -147.92 151.92 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 125.258 1.423 . . . . 0.0 111.739 -176.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -158.0 147.11 19.46 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.451 1.5 . . . . 0.0 112.513 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -162.49 144.4 10.67 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.443 1.897 . . . . 0.0 111.268 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -156.91 148.15 22.09 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.898 1.279 . . . . 0.0 113.065 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 64.0 p -164.45 151.22 11.19 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.554 1.942 . . . . 0.0 110.824 171.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -108.07 -22.85 12.23 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -173.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 71.5 -170.92 47.69 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.48 1.038 . . . . 0.0 114.549 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -164.96 151.66 10.6 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.414 1.886 . . . . 0.0 111.975 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -165.28 158.3 16.18 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.885 2.074 . . . . 0.0 110.097 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 57.8 t -148.13 129.41 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 127.395 2.278 . . . . 0.0 108.758 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -167.37 116.64 0.82 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.313 1.845 . . . . 0.0 109.93 -177.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 35.6 mm -131.51 122.88 19.1 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 125.325 1.45 . . . . 0.0 109.77 -177.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -78.6 143.73 19.27 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.387 2.725 . . . . 0.0 110.905 175.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 24.4 ptp -166.35 151.93 8.46 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.104 1.362 . . . . 0.0 112.431 -175.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -164.09 157.46 18.23 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.181 1.792 . . . . 0.0 111.647 -178.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -143.78 11.09 1.61 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.831 2.052 . . . . 0.0 112.217 176.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 18.8 m -68.62 133.84 90.65 Favored Pre-proline 0 CA--C 1.552 1.026 0 O-C-N 120.589 -1.319 . . . . 0.0 112.712 -176.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.64 -23.9 6.66 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 123.061 2.507 . . . . 0.0 114.297 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 77.35 149.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 127.654 2.381 . . . . 0.0 113.238 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 32.2 m120 . . . . . 0 C--O 1.252 1.207 0 C-N-CA 125.977 1.711 . . . . 0.0 111.916 -176.142 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.839 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 56.2 p -152.35 21.63 0.64 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.121 0.968 . . . . 0.0 113.236 -173.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -162.64 141.98 9.12 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.138 1.375 . . . . 0.0 110.289 -174.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 15.6 m -135.91 156.82 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 125.159 1.384 . . . . 0.0 111.584 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 5.4 mp -116.13 138.32 46.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 126.858 2.063 . . . . 0.0 107.129 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 34.3 m -120.22 129.76 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.28 1.032 . . . . 0.0 109.338 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -146.17 58.5 1.22 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.779 0.8 . . . . 0.0 111.907 -157.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -164.36 -45.14 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.798 1.239 . . . . 0.0 111.471 -176.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 27.7 mt -40.12 117.53 1.32 Allowed Pre-proline 0 CA--C 1.557 1.242 0 C-N-CA 126.099 1.76 . . . . 0.0 111.496 158.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -95.33 -177.95 0.47 Allowed 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.633 3.555 . . . . 0.0 111.703 -176.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -54.44 -14.19 1.16 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.577 1.551 . . . . 0.0 115.16 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 17.1 m -65.91 -21.12 66.42 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.111 1.364 . . . . 0.0 113.987 172.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 8.2 p -101.4 132.84 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 119.428 1.013 . . . . 0.0 110.643 172.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -90.59 157.1 17.68 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.271 1.428 . . . . 0.0 111.373 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -59.59 -31.62 69.63 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 120.478 -1.389 . . . . 0.0 113.213 178.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -68.24 -34.59 76.5 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.282 -0.886 . . . . 0.0 111.042 176.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.94 -38.8 76.27 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 117.733 -1.127 . . . . 0.0 113.098 168.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 3.9 tt -53.37 -51.25 63.11 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.84 1.2 . . . . 0.0 109.883 172.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -48.84 -44.52 39.61 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.138 0.975 . . . . 0.0 111.953 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -68.71 -25.49 64.79 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 21.1 mt -53.32 -45.05 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 124.627 1.171 . . . . 0.0 111.377 176.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -98.09 -34.15 10.88 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.449 1.1 . . . . 0.0 111.627 -175.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -61.17 -10.33 6.35 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.611 1.164 . . . . 0.0 113.803 173.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 15.4 tm-20 -52.23 -24.71 7.69 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.638 1.575 . . . . 0.0 113.484 165.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 87.0 m -63.82 -8.21 10.15 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 172.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 88.8 2.28 78.83 Favored Glycine 0 N--CA 1.479 1.516 0 C-N-CA 124.663 1.125 . . . . 0.0 114.777 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -138.39 -177.92 5.06 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 127.237 2.215 . . . . 0.0 108.227 172.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.6 p -132.01 146.75 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 120.828 1.649 . . . . 0.0 114.063 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -106.48 -120.03 0.24 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.27 1.828 . . . . 0.0 110.821 171.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -161.08 156.69 24.92 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.602 1.961 . . . . 0.0 112.733 -174.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.39 164.85 35.9 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.487 1.115 . . . . 0.0 113.174 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -156.64 160.03 39.01 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.279 1.832 . . . . 0.0 110.995 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 3.5 t -151.63 141.58 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.354 1.462 . . . . 0.0 109.555 -172.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -113.06 134.49 54.5 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.463 1.105 . . . . 0.0 109.515 168.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 13.9 mt -98.69 172.59 7.37 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.182 0.993 . . . . 0.0 113.037 -170.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.25 153.72 0.68 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.094 2.158 . . . . 0.0 113.277 165.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -72.09 -3.92 57.87 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.911 1.243 . . . . 0.0 115.808 -172.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -114.65 0.62 13.97 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 126.267 1.827 . . . . 0.0 111.709 168.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 94.84 8.93 58.93 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 126.345 1.926 . . . . 0.0 114.476 176.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 4.8 t -87.58 58.28 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 118.819 1.31 . . . . 0.0 111.074 -171.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 75.6 m 61.1 -168.08 0.18 Allowed 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 126.325 1.85 . . . . 0.0 114.501 170.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -167.04 -45.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 127.249 2.22 . . . . 0.0 112.276 175.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 82.08 -57.14 4.98 Favored Glycine 0 N--CA 1.472 1.042 0 C-N-CA 125.252 1.406 . . . . 0.0 112.051 -176.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 61.9 p -55.57 111.04 0.8 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.715 1.606 . . . . 0.0 112.459 169.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -139.37 -166.35 10.59 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.008 1.29 . . . . 0.0 113.996 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 93.7 m -115.99 141.63 47.87 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.528 1.931 . . . . 0.0 108.934 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 t -129.9 116.11 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 125.446 1.498 . . . . 0.0 107.412 -173.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 46.2 m -101.52 110.25 22.22 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.223 1.409 . . . . 0.0 108.176 -174.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.28 168.65 12.53 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -151.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -53.68 -65.31 0.59 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.847 1.259 . . . . 0.0 111.024 175.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -172.65 -175.73 1.37 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 129.153 2.981 . . . . 0.0 108.005 162.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 16.3 tt -55.14 -37.03 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -175.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -49.63 67.76 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -92.05 -18.82 23.06 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.439 0.296 . . . . 0.0 110.836 -174.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 57.5 tp -66.25 -47.36 73.97 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.462 0.705 . . . . 0.0 111.093 171.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -68.32 -20.87 64.78 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.342 -0.848 . . . . 0.0 113.037 178.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 35.5 mtp85 -70.61 -54.57 11.51 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.36 1.064 . . . . 0.0 111.621 162.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.03 -43.99 82.48 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.026 1.33 . . . . 0.0 113.752 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 2.6 pp -65.38 -21.35 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 177.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -82.6 -46.32 13.46 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.438 1.095 . . . . 0.0 111.199 172.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -71.57 -47.99 51.32 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -176.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -98.39 -22.26 16.16 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -163.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -67.15 120.47 13.78 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.872 -1.142 . . . . 0.0 110.494 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 92.37 -1.0 72.18 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.071 1.319 . . . . 0.0 114.95 -173.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -98.59 139.76 33.83 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.126 1.463 . . . . 0.0 111.328 177.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 23.7 p -103.15 133.99 47.33 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.136 0.975 . . . . 0.0 113.155 -174.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 56.3 mt -144.17 113.59 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.953 1.301 . . . . 0.0 108.763 -176.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 58.07 25.84 12.87 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.806 1.242 . . . . 0.0 113.832 176.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 166.37 -129.63 1.97 Allowed Glycine 0 C--N 1.342 0.905 0 C-N-CA 124.424 1.012 . . . . 0.0 113.194 -176.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -83.76 177.7 8.25 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.889 0.876 . . . . 0.0 111.099 -177.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 32.9 m -62.69 149.83 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 O-C-N 121.55 -0.718 . . . . 0.0 110.739 166.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 10.9 mt -73.35 137.18 44.59 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.186 0.994 . . . . 0.0 111.489 170.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -125.37 108.48 11.72 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.667 1.587 . . . . 0.0 107.747 167.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.84 120.96 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.27 1.428 . . . . 0.0 109.798 -165.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -139.54 162.5 34.93 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.391 1.477 . . . . 0.0 111.859 -171.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 77.8 p -145.19 159.18 43.39 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 120.869 -1.145 . . . . 0.0 113.078 -176.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -83.31 59.57 5.1 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.393 1.077 . . . . 0.0 111.981 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -160.92 149.86 16.61 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.294 1.438 . . . . 0.0 111.523 -172.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 79.2 p -166.68 167.9 14.87 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.58 1.152 . . . . 0.0 112.566 176.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 18.1 m -147.39 152.36 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 125.364 1.466 . . . . 0.0 111.89 -173.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -70.88 153.7 42.48 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.763 1.225 . . . . 0.0 113.918 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -162.33 -176.01 4.86 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.899 1.68 . . . . 0.0 111.337 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 22.7 m80 62.32 24.49 14.58 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 126.211 1.804 . . . . 0.0 114.456 174.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 22.8 t -157.15 32.78 0.29 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.814 1.246 . . . . 0.0 111.661 -168.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -113.31 0.13 14.73 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -156.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 92.9 170.86 40.22 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.278 1.418 . . . . 0.0 115.274 172.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -152.08 155.87 38.77 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.511 2.324 . . . . 0.0 110.307 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -161.95 150.46 15.21 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.869 1.667 . . . . 0.0 111.266 -177.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 14.9 p -164.0 143.29 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 126.633 1.973 . . . . 0.0 110.414 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -161.84 113.91 1.74 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.761 1.625 . . . . 0.0 109.778 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.36 149.06 71.36 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 125.936 1.694 . . . . 0.0 111.851 -176.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -71.76 149.19 53.98 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.217 2.611 . . . . 0.0 110.905 173.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 28.4 ttm -150.84 13.95 0.72 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -172.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -160.82 160.31 30.98 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.933 1.693 . . . . 0.0 111.575 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -156.88 100.48 1.9 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.046 1.738 . . . . 0.0 109.979 177.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 77.6 p -115.17 151.5 45.79 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 125.284 1.434 . . . . 0.0 112.746 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -73.14 148.83 45.08 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.491 2.794 . . . . 0.0 111.501 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 14.9 p -163.61 140.42 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.12 1.368 . . . . 0.0 110.792 -177.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.187 0 C-N-CA 125.799 1.639 . . . . 0.0 111.134 -178.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.986 0 N-CA-C 112.157 -0.377 . . . . 0.0 112.157 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 18.0 m -92.15 -10.56 38.38 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -172.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 71.83 163.61 0.27 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 127.489 2.315 . . . . 0.0 113.025 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 16.1 m -137.03 159.76 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.248 1.019 . . . . 0.0 111.069 173.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.4 mp -131.66 141.47 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 127.249 2.22 . . . . 0.0 107.469 -175.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 19.4 m -129.68 133.43 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.834 0.854 . . . . 0.0 111.086 -174.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -148.57 73.23 1.22 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.863 1.265 . . . . 0.0 112.772 -164.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -169.12 -41.68 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.627 1.571 . . . . 0.0 111.237 171.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 49.6 mt -28.17 110.92 0.24 Allowed Pre-proline 0 CA--C 1.561 1.396 0 C-N-CA 127.159 2.183 . . . . 0.0 111.415 153.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -95.64 -170.64 0.18 Allowed 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 125.238 3.959 . . . . 0.0 112.658 -175.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -58.1 -20.25 38.55 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -173.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 58.8 m -76.93 -11.6 59.83 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 176.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 1.4 p -108.51 145.56 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 126.969 2.107 . . . . 0.0 108.227 167.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -155.59 174.63 14.99 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.678 1.591 . . . . 0.0 109.638 -176.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -41.99 -49.41 4.65 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.817 1.647 . . . . 0.0 114.853 -170.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -68.52 -35.71 77.86 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 118.916 0.78 . . . . 0.0 112.18 -175.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.37 -37.75 74.64 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 168.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 7.8 tt -61.79 -35.3 77.77 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.233 0.613 . . . . 0.0 111.727 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -53.03 -52.39 58.63 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.686 0.676 . . . . 0.0 110.641 170.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -59.63 -27.99 66.82 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.041 1.336 . . . . 0.0 113.331 -175.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 32.9 mt -51.7 -45.7 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.782 1.233 . . . . 0.0 112.082 173.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -106.17 -24.6 12.29 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.164 0.986 . . . . 0.0 112.548 -174.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -64.03 -2.93 2.21 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 126.626 1.97 . . . . 0.0 114.713 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -57.82 -20.76 38.22 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 120.567 -1.333 . . . . 0.0 113.307 168.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 72.0 m -69.02 0.32 4.71 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 125.436 1.494 . . . . 0.0 114.451 170.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 100.32 -76.69 0.44 Allowed Glycine 0 C--N 1.342 0.875 0 C-N-CA 126.36 1.933 . . . . 0.0 110.876 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -73.46 175.53 6.91 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.286 1.034 . . . . 0.0 111.173 172.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.01 142.08 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 120.65 -1.281 . . . . 0.0 111.442 172.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -76.95 -96.28 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.749 1.22 . . . . 0.0 111.142 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -160.66 147.07 15.24 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.633 1.573 . . . . 0.0 111.978 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.48 172.01 19.11 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.968 -1.082 . . . . 0.0 112.185 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -158.26 153.22 25.23 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -178.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 27.2 t -157.28 136.25 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 129.476 3.11 . . . . 0.0 105.674 176.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -132.24 144.27 50.51 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.02 0.528 . . . . 0.0 111.892 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 9.1 mp -64.77 144.07 57.5 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.6 1.16 . . . . 0.0 111.755 175.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -69.79 151.41 45.8 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.864 1.266 . . . . 0.0 111.339 169.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -64.86 -11.31 49.85 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.949 1.261 . . . . 0.0 115.348 -176.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -70.49 -6.45 36.19 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 118.782 1.291 . . . . 0.0 113.151 166.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 85.74 49.19 4.42 Favored Glycine 0 C--N 1.343 0.918 0 C-N-CA 125.481 1.515 . . . . 0.0 112.367 176.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 9.5 p -155.13 143.83 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.922 0.889 . . . . 0.0 112.135 -170.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 38.3 t -68.15 170.34 8.72 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.414 1.086 . . . . 0.0 113.209 176.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 12.1 t -144.15 -25.02 0.54 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -173.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 73.98 -48.25 1.67 Allowed Glycine 0 N--CA 1.475 1.246 0 C-N-CA 125.624 1.583 . . . . 0.0 114.589 177.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 7.8 p -51.07 123.12 8.67 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.542 1.937 . . . . 0.0 112.411 168.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -168.74 -168.6 31.04 Favored Glycine 0 N--CA 1.469 0.894 0 C-N-CA 124.075 0.845 . . . . 0.0 115.177 -174.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 18.7 p -115.56 152.54 32.86 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.259 1.824 . . . . 0.0 111.073 -170.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.5 t -138.99 120.53 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.177 1.391 . . . . 0.0 108.095 -177.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 4.5 t -100.12 108.22 20.31 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.398 1.079 . . . . 0.0 108.849 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.25 162.09 22.45 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -158.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -53.91 -63.51 1.13 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.906 1.282 . . . . 0.0 111.052 174.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -172.32 -176.34 1.57 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.995 2.518 . . . . 0.0 109.533 159.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.5 mp -49.11 -39.08 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 125.605 1.562 . . . . 0.0 113.569 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.25 -42.03 66.06 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 177.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -95.21 -31.43 13.5 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 123.321 0.388 . . . . 0.0 110.617 -174.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.5 tt -55.93 -51.32 68.08 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 125.469 1.508 . . . . 0.0 110.755 175.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -61.92 -46.59 88.69 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.056 0.844 . . . . 0.0 112.516 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -70.45 -32.74 70.43 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 176.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -65.87 -38.37 88.61 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.18 0.992 . . . . 0.0 112.045 171.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -57.74 -40.86 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.653 1.181 . . . . 0.0 112.168 176.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -81.99 -24.57 35.38 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -79.27 -45.09 20.42 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.355 1.062 . . . . 0.0 112.959 -177.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -103.68 -26.18 12.86 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -167.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -65.32 116.26 6.46 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 119.682 1.128 . . . . 0.0 110.023 173.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 99.61 0.55 56.58 Favored Glycine 0 CA--C 1.538 1.486 0 CA-C-O 119.101 -0.833 . . . . 0.0 114.962 -174.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -104.27 151.7 23.09 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.795 1.638 . . . . 0.0 111.63 175.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 26.9 p -111.92 134.11 53.69 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 120.433 -1.417 . . . . 0.0 113.09 -177.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 59.3 mt -145.27 118.71 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.898 1.279 . . . . 0.0 109.604 -176.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 57.15 23.27 8.39 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.636 1.574 . . . . 0.0 114.32 173.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 170.17 -119.84 0.83 Allowed Glycine 0 C--N 1.341 0.839 0 O-C-N 120.992 -1.067 . . . . 0.0 113.029 -177.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -86.03 176.66 7.9 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.355 0.662 . . . . 0.0 111.079 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 9.4 p -57.1 138.45 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 121.655 -0.653 . . . . 0.0 109.335 155.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 1.5 pp -100.48 145.03 28.76 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.831 0.824 . . . . 0.0 111.432 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -126.28 137.9 53.55 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.038 1.735 . . . . 0.0 109.374 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 18.5 t -120.54 132.19 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.36 1.464 . . . . 0.0 109.996 -170.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -131.41 154.72 48.36 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.377 1.871 . . . . 0.0 110.652 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 79.3 p -145.14 167.37 22.9 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 120.599 -1.313 . . . . 0.0 112.754 -172.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -69.32 144.96 53.37 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.904 0.882 . . . . 0.0 111.945 176.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -157.3 -60.81 0.09 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.245 1.018 . . . . 0.0 111.34 -173.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 1.4 t 68.62 19.02 8.73 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 164.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 7.9 p -157.54 141.88 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.295 1.438 . . . . 0.0 111.123 -177.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -143.96 155.82 44.19 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.419 1.488 . . . . 0.0 112.595 -173.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -79.05 167.19 21.43 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.263 1.025 . . . . 0.0 113.111 177.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -141.95 168.56 19.47 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.674 1.589 . . . . 0.0 112.81 -175.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 19.4 m 75.84 158.62 0.21 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 127.757 2.423 . . . . 0.0 113.484 -177.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -86.06 -7.63 58.48 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -172.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 95.79 -149.06 19.2 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.221 1.391 . . . . 0.0 113.266 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -158.57 148.98 19.96 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.55 1.54 . . . . 0.0 111.875 -172.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -164.42 149.9 10.31 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.983 2.113 . . . . 0.0 110.617 -177.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 13.4 p -162.46 139.83 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.746 1.618 . . . . 0.0 110.95 -178.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -164.14 114.73 1.27 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.091 1.756 . . . . 0.0 109.91 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 1.8 mp -91.07 126.34 55.56 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 124.411 1.084 . . . . 0.0 108.785 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -73.51 143.17 34.05 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.297 2.665 . . . . 0.0 111.03 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 24.9 ptp -165.04 156.37 14.78 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.405 1.482 . . . . 0.0 112.088 -175.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -161.69 163.71 29.58 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.919 1.688 . . . . 0.0 111.228 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -151.67 104.32 3.03 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.602 1.561 . . . . 0.0 110.259 177.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 46.4 m -66.02 140.2 96.96 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 123.944 0.897 . . . . 0.0 113.033 -177.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -74.54 162.59 37.73 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.593 2.862 . . . . 0.0 111.691 176.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 96.4 t -68.83 -28.25 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.451 0.7 . . . . 0.0 111.812 178.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 8.3 t30 . . . . . 0 C--O 1.254 1.339 0 C-N-CA 126.098 1.759 . . . . 0.0 111.811 179.597 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.906 0 CA-C-O 121.025 0.236 . . . . 0.0 112.591 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 33.3 t -159.09 105.78 1.76 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.869 1.268 . . . . 0.0 110.08 -177.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -158.08 140.53 14.46 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 120.875 -1.14 . . . . 0.0 112.289 -167.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 21.2 t -126.96 140.01 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 127.33 2.252 . . . . 0.0 108.499 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.4 mp -106.79 131.04 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.736 1.614 . . . . 0.0 107.057 175.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 23.0 m -110.59 126.39 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.617 0.767 . . . . 0.0 109.232 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -148.69 59.64 1.07 Allowed 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 121.64 0.733 . . . . 0.0 112.127 -155.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -171.42 -38.26 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 126.116 1.767 . . . . 0.0 111.285 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -34.29 122.52 0.53 Allowed Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 126.637 1.975 . . . . 0.0 111.517 162.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -86.18 167.13 9.39 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.46 3.44 . . . . 0.0 110.671 175.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -60.53 -4.6 0.94 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -174.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 8.3 t -60.58 -31.05 70.2 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.606 1.163 . . . . 0.0 113.205 169.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 8.8 p -79.73 121.63 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 121.639 0.733 . . . . 0.0 111.511 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -79.15 156.68 28.14 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.965 1.306 . . . . 0.0 110.6 170.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -52.04 -37.92 55.28 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 120.804 -1.185 . . . . 0.0 113.087 178.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -71.42 -38.24 71.41 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.502 -0.749 . . . . 0.0 111.354 178.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.98 -26.36 64.99 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.05 -1.031 . . . . 0.0 112.651 171.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 1.8 tt -66.95 -46.93 73.22 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.623 0.769 . . . . 0.0 111.367 170.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -28.56 66.42 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.808 1.186 . . . . 0.0 111.218 177.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -64.99 -23.17 67.14 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.675 1.19 . . . . 0.0 113.258 173.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 41.3 mt -55.02 -51.33 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 119.226 0.921 . . . . 0.0 110.315 171.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -91.09 -18.73 24.06 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.267 1.027 . . . . 0.0 112.508 -173.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -57.17 -17.86 12.98 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.863 1.665 . . . . 0.0 114.146 176.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -57.17 -14.86 4.56 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.343 1.457 . . . . 0.0 114.146 173.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 9.3 t -66.15 -11.38 48.98 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 171.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 91.23 -3.29 79.79 Favored Glycine 0 N--CA 1.479 1.537 0 C-N-CA 125.488 1.518 . . . . 0.0 114.219 -177.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -138.53 -179.6 5.91 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.971 2.509 . . . . 0.0 108.189 171.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 5.0 p -145.78 143.3 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 120.158 1.345 . . . . 0.0 112.68 164.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -78.77 -94.73 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.529 1.532 . . . . 0.0 112.183 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -170.6 153.47 4.18 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 127.717 2.407 . . . . 0.0 110.072 -167.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.56 170.15 22.82 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.156 -0.965 . . . . 0.0 112.626 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -149.65 143.27 25.4 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.43 1.092 . . . . 0.0 113.314 -177.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 32.2 t -158.66 136.82 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 127.498 2.319 . . . . 0.0 107.999 -171.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -132.67 128.06 36.2 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.998 0.919 . . . . 0.0 110.322 170.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 12.1 mt -75.49 167.68 21.45 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 122.206 1.003 . . . . 0.0 113.631 -169.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.96 151.97 0.86 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 127.842 2.457 . . . . 0.0 113.804 167.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -70.9 -6.93 60.99 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.938 1.256 . . . . 0.0 116.082 -172.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -109.72 0.43 18.92 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.101 1.76 . . . . 0.0 111.83 169.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 95.26 8.6 58.66 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.735 2.112 . . . . 0.0 114.393 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 6.2 t -90.19 58.74 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 118.804 1.302 . . . . 0.0 111.019 -166.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 7.6 t 60.36 -163.48 0.24 Allowed 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 125.598 1.559 . . . . 0.0 114.096 172.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -166.47 143.53 5.02 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 129.041 2.937 . . . . 0.0 108.631 173.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -89.11 -76.9 1.3 Allowed Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.148 0.88 . . . . 0.0 112.086 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 32.2 p -54.92 149.34 11.74 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.372 1.469 . . . . 0.0 113.676 169.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -163.32 -177.46 36.26 Favored Glycine 0 N--CA 1.471 1.028 0 C-N-CA 125.045 1.307 . . . . 0.0 114.664 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 40.6 m -116.38 135.3 53.98 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.503 1.521 . . . . 0.0 108.623 -177.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 13.2 m -129.93 130.73 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.066 0.946 . . . . 0.0 109.181 178.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 33.0 m -90.52 115.51 27.72 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.953 0.901 . . . . 0.0 108.715 -175.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -83.59 147.54 27.67 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -163.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -49.78 -55.62 13.38 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.95 1.3 . . . . 0.0 112.573 -175.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.59 172.84 4.15 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.85 2.06 . . . . 0.0 110.039 162.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.42 -24.84 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.3 1.04 . . . . 0.0 112.422 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -45.54 69.72 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 169.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -98.18 -20.04 17.52 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.35 0.523 . . . . 0.0 111.947 -175.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -49.3 -52.15 29.5 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.066 1.747 . . . . 0.0 111.117 174.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -67.32 -29.67 69.3 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -70.49 -52.25 23.32 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.314 0.645 . . . . 0.0 110.888 170.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -59.65 -35.9 75.33 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.276 1.43 . . . . 0.0 113.004 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -50.67 -44.38 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.639 1.176 . . . . 0.0 112.393 176.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -90.39 -34.35 15.68 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 177.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -62.43 -40.08 95.4 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.994 -1.066 . . . . 0.0 113.025 -176.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -92.98 -13.39 28.82 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -62.71 115.28 4.17 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.532 -0.73 . . . . 0.0 110.189 169.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 91.93 0.18 72.01 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-O 118.935 -0.925 . . . . 0.0 114.898 -175.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -103.42 135.54 44.85 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.011 1.405 . . . . 0.0 111.5 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 30.1 p -112.82 133.48 54.79 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.411 1.084 . . . . 0.0 112.563 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -144.0 119.65 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.579 1.151 . . . . 0.0 109.015 -170.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 56.94 28.35 14.54 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.447 1.099 . . . . 0.0 113.44 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 149.18 -119.67 1.08 Allowed Glycine 0 C--N 1.343 0.964 0 C-N-CA 124.433 1.016 . . . . 0.0 113.09 -174.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -89.67 175.32 7.3 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.112 0.965 . . . . 0.0 112.239 -169.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.94 137.06 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.161 0.984 . . . . 0.0 110.014 169.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.56 124.57 24.97 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.726 0.81 . . . . 0.0 111.832 -177.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.5 113.43 24.81 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 158.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 91.4 t -105.83 121.22 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.648 1.179 . . . . 0.0 108.609 177.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -140.98 133.69 28.79 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.239 1.416 . . . . 0.0 110.042 175.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 65.2 p -82.9 166.61 18.76 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.377 -0.827 . . . . 0.0 111.811 173.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -71.58 94.12 1.28 Allowed 'General case' 0 CA--C 1.547 0.863 0 O-C-N 121.244 -0.91 . . . . 0.0 111.001 174.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -168.49 178.92 4.58 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.477 1.911 . . . . 0.0 110.185 -173.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 12.0 t -161.15 176.76 10.94 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.846 1.258 . . . . 0.0 112.05 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 14.0 p -166.84 146.14 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.303 1.841 . . . . 0.0 110.84 -171.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 35.1 p80 -133.26 8.57 4.0 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.153 1.381 . . . . 0.0 114.548 -173.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -67.35 162.57 22.6 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.86 1.264 . . . . 0.0 113.078 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -147.42 165.3 30.65 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.159 1.784 . . . . 0.0 112.664 -176.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 64.9 p -146.27 20.68 1.38 Allowed 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -165.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -67.14 -23.98 65.85 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -176.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 83.06 168.1 42.49 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.079 1.323 . . . . 0.0 114.593 174.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -160.03 26.48 0.17 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.907 1.683 . . . . 0.0 111.561 -175.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -102.19 7.04 40.99 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -154.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 58.3 t -143.2 126.74 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 126.267 1.827 . . . . 0.0 109.247 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -154.4 35.71 0.42 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.304 1.441 . . . . 0.0 111.516 -175.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 7.9 tp -133.45 138.68 31.86 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 125.854 1.661 . . . . 0.0 110.805 -173.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.31 160.96 41.32 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.015 2.477 . . . . 0.0 111.45 174.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 63.0 ttp -158.11 142.15 15.76 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.741 1.216 . . . . 0.0 111.514 -175.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -157.27 158.5 36.23 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.898 1.679 . . . . 0.0 111.4 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -153.74 1.79 0.25 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.449 2.3 . . . . 0.0 113.285 -176.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 73.3 m -67.33 139.43 94.7 Favored Pre-proline 0 CA--C 1.551 1.009 0 O-C-N 121.021 -1.049 . . . . 0.0 112.442 178.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -76.23 153.11 35.82 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.707 2.938 . . . . 0.0 111.779 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 18.3 m -147.16 149.97 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 125.445 1.498 . . . . 0.0 111.567 -178.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.252 1.226 0 C-N-CA 126.82 2.048 . . . . 0.0 111.858 -177.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.939 0 CA-C-O 121.116 0.287 . . . . 0.0 112.424 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 9.9 p -78.55 62.22 3.09 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.501 1.521 . . . . 0.0 112.788 -177.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.14 138.66 24.1 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.624 1.17 . . . . 0.0 111.029 -173.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 65.5 t -151.32 146.35 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 126.642 1.977 . . . . 0.0 108.898 -165.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 2.0 mp -131.29 136.99 56.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.026 1.731 . . . . 0.0 107.835 176.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 31.5 m -120.3 124.64 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.809 1.244 . . . . 0.0 108.797 -176.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -143.85 80.0 1.64 Allowed 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -156.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -172.27 -38.82 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.245 1.818 . . . . 0.0 111.105 169.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 59.0 mt -34.82 123.26 0.56 Allowed Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 128.362 2.665 . . . . 0.0 113.132 167.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -85.44 174.89 6.6 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.102 3.201 . . . . 0.0 111.459 173.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -53.87 -12.73 0.59 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.248 1.819 . . . . 0.0 115.832 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 41.2 t -55.3 -30.99 61.26 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.731 1.612 . . . . 0.0 113.746 171.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 8.8 p -91.57 122.62 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 119.318 0.963 . . . . 0.0 110.712 176.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -84.48 158.4 21.02 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.625 1.57 . . . . 0.0 111.147 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -49.85 -34.51 20.19 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 175.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -67.31 -38.31 84.75 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.97 -1.081 . . . . 0.0 111.04 177.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -76.8 -27.42 55.21 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 173.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 3.7 tp -53.6 -51.58 62.57 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 120.218 1.372 . . . . 0.0 109.491 166.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -55.22 -43.97 74.99 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 122.971 0.508 . . . . 0.0 111.067 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.45 -19.83 62.43 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.056 1.343 . . . . 0.0 114.505 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 66.0 mt -58.73 -29.67 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 119.293 0.951 . . . . 0.0 111.526 171.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -123.27 -23.05 4.96 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.54 1.136 . . . . 0.0 113.716 -175.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -65.97 -12.39 54.63 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.34 1.456 . . . . 0.0 113.892 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -60.51 -12.18 9.04 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 177.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 23.6 p -72.62 -8.62 56.16 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 170.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 93.13 13.37 56.28 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.203 1.382 . . . . 0.0 114.509 -177.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -138.45 176.51 8.63 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.417 1.887 . . . . 0.0 111.116 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 6.8 p -145.47 140.58 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 O-C-N 121.184 -0.948 . . . . 0.0 112.633 168.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -95.06 -99.15 0.16 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.103 1.361 . . . . 0.0 110.295 167.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -160.72 154.5 22.48 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.975 1.71 . . . . 0.0 111.959 176.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.04 149.85 21.73 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.119 -0.988 . . . . 0.0 111.894 -170.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -157.32 165.11 36.7 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.539 1.136 . . . . 0.0 113.881 -174.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 8.1 m -141.02 144.93 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 127.222 2.209 . . . . 0.0 110.525 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -108.94 129.3 55.43 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.471 1.109 . . . . 0.0 109.476 171.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -134.66 171.85 13.77 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.602 1.161 . . . . 0.0 113.098 -171.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -68.88 152.6 45.08 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.956 1.302 . . . . 0.0 113.144 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -70.61 -18.31 75.55 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.616 1.103 . . . . 0.0 115.252 -175.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -88.96 0.25 56.8 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 118.824 1.312 . . . . 0.0 112.67 169.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 92.61 10.77 60.04 Favored Glycine 0 N--CA 1.471 1.019 0 C-N-CA 125.004 1.287 . . . . 0.0 115.008 173.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 57.9 t -70.75 116.06 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 118.386 1.093 . . . . 0.0 108.613 172.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 68.5 p -76.69 177.35 7.62 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.063 1.345 . . . . 0.0 114.555 -170.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 21.0 p -145.28 139.48 27.12 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 127.03 2.132 . . . . 0.0 109.884 -170.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -94.74 -34.99 6.02 Favored Glycine 0 N--CA 1.472 1.045 0 C-N-CA 123.391 0.52 . . . . 0.0 113.822 175.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 17.6 t -55.73 111.96 1.04 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.825 1.25 . . . . 0.0 110.293 167.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -142.89 169.22 25.72 Favored Glycine 0 N--CA 1.471 0.981 0 C-N-CA 124.789 1.185 . . . . 0.0 114.919 -165.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 85.7 m -115.73 141.31 48.26 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.414 1.886 . . . . 0.0 109.086 -173.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.34 113.04 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 124.829 1.252 . . . . 0.0 109.613 -170.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 13.6 t -74.34 147.88 41.83 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 113.911 -1.495 . . . . 0.0 110.159 170.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.72 157.46 19.72 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 -169.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -59.2 -53.9 52.99 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 113.974 -1.466 . . . . 0.0 111.519 176.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -172.67 166.19 5.44 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.814 2.846 . . . . 0.0 108.498 171.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 67.5 mt -60.25 -30.57 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.027 0.931 . . . . 0.0 111.603 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.56 -43.38 45.95 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.935 1.294 . . . . 0.0 114.273 171.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -96.33 -22.34 17.26 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 6.0 tt -58.4 -52.19 66.67 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.708 1.203 . . . . 0.0 110.524 177.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -65.79 -28.88 69.34 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -70.16 -51.65 29.63 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.267 1.027 . . . . 0.0 110.978 172.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -61.73 -33.99 75.03 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.785 1.634 . . . . 0.0 113.191 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -56.92 -41.55 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.817 1.247 . . . . 0.0 112.72 177.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -82.61 -29.24 30.29 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 175.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -75.03 -45.44 41.7 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -171.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -100.26 -16.7 17.63 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -172.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -70.35 118.62 13.39 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.437 -0.789 . . . . 0.0 110.754 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 102.24 0.11 50.77 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.68 1.61 . . . . 0.0 114.726 -176.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -105.47 144.24 32.52 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.941 1.371 . . . . 0.0 112.441 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 67.3 m -94.06 125.6 38.79 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.184 -0.948 . . . . 0.0 112.54 -176.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 46.5 mt -138.32 108.36 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.403 1.081 . . . . 0.0 109.427 176.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 59.48 20.31 8.72 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.77 1.628 . . . . 0.0 114.314 177.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . -168.59 -133.21 1.53 Allowed Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.157 1.36 . . . . 0.0 112.406 -176.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 49.4 p30 -98.01 -172.94 2.47 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.599 1.16 . . . . 0.0 110.282 172.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 20.4 m -58.31 131.38 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-N 119.163 0.892 . . . . 0.0 109.353 172.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 2.4 pp -91.26 138.15 31.81 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 122.378 1.085 . . . . 0.0 111.126 178.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -91.48 156.0 18.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 113.925 -1.489 . . . . 0.0 109.998 166.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 18.6 t -136.93 131.68 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.953 1.701 . . . . 0.0 108.977 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -148.11 143.34 27.07 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.116 1.367 . . . . 0.0 111.366 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 83.5 p -119.09 171.7 8.08 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 120.919 -1.113 . . . . 0.0 112.503 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -77.64 -8.43 57.88 Favored 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -164.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -63.46 150.42 43.77 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.334 1.454 . . . . 0.0 113.536 -176.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 19.3 t -159.33 160.31 34.91 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.077 1.751 . . . . 0.0 110.325 173.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 12.8 p -164.42 140.52 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.852 1.261 . . . . 0.0 111.284 -171.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -88.01 -7.45 57.04 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.721 1.208 . . . . 0.0 114.223 -176.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -152.14 -144.14 0.14 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.243 1.817 . . . . 0.0 110.613 -175.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 35.6 p-80 -154.16 168.51 26.27 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.989 1.316 . . . . 0.0 113.555 -174.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 28.6 t -162.21 151.73 16.0 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.608 1.563 . . . . 0.0 110.874 -177.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -82.5 0.51 42.12 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.464 1.506 . . . . 0.0 112.592 172.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 99.79 10.21 47.26 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.738 1.637 . . . . 0.0 112.376 -162.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -85.02 -18.04 35.67 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.053 2.141 . . . . 0.0 113.737 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -78.33 57.96 2.01 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.708 1.603 . . . . 0.0 111.603 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 28.1 m -143.39 152.44 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 126.535 1.934 . . . . 0.0 111.677 -172.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -153.82 110.43 3.35 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.863 2.065 . . . . 0.0 108.516 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 8.1 tp -133.46 135.74 25.77 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 125.087 1.355 . . . . 0.0 111.141 -176.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -86.08 170.64 8.29 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.742 2.961 . . . . 0.0 111.791 175.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -136.59 144.66 44.24 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.417 1.487 . . . . 0.0 110.911 174.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -147.2 152.59 38.64 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.137 1.775 . . . . 0.0 111.202 -177.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -127.56 9.8 6.59 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.921 1.289 . . . . 0.0 113.678 -170.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 26.8 p -75.46 143.71 76.51 Favored Pre-proline 0 CA--C 1.553 1.068 0 O-C-N 120.794 -1.191 . . . . 0.0 113.059 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.53 157.64 32.44 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.773 2.982 . . . . 0.0 111.767 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 14.7 p -161.87 141.11 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.104 1.361 . . . . 0.0 110.797 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 . . . . . 0 C--O 1.254 1.307 0 C-N-CA 125.971 1.708 . . . . 0.0 111.591 -175.898 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.925 0 N-CA-C 112.655 -0.178 . . . . 0.0 112.655 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 49.0 m 70.91 -55.98 0.63 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.979 2.512 . . . . 0.0 114.534 174.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 63.09 176.65 0.15 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.65 1.98 . . . . 0.0 113.857 172.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 35.5 m -139.01 152.4 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 120.906 -1.121 . . . . 0.0 110.95 163.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 5.1 mp -118.72 138.84 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 126.024 1.729 . . . . 0.0 108.355 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 20.8 m -112.73 125.57 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.643 1.177 . . . . 0.0 107.95 172.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -142.95 46.47 1.55 Allowed 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -148.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -168.99 -26.36 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 88.1 mt -51.85 144.79 18.51 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 124.338 1.055 . . . . 0.0 111.583 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -79.74 -179.16 5.09 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.497 3.465 . . . . 0.0 111.017 178.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -62.54 -7.49 4.75 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 115.216 1.561 . . . . 0.0 115.216 -176.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 16.4 m -68.96 -17.08 63.89 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.86 1.664 . . . . 0.0 114.589 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 9.9 p -98.98 142.79 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.458 1.103 . . . . 0.0 110.482 175.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -142.53 168.33 19.99 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.722 2.009 . . . . 0.0 110.219 -177.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -46.31 -51.03 15.46 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -171.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -63.59 -36.37 83.59 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.793 0.724 . . . . 0.0 112.226 -178.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.89 -39.95 75.93 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 169.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 6.8 tt -60.06 -35.57 75.44 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.863 0.865 . . . . 0.0 111.698 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -53.79 -52.86 58.94 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.508 0.723 . . . . 0.0 111.306 169.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -62.42 -21.18 65.2 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.605 1.562 . . . . 0.0 113.561 -176.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 28.2 mt -54.9 -29.82 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 124.654 1.182 . . . . 0.0 111.992 171.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -121.29 -27.55 4.84 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.142 1.377 . . . . 0.0 112.577 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.6 -8.93 30.51 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.6 1.56 . . . . 0.0 115.005 -177.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -60.38 -15.48 26.39 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 120.348 -1.47 . . . . 0.0 114.139 172.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 71.3 m -66.37 -5.62 11.43 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 171.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 91.26 5.28 67.65 Favored Glycine 0 N--CA 1.477 1.43 0 C-N-CA 125.35 1.453 . . . . 0.0 114.54 177.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -138.43 179.3 6.55 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.904 2.481 . . . . 0.0 110.719 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.41 144.27 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 121.118 -0.989 . . . . 0.0 112.439 177.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -100.63 -114.0 0.18 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.518 1.527 . . . . 0.0 110.528 172.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -156.59 143.38 18.62 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.645 1.178 . . . . 0.0 113.475 -178.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.3 174.07 15.71 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.594 1.158 . . . . 0.0 112.06 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -159.25 152.0 21.77 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.143 1.377 . . . . 0.0 112.608 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 20.4 t -150.04 140.09 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.225 1.81 . . . . 0.0 108.203 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -132.19 135.75 46.56 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.289 1.035 . . . . 0.0 109.939 173.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 8.7 mt -91.34 158.09 16.74 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.759 0.824 . . . . 0.0 111.705 -169.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -77.86 146.43 35.68 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.706 1.203 . . . . 0.0 112.129 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -66.55 -12.67 59.42 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.095 1.331 . . . . 0.0 115.792 -174.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -74.97 -1.12 21.18 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 119.157 1.478 . . . . 0.0 113.237 166.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 87.85 38.63 7.37 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.094 1.33 . . . . 0.0 113.308 174.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 23.9 m -142.49 143.79 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 125.158 1.383 . . . . 0.0 111.732 -174.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.71 154.46 40.69 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.218 1.007 . . . . 0.0 113.114 -178.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 37.1 p -69.54 -32.14 70.79 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.076 0.951 . . . . 0.0 112.874 173.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 78.29 -61.37 3.86 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.932 1.253 . . . . 0.0 111.641 -176.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 52.2 p -60.07 146.63 42.25 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 122.471 1.129 . . . . 0.0 112.243 161.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -159.37 170.08 35.61 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.569 1.557 . . . . 0.0 113.924 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 99.0 m -119.9 142.49 48.64 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.751 1.62 . . . . 0.0 109.492 -175.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.0 t -133.54 127.62 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.689 1.596 . . . . 0.0 109.059 -170.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 14.9 t -92.92 127.85 38.57 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.916 0.886 . . . . 0.0 109.24 172.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -85.3 163.53 18.55 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -164.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -52.4 -54.44 31.94 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.776 1.23 . . . . 0.0 112.108 175.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -172.35 161.88 5.33 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 129.081 2.952 . . . . 0.0 108.375 170.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.78 -28.01 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.99 0.916 . . . . 0.0 112.02 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.54 -43.44 56.1 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 171.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -102.44 -17.55 15.76 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -176.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 4.1 tt -58.6 -50.66 73.01 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.318 1.047 . . . . 0.0 110.021 174.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -64.98 -28.12 69.3 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 45.4 mtp85 -70.01 -53.33 18.11 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.349 1.06 . . . . 0.0 111.071 169.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -60.02 -36.28 76.9 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.703 1.601 . . . . 0.0 113.264 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -53.34 -46.54 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.826 1.25 . . . . 0.0 112.482 -178.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -85.82 -37.27 19.41 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.168 0.587 . . . . 0.0 112.339 175.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -61.05 -34.42 74.85 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.193 -0.942 . . . . 0.0 113.324 -175.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -97.61 -1.51 43.61 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 175.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -60.03 111.51 1.52 Allowed 'General case' 0 CA--C 1.552 1.038 0 O-C-N 119.576 -1.952 . . . . 0.0 111.891 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 96.44 -0.01 61.36 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.462 1.506 . . . . 0.0 115.499 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.2 169.31 15.38 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 119.137 1.469 . . . . 0.0 114.576 179.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 56.0 p -138.5 124.3 19.86 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.262 1.025 . . . . 0.0 111.833 172.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 10.1 mt -138.28 116.66 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 125.147 1.379 . . . . 0.0 108.77 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 61.98 30.34 17.98 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.42 1.488 . . . . 0.0 113.271 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 173.68 -127.94 1.42 Allowed Glycine 0 C--N 1.342 0.864 0 N-CA-C 115.116 0.806 . . . . 0.0 115.116 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 42.7 p30 -110.27 -177.2 3.19 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.397 1.879 . . . . 0.0 111.376 -171.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 26.6 m -66.12 139.65 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 121.476 -0.765 . . . . 0.0 111.315 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.83 130.22 56.75 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.453 1.501 . . . . 0.0 112.29 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -72.24 154.66 40.88 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.86 148.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 47.1 t -136.45 124.34 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.295 1.438 . . . . 0.0 108.79 -174.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 58.2 mttt -146.28 141.93 27.81 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.613 1.565 . . . . 0.0 111.742 -170.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 30.2 p -89.61 167.34 13.01 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.11 1.364 . . . . 0.0 112.369 173.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -80.87 58.44 3.38 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.332 1.453 . . . . 0.0 112.351 -173.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -161.23 175.73 12.0 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.937 1.695 . . . . 0.0 112.123 -172.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 23.0 t -155.08 131.45 10.4 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.495 1.118 . . . . 0.0 111.065 176.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 61.4 t -151.13 133.77 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 125.882 1.673 . . . . 0.0 109.318 -172.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -155.01 144.57 21.35 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.863 1.265 . . . . 0.0 112.906 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -163.37 153.76 15.94 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.375 1.87 . . . . 0.0 111.477 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -147.19 147.24 30.29 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.929 1.292 . . . . 0.0 112.768 175.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 33.2 t -162.03 133.28 5.22 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.309 1.844 . . . . 0.0 109.37 171.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -79.47 -15.79 57.18 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.794 0.837 . . . . 0.0 113.162 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 77.94 -37.22 1.7 Allowed Glycine 0 CA--C 1.534 1.273 0 C-N-CA 126.438 1.97 . . . . 0.0 116.066 167.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -165.2 156.72 14.78 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.41 1.484 . . . . 0.0 112.318 -170.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -160.77 153.86 21.48 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.152 2.181 . . . . 0.0 109.731 175.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 14.6 p -167.95 147.53 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 126.569 1.947 . . . . 0.0 111.137 -170.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -158.99 113.02 2.39 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.981 1.713 . . . . 0.0 109.837 177.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 8.0 tp -133.48 136.18 26.52 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 125.61 1.564 . . . . 0.0 111.132 -176.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.4 166.51 24.13 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.371 2.714 . . . . 0.0 111.611 176.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 27.9 ttt -158.55 139.71 13.15 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.015 1.326 . . . . 0.0 111.321 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -146.55 147.43 31.12 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.393 1.877 . . . . 0.0 110.797 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -152.34 30.54 0.54 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.873 1.269 . . . . 0.0 112.444 -172.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 37.4 p -71.02 148.16 94.24 Favored Pre-proline 0 CA--C 1.553 1.07 0 O-C-N 120.793 -1.192 . . . . 0.0 113.176 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -75.73 152.13 37.09 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.623 2.882 . . . . 0.0 111.714 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 15.9 m -147.59 148.46 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.793 1.637 . . . . 0.0 110.722 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 6.4 t30 . . . . . 0 C--O 1.253 1.287 0 C-N-CA 125.786 1.634 . . . . 0.0 111.654 -177.552 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.66 157.87 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 O-C-N 121.257 -0.902 . . . . 0.0 111.495 172.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 3.7 mp -131.86 132.81 61.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 126.166 1.787 . . . . 0.0 107.235 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 36.0 m -104.43 137.27 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.212 1.005 . . . . 0.0 109.254 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -140.15 35.59 1.91 Allowed 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -157.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -160.58 -22.43 0.06 Allowed 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 12.7 mt -47.41 130.67 10.22 Favored Pre-proline 0 CA--C 1.557 1.243 0 O-C-N 120.77 -1.206 . . . . 0.0 111.341 160.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -88.44 170.29 5.66 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 124.82 3.68 . . . . 0.0 111.791 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -61.13 -8.36 3.43 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 9.1 m -68.89 -22.87 64.16 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.474 1.11 . . . . 0.0 113.121 171.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.5 p -108.6 136.69 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 126.882 2.073 . . . . 0.0 109.247 173.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -141.7 174.2 10.79 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.498 1.519 . . . . 0.0 111.447 -167.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -43.48 -50.8 6.95 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -168.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -69.14 -28.47 66.48 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 119.315 0.961 . . . . 0.0 113.014 -175.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -77.48 -40.13 44.06 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 167.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.419 HD23 ' C ' ' A' ' 277' ' ' LEU . 3.9 tt -53.16 -46.03 68.72 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.993 1.317 . . . . 0.0 109.743 175.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -46.15 -54.17 9.13 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.932 0.893 . . . . 0.0 111.586 172.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -61.75 -27.89 69.05 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.881 1.272 . . . . 0.0 113.891 -175.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 23.8 mt -53.79 -27.38 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 124.587 1.155 . . . . 0.0 112.125 172.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -118.26 -29.46 5.53 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.357 1.463 . . . . 0.0 112.309 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.8 -13.61 62.36 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.571 1.548 . . . . 0.0 113.709 176.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -57.9 -17.74 18.57 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 172.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 75.8 m -71.72 -1.85 15.34 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 173.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 89.11 14.25 60.84 Favored Glycine 0 N--CA 1.476 1.334 0 C-N-CA 124.973 1.273 . . . . 0.0 114.63 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -138.54 -178.82 5.47 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 126.811 2.044 . . . . 0.0 109.755 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.36 147.05 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 120.476 -1.39 . . . . 0.0 112.896 169.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -109.31 -114.5 0.3 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.481 1.513 . . . . 0.0 110.205 169.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -158.44 155.11 27.97 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.174 1.39 . . . . 0.0 113.081 175.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.34 171.52 20.02 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.573 1.149 . . . . 0.0 112.54 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -161.63 168.27 23.73 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.559 1.143 . . . . 0.0 113.197 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 11.7 m -140.66 158.74 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 127.951 2.5 . . . . 0.0 109.52 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -128.1 108.14 10.39 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.517 0.727 . . . . 0.0 110.521 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 8.3 mp -70.44 145.6 50.9 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.945 1.298 . . . . 0.0 111.74 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -65.14 159.11 24.19 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.747 0.819 . . . . 0.0 111.269 164.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -62.81 -17.63 58.36 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 124.333 0.968 . . . . 0.0 115.391 -177.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -81.83 -3.25 53.54 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 118.992 1.396 . . . . 0.0 113.675 170.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 84.07 21.91 56.12 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 125.106 1.336 . . . . 0.0 114.928 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 19.9 m -99.43 -6.1 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 -164.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 4.8 t 66.76 -177.11 0.2 Allowed 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 38.1 p -142.87 -35.46 0.41 Allowed 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -164.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 75.02 -57.63 2.71 Favored Glycine 0 N--CA 1.475 1.256 0 C-N-CA 124.547 1.07 . . . . 0.0 111.936 -168.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 19.2 t -40.74 118.1 0.92 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.397 1.879 . . . . 0.0 111.381 158.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -169.98 177.62 43.26 Favored Glycine 0 N--CA 1.473 1.121 0 C-N-CA 124.722 1.153 . . . . 0.0 115.193 -169.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 25.4 p -106.41 142.06 36.7 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.392 1.877 . . . . 0.0 111.497 -169.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 1.7 t -128.3 121.7 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.398 1.479 . . . . 0.0 108.789 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 42.7 m -93.82 109.82 21.49 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.962 1.305 . . . . 0.0 108.572 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.4 162.1 28.14 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -163.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -51.69 -54.86 23.62 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.42 1.088 . . . . 0.0 111.699 173.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -172.56 163.69 5.41 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 129.139 2.976 . . . . 0.0 108.551 171.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 87.8 mt -58.26 -30.74 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.048 0.939 . . . . 0.0 111.74 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.06 -40.21 57.79 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 172.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -102.25 -20.78 14.52 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.377 0.535 . . . . 0.0 112.365 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -55.08 -52.35 63.5 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.22 1.408 . . . . 0.0 110.381 174.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -64.04 -30.46 71.53 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 32.4 mtp-105 -70.33 -46.67 63.74 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.557 1.143 . . . . 0.0 111.383 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -69.18 -32.08 71.13 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.31 1.444 . . . . 0.0 113.032 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -57.92 -38.96 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.438 1.095 . . . . 0.0 112.418 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -82.49 -18.79 40.37 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -84.23 -45.91 12.39 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.224 1.01 . . . . 0.0 112.572 -177.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -100.94 -21.14 15.16 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.644 1.349 . . . . 0.0 114.644 -170.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -67.33 111.96 4.3 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.386 0.993 . . . . 0.0 109.919 171.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 99.04 0.34 57.29 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 124.59 1.09 . . . . 0.0 114.88 -171.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -94.22 168.1 11.13 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 118.938 1.369 . . . . 0.0 111.668 173.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 45.6 p -138.42 129.2 26.61 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 120.181 -1.575 . . . . 0.0 112.615 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 11.5 mt -144.63 111.3 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 124.308 1.043 . . . . 0.0 110.099 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 63.07 16.77 9.59 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.771 1.628 . . . . 0.0 114.048 173.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . -159.42 -132.84 1.42 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.969 1.271 . . . . 0.0 113.319 -171.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -95.97 -176.55 3.73 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.933 0.893 . . . . 0.0 110.279 176.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 12.1 p -55.39 131.88 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 121.259 -0.9 . . . . 0.0 108.784 152.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 1.2 pp -103.53 143.22 33.01 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.144 0.978 . . . . 0.0 110.687 -176.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -128.36 141.22 51.49 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.623 1.569 . . . . 0.0 109.33 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 17.3 t -126.66 129.88 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.068 1.347 . . . . 0.0 110.174 -164.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -129.14 169.96 14.12 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.061 1.744 . . . . 0.0 110.822 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 94.5 p -138.38 169.43 17.8 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.885 1.274 . . . . 0.0 111.833 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -176.399 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 . . . . . 0 CA--C 1.554 1.116 0 N-CA-C 112.494 0.554 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 34.2 m -137.37 151.37 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 120.977 -1.077 . . . . 0.0 112.243 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 3.2 mp -102.04 143.68 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 127.865 2.466 . . . . 0.0 108.305 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 18.9 m -126.83 140.38 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 125.695 1.598 . . . . 0.0 108.622 168.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -145.61 24.99 1.36 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -145.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -161.55 -22.54 0.05 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 84.5 mt -47.7 119.37 6.74 Favored Pre-proline 0 CA--C 1.563 1.453 0 C-N-CA 127.023 2.129 . . . . 0.0 111.585 168.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -89.33 -172.71 0.67 Allowed 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 124.986 3.791 . . . . 0.0 113.375 -176.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -54.27 -29.53 47.38 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -173.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 30.6 m -71.09 -18.06 62.56 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.374 -0.829 . . . . 0.0 112.987 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . 0.263 2.4 p -113.6 60.58 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 127.53 2.332 . . . . 0.0 109.948 176.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -62.52 175.6 0.76 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.733 1.613 . . . . 0.0 111.969 176.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -45.63 -42.25 11.13 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.803 1.641 . . . . 0.0 114.952 -174.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -68.72 -40.03 80.12 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.272 0.942 . . . . 0.0 111.696 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.66 -35.73 75.44 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 172.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.506 HD23 ' C ' ' A' ' 277' ' ' LEU . 2.2 tt -54.74 -51.55 65.29 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.18 0.9 . . . . 0.0 109.229 168.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 4.6 tmmm? -57.2 -35.96 70.26 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.575 0.75 . . . . 0.0 111.905 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -67.57 -23.89 65.45 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 175.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 18.3 mt -58.83 -51.44 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-N 119.38 0.991 . . . . 0.0 110.86 173.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -79.03 -27.5 43.21 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.226 0.61 . . . . 0.0 111.5 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -51.86 -23.27 4.59 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.177 1.391 . . . . 0.0 113.927 173.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -61.59 -13.43 21.87 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 175.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 97.5 m -73.13 -5.58 40.07 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 168.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 96.69 -12.23 66.14 Favored Glycine 0 N--CA 1.476 1.366 0 C-N-CA 126.118 1.818 . . . . 0.0 114.608 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -138.33 172.84 12.3 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.305 2.242 . . . . 0.0 108.98 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 4.8 p -145.3 145.16 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -91.8 -125.39 0.08 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 126.238 1.815 . . . . 0.0 111.807 176.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -153.31 158.01 40.95 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.787 1.635 . . . . 0.0 113.232 -175.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.57 175.96 13.0 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -172.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -159.05 168.19 27.33 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.9 2.08 . . . . 0.0 111.312 176.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 28.7 m -151.01 170.99 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 126.72 2.008 . . . . 0.0 112.722 -171.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -103.71 153.52 20.58 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.489 1.516 . . . . 0.0 112.424 174.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.8 mp -126.71 144.18 51.01 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.115 1.366 . . . . 0.0 111.902 174.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -71.14 160.49 32.77 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.946 0.898 . . . . 0.0 111.304 162.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -66.95 -12.61 60.33 Favored Glycine 0 CA--C 1.534 1.276 0 N-CA-C 115.926 1.13 . . . . 0.0 115.926 -169.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -85.67 -1.36 57.09 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.688 1.195 . . . . 0.0 113.062 172.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.86 15.31 73.18 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.146 1.355 . . . . 0.0 115.131 175.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 97.7 t -81.22 -17.72 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -168.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.4 p 75.98 171.68 0.25 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 127.319 2.248 . . . . 0.0 114.943 176.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 30.3 p -146.26 164.05 33.55 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 127.672 2.389 . . . . 0.0 107.518 172.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -94.7 -16.2 43.24 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.137 0.875 . . . . 0.0 113.862 170.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 8.7 t -55.45 121.7 9.58 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.578 1.151 . . . . 0.0 110.852 166.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 174.86 -160.39 29.43 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.211 0.91 . . . . 0.0 114.46 -171.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 20.1 p -123.55 148.19 46.56 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.845 1.658 . . . . 0.0 110.537 -172.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.9 123.48 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.134 1.774 . . . . 0.0 106.851 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 8.1 t -99.32 110.56 23.06 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.733 1.213 . . . . 0.0 108.255 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.18 165.23 16.71 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -149.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -52.12 -51.57 57.01 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.086 1.354 . . . . 0.0 111.89 174.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -172.55 166.44 5.58 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 129.813 3.245 . . . . 0.0 108.059 171.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.55 -26.82 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 123.863 0.865 . . . . 0.0 111.81 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -30.89 64.85 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 171.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -91.14 -14.48 31.05 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -168.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 10.6 mp -49.52 -49.07 47.48 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.958 0.903 . . . . 0.0 109.311 161.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -61.52 -31.77 71.78 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -172.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -75.21 -56.65 4.52 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.064 1.345 . . . . 0.0 112.039 168.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -65.92 -33.04 74.91 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.967 1.307 . . . . 0.0 114.01 -170.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.18 -27.08 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.594 1.158 . . . . 0.0 111.599 177.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -82.61 -38.82 23.06 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.788 0.835 . . . . 0.0 111.569 170.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -77.32 -41.19 41.56 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -170.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -106.35 -17.33 14.32 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -172.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -54.92 126.24 23.62 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.407 1.003 . . . . 0.0 111.025 167.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 82.77 0.31 90.05 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 119.258 -0.745 . . . . 0.0 114.383 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -97.66 162.59 13.21 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.985 1.314 . . . . 0.0 112.034 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 47.5 p -138.27 128.26 25.53 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.547 1.139 . . . . 0.0 111.468 -176.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 12.2 mt -136.05 112.85 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.038 0.935 . . . . 0.0 109.858 -177.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 56.61 27.54 12.62 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.935 1.694 . . . . 0.0 112.961 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . -176.76 -143.44 4.8 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.428 1.014 . . . . 0.0 113.754 -166.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -93.23 174.96 6.95 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.971 0.908 . . . . 0.0 111.054 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 11.4 p -58.39 141.28 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 121.645 -0.66 . . . . 0.0 110.182 163.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 1.7 pp -122.81 156.26 34.9 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 122.429 1.109 . . . . 0.0 112.804 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -122.83 166.1 15.55 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.707 1.603 . . . . 0.0 110.172 163.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.03 125.64 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 126.824 2.05 . . . . 0.0 107.466 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -141.86 133.7 27.24 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.146 0.578 . . . . 0.0 112.389 -169.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 20.0 p -110.47 153.82 24.51 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.542 1.537 . . . . 0.0 111.997 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp . . . . . 0 CA--C 1.546 0.813 0 O-C-N 121.208 -0.933 . . . . 0.0 110.908 173.728 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 31.1 m -130.99 147.37 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.978 1.711 . . . . 0.0 110.553 173.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.7 mp -97.84 140.91 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 127.461 2.305 . . . . 0.0 107.232 175.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 30.0 m -131.48 120.64 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.608 0.763 . . . . 0.0 110.388 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -147.66 77.93 1.44 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.972 0.909 . . . . 0.0 110.9 -162.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -174.36 -42.21 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 126.383 1.873 . . . . 0.0 110.732 177.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 71.3 mt -34.75 116.97 0.54 Allowed Pre-proline 0 CA--C 1.558 1.271 0 C-N-CA 127.377 2.271 . . . . 0.0 111.582 160.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -89.64 177.92 2.54 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 125.121 3.881 . . . . 0.0 112.641 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -51.36 -26.94 8.54 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 -171.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 5.5 t -76.85 -14.85 59.85 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . 0.259 1.6 p -108.28 79.88 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.938 1.695 . . . . 0.0 108.863 174.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -69.81 179.14 2.32 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.965 2.106 . . . . 0.0 112.546 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -57.05 -37.76 72.27 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 120.6 -1.313 . . . . 0.0 112.689 177.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -65.5 -37.33 86.49 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.239 -0.913 . . . . 0.0 111.321 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -71.12 -38.2 72.31 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 168.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.462 HD23 ' C ' ' A' ' 277' ' ' LEU . 5.4 tt -53.79 -45.67 70.8 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.819 1.248 . . . . 0.0 110.517 176.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -47.76 -51.77 21.1 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.483 0.713 . . . . 0.0 111.706 172.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -64.99 -22.55 67.02 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -174.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 45.0 mt -55.73 -44.98 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.271 1.028 . . . . 0.0 111.509 171.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -104.89 -22.34 13.17 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.181 0.993 . . . . 0.0 113.047 -173.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -64.93 0.15 1.32 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.426 1.89 . . . . 0.0 115.138 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -55.45 -19.05 8.24 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 120.501 -1.374 . . . . 0.0 113.834 168.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 21.8 t -56.54 -20.48 20.76 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.624 1.57 . . . . 0.0 114.072 169.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 92.3 -7.46 78.12 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.919 1.724 . . . . 0.0 113.454 -173.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -138.46 175.87 9.19 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.362 2.665 . . . . 0.0 109.116 174.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.4 p -145.12 145.24 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 120.705 -1.247 . . . . 0.0 113.136 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -79.44 -104.75 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.656 1.582 . . . . 0.0 111.877 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -152.04 146.03 25.25 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.995 1.718 . . . . 0.0 112.253 -175.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.35 166.83 31.33 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.798 0.839 . . . . 0.0 113.254 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -159.82 172.83 16.94 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.942 1.697 . . . . 0.0 111.153 -177.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 4.2 m -142.32 152.07 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.471 1.909 . . . . 0.0 111.753 -177.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -111.18 99.05 7.96 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.108 0.963 . . . . 0.0 109.765 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 8.9 mt -91.33 160.11 15.66 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.943 0.897 . . . . 0.0 112.074 -172.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -80.7 147.18 30.72 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.437 1.095 . . . . 0.0 112.445 -173.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -67.61 -13.12 62.82 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.0 1.286 . . . . 0.0 115.963 -172.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -82.36 -0.13 44.45 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 119.175 1.487 . . . . 0.0 113.152 169.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.84 61.59 1.93 Allowed Glycine 0 C--N 1.341 0.849 0 C-N-CA 125.132 1.349 . . . . 0.0 112.161 176.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 13.6 p -154.29 146.48 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.36 1.064 . . . . 0.0 111.839 -174.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 26.6 t -62.79 161.45 12.56 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.44 1.096 . . . . 0.0 113.932 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 35.9 p -146.09 -27.24 0.43 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 126.846 2.058 . . . . 0.0 114.082 -169.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 78.46 -41.07 2.04 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 126.545 2.022 . . . . 0.0 114.82 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 5.3 p -50.14 132.89 23.75 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.388 1.875 . . . . 0.0 112.828 166.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -172.59 -159.99 20.25 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 124.49 1.043 . . . . 0.0 115.475 -172.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 46.0 p -137.46 155.01 49.8 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.668 1.587 . . . . 0.0 110.638 -173.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.48 119.2 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.593 1.557 . . . . 0.0 107.44 -176.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 44.1 t -108.9 124.81 51.23 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.677 1.191 . . . . 0.0 109.128 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.18 165.63 12.52 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 -144.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -52.75 -53.9 41.43 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.081 170.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -172.91 168.43 4.95 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 129.01 2.924 . . . . 0.0 108.205 165.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 19.5 tt -57.58 -28.3 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.2 -41.38 68.54 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 172.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -94.48 -28.56 15.4 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.179 0.445 . . . . 0.0 111.44 -176.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.1 tt -52.56 -49.01 65.79 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.526 1.531 . . . . 0.0 110.089 169.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -56.69 -35.35 68.37 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -70.71 -55.98 7.43 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.324 0.65 . . . . 0.0 111.381 169.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.72 -35.26 72.4 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.568 1.547 . . . . 0.0 113.712 -174.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.71 -33.43 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.123 0.969 . . . . 0.0 112.291 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -82.58 -42.29 18.48 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.754 0.822 . . . . 0.0 111.711 172.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -64.91 -40.56 95.26 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -174.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -105.95 -10.13 16.76 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -169.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -69.13 116.26 9.37 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 121.096 -1.002 . . . . 0.0 110.542 169.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 93.46 -0.14 67.87 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.817 1.675 . . . . 0.0 114.774 -175.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -80.55 133.98 35.87 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.139 1.375 . . . . 0.0 111.279 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 16.0 p -99.6 126.7 45.64 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.072 -1.643 . . . . 0.0 111.989 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.45 96.84 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.908 0.883 . . . . 0.0 110.058 -171.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 56.84 30.12 17.28 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.279 1.432 . . . . 0.0 113.211 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 178.8 -130.86 1.61 Allowed Glycine 0 C--N 1.342 0.9 0 O-C-N 121.162 -0.961 . . . . 0.0 113.468 -171.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -90.07 178.96 6.05 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.427 0.691 . . . . 0.0 110.562 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 35.2 m -63.6 137.28 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 O-C-N 121.403 -0.811 . . . . 0.0 109.634 162.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 22.7 tp -83.02 118.95 23.87 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.402 1.481 . . . . 0.0 110.181 -175.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -94.43 143.39 26.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.749 0.82 . . . . 0.0 109.721 165.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 19.8 t -136.42 124.9 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.646 1.579 . . . . 0.0 108.418 -171.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -132.75 133.85 43.99 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.545 1.138 . . . . 0.0 111.249 -170.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 34.8 p -83.83 155.95 22.71 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.859 -1.151 . . . . 0.0 111.983 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 85.3 tttt . . . . . 0 CA--C 1.549 0.932 0 O-C-N 121.288 -0.882 . . . . 0.0 111.599 179.544 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 . . . . . 0 CA--C 1.54 0.575 0 N-CA-C 111.335 0.124 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 21.2 m -133.52 156.39 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.605 1.162 . . . . 0.0 110.324 166.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 76.4 mt -106.97 139.17 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 127.276 2.23 . . . . 0.0 107.252 -178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 19.0 m -125.54 118.36 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.317 1.047 . . . . 0.0 108.838 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -143.78 62.41 1.36 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 121.897 0.856 . . . . 0.0 112.33 -151.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -168.21 -25.64 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.533 1.133 . . . . 0.0 113.697 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 23.5 mt -61.13 136.86 94.04 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 125.741 1.616 . . . . 0.0 111.83 175.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -88.52 171.02 5.36 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 124.484 3.456 . . . . 0.0 110.758 173.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -59.98 -5.78 1.11 Allowed 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 6.3 t -59.06 -30.56 68.15 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.824 1.25 . . . . 0.0 112.938 169.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 9.0 p -89.37 123.99 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 170.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -77.92 157.05 29.92 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.724 0.81 . . . . 0.0 110.655 172.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -51.43 -37.72 50.03 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.722 -1.236 . . . . 0.0 113.285 176.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -73.72 -31.09 63.2 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.007 -1.058 . . . . 0.0 112.188 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.85 -32.56 71.02 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.184 -0.947 . . . . 0.0 112.635 167.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.52 HD21 ' CG1' ' A' ' 306' ' ' VAL . 3.1 tt -61.06 -42.44 98.49 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.218 0.917 . . . . 0.0 111.406 169.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -57.17 -46.75 82.52 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 118.785 0.721 . . . . 0.0 110.312 171.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -61.44 -23.1 65.62 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 18.7 mt -51.74 -30.23 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 124.73 1.212 . . . . 0.0 111.83 172.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -116.73 -38.33 3.48 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.275 1.43 . . . . 0.0 110.913 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -5.4 4.43 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.008 1.323 . . . . 0.0 114.142 176.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -55.53 -17.33 5.14 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 120.432 -1.418 . . . . 0.0 113.767 160.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 65.2 m -70.87 -0.72 9.73 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.032 1.333 . . . . 0.0 114.264 168.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 88.31 -58.49 4.18 Favored Glycine 0 N--CA 1.471 1.0 0 C-N-CA 126.589 2.043 . . . . 0.0 111.729 -176.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -70.14 165.21 22.52 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.857 1.263 . . . . 0.0 111.921 175.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.9 p -142.03 142.5 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 120.911 -1.118 . . . . 0.0 112.475 178.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -89.35 -96.01 0.1 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.85 1.26 . . . . 0.0 110.203 167.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -165.31 157.85 15.67 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 127.133 2.173 . . . . 0.0 111.208 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.72 159.61 35.45 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.083 -1.011 . . . . 0.0 113.667 -173.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -161.22 171.67 18.02 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.284 1.434 . . . . 0.0 113.21 -176.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 16.8 m -144.03 160.17 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 128.009 2.523 . . . . 0.0 110.244 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -132.15 99.63 4.78 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.51 0.724 . . . . 0.0 111.428 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.69 170.77 7.74 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.065 1.346 . . . . 0.0 113.338 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -74.85 153.7 38.58 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 122.766 0.426 . . . . 0.0 111.391 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -64.99 -10.84 48.73 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 124.121 0.867 . . . . 0.0 114.873 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 44.5 p30 -74.14 -12.65 60.65 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.859 1.263 . . . . 0.0 114.289 169.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 88.15 12.62 65.32 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 117.226 -1.874 . . . . 0.0 116.613 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 14.6 m -67.73 -17.18 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-N 121.408 2.604 . . . . 0.0 116.297 -172.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 3.7 t 73.54 163.65 0.27 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 126.025 1.73 . . . . 0.0 113.687 -176.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 29.1 p -151.65 136.89 17.52 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.44 1.896 . . . . 0.0 110.089 -171.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -79.98 -35.71 26.93 Favored Glycine 0 N--CA 1.47 0.93 0 O-C-N 123.246 0.341 . . . . 0.0 112.823 173.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 33.9 p -57.05 124.46 18.8 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.057 1.343 . . . . 0.0 111.878 167.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -161.53 -165.83 19.13 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.952 1.263 . . . . 0.0 113.788 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 99.1 m -130.53 138.83 50.4 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.943 1.297 . . . . 0.0 108.656 -175.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.52 ' CG1' HD21 ' A' ' 277' ' ' LEU . 8.4 m -128.45 128.11 67.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 124.442 1.097 . . . . 0.0 109.374 -175.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 36.8 m -79.87 146.93 31.94 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.669 173.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.39 146.89 35.05 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -173.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -49.65 -49.05 48.76 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.148 1.779 . . . . 0.0 112.552 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -172.24 173.31 4.27 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 128.13 2.572 . . . . 0.0 108.466 159.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 15.1 tt -62.27 -24.06 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -177.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.7 -42.69 65.04 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.267 1.427 . . . . 0.0 114.161 168.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -98.32 -20.34 17.25 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -175.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 6.7 tt -60.26 -52.63 64.47 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.838 1.255 . . . . 0.0 111.109 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -73.3 -20.78 60.73 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.017 -1.052 . . . . 0.0 113.247 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -70.66 -44.98 65.95 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.198 0.999 . . . . 0.0 111.682 166.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -73.16 -38.62 66.14 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.783 1.633 . . . . 0.0 113.284 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 2.5 pp -64.09 -22.21 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 121.147 -0.971 . . . . 0.0 113.556 176.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -82.31 -23.23 35.26 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.958 0.903 . . . . 0.0 112.951 169.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -89.44 -47.17 8.18 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.153 1.381 . . . . 0.0 112.968 -175.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -90.56 -30.01 17.5 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -172.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -65.85 118.18 9.31 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 121.245 -0.909 . . . . 0.0 110.28 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 96.69 -1.98 62.04 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.269 0.937 . . . . 0.0 115.265 -173.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -92.16 173.89 7.59 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.05 1.425 . . . . 0.0 111.097 169.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 60.0 p -138.57 129.7 26.99 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 119.83 -1.793 . . . . 0.0 112.395 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 18.9 mt -143.21 116.73 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 124.305 1.042 . . . . 0.0 109.58 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 59.49 18.96 7.39 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 125.633 1.573 . . . . 0.0 114.357 175.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . -177.55 -131.47 1.53 Allowed Glycine 0 CA--C 1.527 0.83 0 O-C-N 120.98 -1.075 . . . . 0.0 114.301 -173.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -94.96 -178.81 4.62 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.448 1.099 . . . . 0.0 110.929 -176.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 10.4 p -61.44 125.52 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 121.513 -0.742 . . . . 0.0 110.714 169.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 88.4 mt -62.9 132.85 53.49 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.174 1.79 . . . . 0.0 111.753 176.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -132.81 120.94 22.24 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.027 1.731 . . . . 0.0 108.19 174.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 15.1 t -129.31 125.38 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.72 1.208 . . . . 0.0 109.915 -160.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -142.94 171.19 14.38 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.447 1.499 . . . . 0.0 111.476 -171.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 90.3 p -145.29 152.75 40.42 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.147 -1.596 . . . . 0.0 112.842 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 62.8 tttm . . . . . 0 CA--C 1.549 0.914 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.501 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 . . . . . 0 CA--C 1.538 0.51 0 CA-C-O 121.415 0.626 . . . . 0.0 111.79 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 35.7 m -132.05 159.94 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 126.262 1.825 . . . . 0.0 110.052 170.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 5.0 mp -124.08 130.67 73.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.184 1.794 . . . . 0.0 106.95 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 29.3 m -99.48 138.11 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 170.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -150.01 78.37 1.34 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.053 0.541 . . . . 0.0 112.281 -165.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -176.71 -34.83 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.227 1.411 . . . . 0.0 113.649 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 74.2 mt -62.99 140.5 97.63 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 125.613 1.565 . . . . 0.0 111.711 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -83.1 177.17 6.84 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 124.8 3.667 . . . . 0.0 112.013 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -57.89 -7.42 0.74 Allowed 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 -176.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 4.0 t -62.65 -31.5 72.39 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.217 -0.927 . . . . 0.0 112.318 170.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 3.7 p -84.05 133.06 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.651 0.739 . . . . 0.0 109.915 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -137.71 167.11 22.37 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.53 1.932 . . . . 0.0 109.144 -176.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -43.74 -50.63 7.6 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -168.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -68.5 -36.17 78.52 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.635 -0.666 . . . . 0.0 111.987 -175.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.83 -38.36 76.5 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.483 -0.761 . . . . 0.0 112.977 169.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 8.1 tt -63.08 -37.41 87.09 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.129 0.972 . . . . 0.0 111.531 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -53.3 -53.5 50.0 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.483 0.713 . . . . 0.0 110.606 168.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -60.93 -25.26 66.66 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.139 1.376 . . . . 0.0 113.672 -173.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 29.8 mt -49.83 -40.32 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 124.351 1.06 . . . . 0.0 111.686 171.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -111.5 -31.63 6.96 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.009 1.323 . . . . 0.0 112.215 -175.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -63.24 -2.99 1.6 Allowed 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.698 1.599 . . . . 0.0 113.493 170.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -51.79 -27.7 13.1 Favored 'General case' 0 CA--C 1.55 0.979 0 O-C-N 120.699 -1.251 . . . . 0.0 112.449 160.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 96.5 m -66.95 -1.69 4.36 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 169.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 86.71 -51.03 4.28 Favored Glycine 0 N--CA 1.473 1.148 0 C-N-CA 126.303 1.906 . . . . 0.0 113.059 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -71.79 169.88 14.79 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.65 1.18 . . . . 0.0 111.16 171.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.0 p -139.88 144.14 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 120.59 -1.319 . . . . 0.0 112.925 174.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -101.01 -108.72 0.22 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.671 1.589 . . . . 0.0 110.608 172.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -158.47 149.42 20.55 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.582 1.553 . . . . 0.0 112.267 -176.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.43 175.42 13.72 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.107 -0.996 . . . . 0.0 112.964 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -154.39 153.62 31.9 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -174.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 50.7 t -158.0 135.82 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 129.055 2.942 . . . . 0.0 106.893 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -132.53 146.43 51.9 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.657 0.783 . . . . 0.0 110.667 171.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 4.7 mt -92.75 142.98 26.75 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.458 0.647 . . . . 0.0 111.587 -171.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -72.73 144.06 47.79 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.967 1.307 . . . . 0.0 111.036 171.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -66.91 -9.98 54.57 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.15 1.357 . . . . 0.0 116.209 -171.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -75.4 -2.13 27.14 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 119.321 1.561 . . . . 0.0 113.045 165.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 86.9 44.49 5.71 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.58 1.562 . . . . 0.0 112.48 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 53.9 t -136.47 129.1 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.384 1.073 . . . . 0.0 110.656 -169.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 22.1 m -81.28 141.14 34.38 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -177.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 67.9 p -78.93 104.49 9.6 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.604 0.762 . . . . 0.0 109.102 171.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -69.82 -36.83 74.97 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 111.952 -0.459 . . . . 0.0 111.952 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 27.4 m -66.46 111.22 3.46 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.148 0.979 . . . . 0.0 110.76 161.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -131.65 165.31 23.36 Favored Glycine 0 N--CA 1.474 1.21 0 C-N-CA 124.765 1.174 . . . . 0.0 114.892 -173.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.74 146.02 24.46 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 126.562 1.945 . . . . 0.0 110.902 178.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -140.68 138.91 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.821 1.648 . . . . 0.0 108.259 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 26.9 t -116.33 132.4 56.68 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.127 0.971 . . . . 0.0 110.888 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.63 156.8 16.85 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 -158.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -55.73 -52.72 62.94 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 113.934 -1.484 . . . . 0.0 111.179 171.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -172.9 170.31 4.57 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 129.061 2.944 . . . . 0.0 108.623 170.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 10.7 tp -57.7 -30.87 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.954 0.901 . . . . 0.0 113.323 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -46.66 78.94 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.831 0.852 . . . . 0.0 113.11 171.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -84.43 -25.04 29.29 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 119.581 -0.247 . . . . 0.0 110.819 -175.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 4.9 tt -60.14 -45.64 92.35 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.845 1.258 . . . . 0.0 109.725 171.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -67.27 -25.54 66.11 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 171.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 21.3 mmm-85 -70.33 -43.1 70.97 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.962 1.255 . . . . 0.0 111.649 166.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -68.84 -38.42 79.81 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.675 1.59 . . . . 0.0 113.073 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 2.6 pp -69.56 -19.94 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 171.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -82.41 -42.59 18.4 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.62 1.168 . . . . 0.0 111.879 170.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -76.51 -53.4 8.14 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -105.62 -19.99 13.6 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -159.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -67.43 113.69 5.5 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 119.269 0.94 . . . . 0.0 109.423 172.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 97.65 -0.26 59.47 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.692 1.615 . . . . 0.0 114.962 -171.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -100.38 149.58 23.49 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.966 1.383 . . . . 0.0 111.472 176.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 23.1 p -113.42 128.29 56.4 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.108 0.963 . . . . 0.0 113.269 -173.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 15.2 mt -147.95 122.65 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.754 1.622 . . . . 0.0 107.943 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 59.18 37.66 23.83 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.364 1.065 . . . . 0.0 113.133 -177.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 140.36 -111.13 0.72 Allowed Glycine 0 N--CA 1.47 0.942 0 C-N-CA 124.449 1.023 . . . . 0.0 114.085 171.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -84.58 177.03 8.23 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.52 0.728 . . . . 0.0 111.008 -170.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 17.9 m -63.77 142.59 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 159.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 3.1 pp -99.52 144.86 28.13 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.74 0.781 . . . . 0.0 111.922 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -105.61 165.58 11.06 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.117 1.767 . . . . 0.0 109.205 162.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 26.6 t -136.16 120.3 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.718 1.607 . . . . 0.0 109.204 -174.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -122.69 170.39 10.1 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.239 1.815 . . . . 0.0 110.841 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 32.2 t -145.19 155.63 43.38 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 120.218 -1.551 . . . . 0.0 112.058 177.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 15.3 tptm . . . . . 0 CA--C 1.552 1.054 0 C-N-CA 125.0 1.32 . . . . 0.0 113.215 179.493 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 . . . . . 0 N--CA 1.47 0.544 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 30.1 m -143.26 164.7 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 126.166 1.787 . . . . 0.0 110.624 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.6 mp -116.97 145.85 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 127.437 2.295 . . . . 0.0 107.446 173.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 19.2 m -118.62 146.19 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.43 1.092 . . . . 0.0 110.488 171.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -150.52 153.63 36.17 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.289 1.036 . . . . 0.0 113.135 -163.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 28.1 t30 83.91 -23.03 0.2 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 128.999 2.919 . . . . 0.0 114.259 176.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 47.8 mt -28.91 116.58 0.28 Allowed Pre-proline 0 CA--C 1.563 1.454 0 C-N-CA 126.495 1.918 . . . . 0.0 111.285 144.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -81.81 -175.52 2.61 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 125.107 3.871 . . . . 0.0 112.95 -173.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -61.92 -12.91 20.36 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 -176.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 16.1 m -85.27 -10.04 56.97 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.96 1.304 . . . . 0.0 114.12 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -108.72 127.43 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 126.704 2.002 . . . . 0.0 109.609 177.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -136.74 -177.26 4.66 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.175 2.19 . . . . 0.0 110.407 -173.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -43.76 -51.15 7.46 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.426 1.49 . . . . 0.0 114.595 -176.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -63.47 -38.04 89.61 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.076 0.853 . . . . 0.0 112.293 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.31 -41.66 73.02 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 170.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.459 HD23 ' C ' ' A' ' 277' ' ' LEU . 5.8 tt -55.65 -43.31 76.12 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.89 1.276 . . . . 0.0 110.719 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -46.8 -58.46 3.88 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.321 1.049 . . . . 0.0 111.643 171.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -61.19 -24.19 66.14 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.489 1.515 . . . . 0.0 113.293 -175.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 34.9 mt -52.14 -40.41 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 119.861 1.209 . . . . 0.0 111.185 172.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -102.02 -29.58 11.7 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.867 1.267 . . . . 0.0 111.718 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 23.7 tptt -70.16 -18.09 63.2 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.148 1.379 . . . . 0.0 113.553 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -61.07 -18.73 59.45 Favored 'General case' 0 CA--C 1.551 1.011 0 O-C-N 120.323 -1.486 . . . . 0.0 113.281 168.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 10.4 t -66.18 -11.03 47.04 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 124.709 1.203 . . . . 0.0 113.837 171.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 100.45 -8.94 58.85 Favored Glycine 0 N--CA 1.475 1.272 0 C-N-CA 125.973 1.749 . . . . 0.0 114.099 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -138.47 143.12 39.47 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.943 1.697 . . . . 0.0 109.936 172.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.9 p -89.54 141.26 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.176 0.99 . . . . 0.0 111.301 -177.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -83.52 -128.84 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.206 1.402 . . . . 0.0 110.583 170.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -157.64 162.22 38.67 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 127.457 2.303 . . . . 0.0 110.327 169.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -155.43 165.79 35.54 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.936 -1.103 . . . . 0.0 113.651 -170.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -147.69 137.26 22.58 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.609 1.564 . . . . 0.0 111.822 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 22.6 t -154.9 137.76 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.771 2.028 . . . . 0.0 108.375 -174.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -132.49 123.01 25.77 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.09 0.956 . . . . 0.0 110.097 170.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 18.8 mt -89.63 161.73 15.98 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.677 0.791 . . . . 0.0 112.948 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -74.03 139.04 44.46 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.481 1.112 . . . . 0.0 110.728 177.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -68.8 -8.99 58.46 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 116.59 1.396 . . . . 0.0 116.59 -163.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -78.53 -2.07 36.96 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 118.879 1.34 . . . . 0.0 112.791 166.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 89.03 46.63 4.41 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 125.519 1.533 . . . . 0.0 112.133 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.06 128.81 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.508 1.123 . . . . 0.0 110.896 -168.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 51.8 m -61.22 146.34 48.09 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.026 1.73 . . . . 0.0 114.449 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 29.4 p -84.79 -32.02 23.59 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.12 1.368 . . . . 0.0 112.895 172.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 77.78 -60.81 3.73 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.911 1.243 . . . . 0.0 111.433 -171.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 59.3 p -67.3 154.99 40.02 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.16 1.784 . . . . 0.0 113.393 167.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -167.05 171.31 41.81 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.802 1.192 . . . . 0.0 114.773 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 94.8 m -106.85 146.18 31.25 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.833 1.653 . . . . 0.0 110.092 -174.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 1.1 t -134.6 135.0 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.143 1.777 . . . . 0.0 109.292 -175.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 8.2 m -109.39 119.76 40.45 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.17 1.788 . . . . 0.0 108.347 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.45 164.49 25.4 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -157.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -56.09 -47.0 78.84 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.784 173.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -172.39 162.07 5.32 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 129.746 3.218 . . . . 0.0 108.921 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.56 HD12 ' H ' ' A' ' 311' ' ' ILE . 4.5 mp -62.19 -31.4 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.99 0.916 . . . . 0.0 111.823 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.62 -43.4 62.56 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 177.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -97.91 -14.97 20.36 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -176.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.8 tt -55.41 -51.6 66.32 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.178 1.391 . . . . 0.0 110.828 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -66.91 -29.33 69.18 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 39.1 mtp85 -70.16 -51.05 34.3 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.653 1.181 . . . . 0.0 111.126 170.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -63.07 -32.98 74.48 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.982 1.713 . . . . 0.0 113.524 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -54.83 -39.17 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.213 1.405 . . . . 0.0 112.051 177.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -82.67 -39.19 22.39 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.217 0.607 . . . . 0.0 112.055 174.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -65.51 -49.05 70.41 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -171.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -85.87 -20.84 28.48 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -176.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -67.19 113.69 5.33 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.415 -0.803 . . . . 0.0 110.03 173.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 101.03 0.07 54.86 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.29 0.947 . . . . 0.0 114.864 -173.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -94.21 168.83 10.67 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 118.962 1.381 . . . . 0.0 111.742 172.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 55.3 p -138.22 127.06 23.83 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 120.399 -1.438 . . . . 0.0 112.671 -175.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 22.6 mt -143.53 125.13 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.688 1.195 . . . . 0.0 109.487 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 59.49 20.73 9.16 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.7 1.6 . . . . 0.0 114.217 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 170.78 -118.49 0.75 Allowed Glycine 0 C--N 1.342 0.893 0 O-C-N 121.004 -1.06 . . . . 0.0 114.935 -178.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -96.48 178.13 5.45 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.8 0.84 . . . . 0.0 111.081 -171.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 12.6 p -52.64 137.49 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 O-C-N 121.879 -0.513 . . . . 0.0 109.948 157.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 2.1 pp -112.98 147.53 36.95 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.475 1.11 . . . . 0.0 112.195 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -104.56 157.45 17.16 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.176 1.39 . . . . 0.0 110.475 170.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 16.6 t -133.91 135.64 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.242 1.417 . . . . 0.0 109.313 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -149.29 159.57 44.15 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.819 1.248 . . . . 0.0 111.515 -171.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 23.0 t -144.39 151.7 39.65 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 120.59 -1.319 . . . . 0.0 111.099 172.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt . . . . . 0 N--CA 1.478 0.948 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -174.397 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 35.3 m -134.28 157.72 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.197 0.999 . . . . 0.0 111.454 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 3.8 mp -131.82 140.29 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 126.258 1.823 . . . . 0.0 107.485 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 28.0 m -123.74 125.79 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.796 0.838 . . . . 0.0 109.984 -177.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -142.08 66.84 1.33 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.301 1.44 . . . . 0.0 111.82 -160.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -170.61 -44.67 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.957 1.703 . . . . 0.0 111.069 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 33.1 mt -40.09 119.26 1.45 Allowed Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 126.98 2.112 . . . . 0.0 112.327 165.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -94.06 -174.54 0.39 Allowed 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 124.505 3.47 . . . . 0.0 111.593 -176.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -51.32 -18.23 0.93 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.449 1.9 . . . . 0.0 115.379 177.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 15.8 m -64.68 -21.5 66.75 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.324 1.45 . . . . 0.0 113.879 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 5.4 p -105.72 148.54 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.742 1.217 . . . . 0.0 109.816 169.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -127.26 168.13 15.17 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.171 1.389 . . . . 0.0 111.549 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -54.1 -40.87 67.68 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -167.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -68.98 -37.75 78.94 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.482 -0.761 . . . . 0.0 111.687 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.47 -33.52 73.03 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 171.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 7.2 tt -60.48 -43.39 97.0 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.939 0.79 . . . . 0.0 110.962 172.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.49 -36.44 78.33 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.766 -0.584 . . . . 0.0 111.928 174.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -69.2 -20.06 63.97 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 23.7 mt -54.48 -45.53 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-N 119.604 1.093 . . . . 0.0 112.484 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -103.17 -3.97 25.06 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.662 1.185 . . . . 0.0 112.496 -174.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -61.8 -23.95 66.55 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.818 2.047 . . . . 0.0 115.217 -169.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -76.2 -10.87 59.75 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 14.0 t -79.03 -23.82 44.05 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 174.08 -165.99 37.88 Favored Glycine 0 N--CA 1.473 1.158 0 C-N-CA 124.346 0.974 . . . . 0.0 114.543 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -64.03 105.5 0.88 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.428 1.091 . . . . 0.0 110.087 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 5.3 p -52.94 137.2 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -153.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -73.43 -111.05 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.469 1.508 . . . . 0.0 112.397 -176.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -162.86 161.66 26.04 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.434 1.894 . . . . 0.0 111.091 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.3 168.39 27.14 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.076 -1.015 . . . . 0.0 112.386 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -156.86 153.62 28.52 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.313 1.045 . . . . 0.0 112.118 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 20.1 t -151.66 142.46 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.752 2.021 . . . . 0.0 108.302 -172.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -127.87 152.18 48.15 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.924 0.889 . . . . 0.0 110.861 172.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 15.4 mt -103.62 -157.06 0.59 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.762 1.225 . . . . 0.0 110.655 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -149.9 151.12 32.91 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.026 0.93 . . . . 0.0 111.273 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -63.26 -20.94 63.62 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-O 118.784 -1.009 . . . . 0.0 115.604 -174.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -117.55 -9.8 10.74 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 118.924 1.362 . . . . 0.0 113.962 165.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -70.27 -51.58 21.62 Favored Glycine 0 N--CA 1.47 0.92 0 C-N-CA 124.362 0.982 . . . . 0.0 112.267 169.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 2.8 t 58.94 10.46 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 C-N-CA 127.145 2.178 . . . . 0.0 112.016 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 86.4 p -179.57 153.45 0.56 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 127.94 2.496 . . . . 0.0 110.652 -168.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 5.0 p -152.97 -54.81 0.12 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 125.385 1.474 . . . . 0.0 112.774 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 78.3 -62.9 3.7 Favored Glycine 0 N--CA 1.473 1.111 0 C-N-CA 125.186 1.374 . . . . 0.0 112.023 -176.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 38.3 m -49.48 120.8 4.41 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.73 1.612 . . . . 0.0 112.451 165.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -157.25 -160.82 10.39 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.114 1.34 . . . . 0.0 114.522 -177.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 22.0 p -108.96 145.74 34.97 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.615 1.966 . . . . 0.0 111.149 -173.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.68 127.14 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.915 1.286 . . . . 0.0 109.047 -177.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 19.4 m -85.21 151.84 23.78 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.036 0.934 . . . . 0.0 110.138 171.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.33 157.74 27.51 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 -169.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -57.91 -55.66 32.01 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.608 1.563 . . . . 0.0 111.52 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -172.26 175.35 3.69 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 128.184 2.594 . . . . 0.0 108.975 161.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 74.2 mt -57.05 -35.9 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.241 1.416 . . . . 0.0 111.77 -176.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.39 -50.16 9.34 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.957 1.703 . . . . 0.0 114.874 172.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -95.76 -21.67 18.0 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.333 0.653 . . . . 0.0 112.129 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.0 tt -56.01 -49.4 73.78 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.549 1.14 . . . . 0.0 109.881 170.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -59.87 -33.64 72.08 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -70.51 -53.79 14.8 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.236 0.614 . . . . 0.0 111.267 170.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.52 -37.06 74.85 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.331 1.452 . . . . 0.0 113.602 -176.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.16 -40.17 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.306 1.042 . . . . 0.0 112.071 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -82.54 -38.94 23.04 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.487 0.715 . . . . 0.0 111.776 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -64.46 -47.72 77.94 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.519 1.128 . . . . 0.0 113.403 -173.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -92.54 -18.48 23.08 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -172.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -70.0 116.36 10.28 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.023 -1.048 . . . . 0.0 110.479 175.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 97.72 -5.84 62.29 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.628 1.585 . . . . 0.0 115.139 -174.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -80.09 172.79 13.31 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 118.824 1.312 . . . . 0.0 111.164 170.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 53.8 m -134.56 130.86 37.18 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 120.703 1.592 . . . . 0.0 111.697 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 39.0 mt -145.63 114.62 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.297 1.039 . . . . 0.0 109.159 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 57.1 28.52 15.06 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.439 1.096 . . . . 0.0 113.897 172.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 168.87 -125.52 1.28 Allowed Glycine 0 C--N 1.342 0.909 0 O-C-N 120.825 -1.172 . . . . 0.0 114.33 -177.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -87.35 -178.94 6.3 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.193 0.997 . . . . 0.0 110.824 -176.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 35.1 m -59.87 137.19 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 121.9 -0.5 . . . . 0.0 109.655 161.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 11.1 mp -71.34 128.31 35.47 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.135 1.374 . . . . 0.0 109.476 173.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -106.05 146.28 30.33 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 154.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 14.4 t -136.7 128.76 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.561 1.544 . . . . 0.0 108.938 -172.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -130.03 169.69 14.96 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.77 2.028 . . . . 0.0 110.512 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 32.9 t -138.5 151.66 47.58 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 120.537 -1.352 . . . . 0.0 111.833 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 40.6 tttm . . . . . 0 CA--C 1.552 1.022 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 -168.225 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 120.02 -0.038 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 32.6 m -133.24 147.14 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.142 0.977 . . . . 0.0 111.056 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.7 mp -91.57 141.23 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 126.675 1.99 . . . . 0.0 108.606 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 34.7 m -132.84 129.07 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.577 1.151 . . . . 0.0 109.036 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.3 tptm -150.5 50.46 0.88 Allowed 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 -148.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -160.94 -17.68 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 170.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 39.3 mt -54.35 131.96 61.93 Favored Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 125.713 1.605 . . . . 0.0 111.598 168.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -86.09 169.5 8.75 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.312 3.341 . . . . 0.0 111.276 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -55.81 -10.66 0.78 Allowed 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 6.2 t -59.32 -31.21 68.95 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.696 1.198 . . . . 0.0 113.006 171.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.62 116.33 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 169.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -69.36 153.28 43.85 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.562 0.745 . . . . 0.0 110.097 171.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -55.46 -32.67 62.99 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 120.538 -1.351 . . . . 0.0 113.108 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -69.11 -39.57 78.85 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.021 0.929 . . . . 0.0 111.033 175.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.53 -25.51 64.06 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.078 -1.014 . . . . 0.0 113.065 170.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.74 -49.05 64.63 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.258 0.935 . . . . 0.0 111.343 170.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -25.89 68.25 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 119.762 1.165 . . . . 0.0 111.852 174.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -68.93 -21.66 64.19 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 171.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.441 HG23 HD12 ' A' ' 326' ' ' ILE . 30.1 mt -56.97 -51.35 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 CA-C-N 119.696 1.134 . . . . 0.0 111.269 173.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -85.84 -19.55 30.46 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.678 0.791 . . . . 0.0 111.824 -174.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -57.62 -13.98 4.71 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.103 1.761 . . . . 0.0 114.808 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -59.48 -15.32 16.84 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 168.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 83.9 m -68.79 -5.62 21.86 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 168.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.39 -8.58 60.5 Favored Glycine 0 N--CA 1.48 1.575 0 C-N-CA 125.789 1.662 . . . . 0.0 115.666 172.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -138.69 -174.65 3.89 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.823 2.049 . . . . 0.0 108.634 170.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 6.8 p -144.06 144.22 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 121.159 1.799 . . . . 0.0 113.618 172.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -94.81 -121.04 0.1 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.184 1.793 . . . . 0.0 111.189 177.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -143.82 158.55 43.61 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.538 1.935 . . . . 0.0 111.567 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.96 -179.72 8.3 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 120.974 -1.079 . . . . 0.0 113.855 -177.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 8.2 p30 -155.54 173.7 16.32 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.656 1.583 . . . . 0.0 113.781 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 17.2 m -149.92 173.86 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 127.69 2.396 . . . . 0.0 110.075 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -108.22 159.54 16.54 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.674 1.19 . . . . 0.0 111.318 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.3 mp -132.96 134.17 44.15 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.542 1.137 . . . . 0.0 111.347 173.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -66.77 164.27 17.5 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.691 1.196 . . . . 0.0 111.221 165.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -61.97 -19.93 59.5 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.019 0.819 . . . . 0.0 114.669 176.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -79.14 -6.16 55.86 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.917 1.287 . . . . 0.0 113.47 171.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 80.87 14.13 80.12 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.034 1.302 . . . . 0.0 115.135 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 3.7 p -91.11 4.66 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 -165.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 10.9 p 64.87 -179.39 0.18 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 126.992 2.117 . . . . 0.0 116.159 175.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 68.6 p -141.99 156.3 45.45 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 128.368 2.667 . . . . 0.0 108.229 172.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -88.01 -34.31 10.0 Favored Glycine 0 N--CA 1.47 0.947 0 C-N-CA 123.245 0.45 . . . . 0.0 112.203 169.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 18.7 p -56.81 143.04 38.58 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.762 1.625 . . . . 0.0 111.922 163.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 169.55 -153.59 22.09 Favored Glycine 0 N--CA 1.471 0.985 0 C-N-CA 126.172 1.844 . . . . 0.0 112.253 -175.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 17.8 p -125.09 154.97 40.57 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 117.994 0.897 . . . . 0.0 111.357 173.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 13.4 m -123.82 121.96 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 125.222 1.409 . . . . 0.0 107.782 172.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 4.5 m -91.09 120.79 32.34 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.013 1.725 . . . . 0.0 109.356 -175.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.85 157.47 21.99 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -158.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -54.38 -54.03 46.0 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 113.56 -1.655 . . . . 0.0 111.793 172.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -172.68 170.24 4.78 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 129.366 3.067 . . . . 0.0 108.676 171.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 89.5 mt -57.49 -34.32 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 124.864 1.266 . . . . 0.0 112.054 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.14 -40.2 64.07 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.138 1.375 . . . . 0.0 114.433 172.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -89.39 -33.15 16.96 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 119.328 -0.368 . . . . 0.0 110.418 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 6.2 tt -56.64 -52.16 65.94 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.854 1.262 . . . . 0.0 111.378 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -62.3 -47.58 83.66 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.67 -0.644 . . . . 0.0 112.541 -177.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 28.1 ptt85 -70.44 -28.83 65.34 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -74.12 -33.78 63.68 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.502 1.121 . . . . 0.0 112.997 173.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -53.71 -44.04 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.156 1.382 . . . . 0.0 112.3 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -82.75 -17.37 44.47 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -89.07 -48.51 7.36 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.913 0.885 . . . . 0.0 112.671 -171.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -85.32 -21.55 28.89 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -49.8 125.26 11.37 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.885 0.874 . . . . 0.0 110.761 159.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 86.93 0.34 85.74 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 119.141 -0.811 . . . . 0.0 114.757 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -103.69 163.43 12.33 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.139 1.375 . . . . 0.0 112.045 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 34.1 p -138.03 129.35 27.66 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 120.684 -1.26 . . . . 0.0 111.897 -175.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.441 HD12 HG23 ' A' ' 280' ' ' ILE . 11.0 mt -146.71 116.86 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.49 1.116 . . . . 0.0 109.104 -177.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 60.86 25.95 15.84 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.695 1.198 . . . . 0.0 112.792 176.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 178.2 -140.01 4.42 Favored Glycine 0 C--N 1.342 0.888 0 O-C-N 120.931 -1.106 . . . . 0.0 114.474 -170.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -91.42 178.26 6.0 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.399 1.08 . . . . 0.0 110.644 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 11.7 p -59.92 129.19 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 O-C-N 121.642 -0.661 . . . . 0.0 109.308 160.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 1.8 pp -104.37 149.09 25.69 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 122.406 1.098 . . . . 0.0 111.533 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -113.37 163.54 14.72 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.017 1.327 . . . . 0.0 110.092 166.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 24.3 t -135.93 130.52 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 126.561 1.945 . . . . 0.0 107.51 -175.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -135.28 133.94 39.41 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.234 1.014 . . . . 0.0 111.46 -173.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 77.3 p -118.0 167.54 11.35 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.186 1.394 . . . . 0.0 112.894 -171.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt . . . . . 0 N--CA 1.474 0.736 0 C-N-CA 125.081 1.352 . . . . 0.0 110.718 175.72 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 34.7 m -132.86 157.43 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.687 1.195 . . . . 0.0 111.109 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.0 mp -125.17 136.91 59.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 127.044 2.137 . . . . 0.0 107.033 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.93 128.89 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.116 0.967 . . . . 0.0 109.427 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 60.2 mmtt -138.76 73.84 1.45 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.034 1.334 . . . . 0.0 110.784 -161.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -179.13 -32.21 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.554 1.942 . . . . 0.0 113.3 -173.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 89.1 mt -74.07 131.35 81.29 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-O 117.917 -1.04 . . . . 0.0 109.834 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -94.83 -168.88 0.16 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 124.272 3.315 . . . . 0.0 110.759 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -55.59 -13.62 1.68 Allowed 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 50.0 m -60.26 -24.19 64.71 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.386 1.474 . . . . 0.0 113.872 170.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.3 p -103.5 144.57 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.43 1.092 . . . . 0.0 109.893 170.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -135.91 173.56 11.58 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.944 1.698 . . . . 0.0 109.775 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -44.35 -51.28 8.65 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.959 1.303 . . . . 0.0 113.777 -170.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -70.07 -40.82 74.8 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.917 -0.49 . . . . 0.0 111.618 -175.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.25 -33.56 73.45 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.789 0.722 . . . . 0.0 112.82 176.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 8.2 tt -63.1 -45.2 93.2 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.98 0.809 . . . . 0.0 110.409 172.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 3.7 tmmm? -60.69 -37.63 82.27 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.864 -0.523 . . . . 0.0 111.161 174.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -63.68 -25.32 68.16 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 176.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 28.1 mt -55.92 -51.37 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 124.112 0.965 . . . . 0.0 110.609 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -89.0 -26.26 21.56 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.666 0.786 . . . . 0.0 112.343 -175.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 2.9 ttpt -52.7 -22.03 4.71 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.292 1.437 . . . . 0.0 114.356 173.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -61.8 -13.75 26.7 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 120.77 -1.206 . . . . 0.0 113.79 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 79.3 m -71.54 -0.37 10.42 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.968 1.307 . . . . 0.0 114.403 167.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.58 -73.57 0.25 Allowed Glycine 0 N--CA 1.471 1.001 0 C-N-CA 126.393 1.949 . . . . 0.0 111.449 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -73.08 172.3 11.3 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.19 0.996 . . . . 0.0 111.136 170.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.29 142.05 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 O-C-N 120.635 -1.29 . . . . 0.0 113.827 172.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -85.36 -125.56 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.733 1.613 . . . . 0.0 111.415 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -152.1 162.0 41.77 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.4 1.48 . . . . 0.0 112.89 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.6 173.72 16.16 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.11 -0.994 . . . . 0.0 113.641 -173.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -154.87 158.42 39.33 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.799 1.24 . . . . 0.0 113.398 -177.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 21.8 m -151.53 163.45 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 127.486 2.314 . . . . 0.0 110.914 -172.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -131.97 167.46 19.61 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.77 1.228 . . . . 0.0 111.84 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 4.0 mp -129.05 152.68 48.39 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.228 1.411 . . . . 0.0 112.203 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -92.84 153.17 19.0 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.066 1.746 . . . . 0.0 111.487 173.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -68.5 -7.08 52.25 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.801 1.191 . . . . 0.0 114.989 -178.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -74.08 -4.77 37.57 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.31 1.444 . . . . 0.0 112.953 168.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 86.45 38.29 8.37 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.035 1.302 . . . . 0.0 113.392 176.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 30.6 m -142.05 148.41 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.678 1.591 . . . . 0.0 111.143 -174.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 75.0 p -81.1 152.74 27.67 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.924 0.89 . . . . 0.0 113.039 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 39.1 p -76.25 -29.4 57.48 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.858 0.863 . . . . 0.0 112.881 176.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 74.49 -64.26 2.16 Favored Glycine 0 N--CA 1.47 0.926 0 C-N-CA 125.724 1.63 . . . . 0.0 112.207 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 58.1 m -55.0 110.61 0.69 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.427 1.891 . . . . 0.0 111.435 166.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -146.67 -160.11 8.61 Favored Glycine 0 N--CA 1.469 0.851 0 C-N-CA 124.695 1.14 . . . . 0.0 113.897 -173.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 98.0 m -114.89 136.67 52.85 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.526 1.53 . . . . 0.0 109.625 -170.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 1.3 t -120.41 120.23 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 125.751 1.621 . . . . 0.0 107.622 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 42.9 m -88.46 108.04 19.18 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.416 1.086 . . . . 0.0 108.426 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -79.6 162.91 25.02 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 -160.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -53.21 -55.58 23.21 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.625 1.17 . . . . 0.0 111.35 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -172.39 178.82 2.69 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.039 2.535 . . . . 0.0 109.007 154.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 16.7 tt -53.51 -33.31 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.101 1.36 . . . . 0.0 113.488 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.69 -42.72 68.28 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.207 1.403 . . . . 0.0 113.956 173.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -95.26 -24.58 16.72 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.5 tt -58.35 -51.97 67.57 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 125.434 1.493 . . . . 0.0 110.221 175.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -62.21 -33.43 74.54 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -70.33 -42.39 71.97 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.695 1.198 . . . . 0.0 112.036 174.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -72.92 -33.55 66.05 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.432 1.493 . . . . 0.0 113.134 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.44 -37.01 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.833 0.853 . . . . 0.0 112.6 -176.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -82.17 -19.59 39.6 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.855 0.862 . . . . 0.0 113.206 175.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -89.01 -46.09 9.13 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.68 1.192 . . . . 0.0 112.645 -175.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -87.71 -30.71 20.14 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -171.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -65.09 118.84 9.75 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 119.011 0.823 . . . . 0.0 110.324 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 103.42 -7.07 50.45 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 125.644 1.592 . . . . 0.0 115.629 -172.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -93.88 142.92 26.82 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 119.451 1.625 . . . . 0.0 111.78 176.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 11.0 p -111.96 126.64 55.35 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.793 1.237 . . . . 0.0 112.234 -174.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -148.58 103.16 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.113 0.965 . . . . 0.0 109.517 -166.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 57.06 35.89 26.96 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 121.932 0.872 . . . . 0.0 111.462 -172.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 163.31 -148.69 15.47 Favored Glycine 0 C--N 1.343 0.952 0 O-C-N 121.152 -0.968 . . . . 0.0 114.787 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -80.93 174.55 11.51 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.804 1.642 . . . . 0.0 111.066 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 32.8 m -63.37 136.18 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 121.213 -0.929 . . . . 0.0 111.301 175.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 14.6 mt -63.41 122.28 15.86 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.674 0.79 . . . . 0.0 113.001 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -106.04 102.37 11.8 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.36 1.864 . . . . 0.0 107.599 160.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.45 131.69 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.286 1.435 . . . . 0.0 109.698 -171.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -130.0 135.13 47.94 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.978 1.311 . . . . 0.0 110.806 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 50.1 p -97.05 159.0 15.16 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.874 -1.141 . . . . 0.0 112.005 175.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 23.6 tptm . . . . . 0 CA--C 1.548 0.866 0 O-C-N 121.286 -0.883 . . . . 0.0 111.079 178.664 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.54 0.576 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 31.3 m -138.59 147.26 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.45 1.5 . . . . 0.0 111.126 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.4 mp -92.05 137.83 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 126.01 1.724 . . . . 0.0 107.683 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 5.4 m -117.75 118.5 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.417 ' H ' HD11 ' A' ' 331' ' ' LEU . 6.8 tmtt? -139.37 44.75 1.97 Allowed 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -148.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -168.51 -6.65 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 116.623 2.083 . . . . 0.0 116.623 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 68.0 mt -69.84 144.17 93.04 Favored Pre-proline 0 CA--C 1.553 1.079 0 O-C-N 120.532 -1.355 . . . . 0.0 110.103 174.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -90.62 -175.24 0.83 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.3 3.333 . . . . 0.0 110.905 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -56.37 -12.47 1.68 Allowed 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 20.4 m -60.48 -31.05 70.1 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.78 1.232 . . . . 0.0 113.266 171.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.6 p -93.73 142.49 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.503 0.721 . . . . 0.0 109.697 172.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -137.26 168.41 19.69 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.004 1.722 . . . . 0.0 109.09 176.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -50.56 -40.92 53.43 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -167.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -68.64 -39.01 80.94 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.761 -0.587 . . . . 0.0 111.895 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.58 -36.25 76.09 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.382 -0.824 . . . . 0.0 112.715 170.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.453 HD21 HG12 ' A' ' 306' ' ' VAL . 3.3 tt -61.03 -38.27 85.51 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.189 0.996 . . . . 0.0 112.138 176.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -57.84 -46.94 84.02 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 121.537 -0.727 . . . . 0.0 110.947 169.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.29 -17.82 64.82 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 29.3 mt -54.41 -33.45 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.344 1.058 . . . . 0.0 111.803 169.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -118.05 -27.7 6.05 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.171 1.389 . . . . 0.0 112.183 -176.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -64.31 -6.66 7.39 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -52.72 -25.29 10.65 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.198 1.399 . . . . 0.0 113.06 167.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 70.8 m -67.66 -5.17 14.52 Favored 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 172.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 97.06 -12.17 65.59 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 126.436 1.969 . . . . 0.0 115.017 175.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -138.67 172.47 12.83 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.394 1.878 . . . . 0.0 109.659 174.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.1 p -145.34 144.35 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 120.341 -1.474 . . . . 0.0 112.318 173.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -72.57 -79.4 0.08 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.473 1.109 . . . . 0.0 112.077 178.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -178.45 147.01 0.39 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 127.947 2.499 . . . . 0.0 109.813 -167.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.59 166.56 31.79 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.11 -0.994 . . . . 0.0 112.658 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -157.46 165.8 34.71 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.898 1.279 . . . . 0.0 112.496 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 22.7 m -146.37 155.4 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 126.838 2.055 . . . . 0.0 110.793 -174.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -132.0 115.21 15.54 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.875 1.27 . . . . 0.0 108.848 174.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 17.2 mt -96.13 169.1 10.19 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.466 1.106 . . . . 0.0 111.376 -173.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -78.16 144.76 36.11 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.009 0.923 . . . . 0.0 112.119 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -68.44 -12.35 63.58 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.88 1.229 . . . . 0.0 115.795 -173.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -80.81 0.01 36.77 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 119.301 1.551 . . . . 0.0 113.22 168.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 85.81 43.35 6.44 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.575 1.083 . . . . 0.0 113.172 175.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.19 148.9 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.08 1.352 . . . . 0.0 111.89 -177.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 58.5 m -77.79 139.32 39.32 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -169.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 7.9 p -89.22 -26.66 21.1 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.69 1.996 . . . . 0.0 113.529 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 80.27 -54.27 4.52 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.103 1.811 . . . . 0.0 113.067 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 23.4 p -52.34 139.75 23.63 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 122.998 1.38 . . . . 0.0 113.28 163.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -161.23 -171.73 27.63 Favored Glycine 0 N--CA 1.468 0.832 0 C-N-CA 124.831 1.205 . . . . 0.0 114.682 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 26.6 p -123.39 122.41 38.22 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.48 1.512 . . . . 0.0 109.493 -176.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.453 HG12 HD21 ' A' ' 277' ' ' LEU . 19.6 m -112.58 129.73 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 175.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 5.1 m -87.88 150.03 23.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.709 172.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.74 157.44 19.76 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -165.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -53.82 -52.57 59.92 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.743 1.617 . . . . 0.0 111.88 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -172.66 170.36 4.77 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.351 2.66 . . . . 0.0 108.532 162.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.553 HD12 ' H ' ' A' ' 311' ' ' ILE . 4.3 mp -47.1 -38.23 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 125.121 1.368 . . . . 0.0 112.11 175.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.67 -48.99 19.98 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.878 1.671 . . . . 0.0 115.111 173.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -96.39 -21.44 17.77 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 118.749 -0.643 . . . . 0.0 111.993 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.3 tt -57.87 -52.33 65.91 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.234 1.013 . . . . 0.0 110.191 173.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -68.87 -26.61 65.21 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -70.29 -43.36 70.56 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.043 0.937 . . . . 0.0 111.594 169.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -75.24 -30.6 60.57 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.511 1.525 . . . . 0.0 113.675 -177.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.01 -42.28 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.179 0.991 . . . . 0.0 113.12 -172.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -82.77 -37.79 24.09 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.688 0.795 . . . . 0.0 112.449 175.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -57.46 -38.15 74.01 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.198 -0.939 . . . . 0.0 111.997 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -106.31 28.53 7.65 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.322 1.849 . . . . 0.0 112.616 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -89.94 118.75 29.74 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.421 -1.424 . . . . 0.0 110.866 161.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 84.41 -8.67 67.15 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.975 1.274 . . . . 0.0 115.523 172.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 324' ' ' TYR . . . . . 0.458 ' CE1' HD23 ' A' ' 331' ' ' LEU . 0.2 OUTLIER -60.43 171.55 1.06 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.282 1.833 . . . . 0.0 113.78 168.395 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 73.4 p -138.52 122.25 17.55 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.077 -1.015 . . . . 0.0 112.048 175.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 13.4 mt -135.54 111.3 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.714 1.206 . . . . 0.0 108.878 177.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 65.09 26.6 12.52 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.359 1.464 . . . . 0.0 112.939 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . -179.07 -131.83 1.65 Allowed Glycine 0 CA--C 1.53 1.014 0 N-CA-C 115.707 1.043 . . . . 0.0 115.707 -176.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -98.61 179.28 4.74 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.481 1.513 . . . . 0.0 111.077 -172.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 30.8 m -60.29 132.28 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 162.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 331' ' ' LEU . . . . . 0.458 HD23 ' CE1' ' A' ' 324' ' ' TYR . 59.7 tp -126.21 117.16 22.5 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.553 0.741 . . . . 0.0 111.147 -165.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -75.67 148.74 38.45 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.147 160.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 96.6 t -136.89 137.69 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 126.074 1.75 . . . . 0.0 108.998 -176.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -144.13 135.74 25.92 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.994 0.918 . . . . 0.0 111.952 -170.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 82.5 p -89.37 161.74 16.17 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 45.0 tttm . . . . . 0 CA--C 1.557 1.214 0 C-N-CA 124.826 1.25 . . . . 0.0 113.219 -179.826 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 . . . . . 0 N--CA 1.476 0.852 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 12.1 m -133.94 161.46 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 124.976 1.311 . . . . 0.0 110.963 169.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.97 139.57 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 127.343 2.257 . . . . 0.0 108.368 178.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.57 126.6 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.329 1.051 . . . . 0.0 108.961 175.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -140.15 42.5 1.93 Allowed 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -153.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -158.34 -15.31 0.07 Allowed 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 171.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 16.2 mt -52.29 133.47 42.36 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 125.641 1.577 . . . . 0.0 112.969 173.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -88.24 166.55 6.71 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.929 3.753 . . . . 0.0 110.931 172.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -60.32 -12.48 9.23 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -174.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 16.0 m -61.76 -23.47 66.2 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.289 1.036 . . . . 0.0 112.789 171.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.5 p -115.32 131.51 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 126.936 2.094 . . . . 0.0 108.958 167.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -148.5 178.2 8.82 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.109 1.764 . . . . 0.0 109.224 -171.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -38.87 -50.67 1.73 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.284 1.834 . . . . 0.0 115.932 -162.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -67.35 -44.51 78.86 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.234 0.925 . . . . 0.0 111.886 -176.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.84 -32.0 70.17 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 172.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.496 HD23 ' C ' ' A' ' 277' ' ' LEU . 4.1 tt -58.64 -45.31 89.59 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.257 1.023 . . . . 0.0 109.91 174.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -56.08 -38.3 70.49 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.577 -0.702 . . . . 0.0 112.376 173.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -69.04 -19.95 64.11 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 178.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 29.7 mt -58.19 -30.47 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 124.157 0.983 . . . . 0.0 111.707 170.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -114.19 -26.46 8.03 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.666 1.186 . . . . 0.0 113.434 -175.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 1.8 tmmt? -63.54 -20.73 65.87 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -176.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -75.0 -13.54 60.52 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 171.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 11.2 t -107.08 -33.55 7.43 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.185 1.394 . . . . 0.0 113.301 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -138.03 153.52 22.32 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.843 1.211 . . . . 0.0 114.84 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -69.45 115.25 8.49 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.707 1.203 . . . . 0.0 110.751 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 4.8 p -41.14 132.9 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 -154.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -99.09 -111.76 0.17 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.971 1.708 . . . . 0.0 110.274 174.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 -159.58 155.23 25.91 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.667 1.587 . . . . 0.0 112.456 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.23 171.31 20.44 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.132 -0.98 . . . . 0.0 112.621 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -157.59 165.6 35.1 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.828 1.251 . . . . 0.0 112.814 -173.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 23.1 t -151.01 142.78 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 127.421 2.288 . . . . 0.0 107.387 -177.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -119.52 133.09 55.83 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.224 0.61 . . . . 0.0 110.921 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 11.8 mt -86.34 164.99 16.76 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.981 0.912 . . . . 0.0 111.471 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -64.72 133.33 51.88 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 155.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -67.51 -11.88 60.47 Favored Glycine 0 N--CA 1.475 1.265 0 N-CA-C 117.385 1.714 . . . . 0.0 117.385 -153.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -79.73 0.4 30.7 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 118.556 1.178 . . . . 0.0 112.736 168.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 93.75 33.91 6.83 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 126.356 1.931 . . . . 0.0 113.584 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.32 15.38 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -157.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 21.0 p 73.27 148.0 0.09 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 127.532 2.333 . . . . 0.0 115.484 171.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 11.9 p -159.75 158.05 30.53 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 128.183 2.593 . . . . 0.0 109.022 -177.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -112.82 -50.22 0.56 Allowed Glycine 0 N--CA 1.473 1.137 0 C-N-CA 124.187 0.898 . . . . 0.0 112.844 169.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 69.1 m -44.19 120.82 2.27 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.901 1.68 . . . . 0.0 113.093 170.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -152.01 -168.22 16.05 Favored Glycine 0 N--CA 1.468 0.826 0 C-N-CA 125.047 1.308 . . . . 0.0 114.288 -173.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 30.0 p -122.65 152.75 40.19 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.101 1.76 . . . . 0.0 110.314 -174.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 1.7 t -139.46 126.19 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.353 1.061 . . . . 0.0 108.474 -170.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 19.4 t -92.57 121.0 33.58 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.819 0.847 . . . . 0.0 108.757 172.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.94 155.54 18.65 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -165.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -55.02 -53.83 50.81 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.844 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -172.85 -170.62 0.68 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 128.519 2.728 . . . . 0.0 108.805 145.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.4 mp -55.96 -34.18 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.426 1.49 . . . . 0.0 113.284 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.36 -35.61 60.46 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.293 1.219 . . . . 0.0 114.293 174.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -98.82 -35.57 10.08 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 123.703 0.627 . . . . 0.0 110.127 -173.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.5 tt -51.21 -52.32 45.59 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 126.971 2.108 . . . . 0.0 110.659 174.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -65.15 -25.27 67.67 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 119.13 0.877 . . . . 0.0 113.21 -176.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -70.64 -55.96 7.57 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.917 1.287 . . . . 0.0 110.427 169.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -63.88 -37.2 86.52 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.124 1.37 . . . . 0.0 113.351 -175.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.15 -34.01 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.446 1.098 . . . . 0.0 112.031 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -82.53 -40.82 20.47 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.054 0.942 . . . . 0.0 111.901 173.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.07 -41.69 85.99 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.224 1.01 . . . . 0.0 113.501 -175.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -106.13 -17.53 14.29 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -169.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -66.78 121.05 14.6 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.977 1.262 . . . . 0.0 109.836 168.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 91.41 -1.2 75.89 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 124.193 0.901 . . . . 0.0 114.693 -171.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -97.49 166.75 11.38 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.318 1.447 . . . . 0.0 111.446 175.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 61.7 p -138.43 127.21 23.66 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 120.11 -1.619 . . . . 0.0 112.358 -177.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 16.9 mt -137.47 106.91 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.991 0.917 . . . . 0.0 109.72 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 59.03 25.18 13.54 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.402 1.481 . . . . 0.0 112.996 175.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . -167.29 -140.61 2.94 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.807 1.194 . . . . 0.0 113.808 -169.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -96.2 179.94 4.87 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.891 0.876 . . . . 0.0 111.101 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.53 128.2 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 165.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 16.3 mt -72.37 129.46 38.42 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.042 1.337 . . . . 0.0 112.111 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -112.79 118.84 36.08 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.021 1.728 . . . . 0.0 107.3 163.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 18.0 t -127.25 138.49 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.18 1.392 . . . . 0.0 109.436 -166.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -140.37 139.96 35.44 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.622 1.169 . . . . 0.0 111.521 -177.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 32.4 t -91.15 146.98 23.38 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.27 -0.894 . . . . 0.0 112.594 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 79.8 tttt . . . . . 0 CA--C 1.553 1.066 0 C-N-CA 124.121 0.968 . . . . 0.0 112.877 170.477 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 . . . . . 0 N--CA 1.467 0.406 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.37 149.47 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 126.3 1.84 . . . . 0.0 110.957 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.79 126.41 62.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 126.842 2.057 . . . . 0.0 106.277 172.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 29.5 m -91.44 144.74 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 167.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -144.94 138.21 26.72 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.6 0.76 . . . . 0.0 112.647 -167.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 50.2 t30 96.97 -3.03 0.05 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 129.461 3.104 . . . . 0.0 114.051 175.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 82.6 mt -70.62 133.62 86.68 Favored Pre-proline 0 CA--C 1.556 1.173 0 O-C-N 120.954 -1.091 . . . . 0.0 109.491 165.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -88.95 -168.58 0.35 Allowed 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 124.396 3.397 . . . . 0.0 111.471 -174.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -52.71 -17.09 1.16 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.908 1.683 . . . . 0.0 115.249 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 7.6 t -63.47 -31.25 72.36 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.567 1.147 . . . . 0.0 113.135 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.23 137.32 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 118.712 0.687 . . . . 0.0 110.74 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -145.24 173.0 12.33 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.35 2.26 . . . . 0.0 108.554 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -48.61 -44.38 37.04 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 120.156 1.344 . . . . 0.0 114.135 -166.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -74.7 -23.75 58.65 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -79.85 -37.26 35.37 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.852 1.206 . . . . 0.0 113.166 164.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.48 -48.54 76.91 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.835 0.854 . . . . 0.0 111.044 177.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.28 -30.86 71.43 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.773 -0.579 . . . . 0.0 111.344 -178.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.47 -18.91 63.75 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.011 1.724 . . . . 0.0 114.699 172.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.416 HG23 HD12 ' A' ' 326' ' ' ILE . 56.3 mt -56.78 -42.91 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 119.52 1.055 . . . . 0.0 110.27 168.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.445 ' CE1' HG21 ' A' ' 306' ' ' VAL . 79.0 m-85 -104.96 -9.71 17.73 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -173.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -61.95 -8.56 5.32 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -175.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -57.9 -21.07 41.61 Favored 'General case' 0 CA--C 1.55 0.955 0 O-C-N 120.818 -1.176 . . . . 0.0 112.873 168.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 34.2 t -56.87 -21.85 32.52 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.505 1.522 . . . . 0.0 114.074 167.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.1 -17.37 58.16 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 126.907 2.194 . . . . 0.0 113.794 -176.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -139.35 -172.9 3.46 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.624 1.97 . . . . 0.0 109.875 173.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.41 134.56 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 120.544 -1.348 . . . . 0.0 111.294 167.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -74.25 -72.69 0.26 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.591 1.156 . . . . 0.0 112.674 -172.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -159.13 136.54 9.94 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.049 1.74 . . . . 0.0 110.888 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.45 137.89 11.75 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.326 -0.859 . . . . 0.0 112.459 -154.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -162.53 175.37 11.52 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.399 1.48 . . . . 0.0 112.499 -174.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 17.6 m -145.68 167.03 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 126.59 1.956 . . . . 0.0 110.821 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -132.12 148.11 52.46 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.643 1.577 . . . . 0.0 109.684 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.1 mp -134.88 142.05 46.49 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.642 1.177 . . . . 0.0 111.746 -177.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -79.92 179.75 7.41 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.0 0.92 . . . . 0.0 111.072 170.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -67.68 -17.8 69.46 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 121.105 -0.997 . . . . 0.0 114.589 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -88.61 -0.42 57.25 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.184 1.394 . . . . 0.0 113.569 175.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 72.65 25.07 74.99 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.066 0.841 . . . . 0.0 114.238 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 4.8 p -96.18 12.06 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -163.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 22.7 p 59.97 10.85 2.34 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 127.336 2.254 . . . . 0.0 115.132 -176.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . 0.27 1.1 t 50.47 10.07 0.05 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 129.389 3.075 . . . . 0.0 115.752 176.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 86.44 20.23 55.02 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.552 1.548 . . . . 0.0 114.531 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 95.1 p -164.37 167.99 19.08 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 120.103 1.951 . . . . 0.0 116.027 -172.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -153.78 163.6 30.91 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.303 1.906 . . . . 0.0 112.082 173.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 55.1 m -125.71 130.96 52.56 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 118.367 1.083 . . . . 0.0 110.779 -165.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.445 HG21 ' CE1' ' A' ' 281' ' ' PHE . 21.7 t -135.83 123.77 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.789 0.836 . . . . 0.0 109.455 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 66.2 m -104.07 128.26 51.67 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.077 1.351 . . . . 0.0 109.914 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.27 163.38 13.46 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 -141.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -54.21 -51.45 64.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.324 1.45 . . . . 0.0 111.688 175.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -172.86 167.33 5.16 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 128.7 2.8 . . . . 0.0 108.507 164.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.27 -30.62 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.92 0.888 . . . . 0.0 111.306 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.59 -43.7 46.54 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 171.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -95.72 -26.43 15.7 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 118.13 0.423 . . . . 0.0 111.581 -176.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 4.6 tt -53.87 -48.25 70.24 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.507 1.523 . . . . 0.0 109.973 172.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -57.81 -37.57 74.0 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -70.67 -52.43 21.19 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.515 0.726 . . . . 0.0 111.462 171.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -59.64 -34.72 73.15 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.32 1.448 . . . . 0.0 113.452 -175.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.89 -36.81 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.336 1.055 . . . . 0.0 112.382 176.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -83.66 -43.13 15.91 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.753 0.821 . . . . 0.0 112.268 173.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -58.65 -48.51 80.78 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.337 1.455 . . . . 0.0 113.898 -171.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -93.17 -18.51 22.47 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -174.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -73.74 111.89 9.32 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.598 -0.689 . . . . 0.0 110.558 177.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 101.07 -0.05 54.73 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.731 1.157 . . . . 0.0 114.414 -170.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -103.87 173.81 6.14 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.532 1.533 . . . . 0.0 111.446 174.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 30.5 p -138.03 122.94 18.94 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 120.412 -1.43 . . . . 0.0 111.933 -175.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.416 HD12 HG23 ' A' ' 280' ' ' ILE . 11.7 mt -145.02 115.09 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.636 1.174 . . . . 0.0 108.34 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 63.95 34.88 11.18 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.27 1.028 . . . . 0.0 112.565 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 167.45 -132.24 2.55 Favored Glycine 0 C--N 1.341 0.823 0 O-C-N 121.305 -0.872 . . . . 0.0 115.24 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -97.75 -174.64 2.95 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.516 1.526 . . . . 0.0 110.215 -173.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 55.1 t -58.76 126.12 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 159.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 2.2 pp -103.85 144.16 31.87 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 122.419 1.104 . . . . 0.0 112.006 -177.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -94.05 158.62 15.53 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.497 1.919 . . . . 0.0 109.931 165.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 26.3 t -136.2 132.03 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.303 1.441 . . . . 0.0 108.567 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -132.2 133.81 44.62 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.307 1.443 . . . . 0.0 109.98 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 78.0 p -94.73 154.4 17.32 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.973 -1.079 . . . . 0.0 112.154 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 84.2 tttt . . . . . 0 CA--C 1.546 0.803 0 C-N-CA 123.864 0.866 . . . . 0.0 110.955 178.378 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 110.801 -0.074 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 29.9 m -135.24 149.97 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 125.15 1.38 . . . . 0.0 111.249 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.74 144.34 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 126.606 1.962 . . . . 0.0 107.848 169.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 17.4 m -138.57 128.63 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.452 1.501 . . . . 0.0 109.432 -177.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -141.3 158.01 44.46 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -159.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 82.35 -26.25 0.14 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 129.847 3.259 . . . . 0.0 113.938 173.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 92.2 mt -28.71 108.67 0.23 Allowed Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 126.664 1.986 . . . . 0.0 111.482 145.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -87.56 -175.64 1.54 Allowed 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.89 3.06 . . . . 0.0 111.692 177.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -56.29 -25.2 47.55 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 16.8 m -67.47 -16.8 64.41 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . 0.262 2.7 p -108.6 85.36 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 126.407 1.883 . . . . 0.0 109.671 176.129 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -68.19 174.48 3.88 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.877 2.071 . . . . 0.0 113.39 -174.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -54.31 -43.31 71.02 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.85 -1.156 . . . . 0.0 113.573 -177.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -59.5 -45.12 92.61 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.373 0.669 . . . . 0.0 111.388 176.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.37 -32.98 72.39 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 176.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.569 HD21 ' CG1' ' A' ' 306' ' ' VAL . 2.6 tt -62.19 -42.13 98.99 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.299 1.04 . . . . 0.0 111.258 170.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -64.55 -38.67 91.83 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.415 -0.803 . . . . 0.0 111.036 173.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -62.7 -25.21 68.05 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 177.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 30.8 mt -50.34 -51.18 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 124.667 1.187 . . . . 0.0 111.432 175.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -94.33 -29.92 14.78 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.999 0.92 . . . . 0.0 111.19 -176.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -58.35 -20.53 44.32 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -177.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -61.73 -11.42 12.01 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 172.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 7.8 t -65.95 -14.08 60.93 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 124.358 1.063 . . . . 0.0 113.606 168.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.89 -10.1 60.33 Favored Glycine 0 N--CA 1.476 1.363 0 C-N-CA 126.337 1.922 . . . . 0.0 113.718 -177.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 34.5 p-10 -138.63 166.32 24.64 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 128.312 2.645 . . . . 0.0 110.028 173.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.5 p -145.28 140.92 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 120.936 -1.102 . . . . 0.0 111.733 168.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -69.98 -79.61 0.06 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.421 1.088 . . . . 0.0 111.828 -177.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -168.16 149.41 5.11 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 127.433 2.293 . . . . 0.0 110.66 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.14 150.07 21.75 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.95 0.9 . . . . 0.0 112.027 -168.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -170.14 179.84 3.38 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 126.37 1.868 . . . . 0.0 110.731 -176.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -165.21 138.51 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 127.246 2.219 . . . . 0.0 109.78 170.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -76.86 131.25 38.51 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 163.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 14.2 mt -103.25 170.5 7.92 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.633 0.773 . . . . 0.0 112.996 -168.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -51.09 154.67 1.48 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.149 1.779 . . . . 0.0 112.701 165.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -65.41 -15.78 61.86 Favored Glycine 0 CA--C 1.536 1.361 0 N-CA-C 115.983 1.153 . . . . 0.0 115.983 -173.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -88.48 -0.01 56.76 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 119.27 1.535 . . . . 0.0 113.15 169.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.07 21.18 61.47 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.409 1.48 . . . . 0.0 114.566 173.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 63.5 t -86.89 -62.53 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 117.939 0.87 . . . . 0.0 111.938 -167.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 10.3 t -175.05 -174.13 0.74 Allowed 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.051 1.34 . . . . 0.0 111.584 -171.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -161.71 -51.71 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 127.54 2.336 . . . . 0.0 112.106 174.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 87.51 -68.14 3.16 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.807 1.194 . . . . 0.0 112.241 -178.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 34.4 p -61.97 122.54 15.73 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.52 1.128 . . . . 0.0 112.665 172.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -177.54 -141.06 3.95 Favored Glycine 0 N--CA 1.471 1.021 0 C-N-CA 125.41 1.481 . . . . 0.0 113.856 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 8.0 p -130.77 148.81 52.59 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.911 1.685 . . . . 0.0 111.624 -175.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.569 ' CG1' HD21 ' A' ' 277' ' ' LEU . 13.4 m -130.25 147.9 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.004 1.322 . . . . 0.0 110.376 169.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 38.4 m -80.15 155.97 27.2 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.469 169.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.2 159.21 29.13 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 -172.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -58.06 -51.79 68.21 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.781 1.632 . . . . 0.0 112.237 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -172.16 -178.3 2.05 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.8 2.44 . . . . 0.0 109.398 159.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 17.9 tt -56.09 -33.21 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.095 1.358 . . . . 0.0 114.29 -175.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.31 -34.19 72.02 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 175.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.47 -22.2 25.07 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 119.208 -0.425 . . . . 0.0 111.674 -161.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 7.9 mp -50.09 -50.42 48.29 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.636 1.174 . . . . 0.0 109.848 163.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -62.92 -36.05 82.11 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -172.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.34 -51.73 27.86 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.465 1.106 . . . . 0.0 111.839 170.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -67.17 -32.41 73.48 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.48 1.512 . . . . 0.0 113.548 -172.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -62.65 -31.3 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 120.949 -1.094 . . . . 0.0 112.531 -178.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -82.33 -16.16 50.27 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.204 1.002 . . . . 0.0 113.308 174.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -89.0 -42.05 12.0 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.851 1.26 . . . . 0.0 112.438 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -101.48 -21.51 14.75 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -166.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -67.27 115.13 6.59 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 119.145 0.884 . . . . 0.0 110.999 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 91.67 0.3 72.66 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.03 1.3 . . . . 0.0 114.55 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -90.75 130.59 36.72 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.687 1.243 . . . . 0.0 111.23 -178.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 22.5 p -92.26 134.51 34.82 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 120.341 -1.474 . . . . 0.0 113.261 -175.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 49.1 mt -138.16 101.78 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.416 1.087 . . . . 0.0 109.68 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 53.34 38.84 28.79 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.913 1.685 . . . . 0.0 113.224 170.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 168.56 -128.82 1.76 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.017 0.818 . . . . 0.0 112.953 -169.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -90.63 -168.46 2.1 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.62 0.768 . . . . 0.0 110.372 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 34.4 m -68.46 145.89 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 O-C-N 120.896 -1.128 . . . . 0.0 109.587 164.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 42.7 tp -83.84 141.91 31.0 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.281 1.433 . . . . 0.0 109.309 167.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -126.64 154.31 44.17 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.976 0.911 . . . . 0.0 109.376 159.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 41.1 t -136.35 127.94 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.582 1.553 . . . . 0.0 108.838 -169.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -136.04 153.21 51.42 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.901 1.28 . . . . 0.0 112.817 -167.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 89.8 p -82.78 173.97 11.39 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.216 -0.927 . . . . 0.0 112.193 172.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 67.1 mttm . . . . . 0 CA--C 1.552 1.022 0 O-C-N 121.629 -0.669 . . . . 0.0 111.996 157.803 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 . . . . . 0 N--CA 1.47 0.545 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 25.7 m -125.47 154.35 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.183 1.393 . . . . 0.0 110.341 165.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.1 mp -115.1 134.24 58.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.998 1.719 . . . . 0.0 107.434 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 20.5 m -105.78 129.65 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.233 1.013 . . . . 0.0 109.968 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -138.95 64.27 1.48 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.318 1.447 . . . . 0.0 111.257 -162.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -169.12 -40.48 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.179 1.792 . . . . 0.0 113.07 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 48.9 mt -57.19 116.58 14.03 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 127.16 2.184 . . . . 0.0 110.221 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -91.25 -170.17 0.33 Allowed 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 124.669 3.579 . . . . 0.0 112.342 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -56.56 -25.77 53.19 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -175.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 15.7 m -72.81 -16.58 61.61 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.441 1.096 . . . . 0.0 113.958 -177.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 1.3 p -108.34 105.67 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.926 2.09 . . . . 0.0 108.047 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -79.63 168.26 19.62 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.537 1.135 . . . . 0.0 111.912 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.7 -36.29 73.99 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 120.894 -1.129 . . . . 0.0 112.62 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -68.77 -32.93 73.03 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.333 -0.854 . . . . 0.0 112.233 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.53 -39.93 77.22 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.461 -0.781 . . . . 0.0 112.438 170.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.48 HD23 ' C ' ' A' ' 277' ' ' LEU . 4.2 tt -54.33 -48.3 71.53 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.938 0.895 . . . . 0.0 109.856 170.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.83 -39.85 68.96 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.387 0.675 . . . . 0.0 112.161 175.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -68.88 -20.73 64.27 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 27.5 mt -60.13 -46.96 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 120.04 1.291 . . . . 0.0 112.259 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -98.43 -9.43 25.18 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.188 0.995 . . . . 0.0 113.429 -173.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -71.58 -0.74 11.38 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 128.23 2.612 . . . . 0.0 115.086 -177.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -61.56 -15.42 38.53 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 120.43 -1.419 . . . . 0.0 114.011 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 63.3 m -68.98 -3.35 12.59 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.678 1.591 . . . . 0.0 114.398 172.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 87.25 -52.99 4.39 Favored Glycine 0 N--CA 1.473 1.103 0 C-N-CA 126.074 1.797 . . . . 0.0 111.456 -176.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -72.16 170.23 14.44 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.31 1.044 . . . . 0.0 111.044 162.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.6 p -145.72 146.35 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.03 0.932 . . . . 0.0 111.827 164.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -77.53 -107.72 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.221 1.408 . . . . 0.0 112.158 177.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -158.38 149.25 20.55 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.3 1.84 . . . . 0.0 111.354 -171.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.31 165.65 34.26 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.478 1.111 . . . . 0.0 111.514 177.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -161.34 166.93 26.74 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.113 1.365 . . . . 0.0 111.619 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 14.8 m -145.48 153.82 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 126.516 1.926 . . . . 0.0 110.97 -171.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -106.45 117.63 34.53 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.344 1.057 . . . . 0.0 108.716 170.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 12.9 mt -89.77 160.22 16.65 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.642 0.734 . . . . 0.0 112.497 -175.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -78.77 137.46 37.75 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.753 1.221 . . . . 0.0 110.616 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -70.2 -8.03 61.14 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 116.488 1.355 . . . . 0.0 116.488 -162.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -79.78 -0.43 34.39 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 118.797 1.299 . . . . 0.0 112.699 166.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 88.55 48.48 3.95 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.429 1.49 . . . . 0.0 111.789 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 39.5 t -132.15 140.54 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.377 1.071 . . . . 0.0 110.78 -170.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 22.2 p -65.28 158.01 27.49 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.457 1.503 . . . . 0.0 114.021 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 21.7 p -139.15 -16.82 1.06 Allowed 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -168.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 67.85 -71.8 0.28 Allowed Glycine 0 N--CA 1.476 1.3 0 C-N-CA 126.26 1.886 . . . . 0.0 113.611 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 49.9 p -36.7 126.94 0.87 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.915 2.486 . . . . 0.0 113.881 167.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 176.34 -165.22 35.49 Favored Glycine 0 N--CA 1.471 1.027 0 N-CA-C 115.256 0.862 . . . . 0.0 115.256 -175.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 16.6 p -100.46 137.53 38.75 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.621 1.968 . . . . 0.0 110.893 -174.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.3 t -119.85 119.52 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.626 1.57 . . . . 0.0 107.111 172.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 53.7 m -93.81 110.16 21.82 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.774 1.229 . . . . 0.0 108.208 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.51 158.28 24.54 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -159.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -51.83 -54.17 31.9 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.675 1.19 . . . . 0.0 111.147 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -172.97 169.3 4.74 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 128.641 2.776 . . . . 0.0 109.272 161.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 19.5 tt -54.35 -29.02 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.325 1.05 . . . . 0.0 113.719 177.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.38 -37.91 62.87 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.17 1.388 . . . . 0.0 114.736 171.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -104.49 -20.88 13.56 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 7.0 tt -55.08 -51.55 66.01 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.332 1.453 . . . . 0.0 111.332 177.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -69.02 -24.16 64.16 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 33.6 mtp-105 -70.36 -44.28 68.45 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.135 0.974 . . . . 0.0 110.773 168.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -68.4 -43.26 77.67 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.215 1.406 . . . . 0.0 113.349 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 2.6 pt -70.96 -16.67 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 177.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -82.05 -40.91 21.35 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.84 0.856 . . . . 0.0 110.831 168.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -70.3 -53.74 15.56 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.451 1.1 . . . . 0.0 113.605 -178.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -90.18 -24.26 21.08 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -163.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -62.72 121.53 13.62 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 119.364 0.984 . . . . 0.0 110.244 173.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 101.82 0.32 52.23 Favored Glycine 0 CA--C 1.538 1.499 0 CA-C-O 118.833 -0.982 . . . . 0.0 115.098 -174.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -108.1 145.34 34.21 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.998 1.399 . . . . 0.0 112.032 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 62.1 m -112.59 129.15 56.47 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 120.779 -1.201 . . . . 0.0 111.974 -174.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 55.5 mt -137.33 106.95 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.298 1.039 . . . . 0.0 109.915 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 56.19 33.31 21.87 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.463 1.505 . . . . 0.0 112.95 170.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 171.78 -135.63 3.5 Favored Glycine 0 C--N 1.341 0.843 0 O-C-N 121.122 -0.986 . . . . 0.0 113.94 -168.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -99.8 165.31 11.64 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.164 0.986 . . . . 0.0 110.78 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 9.0 p -60.12 130.09 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.8 0.84 . . . . 0.0 112.771 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 35.9 mt -57.37 127.97 34.65 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.661 1.584 . . . . 0.0 113.923 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -134.02 122.57 23.2 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.527 2.731 . . . . 0.0 107.33 173.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 13.6 t -136.59 126.57 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.726 1.21 . . . . 0.0 109.476 -162.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -135.33 134.05 39.43 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.729 0.812 . . . . 0.0 111.532 -170.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 95.9 p -82.38 155.28 24.79 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.824 -1.173 . . . . 0.0 113.589 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 54.7 tptt . . . . . 0 CA--C 1.555 1.137 0 C-N-CA 125.386 1.474 . . . . 0.0 111.579 178.061 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.541 0.628 0 N-CA-C 111.544 0.201 . . . . 0.0 111.544 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 31.0 m -138.49 153.88 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.568 1.147 . . . . 0.0 110.919 175.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 2.7 mp -103.93 134.32 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 30.7 m -107.36 132.26 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.916 1.286 . . . . 0.0 108.134 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -149.71 55.33 0.95 Allowed 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -154.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -167.58 -24.46 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.337 1.055 . . . . 0.0 113.728 172.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 52.6 mt -47.39 127.02 9.93 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 126.205 1.802 . . . . 0.0 111.311 165.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -82.78 173.28 10.45 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.879 3.053 . . . . 0.0 110.154 172.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -62.61 0.3 0.52 Allowed 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 8.3 t -65.67 -31.11 71.94 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.435 1.094 . . . . 0.0 113.089 171.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 8.0 p -83.24 130.0 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 118.457 0.571 . . . . 0.0 109.801 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -94.08 159.84 14.97 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.753 1.221 . . . . 0.0 111.16 177.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -48.62 -40.88 29.21 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -68.21 -39.35 82.43 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.458 -0.776 . . . . 0.0 111.727 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.42 -32.55 71.59 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.438 -0.789 . . . . 0.0 112.491 172.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.489 HD21 ' CG1' ' A' ' 306' ' ' VAL . 1.9 tt -62.26 -38.96 91.31 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.312 1.045 . . . . 0.0 112.0 171.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -60.5 -48.7 80.62 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.549 -0.719 . . . . 0.0 110.012 171.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -59.7 -24.43 63.96 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.26 1.424 . . . . 0.0 114.171 -175.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 9.1 mt -49.56 -39.86 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 125.117 1.367 . . . . 0.0 111.687 171.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -110.52 -35.19 6.09 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.051 1.34 . . . . 0.0 111.592 -176.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -61.31 -7.17 2.66 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.596 1.558 . . . . 0.0 113.915 174.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -44.95 -31.04 1.14 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.017 1.327 . . . . 0.0 112.955 159.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 83.5 m -64.37 -7.09 8.46 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 176.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 91.18 -3.01 79.74 Favored Glycine 0 N--CA 1.477 1.424 0 C-N-CA 125.678 1.609 . . . . 0.0 114.958 177.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -138.36 178.3 7.24 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.207 2.203 . . . . 0.0 109.496 176.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.11 142.03 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 120.458 -1.402 . . . . 0.0 112.912 177.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -83.65 -106.42 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.256 1.422 . . . . 0.0 110.161 167.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -148.69 147.0 28.39 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.848 1.659 . . . . 0.0 111.834 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.08 148.66 20.58 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.577 1.151 . . . . 0.0 111.628 -176.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -168.27 160.04 11.2 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.843 1.657 . . . . 0.0 110.943 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.68 131.71 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 126.827 2.051 . . . . 0.0 110.271 177.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -75.29 130.33 38.9 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.659 0.783 . . . . 0.0 110.534 167.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 10.4 mt -87.43 153.48 21.4 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.303 0.641 . . . . 0.0 111.392 -178.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -76.81 149.83 36.18 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.867 0.867 . . . . 0.0 112.537 -177.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -67.29 -15.74 66.07 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.801 1.191 . . . . 0.0 115.483 -176.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -81.68 0.16 39.99 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 119.059 1.429 . . . . 0.0 113.193 168.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 85.45 47.35 5.19 Favored Glycine 0 N--CA 1.469 0.889 0 C-N-CA 124.944 1.259 . . . . 0.0 113.402 171.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 35.5 m -137.54 151.18 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.658 1.183 . . . . 0.0 112.24 -176.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 10.9 m -90.04 11.69 19.94 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 -150.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 18.2 p 45.59 80.53 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 127.263 2.225 . . . . 0.0 114.16 167.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -69.36 -47.09 53.67 Favored Glycine 0 N--CA 1.472 1.069 0 O-C-N 121.692 -0.63 . . . . 0.0 113.481 -175.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 5.9 p -60.26 117.69 5.48 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.849 1.259 . . . . 0.0 110.932 164.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -179.13 -160.87 25.7 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.394 0.997 . . . . 0.0 115.336 -173.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 14.2 p -104.77 146.64 28.69 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.152 1.781 . . . . 0.0 112.867 -169.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.489 ' CG1' HD21 ' A' ' 277' ' ' LEU . 0.8 OUTLIER -145.71 137.23 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.314 1.446 . . . . 0.0 109.912 169.054 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 8.7 t -102.29 144.55 30.66 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.86 0.864 . . . . 0.0 110.993 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -104.01 158.76 16.2 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -165.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -57.34 -55.93 28.45 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.145 -1.388 . . . . 0.0 111.152 175.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -172.64 179.78 2.34 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 128.46 2.704 . . . . 0.0 108.521 161.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.23 -25.37 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.637 1.175 . . . . 0.0 112.075 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.18 -33.56 41.28 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 168.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.56 -26.07 9.66 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.315 0.646 . . . . 0.0 112.514 -174.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 6.5 tt -55.05 -49.25 72.07 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.534 1.534 . . . . 0.0 111.041 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -68.82 -30.76 69.38 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.404 -0.81 . . . . 0.0 113.042 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 33.9 mtm180 -69.62 -37.4 76.82 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 121.52 -0.737 . . . . 0.0 111.107 174.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -70.48 -47.89 58.36 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.2 1.4 . . . . 0.0 112.284 174.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 3.5 pt -68.87 -21.65 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -75.38 -31.6 60.54 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 118.822 0.737 . . . . 0.0 112.205 170.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -88.91 -53.1 4.76 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.792 0.837 . . . . 0.0 113.081 -176.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -90.14 -16.98 28.47 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -164.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -71.49 110.2 5.94 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 121.102 -0.999 . . . . 0.0 110.013 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 99.21 0.12 57.14 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 125.193 1.377 . . . . 0.0 114.537 -170.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -98.55 145.67 26.58 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.193 1.397 . . . . 0.0 111.312 175.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 18.7 p -110.19 128.43 55.48 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.25 1.02 . . . . 0.0 113.155 -173.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 18.6 mt -143.9 115.48 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.883 1.273 . . . . 0.0 109.042 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 61.73 25.81 15.6 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.924 1.29 . . . . 0.0 113.449 173.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 173.87 -134.43 2.86 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 120.996 -1.065 . . . . 0.0 114.076 -171.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -86.39 -176.14 5.76 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.824 0.849 . . . . 0.0 109.751 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 19.9 m -58.94 142.84 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 O-C-N 120.981 -1.074 . . . . 0.0 108.687 155.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 3.0 pp -98.43 143.03 29.31 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.773 0.797 . . . . 0.0 111.006 175.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -125.58 137.06 53.9 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.779 1.632 . . . . 0.0 108.953 173.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 12.5 t -118.44 137.19 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.574 1.549 . . . . 0.0 110.026 -165.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -134.81 159.25 41.97 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.755 1.622 . . . . 0.0 112.328 -171.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 35.0 t -114.9 148.25 38.88 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.412 1.085 . . . . 0.0 112.101 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 77.0 tttt . . . . . 0 CA--C 1.554 1.104 0 C-N-CA 124.749 1.22 . . . . 0.0 112.946 172.404 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 . . . . . 0 CA--C 1.54 0.589 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 15.6 m -135.91 156.82 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 125.159 1.384 . . . . 0.0 111.584 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 5.4 mp -116.13 138.32 46.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 126.858 2.063 . . . . 0.0 107.129 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 34.3 m -120.22 129.76 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.28 1.032 . . . . 0.0 109.338 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -146.17 58.5 1.22 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.779 0.8 . . . . 0.0 111.907 -157.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -164.36 -45.14 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.798 1.239 . . . . 0.0 111.471 -176.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 27.7 mt -40.12 117.53 1.32 Allowed Pre-proline 0 CA--C 1.557 1.242 0 C-N-CA 126.099 1.76 . . . . 0.0 111.496 158.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -95.33 -177.95 0.47 Allowed 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.633 3.555 . . . . 0.0 111.703 -176.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -54.44 -14.19 1.16 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.577 1.551 . . . . 0.0 115.16 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 17.1 m -65.91 -21.12 66.42 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.111 1.364 . . . . 0.0 113.987 172.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 8.2 p -101.4 132.84 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 119.428 1.013 . . . . 0.0 110.643 172.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -90.59 157.1 17.68 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.271 1.428 . . . . 0.0 111.373 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -59.59 -31.62 69.63 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 120.478 -1.389 . . . . 0.0 113.213 178.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -68.24 -34.59 76.5 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.282 -0.886 . . . . 0.0 111.042 176.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.94 -38.8 76.27 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 117.733 -1.127 . . . . 0.0 113.098 168.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.495 HD23 ' C ' ' A' ' 277' ' ' LEU . 3.9 tt -53.37 -51.25 63.11 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.84 1.2 . . . . 0.0 109.883 172.088 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -48.84 -44.52 39.61 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.138 0.975 . . . . 0.0 111.953 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -68.71 -25.49 64.79 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 21.1 mt -53.32 -45.05 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 124.627 1.171 . . . . 0.0 111.377 176.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -98.09 -34.15 10.88 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.449 1.1 . . . . 0.0 111.627 -175.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -61.17 -10.33 6.35 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.611 1.164 . . . . 0.0 113.803 173.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 15.4 tm-20 -52.23 -24.71 7.69 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.638 1.575 . . . . 0.0 113.484 165.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 87.0 m -63.82 -8.21 10.15 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 172.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 88.8 2.28 78.83 Favored Glycine 0 N--CA 1.479 1.516 0 C-N-CA 124.663 1.125 . . . . 0.0 114.777 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -138.39 -177.92 5.06 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 127.237 2.215 . . . . 0.0 108.227 172.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.6 p -132.01 146.75 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 120.828 1.649 . . . . 0.0 114.063 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -106.48 -120.03 0.24 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.27 1.828 . . . . 0.0 110.821 171.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -161.08 156.69 24.92 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.602 1.961 . . . . 0.0 112.733 -174.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.39 164.85 35.9 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.487 1.115 . . . . 0.0 113.174 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -156.64 160.03 39.01 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.279 1.832 . . . . 0.0 110.995 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 3.5 t -151.63 141.58 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.354 1.462 . . . . 0.0 109.555 -172.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -113.06 134.49 54.5 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.463 1.105 . . . . 0.0 109.515 168.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 13.9 mt -98.69 172.59 7.37 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.182 0.993 . . . . 0.0 113.037 -170.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.25 153.72 0.68 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.094 2.158 . . . . 0.0 113.277 165.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -72.09 -3.92 57.87 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.911 1.243 . . . . 0.0 115.808 -172.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -114.65 0.62 13.97 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 126.267 1.827 . . . . 0.0 111.709 168.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 94.84 8.93 58.93 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 126.345 1.926 . . . . 0.0 114.476 176.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 4.8 t -87.58 58.28 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 118.819 1.31 . . . . 0.0 111.074 -171.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 75.6 m 61.1 -168.08 0.18 Allowed 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 126.325 1.85 . . . . 0.0 114.501 170.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -167.04 -45.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 127.249 2.22 . . . . 0.0 112.276 175.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 82.08 -57.14 4.98 Favored Glycine 0 N--CA 1.472 1.042 0 C-N-CA 125.252 1.406 . . . . 0.0 112.051 -176.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 61.9 p -55.57 111.04 0.8 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.715 1.606 . . . . 0.0 112.459 169.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -139.37 -166.35 10.59 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.008 1.29 . . . . 0.0 113.996 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 93.7 m -115.99 141.63 47.87 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.528 1.931 . . . . 0.0 108.934 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 t -129.9 116.11 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 125.446 1.498 . . . . 0.0 107.412 -173.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 46.2 m -101.52 110.25 22.22 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.223 1.409 . . . . 0.0 108.176 -174.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.28 168.65 12.53 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -151.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -53.68 -65.31 0.59 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.847 1.259 . . . . 0.0 111.024 175.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -172.65 -175.73 1.37 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 129.153 2.981 . . . . 0.0 108.005 162.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 16.3 tt -55.14 -37.03 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -175.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -49.63 67.76 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -92.05 -18.82 23.06 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.439 0.296 . . . . 0.0 110.836 -174.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 57.5 tp -66.25 -47.36 73.97 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.462 0.705 . . . . 0.0 111.093 171.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -68.32 -20.87 64.78 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.342 -0.848 . . . . 0.0 113.037 178.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 35.5 mtp85 -70.61 -54.57 11.51 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.36 1.064 . . . . 0.0 111.621 162.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.03 -43.99 82.48 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.026 1.33 . . . . 0.0 113.752 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 2.6 pp -65.38 -21.35 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 177.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -82.6 -46.32 13.46 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.438 1.095 . . . . 0.0 111.199 172.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -71.57 -47.99 51.32 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -176.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -98.39 -22.26 16.16 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -163.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -67.15 120.47 13.78 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.872 -1.142 . . . . 0.0 110.494 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 92.37 -1.0 72.18 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.071 1.319 . . . . 0.0 114.95 -173.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -98.59 139.76 33.83 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.126 1.463 . . . . 0.0 111.328 177.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 23.7 p -103.15 133.99 47.33 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.136 0.975 . . . . 0.0 113.155 -174.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 56.3 mt -144.17 113.59 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.953 1.301 . . . . 0.0 108.763 -176.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 58.07 25.84 12.87 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.806 1.242 . . . . 0.0 113.832 176.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 166.37 -129.63 1.97 Allowed Glycine 0 C--N 1.342 0.905 0 C-N-CA 124.424 1.012 . . . . 0.0 113.194 -176.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -83.76 177.7 8.25 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.889 0.876 . . . . 0.0 111.099 -177.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 32.9 m -62.69 149.83 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 O-C-N 121.55 -0.718 . . . . 0.0 110.739 166.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 10.9 mt -73.35 137.18 44.59 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.186 0.994 . . . . 0.0 111.489 170.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -125.37 108.48 11.72 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.667 1.587 . . . . 0.0 107.747 167.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.84 120.96 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.27 1.428 . . . . 0.0 109.798 -165.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -139.54 162.5 34.93 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.391 1.477 . . . . 0.0 111.859 -171.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 77.8 p -145.19 159.18 43.39 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 120.869 -1.145 . . . . 0.0 113.078 -176.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? . . . . . 0 CA--C 1.551 1.006 0 C-N-CA 124.393 1.077 . . . . 0.0 111.981 179.378 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 . . . . . 0 CA--C 1.549 0.937 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 16.1 m -137.03 159.76 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.248 1.019 . . . . 0.0 111.069 173.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.4 mp -131.66 141.47 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 127.249 2.22 . . . . 0.0 107.469 -175.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 19.4 m -129.68 133.43 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.834 0.854 . . . . 0.0 111.086 -174.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -148.57 73.23 1.22 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.863 1.265 . . . . 0.0 112.772 -164.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -169.12 -41.68 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.627 1.571 . . . . 0.0 111.237 171.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 49.6 mt -28.17 110.92 0.24 Allowed Pre-proline 0 CA--C 1.561 1.396 0 C-N-CA 127.159 2.183 . . . . 0.0 111.415 153.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -95.64 -170.64 0.18 Allowed 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 125.238 3.959 . . . . 0.0 112.658 -175.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -58.1 -20.25 38.55 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -173.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 58.8 m -76.93 -11.6 59.83 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 176.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 1.4 p -108.51 145.56 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 126.969 2.107 . . . . 0.0 108.227 167.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -155.59 174.63 14.99 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.678 1.591 . . . . 0.0 109.638 -176.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -41.99 -49.41 4.65 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.817 1.647 . . . . 0.0 114.853 -170.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -68.52 -35.71 77.86 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 118.916 0.78 . . . . 0.0 112.18 -175.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.37 -37.75 74.64 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 168.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 7.8 tt -61.79 -35.3 77.77 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.233 0.613 . . . . 0.0 111.727 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -53.03 -52.39 58.63 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.686 0.676 . . . . 0.0 110.641 170.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -59.63 -27.99 66.82 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.041 1.336 . . . . 0.0 113.331 -175.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 32.9 mt -51.7 -45.7 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.782 1.233 . . . . 0.0 112.082 173.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -106.17 -24.6 12.29 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.164 0.986 . . . . 0.0 112.548 -174.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -64.03 -2.93 2.21 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 126.626 1.97 . . . . 0.0 114.713 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -57.82 -20.76 38.22 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 120.567 -1.333 . . . . 0.0 113.307 168.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 72.0 m -69.02 0.32 4.71 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 125.436 1.494 . . . . 0.0 114.451 170.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 100.32 -76.69 0.44 Allowed Glycine 0 C--N 1.342 0.875 0 C-N-CA 126.36 1.933 . . . . 0.0 110.876 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -73.46 175.53 6.91 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.286 1.034 . . . . 0.0 111.173 172.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.01 142.08 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 120.65 -1.281 . . . . 0.0 111.442 172.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -76.95 -96.28 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.749 1.22 . . . . 0.0 111.142 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -160.66 147.07 15.24 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.633 1.573 . . . . 0.0 111.978 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.48 172.01 19.11 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.968 -1.082 . . . . 0.0 112.185 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -158.26 153.22 25.23 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -178.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 27.2 t -157.28 136.25 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 129.476 3.11 . . . . 0.0 105.674 176.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -132.24 144.27 50.51 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.02 0.528 . . . . 0.0 111.892 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 9.1 mp -64.77 144.07 57.5 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.6 1.16 . . . . 0.0 111.755 175.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -69.79 151.41 45.8 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.864 1.266 . . . . 0.0 111.339 169.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -64.86 -11.31 49.85 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.949 1.261 . . . . 0.0 115.348 -176.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -70.49 -6.45 36.19 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 118.782 1.291 . . . . 0.0 113.151 166.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 85.74 49.19 4.42 Favored Glycine 0 C--N 1.343 0.918 0 C-N-CA 125.481 1.515 . . . . 0.0 112.367 176.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 9.5 p -155.13 143.83 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.922 0.889 . . . . 0.0 112.135 -170.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 38.3 t -68.15 170.34 8.72 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.414 1.086 . . . . 0.0 113.209 176.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 12.1 t -144.15 -25.02 0.54 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -173.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 73.98 -48.25 1.67 Allowed Glycine 0 N--CA 1.475 1.246 0 C-N-CA 125.624 1.583 . . . . 0.0 114.589 177.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 7.8 p -51.07 123.12 8.67 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.542 1.937 . . . . 0.0 112.411 168.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -168.74 -168.6 31.04 Favored Glycine 0 N--CA 1.469 0.894 0 C-N-CA 124.075 0.845 . . . . 0.0 115.177 -174.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 18.7 p -115.56 152.54 32.86 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.259 1.824 . . . . 0.0 111.073 -170.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.5 t -138.99 120.53 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.177 1.391 . . . . 0.0 108.095 -177.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 4.5 t -100.12 108.22 20.31 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.398 1.079 . . . . 0.0 108.849 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.25 162.09 22.45 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -158.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -53.91 -63.51 1.13 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.906 1.282 . . . . 0.0 111.052 174.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -172.32 -176.34 1.57 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.995 2.518 . . . . 0.0 109.533 159.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.5 mp -49.11 -39.08 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 125.605 1.562 . . . . 0.0 113.569 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.25 -42.03 66.06 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 177.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -95.21 -31.43 13.5 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 123.321 0.388 . . . . 0.0 110.617 -174.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.5 tt -55.93 -51.32 68.08 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 125.469 1.508 . . . . 0.0 110.755 175.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -61.92 -46.59 88.69 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.056 0.844 . . . . 0.0 112.516 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -70.45 -32.74 70.43 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 176.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -65.87 -38.37 88.61 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.18 0.992 . . . . 0.0 112.045 171.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -57.74 -40.86 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.653 1.181 . . . . 0.0 112.168 176.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -81.99 -24.57 35.38 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -79.27 -45.09 20.42 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.355 1.062 . . . . 0.0 112.959 -177.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -103.68 -26.18 12.86 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -167.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -65.32 116.26 6.46 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 119.682 1.128 . . . . 0.0 110.023 173.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 99.61 0.55 56.58 Favored Glycine 0 CA--C 1.538 1.486 0 CA-C-O 119.101 -0.833 . . . . 0.0 114.962 -174.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -104.27 151.7 23.09 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.795 1.638 . . . . 0.0 111.63 175.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 26.9 p -111.92 134.11 53.69 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 120.433 -1.417 . . . . 0.0 113.09 -177.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 59.3 mt -145.27 118.71 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.898 1.279 . . . . 0.0 109.604 -176.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 57.15 23.27 8.39 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.636 1.574 . . . . 0.0 114.32 173.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 170.17 -119.84 0.83 Allowed Glycine 0 C--N 1.341 0.839 0 O-C-N 120.992 -1.067 . . . . 0.0 113.029 -177.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -86.03 176.66 7.9 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.355 0.662 . . . . 0.0 111.079 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 9.4 p -57.1 138.45 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 121.655 -0.653 . . . . 0.0 109.335 155.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 1.5 pp -100.48 145.03 28.76 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.831 0.824 . . . . 0.0 111.432 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -126.28 137.9 53.55 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.038 1.735 . . . . 0.0 109.374 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 18.5 t -120.54 132.19 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.36 1.464 . . . . 0.0 109.996 -170.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -131.41 154.72 48.36 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.377 1.871 . . . . 0.0 110.652 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 79.3 p -145.14 167.37 22.9 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 120.599 -1.313 . . . . 0.0 112.754 -172.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt . . . . . 0 CA--C 1.547 0.831 0 C-N-CA 123.904 0.882 . . . . 0.0 111.945 176.319 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 . . . . . 0 N--CA 1.469 0.511 0 CA-C-O 121.148 0.499 . . . . 0.0 112.289 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 21.2 t -126.96 140.01 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 127.33 2.252 . . . . 0.0 108.499 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.4 mp -106.79 131.04 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.736 1.614 . . . . 0.0 107.057 175.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 23.0 m -110.59 126.39 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.617 0.767 . . . . 0.0 109.232 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -148.69 59.64 1.07 Allowed 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 121.64 0.733 . . . . 0.0 112.127 -155.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -171.42 -38.26 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 126.116 1.767 . . . . 0.0 111.285 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -34.29 122.52 0.53 Allowed Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 126.637 1.975 . . . . 0.0 111.517 162.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -86.18 167.13 9.39 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.46 3.44 . . . . 0.0 110.671 175.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -60.53 -4.6 0.94 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -174.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 8.3 t -60.58 -31.05 70.2 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.606 1.163 . . . . 0.0 113.205 169.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 8.8 p -79.73 121.63 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 121.639 0.733 . . . . 0.0 111.511 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -79.15 156.68 28.14 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.965 1.306 . . . . 0.0 110.6 170.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -52.04 -37.92 55.28 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 120.804 -1.185 . . . . 0.0 113.087 178.081 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -71.42 -38.24 71.41 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.502 -0.749 . . . . 0.0 111.354 178.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.98 -26.36 64.99 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.05 -1.031 . . . . 0.0 112.651 171.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.793 HD21 HG12 ' A' ' 306' ' ' VAL . 1.8 tt -66.95 -46.93 73.22 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.623 0.769 . . . . 0.0 111.367 170.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 278' ' ' LYS . . . . . 0.469 ' N ' HD23 ' A' ' 277' ' ' LEU . 0.0 OUTLIER -69.26 -28.56 66.42 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.808 1.186 . . . . 0.0 111.218 177.907 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -64.99 -23.17 67.14 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.675 1.19 . . . . 0.0 113.258 173.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 41.3 mt -55.02 -51.33 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 119.226 0.921 . . . . 0.0 110.315 171.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -91.09 -18.73 24.06 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.267 1.027 . . . . 0.0 112.508 -173.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -57.17 -17.86 12.98 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.863 1.665 . . . . 0.0 114.146 176.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -57.17 -14.86 4.56 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.343 1.457 . . . . 0.0 114.146 173.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 9.3 t -66.15 -11.38 48.98 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 171.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 91.23 -3.29 79.79 Favored Glycine 0 N--CA 1.479 1.537 0 C-N-CA 125.488 1.518 . . . . 0.0 114.219 -177.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -138.53 -179.6 5.91 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.971 2.509 . . . . 0.0 108.189 171.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 5.0 p -145.78 143.3 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 120.158 1.345 . . . . 0.0 112.68 164.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -78.77 -94.73 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.529 1.532 . . . . 0.0 112.183 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -170.6 153.47 4.18 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 127.717 2.407 . . . . 0.0 110.072 -167.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.56 170.15 22.82 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.156 -0.965 . . . . 0.0 112.626 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -149.65 143.27 25.4 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.43 1.092 . . . . 0.0 113.314 -177.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 32.2 t -158.66 136.82 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 127.498 2.319 . . . . 0.0 107.999 -171.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -132.67 128.06 36.2 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.998 0.919 . . . . 0.0 110.322 170.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 12.1 mt -75.49 167.68 21.45 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 122.206 1.003 . . . . 0.0 113.631 -169.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.96 151.97 0.86 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 127.842 2.457 . . . . 0.0 113.804 167.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -70.9 -6.93 60.99 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.938 1.256 . . . . 0.0 116.082 -172.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -109.72 0.43 18.92 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.101 1.76 . . . . 0.0 111.83 169.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 95.26 8.6 58.66 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.735 2.112 . . . . 0.0 114.393 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 6.2 t -90.19 58.74 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 118.804 1.302 . . . . 0.0 111.019 -166.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 7.6 t 60.36 -163.48 0.24 Allowed 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 125.598 1.559 . . . . 0.0 114.096 172.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -166.47 143.53 5.02 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 129.041 2.937 . . . . 0.0 108.631 173.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -89.11 -76.9 1.3 Allowed Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.148 0.88 . . . . 0.0 112.086 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 32.2 p -54.92 149.34 11.74 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.372 1.469 . . . . 0.0 113.676 169.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -163.32 -177.46 36.26 Favored Glycine 0 N--CA 1.471 1.028 0 C-N-CA 125.045 1.307 . . . . 0.0 114.664 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 40.6 m -116.38 135.3 53.98 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.503 1.521 . . . . 0.0 108.623 -177.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.793 HG12 HD21 ' A' ' 277' ' ' LEU . 13.2 m -129.93 130.73 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.066 0.946 . . . . 0.0 109.181 178.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 33.0 m -90.52 115.51 27.72 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.953 0.901 . . . . 0.0 108.715 -175.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -83.59 147.54 27.67 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -163.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -49.78 -55.62 13.38 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.95 1.3 . . . . 0.0 112.573 -175.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.59 172.84 4.15 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.85 2.06 . . . . 0.0 110.039 162.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.42 -24.84 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.3 1.04 . . . . 0.0 112.422 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -45.54 69.72 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 169.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -98.18 -20.04 17.52 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.35 0.523 . . . . 0.0 111.947 -175.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -49.3 -52.15 29.5 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.066 1.747 . . . . 0.0 111.117 174.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -67.32 -29.67 69.3 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -70.49 -52.25 23.32 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.314 0.645 . . . . 0.0 110.888 170.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -59.65 -35.9 75.33 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.276 1.43 . . . . 0.0 113.004 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -50.67 -44.38 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.639 1.176 . . . . 0.0 112.393 176.447 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -90.39 -34.35 15.68 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 177.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -62.43 -40.08 95.4 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.994 -1.066 . . . . 0.0 113.025 -176.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -92.98 -13.39 28.82 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -62.71 115.28 4.17 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.532 -0.73 . . . . 0.0 110.189 169.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 91.93 0.18 72.01 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-O 118.935 -0.925 . . . . 0.0 114.898 -175.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -103.42 135.54 44.85 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.011 1.405 . . . . 0.0 111.5 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 30.1 p -112.82 133.48 54.79 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.411 1.084 . . . . 0.0 112.563 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -144.0 119.65 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.579 1.151 . . . . 0.0 109.015 -170.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 56.94 28.35 14.54 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.447 1.099 . . . . 0.0 113.44 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 149.18 -119.67 1.08 Allowed Glycine 0 C--N 1.343 0.964 0 C-N-CA 124.433 1.016 . . . . 0.0 113.09 -174.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -89.67 175.32 7.3 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.112 0.965 . . . . 0.0 112.239 -169.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.94 137.06 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.161 0.984 . . . . 0.0 110.014 169.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.56 124.57 24.97 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.726 0.81 . . . . 0.0 111.832 -177.035 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.5 113.43 24.81 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 158.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 91.4 t -105.83 121.22 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.648 1.179 . . . . 0.0 108.609 177.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -140.98 133.69 28.79 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.239 1.416 . . . . 0.0 110.042 175.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 65.2 p -82.9 166.61 18.76 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.377 -0.827 . . . . 0.0 111.811 173.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 86.1 tttt . . . . . 0 CA--C 1.547 0.863 0 O-C-N 121.244 -0.91 . . . . 0.0 111.001 174.712 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.538 0.507 0 CA-C-O 120.999 0.428 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 65.5 t -151.32 146.35 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 126.642 1.977 . . . . 0.0 108.898 -165.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 2.0 mp -131.29 136.99 56.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.026 1.731 . . . . 0.0 107.835 176.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 31.5 m -120.3 124.64 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.809 1.244 . . . . 0.0 108.797 -176.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -143.85 80.0 1.64 Allowed 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -156.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -172.27 -38.82 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.245 1.818 . . . . 0.0 111.105 169.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 59.0 mt -34.82 123.26 0.56 Allowed Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 128.362 2.665 . . . . 0.0 113.132 167.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -85.44 174.89 6.6 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.102 3.201 . . . . 0.0 111.459 173.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -53.87 -12.73 0.59 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.248 1.819 . . . . 0.0 115.832 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 41.2 t -55.3 -30.99 61.26 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.731 1.612 . . . . 0.0 113.746 171.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 8.8 p -91.57 122.62 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 119.318 0.963 . . . . 0.0 110.712 176.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -84.48 158.4 21.02 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.625 1.57 . . . . 0.0 111.147 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -49.85 -34.51 20.19 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 175.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -67.31 -38.31 84.75 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.97 -1.081 . . . . 0.0 111.04 177.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -76.8 -27.42 55.21 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 173.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 3.7 tp -53.6 -51.58 62.57 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 120.218 1.372 . . . . 0.0 109.491 166.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -55.22 -43.97 74.99 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 122.971 0.508 . . . . 0.0 111.067 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.45 -19.83 62.43 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.056 1.343 . . . . 0.0 114.505 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 66.0 mt -58.73 -29.67 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 119.293 0.951 . . . . 0.0 111.526 171.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -123.27 -23.05 4.96 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.54 1.136 . . . . 0.0 113.716 -175.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -65.97 -12.39 54.63 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.34 1.456 . . . . 0.0 113.892 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -60.51 -12.18 9.04 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 177.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 23.6 p -72.62 -8.62 56.16 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 170.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 93.13 13.37 56.28 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.203 1.382 . . . . 0.0 114.509 -177.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -138.45 176.51 8.63 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.417 1.887 . . . . 0.0 111.116 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 6.8 p -145.47 140.58 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 O-C-N 121.184 -0.948 . . . . 0.0 112.633 168.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -95.06 -99.15 0.16 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.103 1.361 . . . . 0.0 110.295 167.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -160.72 154.5 22.48 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.975 1.71 . . . . 0.0 111.959 176.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.04 149.85 21.73 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.119 -0.988 . . . . 0.0 111.894 -170.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -157.32 165.11 36.7 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.539 1.136 . . . . 0.0 113.881 -174.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 8.1 m -141.02 144.93 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 127.222 2.209 . . . . 0.0 110.525 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -108.94 129.3 55.43 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.471 1.109 . . . . 0.0 109.476 171.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -134.66 171.85 13.77 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.602 1.161 . . . . 0.0 113.098 -171.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -68.88 152.6 45.08 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.956 1.302 . . . . 0.0 113.144 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -70.61 -18.31 75.55 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.616 1.103 . . . . 0.0 115.252 -175.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -88.96 0.25 56.8 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 118.824 1.312 . . . . 0.0 112.67 169.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 92.61 10.77 60.04 Favored Glycine 0 N--CA 1.471 1.019 0 C-N-CA 125.004 1.287 . . . . 0.0 115.008 173.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 57.9 t -70.75 116.06 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 118.386 1.093 . . . . 0.0 108.613 172.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 68.5 p -76.69 177.35 7.62 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.063 1.345 . . . . 0.0 114.555 -170.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 21.0 p -145.28 139.48 27.12 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 127.03 2.132 . . . . 0.0 109.884 -170.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -94.74 -34.99 6.02 Favored Glycine 0 N--CA 1.472 1.045 0 C-N-CA 123.391 0.52 . . . . 0.0 113.822 175.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 17.6 t -55.73 111.96 1.04 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.825 1.25 . . . . 0.0 110.293 167.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -142.89 169.22 25.72 Favored Glycine 0 N--CA 1.471 0.981 0 C-N-CA 124.789 1.185 . . . . 0.0 114.919 -165.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 85.7 m -115.73 141.31 48.26 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.414 1.886 . . . . 0.0 109.086 -173.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.34 113.04 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 124.829 1.252 . . . . 0.0 109.613 -170.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 13.6 t -74.34 147.88 41.83 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 113.911 -1.495 . . . . 0.0 110.159 170.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.72 157.46 19.72 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 -169.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -59.2 -53.9 52.99 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 113.974 -1.466 . . . . 0.0 111.519 176.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -172.67 166.19 5.44 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.814 2.846 . . . . 0.0 108.498 171.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 67.5 mt -60.25 -30.57 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.027 0.931 . . . . 0.0 111.603 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.56 -43.38 45.95 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.935 1.294 . . . . 0.0 114.273 171.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -96.33 -22.34 17.26 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 6.0 tt -58.4 -52.19 66.67 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.708 1.203 . . . . 0.0 110.524 177.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -65.79 -28.88 69.34 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -70.16 -51.65 29.63 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.267 1.027 . . . . 0.0 110.978 172.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -61.73 -33.99 75.03 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.785 1.634 . . . . 0.0 113.191 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -56.92 -41.55 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.817 1.247 . . . . 0.0 112.72 177.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -82.61 -29.24 30.29 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 175.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -75.03 -45.44 41.7 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -171.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -100.26 -16.7 17.63 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -172.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 322' ' ' ASN . . . . . 0.403 ' ND2' ' H ' ' A' ' 333' ' ' VAL . 32.0 t-20 -70.35 118.62 13.39 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.437 -0.789 . . . . 0.0 110.754 178.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 102.24 0.11 50.77 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.68 1.61 . . . . 0.0 114.726 -176.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -105.47 144.24 32.52 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.941 1.371 . . . . 0.0 112.441 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 67.3 m -94.06 125.6 38.79 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.184 -0.948 . . . . 0.0 112.54 -176.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 46.5 mt -138.32 108.36 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.403 1.081 . . . . 0.0 109.427 176.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 59.48 20.31 8.72 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.77 1.628 . . . . 0.0 114.314 177.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . -168.59 -133.21 1.53 Allowed Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.157 1.36 . . . . 0.0 112.406 -176.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 49.4 p30 -98.01 -172.94 2.47 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.599 1.16 . . . . 0.0 110.282 172.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 20.4 m -58.31 131.38 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-N 119.163 0.892 . . . . 0.0 109.353 172.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 2.4 pp -91.26 138.15 31.81 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 122.378 1.085 . . . . 0.0 111.126 178.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -91.48 156.0 18.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 113.925 -1.489 . . . . 0.0 109.998 166.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.403 ' H ' ' ND2' ' A' ' 322' ' ' ASN . 18.6 t -136.93 131.68 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.953 1.701 . . . . 0.0 108.977 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -148.11 143.34 27.07 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.116 1.367 . . . . 0.0 111.366 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 83.5 p -119.09 171.7 8.08 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 120.919 -1.113 . . . . 0.0 112.503 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 52.6 tttm . . . . . 0 CA--C 1.552 1.043 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -164.497 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 . . . . . 0 CA--C 1.551 1.01 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 35.5 m -139.01 152.4 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 120.906 -1.121 . . . . 0.0 110.95 163.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 5.1 mp -118.72 138.84 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 126.024 1.729 . . . . 0.0 108.355 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 20.8 m -112.73 125.57 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.643 1.177 . . . . 0.0 107.95 172.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -142.95 46.47 1.55 Allowed 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -148.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -168.99 -26.36 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 88.1 mt -51.85 144.79 18.51 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 124.338 1.055 . . . . 0.0 111.583 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -79.74 -179.16 5.09 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.497 3.465 . . . . 0.0 111.017 178.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -62.54 -7.49 4.75 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 115.216 1.561 . . . . 0.0 115.216 -176.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 16.4 m -68.96 -17.08 63.89 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.86 1.664 . . . . 0.0 114.589 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 9.9 p -98.98 142.79 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.458 1.103 . . . . 0.0 110.482 175.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -142.53 168.33 19.99 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.722 2.009 . . . . 0.0 110.219 -177.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -46.31 -51.03 15.46 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -171.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -63.59 -36.37 83.59 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.793 0.724 . . . . 0.0 112.226 -178.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.89 -39.95 75.93 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 169.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 6.8 tt -60.06 -35.57 75.44 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.863 0.865 . . . . 0.0 111.698 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -53.79 -52.86 58.94 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.508 0.723 . . . . 0.0 111.306 169.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -62.42 -21.18 65.2 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.605 1.562 . . . . 0.0 113.561 -176.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 28.2 mt -54.9 -29.82 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 124.654 1.182 . . . . 0.0 111.992 171.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -121.29 -27.55 4.84 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.142 1.377 . . . . 0.0 112.577 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.6 -8.93 30.51 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.6 1.56 . . . . 0.0 115.005 -177.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -60.38 -15.48 26.39 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 120.348 -1.47 . . . . 0.0 114.139 172.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 71.3 m -66.37 -5.62 11.43 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 171.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 91.26 5.28 67.65 Favored Glycine 0 N--CA 1.477 1.43 0 C-N-CA 125.35 1.453 . . . . 0.0 114.54 177.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -138.43 179.3 6.55 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.904 2.481 . . . . 0.0 110.719 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.41 144.27 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 121.118 -0.989 . . . . 0.0 112.439 177.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -100.63 -114.0 0.18 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.518 1.527 . . . . 0.0 110.528 172.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -156.59 143.38 18.62 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.645 1.178 . . . . 0.0 113.475 -178.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.3 174.07 15.71 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.594 1.158 . . . . 0.0 112.06 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -159.25 152.0 21.77 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.143 1.377 . . . . 0.0 112.608 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 20.4 t -150.04 140.09 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.225 1.81 . . . . 0.0 108.203 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -132.19 135.75 46.56 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.289 1.035 . . . . 0.0 109.939 173.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 8.7 mt -91.34 158.09 16.74 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.759 0.824 . . . . 0.0 111.705 -169.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -77.86 146.43 35.68 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.706 1.203 . . . . 0.0 112.129 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -66.55 -12.67 59.42 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.095 1.331 . . . . 0.0 115.792 -174.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -74.97 -1.12 21.18 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 119.157 1.478 . . . . 0.0 113.237 166.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 87.85 38.63 7.37 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.094 1.33 . . . . 0.0 113.308 174.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 23.9 m -142.49 143.79 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 125.158 1.383 . . . . 0.0 111.732 -174.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.71 154.46 40.69 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.218 1.007 . . . . 0.0 113.114 -178.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 37.1 p -69.54 -32.14 70.79 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.076 0.951 . . . . 0.0 112.874 173.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 78.29 -61.37 3.86 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.932 1.253 . . . . 0.0 111.641 -176.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 52.2 p -60.07 146.63 42.25 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 122.471 1.129 . . . . 0.0 112.243 161.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -159.37 170.08 35.61 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.569 1.557 . . . . 0.0 113.924 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 99.0 m -119.9 142.49 48.64 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.751 1.62 . . . . 0.0 109.492 -175.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.0 t -133.54 127.62 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.689 1.596 . . . . 0.0 109.059 -170.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 14.9 t -92.92 127.85 38.57 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.916 0.886 . . . . 0.0 109.24 172.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -85.3 163.53 18.55 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -164.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -52.4 -54.44 31.94 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.776 1.23 . . . . 0.0 112.108 175.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -172.35 161.88 5.33 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 129.081 2.952 . . . . 0.0 108.375 170.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.78 -28.01 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.99 0.916 . . . . 0.0 112.02 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.54 -43.44 56.1 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 171.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -102.44 -17.55 15.76 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -176.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 4.1 tt -58.6 -50.66 73.01 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.318 1.047 . . . . 0.0 110.021 174.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -64.98 -28.12 69.3 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 45.4 mtp85 -70.01 -53.33 18.11 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.349 1.06 . . . . 0.0 111.071 169.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -60.02 -36.28 76.9 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.703 1.601 . . . . 0.0 113.264 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -53.34 -46.54 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.826 1.25 . . . . 0.0 112.482 -178.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -85.82 -37.27 19.41 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.168 0.587 . . . . 0.0 112.339 175.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -61.05 -34.42 74.85 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.193 -0.942 . . . . 0.0 113.324 -175.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -97.61 -1.51 43.61 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 175.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -60.03 111.51 1.52 Allowed 'General case' 0 CA--C 1.552 1.038 0 O-C-N 119.576 -1.952 . . . . 0.0 111.891 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 96.44 -0.01 61.36 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.462 1.506 . . . . 0.0 115.499 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.2 169.31 15.38 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 119.137 1.469 . . . . 0.0 114.576 179.038 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 56.0 p -138.5 124.3 19.86 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.262 1.025 . . . . 0.0 111.833 172.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 10.1 mt -138.28 116.66 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 125.147 1.379 . . . . 0.0 108.77 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 61.98 30.34 17.98 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.42 1.488 . . . . 0.0 113.271 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 173.68 -127.94 1.42 Allowed Glycine 0 C--N 1.342 0.864 0 N-CA-C 115.116 0.806 . . . . 0.0 115.116 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 42.7 p30 -110.27 -177.2 3.19 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.397 1.879 . . . . 0.0 111.376 -171.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 26.6 m -66.12 139.65 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 121.476 -0.765 . . . . 0.0 111.315 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.83 130.22 56.75 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.453 1.501 . . . . 0.0 112.29 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -72.24 154.66 40.88 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.86 148.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 47.1 t -136.45 124.34 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.295 1.438 . . . . 0.0 108.79 -174.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 58.2 mttt -146.28 141.93 27.81 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.613 1.565 . . . . 0.0 111.742 -170.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 30.2 p -89.61 167.34 13.01 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.11 1.364 . . . . 0.0 112.369 173.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 77.9 tttt . . . . . 0 CA--C 1.552 1.023 0 C-N-CA 125.332 1.453 . . . . 0.0 112.351 -173.963 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.913 0 N-CA-C 112.099 -0.4 . . . . 0.0 112.099 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 53.9 p -169.89 152.7 4.52 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.472 1.509 . . . . 0.0 111.403 -175.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 67.99 168.34 0.26 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 127.068 2.147 . . . . 0.0 113.52 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.66 157.87 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 O-C-N 121.257 -0.902 . . . . 0.0 111.495 172.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 3.7 mp -131.86 132.81 61.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 126.166 1.787 . . . . 0.0 107.235 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 36.0 m -104.43 137.27 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.212 1.005 . . . . 0.0 109.254 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -140.15 35.59 1.91 Allowed 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -157.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -160.58 -22.43 0.06 Allowed 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 12.7 mt -47.41 130.67 10.22 Favored Pre-proline 0 CA--C 1.557 1.243 0 O-C-N 120.77 -1.206 . . . . 0.0 111.341 160.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -88.44 170.29 5.66 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 124.82 3.68 . . . . 0.0 111.791 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -61.13 -8.36 3.43 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 9.1 m -68.89 -22.87 64.16 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.474 1.11 . . . . 0.0 113.121 171.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.5 p -108.6 136.69 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 126.882 2.073 . . . . 0.0 109.247 173.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -141.7 174.2 10.79 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.498 1.519 . . . . 0.0 111.447 -167.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -43.48 -50.8 6.95 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -168.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -69.14 -28.47 66.48 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 119.315 0.961 . . . . 0.0 113.014 -175.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -77.48 -40.13 44.06 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 167.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.419 HD23 ' C ' ' A' ' 277' ' ' LEU . 3.9 tt -53.16 -46.03 68.72 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.993 1.317 . . . . 0.0 109.743 175.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -46.15 -54.17 9.13 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.932 0.893 . . . . 0.0 111.586 172.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -61.75 -27.89 69.05 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.881 1.272 . . . . 0.0 113.891 -175.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 23.8 mt -53.79 -27.38 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 124.587 1.155 . . . . 0.0 112.125 172.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -118.26 -29.46 5.53 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.357 1.463 . . . . 0.0 112.309 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.8 -13.61 62.36 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.571 1.548 . . . . 0.0 113.709 176.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -57.9 -17.74 18.57 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 172.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 75.8 m -71.72 -1.85 15.34 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 173.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 89.11 14.25 60.84 Favored Glycine 0 N--CA 1.476 1.334 0 C-N-CA 124.973 1.273 . . . . 0.0 114.63 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -138.54 -178.82 5.47 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 126.811 2.044 . . . . 0.0 109.755 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.36 147.05 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 120.476 -1.39 . . . . 0.0 112.896 169.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -109.31 -114.5 0.3 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.481 1.513 . . . . 0.0 110.205 169.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -158.44 155.11 27.97 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.174 1.39 . . . . 0.0 113.081 175.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.34 171.52 20.02 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.573 1.149 . . . . 0.0 112.54 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -161.63 168.27 23.73 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.559 1.143 . . . . 0.0 113.197 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 11.7 m -140.66 158.74 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 127.951 2.5 . . . . 0.0 109.52 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -128.1 108.14 10.39 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.517 0.727 . . . . 0.0 110.521 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 8.3 mp -70.44 145.6 50.9 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.945 1.298 . . . . 0.0 111.74 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -65.14 159.11 24.19 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.747 0.819 . . . . 0.0 111.269 164.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -62.81 -17.63 58.36 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 124.333 0.968 . . . . 0.0 115.391 -177.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -81.83 -3.25 53.54 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 118.992 1.396 . . . . 0.0 113.675 170.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 84.07 21.91 56.12 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 125.106 1.336 . . . . 0.0 114.928 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 19.9 m -99.43 -6.1 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 -164.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 4.8 t 66.76 -177.11 0.2 Allowed 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 38.1 p -142.87 -35.46 0.41 Allowed 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -164.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 75.02 -57.63 2.71 Favored Glycine 0 N--CA 1.475 1.256 0 C-N-CA 124.547 1.07 . . . . 0.0 111.936 -168.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 19.2 t -40.74 118.1 0.92 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.397 1.879 . . . . 0.0 111.381 158.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -169.98 177.62 43.26 Favored Glycine 0 N--CA 1.473 1.121 0 C-N-CA 124.722 1.153 . . . . 0.0 115.193 -169.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 25.4 p -106.41 142.06 36.7 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.392 1.877 . . . . 0.0 111.497 -169.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 1.7 t -128.3 121.7 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.398 1.479 . . . . 0.0 108.789 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 42.7 m -93.82 109.82 21.49 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.962 1.305 . . . . 0.0 108.572 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.4 162.1 28.14 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -163.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -51.69 -54.86 23.62 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.42 1.088 . . . . 0.0 111.699 173.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -172.56 163.69 5.41 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 129.139 2.976 . . . . 0.0 108.551 171.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 87.8 mt -58.26 -30.74 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.048 0.939 . . . . 0.0 111.74 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.06 -40.21 57.79 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 172.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -102.25 -20.78 14.52 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.377 0.535 . . . . 0.0 112.365 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -55.08 -52.35 63.5 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.22 1.408 . . . . 0.0 110.381 174.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -64.04 -30.46 71.53 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 32.4 mtp-105 -70.33 -46.67 63.74 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.557 1.143 . . . . 0.0 111.383 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -69.18 -32.08 71.13 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.31 1.444 . . . . 0.0 113.032 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -57.92 -38.96 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.438 1.095 . . . . 0.0 112.418 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -82.49 -18.79 40.37 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -84.23 -45.91 12.39 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.224 1.01 . . . . 0.0 112.572 -177.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -100.94 -21.14 15.16 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.644 1.349 . . . . 0.0 114.644 -170.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -67.33 111.96 4.3 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.386 0.993 . . . . 0.0 109.919 171.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 99.04 0.34 57.29 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 124.59 1.09 . . . . 0.0 114.88 -171.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -94.22 168.1 11.13 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 118.938 1.369 . . . . 0.0 111.668 173.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 45.6 p -138.42 129.2 26.61 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 120.181 -1.575 . . . . 0.0 112.615 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 11.5 mt -144.63 111.3 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 124.308 1.043 . . . . 0.0 110.099 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 63.07 16.77 9.59 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.771 1.628 . . . . 0.0 114.048 173.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . -159.42 -132.84 1.42 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.969 1.271 . . . . 0.0 113.319 -171.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -95.97 -176.55 3.73 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.933 0.893 . . . . 0.0 110.279 176.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 12.1 p -55.39 131.88 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 121.259 -0.9 . . . . 0.0 108.784 152.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 1.2 pp -103.53 143.22 33.01 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.144 0.978 . . . . 0.0 110.687 -176.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -128.36 141.22 51.49 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.623 1.569 . . . . 0.0 109.33 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 17.3 t -126.66 129.88 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.068 1.347 . . . . 0.0 110.174 -164.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -129.14 169.96 14.12 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.061 1.744 . . . . 0.0 110.822 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 94.5 p -138.38 169.43 17.8 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.885 1.274 . . . . 0.0 111.833 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -74.39 -13.0 60.67 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -176.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 61.68 -144.89 0.43 Allowed 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 126.045 1.738 . . . . 0.0 112.357 170.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 9.5 t -165.85 173.79 10.23 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.379 1.872 . . . . 0.0 111.067 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 59.2 t -145.53 122.24 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 126.22 1.808 . . . . 0.0 108.817 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -160.09 2.32 0.08 Allowed 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -171.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -78.81 -22.29 46.45 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -161.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 18.6 t60 61.86 -179.25 0.12 Allowed 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 126.327 1.851 . . . . 0.0 114.268 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 29.4 m -163.23 114.53 1.45 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.478 2.311 . . . . 0.0 108.763 170.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -115.55 0.07 13.2 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.119 1.367 . . . . 0.0 114.244 -166.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 98.09 63.73 0.87 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.171 1.367 . . . . 0.0 110.234 -165.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -98.25 12.37 34.92 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.441 1.496 . . . . 0.0 113.558 -167.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -157.46 164.24 37.65 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.068 2.147 . . . . 0.0 109.875 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 28.4 m -146.7 166.22 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 127.675 2.39 . . . . 0.0 111.489 -170.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -142.65 45.88 1.6 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.913 1.285 . . . . 0.0 111.631 -173.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 40.4 pt -133.12 149.34 72.45 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 126.054 1.742 . . . . 0.0 111.622 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -75.06 163.99 34.13 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.792 2.995 . . . . 0.0 112.048 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 27.4 ttt -157.22 129.47 7.31 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.097 1.359 . . . . 0.0 110.677 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -165.86 168.47 15.85 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.241 1.816 . . . . 0.0 111.015 -176.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -147.34 113.81 5.97 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.565 1.546 . . . . 0.0 110.5 171.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 56.7 p -115.28 148.38 40.65 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 125.59 1.556 . . . . 0.0 112.241 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.19 139.74 39.45 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.213 2.609 . . . . 0.0 110.926 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 13.0 p -165.55 144.14 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.024 1.33 . . . . 0.0 110.648 -174.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 29.0 m120 . . . . . 0 C--O 1.253 1.27 0 C-N-CA 126.166 1.786 . . . . 0.0 111.726 -178.078 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.818 0 CA-C-O 119.267 -0.74 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 15.5 m 76.38 154.73 0.16 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 127.091 2.156 . . . . 0.0 114.296 175.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 68.68 170.92 0.29 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 126.939 2.096 . . . . 0.0 112.494 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 34.2 m -137.37 151.37 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 120.977 -1.077 . . . . 0.0 112.243 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 3.2 mp -102.04 143.68 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 127.865 2.466 . . . . 0.0 108.305 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 18.9 m -126.83 140.38 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 125.695 1.598 . . . . 0.0 108.622 168.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -145.61 24.99 1.36 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -145.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -161.55 -22.54 0.05 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 84.5 mt -47.7 119.37 6.74 Favored Pre-proline 0 CA--C 1.563 1.453 0 C-N-CA 127.023 2.129 . . . . 0.0 111.585 168.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -89.33 -172.71 0.67 Allowed 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 124.986 3.791 . . . . 0.0 113.375 -176.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -54.27 -29.53 47.38 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -173.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 30.6 m -71.09 -18.06 62.56 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.374 -0.829 . . . . 0.0 112.987 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . 0.263 2.4 p -113.6 60.58 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 127.53 2.332 . . . . 0.0 109.948 176.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -62.52 175.6 0.76 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.733 1.613 . . . . 0.0 111.969 176.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -45.63 -42.25 11.13 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.803 1.641 . . . . 0.0 114.952 -174.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -68.72 -40.03 80.12 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.272 0.942 . . . . 0.0 111.696 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.66 -35.73 75.44 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 172.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.506 HD23 ' C ' ' A' ' 277' ' ' LEU . 2.2 tt -54.74 -51.55 65.29 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.18 0.9 . . . . 0.0 109.229 168.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 4.6 tmmm? -57.2 -35.96 70.26 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.575 0.75 . . . . 0.0 111.905 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -67.57 -23.89 65.45 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 175.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 18.3 mt -58.83 -51.44 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-N 119.38 0.991 . . . . 0.0 110.86 173.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -79.03 -27.5 43.21 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.226 0.61 . . . . 0.0 111.5 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -51.86 -23.27 4.59 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.177 1.391 . . . . 0.0 113.927 173.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -61.59 -13.43 21.87 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 175.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 97.5 m -73.13 -5.58 40.07 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 168.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 96.69 -12.23 66.14 Favored Glycine 0 N--CA 1.476 1.366 0 C-N-CA 126.118 1.818 . . . . 0.0 114.608 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -138.33 172.84 12.3 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.305 2.242 . . . . 0.0 108.98 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 4.8 p -145.3 145.16 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -91.8 -125.39 0.08 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 126.238 1.815 . . . . 0.0 111.807 176.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -153.31 158.01 40.95 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.787 1.635 . . . . 0.0 113.232 -175.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.57 175.96 13.0 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -172.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -159.05 168.19 27.33 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.9 2.08 . . . . 0.0 111.312 176.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 28.7 m -151.01 170.99 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 126.72 2.008 . . . . 0.0 112.722 -171.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -103.71 153.52 20.58 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.489 1.516 . . . . 0.0 112.424 174.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.8 mp -126.71 144.18 51.01 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.115 1.366 . . . . 0.0 111.902 174.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -71.14 160.49 32.77 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.946 0.898 . . . . 0.0 111.304 162.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -66.95 -12.61 60.33 Favored Glycine 0 CA--C 1.534 1.276 0 N-CA-C 115.926 1.13 . . . . 0.0 115.926 -169.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -85.67 -1.36 57.09 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.688 1.195 . . . . 0.0 113.062 172.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.86 15.31 73.18 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.146 1.355 . . . . 0.0 115.131 175.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 97.7 t -81.22 -17.72 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -168.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.4 p 75.98 171.68 0.25 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 127.319 2.248 . . . . 0.0 114.943 176.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 30.3 p -146.26 164.05 33.55 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 127.672 2.389 . . . . 0.0 107.518 172.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -94.7 -16.2 43.24 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.137 0.875 . . . . 0.0 113.862 170.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 8.7 t -55.45 121.7 9.58 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.578 1.151 . . . . 0.0 110.852 166.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 174.86 -160.39 29.43 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.211 0.91 . . . . 0.0 114.46 -171.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 20.1 p -123.55 148.19 46.56 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.845 1.658 . . . . 0.0 110.537 -172.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.9 123.48 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.134 1.774 . . . . 0.0 106.851 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 8.1 t -99.32 110.56 23.06 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.733 1.213 . . . . 0.0 108.255 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.18 165.23 16.71 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -149.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -52.12 -51.57 57.01 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.086 1.354 . . . . 0.0 111.89 174.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -172.55 166.44 5.58 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 129.813 3.245 . . . . 0.0 108.059 171.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.55 -26.82 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 123.863 0.865 . . . . 0.0 111.81 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -30.89 64.85 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 171.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -91.14 -14.48 31.05 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -168.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 10.6 mp -49.52 -49.07 47.48 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.958 0.903 . . . . 0.0 109.311 161.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -61.52 -31.77 71.78 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -172.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -75.21 -56.65 4.52 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.064 1.345 . . . . 0.0 112.039 168.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -65.92 -33.04 74.91 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.967 1.307 . . . . 0.0 114.01 -170.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.18 -27.08 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.594 1.158 . . . . 0.0 111.599 177.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -82.61 -38.82 23.06 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.788 0.835 . . . . 0.0 111.569 170.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -77.32 -41.19 41.56 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -170.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -106.35 -17.33 14.32 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -172.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -54.92 126.24 23.62 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.407 1.003 . . . . 0.0 111.025 167.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 82.77 0.31 90.05 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 119.258 -0.745 . . . . 0.0 114.383 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -97.66 162.59 13.21 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.985 1.314 . . . . 0.0 112.034 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 47.5 p -138.27 128.26 25.53 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.547 1.139 . . . . 0.0 111.468 -176.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 12.2 mt -136.05 112.85 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.038 0.935 . . . . 0.0 109.858 -177.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 56.61 27.54 12.62 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.935 1.694 . . . . 0.0 112.961 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . -176.76 -143.44 4.8 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.428 1.014 . . . . 0.0 113.754 -166.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -93.23 174.96 6.95 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.971 0.908 . . . . 0.0 111.054 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 11.4 p -58.39 141.28 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 121.645 -0.66 . . . . 0.0 110.182 163.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 1.7 pp -122.81 156.26 34.9 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 122.429 1.109 . . . . 0.0 112.804 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -122.83 166.1 15.55 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.707 1.603 . . . . 0.0 110.172 163.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.03 125.64 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 126.824 2.05 . . . . 0.0 107.466 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -141.86 133.7 27.24 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.146 0.578 . . . . 0.0 112.389 -169.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 20.0 p -110.47 153.82 24.51 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.542 1.537 . . . . 0.0 111.997 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -75.82 103.86 6.1 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.208 -0.933 . . . . 0.0 110.908 173.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -166.87 144.42 4.89 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.925 1.69 . . . . 0.0 110.224 -177.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 23.2 t -166.08 153.62 10.18 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.092 0.957 . . . . 0.0 112.217 173.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 14.8 p -170.82 144.88 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 126.93 2.092 . . . . 0.0 109.543 -174.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -155.45 161.79 40.89 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.711 1.204 . . . . 0.0 113.273 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -158.89 137.11 10.64 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.772 1.629 . . . . 0.0 110.664 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -72.56 -31.12 65.0 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -174.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 27.2 t -171.43 143.57 1.83 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.192 1.397 . . . . 0.0 111.837 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -80.0 -10.22 59.75 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.136 0.975 . . . . 0.0 112.866 171.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 88.24 161.19 36.81 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.578 1.561 . . . . 0.0 113.707 -178.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -166.85 138.48 3.38 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.161 1.785 . . . . 0.0 110.731 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -163.59 155.56 17.38 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.999 1.719 . . . . 0.0 110.546 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 10.1 p -170.27 135.42 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 127.977 2.511 . . . . 0.0 109.556 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -156.44 39.64 0.34 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.431 1.093 . . . . 0.0 112.086 -172.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 6.4 pt -129.51 96.9 26.14 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 125.239 1.416 . . . . 0.0 111.529 -172.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -81.36 164.03 19.3 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.895 3.064 . . . . 0.0 111.597 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -157.01 124.62 5.37 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.94 1.296 . . . . 0.0 110.423 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -153.76 146.07 23.9 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.258 1.823 . . . . 0.0 111.226 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -150.53 126.68 10.57 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.036 1.735 . . . . 0.0 109.905 172.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 39.4 m -115.22 146.6 36.71 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 125.018 1.327 . . . . 0.0 111.964 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -72.61 153.45 54.53 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.455 2.77 . . . . 0.0 111.518 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 10.1 p -161.76 143.4 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 125.028 1.331 . . . . 0.0 110.736 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 . . . . . 0 C--O 1.255 1.343 0 C-N-CA 126.83 2.052 . . . . 0.0 112.553 -178.141 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.957 0 CA-C-O 121.029 0.239 . . . . 0.0 112.699 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 18.7 m -169.43 164.27 10.58 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 127.196 2.198 . . . . 0.0 110.155 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -156.75 160.21 39.06 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.042 -1.037 . . . . 0.0 112.923 -171.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 31.1 m -130.99 147.37 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.978 1.711 . . . . 0.0 110.553 173.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.7 mp -97.84 140.91 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 127.461 2.305 . . . . 0.0 107.232 175.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 30.0 m -131.48 120.64 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.608 0.763 . . . . 0.0 110.388 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -147.66 77.93 1.44 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.972 0.909 . . . . 0.0 110.9 -162.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -174.36 -42.21 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 126.383 1.873 . . . . 0.0 110.732 177.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 71.3 mt -34.75 116.97 0.54 Allowed Pre-proline 0 CA--C 1.558 1.271 0 C-N-CA 127.377 2.271 . . . . 0.0 111.582 160.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -89.64 177.92 2.54 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 125.121 3.881 . . . . 0.0 112.641 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -51.36 -26.94 8.54 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 -171.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 5.5 t -76.85 -14.85 59.85 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . 0.259 1.6 p -108.28 79.88 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.938 1.695 . . . . 0.0 108.863 174.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -69.81 179.14 2.32 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.965 2.106 . . . . 0.0 112.546 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -57.05 -37.76 72.27 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 120.6 -1.313 . . . . 0.0 112.689 177.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -65.5 -37.33 86.49 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.239 -0.913 . . . . 0.0 111.321 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -71.12 -38.2 72.31 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 168.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.462 HD23 ' C ' ' A' ' 277' ' ' LEU . 5.4 tt -53.79 -45.67 70.8 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.819 1.248 . . . . 0.0 110.517 176.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -47.76 -51.77 21.1 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.483 0.713 . . . . 0.0 111.706 172.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -64.99 -22.55 67.02 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -174.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 45.0 mt -55.73 -44.98 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.271 1.028 . . . . 0.0 111.509 171.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -104.89 -22.34 13.17 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.181 0.993 . . . . 0.0 113.047 -173.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -64.93 0.15 1.32 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.426 1.89 . . . . 0.0 115.138 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -55.45 -19.05 8.24 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 120.501 -1.374 . . . . 0.0 113.834 168.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 21.8 t -56.54 -20.48 20.76 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.624 1.57 . . . . 0.0 114.072 169.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 92.3 -7.46 78.12 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.919 1.724 . . . . 0.0 113.454 -173.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -138.46 175.87 9.19 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.362 2.665 . . . . 0.0 109.116 174.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.4 p -145.12 145.24 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 120.705 -1.247 . . . . 0.0 113.136 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -79.44 -104.75 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.656 1.582 . . . . 0.0 111.877 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -152.04 146.03 25.25 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.995 1.718 . . . . 0.0 112.253 -175.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.35 166.83 31.33 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.798 0.839 . . . . 0.0 113.254 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -159.82 172.83 16.94 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.942 1.697 . . . . 0.0 111.153 -177.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 4.2 m -142.32 152.07 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.471 1.909 . . . . 0.0 111.753 -177.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -111.18 99.05 7.96 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.108 0.963 . . . . 0.0 109.765 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 8.9 mt -91.33 160.11 15.66 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.943 0.897 . . . . 0.0 112.074 -172.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -80.7 147.18 30.72 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.437 1.095 . . . . 0.0 112.445 -173.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -67.61 -13.12 62.82 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.0 1.286 . . . . 0.0 115.963 -172.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -82.36 -0.13 44.45 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 119.175 1.487 . . . . 0.0 113.152 169.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.84 61.59 1.93 Allowed Glycine 0 C--N 1.341 0.849 0 C-N-CA 125.132 1.349 . . . . 0.0 112.161 176.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 13.6 p -154.29 146.48 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.36 1.064 . . . . 0.0 111.839 -174.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 26.6 t -62.79 161.45 12.56 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.44 1.096 . . . . 0.0 113.932 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 35.9 p -146.09 -27.24 0.43 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 126.846 2.058 . . . . 0.0 114.082 -169.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 78.46 -41.07 2.04 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 126.545 2.022 . . . . 0.0 114.82 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 5.3 p -50.14 132.89 23.75 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.388 1.875 . . . . 0.0 112.828 166.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -172.59 -159.99 20.25 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 124.49 1.043 . . . . 0.0 115.475 -172.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 46.0 p -137.46 155.01 49.8 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.668 1.587 . . . . 0.0 110.638 -173.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.48 119.2 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.593 1.557 . . . . 0.0 107.44 -176.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 44.1 t -108.9 124.81 51.23 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.677 1.191 . . . . 0.0 109.128 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.18 165.63 12.52 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 -144.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -52.75 -53.9 41.43 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.081 170.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -172.91 168.43 4.95 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 129.01 2.924 . . . . 0.0 108.205 165.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 19.5 tt -57.58 -28.3 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.2 -41.38 68.54 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 172.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -94.48 -28.56 15.4 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.179 0.445 . . . . 0.0 111.44 -176.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.1 tt -52.56 -49.01 65.79 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.526 1.531 . . . . 0.0 110.089 169.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -56.69 -35.35 68.37 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -70.71 -55.98 7.43 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.324 0.65 . . . . 0.0 111.381 169.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.72 -35.26 72.4 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.568 1.547 . . . . 0.0 113.712 -174.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.71 -33.43 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.123 0.969 . . . . 0.0 112.291 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -82.58 -42.29 18.48 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.754 0.822 . . . . 0.0 111.711 172.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -64.91 -40.56 95.26 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -174.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -105.95 -10.13 16.76 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -169.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -69.13 116.26 9.37 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 121.096 -1.002 . . . . 0.0 110.542 169.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 93.46 -0.14 67.87 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.817 1.675 . . . . 0.0 114.774 -175.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -80.55 133.98 35.87 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.139 1.375 . . . . 0.0 111.279 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 16.0 p -99.6 126.7 45.64 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.072 -1.643 . . . . 0.0 111.989 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.45 96.84 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.908 0.883 . . . . 0.0 110.058 -171.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 56.84 30.12 17.28 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.279 1.432 . . . . 0.0 113.211 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 178.8 -130.86 1.61 Allowed Glycine 0 C--N 1.342 0.9 0 O-C-N 121.162 -0.961 . . . . 0.0 113.468 -171.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -90.07 178.96 6.05 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.427 0.691 . . . . 0.0 110.562 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 35.2 m -63.6 137.28 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 O-C-N 121.403 -0.811 . . . . 0.0 109.634 162.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 22.7 tp -83.02 118.95 23.87 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.402 1.481 . . . . 0.0 110.181 -175.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -94.43 143.39 26.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.749 0.82 . . . . 0.0 109.721 165.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 19.8 t -136.42 124.9 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.646 1.579 . . . . 0.0 108.418 -171.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -132.75 133.85 43.99 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.545 1.138 . . . . 0.0 111.249 -170.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 34.8 p -83.83 155.95 22.71 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.859 -1.151 . . . . 0.0 111.983 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -72.42 129.94 39.54 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 121.288 -0.882 . . . . 0.0 111.599 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -72.18 137.49 46.96 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.767 0.827 . . . . 0.0 111.166 176.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 12.8 t -167.41 -169.86 1.32 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.683 1.593 . . . . 0.0 111.151 -177.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 16.3 m -143.27 145.41 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 126.975 2.11 . . . . 0.0 110.041 178.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -148.61 151.63 35.35 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.168 1.387 . . . . 0.0 112.654 -171.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -142.73 140.69 31.56 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.917 1.687 . . . . 0.0 110.729 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 30.4 p80 -160.41 168.75 24.51 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.261 1.425 . . . . 0.0 113.224 -173.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 1.4 p 77.89 155.8 0.16 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 128.526 2.73 . . . . 0.0 113.619 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -115.19 -0.34 13.3 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.966 1.306 . . . . 0.0 113.842 -170.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 72.08 -137.97 26.05 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.419 1.009 . . . . 0.0 112.747 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -156.69 135.52 11.74 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.843 1.657 . . . . 0.0 111.146 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -164.46 157.03 16.85 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.843 2.057 . . . . 0.0 109.83 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 12.1 p -165.78 136.15 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 126.933 2.093 . . . . 0.0 110.162 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -166.75 115.1 0.86 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.318 1.847 . . . . 0.0 109.415 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 17.5 tt -69.73 129.69 91.0 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.812 0.845 . . . . 0.0 111.545 -176.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -75.08 158.04 42.11 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.203 2.602 . . . . 0.0 111.693 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 57.6 ttp -159.36 148.14 18.04 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.315 1.446 . . . . 0.0 111.001 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -119.2 146.25 45.35 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.524 1.53 . . . . 0.0 111.433 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -80.32 115.72 20.02 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.602 1.161 . . . . 0.0 111.673 174.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 41.8 p -82.5 153.15 68.06 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 124.925 1.29 . . . . 0.0 112.926 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -72.23 151.71 55.03 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.516 2.811 . . . . 0.0 111.383 177.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 14.6 p -162.79 140.55 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.821 1.249 . . . . 0.0 111.09 -177.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.19 0 C-N-CA 126.007 1.723 . . . . 0.0 110.994 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.895 0 N-CA-C 112.534 -0.227 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 29.1 t -159.71 94.7 1.16 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.643 1.177 . . . . 0.0 110.077 -177.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -166.24 142.91 5.04 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.065 0.946 . . . . 0.0 111.335 -165.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 21.2 m -133.52 156.39 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.605 1.162 . . . . 0.0 110.324 166.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 76.4 mt -106.97 139.17 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 127.276 2.23 . . . . 0.0 107.252 -178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 19.0 m -125.54 118.36 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.317 1.047 . . . . 0.0 108.838 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -143.78 62.41 1.36 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 121.897 0.856 . . . . 0.0 112.33 -151.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -168.21 -25.64 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.533 1.133 . . . . 0.0 113.697 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 23.5 mt -61.13 136.86 94.04 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 125.741 1.616 . . . . 0.0 111.83 175.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -88.52 171.02 5.36 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 124.484 3.456 . . . . 0.0 110.758 173.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -59.98 -5.78 1.11 Allowed 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 6.3 t -59.06 -30.56 68.15 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.824 1.25 . . . . 0.0 112.938 169.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 9.0 p -89.37 123.99 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 170.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -77.92 157.05 29.92 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.724 0.81 . . . . 0.0 110.655 172.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -51.43 -37.72 50.03 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.722 -1.236 . . . . 0.0 113.285 176.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -73.72 -31.09 63.2 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.007 -1.058 . . . . 0.0 112.188 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.85 -32.56 71.02 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.184 -0.947 . . . . 0.0 112.635 167.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.52 HD21 ' CG1' ' A' ' 306' ' ' VAL . 3.1 tt -61.06 -42.44 98.49 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.218 0.917 . . . . 0.0 111.406 169.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -57.17 -46.75 82.52 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 118.785 0.721 . . . . 0.0 110.312 171.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -61.44 -23.1 65.62 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 18.7 mt -51.74 -30.23 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 124.73 1.212 . . . . 0.0 111.83 172.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -116.73 -38.33 3.48 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.275 1.43 . . . . 0.0 110.913 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -5.4 4.43 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.008 1.323 . . . . 0.0 114.142 176.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -55.53 -17.33 5.14 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 120.432 -1.418 . . . . 0.0 113.767 160.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 65.2 m -70.87 -0.72 9.73 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.032 1.333 . . . . 0.0 114.264 168.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 88.31 -58.49 4.18 Favored Glycine 0 N--CA 1.471 1.0 0 C-N-CA 126.589 2.043 . . . . 0.0 111.729 -176.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -70.14 165.21 22.52 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.857 1.263 . . . . 0.0 111.921 175.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.9 p -142.03 142.5 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 120.911 -1.118 . . . . 0.0 112.475 178.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -89.35 -96.01 0.1 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.85 1.26 . . . . 0.0 110.203 167.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -165.31 157.85 15.67 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 127.133 2.173 . . . . 0.0 111.208 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.72 159.61 35.45 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.083 -1.011 . . . . 0.0 113.667 -173.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -161.22 171.67 18.02 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.284 1.434 . . . . 0.0 113.21 -176.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 16.8 m -144.03 160.17 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 128.009 2.523 . . . . 0.0 110.244 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -132.15 99.63 4.78 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.51 0.724 . . . . 0.0 111.428 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.69 170.77 7.74 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.065 1.346 . . . . 0.0 113.338 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -74.85 153.7 38.58 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 122.766 0.426 . . . . 0.0 111.391 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -64.99 -10.84 48.73 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 124.121 0.867 . . . . 0.0 114.873 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 44.5 p30 -74.14 -12.65 60.65 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.859 1.263 . . . . 0.0 114.289 169.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 88.15 12.62 65.32 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 117.226 -1.874 . . . . 0.0 116.613 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 14.6 m -67.73 -17.18 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-N 121.408 2.604 . . . . 0.0 116.297 -172.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 3.7 t 73.54 163.65 0.27 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 126.025 1.73 . . . . 0.0 113.687 -176.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 29.1 p -151.65 136.89 17.52 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.44 1.896 . . . . 0.0 110.089 -171.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -79.98 -35.71 26.93 Favored Glycine 0 N--CA 1.47 0.93 0 O-C-N 123.246 0.341 . . . . 0.0 112.823 173.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 33.9 p -57.05 124.46 18.8 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.057 1.343 . . . . 0.0 111.878 167.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -161.53 -165.83 19.13 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.952 1.263 . . . . 0.0 113.788 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 99.1 m -130.53 138.83 50.4 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.943 1.297 . . . . 0.0 108.656 -175.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.52 ' CG1' HD21 ' A' ' 277' ' ' LEU . 8.4 m -128.45 128.11 67.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 124.442 1.097 . . . . 0.0 109.374 -175.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 36.8 m -79.87 146.93 31.94 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.669 173.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.39 146.89 35.05 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -173.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -49.65 -49.05 48.76 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.148 1.779 . . . . 0.0 112.552 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -172.24 173.31 4.27 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 128.13 2.572 . . . . 0.0 108.466 159.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 15.1 tt -62.27 -24.06 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -177.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.7 -42.69 65.04 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.267 1.427 . . . . 0.0 114.161 168.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -98.32 -20.34 17.25 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -175.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 6.7 tt -60.26 -52.63 64.47 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.838 1.255 . . . . 0.0 111.109 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -73.3 -20.78 60.73 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.017 -1.052 . . . . 0.0 113.247 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -70.66 -44.98 65.95 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.198 0.999 . . . . 0.0 111.682 166.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -73.16 -38.62 66.14 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.783 1.633 . . . . 0.0 113.284 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 2.5 pp -64.09 -22.21 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 121.147 -0.971 . . . . 0.0 113.556 176.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -82.31 -23.23 35.26 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.958 0.903 . . . . 0.0 112.951 169.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -89.44 -47.17 8.18 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.153 1.381 . . . . 0.0 112.968 -175.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -90.56 -30.01 17.5 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -172.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -65.85 118.18 9.31 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 121.245 -0.909 . . . . 0.0 110.28 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 96.69 -1.98 62.04 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.269 0.937 . . . . 0.0 115.265 -173.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -92.16 173.89 7.59 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.05 1.425 . . . . 0.0 111.097 169.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 60.0 p -138.57 129.7 26.99 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 119.83 -1.793 . . . . 0.0 112.395 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 18.9 mt -143.21 116.73 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 124.305 1.042 . . . . 0.0 109.58 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 59.49 18.96 7.39 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 125.633 1.573 . . . . 0.0 114.357 175.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . -177.55 -131.47 1.53 Allowed Glycine 0 CA--C 1.527 0.83 0 O-C-N 120.98 -1.075 . . . . 0.0 114.301 -173.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -94.96 -178.81 4.62 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.448 1.099 . . . . 0.0 110.929 -176.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 10.4 p -61.44 125.52 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 121.513 -0.742 . . . . 0.0 110.714 169.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 88.4 mt -62.9 132.85 53.49 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.174 1.79 . . . . 0.0 111.753 176.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -132.81 120.94 22.24 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.027 1.731 . . . . 0.0 108.19 174.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 15.1 t -129.31 125.38 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.72 1.208 . . . . 0.0 109.915 -160.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -142.94 171.19 14.38 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.447 1.499 . . . . 0.0 111.476 -171.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 90.3 p -145.29 152.75 40.42 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.147 -1.596 . . . . 0.0 112.842 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -78.26 -19.13 54.31 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -142.2 167.81 21.24 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.549 2.34 . . . . 0.0 109.686 175.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 16.9 t -160.04 -170.73 2.96 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.177 1.391 . . . . 0.0 111.379 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 26.2 m -144.49 147.14 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 126.658 1.983 . . . . 0.0 110.701 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -162.87 148.8 12.23 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.36 1.464 . . . . 0.0 112.433 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -158.65 152.26 23.2 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.778 1.631 . . . . 0.0 111.739 175.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -159.33 143.38 15.04 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.328 1.451 . . . . 0.0 112.225 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 19.9 m -155.44 150.05 26.25 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.585 1.554 . . . . 0.0 110.955 -177.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -75.34 -19.12 59.79 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 87.96 170.78 46.31 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.336 1.446 . . . . 0.0 114.464 175.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -164.06 134.12 4.12 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.286 1.835 . . . . 0.0 110.64 -178.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -165.37 162.84 19.8 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.515 1.926 . . . . 0.0 109.957 -177.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 11.8 p -165.24 139.87 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 127.13 2.172 . . . . 0.0 110.318 -177.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -166.03 120.74 1.19 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.483 1.913 . . . . 0.0 109.92 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 7.8 tp -133.46 133.68 22.96 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 125.713 1.605 . . . . 0.0 110.843 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -81.88 174.11 10.53 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.602 2.868 . . . . 0.0 111.897 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 13.0 tpt -153.56 129.3 10.11 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.836 1.254 . . . . 0.0 111.418 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -159.51 8.31 0.11 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.267 2.227 . . . . 0.0 112.18 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -85.92 31.72 0.62 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.422 2.289 . . . . 0.0 113.824 -158.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 25.3 p -63.34 130.24 94.11 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 125.05 1.34 . . . . 0.0 112.348 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.31 156.01 50.95 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.52 2.813 . . . . 0.0 112.162 -176.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 22.1 t 74.49 115.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 127.733 2.413 . . . . 0.0 111.356 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.912 1.685 . . . . 0.0 112.07 -178.024 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.797 0 N-CA-C 112.127 -0.389 . . . . 0.0 112.127 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 59.0 p -143.26 17.98 1.9 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.678 1.191 . . . . 0.0 113.211 -174.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -148.38 141.44 24.91 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.993 -1.067 . . . . 0.0 111.79 -169.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 35.7 m -132.05 159.94 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 126.262 1.825 . . . . 0.0 110.052 170.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 5.0 mp -124.08 130.67 73.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.184 1.794 . . . . 0.0 106.95 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 29.3 m -99.48 138.11 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 170.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -150.01 78.37 1.34 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.053 0.541 . . . . 0.0 112.281 -165.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -176.71 -34.83 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.227 1.411 . . . . 0.0 113.649 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 74.2 mt -62.99 140.5 97.63 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 125.613 1.565 . . . . 0.0 111.711 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -83.1 177.17 6.84 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 124.8 3.667 . . . . 0.0 112.013 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -57.89 -7.42 0.74 Allowed 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 -176.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 4.0 t -62.65 -31.5 72.39 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.217 -0.927 . . . . 0.0 112.318 170.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 3.7 p -84.05 133.06 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.651 0.739 . . . . 0.0 109.915 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -137.71 167.11 22.37 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.53 1.932 . . . . 0.0 109.144 -176.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -43.74 -50.63 7.6 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -168.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -68.5 -36.17 78.52 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.635 -0.666 . . . . 0.0 111.987 -175.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.83 -38.36 76.5 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.483 -0.761 . . . . 0.0 112.977 169.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 8.1 tt -63.08 -37.41 87.09 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.129 0.972 . . . . 0.0 111.531 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -53.3 -53.5 50.0 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.483 0.713 . . . . 0.0 110.606 168.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -60.93 -25.26 66.66 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.139 1.376 . . . . 0.0 113.672 -173.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 29.8 mt -49.83 -40.32 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 124.351 1.06 . . . . 0.0 111.686 171.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -111.5 -31.63 6.96 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.009 1.323 . . . . 0.0 112.215 -175.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -63.24 -2.99 1.6 Allowed 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.698 1.599 . . . . 0.0 113.493 170.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -51.79 -27.7 13.1 Favored 'General case' 0 CA--C 1.55 0.979 0 O-C-N 120.699 -1.251 . . . . 0.0 112.449 160.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 96.5 m -66.95 -1.69 4.36 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 169.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 86.71 -51.03 4.28 Favored Glycine 0 N--CA 1.473 1.148 0 C-N-CA 126.303 1.906 . . . . 0.0 113.059 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -71.79 169.88 14.79 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.65 1.18 . . . . 0.0 111.16 171.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.0 p -139.88 144.14 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 120.59 -1.319 . . . . 0.0 112.925 174.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -101.01 -108.72 0.22 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.671 1.589 . . . . 0.0 110.608 172.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -158.47 149.42 20.55 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.582 1.553 . . . . 0.0 112.267 -176.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.43 175.42 13.72 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.107 -0.996 . . . . 0.0 112.964 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -154.39 153.62 31.9 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -174.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 50.7 t -158.0 135.82 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 129.055 2.942 . . . . 0.0 106.893 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -132.53 146.43 51.9 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.657 0.783 . . . . 0.0 110.667 171.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 4.7 mt -92.75 142.98 26.75 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.458 0.647 . . . . 0.0 111.587 -171.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -72.73 144.06 47.79 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.967 1.307 . . . . 0.0 111.036 171.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -66.91 -9.98 54.57 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.15 1.357 . . . . 0.0 116.209 -171.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -75.4 -2.13 27.14 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 119.321 1.561 . . . . 0.0 113.045 165.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 86.9 44.49 5.71 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.58 1.562 . . . . 0.0 112.48 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 53.9 t -136.47 129.1 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.384 1.073 . . . . 0.0 110.656 -169.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 22.1 m -81.28 141.14 34.38 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -177.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 67.9 p -78.93 104.49 9.6 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.604 0.762 . . . . 0.0 109.102 171.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -69.82 -36.83 74.97 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 111.952 -0.459 . . . . 0.0 111.952 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 27.4 m -66.46 111.22 3.46 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.148 0.979 . . . . 0.0 110.76 161.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -131.65 165.31 23.36 Favored Glycine 0 N--CA 1.474 1.21 0 C-N-CA 124.765 1.174 . . . . 0.0 114.892 -173.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.74 146.02 24.46 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 126.562 1.945 . . . . 0.0 110.902 178.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -140.68 138.91 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.821 1.648 . . . . 0.0 108.259 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 26.9 t -116.33 132.4 56.68 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.127 0.971 . . . . 0.0 110.888 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.63 156.8 16.85 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 -158.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -55.73 -52.72 62.94 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 113.934 -1.484 . . . . 0.0 111.179 171.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -172.9 170.31 4.57 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 129.061 2.944 . . . . 0.0 108.623 170.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 10.7 tp -57.7 -30.87 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.954 0.901 . . . . 0.0 113.323 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -46.66 78.94 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.831 0.852 . . . . 0.0 113.11 171.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -84.43 -25.04 29.29 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 119.581 -0.247 . . . . 0.0 110.819 -175.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 4.9 tt -60.14 -45.64 92.35 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.845 1.258 . . . . 0.0 109.725 171.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -67.27 -25.54 66.11 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 171.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 21.3 mmm-85 -70.33 -43.1 70.97 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.962 1.255 . . . . 0.0 111.649 166.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -68.84 -38.42 79.81 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.675 1.59 . . . . 0.0 113.073 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 2.6 pp -69.56 -19.94 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 171.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -82.41 -42.59 18.4 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.62 1.168 . . . . 0.0 111.879 170.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -76.51 -53.4 8.14 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -105.62 -19.99 13.6 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -159.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -67.43 113.69 5.5 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 119.269 0.94 . . . . 0.0 109.423 172.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 97.65 -0.26 59.47 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.692 1.615 . . . . 0.0 114.962 -171.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -100.38 149.58 23.49 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.966 1.383 . . . . 0.0 111.472 176.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 23.1 p -113.42 128.29 56.4 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.108 0.963 . . . . 0.0 113.269 -173.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 15.2 mt -147.95 122.65 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.754 1.622 . . . . 0.0 107.943 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 59.18 37.66 23.83 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.364 1.065 . . . . 0.0 113.133 -177.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 140.36 -111.13 0.72 Allowed Glycine 0 N--CA 1.47 0.942 0 C-N-CA 124.449 1.023 . . . . 0.0 114.085 171.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -84.58 177.03 8.23 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.52 0.728 . . . . 0.0 111.008 -170.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 17.9 m -63.77 142.59 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 159.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 3.1 pp -99.52 144.86 28.13 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.74 0.781 . . . . 0.0 111.922 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -105.61 165.58 11.06 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.117 1.767 . . . . 0.0 109.205 162.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 26.6 t -136.16 120.3 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.718 1.607 . . . . 0.0 109.204 -174.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -122.69 170.39 10.1 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.239 1.815 . . . . 0.0 110.841 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 32.2 t -145.19 155.63 43.38 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 120.218 -1.551 . . . . 0.0 112.058 177.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -84.69 3.46 37.11 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 125.0 1.32 . . . . 0.0 113.215 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -150.9 177.79 9.78 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.696 1.999 . . . . 0.0 109.622 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 14.9 t -67.86 152.24 45.88 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 120.703 -1.248 . . . . 0.0 113.08 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 45.9 t -142.05 118.74 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 126.635 1.974 . . . . 0.0 107.959 -175.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -162.63 152.27 15.81 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.857 1.263 . . . . 0.0 113.01 -169.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -159.96 127.38 4.6 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.633 1.573 . . . . 0.0 110.155 -177.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 29.4 p80 -169.13 172.56 7.34 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.539 1.536 . . . . 0.0 112.794 -166.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 88.7 p -158.88 165.01 35.16 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.218 1.407 . . . . 0.0 111.758 176.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -79.9 -13.01 59.69 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 79.23 -131.74 10.89 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.47 1.033 . . . . 0.0 111.967 -176.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -158.7 173.64 16.25 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.755 1.622 . . . . 0.0 112.676 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -125.46 25.74 6.97 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.245 1.818 . . . . 0.0 113.912 -174.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 31.2 m -135.04 156.01 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -171.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -132.92 17.77 4.18 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.126 1.77 . . . . 0.0 113.597 -174.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 18.9 tt -60.94 130.19 90.89 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 124.804 1.242 . . . . 0.0 111.939 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.13 128.41 12.99 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.952 2.434 . . . . 0.0 110.237 175.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 53.7 ttm -164.55 139.05 5.4 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.196 1.398 . . . . 0.0 110.695 -173.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -159.37 142.34 14.23 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.99 1.316 . . . . 0.0 111.791 -177.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -80.27 53.34 1.76 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.733 1.613 . . . . 0.0 111.647 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 57.4 p -68.33 149.07 98.2 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.15 1.38 . . . . 0.0 113.631 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -73.2 150.59 47.83 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.581 2.854 . . . . 0.0 111.747 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 8.2 p -149.14 22.36 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 124.331 1.052 . . . . 0.0 112.861 -175.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 . . . . . 0 C--O 1.255 1.343 0 C-N-CA 126.499 1.919 . . . . 0.0 111.552 -177.905 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.921 0 N-CA-C 112.385 -0.286 . . . . 0.0 112.385 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 18.0 t -153.29 33.45 0.46 Allowed 'General case' 0 N--CA 1.48 1.069 0 O-C-N 121.718 -0.872 . . . . 0.0 112.496 -174.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -140.19 157.15 46.05 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.134 0.974 . . . . 0.0 112.017 -172.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 30.1 m -143.26 164.7 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 126.166 1.787 . . . . 0.0 110.624 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.6 mp -116.97 145.85 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 127.437 2.295 . . . . 0.0 107.446 173.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 19.2 m -118.62 146.19 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.43 1.092 . . . . 0.0 110.488 171.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -150.52 153.63 36.17 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.289 1.036 . . . . 0.0 113.135 -163.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 28.1 t30 83.91 -23.03 0.2 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 128.999 2.919 . . . . 0.0 114.259 176.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 47.8 mt -28.91 116.58 0.28 Allowed Pre-proline 0 CA--C 1.563 1.454 0 C-N-CA 126.495 1.918 . . . . 0.0 111.285 144.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -81.81 -175.52 2.61 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 125.107 3.871 . . . . 0.0 112.95 -173.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -61.92 -12.91 20.36 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 -176.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 16.1 m -85.27 -10.04 56.97 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.96 1.304 . . . . 0.0 114.12 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -108.72 127.43 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 126.704 2.002 . . . . 0.0 109.609 177.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -136.74 -177.26 4.66 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.175 2.19 . . . . 0.0 110.407 -173.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -43.76 -51.15 7.46 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.426 1.49 . . . . 0.0 114.595 -176.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -63.47 -38.04 89.61 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.076 0.853 . . . . 0.0 112.293 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.31 -41.66 73.02 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 170.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.459 HD23 ' C ' ' A' ' 277' ' ' LEU . 5.8 tt -55.65 -43.31 76.12 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.89 1.276 . . . . 0.0 110.719 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -46.8 -58.46 3.88 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.321 1.049 . . . . 0.0 111.643 171.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -61.19 -24.19 66.14 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.489 1.515 . . . . 0.0 113.293 -175.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 34.9 mt -52.14 -40.41 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 119.861 1.209 . . . . 0.0 111.185 172.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -102.02 -29.58 11.7 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.867 1.267 . . . . 0.0 111.718 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 23.7 tptt -70.16 -18.09 63.2 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.148 1.379 . . . . 0.0 113.553 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -61.07 -18.73 59.45 Favored 'General case' 0 CA--C 1.551 1.011 0 O-C-N 120.323 -1.486 . . . . 0.0 113.281 168.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 10.4 t -66.18 -11.03 47.04 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 124.709 1.203 . . . . 0.0 113.837 171.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 100.45 -8.94 58.85 Favored Glycine 0 N--CA 1.475 1.272 0 C-N-CA 125.973 1.749 . . . . 0.0 114.099 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -138.47 143.12 39.47 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.943 1.697 . . . . 0.0 109.936 172.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.9 p -89.54 141.26 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.176 0.99 . . . . 0.0 111.301 -177.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -83.52 -128.84 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.206 1.402 . . . . 0.0 110.583 170.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -157.64 162.22 38.67 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 127.457 2.303 . . . . 0.0 110.327 169.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -155.43 165.79 35.54 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.936 -1.103 . . . . 0.0 113.651 -170.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -147.69 137.26 22.58 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.609 1.564 . . . . 0.0 111.822 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 22.6 t -154.9 137.76 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.771 2.028 . . . . 0.0 108.375 -174.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -132.49 123.01 25.77 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.09 0.956 . . . . 0.0 110.097 170.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 18.8 mt -89.63 161.73 15.98 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.677 0.791 . . . . 0.0 112.948 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -74.03 139.04 44.46 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.481 1.112 . . . . 0.0 110.728 177.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -68.8 -8.99 58.46 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 116.59 1.396 . . . . 0.0 116.59 -163.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -78.53 -2.07 36.96 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 118.879 1.34 . . . . 0.0 112.791 166.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 89.03 46.63 4.41 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 125.519 1.533 . . . . 0.0 112.133 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.06 128.81 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.508 1.123 . . . . 0.0 110.896 -168.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 51.8 m -61.22 146.34 48.09 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.026 1.73 . . . . 0.0 114.449 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 29.4 p -84.79 -32.02 23.59 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.12 1.368 . . . . 0.0 112.895 172.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 77.78 -60.81 3.73 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.911 1.243 . . . . 0.0 111.433 -171.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 59.3 p -67.3 154.99 40.02 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.16 1.784 . . . . 0.0 113.393 167.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -167.05 171.31 41.81 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.802 1.192 . . . . 0.0 114.773 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 94.8 m -106.85 146.18 31.25 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.833 1.653 . . . . 0.0 110.092 -174.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 1.1 t -134.6 135.0 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.143 1.777 . . . . 0.0 109.292 -175.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 8.2 m -109.39 119.76 40.45 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.17 1.788 . . . . 0.0 108.347 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.45 164.49 25.4 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -157.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -56.09 -47.0 78.84 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.784 173.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -172.39 162.07 5.32 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 129.746 3.218 . . . . 0.0 108.921 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.56 HD12 ' H ' ' A' ' 311' ' ' ILE . 4.5 mp -62.19 -31.4 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.99 0.916 . . . . 0.0 111.823 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.62 -43.4 62.56 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 177.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -97.91 -14.97 20.36 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -176.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.8 tt -55.41 -51.6 66.32 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.178 1.391 . . . . 0.0 110.828 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -66.91 -29.33 69.18 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 39.1 mtp85 -70.16 -51.05 34.3 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.653 1.181 . . . . 0.0 111.126 170.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -63.07 -32.98 74.48 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.982 1.713 . . . . 0.0 113.524 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -54.83 -39.17 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.213 1.405 . . . . 0.0 112.051 177.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -82.67 -39.19 22.39 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.217 0.607 . . . . 0.0 112.055 174.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -65.51 -49.05 70.41 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -171.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -85.87 -20.84 28.48 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -176.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -67.19 113.69 5.33 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.415 -0.803 . . . . 0.0 110.03 173.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 101.03 0.07 54.86 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.29 0.947 . . . . 0.0 114.864 -173.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -94.21 168.83 10.67 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 118.962 1.381 . . . . 0.0 111.742 172.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 55.3 p -138.22 127.06 23.83 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 120.399 -1.438 . . . . 0.0 112.671 -175.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 22.6 mt -143.53 125.13 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.688 1.195 . . . . 0.0 109.487 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 59.49 20.73 9.16 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.7 1.6 . . . . 0.0 114.217 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 170.78 -118.49 0.75 Allowed Glycine 0 C--N 1.342 0.893 0 O-C-N 121.004 -1.06 . . . . 0.0 114.935 -178.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -96.48 178.13 5.45 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.8 0.84 . . . . 0.0 111.081 -171.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 12.6 p -52.64 137.49 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 O-C-N 121.879 -0.513 . . . . 0.0 109.948 157.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 2.1 pp -112.98 147.53 36.95 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.475 1.11 . . . . 0.0 112.195 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -104.56 157.45 17.16 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.176 1.39 . . . . 0.0 110.475 170.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 16.6 t -133.91 135.64 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.242 1.417 . . . . 0.0 109.313 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -149.29 159.57 44.15 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.819 1.248 . . . . 0.0 111.515 -171.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 23.0 t -144.39 151.7 39.65 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 120.59 -1.319 . . . . 0.0 111.099 172.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -72.73 -28.82 62.88 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -174.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 59.1 -167.12 0.16 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 126.809 2.044 . . . . 0.0 113.004 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 24.9 t -164.75 126.48 2.16 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.712 1.605 . . . . 0.0 110.23 174.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 11.6 p -169.46 141.2 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 125.299 1.44 . . . . 0.0 111.162 -174.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -157.58 129.05 6.82 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.317 1.447 . . . . 0.0 111.718 171.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -165.92 150.09 8.07 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.77 1.628 . . . . 0.0 111.939 -176.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -152.42 152.72 32.35 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.019 1.328 . . . . 0.0 112.66 172.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 34.4 p -163.76 127.71 2.74 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.144 1.778 . . . . 0.0 109.496 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -77.38 -16.76 58.7 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -173.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 79.23 -179.25 53.1 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.205 1.383 . . . . 0.0 115.06 171.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -163.64 132.21 3.78 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.83 2.052 . . . . 0.0 110.071 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -158.23 149.81 21.34 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.674 1.989 . . . . 0.0 110.241 -172.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 14.7 p -159.23 139.65 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 126.164 1.786 . . . . 0.0 110.356 176.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -170.63 128.84 0.8 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.507 2.323 . . . . 0.0 108.873 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 44.6 pt -133.06 151.08 77.25 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 126.018 1.727 . . . . 0.0 111.977 -176.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -73.82 158.24 46.84 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.597 2.865 . . . . 0.0 111.743 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 59.7 ttm -159.55 134.46 8.02 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.276 1.43 . . . . 0.0 110.754 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -80.05 155.32 27.62 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.207 1.403 . . . . 0.0 113.524 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -157.62 115.66 3.11 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.58 1.552 . . . . 0.0 110.447 175.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 73.2 m -115.32 147.26 38.23 Favored Pre-proline 0 N--CA 1.477 0.882 0 C-N-CA 124.979 1.312 . . . . 0.0 112.157 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.35 147.17 52.34 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.467 2.778 . . . . 0.0 111.414 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 14.6 p -164.01 143.18 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 125.172 1.389 . . . . 0.0 110.804 -176.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 5.9 p30 . . . . . 0 C--O 1.254 1.311 0 C-N-CA 126.281 1.832 . . . . 0.0 112.682 -179.48 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.925 0 N-CA-C 112.253 -0.339 . . . . 0.0 112.253 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 5.0 m 66.22 -156.14 0.25 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.392 1.477 . . . . 0.0 112.966 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 71.96 166.8 0.3 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 127.515 2.326 . . . . 0.0 114.016 176.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 35.3 m -134.28 157.72 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.197 0.999 . . . . 0.0 111.454 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 3.8 mp -131.82 140.29 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 126.258 1.823 . . . . 0.0 107.485 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 28.0 m -123.74 125.79 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.796 0.838 . . . . 0.0 109.984 -177.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -142.08 66.84 1.33 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.301 1.44 . . . . 0.0 111.82 -160.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -170.61 -44.67 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.957 1.703 . . . . 0.0 111.069 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 33.1 mt -40.09 119.26 1.45 Allowed Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 126.98 2.112 . . . . 0.0 112.327 165.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -94.06 -174.54 0.39 Allowed 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 124.505 3.47 . . . . 0.0 111.593 -176.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -51.32 -18.23 0.93 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.449 1.9 . . . . 0.0 115.379 177.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 15.8 m -64.68 -21.5 66.75 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.324 1.45 . . . . 0.0 113.879 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 5.4 p -105.72 148.54 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.742 1.217 . . . . 0.0 109.816 169.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -127.26 168.13 15.17 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.171 1.389 . . . . 0.0 111.549 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -54.1 -40.87 67.68 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -167.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -68.98 -37.75 78.94 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.482 -0.761 . . . . 0.0 111.687 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.47 -33.52 73.03 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 171.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 7.2 tt -60.48 -43.39 97.0 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.939 0.79 . . . . 0.0 110.962 172.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.49 -36.44 78.33 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.766 -0.584 . . . . 0.0 111.928 174.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -69.2 -20.06 63.97 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 23.7 mt -54.48 -45.53 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-N 119.604 1.093 . . . . 0.0 112.484 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -103.17 -3.97 25.06 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.662 1.185 . . . . 0.0 112.496 -174.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -61.8 -23.95 66.55 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.818 2.047 . . . . 0.0 115.217 -169.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -76.2 -10.87 59.75 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 14.0 t -79.03 -23.82 44.05 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 174.08 -165.99 37.88 Favored Glycine 0 N--CA 1.473 1.158 0 C-N-CA 124.346 0.974 . . . . 0.0 114.543 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -64.03 105.5 0.88 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.428 1.091 . . . . 0.0 110.087 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 5.3 p -52.94 137.2 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -153.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -73.43 -111.05 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.469 1.508 . . . . 0.0 112.397 -176.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -162.86 161.66 26.04 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.434 1.894 . . . . 0.0 111.091 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.3 168.39 27.14 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.076 -1.015 . . . . 0.0 112.386 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -156.86 153.62 28.52 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.313 1.045 . . . . 0.0 112.118 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 20.1 t -151.66 142.46 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.752 2.021 . . . . 0.0 108.302 -172.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -127.87 152.18 48.15 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.924 0.889 . . . . 0.0 110.861 172.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 15.4 mt -103.62 -157.06 0.59 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.762 1.225 . . . . 0.0 110.655 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -149.9 151.12 32.91 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.026 0.93 . . . . 0.0 111.273 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -63.26 -20.94 63.62 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-O 118.784 -1.009 . . . . 0.0 115.604 -174.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -117.55 -9.8 10.74 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 118.924 1.362 . . . . 0.0 113.962 165.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -70.27 -51.58 21.62 Favored Glycine 0 N--CA 1.47 0.92 0 C-N-CA 124.362 0.982 . . . . 0.0 112.267 169.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 2.8 t 58.94 10.46 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 C-N-CA 127.145 2.178 . . . . 0.0 112.016 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 86.4 p -179.57 153.45 0.56 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 127.94 2.496 . . . . 0.0 110.652 -168.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 5.0 p -152.97 -54.81 0.12 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 125.385 1.474 . . . . 0.0 112.774 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 78.3 -62.9 3.7 Favored Glycine 0 N--CA 1.473 1.111 0 C-N-CA 125.186 1.374 . . . . 0.0 112.023 -176.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 38.3 m -49.48 120.8 4.41 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.73 1.612 . . . . 0.0 112.451 165.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -157.25 -160.82 10.39 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.114 1.34 . . . . 0.0 114.522 -177.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 22.0 p -108.96 145.74 34.97 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.615 1.966 . . . . 0.0 111.149 -173.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.68 127.14 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.915 1.286 . . . . 0.0 109.047 -177.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 19.4 m -85.21 151.84 23.78 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.036 0.934 . . . . 0.0 110.138 171.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.33 157.74 27.51 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 -169.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -57.91 -55.66 32.01 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.608 1.563 . . . . 0.0 111.52 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -172.26 175.35 3.69 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 128.184 2.594 . . . . 0.0 108.975 161.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 74.2 mt -57.05 -35.9 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.241 1.416 . . . . 0.0 111.77 -176.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.39 -50.16 9.34 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.957 1.703 . . . . 0.0 114.874 172.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -95.76 -21.67 18.0 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.333 0.653 . . . . 0.0 112.129 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.0 tt -56.01 -49.4 73.78 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.549 1.14 . . . . 0.0 109.881 170.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -59.87 -33.64 72.08 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -70.51 -53.79 14.8 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.236 0.614 . . . . 0.0 111.267 170.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.52 -37.06 74.85 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.331 1.452 . . . . 0.0 113.602 -176.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.16 -40.17 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.306 1.042 . . . . 0.0 112.071 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -82.54 -38.94 23.04 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.487 0.715 . . . . 0.0 111.776 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -64.46 -47.72 77.94 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.519 1.128 . . . . 0.0 113.403 -173.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -92.54 -18.48 23.08 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -172.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -70.0 116.36 10.28 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.023 -1.048 . . . . 0.0 110.479 175.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 97.72 -5.84 62.29 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.628 1.585 . . . . 0.0 115.139 -174.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -80.09 172.79 13.31 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 118.824 1.312 . . . . 0.0 111.164 170.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 53.8 m -134.56 130.86 37.18 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 120.703 1.592 . . . . 0.0 111.697 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 39.0 mt -145.63 114.62 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.297 1.039 . . . . 0.0 109.159 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 57.1 28.52 15.06 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.439 1.096 . . . . 0.0 113.897 172.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 168.87 -125.52 1.28 Allowed Glycine 0 C--N 1.342 0.909 0 O-C-N 120.825 -1.172 . . . . 0.0 114.33 -177.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -87.35 -178.94 6.3 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.193 0.997 . . . . 0.0 110.824 -176.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 35.1 m -59.87 137.19 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 121.9 -0.5 . . . . 0.0 109.655 161.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 11.1 mp -71.34 128.31 35.47 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.135 1.374 . . . . 0.0 109.476 173.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -106.05 146.28 30.33 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 154.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 14.4 t -136.7 128.76 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.561 1.544 . . . . 0.0 108.938 -172.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -130.03 169.69 14.96 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.77 2.028 . . . . 0.0 110.512 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 32.9 t -138.5 151.66 47.58 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 120.537 -1.352 . . . . 0.0 111.833 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 40.6 tttm -80.13 2.11 25.43 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 -168.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -152.88 121.98 6.6 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.671 1.189 . . . . 0.0 110.91 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 23.3 t -172.93 165.41 5.11 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.679 1.992 . . . . 0.0 110.977 173.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 14.9 p -168.91 -40.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 125.043 1.337 . . . . 0.0 113.871 -176.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -141.63 157.17 45.42 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.495 1.118 . . . . 0.0 113.41 -174.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -120.51 3.38 10.73 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.318 1.447 . . . . 0.0 113.844 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 23.5 t60 58.83 34.35 23.64 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.912 1.685 . . . . 0.0 113.713 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 16.0 m -67.72 -15.92 63.88 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -171.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -83.31 -10.8 58.29 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.741 1.216 . . . . 0.0 113.307 175.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -87.52 141.14 17.14 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.147 1.356 . . . . 0.0 112.63 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -163.34 133.95 4.56 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.61 1.564 . . . . 0.0 111.432 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -166.23 156.81 12.69 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.105 2.162 . . . . 0.0 109.83 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 16.2 m -151.35 149.89 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 127.197 2.199 . . . . 0.0 111.037 -175.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -166.75 118.0 0.94 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.926 1.69 . . . . 0.0 110.222 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 5.3 mp -130.2 108.04 16.37 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 125.259 1.424 . . . . 0.0 108.699 178.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.47 152.69 13.64 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.568 2.845 . . . . 0.0 112.235 -176.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 42.3 tpp 73.38 146.08 0.08 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 128.103 2.561 . . . . 0.0 114.228 174.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -163.3 -41.73 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.007 1.323 . . . . 0.0 114.012 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -118.84 -11.17 9.79 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -160.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 66.0 m -115.52 152.05 46.71 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 124.491 1.116 . . . . 0.0 112.997 -166.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.24 150.84 53.93 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.234 2.623 . . . . 0.0 111.08 174.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 59.9 t -142.68 128.54 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.397 1.479 . . . . 0.0 108.798 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 32.9 m120 . . . . . 0 C--O 1.254 1.291 0 C-N-CA 125.939 1.696 . . . . 0.0 111.61 -174.878 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.938 0 N-CA-C 112.389 -0.284 . . . . 0.0 112.389 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 92.5 p -157.25 33.6 0.28 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.129 0.972 . . . . 0.0 112.723 -171.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -159.74 145.94 16.03 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.771 -1.206 . . . . 0.0 110.972 -170.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 32.6 m -133.24 147.14 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.142 0.977 . . . . 0.0 111.056 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.7 mp -91.57 141.23 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 126.675 1.99 . . . . 0.0 108.606 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 34.7 m -132.84 129.07 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.577 1.151 . . . . 0.0 109.036 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.3 tptm -150.5 50.46 0.88 Allowed 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 -148.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -160.94 -17.68 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 170.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 39.3 mt -54.35 131.96 61.93 Favored Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 125.713 1.605 . . . . 0.0 111.598 168.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -86.09 169.5 8.75 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.312 3.341 . . . . 0.0 111.276 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -55.81 -10.66 0.78 Allowed 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 6.2 t -59.32 -31.21 68.95 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.696 1.198 . . . . 0.0 113.006 171.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.62 116.33 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 169.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -69.36 153.28 43.85 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.562 0.745 . . . . 0.0 110.097 171.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -55.46 -32.67 62.99 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 120.538 -1.351 . . . . 0.0 113.108 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -69.11 -39.57 78.85 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.021 0.929 . . . . 0.0 111.033 175.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.53 -25.51 64.06 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.078 -1.014 . . . . 0.0 113.065 170.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.74 -49.05 64.63 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.258 0.935 . . . . 0.0 111.343 170.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -25.89 68.25 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 119.762 1.165 . . . . 0.0 111.852 174.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -68.93 -21.66 64.19 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 171.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.441 HG23 HD12 ' A' ' 326' ' ' ILE . 30.1 mt -56.97 -51.35 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 CA-C-N 119.696 1.134 . . . . 0.0 111.269 173.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -85.84 -19.55 30.46 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.678 0.791 . . . . 0.0 111.824 -174.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -57.62 -13.98 4.71 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.103 1.761 . . . . 0.0 114.808 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -59.48 -15.32 16.84 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 168.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 83.9 m -68.79 -5.62 21.86 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 168.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.39 -8.58 60.5 Favored Glycine 0 N--CA 1.48 1.575 0 C-N-CA 125.789 1.662 . . . . 0.0 115.666 172.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -138.69 -174.65 3.89 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.823 2.049 . . . . 0.0 108.634 170.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 6.8 p -144.06 144.22 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 121.159 1.799 . . . . 0.0 113.618 172.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -94.81 -121.04 0.1 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.184 1.793 . . . . 0.0 111.189 177.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -143.82 158.55 43.61 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.538 1.935 . . . . 0.0 111.567 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.96 -179.72 8.3 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 120.974 -1.079 . . . . 0.0 113.855 -177.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 8.2 p30 -155.54 173.7 16.32 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.656 1.583 . . . . 0.0 113.781 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 17.2 m -149.92 173.86 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 127.69 2.396 . . . . 0.0 110.075 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -108.22 159.54 16.54 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.674 1.19 . . . . 0.0 111.318 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.3 mp -132.96 134.17 44.15 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.542 1.137 . . . . 0.0 111.347 173.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -66.77 164.27 17.5 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.691 1.196 . . . . 0.0 111.221 165.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -61.97 -19.93 59.5 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.019 0.819 . . . . 0.0 114.669 176.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -79.14 -6.16 55.86 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.917 1.287 . . . . 0.0 113.47 171.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 80.87 14.13 80.12 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.034 1.302 . . . . 0.0 115.135 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 3.7 p -91.11 4.66 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 -165.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 10.9 p 64.87 -179.39 0.18 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 126.992 2.117 . . . . 0.0 116.159 175.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 68.6 p -141.99 156.3 45.45 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 128.368 2.667 . . . . 0.0 108.229 172.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -88.01 -34.31 10.0 Favored Glycine 0 N--CA 1.47 0.947 0 C-N-CA 123.245 0.45 . . . . 0.0 112.203 169.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 18.7 p -56.81 143.04 38.58 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.762 1.625 . . . . 0.0 111.922 163.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 169.55 -153.59 22.09 Favored Glycine 0 N--CA 1.471 0.985 0 C-N-CA 126.172 1.844 . . . . 0.0 112.253 -175.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 17.8 p -125.09 154.97 40.57 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 117.994 0.897 . . . . 0.0 111.357 173.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 13.4 m -123.82 121.96 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 125.222 1.409 . . . . 0.0 107.782 172.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 4.5 m -91.09 120.79 32.34 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.013 1.725 . . . . 0.0 109.356 -175.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.85 157.47 21.99 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -158.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -54.38 -54.03 46.0 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 113.56 -1.655 . . . . 0.0 111.793 172.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -172.68 170.24 4.78 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 129.366 3.067 . . . . 0.0 108.676 171.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 89.5 mt -57.49 -34.32 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 124.864 1.266 . . . . 0.0 112.054 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.14 -40.2 64.07 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.138 1.375 . . . . 0.0 114.433 172.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -89.39 -33.15 16.96 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 119.328 -0.368 . . . . 0.0 110.418 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 6.2 tt -56.64 -52.16 65.94 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.854 1.262 . . . . 0.0 111.378 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -62.3 -47.58 83.66 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.67 -0.644 . . . . 0.0 112.541 -177.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 28.1 ptt85 -70.44 -28.83 65.34 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -74.12 -33.78 63.68 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.502 1.121 . . . . 0.0 112.997 173.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -53.71 -44.04 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.156 1.382 . . . . 0.0 112.3 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -82.75 -17.37 44.47 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -89.07 -48.51 7.36 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.913 0.885 . . . . 0.0 112.671 -171.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -85.32 -21.55 28.89 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -49.8 125.26 11.37 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.885 0.874 . . . . 0.0 110.761 159.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 86.93 0.34 85.74 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 119.141 -0.811 . . . . 0.0 114.757 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -103.69 163.43 12.33 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.139 1.375 . . . . 0.0 112.045 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 34.1 p -138.03 129.35 27.66 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 120.684 -1.26 . . . . 0.0 111.897 -175.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.441 HD12 HG23 ' A' ' 280' ' ' ILE . 11.0 mt -146.71 116.86 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.49 1.116 . . . . 0.0 109.104 -177.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 60.86 25.95 15.84 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.695 1.198 . . . . 0.0 112.792 176.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 178.2 -140.01 4.42 Favored Glycine 0 C--N 1.342 0.888 0 O-C-N 120.931 -1.106 . . . . 0.0 114.474 -170.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -91.42 178.26 6.0 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.399 1.08 . . . . 0.0 110.644 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 11.7 p -59.92 129.19 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 O-C-N 121.642 -0.661 . . . . 0.0 109.308 160.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 1.8 pp -104.37 149.09 25.69 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 122.406 1.098 . . . . 0.0 111.533 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -113.37 163.54 14.72 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.017 1.327 . . . . 0.0 110.092 166.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 24.3 t -135.93 130.52 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 126.561 1.945 . . . . 0.0 107.51 -175.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -135.28 133.94 39.41 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.234 1.014 . . . . 0.0 111.46 -173.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 77.3 p -118.0 167.54 11.35 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.186 1.394 . . . . 0.0 112.894 -171.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -122.22 124.01 42.82 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.081 1.352 . . . . 0.0 110.718 175.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -161.05 -59.8 0.05 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.64 1.176 . . . . 0.0 110.997 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 12.1 t -163.77 -169.8 2.0 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.026 1.33 . . . . 0.0 111.865 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 21.7 m -143.56 149.81 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 127.307 2.243 . . . . 0.0 110.535 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -146.73 156.74 43.4 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.133 1.373 . . . . 0.0 112.749 -170.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -159.48 177.35 11.04 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.901 1.68 . . . . 0.0 112.08 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -116.35 21.13 13.81 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.505 1.522 . . . . 0.0 112.825 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 20.1 m -79.58 71.64 6.19 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.326 1.45 . . . . 0.0 111.674 -176.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -75.42 -10.65 59.64 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.021 1.328 . . . . 0.0 114.214 -175.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 92.04 -2.86 76.26 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.29 1.424 . . . . 0.0 115.107 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -151.51 138.98 19.51 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.257 1.823 . . . . 0.0 110.897 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -164.62 134.18 3.77 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.934 1.693 . . . . 0.0 110.938 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 17.1 m -153.8 154.27 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 126.212 1.805 . . . . 0.0 111.232 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -148.61 106.11 3.66 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.86 1.664 . . . . 0.0 109.652 174.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 7.4 pt -133.33 96.56 17.08 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 125.172 1.389 . . . . 0.0 110.596 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -83.13 147.53 13.02 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.238 2.625 . . . . 0.0 111.806 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -73.39 149.27 42.63 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.558 1.143 . . . . 0.0 111.411 172.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -71.56 133.77 45.99 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.359 0.664 . . . . 0.0 111.994 173.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -151.94 26.46 0.63 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.009 1.724 . . . . 0.0 111.4 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 21.3 t -63.43 128.75 92.97 Favored Pre-proline 0 CA--C 1.55 0.978 0 O-C-N 120.994 -1.066 . . . . 0.0 112.347 -176.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.43 151.31 33.13 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.585 2.857 . . . . 0.0 111.742 -177.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 15.9 m -148.58 144.98 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 125.432 1.493 . . . . 0.0 111.095 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 . . . . . 0 C--O 1.254 1.339 0 C-N-CA 126.291 1.836 . . . . 0.0 111.56 -178.942 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.719 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 73.0 m -146.8 164.79 31.69 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.198 1.399 . . . . 0.0 111.229 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -142.56 160.07 41.0 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.156 0.982 . . . . 0.0 112.156 -170.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 34.7 m -132.86 157.43 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.687 1.195 . . . . 0.0 111.109 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.0 mp -125.17 136.91 59.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 127.044 2.137 . . . . 0.0 107.033 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.93 128.89 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.116 0.967 . . . . 0.0 109.427 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 60.2 mmtt -138.76 73.84 1.45 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.034 1.334 . . . . 0.0 110.784 -161.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -179.13 -32.21 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.554 1.942 . . . . 0.0 113.3 -173.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 89.1 mt -74.07 131.35 81.29 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-O 117.917 -1.04 . . . . 0.0 109.834 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -94.83 -168.88 0.16 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 124.272 3.315 . . . . 0.0 110.759 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -55.59 -13.62 1.68 Allowed 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 50.0 m -60.26 -24.19 64.71 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.386 1.474 . . . . 0.0 113.872 170.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.3 p -103.5 144.57 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.43 1.092 . . . . 0.0 109.893 170.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -135.91 173.56 11.58 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.944 1.698 . . . . 0.0 109.775 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -44.35 -51.28 8.65 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.959 1.303 . . . . 0.0 113.777 -170.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -70.07 -40.82 74.8 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.917 -0.49 . . . . 0.0 111.618 -175.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.25 -33.56 73.45 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.789 0.722 . . . . 0.0 112.82 176.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 8.2 tt -63.1 -45.2 93.2 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.98 0.809 . . . . 0.0 110.409 172.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 3.7 tmmm? -60.69 -37.63 82.27 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.864 -0.523 . . . . 0.0 111.161 174.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -63.68 -25.32 68.16 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 176.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 28.1 mt -55.92 -51.37 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 124.112 0.965 . . . . 0.0 110.609 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -89.0 -26.26 21.56 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.666 0.786 . . . . 0.0 112.343 -175.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 2.9 ttpt -52.7 -22.03 4.71 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.292 1.437 . . . . 0.0 114.356 173.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -61.8 -13.75 26.7 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 120.77 -1.206 . . . . 0.0 113.79 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 79.3 m -71.54 -0.37 10.42 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.968 1.307 . . . . 0.0 114.403 167.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.58 -73.57 0.25 Allowed Glycine 0 N--CA 1.471 1.001 0 C-N-CA 126.393 1.949 . . . . 0.0 111.449 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -73.08 172.3 11.3 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.19 0.996 . . . . 0.0 111.136 170.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.29 142.05 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 O-C-N 120.635 -1.29 . . . . 0.0 113.827 172.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -85.36 -125.56 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.733 1.613 . . . . 0.0 111.415 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -152.1 162.0 41.77 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.4 1.48 . . . . 0.0 112.89 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.6 173.72 16.16 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.11 -0.994 . . . . 0.0 113.641 -173.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -154.87 158.42 39.33 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.799 1.24 . . . . 0.0 113.398 -177.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 21.8 m -151.53 163.45 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 127.486 2.314 . . . . 0.0 110.914 -172.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -131.97 167.46 19.61 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.77 1.228 . . . . 0.0 111.84 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 4.0 mp -129.05 152.68 48.39 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.228 1.411 . . . . 0.0 112.203 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -92.84 153.17 19.0 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.066 1.746 . . . . 0.0 111.487 173.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -68.5 -7.08 52.25 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.801 1.191 . . . . 0.0 114.989 -178.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -74.08 -4.77 37.57 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.31 1.444 . . . . 0.0 112.953 168.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 86.45 38.29 8.37 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.035 1.302 . . . . 0.0 113.392 176.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 30.6 m -142.05 148.41 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.678 1.591 . . . . 0.0 111.143 -174.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 75.0 p -81.1 152.74 27.67 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.924 0.89 . . . . 0.0 113.039 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 39.1 p -76.25 -29.4 57.48 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.858 0.863 . . . . 0.0 112.881 176.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 74.49 -64.26 2.16 Favored Glycine 0 N--CA 1.47 0.926 0 C-N-CA 125.724 1.63 . . . . 0.0 112.207 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 58.1 m -55.0 110.61 0.69 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.427 1.891 . . . . 0.0 111.435 166.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -146.67 -160.11 8.61 Favored Glycine 0 N--CA 1.469 0.851 0 C-N-CA 124.695 1.14 . . . . 0.0 113.897 -173.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 98.0 m -114.89 136.67 52.85 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.526 1.53 . . . . 0.0 109.625 -170.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 1.3 t -120.41 120.23 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 125.751 1.621 . . . . 0.0 107.622 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 42.9 m -88.46 108.04 19.18 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.416 1.086 . . . . 0.0 108.426 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -79.6 162.91 25.02 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 -160.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -53.21 -55.58 23.21 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.625 1.17 . . . . 0.0 111.35 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -172.39 178.82 2.69 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.039 2.535 . . . . 0.0 109.007 154.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 16.7 tt -53.51 -33.31 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.101 1.36 . . . . 0.0 113.488 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.69 -42.72 68.28 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.207 1.403 . . . . 0.0 113.956 173.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -95.26 -24.58 16.72 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.5 tt -58.35 -51.97 67.57 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 125.434 1.493 . . . . 0.0 110.221 175.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -62.21 -33.43 74.54 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -70.33 -42.39 71.97 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.695 1.198 . . . . 0.0 112.036 174.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -72.92 -33.55 66.05 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.432 1.493 . . . . 0.0 113.134 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.44 -37.01 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.833 0.853 . . . . 0.0 112.6 -176.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -82.17 -19.59 39.6 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.855 0.862 . . . . 0.0 113.206 175.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -89.01 -46.09 9.13 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.68 1.192 . . . . 0.0 112.645 -175.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -87.71 -30.71 20.14 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -171.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -65.09 118.84 9.75 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 119.011 0.823 . . . . 0.0 110.324 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 103.42 -7.07 50.45 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 125.644 1.592 . . . . 0.0 115.629 -172.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -93.88 142.92 26.82 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 119.451 1.625 . . . . 0.0 111.78 176.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 11.0 p -111.96 126.64 55.35 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.793 1.237 . . . . 0.0 112.234 -174.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -148.58 103.16 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.113 0.965 . . . . 0.0 109.517 -166.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 57.06 35.89 26.96 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 121.932 0.872 . . . . 0.0 111.462 -172.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 163.31 -148.69 15.47 Favored Glycine 0 C--N 1.343 0.952 0 O-C-N 121.152 -0.968 . . . . 0.0 114.787 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -80.93 174.55 11.51 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.804 1.642 . . . . 0.0 111.066 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 32.8 m -63.37 136.18 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 121.213 -0.929 . . . . 0.0 111.301 175.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 14.6 mt -63.41 122.28 15.86 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.674 0.79 . . . . 0.0 113.001 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -106.04 102.37 11.8 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.36 1.864 . . . . 0.0 107.599 160.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.45 131.69 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.286 1.435 . . . . 0.0 109.698 -171.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -130.0 135.13 47.94 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.978 1.311 . . . . 0.0 110.806 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 50.1 p -97.05 159.0 15.16 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.874 -1.141 . . . . 0.0 112.005 175.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -82.07 97.85 8.36 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 121.286 -0.883 . . . . 0.0 111.079 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.04 174.24 12.53 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.987 1.715 . . . . 0.0 112.087 -175.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 20.3 t -160.94 163.63 31.71 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.478 1.511 . . . . 0.0 111.293 174.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 9.9 p -91.82 -24.23 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.442 1.097 . . . . 0.0 113.614 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 57.27 26.96 12.96 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 125.535 1.534 . . . . 0.0 114.538 174.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -71.18 -21.97 62.09 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -167.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 63.94 175.88 0.17 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 126.473 1.909 . . . . 0.0 114.356 177.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 33.5 t -163.41 140.16 7.17 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.465 1.506 . . . . 0.0 111.152 177.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -84.68 -8.11 58.98 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.401 1.08 . . . . 0.0 113.107 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 84.21 -171.24 47.98 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.177 1.37 . . . . 0.0 114.045 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -150.07 146.63 27.06 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.177 1.791 . . . . 0.0 111.153 -176.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -164.49 158.74 18.61 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.994 2.117 . . . . 0.0 109.697 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 14.9 p -165.36 143.45 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 126.86 2.064 . . . . 0.0 110.606 -175.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -161.83 114.24 1.77 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.311 1.844 . . . . 0.0 109.167 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 40.5 mm -99.1 119.99 59.39 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 124.325 1.05 . . . . 0.0 110.0 -175.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -79.42 163.67 24.42 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.684 2.923 . . . . 0.0 112.106 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 27.8 ttt -158.12 132.92 8.43 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.257 1.423 . . . . 0.0 110.53 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -161.07 158.37 27.64 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.142 1.377 . . . . 0.0 112.171 -178.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -149.05 9.65 0.77 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 128.115 2.566 . . . . 0.0 112.547 177.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 12.7 t -64.3 147.56 96.91 Favored Pre-proline 0 CA--C 1.552 1.023 0 O-C-N 120.663 -1.273 . . . . 0.0 112.304 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.28 -14.16 41.98 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.957 2.438 . . . . 0.0 113.289 164.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 21.6 t 73.49 95.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 126.4 1.88 . . . . 0.0 110.9 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 . . . . . 0 C--O 1.254 1.316 0 C-N-CA 126.653 1.981 . . . . 0.0 111.163 179.346 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.913 0 CA-C-O 121.151 0.306 . . . . 0.0 112.608 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 8.3 m -176.6 98.04 0.05 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 128.288 2.635 . . . . 0.0 109.122 175.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -167.47 153.35 7.63 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.218 -0.926 . . . . 0.0 112.853 -173.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 31.3 m -138.59 147.26 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.45 1.5 . . . . 0.0 111.126 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.4 mp -92.05 137.83 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 126.01 1.724 . . . . 0.0 107.683 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 5.4 m -117.75 118.5 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.417 ' H ' HD11 ' A' ' 331' ' ' LEU . 6.8 tmtt? -139.37 44.75 1.97 Allowed 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -148.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -168.51 -6.65 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 116.623 2.083 . . . . 0.0 116.623 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 68.0 mt -69.84 144.17 93.04 Favored Pre-proline 0 CA--C 1.553 1.079 0 O-C-N 120.532 -1.355 . . . . 0.0 110.103 174.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -90.62 -175.24 0.83 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.3 3.333 . . . . 0.0 110.905 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -56.37 -12.47 1.68 Allowed 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 20.4 m -60.48 -31.05 70.1 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.78 1.232 . . . . 0.0 113.266 171.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.6 p -93.73 142.49 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.503 0.721 . . . . 0.0 109.697 172.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -137.26 168.41 19.69 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.004 1.722 . . . . 0.0 109.09 176.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -50.56 -40.92 53.43 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -167.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -68.64 -39.01 80.94 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.761 -0.587 . . . . 0.0 111.895 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.58 -36.25 76.09 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.382 -0.824 . . . . 0.0 112.715 170.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.453 HD21 HG12 ' A' ' 306' ' ' VAL . 3.3 tt -61.03 -38.27 85.51 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.189 0.996 . . . . 0.0 112.138 176.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -57.84 -46.94 84.02 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 121.537 -0.727 . . . . 0.0 110.947 169.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.29 -17.82 64.82 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 29.3 mt -54.41 -33.45 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.344 1.058 . . . . 0.0 111.803 169.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -118.05 -27.7 6.05 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.171 1.389 . . . . 0.0 112.183 -176.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -64.31 -6.66 7.39 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -52.72 -25.29 10.65 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.198 1.399 . . . . 0.0 113.06 167.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 70.8 m -67.66 -5.17 14.52 Favored 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 172.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 97.06 -12.17 65.59 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 126.436 1.969 . . . . 0.0 115.017 175.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -138.67 172.47 12.83 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.394 1.878 . . . . 0.0 109.659 174.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.1 p -145.34 144.35 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 120.341 -1.474 . . . . 0.0 112.318 173.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -72.57 -79.4 0.08 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.473 1.109 . . . . 0.0 112.077 178.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -178.45 147.01 0.39 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 127.947 2.499 . . . . 0.0 109.813 -167.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.59 166.56 31.79 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.11 -0.994 . . . . 0.0 112.658 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -157.46 165.8 34.71 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.898 1.279 . . . . 0.0 112.496 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 22.7 m -146.37 155.4 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 126.838 2.055 . . . . 0.0 110.793 -174.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -132.0 115.21 15.54 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.875 1.27 . . . . 0.0 108.848 174.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 17.2 mt -96.13 169.1 10.19 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.466 1.106 . . . . 0.0 111.376 -173.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -78.16 144.76 36.11 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.009 0.923 . . . . 0.0 112.119 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -68.44 -12.35 63.58 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.88 1.229 . . . . 0.0 115.795 -173.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -80.81 0.01 36.77 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 119.301 1.551 . . . . 0.0 113.22 168.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 85.81 43.35 6.44 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.575 1.083 . . . . 0.0 113.172 175.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.19 148.9 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.08 1.352 . . . . 0.0 111.89 -177.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 58.5 m -77.79 139.32 39.32 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -169.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 7.9 p -89.22 -26.66 21.1 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.69 1.996 . . . . 0.0 113.529 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 80.27 -54.27 4.52 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.103 1.811 . . . . 0.0 113.067 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 23.4 p -52.34 139.75 23.63 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 122.998 1.38 . . . . 0.0 113.28 163.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -161.23 -171.73 27.63 Favored Glycine 0 N--CA 1.468 0.832 0 C-N-CA 124.831 1.205 . . . . 0.0 114.682 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 26.6 p -123.39 122.41 38.22 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.48 1.512 . . . . 0.0 109.493 -176.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.453 HG12 HD21 ' A' ' 277' ' ' LEU . 19.6 m -112.58 129.73 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 175.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 5.1 m -87.88 150.03 23.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.709 172.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.74 157.44 19.76 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -165.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -53.82 -52.57 59.92 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.743 1.617 . . . . 0.0 111.88 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -172.66 170.36 4.77 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.351 2.66 . . . . 0.0 108.532 162.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.553 HD12 ' H ' ' A' ' 311' ' ' ILE . 4.3 mp -47.1 -38.23 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 125.121 1.368 . . . . 0.0 112.11 175.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.67 -48.99 19.98 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.878 1.671 . . . . 0.0 115.111 173.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -96.39 -21.44 17.77 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 118.749 -0.643 . . . . 0.0 111.993 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.3 tt -57.87 -52.33 65.91 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.234 1.013 . . . . 0.0 110.191 173.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -68.87 -26.61 65.21 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -70.29 -43.36 70.56 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.043 0.937 . . . . 0.0 111.594 169.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -75.24 -30.6 60.57 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.511 1.525 . . . . 0.0 113.675 -177.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.01 -42.28 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.179 0.991 . . . . 0.0 113.12 -172.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -82.77 -37.79 24.09 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.688 0.795 . . . . 0.0 112.449 175.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -57.46 -38.15 74.01 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.198 -0.939 . . . . 0.0 111.997 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -106.31 28.53 7.65 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.322 1.849 . . . . 0.0 112.616 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -89.94 118.75 29.74 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.421 -1.424 . . . . 0.0 110.866 161.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 84.41 -8.67 67.15 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.975 1.274 . . . . 0.0 115.523 172.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' TYR . . . . . 0.458 ' CE1' HD23 ' A' ' 331' ' ' LEU . 0.2 OUTLIER -60.43 171.55 1.06 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.282 1.833 . . . . 0.0 113.78 168.395 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 73.4 p -138.52 122.25 17.55 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.077 -1.015 . . . . 0.0 112.048 175.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 13.4 mt -135.54 111.3 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.714 1.206 . . . . 0.0 108.878 177.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 65.09 26.6 12.52 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.359 1.464 . . . . 0.0 112.939 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . -179.07 -131.83 1.65 Allowed Glycine 0 CA--C 1.53 1.014 0 N-CA-C 115.707 1.043 . . . . 0.0 115.707 -176.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -98.61 179.28 4.74 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.481 1.513 . . . . 0.0 111.077 -172.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 30.8 m -60.29 132.28 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 162.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' LEU . . . . . 0.458 HD23 ' CE1' ' A' ' 324' ' ' TYR . 59.7 tp -126.21 117.16 22.5 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.553 0.741 . . . . 0.0 111.147 -165.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -75.67 148.74 38.45 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.147 160.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 96.6 t -136.89 137.69 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 126.074 1.75 . . . . 0.0 108.998 -176.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -144.13 135.74 25.92 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.994 0.918 . . . . 0.0 111.952 -170.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 82.5 p -89.37 161.74 16.17 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 45.0 tttm -86.87 16.36 4.95 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 124.826 1.25 . . . . 0.0 113.219 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -82.02 -26.08 34.1 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -168.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 53.7 m 69.66 164.62 0.26 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 126.647 1.979 . . . . 0.0 114.155 -176.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 15.8 m -148.01 150.95 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 125.794 1.638 . . . . 0.0 111.358 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -147.34 -13.67 0.4 Allowed 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -72.92 128.09 34.46 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.203 -0.936 . . . . 0.0 111.367 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -109.56 -17.15 13.8 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 -170.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 22.9 t -169.73 155.62 5.98 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.622 1.569 . . . . 0.0 111.392 -173.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -88.86 -12.31 42.2 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.671 1.188 . . . . 0.0 113.02 173.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 147.34 173.03 18.12 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.485 1.517 . . . . 0.0 114.237 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -85.62 -8.07 58.47 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.022 1.329 . . . . 0.0 114.141 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -163.71 156.98 18.62 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.916 2.487 . . . . 0.0 109.262 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 15.3 m -152.62 144.77 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 127.022 2.129 . . . . 0.0 111.116 -170.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -81.55 -14.85 56.36 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.941 0.896 . . . . 0.0 113.343 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 5.3 mp -133.06 125.46 19.06 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.456 1.903 . . . . 0.0 107.721 172.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.4 133.31 27.84 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.036 2.49 . . . . 0.0 111.518 -174.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 28.0 ttt -165.21 140.45 5.2 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.041 1.736 . . . . 0.0 110.255 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -159.56 153.21 22.77 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.419 1.487 . . . . 0.0 112.328 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -150.21 18.27 0.85 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.085 1.354 . . . . 0.0 112.718 -175.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 32.5 p -87.33 152.96 53.31 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 125.319 1.448 . . . . 0.0 112.808 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -72.39 149.1 49.97 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.517 2.812 . . . . 0.0 111.315 177.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 11.0 p -163.47 142.77 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.017 1.327 . . . . 0.0 110.75 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 . . . . . 0 C--O 1.253 1.275 0 C-N-CA 124.987 1.315 . . . . 0.0 113.885 -179.095 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.916 0 N-CA-C 112.411 -0.276 . . . . 0.0 112.411 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 57.2 m -137.75 75.89 1.55 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.717 1.207 . . . . 0.0 110.367 -174.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -147.25 154.73 41.36 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.436 1.094 . . . . 0.0 112.084 -173.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 12.1 m -133.94 161.46 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 124.976 1.311 . . . . 0.0 110.963 169.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.97 139.57 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 127.343 2.257 . . . . 0.0 108.368 178.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.57 126.6 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.329 1.051 . . . . 0.0 108.961 175.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -140.15 42.5 1.93 Allowed 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -153.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -158.34 -15.31 0.07 Allowed 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 171.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 16.2 mt -52.29 133.47 42.36 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 125.641 1.577 . . . . 0.0 112.969 173.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -88.24 166.55 6.71 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.929 3.753 . . . . 0.0 110.931 172.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -60.32 -12.48 9.23 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -174.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 16.0 m -61.76 -23.47 66.2 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.289 1.036 . . . . 0.0 112.789 171.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.5 p -115.32 131.51 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 126.936 2.094 . . . . 0.0 108.958 167.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -148.5 178.2 8.82 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.109 1.764 . . . . 0.0 109.224 -171.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -38.87 -50.67 1.73 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.284 1.834 . . . . 0.0 115.932 -162.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -67.35 -44.51 78.86 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.234 0.925 . . . . 0.0 111.886 -176.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.84 -32.0 70.17 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 172.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.496 HD23 ' C ' ' A' ' 277' ' ' LEU . 4.1 tt -58.64 -45.31 89.59 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.257 1.023 . . . . 0.0 109.91 174.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -56.08 -38.3 70.49 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.577 -0.702 . . . . 0.0 112.376 173.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -69.04 -19.95 64.11 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 178.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 29.7 mt -58.19 -30.47 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 124.157 0.983 . . . . 0.0 111.707 170.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -114.19 -26.46 8.03 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.666 1.186 . . . . 0.0 113.434 -175.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 1.8 tmmt? -63.54 -20.73 65.87 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -176.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -75.0 -13.54 60.52 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 171.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 11.2 t -107.08 -33.55 7.43 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.185 1.394 . . . . 0.0 113.301 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -138.03 153.52 22.32 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.843 1.211 . . . . 0.0 114.84 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -69.45 115.25 8.49 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.707 1.203 . . . . 0.0 110.751 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 4.8 p -41.14 132.9 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 -154.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -99.09 -111.76 0.17 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.971 1.708 . . . . 0.0 110.274 174.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 -159.58 155.23 25.91 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.667 1.587 . . . . 0.0 112.456 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.23 171.31 20.44 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.132 -0.98 . . . . 0.0 112.621 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -157.59 165.6 35.1 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.828 1.251 . . . . 0.0 112.814 -173.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 23.1 t -151.01 142.78 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 127.421 2.288 . . . . 0.0 107.387 -177.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -119.52 133.09 55.83 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.224 0.61 . . . . 0.0 110.921 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 11.8 mt -86.34 164.99 16.76 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.981 0.912 . . . . 0.0 111.471 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -64.72 133.33 51.88 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 155.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -67.51 -11.88 60.47 Favored Glycine 0 N--CA 1.475 1.265 0 N-CA-C 117.385 1.714 . . . . 0.0 117.385 -153.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -79.73 0.4 30.7 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 118.556 1.178 . . . . 0.0 112.736 168.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 93.75 33.91 6.83 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 126.356 1.931 . . . . 0.0 113.584 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.32 15.38 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -157.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 21.0 p 73.27 148.0 0.09 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 127.532 2.333 . . . . 0.0 115.484 171.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 11.9 p -159.75 158.05 30.53 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 128.183 2.593 . . . . 0.0 109.022 -177.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -112.82 -50.22 0.56 Allowed Glycine 0 N--CA 1.473 1.137 0 C-N-CA 124.187 0.898 . . . . 0.0 112.844 169.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 69.1 m -44.19 120.82 2.27 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.901 1.68 . . . . 0.0 113.093 170.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -152.01 -168.22 16.05 Favored Glycine 0 N--CA 1.468 0.826 0 C-N-CA 125.047 1.308 . . . . 0.0 114.288 -173.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 30.0 p -122.65 152.75 40.19 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.101 1.76 . . . . 0.0 110.314 -174.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 1.7 t -139.46 126.19 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.353 1.061 . . . . 0.0 108.474 -170.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 19.4 t -92.57 121.0 33.58 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.819 0.847 . . . . 0.0 108.757 172.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.94 155.54 18.65 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -165.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -55.02 -53.83 50.81 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.844 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -172.85 -170.62 0.68 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 128.519 2.728 . . . . 0.0 108.805 145.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.4 mp -55.96 -34.18 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.426 1.49 . . . . 0.0 113.284 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.36 -35.61 60.46 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.293 1.219 . . . . 0.0 114.293 174.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -98.82 -35.57 10.08 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 123.703 0.627 . . . . 0.0 110.127 -173.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.5 tt -51.21 -52.32 45.59 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 126.971 2.108 . . . . 0.0 110.659 174.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -65.15 -25.27 67.67 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 119.13 0.877 . . . . 0.0 113.21 -176.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -70.64 -55.96 7.57 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.917 1.287 . . . . 0.0 110.427 169.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -63.88 -37.2 86.52 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.124 1.37 . . . . 0.0 113.351 -175.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.15 -34.01 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.446 1.098 . . . . 0.0 112.031 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -82.53 -40.82 20.47 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.054 0.942 . . . . 0.0 111.901 173.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.07 -41.69 85.99 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.224 1.01 . . . . 0.0 113.501 -175.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -106.13 -17.53 14.29 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -169.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -66.78 121.05 14.6 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.977 1.262 . . . . 0.0 109.836 168.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 91.41 -1.2 75.89 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 124.193 0.901 . . . . 0.0 114.693 -171.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -97.49 166.75 11.38 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.318 1.447 . . . . 0.0 111.446 175.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 61.7 p -138.43 127.21 23.66 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 120.11 -1.619 . . . . 0.0 112.358 -177.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 16.9 mt -137.47 106.91 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.991 0.917 . . . . 0.0 109.72 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 59.03 25.18 13.54 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.402 1.481 . . . . 0.0 112.996 175.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . -167.29 -140.61 2.94 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.807 1.194 . . . . 0.0 113.808 -169.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -96.2 179.94 4.87 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.891 0.876 . . . . 0.0 111.101 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.53 128.2 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 165.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 16.3 mt -72.37 129.46 38.42 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.042 1.337 . . . . 0.0 112.111 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -112.79 118.84 36.08 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.021 1.728 . . . . 0.0 107.3 163.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 18.0 t -127.25 138.49 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.18 1.392 . . . . 0.0 109.436 -166.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -140.37 139.96 35.44 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.622 1.169 . . . . 0.0 111.521 -177.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 32.4 t -91.15 146.98 23.38 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.27 -0.894 . . . . 0.0 112.594 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -81.09 -6.96 59.42 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.121 0.968 . . . . 0.0 112.877 170.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -144.91 132.65 21.08 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.423 1.489 . . . . 0.0 111.126 -176.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 21.7 t -168.57 161.87 11.73 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.17 0.988 . . . . 0.0 112.273 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 12.9 p -170.99 147.48 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 127.14 2.176 . . . . 0.0 109.565 -172.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -151.82 137.77 18.13 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.271 1.028 . . . . 0.0 113.349 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -163.89 143.79 8.22 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.542 2.337 . . . . 0.0 109.606 174.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -154.35 143.69 21.35 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.166 0.986 . . . . 0.0 113.348 -176.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 13.6 t -164.21 164.13 22.64 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.995 2.118 . . . . 0.0 109.523 174.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -115.11 -61.21 1.78 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.469 1.108 . . . . 0.0 112.197 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 72.92 3.42 59.93 Favored Glycine 0 CA--C 1.536 1.404 0 N-CA-C 116.552 1.381 . . . . 0.0 116.552 170.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -89.13 118.95 29.21 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.661 1.731 . . . . 0.0 112.484 -174.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -165.85 136.87 3.72 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.486 1.914 . . . . 0.0 110.391 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 13.3 p -167.95 141.77 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 125.405 1.482 . . . . 0.0 111.389 -175.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -149.77 106.22 3.51 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.362 1.865 . . . . 0.0 109.186 172.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 39.0 pt -133.63 153.02 79.99 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 125.598 1.559 . . . . 0.0 112.048 -176.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -72.32 157.42 53.49 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.55 2.833 . . . . 0.0 111.263 172.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 97.8 mtp -79.39 143.35 35.14 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.934 0.893 . . . . 0.0 112.498 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -99.77 20.56 13.93 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.004 2.122 . . . . 0.0 113.098 -178.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -78.01 -1.38 31.85 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.207 1.803 . . . . 0.0 115.577 -169.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 19.9 t -63.16 125.6 87.3 Favored Pre-proline 0 CA--C 1.55 0.978 0 O-C-N 121.276 -0.89 . . . . 0.0 111.867 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.39 158.39 32.93 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.552 2.835 . . . . 0.0 112.35 -174.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 14.9 p -162.98 140.05 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.42 1.488 . . . . 0.0 110.397 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 . . . . . 0 C--O 1.254 1.295 0 C-N-CA 125.974 1.71 . . . . 0.0 111.68 -177.783 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.158 0 CA-C-O 119.67 -0.517 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 83.6 p 62.41 5.09 1.48 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 117.869 2.544 . . . . 0.0 117.869 164.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -156.81 159.58 38.39 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 120.338 -1.477 . . . . 0.0 113.286 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.37 149.47 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 126.3 1.84 . . . . 0.0 110.957 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.79 126.41 62.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 126.842 2.057 . . . . 0.0 106.277 172.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 29.5 m -91.44 144.74 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 167.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -144.94 138.21 26.72 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.6 0.76 . . . . 0.0 112.647 -167.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 50.2 t30 96.97 -3.03 0.05 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 129.461 3.104 . . . . 0.0 114.051 175.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 82.6 mt -70.62 133.62 86.68 Favored Pre-proline 0 CA--C 1.556 1.173 0 O-C-N 120.954 -1.091 . . . . 0.0 109.491 165.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -88.95 -168.58 0.35 Allowed 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 124.396 3.397 . . . . 0.0 111.471 -174.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -52.71 -17.09 1.16 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.908 1.683 . . . . 0.0 115.249 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 7.6 t -63.47 -31.25 72.36 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.567 1.147 . . . . 0.0 113.135 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.23 137.32 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 118.712 0.687 . . . . 0.0 110.74 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -145.24 173.0 12.33 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.35 2.26 . . . . 0.0 108.554 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -48.61 -44.38 37.04 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 120.156 1.344 . . . . 0.0 114.135 -166.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -74.7 -23.75 58.65 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -79.85 -37.26 35.37 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.852 1.206 . . . . 0.0 113.166 164.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.48 -48.54 76.91 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.835 0.854 . . . . 0.0 111.044 177.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.28 -30.86 71.43 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.773 -0.579 . . . . 0.0 111.344 -178.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.47 -18.91 63.75 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.011 1.724 . . . . 0.0 114.699 172.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.416 HG23 HD12 ' A' ' 326' ' ' ILE . 56.3 mt -56.78 -42.91 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 119.52 1.055 . . . . 0.0 110.27 168.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.445 ' CE1' HG21 ' A' ' 306' ' ' VAL . 79.0 m-85 -104.96 -9.71 17.73 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -173.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -61.95 -8.56 5.32 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -175.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -57.9 -21.07 41.61 Favored 'General case' 0 CA--C 1.55 0.955 0 O-C-N 120.818 -1.176 . . . . 0.0 112.873 168.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 34.2 t -56.87 -21.85 32.52 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.505 1.522 . . . . 0.0 114.074 167.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.1 -17.37 58.16 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 126.907 2.194 . . . . 0.0 113.794 -176.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -139.35 -172.9 3.46 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.624 1.97 . . . . 0.0 109.875 173.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.41 134.56 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 120.544 -1.348 . . . . 0.0 111.294 167.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -74.25 -72.69 0.26 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.591 1.156 . . . . 0.0 112.674 -172.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -159.13 136.54 9.94 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.049 1.74 . . . . 0.0 110.888 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.45 137.89 11.75 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.326 -0.859 . . . . 0.0 112.459 -154.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -162.53 175.37 11.52 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.399 1.48 . . . . 0.0 112.499 -174.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 17.6 m -145.68 167.03 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 126.59 1.956 . . . . 0.0 110.821 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -132.12 148.11 52.46 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.643 1.577 . . . . 0.0 109.684 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.1 mp -134.88 142.05 46.49 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.642 1.177 . . . . 0.0 111.746 -177.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -79.92 179.75 7.41 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.0 0.92 . . . . 0.0 111.072 170.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -67.68 -17.8 69.46 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 121.105 -0.997 . . . . 0.0 114.589 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -88.61 -0.42 57.25 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.184 1.394 . . . . 0.0 113.569 175.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 72.65 25.07 74.99 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.066 0.841 . . . . 0.0 114.238 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 4.8 p -96.18 12.06 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -163.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 22.7 p 59.97 10.85 2.34 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 127.336 2.254 . . . . 0.0 115.132 -176.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . 0.27 1.1 t 50.47 10.07 0.05 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 129.389 3.075 . . . . 0.0 115.752 176.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 86.44 20.23 55.02 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.552 1.548 . . . . 0.0 114.531 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 95.1 p -164.37 167.99 19.08 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 120.103 1.951 . . . . 0.0 116.027 -172.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -153.78 163.6 30.91 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.303 1.906 . . . . 0.0 112.082 173.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 55.1 m -125.71 130.96 52.56 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 118.367 1.083 . . . . 0.0 110.779 -165.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.445 HG21 ' CE1' ' A' ' 281' ' ' PHE . 21.7 t -135.83 123.77 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.789 0.836 . . . . 0.0 109.455 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 66.2 m -104.07 128.26 51.67 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.077 1.351 . . . . 0.0 109.914 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.27 163.38 13.46 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 -141.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -54.21 -51.45 64.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.324 1.45 . . . . 0.0 111.688 175.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -172.86 167.33 5.16 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 128.7 2.8 . . . . 0.0 108.507 164.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.27 -30.62 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.92 0.888 . . . . 0.0 111.306 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.59 -43.7 46.54 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 171.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -95.72 -26.43 15.7 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 118.13 0.423 . . . . 0.0 111.581 -176.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 4.6 tt -53.87 -48.25 70.24 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.507 1.523 . . . . 0.0 109.973 172.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -57.81 -37.57 74.0 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -70.67 -52.43 21.19 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.515 0.726 . . . . 0.0 111.462 171.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -59.64 -34.72 73.15 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.32 1.448 . . . . 0.0 113.452 -175.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.89 -36.81 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.336 1.055 . . . . 0.0 112.382 176.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -83.66 -43.13 15.91 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.753 0.821 . . . . 0.0 112.268 173.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -58.65 -48.51 80.78 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.337 1.455 . . . . 0.0 113.898 -171.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -93.17 -18.51 22.47 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -174.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -73.74 111.89 9.32 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.598 -0.689 . . . . 0.0 110.558 177.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 101.07 -0.05 54.73 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.731 1.157 . . . . 0.0 114.414 -170.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -103.87 173.81 6.14 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.532 1.533 . . . . 0.0 111.446 174.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 30.5 p -138.03 122.94 18.94 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 120.412 -1.43 . . . . 0.0 111.933 -175.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.416 HD12 HG23 ' A' ' 280' ' ' ILE . 11.7 mt -145.02 115.09 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.636 1.174 . . . . 0.0 108.34 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 63.95 34.88 11.18 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.27 1.028 . . . . 0.0 112.565 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 167.45 -132.24 2.55 Favored Glycine 0 C--N 1.341 0.823 0 O-C-N 121.305 -0.872 . . . . 0.0 115.24 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -97.75 -174.64 2.95 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.516 1.526 . . . . 0.0 110.215 -173.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 55.1 t -58.76 126.12 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 159.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 2.2 pp -103.85 144.16 31.87 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 122.419 1.104 . . . . 0.0 112.006 -177.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -94.05 158.62 15.53 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.497 1.919 . . . . 0.0 109.931 165.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 26.3 t -136.2 132.03 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.303 1.441 . . . . 0.0 108.567 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -132.2 133.81 44.62 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.307 1.443 . . . . 0.0 109.98 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 78.0 p -94.73 154.4 17.32 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.973 -1.079 . . . . 0.0 112.154 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -80.21 70.06 6.76 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.864 0.866 . . . . 0.0 110.955 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -141.03 147.31 38.44 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.955 1.702 . . . . 0.0 111.283 -171.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 23.0 t -160.48 96.16 1.15 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.737 1.215 . . . . 0.0 109.916 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 27.6 m -142.32 14.84 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 124.887 1.275 . . . . 0.0 113.53 -172.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -70.32 149.75 47.05 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -173.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -152.16 129.89 11.61 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.11 1.764 . . . . 0.0 110.622 173.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -77.05 121.76 23.99 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.833 0.853 . . . . 0.0 112.207 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 32.8 t -165.58 141.0 5.05 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.336 1.454 . . . . 0.0 111.03 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -89.12 -14.38 36.34 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.413 1.085 . . . . 0.0 113.219 177.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 74.52 -172.75 52.21 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.987 1.28 . . . . 0.0 113.801 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -162.48 121.74 2.28 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.403 1.481 . . . . 0.0 111.244 178.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -168.64 159.05 9.72 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.261 2.224 . . . . 0.0 109.743 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 11.3 m -150.24 137.67 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 127.21 2.204 . . . . 0.0 110.648 -178.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -170.19 118.17 0.56 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.67 1.988 . . . . 0.0 109.886 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 18.0 tt -133.72 132.98 21.91 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 125.06 1.344 . . . . 0.0 111.255 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.5 154.91 35.94 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 123.217 2.611 . . . . 0.0 111.557 176.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 25.1 ptp -163.99 153.2 13.99 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.396 1.478 . . . . 0.0 112.045 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -162.49 149.69 13.58 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.651 1.58 . . . . 0.0 111.752 -176.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -154.15 66.58 0.72 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.555 1.542 . . . . 0.0 110.233 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 21.9 t -114.88 137.35 22.79 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.824 1.25 . . . . 0.0 112.577 -171.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -78.92 174.31 12.37 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 124.261 3.308 . . . . 0.0 112.515 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 25.1 m -141.28 154.19 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.564 1.546 . . . . 0.0 111.56 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.158 0 C-N-CA 125.854 1.662 . . . . 0.0 111.418 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.004 0 N-CA-C 111.905 -0.478 . . . . 0.0 111.905 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 55.9 p -148.95 26.0 0.9 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.126 0.97 . . . . 0.0 113.165 -169.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -156.15 142.48 18.4 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.765 1.226 . . . . 0.0 110.801 -175.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 29.9 m -135.24 149.97 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 125.15 1.38 . . . . 0.0 111.249 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.74 144.34 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 126.606 1.962 . . . . 0.0 107.848 169.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 17.4 m -138.57 128.63 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.452 1.501 . . . . 0.0 109.432 -177.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -141.3 158.01 44.46 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -159.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 82.35 -26.25 0.14 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 129.847 3.259 . . . . 0.0 113.938 173.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 92.2 mt -28.71 108.67 0.23 Allowed Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 126.664 1.986 . . . . 0.0 111.482 145.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -87.56 -175.64 1.54 Allowed 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.89 3.06 . . . . 0.0 111.692 177.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -56.29 -25.2 47.55 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 16.8 m -67.47 -16.8 64.41 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . 0.262 2.7 p -108.6 85.36 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 126.407 1.883 . . . . 0.0 109.671 176.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -68.19 174.48 3.88 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.877 2.071 . . . . 0.0 113.39 -174.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -54.31 -43.31 71.02 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.85 -1.156 . . . . 0.0 113.573 -177.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -59.5 -45.12 92.61 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.373 0.669 . . . . 0.0 111.388 176.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.37 -32.98 72.39 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 176.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.569 HD21 ' CG1' ' A' ' 306' ' ' VAL . 2.6 tt -62.19 -42.13 98.99 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.299 1.04 . . . . 0.0 111.258 170.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -64.55 -38.67 91.83 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.415 -0.803 . . . . 0.0 111.036 173.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -62.7 -25.21 68.05 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 177.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 30.8 mt -50.34 -51.18 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 124.667 1.187 . . . . 0.0 111.432 175.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -94.33 -29.92 14.78 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.999 0.92 . . . . 0.0 111.19 -176.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -58.35 -20.53 44.32 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -177.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -61.73 -11.42 12.01 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 172.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 7.8 t -65.95 -14.08 60.93 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 124.358 1.063 . . . . 0.0 113.606 168.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.89 -10.1 60.33 Favored Glycine 0 N--CA 1.476 1.363 0 C-N-CA 126.337 1.922 . . . . 0.0 113.718 -177.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 34.5 p-10 -138.63 166.32 24.64 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 128.312 2.645 . . . . 0.0 110.028 173.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.5 p -145.28 140.92 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 120.936 -1.102 . . . . 0.0 111.733 168.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -69.98 -79.61 0.06 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.421 1.088 . . . . 0.0 111.828 -177.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -168.16 149.41 5.11 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 127.433 2.293 . . . . 0.0 110.66 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.14 150.07 21.75 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.95 0.9 . . . . 0.0 112.027 -168.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -170.14 179.84 3.38 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 126.37 1.868 . . . . 0.0 110.731 -176.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -165.21 138.51 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 127.246 2.219 . . . . 0.0 109.78 170.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -76.86 131.25 38.51 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 163.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 14.2 mt -103.25 170.5 7.92 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.633 0.773 . . . . 0.0 112.996 -168.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -51.09 154.67 1.48 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.149 1.779 . . . . 0.0 112.701 165.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -65.41 -15.78 61.86 Favored Glycine 0 CA--C 1.536 1.361 0 N-CA-C 115.983 1.153 . . . . 0.0 115.983 -173.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -88.48 -0.01 56.76 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 119.27 1.535 . . . . 0.0 113.15 169.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.07 21.18 61.47 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.409 1.48 . . . . 0.0 114.566 173.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 63.5 t -86.89 -62.53 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 117.939 0.87 . . . . 0.0 111.938 -167.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 10.3 t -175.05 -174.13 0.74 Allowed 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.051 1.34 . . . . 0.0 111.584 -171.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -161.71 -51.71 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 127.54 2.336 . . . . 0.0 112.106 174.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 87.51 -68.14 3.16 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.807 1.194 . . . . 0.0 112.241 -178.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 34.4 p -61.97 122.54 15.73 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.52 1.128 . . . . 0.0 112.665 172.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -177.54 -141.06 3.95 Favored Glycine 0 N--CA 1.471 1.021 0 C-N-CA 125.41 1.481 . . . . 0.0 113.856 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 8.0 p -130.77 148.81 52.59 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.911 1.685 . . . . 0.0 111.624 -175.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.569 ' CG1' HD21 ' A' ' 277' ' ' LEU . 13.4 m -130.25 147.9 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.004 1.322 . . . . 0.0 110.376 169.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 38.4 m -80.15 155.97 27.2 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.469 169.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.2 159.21 29.13 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 -172.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -58.06 -51.79 68.21 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.781 1.632 . . . . 0.0 112.237 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -172.16 -178.3 2.05 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.8 2.44 . . . . 0.0 109.398 159.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 17.9 tt -56.09 -33.21 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.095 1.358 . . . . 0.0 114.29 -175.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.31 -34.19 72.02 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 175.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.47 -22.2 25.07 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 119.208 -0.425 . . . . 0.0 111.674 -161.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 7.9 mp -50.09 -50.42 48.29 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.636 1.174 . . . . 0.0 109.848 163.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -62.92 -36.05 82.11 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -172.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.34 -51.73 27.86 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.465 1.106 . . . . 0.0 111.839 170.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -67.17 -32.41 73.48 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.48 1.512 . . . . 0.0 113.548 -172.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -62.65 -31.3 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 120.949 -1.094 . . . . 0.0 112.531 -178.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -82.33 -16.16 50.27 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.204 1.002 . . . . 0.0 113.308 174.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -89.0 -42.05 12.0 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.851 1.26 . . . . 0.0 112.438 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -101.48 -21.51 14.75 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -166.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -67.27 115.13 6.59 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 119.145 0.884 . . . . 0.0 110.999 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 91.67 0.3 72.66 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.03 1.3 . . . . 0.0 114.55 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -90.75 130.59 36.72 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.687 1.243 . . . . 0.0 111.23 -178.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 22.5 p -92.26 134.51 34.82 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 120.341 -1.474 . . . . 0.0 113.261 -175.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 49.1 mt -138.16 101.78 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.416 1.087 . . . . 0.0 109.68 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 53.34 38.84 28.79 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.913 1.685 . . . . 0.0 113.224 170.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 168.56 -128.82 1.76 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.017 0.818 . . . . 0.0 112.953 -169.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -90.63 -168.46 2.1 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.62 0.768 . . . . 0.0 110.372 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 34.4 m -68.46 145.89 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 O-C-N 120.896 -1.128 . . . . 0.0 109.587 164.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 42.7 tp -83.84 141.91 31.0 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.281 1.433 . . . . 0.0 109.309 167.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -126.64 154.31 44.17 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.976 0.911 . . . . 0.0 109.376 159.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 41.1 t -136.35 127.94 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.582 1.553 . . . . 0.0 108.838 -169.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -136.04 153.21 51.42 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.901 1.28 . . . . 0.0 112.817 -167.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 89.8 p -82.78 173.97 11.39 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.216 -0.927 . . . . 0.0 112.193 172.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -59.45 165.18 2.95 Favored 'General case' 0 CA--C 1.552 1.022 0 O-C-N 121.629 -0.669 . . . . 0.0 111.996 157.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -64.43 -33.5 76.02 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -170.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 9.4 t -164.23 172.97 12.9 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.502 1.121 . . . . 0.0 112.172 178.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 57.6 t -148.34 126.83 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 127.088 2.155 . . . . 0.0 108.236 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -67.35 131.78 46.39 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.371 0.668 . . . . 0.0 112.639 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -158.25 144.6 17.35 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.301 1.441 . . . . 0.0 111.559 -174.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -158.91 161.0 36.73 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.978 1.311 . . . . 0.0 113.18 -174.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 95.9 p -167.29 -159.72 0.34 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.873 2.069 . . . . 0.0 108.872 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -64.79 -13.75 56.56 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 120.91 -1.119 . . . . 0.0 113.756 167.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 91.81 -6.4 79.58 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.525 1.536 . . . . 0.0 114.689 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -164.21 175.83 9.77 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.774 2.03 . . . . 0.0 111.918 177.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -131.91 28.07 4.54 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.111 1.765 . . . . 0.0 113.247 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 3.5 p -60.48 138.21 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.01 0.924 . . . . 0.0 112.885 -173.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -163.17 112.51 1.32 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.277 1.831 . . . . 0.0 109.668 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 7.7 tp -74.52 131.32 80.24 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.788 0.835 . . . . 0.0 111.413 -175.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.73 161.93 30.26 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 123.197 2.598 . . . . 0.0 111.461 177.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 15.5 tpt -157.57 146.43 19.6 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.887 1.275 . . . . 0.0 111.472 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -163.22 156.23 18.99 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.765 2.026 . . . . 0.0 111.805 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -155.74 111.53 3.05 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.152 1.381 . . . . 0.0 110.742 177.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 69.2 m -115.42 146.8 37.32 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 124.946 1.298 . . . . 0.0 111.627 174.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -77.0 64.4 7.75 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 124.3 3.334 . . . . 0.0 111.652 -176.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 12.9 p -69.71 138.42 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.255 1.422 . . . . 0.0 111.728 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 9.0 t30 . . . . . 0 C--O 1.252 1.228 0 C-N-CA 125.754 1.622 . . . . 0.0 111.921 -177.649 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.914 0 N-CA-C 112.375 -0.29 . . . . 0.0 112.375 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 25.4 m -169.01 170.69 8.75 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 127.135 2.174 . . . . 0.0 110.2 178.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -151.25 137.09 18.07 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 120.719 -1.238 . . . . 0.0 112.683 -175.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 25.7 m -125.47 154.35 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.183 1.393 . . . . 0.0 110.341 165.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.1 mp -115.1 134.24 58.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.998 1.719 . . . . 0.0 107.434 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 20.5 m -105.78 129.65 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.233 1.013 . . . . 0.0 109.968 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -138.95 64.27 1.48 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.318 1.447 . . . . 0.0 111.257 -162.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -169.12 -40.48 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.179 1.792 . . . . 0.0 113.07 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 48.9 mt -57.19 116.58 14.03 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 127.16 2.184 . . . . 0.0 110.221 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -91.25 -170.17 0.33 Allowed 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 124.669 3.579 . . . . 0.0 112.342 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -56.56 -25.77 53.19 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -175.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 15.7 m -72.81 -16.58 61.61 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.441 1.096 . . . . 0.0 113.958 -177.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 1.3 p -108.34 105.67 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.926 2.09 . . . . 0.0 108.047 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -79.63 168.26 19.62 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.537 1.135 . . . . 0.0 111.912 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.7 -36.29 73.99 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 120.894 -1.129 . . . . 0.0 112.62 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -68.77 -32.93 73.03 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.333 -0.854 . . . . 0.0 112.233 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.53 -39.93 77.22 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.461 -0.781 . . . . 0.0 112.438 170.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.48 HD23 ' C ' ' A' ' 277' ' ' LEU . 4.2 tt -54.33 -48.3 71.53 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.938 0.895 . . . . 0.0 109.856 170.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.83 -39.85 68.96 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.387 0.675 . . . . 0.0 112.161 175.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -68.88 -20.73 64.27 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 27.5 mt -60.13 -46.96 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 120.04 1.291 . . . . 0.0 112.259 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -98.43 -9.43 25.18 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.188 0.995 . . . . 0.0 113.429 -173.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -71.58 -0.74 11.38 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 128.23 2.612 . . . . 0.0 115.086 -177.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -61.56 -15.42 38.53 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 120.43 -1.419 . . . . 0.0 114.011 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 63.3 m -68.98 -3.35 12.59 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.678 1.591 . . . . 0.0 114.398 172.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 87.25 -52.99 4.39 Favored Glycine 0 N--CA 1.473 1.103 0 C-N-CA 126.074 1.797 . . . . 0.0 111.456 -176.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -72.16 170.23 14.44 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.31 1.044 . . . . 0.0 111.044 162.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.6 p -145.72 146.35 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.03 0.932 . . . . 0.0 111.827 164.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -77.53 -107.72 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.221 1.408 . . . . 0.0 112.158 177.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -158.38 149.25 20.55 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.3 1.84 . . . . 0.0 111.354 -171.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.31 165.65 34.26 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.478 1.111 . . . . 0.0 111.514 177.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -161.34 166.93 26.74 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.113 1.365 . . . . 0.0 111.619 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 14.8 m -145.48 153.82 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 126.516 1.926 . . . . 0.0 110.97 -171.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -106.45 117.63 34.53 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.344 1.057 . . . . 0.0 108.716 170.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 12.9 mt -89.77 160.22 16.65 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.642 0.734 . . . . 0.0 112.497 -175.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -78.77 137.46 37.75 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.753 1.221 . . . . 0.0 110.616 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -70.2 -8.03 61.14 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 116.488 1.355 . . . . 0.0 116.488 -162.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -79.78 -0.43 34.39 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 118.797 1.299 . . . . 0.0 112.699 166.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 88.55 48.48 3.95 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.429 1.49 . . . . 0.0 111.789 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 39.5 t -132.15 140.54 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.377 1.071 . . . . 0.0 110.78 -170.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 22.2 p -65.28 158.01 27.49 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.457 1.503 . . . . 0.0 114.021 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 21.7 p -139.15 -16.82 1.06 Allowed 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -168.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 67.85 -71.8 0.28 Allowed Glycine 0 N--CA 1.476 1.3 0 C-N-CA 126.26 1.886 . . . . 0.0 113.611 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 49.9 p -36.7 126.94 0.87 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.915 2.486 . . . . 0.0 113.881 167.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 176.34 -165.22 35.49 Favored Glycine 0 N--CA 1.471 1.027 0 N-CA-C 115.256 0.862 . . . . 0.0 115.256 -175.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 16.6 p -100.46 137.53 38.75 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.621 1.968 . . . . 0.0 110.893 -174.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.3 t -119.85 119.52 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.626 1.57 . . . . 0.0 107.111 172.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 53.7 m -93.81 110.16 21.82 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.774 1.229 . . . . 0.0 108.208 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.51 158.28 24.54 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -159.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -51.83 -54.17 31.9 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.675 1.19 . . . . 0.0 111.147 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -172.97 169.3 4.74 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 128.641 2.776 . . . . 0.0 109.272 161.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 19.5 tt -54.35 -29.02 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.325 1.05 . . . . 0.0 113.719 177.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.38 -37.91 62.87 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.17 1.388 . . . . 0.0 114.736 171.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -104.49 -20.88 13.56 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 7.0 tt -55.08 -51.55 66.01 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.332 1.453 . . . . 0.0 111.332 177.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -69.02 -24.16 64.16 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 33.6 mtp-105 -70.36 -44.28 68.45 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.135 0.974 . . . . 0.0 110.773 168.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -68.4 -43.26 77.67 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.215 1.406 . . . . 0.0 113.349 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 2.6 pt -70.96 -16.67 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 177.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -82.05 -40.91 21.35 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.84 0.856 . . . . 0.0 110.831 168.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -70.3 -53.74 15.56 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.451 1.1 . . . . 0.0 113.605 -178.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -90.18 -24.26 21.08 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -163.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -62.72 121.53 13.62 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 119.364 0.984 . . . . 0.0 110.244 173.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 101.82 0.32 52.23 Favored Glycine 0 CA--C 1.538 1.499 0 CA-C-O 118.833 -0.982 . . . . 0.0 115.098 -174.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -108.1 145.34 34.21 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.998 1.399 . . . . 0.0 112.032 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 62.1 m -112.59 129.15 56.47 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 120.779 -1.201 . . . . 0.0 111.974 -174.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 55.5 mt -137.33 106.95 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.298 1.039 . . . . 0.0 109.915 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 56.19 33.31 21.87 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.463 1.505 . . . . 0.0 112.95 170.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 171.78 -135.63 3.5 Favored Glycine 0 C--N 1.341 0.843 0 O-C-N 121.122 -0.986 . . . . 0.0 113.94 -168.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -99.8 165.31 11.64 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.164 0.986 . . . . 0.0 110.78 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 9.0 p -60.12 130.09 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.8 0.84 . . . . 0.0 112.771 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 35.9 mt -57.37 127.97 34.65 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.661 1.584 . . . . 0.0 113.923 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -134.02 122.57 23.2 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.527 2.731 . . . . 0.0 107.33 173.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 13.6 t -136.59 126.57 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.726 1.21 . . . . 0.0 109.476 -162.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -135.33 134.05 39.43 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.729 0.812 . . . . 0.0 111.532 -170.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 95.9 p -82.38 155.28 24.79 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.824 -1.173 . . . . 0.0 113.589 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -78.2 57.69 1.9 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.386 1.474 . . . . 0.0 111.579 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -138.37 -42.02 0.51 Allowed 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -171.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 42.9 m 66.59 20.55 10.78 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 172.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 89.0 t -87.89 125.7 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.149 1.38 . . . . 0.0 109.876 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -148.5 142.25 25.63 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.516 1.526 . . . . 0.0 112.141 -176.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 19.0 m120 65.65 99.23 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 127.734 2.414 . . . . 0.0 112.483 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -157.6 153.45 26.88 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.927 1.291 . . . . 0.0 113.079 -173.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 61.0 p -165.68 154.25 11.47 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.565 1.946 . . . . 0.0 110.845 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -77.9 -28.13 49.72 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -175.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 76.53 175.78 41.25 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.117 1.341 . . . . 0.0 115.003 175.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 33.6 t70 71.24 146.1 0.07 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 128.44 2.696 . . . . 0.0 114.78 175.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -163.48 142.28 8.09 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.669 1.987 . . . . 0.0 110.853 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 14.9 p -167.01 141.58 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.854 1.662 . . . . 0.0 110.655 -176.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 25.7 t70 75.41 123.75 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 128.213 2.605 . . . . 0.0 113.651 175.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 46.2 pt -133.25 148.99 71.31 Favored Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 125.678 1.591 . . . . 0.0 111.593 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.25 141.91 32.98 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.301 2.668 . . . . 0.0 111.235 178.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.86 166.31 15.66 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.607 1.963 . . . . 0.0 111.437 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -162.92 157.32 20.99 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.677 1.591 . . . . 0.0 112.378 -176.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -158.58 111.2 2.29 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.455 1.502 . . . . 0.0 110.445 176.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 66.2 m -115.57 146.4 36.58 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 124.813 1.245 . . . . 0.0 112.151 176.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -72.07 146.75 47.33 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.413 2.742 . . . . 0.0 111.184 177.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 14.6 p -164.26 142.4 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.086 1.354 . . . . 0.0 110.809 -177.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 . . . . . 0 C--O 1.252 1.219 0 C-N-CA 126.244 1.817 . . . . 0.0 111.683 -178.294 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.733 0 N-CA-C 112.323 -0.311 . . . . 0.0 112.323 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 69.2 p -162.13 13.88 0.08 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.553 1.541 . . . . 0.0 113.517 -177.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -139.4 166.68 23.91 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.826 2.05 . . . . 0.0 111.544 -172.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 31.0 m -138.49 153.88 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.568 1.147 . . . . 0.0 110.919 175.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 2.7 mp -103.93 134.32 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 30.7 m -107.36 132.26 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.916 1.286 . . . . 0.0 108.134 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -149.71 55.33 0.95 Allowed 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -154.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -167.58 -24.46 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.337 1.055 . . . . 0.0 113.728 172.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 52.6 mt -47.39 127.02 9.93 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 126.205 1.802 . . . . 0.0 111.311 165.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -82.78 173.28 10.45 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.879 3.053 . . . . 0.0 110.154 172.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -62.61 0.3 0.52 Allowed 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 8.3 t -65.67 -31.11 71.94 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.435 1.094 . . . . 0.0 113.089 171.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 8.0 p -83.24 130.0 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 118.457 0.571 . . . . 0.0 109.801 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -94.08 159.84 14.97 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.753 1.221 . . . . 0.0 111.16 177.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -48.62 -40.88 29.21 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -68.21 -39.35 82.43 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.458 -0.776 . . . . 0.0 111.727 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.42 -32.55 71.59 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.438 -0.789 . . . . 0.0 112.491 172.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.489 HD21 ' CG1' ' A' ' 306' ' ' VAL . 1.9 tt -62.26 -38.96 91.31 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.312 1.045 . . . . 0.0 112.0 171.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -60.5 -48.7 80.62 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.549 -0.719 . . . . 0.0 110.012 171.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -59.7 -24.43 63.96 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.26 1.424 . . . . 0.0 114.171 -175.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 9.1 mt -49.56 -39.86 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 125.117 1.367 . . . . 0.0 111.687 171.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -110.52 -35.19 6.09 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.051 1.34 . . . . 0.0 111.592 -176.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -61.31 -7.17 2.66 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.596 1.558 . . . . 0.0 113.915 174.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -44.95 -31.04 1.14 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.017 1.327 . . . . 0.0 112.955 159.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 83.5 m -64.37 -7.09 8.46 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 176.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 91.18 -3.01 79.74 Favored Glycine 0 N--CA 1.477 1.424 0 C-N-CA 125.678 1.609 . . . . 0.0 114.958 177.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -138.36 178.3 7.24 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.207 2.203 . . . . 0.0 109.496 176.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.11 142.03 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 120.458 -1.402 . . . . 0.0 112.912 177.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -83.65 -106.42 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.256 1.422 . . . . 0.0 110.161 167.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -148.69 147.0 28.39 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.848 1.659 . . . . 0.0 111.834 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.08 148.66 20.58 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.577 1.151 . . . . 0.0 111.628 -176.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -168.27 160.04 11.2 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.843 1.657 . . . . 0.0 110.943 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.68 131.71 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 126.827 2.051 . . . . 0.0 110.271 177.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -75.29 130.33 38.9 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.659 0.783 . . . . 0.0 110.534 167.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 10.4 mt -87.43 153.48 21.4 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.303 0.641 . . . . 0.0 111.392 -178.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -76.81 149.83 36.18 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.867 0.867 . . . . 0.0 112.537 -177.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -67.29 -15.74 66.07 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.801 1.191 . . . . 0.0 115.483 -176.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -81.68 0.16 39.99 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 119.059 1.429 . . . . 0.0 113.193 168.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 85.45 47.35 5.19 Favored Glycine 0 N--CA 1.469 0.889 0 C-N-CA 124.944 1.259 . . . . 0.0 113.402 171.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 35.5 m -137.54 151.18 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.658 1.183 . . . . 0.0 112.24 -176.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 10.9 m -90.04 11.69 19.94 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 -150.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 18.2 p 45.59 80.53 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 127.263 2.225 . . . . 0.0 114.16 167.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -69.36 -47.09 53.67 Favored Glycine 0 N--CA 1.472 1.069 0 O-C-N 121.692 -0.63 . . . . 0.0 113.481 -175.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 5.9 p -60.26 117.69 5.48 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.849 1.259 . . . . 0.0 110.932 164.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -179.13 -160.87 25.7 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.394 0.997 . . . . 0.0 115.336 -173.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 14.2 p -104.77 146.64 28.69 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.152 1.781 . . . . 0.0 112.867 -169.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.489 ' CG1' HD21 ' A' ' 277' ' ' LEU . 0.8 OUTLIER -145.71 137.23 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.314 1.446 . . . . 0.0 109.912 169.054 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 8.7 t -102.29 144.55 30.66 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.86 0.864 . . . . 0.0 110.993 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -104.01 158.76 16.2 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -165.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -57.34 -55.93 28.45 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.145 -1.388 . . . . 0.0 111.152 175.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -172.64 179.78 2.34 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 128.46 2.704 . . . . 0.0 108.521 161.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.23 -25.37 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.637 1.175 . . . . 0.0 112.075 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.18 -33.56 41.28 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 168.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.56 -26.07 9.66 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.315 0.646 . . . . 0.0 112.514 -174.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 6.5 tt -55.05 -49.25 72.07 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.534 1.534 . . . . 0.0 111.041 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -68.82 -30.76 69.38 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.404 -0.81 . . . . 0.0 113.042 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 33.9 mtm180 -69.62 -37.4 76.82 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 121.52 -0.737 . . . . 0.0 111.107 174.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -70.48 -47.89 58.36 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.2 1.4 . . . . 0.0 112.284 174.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 3.5 pt -68.87 -21.65 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -75.38 -31.6 60.54 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 118.822 0.737 . . . . 0.0 112.205 170.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -88.91 -53.1 4.76 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.792 0.837 . . . . 0.0 113.081 -176.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -90.14 -16.98 28.47 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -164.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -71.49 110.2 5.94 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 121.102 -0.999 . . . . 0.0 110.013 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 99.21 0.12 57.14 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 125.193 1.377 . . . . 0.0 114.537 -170.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -98.55 145.67 26.58 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.193 1.397 . . . . 0.0 111.312 175.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 18.7 p -110.19 128.43 55.48 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.25 1.02 . . . . 0.0 113.155 -173.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 18.6 mt -143.9 115.48 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.883 1.273 . . . . 0.0 109.042 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 61.73 25.81 15.6 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.924 1.29 . . . . 0.0 113.449 173.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 173.87 -134.43 2.86 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 120.996 -1.065 . . . . 0.0 114.076 -171.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -86.39 -176.14 5.76 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.824 0.849 . . . . 0.0 109.751 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 19.9 m -58.94 142.84 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 O-C-N 120.981 -1.074 . . . . 0.0 108.687 155.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 3.0 pp -98.43 143.03 29.31 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.773 0.797 . . . . 0.0 111.006 175.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -125.58 137.06 53.9 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.779 1.632 . . . . 0.0 108.953 173.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 12.5 t -118.44 137.19 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.574 1.549 . . . . 0.0 110.026 -165.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -134.81 159.25 41.97 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.755 1.622 . . . . 0.0 112.328 -171.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 35.0 t -114.9 148.25 38.88 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.412 1.085 . . . . 0.0 112.101 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -86.86 -1.06 57.5 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.749 1.22 . . . . 0.0 112.946 172.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -149.72 136.54 19.44 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.708 1.603 . . . . 0.0 111.539 -171.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 98.3 p -169.72 159.56 8.21 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.942 1.297 . . . . 0.0 112.061 172.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 20.1 m -147.92 151.92 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 125.258 1.423 . . . . 0.0 111.739 -176.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -158.0 147.11 19.46 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.451 1.5 . . . . 0.0 112.513 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -162.49 144.4 10.67 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.443 1.897 . . . . 0.0 111.268 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -156.91 148.15 22.09 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.898 1.279 . . . . 0.0 113.065 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 64.0 p -164.45 151.22 11.19 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.554 1.942 . . . . 0.0 110.824 171.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -108.07 -22.85 12.23 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -173.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 71.5 -170.92 47.69 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.48 1.038 . . . . 0.0 114.549 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -164.96 151.66 10.6 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.414 1.886 . . . . 0.0 111.975 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -165.28 158.3 16.18 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.885 2.074 . . . . 0.0 110.097 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 57.8 t -148.13 129.41 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 127.395 2.278 . . . . 0.0 108.758 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -167.37 116.64 0.82 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.313 1.845 . . . . 0.0 109.93 -177.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 35.6 mm -131.51 122.88 19.1 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 125.325 1.45 . . . . 0.0 109.77 -177.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -78.6 143.73 19.27 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.387 2.725 . . . . 0.0 110.905 175.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 24.4 ptp -166.35 151.93 8.46 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.104 1.362 . . . . 0.0 112.431 -175.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -164.09 157.46 18.23 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.181 1.792 . . . . 0.0 111.647 -178.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -143.78 11.09 1.61 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.831 2.052 . . . . 0.0 112.217 176.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 18.8 m -68.62 133.84 90.65 Favored Pre-proline 0 CA--C 1.552 1.026 0 O-C-N 120.589 -1.319 . . . . 0.0 112.712 -176.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.64 -23.9 6.66 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 123.061 2.507 . . . . 0.0 114.297 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 77.35 149.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 127.654 2.381 . . . . 0.0 113.238 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 32.2 m120 . . . . . 0 C--O 1.252 1.207 0 C-N-CA 125.977 1.711 . . . . 0.0 111.916 -176.142 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.839 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 56.2 p -152.35 21.63 0.64 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.121 0.968 . . . . 0.0 113.236 -173.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -162.64 141.98 9.12 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.138 1.375 . . . . 0.0 110.289 -174.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 15.6 m -135.91 156.82 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 125.159 1.384 . . . . 0.0 111.584 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 5.4 mp -116.13 138.32 46.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 126.858 2.063 . . . . 0.0 107.129 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 34.3 m -120.22 129.76 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.28 1.032 . . . . 0.0 109.338 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -146.17 58.5 1.22 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.779 0.8 . . . . 0.0 111.907 -157.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -164.36 -45.14 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.798 1.239 . . . . 0.0 111.471 -176.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 27.7 mt -40.12 117.53 1.32 Allowed Pre-proline 0 CA--C 1.557 1.242 0 C-N-CA 126.099 1.76 . . . . 0.0 111.496 158.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -95.33 -177.95 0.47 Allowed 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.633 3.555 . . . . 0.0 111.703 -176.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -54.44 -14.19 1.16 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.577 1.551 . . . . 0.0 115.16 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 17.1 m -65.91 -21.12 66.42 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.111 1.364 . . . . 0.0 113.987 172.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 8.2 p -101.4 132.84 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 119.428 1.013 . . . . 0.0 110.643 172.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -90.59 157.1 17.68 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.271 1.428 . . . . 0.0 111.373 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -59.59 -31.62 69.63 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 120.478 -1.389 . . . . 0.0 113.213 178.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -68.24 -34.59 76.5 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.282 -0.886 . . . . 0.0 111.042 176.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.94 -38.8 76.27 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 117.733 -1.127 . . . . 0.0 113.098 168.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.495 HD23 ' C ' ' A' ' 277' ' ' LEU . 3.9 tt -53.37 -51.25 63.11 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.84 1.2 . . . . 0.0 109.883 172.088 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -48.84 -44.52 39.61 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.138 0.975 . . . . 0.0 111.953 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -68.71 -25.49 64.79 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 21.1 mt -53.32 -45.05 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 124.627 1.171 . . . . 0.0 111.377 176.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -98.09 -34.15 10.88 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.449 1.1 . . . . 0.0 111.627 -175.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -61.17 -10.33 6.35 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.611 1.164 . . . . 0.0 113.803 173.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 15.4 tm-20 -52.23 -24.71 7.69 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.638 1.575 . . . . 0.0 113.484 165.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 87.0 m -63.82 -8.21 10.15 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 172.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 88.8 2.28 78.83 Favored Glycine 0 N--CA 1.479 1.516 0 C-N-CA 124.663 1.125 . . . . 0.0 114.777 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -138.39 -177.92 5.06 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 127.237 2.215 . . . . 0.0 108.227 172.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.6 p -132.01 146.75 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 120.828 1.649 . . . . 0.0 114.063 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -106.48 -120.03 0.24 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.27 1.828 . . . . 0.0 110.821 171.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -161.08 156.69 24.92 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.602 1.961 . . . . 0.0 112.733 -174.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.39 164.85 35.9 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.487 1.115 . . . . 0.0 113.174 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -156.64 160.03 39.01 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.279 1.832 . . . . 0.0 110.995 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 3.5 t -151.63 141.58 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.354 1.462 . . . . 0.0 109.555 -172.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -113.06 134.49 54.5 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.463 1.105 . . . . 0.0 109.515 168.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 13.9 mt -98.69 172.59 7.37 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.182 0.993 . . . . 0.0 113.037 -170.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.25 153.72 0.68 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.094 2.158 . . . . 0.0 113.277 165.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -72.09 -3.92 57.87 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.911 1.243 . . . . 0.0 115.808 -172.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -114.65 0.62 13.97 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 126.267 1.827 . . . . 0.0 111.709 168.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 94.84 8.93 58.93 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 126.345 1.926 . . . . 0.0 114.476 176.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 4.8 t -87.58 58.28 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 118.819 1.31 . . . . 0.0 111.074 -171.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 75.6 m 61.1 -168.08 0.18 Allowed 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 126.325 1.85 . . . . 0.0 114.501 170.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -167.04 -45.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 127.249 2.22 . . . . 0.0 112.276 175.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 82.08 -57.14 4.98 Favored Glycine 0 N--CA 1.472 1.042 0 C-N-CA 125.252 1.406 . . . . 0.0 112.051 -176.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 61.9 p -55.57 111.04 0.8 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.715 1.606 . . . . 0.0 112.459 169.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -139.37 -166.35 10.59 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.008 1.29 . . . . 0.0 113.996 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 93.7 m -115.99 141.63 47.87 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.528 1.931 . . . . 0.0 108.934 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 t -129.9 116.11 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 125.446 1.498 . . . . 0.0 107.412 -173.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 46.2 m -101.52 110.25 22.22 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.223 1.409 . . . . 0.0 108.176 -174.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.28 168.65 12.53 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -151.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -53.68 -65.31 0.59 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.847 1.259 . . . . 0.0 111.024 175.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -172.65 -175.73 1.37 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 129.153 2.981 . . . . 0.0 108.005 162.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 16.3 tt -55.14 -37.03 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -175.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -49.63 67.76 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -92.05 -18.82 23.06 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.439 0.296 . . . . 0.0 110.836 -174.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 57.5 tp -66.25 -47.36 73.97 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.462 0.705 . . . . 0.0 111.093 171.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -68.32 -20.87 64.78 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.342 -0.848 . . . . 0.0 113.037 178.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 35.5 mtp85 -70.61 -54.57 11.51 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.36 1.064 . . . . 0.0 111.621 162.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.03 -43.99 82.48 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.026 1.33 . . . . 0.0 113.752 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 2.6 pp -65.38 -21.35 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 177.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -82.6 -46.32 13.46 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.438 1.095 . . . . 0.0 111.199 172.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -71.57 -47.99 51.32 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -176.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -98.39 -22.26 16.16 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -163.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -67.15 120.47 13.78 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.872 -1.142 . . . . 0.0 110.494 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 92.37 -1.0 72.18 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.071 1.319 . . . . 0.0 114.95 -173.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -98.59 139.76 33.83 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.126 1.463 . . . . 0.0 111.328 177.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 23.7 p -103.15 133.99 47.33 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.136 0.975 . . . . 0.0 113.155 -174.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 56.3 mt -144.17 113.59 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.953 1.301 . . . . 0.0 108.763 -176.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 58.07 25.84 12.87 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.806 1.242 . . . . 0.0 113.832 176.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 166.37 -129.63 1.97 Allowed Glycine 0 C--N 1.342 0.905 0 C-N-CA 124.424 1.012 . . . . 0.0 113.194 -176.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -83.76 177.7 8.25 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.889 0.876 . . . . 0.0 111.099 -177.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 32.9 m -62.69 149.83 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 O-C-N 121.55 -0.718 . . . . 0.0 110.739 166.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 10.9 mt -73.35 137.18 44.59 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.186 0.994 . . . . 0.0 111.489 170.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -125.37 108.48 11.72 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.667 1.587 . . . . 0.0 107.747 167.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.84 120.96 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.27 1.428 . . . . 0.0 109.798 -165.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -139.54 162.5 34.93 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.391 1.477 . . . . 0.0 111.859 -171.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 77.8 p -145.19 159.18 43.39 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 120.869 -1.145 . . . . 0.0 113.078 -176.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -83.31 59.57 5.1 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.393 1.077 . . . . 0.0 111.981 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -160.92 149.86 16.61 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.294 1.438 . . . . 0.0 111.523 -172.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 79.2 p -166.68 167.9 14.87 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.58 1.152 . . . . 0.0 112.566 176.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 18.1 m -147.39 152.36 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 125.364 1.466 . . . . 0.0 111.89 -173.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -70.88 153.7 42.48 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.763 1.225 . . . . 0.0 113.918 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -162.33 -176.01 4.86 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.899 1.68 . . . . 0.0 111.337 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 22.7 m80 62.32 24.49 14.58 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 126.211 1.804 . . . . 0.0 114.456 174.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 22.8 t -157.15 32.78 0.29 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.814 1.246 . . . . 0.0 111.661 -168.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -113.31 0.13 14.73 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -156.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 92.9 170.86 40.22 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.278 1.418 . . . . 0.0 115.274 172.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -152.08 155.87 38.77 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.511 2.324 . . . . 0.0 110.307 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -161.95 150.46 15.21 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.869 1.667 . . . . 0.0 111.266 -177.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 14.9 p -164.0 143.29 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 126.633 1.973 . . . . 0.0 110.414 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -161.84 113.91 1.74 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.761 1.625 . . . . 0.0 109.778 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.36 149.06 71.36 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 125.936 1.694 . . . . 0.0 111.851 -176.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -71.76 149.19 53.98 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.217 2.611 . . . . 0.0 110.905 173.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 28.4 ttm -150.84 13.95 0.72 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -172.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -160.82 160.31 30.98 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.933 1.693 . . . . 0.0 111.575 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -156.88 100.48 1.9 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.046 1.738 . . . . 0.0 109.979 177.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 77.6 p -115.17 151.5 45.79 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 125.284 1.434 . . . . 0.0 112.746 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -73.14 148.83 45.08 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.491 2.794 . . . . 0.0 111.501 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 14.9 p -163.61 140.42 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.12 1.368 . . . . 0.0 110.792 -177.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.187 0 C-N-CA 125.799 1.639 . . . . 0.0 111.134 -178.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.986 0 N-CA-C 112.157 -0.377 . . . . 0.0 112.157 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 18.0 m -92.15 -10.56 38.38 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -172.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 71.83 163.61 0.27 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 127.489 2.315 . . . . 0.0 113.025 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 16.1 m -137.03 159.76 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.248 1.019 . . . . 0.0 111.069 173.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.4 mp -131.66 141.47 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 127.249 2.22 . . . . 0.0 107.469 -175.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 19.4 m -129.68 133.43 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.834 0.854 . . . . 0.0 111.086 -174.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -148.57 73.23 1.22 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.863 1.265 . . . . 0.0 112.772 -164.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -169.12 -41.68 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.627 1.571 . . . . 0.0 111.237 171.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 49.6 mt -28.17 110.92 0.24 Allowed Pre-proline 0 CA--C 1.561 1.396 0 C-N-CA 127.159 2.183 . . . . 0.0 111.415 153.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -95.64 -170.64 0.18 Allowed 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 125.238 3.959 . . . . 0.0 112.658 -175.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -58.1 -20.25 38.55 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -173.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 58.8 m -76.93 -11.6 59.83 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 176.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 1.4 p -108.51 145.56 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 126.969 2.107 . . . . 0.0 108.227 167.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -155.59 174.63 14.99 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.678 1.591 . . . . 0.0 109.638 -176.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -41.99 -49.41 4.65 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.817 1.647 . . . . 0.0 114.853 -170.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -68.52 -35.71 77.86 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 118.916 0.78 . . . . 0.0 112.18 -175.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.37 -37.75 74.64 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 168.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 7.8 tt -61.79 -35.3 77.77 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.233 0.613 . . . . 0.0 111.727 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -53.03 -52.39 58.63 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.686 0.676 . . . . 0.0 110.641 170.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -59.63 -27.99 66.82 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.041 1.336 . . . . 0.0 113.331 -175.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 32.9 mt -51.7 -45.7 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.782 1.233 . . . . 0.0 112.082 173.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -106.17 -24.6 12.29 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.164 0.986 . . . . 0.0 112.548 -174.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -64.03 -2.93 2.21 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 126.626 1.97 . . . . 0.0 114.713 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -57.82 -20.76 38.22 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 120.567 -1.333 . . . . 0.0 113.307 168.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 72.0 m -69.02 0.32 4.71 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 125.436 1.494 . . . . 0.0 114.451 170.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 100.32 -76.69 0.44 Allowed Glycine 0 C--N 1.342 0.875 0 C-N-CA 126.36 1.933 . . . . 0.0 110.876 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -73.46 175.53 6.91 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.286 1.034 . . . . 0.0 111.173 172.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.01 142.08 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 120.65 -1.281 . . . . 0.0 111.442 172.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -76.95 -96.28 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.749 1.22 . . . . 0.0 111.142 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -160.66 147.07 15.24 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.633 1.573 . . . . 0.0 111.978 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.48 172.01 19.11 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.968 -1.082 . . . . 0.0 112.185 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -158.26 153.22 25.23 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -178.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 27.2 t -157.28 136.25 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 129.476 3.11 . . . . 0.0 105.674 176.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -132.24 144.27 50.51 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.02 0.528 . . . . 0.0 111.892 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 9.1 mp -64.77 144.07 57.5 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.6 1.16 . . . . 0.0 111.755 175.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -69.79 151.41 45.8 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.864 1.266 . . . . 0.0 111.339 169.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -64.86 -11.31 49.85 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.949 1.261 . . . . 0.0 115.348 -176.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -70.49 -6.45 36.19 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 118.782 1.291 . . . . 0.0 113.151 166.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 85.74 49.19 4.42 Favored Glycine 0 C--N 1.343 0.918 0 C-N-CA 125.481 1.515 . . . . 0.0 112.367 176.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 9.5 p -155.13 143.83 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.922 0.889 . . . . 0.0 112.135 -170.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 38.3 t -68.15 170.34 8.72 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.414 1.086 . . . . 0.0 113.209 176.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 12.1 t -144.15 -25.02 0.54 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -173.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 73.98 -48.25 1.67 Allowed Glycine 0 N--CA 1.475 1.246 0 C-N-CA 125.624 1.583 . . . . 0.0 114.589 177.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 7.8 p -51.07 123.12 8.67 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.542 1.937 . . . . 0.0 112.411 168.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -168.74 -168.6 31.04 Favored Glycine 0 N--CA 1.469 0.894 0 C-N-CA 124.075 0.845 . . . . 0.0 115.177 -174.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 18.7 p -115.56 152.54 32.86 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.259 1.824 . . . . 0.0 111.073 -170.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.5 t -138.99 120.53 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.177 1.391 . . . . 0.0 108.095 -177.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 4.5 t -100.12 108.22 20.31 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.398 1.079 . . . . 0.0 108.849 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.25 162.09 22.45 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -158.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -53.91 -63.51 1.13 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.906 1.282 . . . . 0.0 111.052 174.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -172.32 -176.34 1.57 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.995 2.518 . . . . 0.0 109.533 159.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.5 mp -49.11 -39.08 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 125.605 1.562 . . . . 0.0 113.569 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.25 -42.03 66.06 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 177.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -95.21 -31.43 13.5 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 123.321 0.388 . . . . 0.0 110.617 -174.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.5 tt -55.93 -51.32 68.08 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 125.469 1.508 . . . . 0.0 110.755 175.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -61.92 -46.59 88.69 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.056 0.844 . . . . 0.0 112.516 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -70.45 -32.74 70.43 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 176.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -65.87 -38.37 88.61 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.18 0.992 . . . . 0.0 112.045 171.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -57.74 -40.86 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.653 1.181 . . . . 0.0 112.168 176.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -81.99 -24.57 35.38 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -79.27 -45.09 20.42 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.355 1.062 . . . . 0.0 112.959 -177.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -103.68 -26.18 12.86 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -167.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -65.32 116.26 6.46 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 119.682 1.128 . . . . 0.0 110.023 173.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 99.61 0.55 56.58 Favored Glycine 0 CA--C 1.538 1.486 0 CA-C-O 119.101 -0.833 . . . . 0.0 114.962 -174.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -104.27 151.7 23.09 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.795 1.638 . . . . 0.0 111.63 175.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 26.9 p -111.92 134.11 53.69 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 120.433 -1.417 . . . . 0.0 113.09 -177.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 59.3 mt -145.27 118.71 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.898 1.279 . . . . 0.0 109.604 -176.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 57.15 23.27 8.39 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.636 1.574 . . . . 0.0 114.32 173.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 170.17 -119.84 0.83 Allowed Glycine 0 C--N 1.341 0.839 0 O-C-N 120.992 -1.067 . . . . 0.0 113.029 -177.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -86.03 176.66 7.9 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.355 0.662 . . . . 0.0 111.079 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 9.4 p -57.1 138.45 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 121.655 -0.653 . . . . 0.0 109.335 155.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 1.5 pp -100.48 145.03 28.76 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.831 0.824 . . . . 0.0 111.432 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -126.28 137.9 53.55 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.038 1.735 . . . . 0.0 109.374 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 18.5 t -120.54 132.19 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.36 1.464 . . . . 0.0 109.996 -170.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -131.41 154.72 48.36 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.377 1.871 . . . . 0.0 110.652 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 79.3 p -145.14 167.37 22.9 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 120.599 -1.313 . . . . 0.0 112.754 -172.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -69.32 144.96 53.37 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.904 0.882 . . . . 0.0 111.945 176.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -157.3 -60.81 0.09 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.245 1.018 . . . . 0.0 111.34 -173.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 1.4 t 68.62 19.02 8.73 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 164.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 7.9 p -157.54 141.88 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.295 1.438 . . . . 0.0 111.123 -177.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -143.96 155.82 44.19 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.419 1.488 . . . . 0.0 112.595 -173.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -79.05 167.19 21.43 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.263 1.025 . . . . 0.0 113.111 177.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -141.95 168.56 19.47 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.674 1.589 . . . . 0.0 112.81 -175.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 19.4 m 75.84 158.62 0.21 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 127.757 2.423 . . . . 0.0 113.484 -177.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -86.06 -7.63 58.48 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -172.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 95.79 -149.06 19.2 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.221 1.391 . . . . 0.0 113.266 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -158.57 148.98 19.96 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.55 1.54 . . . . 0.0 111.875 -172.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -164.42 149.9 10.31 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.983 2.113 . . . . 0.0 110.617 -177.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 13.4 p -162.46 139.83 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.746 1.618 . . . . 0.0 110.95 -178.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -164.14 114.73 1.27 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.091 1.756 . . . . 0.0 109.91 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 1.8 mp -91.07 126.34 55.56 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 124.411 1.084 . . . . 0.0 108.785 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -73.51 143.17 34.05 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.297 2.665 . . . . 0.0 111.03 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 24.9 ptp -165.04 156.37 14.78 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.405 1.482 . . . . 0.0 112.088 -175.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -161.69 163.71 29.58 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.919 1.688 . . . . 0.0 111.228 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -151.67 104.32 3.03 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.602 1.561 . . . . 0.0 110.259 177.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 46.4 m -66.02 140.2 96.96 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 123.944 0.897 . . . . 0.0 113.033 -177.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -74.54 162.59 37.73 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.593 2.862 . . . . 0.0 111.691 176.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 96.4 t -68.83 -28.25 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.451 0.7 . . . . 0.0 111.812 178.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 8.3 t30 . . . . . 0 C--O 1.254 1.339 0 C-N-CA 126.098 1.759 . . . . 0.0 111.811 179.597 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.906 0 CA-C-O 121.025 0.236 . . . . 0.0 112.591 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 33.3 t -159.09 105.78 1.76 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.869 1.268 . . . . 0.0 110.08 -177.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -158.08 140.53 14.46 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 120.875 -1.14 . . . . 0.0 112.289 -167.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 21.2 t -126.96 140.01 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 127.33 2.252 . . . . 0.0 108.499 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.4 mp -106.79 131.04 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.736 1.614 . . . . 0.0 107.057 175.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 23.0 m -110.59 126.39 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.617 0.767 . . . . 0.0 109.232 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -148.69 59.64 1.07 Allowed 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 121.64 0.733 . . . . 0.0 112.127 -155.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -171.42 -38.26 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 126.116 1.767 . . . . 0.0 111.285 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -34.29 122.52 0.53 Allowed Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 126.637 1.975 . . . . 0.0 111.517 162.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -86.18 167.13 9.39 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.46 3.44 . . . . 0.0 110.671 175.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -60.53 -4.6 0.94 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -174.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 8.3 t -60.58 -31.05 70.2 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.606 1.163 . . . . 0.0 113.205 169.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 8.8 p -79.73 121.63 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 121.639 0.733 . . . . 0.0 111.511 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -79.15 156.68 28.14 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.965 1.306 . . . . 0.0 110.6 170.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -52.04 -37.92 55.28 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 120.804 -1.185 . . . . 0.0 113.087 178.081 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -71.42 -38.24 71.41 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.502 -0.749 . . . . 0.0 111.354 178.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.98 -26.36 64.99 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.05 -1.031 . . . . 0.0 112.651 171.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.793 HD21 HG12 ' A' ' 306' ' ' VAL . 1.8 tt -66.95 -46.93 73.22 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.623 0.769 . . . . 0.0 111.367 170.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' LYS . . . . . 0.469 ' N ' HD23 ' A' ' 277' ' ' LEU . 0.0 OUTLIER -69.26 -28.56 66.42 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.808 1.186 . . . . 0.0 111.218 177.907 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -64.99 -23.17 67.14 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.675 1.19 . . . . 0.0 113.258 173.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 41.3 mt -55.02 -51.33 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 119.226 0.921 . . . . 0.0 110.315 171.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -91.09 -18.73 24.06 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.267 1.027 . . . . 0.0 112.508 -173.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -57.17 -17.86 12.98 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.863 1.665 . . . . 0.0 114.146 176.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -57.17 -14.86 4.56 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.343 1.457 . . . . 0.0 114.146 173.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 9.3 t -66.15 -11.38 48.98 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 171.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 91.23 -3.29 79.79 Favored Glycine 0 N--CA 1.479 1.537 0 C-N-CA 125.488 1.518 . . . . 0.0 114.219 -177.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -138.53 -179.6 5.91 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.971 2.509 . . . . 0.0 108.189 171.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 5.0 p -145.78 143.3 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 120.158 1.345 . . . . 0.0 112.68 164.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -78.77 -94.73 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.529 1.532 . . . . 0.0 112.183 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -170.6 153.47 4.18 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 127.717 2.407 . . . . 0.0 110.072 -167.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.56 170.15 22.82 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.156 -0.965 . . . . 0.0 112.626 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -149.65 143.27 25.4 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.43 1.092 . . . . 0.0 113.314 -177.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 32.2 t -158.66 136.82 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 127.498 2.319 . . . . 0.0 107.999 -171.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -132.67 128.06 36.2 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.998 0.919 . . . . 0.0 110.322 170.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 12.1 mt -75.49 167.68 21.45 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 122.206 1.003 . . . . 0.0 113.631 -169.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.96 151.97 0.86 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 127.842 2.457 . . . . 0.0 113.804 167.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -70.9 -6.93 60.99 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.938 1.256 . . . . 0.0 116.082 -172.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -109.72 0.43 18.92 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.101 1.76 . . . . 0.0 111.83 169.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 95.26 8.6 58.66 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.735 2.112 . . . . 0.0 114.393 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 6.2 t -90.19 58.74 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 118.804 1.302 . . . . 0.0 111.019 -166.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 7.6 t 60.36 -163.48 0.24 Allowed 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 125.598 1.559 . . . . 0.0 114.096 172.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -166.47 143.53 5.02 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 129.041 2.937 . . . . 0.0 108.631 173.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -89.11 -76.9 1.3 Allowed Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.148 0.88 . . . . 0.0 112.086 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 32.2 p -54.92 149.34 11.74 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.372 1.469 . . . . 0.0 113.676 169.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -163.32 -177.46 36.26 Favored Glycine 0 N--CA 1.471 1.028 0 C-N-CA 125.045 1.307 . . . . 0.0 114.664 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 40.6 m -116.38 135.3 53.98 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.503 1.521 . . . . 0.0 108.623 -177.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.793 HG12 HD21 ' A' ' 277' ' ' LEU . 13.2 m -129.93 130.73 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.066 0.946 . . . . 0.0 109.181 178.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 33.0 m -90.52 115.51 27.72 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.953 0.901 . . . . 0.0 108.715 -175.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -83.59 147.54 27.67 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -163.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -49.78 -55.62 13.38 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.95 1.3 . . . . 0.0 112.573 -175.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.59 172.84 4.15 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.85 2.06 . . . . 0.0 110.039 162.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.42 -24.84 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.3 1.04 . . . . 0.0 112.422 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -45.54 69.72 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 169.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -98.18 -20.04 17.52 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.35 0.523 . . . . 0.0 111.947 -175.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -49.3 -52.15 29.5 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.066 1.747 . . . . 0.0 111.117 174.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -67.32 -29.67 69.3 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -70.49 -52.25 23.32 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.314 0.645 . . . . 0.0 110.888 170.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -59.65 -35.9 75.33 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.276 1.43 . . . . 0.0 113.004 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -50.67 -44.38 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.639 1.176 . . . . 0.0 112.393 176.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -90.39 -34.35 15.68 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 177.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -62.43 -40.08 95.4 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.994 -1.066 . . . . 0.0 113.025 -176.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -92.98 -13.39 28.82 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -62.71 115.28 4.17 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.532 -0.73 . . . . 0.0 110.189 169.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 91.93 0.18 72.01 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-O 118.935 -0.925 . . . . 0.0 114.898 -175.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -103.42 135.54 44.85 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.011 1.405 . . . . 0.0 111.5 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 30.1 p -112.82 133.48 54.79 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.411 1.084 . . . . 0.0 112.563 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -144.0 119.65 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.579 1.151 . . . . 0.0 109.015 -170.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 56.94 28.35 14.54 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.447 1.099 . . . . 0.0 113.44 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 149.18 -119.67 1.08 Allowed Glycine 0 C--N 1.343 0.964 0 C-N-CA 124.433 1.016 . . . . 0.0 113.09 -174.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -89.67 175.32 7.3 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.112 0.965 . . . . 0.0 112.239 -169.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.94 137.06 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.161 0.984 . . . . 0.0 110.014 169.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.56 124.57 24.97 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.726 0.81 . . . . 0.0 111.832 -177.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.5 113.43 24.81 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 158.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 91.4 t -105.83 121.22 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.648 1.179 . . . . 0.0 108.609 177.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -140.98 133.69 28.79 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.239 1.416 . . . . 0.0 110.042 175.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 65.2 p -82.9 166.61 18.76 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.377 -0.827 . . . . 0.0 111.811 173.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -71.58 94.12 1.28 Allowed 'General case' 0 CA--C 1.547 0.863 0 O-C-N 121.244 -0.91 . . . . 0.0 111.001 174.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -168.49 178.92 4.58 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.477 1.911 . . . . 0.0 110.185 -173.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 12.0 t -161.15 176.76 10.94 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.846 1.258 . . . . 0.0 112.05 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 14.0 p -166.84 146.14 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.303 1.841 . . . . 0.0 110.84 -171.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 35.1 p80 -133.26 8.57 4.0 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.153 1.381 . . . . 0.0 114.548 -173.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -67.35 162.57 22.6 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.86 1.264 . . . . 0.0 113.078 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -147.42 165.3 30.65 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.159 1.784 . . . . 0.0 112.664 -176.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 64.9 p -146.27 20.68 1.38 Allowed 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -165.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -67.14 -23.98 65.85 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -176.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 83.06 168.1 42.49 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.079 1.323 . . . . 0.0 114.593 174.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -160.03 26.48 0.17 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.907 1.683 . . . . 0.0 111.561 -175.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -102.19 7.04 40.99 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -154.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 58.3 t -143.2 126.74 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 126.267 1.827 . . . . 0.0 109.247 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -154.4 35.71 0.42 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.304 1.441 . . . . 0.0 111.516 -175.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 7.9 tp -133.45 138.68 31.86 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 125.854 1.661 . . . . 0.0 110.805 -173.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.31 160.96 41.32 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.015 2.477 . . . . 0.0 111.45 174.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 63.0 ttp -158.11 142.15 15.76 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.741 1.216 . . . . 0.0 111.514 -175.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -157.27 158.5 36.23 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.898 1.679 . . . . 0.0 111.4 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -153.74 1.79 0.25 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.449 2.3 . . . . 0.0 113.285 -176.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 73.3 m -67.33 139.43 94.7 Favored Pre-proline 0 CA--C 1.551 1.009 0 O-C-N 121.021 -1.049 . . . . 0.0 112.442 178.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -76.23 153.11 35.82 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.707 2.938 . . . . 0.0 111.779 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 18.3 m -147.16 149.97 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 125.445 1.498 . . . . 0.0 111.567 -178.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.252 1.226 0 C-N-CA 126.82 2.048 . . . . 0.0 111.858 -177.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.939 0 CA-C-O 121.116 0.287 . . . . 0.0 112.424 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 9.9 p -78.55 62.22 3.09 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.501 1.521 . . . . 0.0 112.788 -177.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.14 138.66 24.1 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.624 1.17 . . . . 0.0 111.029 -173.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 65.5 t -151.32 146.35 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 126.642 1.977 . . . . 0.0 108.898 -165.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 2.0 mp -131.29 136.99 56.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.026 1.731 . . . . 0.0 107.835 176.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 31.5 m -120.3 124.64 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.809 1.244 . . . . 0.0 108.797 -176.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -143.85 80.0 1.64 Allowed 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -156.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -172.27 -38.82 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.245 1.818 . . . . 0.0 111.105 169.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 59.0 mt -34.82 123.26 0.56 Allowed Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 128.362 2.665 . . . . 0.0 113.132 167.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -85.44 174.89 6.6 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.102 3.201 . . . . 0.0 111.459 173.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -53.87 -12.73 0.59 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.248 1.819 . . . . 0.0 115.832 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 41.2 t -55.3 -30.99 61.26 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.731 1.612 . . . . 0.0 113.746 171.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 8.8 p -91.57 122.62 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 119.318 0.963 . . . . 0.0 110.712 176.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -84.48 158.4 21.02 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.625 1.57 . . . . 0.0 111.147 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -49.85 -34.51 20.19 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 175.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -67.31 -38.31 84.75 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.97 -1.081 . . . . 0.0 111.04 177.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -76.8 -27.42 55.21 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 173.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 3.7 tp -53.6 -51.58 62.57 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 120.218 1.372 . . . . 0.0 109.491 166.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -55.22 -43.97 74.99 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 122.971 0.508 . . . . 0.0 111.067 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.45 -19.83 62.43 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.056 1.343 . . . . 0.0 114.505 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 66.0 mt -58.73 -29.67 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 119.293 0.951 . . . . 0.0 111.526 171.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -123.27 -23.05 4.96 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.54 1.136 . . . . 0.0 113.716 -175.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -65.97 -12.39 54.63 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.34 1.456 . . . . 0.0 113.892 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -60.51 -12.18 9.04 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 177.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 23.6 p -72.62 -8.62 56.16 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 170.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 93.13 13.37 56.28 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.203 1.382 . . . . 0.0 114.509 -177.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -138.45 176.51 8.63 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.417 1.887 . . . . 0.0 111.116 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 6.8 p -145.47 140.58 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 O-C-N 121.184 -0.948 . . . . 0.0 112.633 168.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -95.06 -99.15 0.16 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.103 1.361 . . . . 0.0 110.295 167.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -160.72 154.5 22.48 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.975 1.71 . . . . 0.0 111.959 176.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.04 149.85 21.73 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.119 -0.988 . . . . 0.0 111.894 -170.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -157.32 165.11 36.7 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.539 1.136 . . . . 0.0 113.881 -174.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 8.1 m -141.02 144.93 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 127.222 2.209 . . . . 0.0 110.525 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -108.94 129.3 55.43 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.471 1.109 . . . . 0.0 109.476 171.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -134.66 171.85 13.77 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.602 1.161 . . . . 0.0 113.098 -171.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -68.88 152.6 45.08 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.956 1.302 . . . . 0.0 113.144 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -70.61 -18.31 75.55 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.616 1.103 . . . . 0.0 115.252 -175.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -88.96 0.25 56.8 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 118.824 1.312 . . . . 0.0 112.67 169.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 92.61 10.77 60.04 Favored Glycine 0 N--CA 1.471 1.019 0 C-N-CA 125.004 1.287 . . . . 0.0 115.008 173.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 57.9 t -70.75 116.06 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 118.386 1.093 . . . . 0.0 108.613 172.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 68.5 p -76.69 177.35 7.62 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.063 1.345 . . . . 0.0 114.555 -170.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 21.0 p -145.28 139.48 27.12 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 127.03 2.132 . . . . 0.0 109.884 -170.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -94.74 -34.99 6.02 Favored Glycine 0 N--CA 1.472 1.045 0 C-N-CA 123.391 0.52 . . . . 0.0 113.822 175.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 17.6 t -55.73 111.96 1.04 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.825 1.25 . . . . 0.0 110.293 167.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -142.89 169.22 25.72 Favored Glycine 0 N--CA 1.471 0.981 0 C-N-CA 124.789 1.185 . . . . 0.0 114.919 -165.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 85.7 m -115.73 141.31 48.26 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.414 1.886 . . . . 0.0 109.086 -173.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.34 113.04 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 124.829 1.252 . . . . 0.0 109.613 -170.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 13.6 t -74.34 147.88 41.83 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 113.911 -1.495 . . . . 0.0 110.159 170.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.72 157.46 19.72 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 -169.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -59.2 -53.9 52.99 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 113.974 -1.466 . . . . 0.0 111.519 176.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -172.67 166.19 5.44 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.814 2.846 . . . . 0.0 108.498 171.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 67.5 mt -60.25 -30.57 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.027 0.931 . . . . 0.0 111.603 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.56 -43.38 45.95 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.935 1.294 . . . . 0.0 114.273 171.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -96.33 -22.34 17.26 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 6.0 tt -58.4 -52.19 66.67 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.708 1.203 . . . . 0.0 110.524 177.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -65.79 -28.88 69.34 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -70.16 -51.65 29.63 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.267 1.027 . . . . 0.0 110.978 172.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -61.73 -33.99 75.03 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.785 1.634 . . . . 0.0 113.191 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -56.92 -41.55 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.817 1.247 . . . . 0.0 112.72 177.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -82.61 -29.24 30.29 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 175.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -75.03 -45.44 41.7 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -171.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -100.26 -16.7 17.63 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -172.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 322' ' ' ASN . . . . . 0.403 ' ND2' ' H ' ' A' ' 333' ' ' VAL . 32.0 t-20 -70.35 118.62 13.39 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.437 -0.789 . . . . 0.0 110.754 178.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 102.24 0.11 50.77 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.68 1.61 . . . . 0.0 114.726 -176.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -105.47 144.24 32.52 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.941 1.371 . . . . 0.0 112.441 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 67.3 m -94.06 125.6 38.79 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.184 -0.948 . . . . 0.0 112.54 -176.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 46.5 mt -138.32 108.36 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.403 1.081 . . . . 0.0 109.427 176.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 59.48 20.31 8.72 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.77 1.628 . . . . 0.0 114.314 177.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . -168.59 -133.21 1.53 Allowed Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.157 1.36 . . . . 0.0 112.406 -176.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 49.4 p30 -98.01 -172.94 2.47 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.599 1.16 . . . . 0.0 110.282 172.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 20.4 m -58.31 131.38 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-N 119.163 0.892 . . . . 0.0 109.353 172.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 2.4 pp -91.26 138.15 31.81 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 122.378 1.085 . . . . 0.0 111.126 178.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -91.48 156.0 18.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 113.925 -1.489 . . . . 0.0 109.998 166.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.403 ' H ' ' ND2' ' A' ' 322' ' ' ASN . 18.6 t -136.93 131.68 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.953 1.701 . . . . 0.0 108.977 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -148.11 143.34 27.07 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.116 1.367 . . . . 0.0 111.366 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 83.5 p -119.09 171.7 8.08 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 120.919 -1.113 . . . . 0.0 112.503 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -77.64 -8.43 57.88 Favored 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -164.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -63.46 150.42 43.77 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.334 1.454 . . . . 0.0 113.536 -176.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 19.3 t -159.33 160.31 34.91 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.077 1.751 . . . . 0.0 110.325 173.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.422 HG22 ' H ' ' A' ' 341' ' ' ASN . 12.8 p -164.42 140.52 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.852 1.261 . . . . 0.0 111.284 -171.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -88.01 -7.45 57.04 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.721 1.208 . . . . 0.0 114.223 -176.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 341' ' ' ASN . . . . . 0.422 ' H ' HG22 ' A' ' 339' ' ' VAL . 4.9 t-20 -152.14 -144.14 0.14 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.243 1.817 . . . . 0.0 110.613 -175.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 35.6 p-80 -154.16 168.51 26.27 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.989 1.316 . . . . 0.0 113.555 -174.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 28.6 t -162.21 151.73 16.0 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.608 1.563 . . . . 0.0 110.874 -177.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -82.5 0.51 42.12 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.464 1.506 . . . . 0.0 112.592 172.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 99.79 10.21 47.26 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.738 1.637 . . . . 0.0 112.376 -162.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -85.02 -18.04 35.67 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.053 2.141 . . . . 0.0 113.737 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -78.33 57.96 2.01 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.708 1.603 . . . . 0.0 111.603 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 28.1 m -143.39 152.44 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 126.535 1.934 . . . . 0.0 111.677 -172.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -153.82 110.43 3.35 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.863 2.065 . . . . 0.0 108.516 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 8.1 tp -133.46 135.74 25.77 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 125.087 1.355 . . . . 0.0 111.141 -176.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -86.08 170.64 8.29 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.742 2.961 . . . . 0.0 111.791 175.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -136.59 144.66 44.24 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.417 1.487 . . . . 0.0 110.911 174.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -147.2 152.59 38.64 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.137 1.775 . . . . 0.0 111.202 -177.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -127.56 9.8 6.59 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.921 1.289 . . . . 0.0 113.678 -170.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 26.8 p -75.46 143.71 76.51 Favored Pre-proline 0 CA--C 1.553 1.068 0 O-C-N 120.794 -1.191 . . . . 0.0 113.059 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.53 157.64 32.44 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.773 2.982 . . . . 0.0 111.767 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 14.7 p -161.87 141.11 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.104 1.361 . . . . 0.0 110.797 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 . . . . . 0 C--O 1.254 1.307 0 C-N-CA 125.971 1.708 . . . . 0.0 111.591 -175.898 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.925 0 N-CA-C 112.655 -0.178 . . . . 0.0 112.655 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 49.0 m 70.91 -55.98 0.63 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.979 2.512 . . . . 0.0 114.534 174.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 63.09 176.65 0.15 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.65 1.98 . . . . 0.0 113.857 172.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 35.5 m -139.01 152.4 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 120.906 -1.121 . . . . 0.0 110.95 163.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 5.1 mp -118.72 138.84 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 126.024 1.729 . . . . 0.0 108.355 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 20.8 m -112.73 125.57 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.643 1.177 . . . . 0.0 107.95 172.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -142.95 46.47 1.55 Allowed 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -148.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -168.99 -26.36 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 88.1 mt -51.85 144.79 18.51 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 124.338 1.055 . . . . 0.0 111.583 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -79.74 -179.16 5.09 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.497 3.465 . . . . 0.0 111.017 178.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -62.54 -7.49 4.75 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 115.216 1.561 . . . . 0.0 115.216 -176.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 16.4 m -68.96 -17.08 63.89 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.86 1.664 . . . . 0.0 114.589 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 9.9 p -98.98 142.79 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.458 1.103 . . . . 0.0 110.482 175.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -142.53 168.33 19.99 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.722 2.009 . . . . 0.0 110.219 -177.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -46.31 -51.03 15.46 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -171.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -63.59 -36.37 83.59 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.793 0.724 . . . . 0.0 112.226 -178.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.89 -39.95 75.93 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 169.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 6.8 tt -60.06 -35.57 75.44 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.863 0.865 . . . . 0.0 111.698 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -53.79 -52.86 58.94 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.508 0.723 . . . . 0.0 111.306 169.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -62.42 -21.18 65.2 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.605 1.562 . . . . 0.0 113.561 -176.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 28.2 mt -54.9 -29.82 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 124.654 1.182 . . . . 0.0 111.992 171.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -121.29 -27.55 4.84 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.142 1.377 . . . . 0.0 112.577 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.6 -8.93 30.51 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.6 1.56 . . . . 0.0 115.005 -177.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -60.38 -15.48 26.39 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 120.348 -1.47 . . . . 0.0 114.139 172.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 71.3 m -66.37 -5.62 11.43 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 171.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 91.26 5.28 67.65 Favored Glycine 0 N--CA 1.477 1.43 0 C-N-CA 125.35 1.453 . . . . 0.0 114.54 177.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -138.43 179.3 6.55 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.904 2.481 . . . . 0.0 110.719 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.41 144.27 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 121.118 -0.989 . . . . 0.0 112.439 177.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -100.63 -114.0 0.18 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.518 1.527 . . . . 0.0 110.528 172.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -156.59 143.38 18.62 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.645 1.178 . . . . 0.0 113.475 -178.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.3 174.07 15.71 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.594 1.158 . . . . 0.0 112.06 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -159.25 152.0 21.77 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.143 1.377 . . . . 0.0 112.608 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 20.4 t -150.04 140.09 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.225 1.81 . . . . 0.0 108.203 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -132.19 135.75 46.56 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.289 1.035 . . . . 0.0 109.939 173.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 8.7 mt -91.34 158.09 16.74 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.759 0.824 . . . . 0.0 111.705 -169.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -77.86 146.43 35.68 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.706 1.203 . . . . 0.0 112.129 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -66.55 -12.67 59.42 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.095 1.331 . . . . 0.0 115.792 -174.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -74.97 -1.12 21.18 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 119.157 1.478 . . . . 0.0 113.237 166.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 87.85 38.63 7.37 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.094 1.33 . . . . 0.0 113.308 174.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 23.9 m -142.49 143.79 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 125.158 1.383 . . . . 0.0 111.732 -174.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.71 154.46 40.69 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.218 1.007 . . . . 0.0 113.114 -178.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 37.1 p -69.54 -32.14 70.79 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.076 0.951 . . . . 0.0 112.874 173.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 78.29 -61.37 3.86 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.932 1.253 . . . . 0.0 111.641 -176.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 52.2 p -60.07 146.63 42.25 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 122.471 1.129 . . . . 0.0 112.243 161.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -159.37 170.08 35.61 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.569 1.557 . . . . 0.0 113.924 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 99.0 m -119.9 142.49 48.64 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.751 1.62 . . . . 0.0 109.492 -175.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.0 t -133.54 127.62 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.689 1.596 . . . . 0.0 109.059 -170.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 14.9 t -92.92 127.85 38.57 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.916 0.886 . . . . 0.0 109.24 172.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -85.3 163.53 18.55 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -164.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -52.4 -54.44 31.94 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.776 1.23 . . . . 0.0 112.108 175.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -172.35 161.88 5.33 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 129.081 2.952 . . . . 0.0 108.375 170.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.78 -28.01 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.99 0.916 . . . . 0.0 112.02 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.54 -43.44 56.1 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 171.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -102.44 -17.55 15.76 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -176.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 4.1 tt -58.6 -50.66 73.01 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.318 1.047 . . . . 0.0 110.021 174.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -64.98 -28.12 69.3 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 45.4 mtp85 -70.01 -53.33 18.11 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.349 1.06 . . . . 0.0 111.071 169.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -60.02 -36.28 76.9 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.703 1.601 . . . . 0.0 113.264 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -53.34 -46.54 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.826 1.25 . . . . 0.0 112.482 -178.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -85.82 -37.27 19.41 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.168 0.587 . . . . 0.0 112.339 175.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -61.05 -34.42 74.85 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.193 -0.942 . . . . 0.0 113.324 -175.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -97.61 -1.51 43.61 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 175.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -60.03 111.51 1.52 Allowed 'General case' 0 CA--C 1.552 1.038 0 O-C-N 119.576 -1.952 . . . . 0.0 111.891 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 96.44 -0.01 61.36 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.462 1.506 . . . . 0.0 115.499 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.2 169.31 15.38 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 119.137 1.469 . . . . 0.0 114.576 179.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 56.0 p -138.5 124.3 19.86 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.262 1.025 . . . . 0.0 111.833 172.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 10.1 mt -138.28 116.66 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 125.147 1.379 . . . . 0.0 108.77 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 61.98 30.34 17.98 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.42 1.488 . . . . 0.0 113.271 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 173.68 -127.94 1.42 Allowed Glycine 0 C--N 1.342 0.864 0 N-CA-C 115.116 0.806 . . . . 0.0 115.116 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 42.7 p30 -110.27 -177.2 3.19 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.397 1.879 . . . . 0.0 111.376 -171.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 26.6 m -66.12 139.65 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 121.476 -0.765 . . . . 0.0 111.315 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.83 130.22 56.75 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.453 1.501 . . . . 0.0 112.29 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -72.24 154.66 40.88 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.86 148.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 47.1 t -136.45 124.34 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.295 1.438 . . . . 0.0 108.79 -174.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 58.2 mttt -146.28 141.93 27.81 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.613 1.565 . . . . 0.0 111.742 -170.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 30.2 p -89.61 167.34 13.01 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.11 1.364 . . . . 0.0 112.369 173.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -80.87 58.44 3.38 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.332 1.453 . . . . 0.0 112.351 -173.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -161.23 175.73 12.0 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.937 1.695 . . . . 0.0 112.123 -172.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 23.0 t -155.08 131.45 10.4 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.495 1.118 . . . . 0.0 111.065 176.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 61.4 t -151.13 133.77 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 125.882 1.673 . . . . 0.0 109.318 -172.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -155.01 144.57 21.35 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.863 1.265 . . . . 0.0 112.906 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -163.37 153.76 15.94 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.375 1.87 . . . . 0.0 111.477 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -147.19 147.24 30.29 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.929 1.292 . . . . 0.0 112.768 175.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 33.2 t -162.03 133.28 5.22 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.309 1.844 . . . . 0.0 109.37 171.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -79.47 -15.79 57.18 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.794 0.837 . . . . 0.0 113.162 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 77.94 -37.22 1.7 Allowed Glycine 0 CA--C 1.534 1.273 0 C-N-CA 126.438 1.97 . . . . 0.0 116.066 167.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -165.2 156.72 14.78 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.41 1.484 . . . . 0.0 112.318 -170.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -160.77 153.86 21.48 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.152 2.181 . . . . 0.0 109.731 175.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 14.6 p -167.95 147.53 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 126.569 1.947 . . . . 0.0 111.137 -170.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -158.99 113.02 2.39 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.981 1.713 . . . . 0.0 109.837 177.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 8.0 tp -133.48 136.18 26.52 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 125.61 1.564 . . . . 0.0 111.132 -176.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.4 166.51 24.13 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.371 2.714 . . . . 0.0 111.611 176.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 27.9 ttt -158.55 139.71 13.15 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.015 1.326 . . . . 0.0 111.321 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -146.55 147.43 31.12 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.393 1.877 . . . . 0.0 110.797 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -152.34 30.54 0.54 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.873 1.269 . . . . 0.0 112.444 -172.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 37.4 p -71.02 148.16 94.24 Favored Pre-proline 0 CA--C 1.553 1.07 0 O-C-N 120.793 -1.192 . . . . 0.0 113.176 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -75.73 152.13 37.09 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.623 2.882 . . . . 0.0 111.714 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 15.9 m -147.59 148.46 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.793 1.637 . . . . 0.0 110.722 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 6.4 t30 . . . . . 0 C--O 1.253 1.287 0 C-N-CA 125.786 1.634 . . . . 0.0 111.654 -177.552 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.66 157.87 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 O-C-N 121.257 -0.902 . . . . 0.0 111.495 172.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 3.7 mp -131.86 132.81 61.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 126.166 1.787 . . . . 0.0 107.235 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 36.0 m -104.43 137.27 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.212 1.005 . . . . 0.0 109.254 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -140.15 35.59 1.91 Allowed 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -157.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -160.58 -22.43 0.06 Allowed 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 12.7 mt -47.41 130.67 10.22 Favored Pre-proline 0 CA--C 1.557 1.243 0 O-C-N 120.77 -1.206 . . . . 0.0 111.341 160.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -88.44 170.29 5.66 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 124.82 3.68 . . . . 0.0 111.791 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -61.13 -8.36 3.43 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 9.1 m -68.89 -22.87 64.16 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.474 1.11 . . . . 0.0 113.121 171.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.5 p -108.6 136.69 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 126.882 2.073 . . . . 0.0 109.247 173.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -141.7 174.2 10.79 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.498 1.519 . . . . 0.0 111.447 -167.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -43.48 -50.8 6.95 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -168.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -69.14 -28.47 66.48 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 119.315 0.961 . . . . 0.0 113.014 -175.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -77.48 -40.13 44.06 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 167.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.419 HD23 ' C ' ' A' ' 277' ' ' LEU . 3.9 tt -53.16 -46.03 68.72 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.993 1.317 . . . . 0.0 109.743 175.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -46.15 -54.17 9.13 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.932 0.893 . . . . 0.0 111.586 172.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -61.75 -27.89 69.05 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.881 1.272 . . . . 0.0 113.891 -175.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 23.8 mt -53.79 -27.38 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 124.587 1.155 . . . . 0.0 112.125 172.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -118.26 -29.46 5.53 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.357 1.463 . . . . 0.0 112.309 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.8 -13.61 62.36 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.571 1.548 . . . . 0.0 113.709 176.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -57.9 -17.74 18.57 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 172.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 75.8 m -71.72 -1.85 15.34 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 173.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 89.11 14.25 60.84 Favored Glycine 0 N--CA 1.476 1.334 0 C-N-CA 124.973 1.273 . . . . 0.0 114.63 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -138.54 -178.82 5.47 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 126.811 2.044 . . . . 0.0 109.755 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.36 147.05 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 120.476 -1.39 . . . . 0.0 112.896 169.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -109.31 -114.5 0.3 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.481 1.513 . . . . 0.0 110.205 169.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -158.44 155.11 27.97 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.174 1.39 . . . . 0.0 113.081 175.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.34 171.52 20.02 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.573 1.149 . . . . 0.0 112.54 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -161.63 168.27 23.73 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.559 1.143 . . . . 0.0 113.197 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 11.7 m -140.66 158.74 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 127.951 2.5 . . . . 0.0 109.52 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -128.1 108.14 10.39 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.517 0.727 . . . . 0.0 110.521 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 8.3 mp -70.44 145.6 50.9 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.945 1.298 . . . . 0.0 111.74 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -65.14 159.11 24.19 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.747 0.819 . . . . 0.0 111.269 164.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -62.81 -17.63 58.36 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 124.333 0.968 . . . . 0.0 115.391 -177.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -81.83 -3.25 53.54 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 118.992 1.396 . . . . 0.0 113.675 170.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 84.07 21.91 56.12 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 125.106 1.336 . . . . 0.0 114.928 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 19.9 m -99.43 -6.1 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 -164.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 4.8 t 66.76 -177.11 0.2 Allowed 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 38.1 p -142.87 -35.46 0.41 Allowed 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -164.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 75.02 -57.63 2.71 Favored Glycine 0 N--CA 1.475 1.256 0 C-N-CA 124.547 1.07 . . . . 0.0 111.936 -168.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 19.2 t -40.74 118.1 0.92 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.397 1.879 . . . . 0.0 111.381 158.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -169.98 177.62 43.26 Favored Glycine 0 N--CA 1.473 1.121 0 C-N-CA 124.722 1.153 . . . . 0.0 115.193 -169.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 25.4 p -106.41 142.06 36.7 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.392 1.877 . . . . 0.0 111.497 -169.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 1.7 t -128.3 121.7 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.398 1.479 . . . . 0.0 108.789 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 42.7 m -93.82 109.82 21.49 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.962 1.305 . . . . 0.0 108.572 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.4 162.1 28.14 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -163.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -51.69 -54.86 23.62 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.42 1.088 . . . . 0.0 111.699 173.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -172.56 163.69 5.41 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 129.139 2.976 . . . . 0.0 108.551 171.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 87.8 mt -58.26 -30.74 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.048 0.939 . . . . 0.0 111.74 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.06 -40.21 57.79 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 172.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -102.25 -20.78 14.52 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.377 0.535 . . . . 0.0 112.365 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -55.08 -52.35 63.5 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.22 1.408 . . . . 0.0 110.381 174.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -64.04 -30.46 71.53 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 32.4 mtp-105 -70.33 -46.67 63.74 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.557 1.143 . . . . 0.0 111.383 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -69.18 -32.08 71.13 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.31 1.444 . . . . 0.0 113.032 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -57.92 -38.96 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.438 1.095 . . . . 0.0 112.418 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -82.49 -18.79 40.37 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -84.23 -45.91 12.39 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.224 1.01 . . . . 0.0 112.572 -177.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -100.94 -21.14 15.16 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.644 1.349 . . . . 0.0 114.644 -170.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -67.33 111.96 4.3 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.386 0.993 . . . . 0.0 109.919 171.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 99.04 0.34 57.29 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 124.59 1.09 . . . . 0.0 114.88 -171.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -94.22 168.1 11.13 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 118.938 1.369 . . . . 0.0 111.668 173.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 45.6 p -138.42 129.2 26.61 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 120.181 -1.575 . . . . 0.0 112.615 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 11.5 mt -144.63 111.3 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 124.308 1.043 . . . . 0.0 110.099 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 63.07 16.77 9.59 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.771 1.628 . . . . 0.0 114.048 173.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . -159.42 -132.84 1.42 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.969 1.271 . . . . 0.0 113.319 -171.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -95.97 -176.55 3.73 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.933 0.893 . . . . 0.0 110.279 176.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 12.1 p -55.39 131.88 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 121.259 -0.9 . . . . 0.0 108.784 152.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 1.2 pp -103.53 143.22 33.01 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.144 0.978 . . . . 0.0 110.687 -176.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -128.36 141.22 51.49 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.623 1.569 . . . . 0.0 109.33 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 17.3 t -126.66 129.88 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.068 1.347 . . . . 0.0 110.174 -164.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -129.14 169.96 14.12 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.061 1.744 . . . . 0.0 110.822 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 94.5 p -138.38 169.43 17.8 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.885 1.274 . . . . 0.0 111.833 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -176.399 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 . . . . . 0 CA--C 1.554 1.116 0 N-CA-C 112.494 0.554 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 34.2 m -137.37 151.37 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 120.977 -1.077 . . . . 0.0 112.243 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 3.2 mp -102.04 143.68 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 127.865 2.466 . . . . 0.0 108.305 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 18.9 m -126.83 140.38 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 125.695 1.598 . . . . 0.0 108.622 168.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -145.61 24.99 1.36 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -145.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -161.55 -22.54 0.05 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 84.5 mt -47.7 119.37 6.74 Favored Pre-proline 0 CA--C 1.563 1.453 0 C-N-CA 127.023 2.129 . . . . 0.0 111.585 168.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -89.33 -172.71 0.67 Allowed 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 124.986 3.791 . . . . 0.0 113.375 -176.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -54.27 -29.53 47.38 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -173.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 30.6 m -71.09 -18.06 62.56 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.374 -0.829 . . . . 0.0 112.987 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . 0.263 2.4 p -113.6 60.58 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 127.53 2.332 . . . . 0.0 109.948 176.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -62.52 175.6 0.76 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.733 1.613 . . . . 0.0 111.969 176.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -45.63 -42.25 11.13 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.803 1.641 . . . . 0.0 114.952 -174.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -68.72 -40.03 80.12 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.272 0.942 . . . . 0.0 111.696 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.66 -35.73 75.44 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 172.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.506 HD23 ' C ' ' A' ' 277' ' ' LEU . 2.2 tt -54.74 -51.55 65.29 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.18 0.9 . . . . 0.0 109.229 168.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 4.6 tmmm? -57.2 -35.96 70.26 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.575 0.75 . . . . 0.0 111.905 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -67.57 -23.89 65.45 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 175.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 18.3 mt -58.83 -51.44 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-N 119.38 0.991 . . . . 0.0 110.86 173.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -79.03 -27.5 43.21 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.226 0.61 . . . . 0.0 111.5 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -51.86 -23.27 4.59 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.177 1.391 . . . . 0.0 113.927 173.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -61.59 -13.43 21.87 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 175.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 97.5 m -73.13 -5.58 40.07 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 168.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 96.69 -12.23 66.14 Favored Glycine 0 N--CA 1.476 1.366 0 C-N-CA 126.118 1.818 . . . . 0.0 114.608 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -138.33 172.84 12.3 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.305 2.242 . . . . 0.0 108.98 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 4.8 p -145.3 145.16 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -91.8 -125.39 0.08 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 126.238 1.815 . . . . 0.0 111.807 176.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -153.31 158.01 40.95 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.787 1.635 . . . . 0.0 113.232 -175.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.57 175.96 13.0 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -172.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -159.05 168.19 27.33 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.9 2.08 . . . . 0.0 111.312 176.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 28.7 m -151.01 170.99 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 126.72 2.008 . . . . 0.0 112.722 -171.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -103.71 153.52 20.58 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.489 1.516 . . . . 0.0 112.424 174.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.8 mp -126.71 144.18 51.01 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.115 1.366 . . . . 0.0 111.902 174.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -71.14 160.49 32.77 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.946 0.898 . . . . 0.0 111.304 162.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -66.95 -12.61 60.33 Favored Glycine 0 CA--C 1.534 1.276 0 N-CA-C 115.926 1.13 . . . . 0.0 115.926 -169.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -85.67 -1.36 57.09 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.688 1.195 . . . . 0.0 113.062 172.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.86 15.31 73.18 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.146 1.355 . . . . 0.0 115.131 175.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 97.7 t -81.22 -17.72 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -168.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.4 p 75.98 171.68 0.25 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 127.319 2.248 . . . . 0.0 114.943 176.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 30.3 p -146.26 164.05 33.55 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 127.672 2.389 . . . . 0.0 107.518 172.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -94.7 -16.2 43.24 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.137 0.875 . . . . 0.0 113.862 170.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 8.7 t -55.45 121.7 9.58 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.578 1.151 . . . . 0.0 110.852 166.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 174.86 -160.39 29.43 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.211 0.91 . . . . 0.0 114.46 -171.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 20.1 p -123.55 148.19 46.56 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.845 1.658 . . . . 0.0 110.537 -172.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.9 123.48 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.134 1.774 . . . . 0.0 106.851 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 8.1 t -99.32 110.56 23.06 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.733 1.213 . . . . 0.0 108.255 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.18 165.23 16.71 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -149.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -52.12 -51.57 57.01 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.086 1.354 . . . . 0.0 111.89 174.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -172.55 166.44 5.58 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 129.813 3.245 . . . . 0.0 108.059 171.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.55 -26.82 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 123.863 0.865 . . . . 0.0 111.81 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -30.89 64.85 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 171.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -91.14 -14.48 31.05 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -168.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 10.6 mp -49.52 -49.07 47.48 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.958 0.903 . . . . 0.0 109.311 161.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -61.52 -31.77 71.78 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -172.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -75.21 -56.65 4.52 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.064 1.345 . . . . 0.0 112.039 168.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -65.92 -33.04 74.91 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.967 1.307 . . . . 0.0 114.01 -170.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.18 -27.08 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.594 1.158 . . . . 0.0 111.599 177.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -82.61 -38.82 23.06 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.788 0.835 . . . . 0.0 111.569 170.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -77.32 -41.19 41.56 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -170.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -106.35 -17.33 14.32 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -172.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -54.92 126.24 23.62 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.407 1.003 . . . . 0.0 111.025 167.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 82.77 0.31 90.05 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 119.258 -0.745 . . . . 0.0 114.383 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -97.66 162.59 13.21 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.985 1.314 . . . . 0.0 112.034 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 47.5 p -138.27 128.26 25.53 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.547 1.139 . . . . 0.0 111.468 -176.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 12.2 mt -136.05 112.85 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.038 0.935 . . . . 0.0 109.858 -177.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 56.61 27.54 12.62 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.935 1.694 . . . . 0.0 112.961 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . -176.76 -143.44 4.8 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.428 1.014 . . . . 0.0 113.754 -166.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -93.23 174.96 6.95 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.971 0.908 . . . . 0.0 111.054 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 11.4 p -58.39 141.28 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 121.645 -0.66 . . . . 0.0 110.182 163.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 1.7 pp -122.81 156.26 34.9 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 122.429 1.109 . . . . 0.0 112.804 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -122.83 166.1 15.55 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.707 1.603 . . . . 0.0 110.172 163.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.03 125.64 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 126.824 2.05 . . . . 0.0 107.466 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -141.86 133.7 27.24 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.146 0.578 . . . . 0.0 112.389 -169.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 20.0 p -110.47 153.82 24.51 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.542 1.537 . . . . 0.0 111.997 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp . . . . . 0 CA--C 1.546 0.813 0 O-C-N 121.208 -0.933 . . . . 0.0 110.908 173.728 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 31.1 m -130.99 147.37 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.978 1.711 . . . . 0.0 110.553 173.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.7 mp -97.84 140.91 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 127.461 2.305 . . . . 0.0 107.232 175.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 30.0 m -131.48 120.64 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.608 0.763 . . . . 0.0 110.388 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -147.66 77.93 1.44 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.972 0.909 . . . . 0.0 110.9 -162.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -174.36 -42.21 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 126.383 1.873 . . . . 0.0 110.732 177.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 71.3 mt -34.75 116.97 0.54 Allowed Pre-proline 0 CA--C 1.558 1.271 0 C-N-CA 127.377 2.271 . . . . 0.0 111.582 160.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -89.64 177.92 2.54 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 125.121 3.881 . . . . 0.0 112.641 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -51.36 -26.94 8.54 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 -171.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 5.5 t -76.85 -14.85 59.85 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . 0.259 1.6 p -108.28 79.88 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.938 1.695 . . . . 0.0 108.863 174.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -69.81 179.14 2.32 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.965 2.106 . . . . 0.0 112.546 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -57.05 -37.76 72.27 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 120.6 -1.313 . . . . 0.0 112.689 177.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -65.5 -37.33 86.49 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.239 -0.913 . . . . 0.0 111.321 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -71.12 -38.2 72.31 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 168.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.462 HD23 ' C ' ' A' ' 277' ' ' LEU . 5.4 tt -53.79 -45.67 70.8 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.819 1.248 . . . . 0.0 110.517 176.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -47.76 -51.77 21.1 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.483 0.713 . . . . 0.0 111.706 172.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -64.99 -22.55 67.02 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -174.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 45.0 mt -55.73 -44.98 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.271 1.028 . . . . 0.0 111.509 171.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -104.89 -22.34 13.17 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.181 0.993 . . . . 0.0 113.047 -173.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -64.93 0.15 1.32 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.426 1.89 . . . . 0.0 115.138 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -55.45 -19.05 8.24 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 120.501 -1.374 . . . . 0.0 113.834 168.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 21.8 t -56.54 -20.48 20.76 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.624 1.57 . . . . 0.0 114.072 169.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 92.3 -7.46 78.12 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.919 1.724 . . . . 0.0 113.454 -173.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -138.46 175.87 9.19 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.362 2.665 . . . . 0.0 109.116 174.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.4 p -145.12 145.24 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 120.705 -1.247 . . . . 0.0 113.136 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -79.44 -104.75 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.656 1.582 . . . . 0.0 111.877 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -152.04 146.03 25.25 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.995 1.718 . . . . 0.0 112.253 -175.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.35 166.83 31.33 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.798 0.839 . . . . 0.0 113.254 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -159.82 172.83 16.94 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.942 1.697 . . . . 0.0 111.153 -177.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 4.2 m -142.32 152.07 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.471 1.909 . . . . 0.0 111.753 -177.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -111.18 99.05 7.96 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.108 0.963 . . . . 0.0 109.765 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 8.9 mt -91.33 160.11 15.66 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.943 0.897 . . . . 0.0 112.074 -172.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -80.7 147.18 30.72 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.437 1.095 . . . . 0.0 112.445 -173.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -67.61 -13.12 62.82 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.0 1.286 . . . . 0.0 115.963 -172.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -82.36 -0.13 44.45 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 119.175 1.487 . . . . 0.0 113.152 169.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.84 61.59 1.93 Allowed Glycine 0 C--N 1.341 0.849 0 C-N-CA 125.132 1.349 . . . . 0.0 112.161 176.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 13.6 p -154.29 146.48 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.36 1.064 . . . . 0.0 111.839 -174.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 26.6 t -62.79 161.45 12.56 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.44 1.096 . . . . 0.0 113.932 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 35.9 p -146.09 -27.24 0.43 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 126.846 2.058 . . . . 0.0 114.082 -169.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 78.46 -41.07 2.04 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 126.545 2.022 . . . . 0.0 114.82 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 5.3 p -50.14 132.89 23.75 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.388 1.875 . . . . 0.0 112.828 166.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -172.59 -159.99 20.25 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 124.49 1.043 . . . . 0.0 115.475 -172.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 46.0 p -137.46 155.01 49.8 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.668 1.587 . . . . 0.0 110.638 -173.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.48 119.2 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.593 1.557 . . . . 0.0 107.44 -176.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 44.1 t -108.9 124.81 51.23 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.677 1.191 . . . . 0.0 109.128 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.18 165.63 12.52 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 -144.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -52.75 -53.9 41.43 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.081 170.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -172.91 168.43 4.95 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 129.01 2.924 . . . . 0.0 108.205 165.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 19.5 tt -57.58 -28.3 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.2 -41.38 68.54 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 172.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -94.48 -28.56 15.4 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.179 0.445 . . . . 0.0 111.44 -176.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.1 tt -52.56 -49.01 65.79 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.526 1.531 . . . . 0.0 110.089 169.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -56.69 -35.35 68.37 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -70.71 -55.98 7.43 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.324 0.65 . . . . 0.0 111.381 169.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.72 -35.26 72.4 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.568 1.547 . . . . 0.0 113.712 -174.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.71 -33.43 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.123 0.969 . . . . 0.0 112.291 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -82.58 -42.29 18.48 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.754 0.822 . . . . 0.0 111.711 172.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -64.91 -40.56 95.26 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -174.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -105.95 -10.13 16.76 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -169.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -69.13 116.26 9.37 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 121.096 -1.002 . . . . 0.0 110.542 169.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 93.46 -0.14 67.87 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.817 1.675 . . . . 0.0 114.774 -175.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -80.55 133.98 35.87 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.139 1.375 . . . . 0.0 111.279 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 16.0 p -99.6 126.7 45.64 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.072 -1.643 . . . . 0.0 111.989 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.45 96.84 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.908 0.883 . . . . 0.0 110.058 -171.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 56.84 30.12 17.28 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.279 1.432 . . . . 0.0 113.211 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 178.8 -130.86 1.61 Allowed Glycine 0 C--N 1.342 0.9 0 O-C-N 121.162 -0.961 . . . . 0.0 113.468 -171.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -90.07 178.96 6.05 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.427 0.691 . . . . 0.0 110.562 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 35.2 m -63.6 137.28 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 O-C-N 121.403 -0.811 . . . . 0.0 109.634 162.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 22.7 tp -83.02 118.95 23.87 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.402 1.481 . . . . 0.0 110.181 -175.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -94.43 143.39 26.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.749 0.82 . . . . 0.0 109.721 165.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 19.8 t -136.42 124.9 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.646 1.579 . . . . 0.0 108.418 -171.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -132.75 133.85 43.99 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.545 1.138 . . . . 0.0 111.249 -170.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 34.8 p -83.83 155.95 22.71 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.859 -1.151 . . . . 0.0 111.983 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 85.3 tttt . . . . . 0 CA--C 1.549 0.932 0 O-C-N 121.288 -0.882 . . . . 0.0 111.599 179.544 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 . . . . . 0 CA--C 1.54 0.575 0 N-CA-C 111.335 0.124 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 21.2 m -133.52 156.39 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.605 1.162 . . . . 0.0 110.324 166.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 76.4 mt -106.97 139.17 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 127.276 2.23 . . . . 0.0 107.252 -178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 19.0 m -125.54 118.36 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.317 1.047 . . . . 0.0 108.838 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -143.78 62.41 1.36 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 121.897 0.856 . . . . 0.0 112.33 -151.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -168.21 -25.64 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.533 1.133 . . . . 0.0 113.697 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 23.5 mt -61.13 136.86 94.04 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 125.741 1.616 . . . . 0.0 111.83 175.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -88.52 171.02 5.36 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 124.484 3.456 . . . . 0.0 110.758 173.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -59.98 -5.78 1.11 Allowed 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 6.3 t -59.06 -30.56 68.15 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.824 1.25 . . . . 0.0 112.938 169.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 9.0 p -89.37 123.99 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 170.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -77.92 157.05 29.92 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.724 0.81 . . . . 0.0 110.655 172.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -51.43 -37.72 50.03 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.722 -1.236 . . . . 0.0 113.285 176.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -73.72 -31.09 63.2 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.007 -1.058 . . . . 0.0 112.188 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.85 -32.56 71.02 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.184 -0.947 . . . . 0.0 112.635 167.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.52 HD21 ' CG1' ' A' ' 306' ' ' VAL . 3.1 tt -61.06 -42.44 98.49 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.218 0.917 . . . . 0.0 111.406 169.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -57.17 -46.75 82.52 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 118.785 0.721 . . . . 0.0 110.312 171.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -61.44 -23.1 65.62 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 18.7 mt -51.74 -30.23 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 124.73 1.212 . . . . 0.0 111.83 172.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -116.73 -38.33 3.48 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.275 1.43 . . . . 0.0 110.913 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -5.4 4.43 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.008 1.323 . . . . 0.0 114.142 176.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -55.53 -17.33 5.14 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 120.432 -1.418 . . . . 0.0 113.767 160.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 65.2 m -70.87 -0.72 9.73 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.032 1.333 . . . . 0.0 114.264 168.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 88.31 -58.49 4.18 Favored Glycine 0 N--CA 1.471 1.0 0 C-N-CA 126.589 2.043 . . . . 0.0 111.729 -176.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -70.14 165.21 22.52 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.857 1.263 . . . . 0.0 111.921 175.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.9 p -142.03 142.5 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 120.911 -1.118 . . . . 0.0 112.475 178.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -89.35 -96.01 0.1 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.85 1.26 . . . . 0.0 110.203 167.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -165.31 157.85 15.67 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 127.133 2.173 . . . . 0.0 111.208 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.72 159.61 35.45 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.083 -1.011 . . . . 0.0 113.667 -173.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -161.22 171.67 18.02 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.284 1.434 . . . . 0.0 113.21 -176.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 16.8 m -144.03 160.17 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 128.009 2.523 . . . . 0.0 110.244 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -132.15 99.63 4.78 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.51 0.724 . . . . 0.0 111.428 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.69 170.77 7.74 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.065 1.346 . . . . 0.0 113.338 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -74.85 153.7 38.58 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 122.766 0.426 . . . . 0.0 111.391 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -64.99 -10.84 48.73 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 124.121 0.867 . . . . 0.0 114.873 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 44.5 p30 -74.14 -12.65 60.65 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.859 1.263 . . . . 0.0 114.289 169.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 88.15 12.62 65.32 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 117.226 -1.874 . . . . 0.0 116.613 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 14.6 m -67.73 -17.18 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-N 121.408 2.604 . . . . 0.0 116.297 -172.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 3.7 t 73.54 163.65 0.27 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 126.025 1.73 . . . . 0.0 113.687 -176.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 29.1 p -151.65 136.89 17.52 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.44 1.896 . . . . 0.0 110.089 -171.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -79.98 -35.71 26.93 Favored Glycine 0 N--CA 1.47 0.93 0 O-C-N 123.246 0.341 . . . . 0.0 112.823 173.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 33.9 p -57.05 124.46 18.8 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.057 1.343 . . . . 0.0 111.878 167.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -161.53 -165.83 19.13 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.952 1.263 . . . . 0.0 113.788 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 99.1 m -130.53 138.83 50.4 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.943 1.297 . . . . 0.0 108.656 -175.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.52 ' CG1' HD21 ' A' ' 277' ' ' LEU . 8.4 m -128.45 128.11 67.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 124.442 1.097 . . . . 0.0 109.374 -175.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 36.8 m -79.87 146.93 31.94 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.669 173.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.39 146.89 35.05 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -173.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -49.65 -49.05 48.76 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.148 1.779 . . . . 0.0 112.552 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -172.24 173.31 4.27 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 128.13 2.572 . . . . 0.0 108.466 159.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 15.1 tt -62.27 -24.06 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -177.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.7 -42.69 65.04 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.267 1.427 . . . . 0.0 114.161 168.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -98.32 -20.34 17.25 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -175.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 6.7 tt -60.26 -52.63 64.47 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.838 1.255 . . . . 0.0 111.109 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -73.3 -20.78 60.73 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.017 -1.052 . . . . 0.0 113.247 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -70.66 -44.98 65.95 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.198 0.999 . . . . 0.0 111.682 166.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -73.16 -38.62 66.14 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.783 1.633 . . . . 0.0 113.284 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 2.5 pp -64.09 -22.21 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 121.147 -0.971 . . . . 0.0 113.556 176.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -82.31 -23.23 35.26 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.958 0.903 . . . . 0.0 112.951 169.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -89.44 -47.17 8.18 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.153 1.381 . . . . 0.0 112.968 -175.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -90.56 -30.01 17.5 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -172.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -65.85 118.18 9.31 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 121.245 -0.909 . . . . 0.0 110.28 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 96.69 -1.98 62.04 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.269 0.937 . . . . 0.0 115.265 -173.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -92.16 173.89 7.59 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.05 1.425 . . . . 0.0 111.097 169.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 60.0 p -138.57 129.7 26.99 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 119.83 -1.793 . . . . 0.0 112.395 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 18.9 mt -143.21 116.73 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 124.305 1.042 . . . . 0.0 109.58 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 59.49 18.96 7.39 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 125.633 1.573 . . . . 0.0 114.357 175.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . -177.55 -131.47 1.53 Allowed Glycine 0 CA--C 1.527 0.83 0 O-C-N 120.98 -1.075 . . . . 0.0 114.301 -173.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -94.96 -178.81 4.62 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.448 1.099 . . . . 0.0 110.929 -176.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 10.4 p -61.44 125.52 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 121.513 -0.742 . . . . 0.0 110.714 169.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 88.4 mt -62.9 132.85 53.49 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.174 1.79 . . . . 0.0 111.753 176.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -132.81 120.94 22.24 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.027 1.731 . . . . 0.0 108.19 174.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 15.1 t -129.31 125.38 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.72 1.208 . . . . 0.0 109.915 -160.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -142.94 171.19 14.38 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.447 1.499 . . . . 0.0 111.476 -171.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 90.3 p -145.29 152.75 40.42 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.147 -1.596 . . . . 0.0 112.842 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 62.8 tttm . . . . . 0 CA--C 1.549 0.914 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.501 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 . . . . . 0 CA--C 1.538 0.51 0 CA-C-O 121.415 0.626 . . . . 0.0 111.79 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 35.7 m -132.05 159.94 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 126.262 1.825 . . . . 0.0 110.052 170.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 5.0 mp -124.08 130.67 73.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.184 1.794 . . . . 0.0 106.95 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 29.3 m -99.48 138.11 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 170.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -150.01 78.37 1.34 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.053 0.541 . . . . 0.0 112.281 -165.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -176.71 -34.83 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.227 1.411 . . . . 0.0 113.649 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 74.2 mt -62.99 140.5 97.63 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 125.613 1.565 . . . . 0.0 111.711 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -83.1 177.17 6.84 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 124.8 3.667 . . . . 0.0 112.013 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -57.89 -7.42 0.74 Allowed 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 -176.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 4.0 t -62.65 -31.5 72.39 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.217 -0.927 . . . . 0.0 112.318 170.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 3.7 p -84.05 133.06 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.651 0.739 . . . . 0.0 109.915 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -137.71 167.11 22.37 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.53 1.932 . . . . 0.0 109.144 -176.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -43.74 -50.63 7.6 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -168.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -68.5 -36.17 78.52 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.635 -0.666 . . . . 0.0 111.987 -175.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.83 -38.36 76.5 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.483 -0.761 . . . . 0.0 112.977 169.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 8.1 tt -63.08 -37.41 87.09 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.129 0.972 . . . . 0.0 111.531 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -53.3 -53.5 50.0 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.483 0.713 . . . . 0.0 110.606 168.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -60.93 -25.26 66.66 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.139 1.376 . . . . 0.0 113.672 -173.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 29.8 mt -49.83 -40.32 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 124.351 1.06 . . . . 0.0 111.686 171.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -111.5 -31.63 6.96 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.009 1.323 . . . . 0.0 112.215 -175.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -63.24 -2.99 1.6 Allowed 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.698 1.599 . . . . 0.0 113.493 170.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -51.79 -27.7 13.1 Favored 'General case' 0 CA--C 1.55 0.979 0 O-C-N 120.699 -1.251 . . . . 0.0 112.449 160.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 96.5 m -66.95 -1.69 4.36 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 169.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 86.71 -51.03 4.28 Favored Glycine 0 N--CA 1.473 1.148 0 C-N-CA 126.303 1.906 . . . . 0.0 113.059 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -71.79 169.88 14.79 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.65 1.18 . . . . 0.0 111.16 171.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.0 p -139.88 144.14 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 120.59 -1.319 . . . . 0.0 112.925 174.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -101.01 -108.72 0.22 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.671 1.589 . . . . 0.0 110.608 172.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -158.47 149.42 20.55 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.582 1.553 . . . . 0.0 112.267 -176.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.43 175.42 13.72 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.107 -0.996 . . . . 0.0 112.964 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -154.39 153.62 31.9 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -174.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 50.7 t -158.0 135.82 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 129.055 2.942 . . . . 0.0 106.893 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -132.53 146.43 51.9 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.657 0.783 . . . . 0.0 110.667 171.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 4.7 mt -92.75 142.98 26.75 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.458 0.647 . . . . 0.0 111.587 -171.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -72.73 144.06 47.79 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.967 1.307 . . . . 0.0 111.036 171.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -66.91 -9.98 54.57 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.15 1.357 . . . . 0.0 116.209 -171.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -75.4 -2.13 27.14 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 119.321 1.561 . . . . 0.0 113.045 165.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 86.9 44.49 5.71 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.58 1.562 . . . . 0.0 112.48 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 53.9 t -136.47 129.1 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.384 1.073 . . . . 0.0 110.656 -169.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 22.1 m -81.28 141.14 34.38 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -177.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 67.9 p -78.93 104.49 9.6 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.604 0.762 . . . . 0.0 109.102 171.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -69.82 -36.83 74.97 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 111.952 -0.459 . . . . 0.0 111.952 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 27.4 m -66.46 111.22 3.46 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.148 0.979 . . . . 0.0 110.76 161.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -131.65 165.31 23.36 Favored Glycine 0 N--CA 1.474 1.21 0 C-N-CA 124.765 1.174 . . . . 0.0 114.892 -173.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.74 146.02 24.46 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 126.562 1.945 . . . . 0.0 110.902 178.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -140.68 138.91 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.821 1.648 . . . . 0.0 108.259 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 26.9 t -116.33 132.4 56.68 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.127 0.971 . . . . 0.0 110.888 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.63 156.8 16.85 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 -158.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -55.73 -52.72 62.94 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 113.934 -1.484 . . . . 0.0 111.179 171.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -172.9 170.31 4.57 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 129.061 2.944 . . . . 0.0 108.623 170.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 10.7 tp -57.7 -30.87 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.954 0.901 . . . . 0.0 113.323 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -46.66 78.94 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.831 0.852 . . . . 0.0 113.11 171.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -84.43 -25.04 29.29 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 119.581 -0.247 . . . . 0.0 110.819 -175.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 4.9 tt -60.14 -45.64 92.35 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.845 1.258 . . . . 0.0 109.725 171.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -67.27 -25.54 66.11 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 171.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 21.3 mmm-85 -70.33 -43.1 70.97 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.962 1.255 . . . . 0.0 111.649 166.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -68.84 -38.42 79.81 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.675 1.59 . . . . 0.0 113.073 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 2.6 pp -69.56 -19.94 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 171.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -82.41 -42.59 18.4 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.62 1.168 . . . . 0.0 111.879 170.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -76.51 -53.4 8.14 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -105.62 -19.99 13.6 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -159.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -67.43 113.69 5.5 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 119.269 0.94 . . . . 0.0 109.423 172.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 97.65 -0.26 59.47 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.692 1.615 . . . . 0.0 114.962 -171.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -100.38 149.58 23.49 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.966 1.383 . . . . 0.0 111.472 176.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 23.1 p -113.42 128.29 56.4 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.108 0.963 . . . . 0.0 113.269 -173.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 15.2 mt -147.95 122.65 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.754 1.622 . . . . 0.0 107.943 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 59.18 37.66 23.83 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.364 1.065 . . . . 0.0 113.133 -177.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 140.36 -111.13 0.72 Allowed Glycine 0 N--CA 1.47 0.942 0 C-N-CA 124.449 1.023 . . . . 0.0 114.085 171.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -84.58 177.03 8.23 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.52 0.728 . . . . 0.0 111.008 -170.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 17.9 m -63.77 142.59 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 159.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 3.1 pp -99.52 144.86 28.13 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.74 0.781 . . . . 0.0 111.922 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -105.61 165.58 11.06 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.117 1.767 . . . . 0.0 109.205 162.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 26.6 t -136.16 120.3 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.718 1.607 . . . . 0.0 109.204 -174.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -122.69 170.39 10.1 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.239 1.815 . . . . 0.0 110.841 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 32.2 t -145.19 155.63 43.38 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 120.218 -1.551 . . . . 0.0 112.058 177.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 15.3 tptm . . . . . 0 CA--C 1.552 1.054 0 C-N-CA 125.0 1.32 . . . . 0.0 113.215 179.493 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 . . . . . 0 N--CA 1.47 0.544 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 30.1 m -143.26 164.7 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 126.166 1.787 . . . . 0.0 110.624 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.6 mp -116.97 145.85 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 127.437 2.295 . . . . 0.0 107.446 173.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 19.2 m -118.62 146.19 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.43 1.092 . . . . 0.0 110.488 171.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -150.52 153.63 36.17 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.289 1.036 . . . . 0.0 113.135 -163.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 28.1 t30 83.91 -23.03 0.2 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 128.999 2.919 . . . . 0.0 114.259 176.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 47.8 mt -28.91 116.58 0.28 Allowed Pre-proline 0 CA--C 1.563 1.454 0 C-N-CA 126.495 1.918 . . . . 0.0 111.285 144.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -81.81 -175.52 2.61 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 125.107 3.871 . . . . 0.0 112.95 -173.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -61.92 -12.91 20.36 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 -176.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 16.1 m -85.27 -10.04 56.97 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.96 1.304 . . . . 0.0 114.12 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -108.72 127.43 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 126.704 2.002 . . . . 0.0 109.609 177.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -136.74 -177.26 4.66 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.175 2.19 . . . . 0.0 110.407 -173.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -43.76 -51.15 7.46 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.426 1.49 . . . . 0.0 114.595 -176.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -63.47 -38.04 89.61 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.076 0.853 . . . . 0.0 112.293 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.31 -41.66 73.02 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 170.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.459 HD23 ' C ' ' A' ' 277' ' ' LEU . 5.8 tt -55.65 -43.31 76.12 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.89 1.276 . . . . 0.0 110.719 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -46.8 -58.46 3.88 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.321 1.049 . . . . 0.0 111.643 171.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -61.19 -24.19 66.14 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.489 1.515 . . . . 0.0 113.293 -175.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 34.9 mt -52.14 -40.41 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 119.861 1.209 . . . . 0.0 111.185 172.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -102.02 -29.58 11.7 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.867 1.267 . . . . 0.0 111.718 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 23.7 tptt -70.16 -18.09 63.2 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.148 1.379 . . . . 0.0 113.553 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -61.07 -18.73 59.45 Favored 'General case' 0 CA--C 1.551 1.011 0 O-C-N 120.323 -1.486 . . . . 0.0 113.281 168.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 10.4 t -66.18 -11.03 47.04 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 124.709 1.203 . . . . 0.0 113.837 171.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 100.45 -8.94 58.85 Favored Glycine 0 N--CA 1.475 1.272 0 C-N-CA 125.973 1.749 . . . . 0.0 114.099 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -138.47 143.12 39.47 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.943 1.697 . . . . 0.0 109.936 172.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.9 p -89.54 141.26 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.176 0.99 . . . . 0.0 111.301 -177.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -83.52 -128.84 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.206 1.402 . . . . 0.0 110.583 170.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -157.64 162.22 38.67 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 127.457 2.303 . . . . 0.0 110.327 169.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -155.43 165.79 35.54 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.936 -1.103 . . . . 0.0 113.651 -170.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -147.69 137.26 22.58 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.609 1.564 . . . . 0.0 111.822 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 22.6 t -154.9 137.76 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.771 2.028 . . . . 0.0 108.375 -174.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -132.49 123.01 25.77 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.09 0.956 . . . . 0.0 110.097 170.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 18.8 mt -89.63 161.73 15.98 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.677 0.791 . . . . 0.0 112.948 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -74.03 139.04 44.46 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.481 1.112 . . . . 0.0 110.728 177.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -68.8 -8.99 58.46 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 116.59 1.396 . . . . 0.0 116.59 -163.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -78.53 -2.07 36.96 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 118.879 1.34 . . . . 0.0 112.791 166.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 89.03 46.63 4.41 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 125.519 1.533 . . . . 0.0 112.133 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.06 128.81 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.508 1.123 . . . . 0.0 110.896 -168.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 51.8 m -61.22 146.34 48.09 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.026 1.73 . . . . 0.0 114.449 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 29.4 p -84.79 -32.02 23.59 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.12 1.368 . . . . 0.0 112.895 172.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 77.78 -60.81 3.73 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.911 1.243 . . . . 0.0 111.433 -171.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 59.3 p -67.3 154.99 40.02 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.16 1.784 . . . . 0.0 113.393 167.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -167.05 171.31 41.81 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.802 1.192 . . . . 0.0 114.773 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 94.8 m -106.85 146.18 31.25 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.833 1.653 . . . . 0.0 110.092 -174.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 1.1 t -134.6 135.0 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.143 1.777 . . . . 0.0 109.292 -175.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 8.2 m -109.39 119.76 40.45 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.17 1.788 . . . . 0.0 108.347 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.45 164.49 25.4 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -157.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -56.09 -47.0 78.84 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.784 173.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -172.39 162.07 5.32 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 129.746 3.218 . . . . 0.0 108.921 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.56 HD12 ' H ' ' A' ' 311' ' ' ILE . 4.5 mp -62.19 -31.4 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.99 0.916 . . . . 0.0 111.823 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.62 -43.4 62.56 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 177.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -97.91 -14.97 20.36 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -176.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.8 tt -55.41 -51.6 66.32 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.178 1.391 . . . . 0.0 110.828 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -66.91 -29.33 69.18 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 39.1 mtp85 -70.16 -51.05 34.3 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.653 1.181 . . . . 0.0 111.126 170.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -63.07 -32.98 74.48 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.982 1.713 . . . . 0.0 113.524 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -54.83 -39.17 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.213 1.405 . . . . 0.0 112.051 177.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -82.67 -39.19 22.39 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.217 0.607 . . . . 0.0 112.055 174.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -65.51 -49.05 70.41 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -171.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -85.87 -20.84 28.48 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -176.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -67.19 113.69 5.33 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.415 -0.803 . . . . 0.0 110.03 173.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 101.03 0.07 54.86 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.29 0.947 . . . . 0.0 114.864 -173.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -94.21 168.83 10.67 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 118.962 1.381 . . . . 0.0 111.742 172.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 55.3 p -138.22 127.06 23.83 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 120.399 -1.438 . . . . 0.0 112.671 -175.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 22.6 mt -143.53 125.13 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.688 1.195 . . . . 0.0 109.487 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 59.49 20.73 9.16 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.7 1.6 . . . . 0.0 114.217 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 170.78 -118.49 0.75 Allowed Glycine 0 C--N 1.342 0.893 0 O-C-N 121.004 -1.06 . . . . 0.0 114.935 -178.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -96.48 178.13 5.45 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.8 0.84 . . . . 0.0 111.081 -171.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 12.6 p -52.64 137.49 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 O-C-N 121.879 -0.513 . . . . 0.0 109.948 157.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 2.1 pp -112.98 147.53 36.95 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.475 1.11 . . . . 0.0 112.195 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -104.56 157.45 17.16 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.176 1.39 . . . . 0.0 110.475 170.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 16.6 t -133.91 135.64 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.242 1.417 . . . . 0.0 109.313 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -149.29 159.57 44.15 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.819 1.248 . . . . 0.0 111.515 -171.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 23.0 t -144.39 151.7 39.65 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 120.59 -1.319 . . . . 0.0 111.099 172.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt . . . . . 0 N--CA 1.478 0.948 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -174.397 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 35.3 m -134.28 157.72 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.197 0.999 . . . . 0.0 111.454 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 3.8 mp -131.82 140.29 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 126.258 1.823 . . . . 0.0 107.485 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 28.0 m -123.74 125.79 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.796 0.838 . . . . 0.0 109.984 -177.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -142.08 66.84 1.33 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.301 1.44 . . . . 0.0 111.82 -160.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -170.61 -44.67 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.957 1.703 . . . . 0.0 111.069 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 33.1 mt -40.09 119.26 1.45 Allowed Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 126.98 2.112 . . . . 0.0 112.327 165.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -94.06 -174.54 0.39 Allowed 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 124.505 3.47 . . . . 0.0 111.593 -176.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -51.32 -18.23 0.93 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.449 1.9 . . . . 0.0 115.379 177.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 15.8 m -64.68 -21.5 66.75 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.324 1.45 . . . . 0.0 113.879 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 5.4 p -105.72 148.54 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.742 1.217 . . . . 0.0 109.816 169.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -127.26 168.13 15.17 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.171 1.389 . . . . 0.0 111.549 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -54.1 -40.87 67.68 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -167.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -68.98 -37.75 78.94 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.482 -0.761 . . . . 0.0 111.687 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.47 -33.52 73.03 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 171.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 7.2 tt -60.48 -43.39 97.0 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.939 0.79 . . . . 0.0 110.962 172.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.49 -36.44 78.33 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.766 -0.584 . . . . 0.0 111.928 174.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -69.2 -20.06 63.97 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 23.7 mt -54.48 -45.53 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-N 119.604 1.093 . . . . 0.0 112.484 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -103.17 -3.97 25.06 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.662 1.185 . . . . 0.0 112.496 -174.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -61.8 -23.95 66.55 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.818 2.047 . . . . 0.0 115.217 -169.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -76.2 -10.87 59.75 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 14.0 t -79.03 -23.82 44.05 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 174.08 -165.99 37.88 Favored Glycine 0 N--CA 1.473 1.158 0 C-N-CA 124.346 0.974 . . . . 0.0 114.543 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -64.03 105.5 0.88 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.428 1.091 . . . . 0.0 110.087 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 5.3 p -52.94 137.2 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -153.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -73.43 -111.05 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.469 1.508 . . . . 0.0 112.397 -176.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -162.86 161.66 26.04 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.434 1.894 . . . . 0.0 111.091 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.3 168.39 27.14 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.076 -1.015 . . . . 0.0 112.386 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -156.86 153.62 28.52 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.313 1.045 . . . . 0.0 112.118 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 20.1 t -151.66 142.46 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.752 2.021 . . . . 0.0 108.302 -172.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -127.87 152.18 48.15 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.924 0.889 . . . . 0.0 110.861 172.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 15.4 mt -103.62 -157.06 0.59 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.762 1.225 . . . . 0.0 110.655 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -149.9 151.12 32.91 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.026 0.93 . . . . 0.0 111.273 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -63.26 -20.94 63.62 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-O 118.784 -1.009 . . . . 0.0 115.604 -174.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -117.55 -9.8 10.74 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 118.924 1.362 . . . . 0.0 113.962 165.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -70.27 -51.58 21.62 Favored Glycine 0 N--CA 1.47 0.92 0 C-N-CA 124.362 0.982 . . . . 0.0 112.267 169.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 2.8 t 58.94 10.46 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 C-N-CA 127.145 2.178 . . . . 0.0 112.016 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 86.4 p -179.57 153.45 0.56 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 127.94 2.496 . . . . 0.0 110.652 -168.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 5.0 p -152.97 -54.81 0.12 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 125.385 1.474 . . . . 0.0 112.774 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 78.3 -62.9 3.7 Favored Glycine 0 N--CA 1.473 1.111 0 C-N-CA 125.186 1.374 . . . . 0.0 112.023 -176.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 38.3 m -49.48 120.8 4.41 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.73 1.612 . . . . 0.0 112.451 165.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -157.25 -160.82 10.39 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.114 1.34 . . . . 0.0 114.522 -177.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 22.0 p -108.96 145.74 34.97 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.615 1.966 . . . . 0.0 111.149 -173.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.68 127.14 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.915 1.286 . . . . 0.0 109.047 -177.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 19.4 m -85.21 151.84 23.78 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.036 0.934 . . . . 0.0 110.138 171.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.33 157.74 27.51 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 -169.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -57.91 -55.66 32.01 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.608 1.563 . . . . 0.0 111.52 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -172.26 175.35 3.69 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 128.184 2.594 . . . . 0.0 108.975 161.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 74.2 mt -57.05 -35.9 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.241 1.416 . . . . 0.0 111.77 -176.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.39 -50.16 9.34 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.957 1.703 . . . . 0.0 114.874 172.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -95.76 -21.67 18.0 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.333 0.653 . . . . 0.0 112.129 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.0 tt -56.01 -49.4 73.78 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.549 1.14 . . . . 0.0 109.881 170.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -59.87 -33.64 72.08 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -70.51 -53.79 14.8 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.236 0.614 . . . . 0.0 111.267 170.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.52 -37.06 74.85 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.331 1.452 . . . . 0.0 113.602 -176.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.16 -40.17 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.306 1.042 . . . . 0.0 112.071 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -82.54 -38.94 23.04 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.487 0.715 . . . . 0.0 111.776 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -64.46 -47.72 77.94 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.519 1.128 . . . . 0.0 113.403 -173.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -92.54 -18.48 23.08 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -172.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -70.0 116.36 10.28 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.023 -1.048 . . . . 0.0 110.479 175.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 97.72 -5.84 62.29 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.628 1.585 . . . . 0.0 115.139 -174.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -80.09 172.79 13.31 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 118.824 1.312 . . . . 0.0 111.164 170.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 53.8 m -134.56 130.86 37.18 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 120.703 1.592 . . . . 0.0 111.697 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 39.0 mt -145.63 114.62 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.297 1.039 . . . . 0.0 109.159 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 57.1 28.52 15.06 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.439 1.096 . . . . 0.0 113.897 172.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 168.87 -125.52 1.28 Allowed Glycine 0 C--N 1.342 0.909 0 O-C-N 120.825 -1.172 . . . . 0.0 114.33 -177.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -87.35 -178.94 6.3 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.193 0.997 . . . . 0.0 110.824 -176.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 35.1 m -59.87 137.19 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 121.9 -0.5 . . . . 0.0 109.655 161.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 11.1 mp -71.34 128.31 35.47 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.135 1.374 . . . . 0.0 109.476 173.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -106.05 146.28 30.33 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 154.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 14.4 t -136.7 128.76 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.561 1.544 . . . . 0.0 108.938 -172.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -130.03 169.69 14.96 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.77 2.028 . . . . 0.0 110.512 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 32.9 t -138.5 151.66 47.58 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 120.537 -1.352 . . . . 0.0 111.833 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 40.6 tttm . . . . . 0 CA--C 1.552 1.022 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 -168.225 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 120.02 -0.038 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 32.6 m -133.24 147.14 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.142 0.977 . . . . 0.0 111.056 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.7 mp -91.57 141.23 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 126.675 1.99 . . . . 0.0 108.606 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 34.7 m -132.84 129.07 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.577 1.151 . . . . 0.0 109.036 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.3 tptm -150.5 50.46 0.88 Allowed 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 -148.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -160.94 -17.68 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 170.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 39.3 mt -54.35 131.96 61.93 Favored Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 125.713 1.605 . . . . 0.0 111.598 168.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -86.09 169.5 8.75 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.312 3.341 . . . . 0.0 111.276 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -55.81 -10.66 0.78 Allowed 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 6.2 t -59.32 -31.21 68.95 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.696 1.198 . . . . 0.0 113.006 171.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.62 116.33 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 169.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -69.36 153.28 43.85 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.562 0.745 . . . . 0.0 110.097 171.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -55.46 -32.67 62.99 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 120.538 -1.351 . . . . 0.0 113.108 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -69.11 -39.57 78.85 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.021 0.929 . . . . 0.0 111.033 175.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.53 -25.51 64.06 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.078 -1.014 . . . . 0.0 113.065 170.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.74 -49.05 64.63 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.258 0.935 . . . . 0.0 111.343 170.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -25.89 68.25 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 119.762 1.165 . . . . 0.0 111.852 174.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -68.93 -21.66 64.19 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 171.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.441 HG23 HD12 ' A' ' 326' ' ' ILE . 30.1 mt -56.97 -51.35 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 CA-C-N 119.696 1.134 . . . . 0.0 111.269 173.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -85.84 -19.55 30.46 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.678 0.791 . . . . 0.0 111.824 -174.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -57.62 -13.98 4.71 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.103 1.761 . . . . 0.0 114.808 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -59.48 -15.32 16.84 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 168.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 83.9 m -68.79 -5.62 21.86 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 168.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.39 -8.58 60.5 Favored Glycine 0 N--CA 1.48 1.575 0 C-N-CA 125.789 1.662 . . . . 0.0 115.666 172.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -138.69 -174.65 3.89 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.823 2.049 . . . . 0.0 108.634 170.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 6.8 p -144.06 144.22 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 121.159 1.799 . . . . 0.0 113.618 172.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -94.81 -121.04 0.1 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.184 1.793 . . . . 0.0 111.189 177.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -143.82 158.55 43.61 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.538 1.935 . . . . 0.0 111.567 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.96 -179.72 8.3 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 120.974 -1.079 . . . . 0.0 113.855 -177.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 8.2 p30 -155.54 173.7 16.32 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.656 1.583 . . . . 0.0 113.781 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 17.2 m -149.92 173.86 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 127.69 2.396 . . . . 0.0 110.075 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -108.22 159.54 16.54 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.674 1.19 . . . . 0.0 111.318 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.3 mp -132.96 134.17 44.15 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.542 1.137 . . . . 0.0 111.347 173.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -66.77 164.27 17.5 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.691 1.196 . . . . 0.0 111.221 165.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -61.97 -19.93 59.5 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.019 0.819 . . . . 0.0 114.669 176.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -79.14 -6.16 55.86 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.917 1.287 . . . . 0.0 113.47 171.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 80.87 14.13 80.12 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.034 1.302 . . . . 0.0 115.135 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 3.7 p -91.11 4.66 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 -165.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 10.9 p 64.87 -179.39 0.18 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 126.992 2.117 . . . . 0.0 116.159 175.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 68.6 p -141.99 156.3 45.45 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 128.368 2.667 . . . . 0.0 108.229 172.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -88.01 -34.31 10.0 Favored Glycine 0 N--CA 1.47 0.947 0 C-N-CA 123.245 0.45 . . . . 0.0 112.203 169.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 18.7 p -56.81 143.04 38.58 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.762 1.625 . . . . 0.0 111.922 163.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 169.55 -153.59 22.09 Favored Glycine 0 N--CA 1.471 0.985 0 C-N-CA 126.172 1.844 . . . . 0.0 112.253 -175.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 17.8 p -125.09 154.97 40.57 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 117.994 0.897 . . . . 0.0 111.357 173.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 13.4 m -123.82 121.96 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 125.222 1.409 . . . . 0.0 107.782 172.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 4.5 m -91.09 120.79 32.34 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.013 1.725 . . . . 0.0 109.356 -175.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.85 157.47 21.99 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -158.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -54.38 -54.03 46.0 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 113.56 -1.655 . . . . 0.0 111.793 172.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -172.68 170.24 4.78 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 129.366 3.067 . . . . 0.0 108.676 171.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 89.5 mt -57.49 -34.32 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 124.864 1.266 . . . . 0.0 112.054 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.14 -40.2 64.07 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.138 1.375 . . . . 0.0 114.433 172.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -89.39 -33.15 16.96 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 119.328 -0.368 . . . . 0.0 110.418 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 6.2 tt -56.64 -52.16 65.94 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.854 1.262 . . . . 0.0 111.378 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -62.3 -47.58 83.66 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.67 -0.644 . . . . 0.0 112.541 -177.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 28.1 ptt85 -70.44 -28.83 65.34 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -74.12 -33.78 63.68 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.502 1.121 . . . . 0.0 112.997 173.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -53.71 -44.04 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.156 1.382 . . . . 0.0 112.3 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -82.75 -17.37 44.47 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -89.07 -48.51 7.36 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.913 0.885 . . . . 0.0 112.671 -171.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -85.32 -21.55 28.89 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -49.8 125.26 11.37 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.885 0.874 . . . . 0.0 110.761 159.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 86.93 0.34 85.74 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 119.141 -0.811 . . . . 0.0 114.757 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -103.69 163.43 12.33 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.139 1.375 . . . . 0.0 112.045 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 34.1 p -138.03 129.35 27.66 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 120.684 -1.26 . . . . 0.0 111.897 -175.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.441 HD12 HG23 ' A' ' 280' ' ' ILE . 11.0 mt -146.71 116.86 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.49 1.116 . . . . 0.0 109.104 -177.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 60.86 25.95 15.84 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.695 1.198 . . . . 0.0 112.792 176.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 178.2 -140.01 4.42 Favored Glycine 0 C--N 1.342 0.888 0 O-C-N 120.931 -1.106 . . . . 0.0 114.474 -170.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -91.42 178.26 6.0 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.399 1.08 . . . . 0.0 110.644 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 11.7 p -59.92 129.19 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 O-C-N 121.642 -0.661 . . . . 0.0 109.308 160.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 1.8 pp -104.37 149.09 25.69 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 122.406 1.098 . . . . 0.0 111.533 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -113.37 163.54 14.72 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.017 1.327 . . . . 0.0 110.092 166.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 24.3 t -135.93 130.52 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 126.561 1.945 . . . . 0.0 107.51 -175.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -135.28 133.94 39.41 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.234 1.014 . . . . 0.0 111.46 -173.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 77.3 p -118.0 167.54 11.35 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.186 1.394 . . . . 0.0 112.894 -171.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt . . . . . 0 N--CA 1.474 0.736 0 C-N-CA 125.081 1.352 . . . . 0.0 110.718 175.72 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 34.7 m -132.86 157.43 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.687 1.195 . . . . 0.0 111.109 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.0 mp -125.17 136.91 59.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 127.044 2.137 . . . . 0.0 107.033 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.93 128.89 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.116 0.967 . . . . 0.0 109.427 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 60.2 mmtt -138.76 73.84 1.45 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.034 1.334 . . . . 0.0 110.784 -161.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -179.13 -32.21 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.554 1.942 . . . . 0.0 113.3 -173.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 89.1 mt -74.07 131.35 81.29 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-O 117.917 -1.04 . . . . 0.0 109.834 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -94.83 -168.88 0.16 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 124.272 3.315 . . . . 0.0 110.759 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -55.59 -13.62 1.68 Allowed 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 50.0 m -60.26 -24.19 64.71 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.386 1.474 . . . . 0.0 113.872 170.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.3 p -103.5 144.57 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.43 1.092 . . . . 0.0 109.893 170.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -135.91 173.56 11.58 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.944 1.698 . . . . 0.0 109.775 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -44.35 -51.28 8.65 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.959 1.303 . . . . 0.0 113.777 -170.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -70.07 -40.82 74.8 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.917 -0.49 . . . . 0.0 111.618 -175.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.25 -33.56 73.45 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.789 0.722 . . . . 0.0 112.82 176.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 8.2 tt -63.1 -45.2 93.2 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.98 0.809 . . . . 0.0 110.409 172.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 3.7 tmmm? -60.69 -37.63 82.27 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.864 -0.523 . . . . 0.0 111.161 174.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -63.68 -25.32 68.16 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 176.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 28.1 mt -55.92 -51.37 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 124.112 0.965 . . . . 0.0 110.609 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -89.0 -26.26 21.56 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.666 0.786 . . . . 0.0 112.343 -175.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 2.9 ttpt -52.7 -22.03 4.71 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.292 1.437 . . . . 0.0 114.356 173.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -61.8 -13.75 26.7 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 120.77 -1.206 . . . . 0.0 113.79 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 79.3 m -71.54 -0.37 10.42 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.968 1.307 . . . . 0.0 114.403 167.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.58 -73.57 0.25 Allowed Glycine 0 N--CA 1.471 1.001 0 C-N-CA 126.393 1.949 . . . . 0.0 111.449 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -73.08 172.3 11.3 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.19 0.996 . . . . 0.0 111.136 170.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.29 142.05 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 O-C-N 120.635 -1.29 . . . . 0.0 113.827 172.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -85.36 -125.56 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.733 1.613 . . . . 0.0 111.415 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -152.1 162.0 41.77 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.4 1.48 . . . . 0.0 112.89 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.6 173.72 16.16 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.11 -0.994 . . . . 0.0 113.641 -173.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -154.87 158.42 39.33 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.799 1.24 . . . . 0.0 113.398 -177.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 21.8 m -151.53 163.45 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 127.486 2.314 . . . . 0.0 110.914 -172.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -131.97 167.46 19.61 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.77 1.228 . . . . 0.0 111.84 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 4.0 mp -129.05 152.68 48.39 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.228 1.411 . . . . 0.0 112.203 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -92.84 153.17 19.0 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.066 1.746 . . . . 0.0 111.487 173.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -68.5 -7.08 52.25 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.801 1.191 . . . . 0.0 114.989 -178.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -74.08 -4.77 37.57 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.31 1.444 . . . . 0.0 112.953 168.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 86.45 38.29 8.37 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.035 1.302 . . . . 0.0 113.392 176.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 30.6 m -142.05 148.41 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.678 1.591 . . . . 0.0 111.143 -174.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 75.0 p -81.1 152.74 27.67 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.924 0.89 . . . . 0.0 113.039 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 39.1 p -76.25 -29.4 57.48 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.858 0.863 . . . . 0.0 112.881 176.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 74.49 -64.26 2.16 Favored Glycine 0 N--CA 1.47 0.926 0 C-N-CA 125.724 1.63 . . . . 0.0 112.207 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 58.1 m -55.0 110.61 0.69 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.427 1.891 . . . . 0.0 111.435 166.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -146.67 -160.11 8.61 Favored Glycine 0 N--CA 1.469 0.851 0 C-N-CA 124.695 1.14 . . . . 0.0 113.897 -173.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 98.0 m -114.89 136.67 52.85 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.526 1.53 . . . . 0.0 109.625 -170.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 1.3 t -120.41 120.23 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 125.751 1.621 . . . . 0.0 107.622 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 42.9 m -88.46 108.04 19.18 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.416 1.086 . . . . 0.0 108.426 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -79.6 162.91 25.02 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 -160.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -53.21 -55.58 23.21 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.625 1.17 . . . . 0.0 111.35 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -172.39 178.82 2.69 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.039 2.535 . . . . 0.0 109.007 154.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 16.7 tt -53.51 -33.31 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.101 1.36 . . . . 0.0 113.488 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.69 -42.72 68.28 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.207 1.403 . . . . 0.0 113.956 173.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -95.26 -24.58 16.72 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.5 tt -58.35 -51.97 67.57 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 125.434 1.493 . . . . 0.0 110.221 175.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -62.21 -33.43 74.54 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -70.33 -42.39 71.97 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.695 1.198 . . . . 0.0 112.036 174.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -72.92 -33.55 66.05 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.432 1.493 . . . . 0.0 113.134 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.44 -37.01 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.833 0.853 . . . . 0.0 112.6 -176.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -82.17 -19.59 39.6 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.855 0.862 . . . . 0.0 113.206 175.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -89.01 -46.09 9.13 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.68 1.192 . . . . 0.0 112.645 -175.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -87.71 -30.71 20.14 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -171.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -65.09 118.84 9.75 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 119.011 0.823 . . . . 0.0 110.324 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 103.42 -7.07 50.45 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 125.644 1.592 . . . . 0.0 115.629 -172.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -93.88 142.92 26.82 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 119.451 1.625 . . . . 0.0 111.78 176.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 11.0 p -111.96 126.64 55.35 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.793 1.237 . . . . 0.0 112.234 -174.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -148.58 103.16 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.113 0.965 . . . . 0.0 109.517 -166.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 57.06 35.89 26.96 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 121.932 0.872 . . . . 0.0 111.462 -172.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 163.31 -148.69 15.47 Favored Glycine 0 C--N 1.343 0.952 0 O-C-N 121.152 -0.968 . . . . 0.0 114.787 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -80.93 174.55 11.51 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.804 1.642 . . . . 0.0 111.066 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 32.8 m -63.37 136.18 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 121.213 -0.929 . . . . 0.0 111.301 175.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 14.6 mt -63.41 122.28 15.86 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.674 0.79 . . . . 0.0 113.001 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -106.04 102.37 11.8 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.36 1.864 . . . . 0.0 107.599 160.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.45 131.69 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.286 1.435 . . . . 0.0 109.698 -171.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -130.0 135.13 47.94 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.978 1.311 . . . . 0.0 110.806 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 50.1 p -97.05 159.0 15.16 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.874 -1.141 . . . . 0.0 112.005 175.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 23.6 tptm . . . . . 0 CA--C 1.548 0.866 0 O-C-N 121.286 -0.883 . . . . 0.0 111.079 178.664 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.54 0.576 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 31.3 m -138.59 147.26 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.45 1.5 . . . . 0.0 111.126 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.4 mp -92.05 137.83 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 126.01 1.724 . . . . 0.0 107.683 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 5.4 m -117.75 118.5 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.417 ' H ' HD11 ' A' ' 331' ' ' LEU . 6.8 tmtt? -139.37 44.75 1.97 Allowed 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -148.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -168.51 -6.65 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 116.623 2.083 . . . . 0.0 116.623 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 68.0 mt -69.84 144.17 93.04 Favored Pre-proline 0 CA--C 1.553 1.079 0 O-C-N 120.532 -1.355 . . . . 0.0 110.103 174.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -90.62 -175.24 0.83 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.3 3.333 . . . . 0.0 110.905 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -56.37 -12.47 1.68 Allowed 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 20.4 m -60.48 -31.05 70.1 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.78 1.232 . . . . 0.0 113.266 171.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.6 p -93.73 142.49 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.503 0.721 . . . . 0.0 109.697 172.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -137.26 168.41 19.69 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.004 1.722 . . . . 0.0 109.09 176.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -50.56 -40.92 53.43 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -167.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -68.64 -39.01 80.94 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.761 -0.587 . . . . 0.0 111.895 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.58 -36.25 76.09 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.382 -0.824 . . . . 0.0 112.715 170.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.453 HD21 HG12 ' A' ' 306' ' ' VAL . 3.3 tt -61.03 -38.27 85.51 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.189 0.996 . . . . 0.0 112.138 176.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -57.84 -46.94 84.02 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 121.537 -0.727 . . . . 0.0 110.947 169.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.29 -17.82 64.82 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 29.3 mt -54.41 -33.45 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.344 1.058 . . . . 0.0 111.803 169.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -118.05 -27.7 6.05 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.171 1.389 . . . . 0.0 112.183 -176.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -64.31 -6.66 7.39 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -52.72 -25.29 10.65 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.198 1.399 . . . . 0.0 113.06 167.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 70.8 m -67.66 -5.17 14.52 Favored 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 172.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 97.06 -12.17 65.59 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 126.436 1.969 . . . . 0.0 115.017 175.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -138.67 172.47 12.83 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.394 1.878 . . . . 0.0 109.659 174.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.1 p -145.34 144.35 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 120.341 -1.474 . . . . 0.0 112.318 173.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -72.57 -79.4 0.08 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.473 1.109 . . . . 0.0 112.077 178.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -178.45 147.01 0.39 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 127.947 2.499 . . . . 0.0 109.813 -167.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.59 166.56 31.79 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.11 -0.994 . . . . 0.0 112.658 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -157.46 165.8 34.71 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.898 1.279 . . . . 0.0 112.496 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 22.7 m -146.37 155.4 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 126.838 2.055 . . . . 0.0 110.793 -174.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -132.0 115.21 15.54 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.875 1.27 . . . . 0.0 108.848 174.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 17.2 mt -96.13 169.1 10.19 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.466 1.106 . . . . 0.0 111.376 -173.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -78.16 144.76 36.11 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.009 0.923 . . . . 0.0 112.119 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -68.44 -12.35 63.58 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.88 1.229 . . . . 0.0 115.795 -173.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -80.81 0.01 36.77 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 119.301 1.551 . . . . 0.0 113.22 168.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 85.81 43.35 6.44 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.575 1.083 . . . . 0.0 113.172 175.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.19 148.9 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.08 1.352 . . . . 0.0 111.89 -177.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 58.5 m -77.79 139.32 39.32 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -169.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 7.9 p -89.22 -26.66 21.1 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.69 1.996 . . . . 0.0 113.529 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 80.27 -54.27 4.52 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.103 1.811 . . . . 0.0 113.067 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 23.4 p -52.34 139.75 23.63 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 122.998 1.38 . . . . 0.0 113.28 163.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -161.23 -171.73 27.63 Favored Glycine 0 N--CA 1.468 0.832 0 C-N-CA 124.831 1.205 . . . . 0.0 114.682 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 26.6 p -123.39 122.41 38.22 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.48 1.512 . . . . 0.0 109.493 -176.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.453 HG12 HD21 ' A' ' 277' ' ' LEU . 19.6 m -112.58 129.73 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 175.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 5.1 m -87.88 150.03 23.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.709 172.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.74 157.44 19.76 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -165.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -53.82 -52.57 59.92 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.743 1.617 . . . . 0.0 111.88 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -172.66 170.36 4.77 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.351 2.66 . . . . 0.0 108.532 162.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.553 HD12 ' H ' ' A' ' 311' ' ' ILE . 4.3 mp -47.1 -38.23 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 125.121 1.368 . . . . 0.0 112.11 175.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.67 -48.99 19.98 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.878 1.671 . . . . 0.0 115.111 173.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -96.39 -21.44 17.77 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 118.749 -0.643 . . . . 0.0 111.993 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.3 tt -57.87 -52.33 65.91 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.234 1.013 . . . . 0.0 110.191 173.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -68.87 -26.61 65.21 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -70.29 -43.36 70.56 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.043 0.937 . . . . 0.0 111.594 169.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -75.24 -30.6 60.57 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.511 1.525 . . . . 0.0 113.675 -177.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.01 -42.28 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.179 0.991 . . . . 0.0 113.12 -172.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -82.77 -37.79 24.09 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.688 0.795 . . . . 0.0 112.449 175.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -57.46 -38.15 74.01 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.198 -0.939 . . . . 0.0 111.997 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -106.31 28.53 7.65 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.322 1.849 . . . . 0.0 112.616 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -89.94 118.75 29.74 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.421 -1.424 . . . . 0.0 110.866 161.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 84.41 -8.67 67.15 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.975 1.274 . . . . 0.0 115.523 172.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . 0.458 ' CE1' HD23 ' A' ' 331' ' ' LEU . 0.2 OUTLIER -60.43 171.55 1.06 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.282 1.833 . . . . 0.0 113.78 168.395 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 73.4 p -138.52 122.25 17.55 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.077 -1.015 . . . . 0.0 112.048 175.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 13.4 mt -135.54 111.3 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.714 1.206 . . . . 0.0 108.878 177.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 65.09 26.6 12.52 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.359 1.464 . . . . 0.0 112.939 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . -179.07 -131.83 1.65 Allowed Glycine 0 CA--C 1.53 1.014 0 N-CA-C 115.707 1.043 . . . . 0.0 115.707 -176.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -98.61 179.28 4.74 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.481 1.513 . . . . 0.0 111.077 -172.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 30.8 m -60.29 132.28 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 162.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . 0.458 HD23 ' CE1' ' A' ' 324' ' ' TYR . 59.7 tp -126.21 117.16 22.5 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.553 0.741 . . . . 0.0 111.147 -165.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -75.67 148.74 38.45 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.147 160.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 96.6 t -136.89 137.69 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 126.074 1.75 . . . . 0.0 108.998 -176.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -144.13 135.74 25.92 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.994 0.918 . . . . 0.0 111.952 -170.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 82.5 p -89.37 161.74 16.17 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 45.0 tttm . . . . . 0 CA--C 1.557 1.214 0 C-N-CA 124.826 1.25 . . . . 0.0 113.219 -179.826 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 . . . . . 0 N--CA 1.476 0.852 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 12.1 m -133.94 161.46 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 124.976 1.311 . . . . 0.0 110.963 169.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.97 139.57 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 127.343 2.257 . . . . 0.0 108.368 178.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.57 126.6 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.329 1.051 . . . . 0.0 108.961 175.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -140.15 42.5 1.93 Allowed 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -153.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -158.34 -15.31 0.07 Allowed 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 171.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 16.2 mt -52.29 133.47 42.36 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 125.641 1.577 . . . . 0.0 112.969 173.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -88.24 166.55 6.71 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.929 3.753 . . . . 0.0 110.931 172.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -60.32 -12.48 9.23 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -174.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 16.0 m -61.76 -23.47 66.2 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.289 1.036 . . . . 0.0 112.789 171.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.5 p -115.32 131.51 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 126.936 2.094 . . . . 0.0 108.958 167.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -148.5 178.2 8.82 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.109 1.764 . . . . 0.0 109.224 -171.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -38.87 -50.67 1.73 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.284 1.834 . . . . 0.0 115.932 -162.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -67.35 -44.51 78.86 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.234 0.925 . . . . 0.0 111.886 -176.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.84 -32.0 70.17 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 172.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.496 HD23 ' C ' ' A' ' 277' ' ' LEU . 4.1 tt -58.64 -45.31 89.59 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.257 1.023 . . . . 0.0 109.91 174.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -56.08 -38.3 70.49 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.577 -0.702 . . . . 0.0 112.376 173.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -69.04 -19.95 64.11 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 178.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 29.7 mt -58.19 -30.47 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 124.157 0.983 . . . . 0.0 111.707 170.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -114.19 -26.46 8.03 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.666 1.186 . . . . 0.0 113.434 -175.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 1.8 tmmt? -63.54 -20.73 65.87 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -176.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -75.0 -13.54 60.52 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 171.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 11.2 t -107.08 -33.55 7.43 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.185 1.394 . . . . 0.0 113.301 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -138.03 153.52 22.32 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.843 1.211 . . . . 0.0 114.84 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -69.45 115.25 8.49 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.707 1.203 . . . . 0.0 110.751 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 4.8 p -41.14 132.9 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 -154.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -99.09 -111.76 0.17 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.971 1.708 . . . . 0.0 110.274 174.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 -159.58 155.23 25.91 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.667 1.587 . . . . 0.0 112.456 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.23 171.31 20.44 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.132 -0.98 . . . . 0.0 112.621 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -157.59 165.6 35.1 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.828 1.251 . . . . 0.0 112.814 -173.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 23.1 t -151.01 142.78 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 127.421 2.288 . . . . 0.0 107.387 -177.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -119.52 133.09 55.83 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.224 0.61 . . . . 0.0 110.921 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 11.8 mt -86.34 164.99 16.76 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.981 0.912 . . . . 0.0 111.471 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -64.72 133.33 51.88 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 155.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -67.51 -11.88 60.47 Favored Glycine 0 N--CA 1.475 1.265 0 N-CA-C 117.385 1.714 . . . . 0.0 117.385 -153.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -79.73 0.4 30.7 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 118.556 1.178 . . . . 0.0 112.736 168.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 93.75 33.91 6.83 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 126.356 1.931 . . . . 0.0 113.584 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.32 15.38 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -157.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 21.0 p 73.27 148.0 0.09 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 127.532 2.333 . . . . 0.0 115.484 171.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 11.9 p -159.75 158.05 30.53 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 128.183 2.593 . . . . 0.0 109.022 -177.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -112.82 -50.22 0.56 Allowed Glycine 0 N--CA 1.473 1.137 0 C-N-CA 124.187 0.898 . . . . 0.0 112.844 169.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 69.1 m -44.19 120.82 2.27 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.901 1.68 . . . . 0.0 113.093 170.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -152.01 -168.22 16.05 Favored Glycine 0 N--CA 1.468 0.826 0 C-N-CA 125.047 1.308 . . . . 0.0 114.288 -173.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 30.0 p -122.65 152.75 40.19 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.101 1.76 . . . . 0.0 110.314 -174.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 1.7 t -139.46 126.19 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.353 1.061 . . . . 0.0 108.474 -170.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 19.4 t -92.57 121.0 33.58 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.819 0.847 . . . . 0.0 108.757 172.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.94 155.54 18.65 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -165.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -55.02 -53.83 50.81 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.844 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -172.85 -170.62 0.68 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 128.519 2.728 . . . . 0.0 108.805 145.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.4 mp -55.96 -34.18 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.426 1.49 . . . . 0.0 113.284 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.36 -35.61 60.46 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.293 1.219 . . . . 0.0 114.293 174.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -98.82 -35.57 10.08 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 123.703 0.627 . . . . 0.0 110.127 -173.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.5 tt -51.21 -52.32 45.59 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 126.971 2.108 . . . . 0.0 110.659 174.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -65.15 -25.27 67.67 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 119.13 0.877 . . . . 0.0 113.21 -176.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -70.64 -55.96 7.57 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.917 1.287 . . . . 0.0 110.427 169.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -63.88 -37.2 86.52 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.124 1.37 . . . . 0.0 113.351 -175.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.15 -34.01 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.446 1.098 . . . . 0.0 112.031 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -82.53 -40.82 20.47 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.054 0.942 . . . . 0.0 111.901 173.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.07 -41.69 85.99 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.224 1.01 . . . . 0.0 113.501 -175.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -106.13 -17.53 14.29 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -169.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -66.78 121.05 14.6 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.977 1.262 . . . . 0.0 109.836 168.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 91.41 -1.2 75.89 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 124.193 0.901 . . . . 0.0 114.693 -171.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -97.49 166.75 11.38 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.318 1.447 . . . . 0.0 111.446 175.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 61.7 p -138.43 127.21 23.66 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 120.11 -1.619 . . . . 0.0 112.358 -177.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 16.9 mt -137.47 106.91 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.991 0.917 . . . . 0.0 109.72 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 59.03 25.18 13.54 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.402 1.481 . . . . 0.0 112.996 175.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . -167.29 -140.61 2.94 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.807 1.194 . . . . 0.0 113.808 -169.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -96.2 179.94 4.87 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.891 0.876 . . . . 0.0 111.101 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.53 128.2 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 165.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 16.3 mt -72.37 129.46 38.42 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.042 1.337 . . . . 0.0 112.111 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -112.79 118.84 36.08 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.021 1.728 . . . . 0.0 107.3 163.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 18.0 t -127.25 138.49 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.18 1.392 . . . . 0.0 109.436 -166.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -140.37 139.96 35.44 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.622 1.169 . . . . 0.0 111.521 -177.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 32.4 t -91.15 146.98 23.38 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.27 -0.894 . . . . 0.0 112.594 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 79.8 tttt . . . . . 0 CA--C 1.553 1.066 0 C-N-CA 124.121 0.968 . . . . 0.0 112.877 170.477 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 . . . . . 0 N--CA 1.467 0.406 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.37 149.47 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 126.3 1.84 . . . . 0.0 110.957 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.79 126.41 62.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 126.842 2.057 . . . . 0.0 106.277 172.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 29.5 m -91.44 144.74 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 167.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -144.94 138.21 26.72 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.6 0.76 . . . . 0.0 112.647 -167.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 50.2 t30 96.97 -3.03 0.05 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 129.461 3.104 . . . . 0.0 114.051 175.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 82.6 mt -70.62 133.62 86.68 Favored Pre-proline 0 CA--C 1.556 1.173 0 O-C-N 120.954 -1.091 . . . . 0.0 109.491 165.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -88.95 -168.58 0.35 Allowed 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 124.396 3.397 . . . . 0.0 111.471 -174.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -52.71 -17.09 1.16 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.908 1.683 . . . . 0.0 115.249 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 7.6 t -63.47 -31.25 72.36 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.567 1.147 . . . . 0.0 113.135 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.23 137.32 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 118.712 0.687 . . . . 0.0 110.74 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -145.24 173.0 12.33 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.35 2.26 . . . . 0.0 108.554 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -48.61 -44.38 37.04 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 120.156 1.344 . . . . 0.0 114.135 -166.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -74.7 -23.75 58.65 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -79.85 -37.26 35.37 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.852 1.206 . . . . 0.0 113.166 164.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.48 -48.54 76.91 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.835 0.854 . . . . 0.0 111.044 177.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.28 -30.86 71.43 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.773 -0.579 . . . . 0.0 111.344 -178.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.47 -18.91 63.75 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.011 1.724 . . . . 0.0 114.699 172.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.416 HG23 HD12 ' A' ' 326' ' ' ILE . 56.3 mt -56.78 -42.91 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 119.52 1.055 . . . . 0.0 110.27 168.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.445 ' CE1' HG21 ' A' ' 306' ' ' VAL . 79.0 m-85 -104.96 -9.71 17.73 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -173.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -61.95 -8.56 5.32 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -175.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -57.9 -21.07 41.61 Favored 'General case' 0 CA--C 1.55 0.955 0 O-C-N 120.818 -1.176 . . . . 0.0 112.873 168.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 34.2 t -56.87 -21.85 32.52 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.505 1.522 . . . . 0.0 114.074 167.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.1 -17.37 58.16 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 126.907 2.194 . . . . 0.0 113.794 -176.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -139.35 -172.9 3.46 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.624 1.97 . . . . 0.0 109.875 173.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.41 134.56 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 120.544 -1.348 . . . . 0.0 111.294 167.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -74.25 -72.69 0.26 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.591 1.156 . . . . 0.0 112.674 -172.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -159.13 136.54 9.94 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.049 1.74 . . . . 0.0 110.888 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.45 137.89 11.75 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.326 -0.859 . . . . 0.0 112.459 -154.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -162.53 175.37 11.52 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.399 1.48 . . . . 0.0 112.499 -174.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 17.6 m -145.68 167.03 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 126.59 1.956 . . . . 0.0 110.821 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -132.12 148.11 52.46 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.643 1.577 . . . . 0.0 109.684 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.1 mp -134.88 142.05 46.49 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.642 1.177 . . . . 0.0 111.746 -177.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -79.92 179.75 7.41 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.0 0.92 . . . . 0.0 111.072 170.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -67.68 -17.8 69.46 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 121.105 -0.997 . . . . 0.0 114.589 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -88.61 -0.42 57.25 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.184 1.394 . . . . 0.0 113.569 175.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 72.65 25.07 74.99 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.066 0.841 . . . . 0.0 114.238 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 4.8 p -96.18 12.06 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -163.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 22.7 p 59.97 10.85 2.34 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 127.336 2.254 . . . . 0.0 115.132 -176.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . 0.27 1.1 t 50.47 10.07 0.05 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 129.389 3.075 . . . . 0.0 115.752 176.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 86.44 20.23 55.02 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.552 1.548 . . . . 0.0 114.531 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 95.1 p -164.37 167.99 19.08 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 120.103 1.951 . . . . 0.0 116.027 -172.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -153.78 163.6 30.91 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.303 1.906 . . . . 0.0 112.082 173.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 55.1 m -125.71 130.96 52.56 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 118.367 1.083 . . . . 0.0 110.779 -165.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.445 HG21 ' CE1' ' A' ' 281' ' ' PHE . 21.7 t -135.83 123.77 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.789 0.836 . . . . 0.0 109.455 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 66.2 m -104.07 128.26 51.67 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.077 1.351 . . . . 0.0 109.914 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.27 163.38 13.46 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 -141.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -54.21 -51.45 64.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.324 1.45 . . . . 0.0 111.688 175.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -172.86 167.33 5.16 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 128.7 2.8 . . . . 0.0 108.507 164.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.27 -30.62 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.92 0.888 . . . . 0.0 111.306 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.59 -43.7 46.54 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 171.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -95.72 -26.43 15.7 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 118.13 0.423 . . . . 0.0 111.581 -176.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 4.6 tt -53.87 -48.25 70.24 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.507 1.523 . . . . 0.0 109.973 172.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -57.81 -37.57 74.0 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -70.67 -52.43 21.19 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.515 0.726 . . . . 0.0 111.462 171.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -59.64 -34.72 73.15 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.32 1.448 . . . . 0.0 113.452 -175.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.89 -36.81 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.336 1.055 . . . . 0.0 112.382 176.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -83.66 -43.13 15.91 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.753 0.821 . . . . 0.0 112.268 173.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -58.65 -48.51 80.78 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.337 1.455 . . . . 0.0 113.898 -171.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -93.17 -18.51 22.47 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -174.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -73.74 111.89 9.32 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.598 -0.689 . . . . 0.0 110.558 177.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 101.07 -0.05 54.73 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.731 1.157 . . . . 0.0 114.414 -170.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -103.87 173.81 6.14 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.532 1.533 . . . . 0.0 111.446 174.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 30.5 p -138.03 122.94 18.94 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 120.412 -1.43 . . . . 0.0 111.933 -175.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.416 HD12 HG23 ' A' ' 280' ' ' ILE . 11.7 mt -145.02 115.09 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.636 1.174 . . . . 0.0 108.34 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 63.95 34.88 11.18 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.27 1.028 . . . . 0.0 112.565 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 167.45 -132.24 2.55 Favored Glycine 0 C--N 1.341 0.823 0 O-C-N 121.305 -0.872 . . . . 0.0 115.24 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -97.75 -174.64 2.95 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.516 1.526 . . . . 0.0 110.215 -173.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 55.1 t -58.76 126.12 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 159.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 2.2 pp -103.85 144.16 31.87 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 122.419 1.104 . . . . 0.0 112.006 -177.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -94.05 158.62 15.53 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.497 1.919 . . . . 0.0 109.931 165.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 26.3 t -136.2 132.03 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.303 1.441 . . . . 0.0 108.567 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -132.2 133.81 44.62 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.307 1.443 . . . . 0.0 109.98 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 78.0 p -94.73 154.4 17.32 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.973 -1.079 . . . . 0.0 112.154 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 84.2 tttt . . . . . 0 CA--C 1.546 0.803 0 C-N-CA 123.864 0.866 . . . . 0.0 110.955 178.378 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 110.801 -0.074 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 29.9 m -135.24 149.97 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 125.15 1.38 . . . . 0.0 111.249 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.74 144.34 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 126.606 1.962 . . . . 0.0 107.848 169.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 17.4 m -138.57 128.63 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.452 1.501 . . . . 0.0 109.432 -177.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -141.3 158.01 44.46 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -159.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 82.35 -26.25 0.14 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 129.847 3.259 . . . . 0.0 113.938 173.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 92.2 mt -28.71 108.67 0.23 Allowed Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 126.664 1.986 . . . . 0.0 111.482 145.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -87.56 -175.64 1.54 Allowed 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.89 3.06 . . . . 0.0 111.692 177.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -56.29 -25.2 47.55 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 16.8 m -67.47 -16.8 64.41 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . 0.262 2.7 p -108.6 85.36 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 126.407 1.883 . . . . 0.0 109.671 176.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -68.19 174.48 3.88 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.877 2.071 . . . . 0.0 113.39 -174.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -54.31 -43.31 71.02 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.85 -1.156 . . . . 0.0 113.573 -177.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -59.5 -45.12 92.61 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.373 0.669 . . . . 0.0 111.388 176.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.37 -32.98 72.39 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 176.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.569 HD21 ' CG1' ' A' ' 306' ' ' VAL . 2.6 tt -62.19 -42.13 98.99 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.299 1.04 . . . . 0.0 111.258 170.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -64.55 -38.67 91.83 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.415 -0.803 . . . . 0.0 111.036 173.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -62.7 -25.21 68.05 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 177.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 30.8 mt -50.34 -51.18 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 124.667 1.187 . . . . 0.0 111.432 175.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -94.33 -29.92 14.78 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.999 0.92 . . . . 0.0 111.19 -176.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -58.35 -20.53 44.32 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -177.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -61.73 -11.42 12.01 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 172.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 7.8 t -65.95 -14.08 60.93 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 124.358 1.063 . . . . 0.0 113.606 168.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.89 -10.1 60.33 Favored Glycine 0 N--CA 1.476 1.363 0 C-N-CA 126.337 1.922 . . . . 0.0 113.718 -177.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 34.5 p-10 -138.63 166.32 24.64 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 128.312 2.645 . . . . 0.0 110.028 173.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.5 p -145.28 140.92 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 120.936 -1.102 . . . . 0.0 111.733 168.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -69.98 -79.61 0.06 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.421 1.088 . . . . 0.0 111.828 -177.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -168.16 149.41 5.11 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 127.433 2.293 . . . . 0.0 110.66 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.14 150.07 21.75 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.95 0.9 . . . . 0.0 112.027 -168.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -170.14 179.84 3.38 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 126.37 1.868 . . . . 0.0 110.731 -176.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -165.21 138.51 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 127.246 2.219 . . . . 0.0 109.78 170.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -76.86 131.25 38.51 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 163.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 14.2 mt -103.25 170.5 7.92 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.633 0.773 . . . . 0.0 112.996 -168.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -51.09 154.67 1.48 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.149 1.779 . . . . 0.0 112.701 165.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -65.41 -15.78 61.86 Favored Glycine 0 CA--C 1.536 1.361 0 N-CA-C 115.983 1.153 . . . . 0.0 115.983 -173.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -88.48 -0.01 56.76 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 119.27 1.535 . . . . 0.0 113.15 169.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.07 21.18 61.47 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.409 1.48 . . . . 0.0 114.566 173.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 63.5 t -86.89 -62.53 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 117.939 0.87 . . . . 0.0 111.938 -167.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 10.3 t -175.05 -174.13 0.74 Allowed 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.051 1.34 . . . . 0.0 111.584 -171.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -161.71 -51.71 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 127.54 2.336 . . . . 0.0 112.106 174.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 87.51 -68.14 3.16 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.807 1.194 . . . . 0.0 112.241 -178.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 34.4 p -61.97 122.54 15.73 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.52 1.128 . . . . 0.0 112.665 172.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -177.54 -141.06 3.95 Favored Glycine 0 N--CA 1.471 1.021 0 C-N-CA 125.41 1.481 . . . . 0.0 113.856 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 8.0 p -130.77 148.81 52.59 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.911 1.685 . . . . 0.0 111.624 -175.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.569 ' CG1' HD21 ' A' ' 277' ' ' LEU . 13.4 m -130.25 147.9 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.004 1.322 . . . . 0.0 110.376 169.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 38.4 m -80.15 155.97 27.2 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.469 169.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.2 159.21 29.13 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 -172.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -58.06 -51.79 68.21 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.781 1.632 . . . . 0.0 112.237 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -172.16 -178.3 2.05 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.8 2.44 . . . . 0.0 109.398 159.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 17.9 tt -56.09 -33.21 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.095 1.358 . . . . 0.0 114.29 -175.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.31 -34.19 72.02 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 175.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.47 -22.2 25.07 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 119.208 -0.425 . . . . 0.0 111.674 -161.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 7.9 mp -50.09 -50.42 48.29 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.636 1.174 . . . . 0.0 109.848 163.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -62.92 -36.05 82.11 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -172.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.34 -51.73 27.86 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.465 1.106 . . . . 0.0 111.839 170.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -67.17 -32.41 73.48 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.48 1.512 . . . . 0.0 113.548 -172.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -62.65 -31.3 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 120.949 -1.094 . . . . 0.0 112.531 -178.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -82.33 -16.16 50.27 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.204 1.002 . . . . 0.0 113.308 174.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -89.0 -42.05 12.0 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.851 1.26 . . . . 0.0 112.438 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -101.48 -21.51 14.75 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -166.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -67.27 115.13 6.59 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 119.145 0.884 . . . . 0.0 110.999 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 91.67 0.3 72.66 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.03 1.3 . . . . 0.0 114.55 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -90.75 130.59 36.72 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.687 1.243 . . . . 0.0 111.23 -178.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 22.5 p -92.26 134.51 34.82 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 120.341 -1.474 . . . . 0.0 113.261 -175.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 49.1 mt -138.16 101.78 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.416 1.087 . . . . 0.0 109.68 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 53.34 38.84 28.79 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.913 1.685 . . . . 0.0 113.224 170.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 168.56 -128.82 1.76 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.017 0.818 . . . . 0.0 112.953 -169.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -90.63 -168.46 2.1 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.62 0.768 . . . . 0.0 110.372 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 34.4 m -68.46 145.89 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 O-C-N 120.896 -1.128 . . . . 0.0 109.587 164.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 42.7 tp -83.84 141.91 31.0 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.281 1.433 . . . . 0.0 109.309 167.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -126.64 154.31 44.17 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.976 0.911 . . . . 0.0 109.376 159.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 41.1 t -136.35 127.94 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.582 1.553 . . . . 0.0 108.838 -169.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -136.04 153.21 51.42 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.901 1.28 . . . . 0.0 112.817 -167.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 89.8 p -82.78 173.97 11.39 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.216 -0.927 . . . . 0.0 112.193 172.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 67.1 mttm . . . . . 0 CA--C 1.552 1.022 0 O-C-N 121.629 -0.669 . . . . 0.0 111.996 157.803 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 . . . . . 0 N--CA 1.47 0.545 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 25.7 m -125.47 154.35 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.183 1.393 . . . . 0.0 110.341 165.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.1 mp -115.1 134.24 58.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.998 1.719 . . . . 0.0 107.434 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 20.5 m -105.78 129.65 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.233 1.013 . . . . 0.0 109.968 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -138.95 64.27 1.48 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.318 1.447 . . . . 0.0 111.257 -162.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -169.12 -40.48 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.179 1.792 . . . . 0.0 113.07 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 48.9 mt -57.19 116.58 14.03 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 127.16 2.184 . . . . 0.0 110.221 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -91.25 -170.17 0.33 Allowed 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 124.669 3.579 . . . . 0.0 112.342 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -56.56 -25.77 53.19 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -175.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 15.7 m -72.81 -16.58 61.61 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.441 1.096 . . . . 0.0 113.958 -177.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 1.3 p -108.34 105.67 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.926 2.09 . . . . 0.0 108.047 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -79.63 168.26 19.62 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.537 1.135 . . . . 0.0 111.912 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.7 -36.29 73.99 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 120.894 -1.129 . . . . 0.0 112.62 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -68.77 -32.93 73.03 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.333 -0.854 . . . . 0.0 112.233 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.53 -39.93 77.22 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.461 -0.781 . . . . 0.0 112.438 170.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.48 HD23 ' C ' ' A' ' 277' ' ' LEU . 4.2 tt -54.33 -48.3 71.53 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.938 0.895 . . . . 0.0 109.856 170.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.83 -39.85 68.96 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.387 0.675 . . . . 0.0 112.161 175.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -68.88 -20.73 64.27 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 27.5 mt -60.13 -46.96 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 120.04 1.291 . . . . 0.0 112.259 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -98.43 -9.43 25.18 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.188 0.995 . . . . 0.0 113.429 -173.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -71.58 -0.74 11.38 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 128.23 2.612 . . . . 0.0 115.086 -177.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -61.56 -15.42 38.53 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 120.43 -1.419 . . . . 0.0 114.011 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 63.3 m -68.98 -3.35 12.59 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.678 1.591 . . . . 0.0 114.398 172.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 87.25 -52.99 4.39 Favored Glycine 0 N--CA 1.473 1.103 0 C-N-CA 126.074 1.797 . . . . 0.0 111.456 -176.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -72.16 170.23 14.44 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.31 1.044 . . . . 0.0 111.044 162.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.6 p -145.72 146.35 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.03 0.932 . . . . 0.0 111.827 164.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -77.53 -107.72 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.221 1.408 . . . . 0.0 112.158 177.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -158.38 149.25 20.55 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.3 1.84 . . . . 0.0 111.354 -171.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.31 165.65 34.26 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.478 1.111 . . . . 0.0 111.514 177.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -161.34 166.93 26.74 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.113 1.365 . . . . 0.0 111.619 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 14.8 m -145.48 153.82 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 126.516 1.926 . . . . 0.0 110.97 -171.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -106.45 117.63 34.53 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.344 1.057 . . . . 0.0 108.716 170.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 12.9 mt -89.77 160.22 16.65 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.642 0.734 . . . . 0.0 112.497 -175.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -78.77 137.46 37.75 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.753 1.221 . . . . 0.0 110.616 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -70.2 -8.03 61.14 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 116.488 1.355 . . . . 0.0 116.488 -162.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -79.78 -0.43 34.39 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 118.797 1.299 . . . . 0.0 112.699 166.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 88.55 48.48 3.95 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.429 1.49 . . . . 0.0 111.789 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 39.5 t -132.15 140.54 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.377 1.071 . . . . 0.0 110.78 -170.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 22.2 p -65.28 158.01 27.49 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.457 1.503 . . . . 0.0 114.021 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 21.7 p -139.15 -16.82 1.06 Allowed 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -168.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 67.85 -71.8 0.28 Allowed Glycine 0 N--CA 1.476 1.3 0 C-N-CA 126.26 1.886 . . . . 0.0 113.611 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 49.9 p -36.7 126.94 0.87 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.915 2.486 . . . . 0.0 113.881 167.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 176.34 -165.22 35.49 Favored Glycine 0 N--CA 1.471 1.027 0 N-CA-C 115.256 0.862 . . . . 0.0 115.256 -175.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 16.6 p -100.46 137.53 38.75 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.621 1.968 . . . . 0.0 110.893 -174.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.3 t -119.85 119.52 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.626 1.57 . . . . 0.0 107.111 172.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 53.7 m -93.81 110.16 21.82 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.774 1.229 . . . . 0.0 108.208 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.51 158.28 24.54 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -159.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -51.83 -54.17 31.9 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.675 1.19 . . . . 0.0 111.147 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -172.97 169.3 4.74 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 128.641 2.776 . . . . 0.0 109.272 161.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 19.5 tt -54.35 -29.02 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.325 1.05 . . . . 0.0 113.719 177.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.38 -37.91 62.87 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.17 1.388 . . . . 0.0 114.736 171.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -104.49 -20.88 13.56 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 7.0 tt -55.08 -51.55 66.01 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.332 1.453 . . . . 0.0 111.332 177.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -69.02 -24.16 64.16 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 33.6 mtp-105 -70.36 -44.28 68.45 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.135 0.974 . . . . 0.0 110.773 168.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -68.4 -43.26 77.67 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.215 1.406 . . . . 0.0 113.349 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 2.6 pt -70.96 -16.67 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 177.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -82.05 -40.91 21.35 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.84 0.856 . . . . 0.0 110.831 168.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -70.3 -53.74 15.56 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.451 1.1 . . . . 0.0 113.605 -178.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -90.18 -24.26 21.08 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -163.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -62.72 121.53 13.62 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 119.364 0.984 . . . . 0.0 110.244 173.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 101.82 0.32 52.23 Favored Glycine 0 CA--C 1.538 1.499 0 CA-C-O 118.833 -0.982 . . . . 0.0 115.098 -174.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -108.1 145.34 34.21 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.998 1.399 . . . . 0.0 112.032 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 62.1 m -112.59 129.15 56.47 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 120.779 -1.201 . . . . 0.0 111.974 -174.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 55.5 mt -137.33 106.95 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.298 1.039 . . . . 0.0 109.915 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 56.19 33.31 21.87 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.463 1.505 . . . . 0.0 112.95 170.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 171.78 -135.63 3.5 Favored Glycine 0 C--N 1.341 0.843 0 O-C-N 121.122 -0.986 . . . . 0.0 113.94 -168.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -99.8 165.31 11.64 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.164 0.986 . . . . 0.0 110.78 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 9.0 p -60.12 130.09 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.8 0.84 . . . . 0.0 112.771 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 35.9 mt -57.37 127.97 34.65 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.661 1.584 . . . . 0.0 113.923 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -134.02 122.57 23.2 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.527 2.731 . . . . 0.0 107.33 173.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 13.6 t -136.59 126.57 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.726 1.21 . . . . 0.0 109.476 -162.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -135.33 134.05 39.43 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.729 0.812 . . . . 0.0 111.532 -170.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 95.9 p -82.38 155.28 24.79 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.824 -1.173 . . . . 0.0 113.589 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 54.7 tptt . . . . . 0 CA--C 1.555 1.137 0 C-N-CA 125.386 1.474 . . . . 0.0 111.579 178.061 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.541 0.628 0 N-CA-C 111.544 0.201 . . . . 0.0 111.544 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 31.0 m -138.49 153.88 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.568 1.147 . . . . 0.0 110.919 175.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 2.7 mp -103.93 134.32 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 30.7 m -107.36 132.26 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.916 1.286 . . . . 0.0 108.134 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -149.71 55.33 0.95 Allowed 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -154.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -167.58 -24.46 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.337 1.055 . . . . 0.0 113.728 172.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 52.6 mt -47.39 127.02 9.93 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 126.205 1.802 . . . . 0.0 111.311 165.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -82.78 173.28 10.45 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.879 3.053 . . . . 0.0 110.154 172.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -62.61 0.3 0.52 Allowed 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 8.3 t -65.67 -31.11 71.94 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.435 1.094 . . . . 0.0 113.089 171.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 8.0 p -83.24 130.0 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 118.457 0.571 . . . . 0.0 109.801 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -94.08 159.84 14.97 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.753 1.221 . . . . 0.0 111.16 177.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -48.62 -40.88 29.21 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -68.21 -39.35 82.43 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.458 -0.776 . . . . 0.0 111.727 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.42 -32.55 71.59 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.438 -0.789 . . . . 0.0 112.491 172.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.489 HD21 ' CG1' ' A' ' 306' ' ' VAL . 1.9 tt -62.26 -38.96 91.31 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.312 1.045 . . . . 0.0 112.0 171.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -60.5 -48.7 80.62 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.549 -0.719 . . . . 0.0 110.012 171.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -59.7 -24.43 63.96 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.26 1.424 . . . . 0.0 114.171 -175.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 9.1 mt -49.56 -39.86 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 125.117 1.367 . . . . 0.0 111.687 171.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -110.52 -35.19 6.09 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.051 1.34 . . . . 0.0 111.592 -176.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -61.31 -7.17 2.66 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.596 1.558 . . . . 0.0 113.915 174.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -44.95 -31.04 1.14 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.017 1.327 . . . . 0.0 112.955 159.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 83.5 m -64.37 -7.09 8.46 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 176.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 91.18 -3.01 79.74 Favored Glycine 0 N--CA 1.477 1.424 0 C-N-CA 125.678 1.609 . . . . 0.0 114.958 177.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -138.36 178.3 7.24 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.207 2.203 . . . . 0.0 109.496 176.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.11 142.03 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 120.458 -1.402 . . . . 0.0 112.912 177.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -83.65 -106.42 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.256 1.422 . . . . 0.0 110.161 167.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -148.69 147.0 28.39 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.848 1.659 . . . . 0.0 111.834 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.08 148.66 20.58 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.577 1.151 . . . . 0.0 111.628 -176.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -168.27 160.04 11.2 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.843 1.657 . . . . 0.0 110.943 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.68 131.71 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 126.827 2.051 . . . . 0.0 110.271 177.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -75.29 130.33 38.9 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.659 0.783 . . . . 0.0 110.534 167.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 10.4 mt -87.43 153.48 21.4 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.303 0.641 . . . . 0.0 111.392 -178.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -76.81 149.83 36.18 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.867 0.867 . . . . 0.0 112.537 -177.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -67.29 -15.74 66.07 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.801 1.191 . . . . 0.0 115.483 -176.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -81.68 0.16 39.99 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 119.059 1.429 . . . . 0.0 113.193 168.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 85.45 47.35 5.19 Favored Glycine 0 N--CA 1.469 0.889 0 C-N-CA 124.944 1.259 . . . . 0.0 113.402 171.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 35.5 m -137.54 151.18 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.658 1.183 . . . . 0.0 112.24 -176.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 10.9 m -90.04 11.69 19.94 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 -150.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 18.2 p 45.59 80.53 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 127.263 2.225 . . . . 0.0 114.16 167.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -69.36 -47.09 53.67 Favored Glycine 0 N--CA 1.472 1.069 0 O-C-N 121.692 -0.63 . . . . 0.0 113.481 -175.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 5.9 p -60.26 117.69 5.48 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.849 1.259 . . . . 0.0 110.932 164.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -179.13 -160.87 25.7 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.394 0.997 . . . . 0.0 115.336 -173.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 14.2 p -104.77 146.64 28.69 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.152 1.781 . . . . 0.0 112.867 -169.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.489 ' CG1' HD21 ' A' ' 277' ' ' LEU . 0.8 OUTLIER -145.71 137.23 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.314 1.446 . . . . 0.0 109.912 169.054 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 8.7 t -102.29 144.55 30.66 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.86 0.864 . . . . 0.0 110.993 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -104.01 158.76 16.2 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -165.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -57.34 -55.93 28.45 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.145 -1.388 . . . . 0.0 111.152 175.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -172.64 179.78 2.34 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 128.46 2.704 . . . . 0.0 108.521 161.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.23 -25.37 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.637 1.175 . . . . 0.0 112.075 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.18 -33.56 41.28 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 168.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.56 -26.07 9.66 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.315 0.646 . . . . 0.0 112.514 -174.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 6.5 tt -55.05 -49.25 72.07 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.534 1.534 . . . . 0.0 111.041 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -68.82 -30.76 69.38 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.404 -0.81 . . . . 0.0 113.042 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 33.9 mtm180 -69.62 -37.4 76.82 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 121.52 -0.737 . . . . 0.0 111.107 174.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -70.48 -47.89 58.36 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.2 1.4 . . . . 0.0 112.284 174.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 3.5 pt -68.87 -21.65 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -75.38 -31.6 60.54 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 118.822 0.737 . . . . 0.0 112.205 170.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -88.91 -53.1 4.76 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.792 0.837 . . . . 0.0 113.081 -176.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -90.14 -16.98 28.47 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -164.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -71.49 110.2 5.94 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 121.102 -0.999 . . . . 0.0 110.013 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 99.21 0.12 57.14 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 125.193 1.377 . . . . 0.0 114.537 -170.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -98.55 145.67 26.58 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.193 1.397 . . . . 0.0 111.312 175.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 18.7 p -110.19 128.43 55.48 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.25 1.02 . . . . 0.0 113.155 -173.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 18.6 mt -143.9 115.48 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.883 1.273 . . . . 0.0 109.042 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 61.73 25.81 15.6 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.924 1.29 . . . . 0.0 113.449 173.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 173.87 -134.43 2.86 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 120.996 -1.065 . . . . 0.0 114.076 -171.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -86.39 -176.14 5.76 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.824 0.849 . . . . 0.0 109.751 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 19.9 m -58.94 142.84 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 O-C-N 120.981 -1.074 . . . . 0.0 108.687 155.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 3.0 pp -98.43 143.03 29.31 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.773 0.797 . . . . 0.0 111.006 175.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -125.58 137.06 53.9 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.779 1.632 . . . . 0.0 108.953 173.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 12.5 t -118.44 137.19 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.574 1.549 . . . . 0.0 110.026 -165.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -134.81 159.25 41.97 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.755 1.622 . . . . 0.0 112.328 -171.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 35.0 t -114.9 148.25 38.88 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.412 1.085 . . . . 0.0 112.101 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 77.0 tttt . . . . . 0 CA--C 1.554 1.104 0 C-N-CA 124.749 1.22 . . . . 0.0 112.946 172.404 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 . . . . . 0 CA--C 1.54 0.589 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 15.6 m -135.91 156.82 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 125.159 1.384 . . . . 0.0 111.584 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 5.4 mp -116.13 138.32 46.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 126.858 2.063 . . . . 0.0 107.129 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 34.3 m -120.22 129.76 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.28 1.032 . . . . 0.0 109.338 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -146.17 58.5 1.22 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.779 0.8 . . . . 0.0 111.907 -157.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -164.36 -45.14 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.798 1.239 . . . . 0.0 111.471 -176.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 27.7 mt -40.12 117.53 1.32 Allowed Pre-proline 0 CA--C 1.557 1.242 0 C-N-CA 126.099 1.76 . . . . 0.0 111.496 158.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -95.33 -177.95 0.47 Allowed 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.633 3.555 . . . . 0.0 111.703 -176.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -54.44 -14.19 1.16 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.577 1.551 . . . . 0.0 115.16 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 17.1 m -65.91 -21.12 66.42 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.111 1.364 . . . . 0.0 113.987 172.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 8.2 p -101.4 132.84 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 119.428 1.013 . . . . 0.0 110.643 172.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -90.59 157.1 17.68 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.271 1.428 . . . . 0.0 111.373 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -59.59 -31.62 69.63 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 120.478 -1.389 . . . . 0.0 113.213 178.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -68.24 -34.59 76.5 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.282 -0.886 . . . . 0.0 111.042 176.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.94 -38.8 76.27 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 117.733 -1.127 . . . . 0.0 113.098 168.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.495 HD23 ' C ' ' A' ' 277' ' ' LEU . 3.9 tt -53.37 -51.25 63.11 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.84 1.2 . . . . 0.0 109.883 172.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -48.84 -44.52 39.61 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.138 0.975 . . . . 0.0 111.953 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -68.71 -25.49 64.79 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 21.1 mt -53.32 -45.05 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 124.627 1.171 . . . . 0.0 111.377 176.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -98.09 -34.15 10.88 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.449 1.1 . . . . 0.0 111.627 -175.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -61.17 -10.33 6.35 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.611 1.164 . . . . 0.0 113.803 173.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 15.4 tm-20 -52.23 -24.71 7.69 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.638 1.575 . . . . 0.0 113.484 165.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 87.0 m -63.82 -8.21 10.15 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 172.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 88.8 2.28 78.83 Favored Glycine 0 N--CA 1.479 1.516 0 C-N-CA 124.663 1.125 . . . . 0.0 114.777 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -138.39 -177.92 5.06 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 127.237 2.215 . . . . 0.0 108.227 172.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.6 p -132.01 146.75 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 120.828 1.649 . . . . 0.0 114.063 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -106.48 -120.03 0.24 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.27 1.828 . . . . 0.0 110.821 171.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -161.08 156.69 24.92 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.602 1.961 . . . . 0.0 112.733 -174.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.39 164.85 35.9 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.487 1.115 . . . . 0.0 113.174 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -156.64 160.03 39.01 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.279 1.832 . . . . 0.0 110.995 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 3.5 t -151.63 141.58 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.354 1.462 . . . . 0.0 109.555 -172.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -113.06 134.49 54.5 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.463 1.105 . . . . 0.0 109.515 168.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 13.9 mt -98.69 172.59 7.37 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.182 0.993 . . . . 0.0 113.037 -170.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.25 153.72 0.68 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.094 2.158 . . . . 0.0 113.277 165.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -72.09 -3.92 57.87 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.911 1.243 . . . . 0.0 115.808 -172.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -114.65 0.62 13.97 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 126.267 1.827 . . . . 0.0 111.709 168.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 94.84 8.93 58.93 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 126.345 1.926 . . . . 0.0 114.476 176.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 4.8 t -87.58 58.28 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 118.819 1.31 . . . . 0.0 111.074 -171.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 75.6 m 61.1 -168.08 0.18 Allowed 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 126.325 1.85 . . . . 0.0 114.501 170.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -167.04 -45.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 127.249 2.22 . . . . 0.0 112.276 175.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 82.08 -57.14 4.98 Favored Glycine 0 N--CA 1.472 1.042 0 C-N-CA 125.252 1.406 . . . . 0.0 112.051 -176.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 61.9 p -55.57 111.04 0.8 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.715 1.606 . . . . 0.0 112.459 169.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -139.37 -166.35 10.59 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.008 1.29 . . . . 0.0 113.996 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 93.7 m -115.99 141.63 47.87 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.528 1.931 . . . . 0.0 108.934 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 t -129.9 116.11 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 125.446 1.498 . . . . 0.0 107.412 -173.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 46.2 m -101.52 110.25 22.22 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.223 1.409 . . . . 0.0 108.176 -174.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.28 168.65 12.53 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -151.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -53.68 -65.31 0.59 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.847 1.259 . . . . 0.0 111.024 175.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -172.65 -175.73 1.37 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 129.153 2.981 . . . . 0.0 108.005 162.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 16.3 tt -55.14 -37.03 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -175.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -49.63 67.76 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -92.05 -18.82 23.06 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.439 0.296 . . . . 0.0 110.836 -174.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 57.5 tp -66.25 -47.36 73.97 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.462 0.705 . . . . 0.0 111.093 171.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -68.32 -20.87 64.78 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.342 -0.848 . . . . 0.0 113.037 178.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 35.5 mtp85 -70.61 -54.57 11.51 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.36 1.064 . . . . 0.0 111.621 162.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.03 -43.99 82.48 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.026 1.33 . . . . 0.0 113.752 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 2.6 pp -65.38 -21.35 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 177.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -82.6 -46.32 13.46 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.438 1.095 . . . . 0.0 111.199 172.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -71.57 -47.99 51.32 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -176.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -98.39 -22.26 16.16 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -163.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -67.15 120.47 13.78 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.872 -1.142 . . . . 0.0 110.494 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 92.37 -1.0 72.18 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.071 1.319 . . . . 0.0 114.95 -173.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -98.59 139.76 33.83 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.126 1.463 . . . . 0.0 111.328 177.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 23.7 p -103.15 133.99 47.33 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.136 0.975 . . . . 0.0 113.155 -174.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 56.3 mt -144.17 113.59 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.953 1.301 . . . . 0.0 108.763 -176.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 58.07 25.84 12.87 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.806 1.242 . . . . 0.0 113.832 176.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 166.37 -129.63 1.97 Allowed Glycine 0 C--N 1.342 0.905 0 C-N-CA 124.424 1.012 . . . . 0.0 113.194 -176.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -83.76 177.7 8.25 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.889 0.876 . . . . 0.0 111.099 -177.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 32.9 m -62.69 149.83 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 O-C-N 121.55 -0.718 . . . . 0.0 110.739 166.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 10.9 mt -73.35 137.18 44.59 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.186 0.994 . . . . 0.0 111.489 170.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -125.37 108.48 11.72 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.667 1.587 . . . . 0.0 107.747 167.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.84 120.96 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.27 1.428 . . . . 0.0 109.798 -165.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -139.54 162.5 34.93 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.391 1.477 . . . . 0.0 111.859 -171.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 77.8 p -145.19 159.18 43.39 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 120.869 -1.145 . . . . 0.0 113.078 -176.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? . . . . . 0 CA--C 1.551 1.006 0 C-N-CA 124.393 1.077 . . . . 0.0 111.981 179.378 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 . . . . . 0 CA--C 1.549 0.937 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 16.1 m -137.03 159.76 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.248 1.019 . . . . 0.0 111.069 173.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.4 mp -131.66 141.47 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 127.249 2.22 . . . . 0.0 107.469 -175.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 19.4 m -129.68 133.43 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.834 0.854 . . . . 0.0 111.086 -174.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -148.57 73.23 1.22 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.863 1.265 . . . . 0.0 112.772 -164.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -169.12 -41.68 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.627 1.571 . . . . 0.0 111.237 171.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 49.6 mt -28.17 110.92 0.24 Allowed Pre-proline 0 CA--C 1.561 1.396 0 C-N-CA 127.159 2.183 . . . . 0.0 111.415 153.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -95.64 -170.64 0.18 Allowed 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 125.238 3.959 . . . . 0.0 112.658 -175.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -58.1 -20.25 38.55 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -173.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 58.8 m -76.93 -11.6 59.83 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 176.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 1.4 p -108.51 145.56 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 126.969 2.107 . . . . 0.0 108.227 167.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -155.59 174.63 14.99 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.678 1.591 . . . . 0.0 109.638 -176.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -41.99 -49.41 4.65 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.817 1.647 . . . . 0.0 114.853 -170.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -68.52 -35.71 77.86 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 118.916 0.78 . . . . 0.0 112.18 -175.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.37 -37.75 74.64 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 168.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 7.8 tt -61.79 -35.3 77.77 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.233 0.613 . . . . 0.0 111.727 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -53.03 -52.39 58.63 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.686 0.676 . . . . 0.0 110.641 170.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -59.63 -27.99 66.82 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.041 1.336 . . . . 0.0 113.331 -175.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 32.9 mt -51.7 -45.7 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.782 1.233 . . . . 0.0 112.082 173.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -106.17 -24.6 12.29 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.164 0.986 . . . . 0.0 112.548 -174.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -64.03 -2.93 2.21 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 126.626 1.97 . . . . 0.0 114.713 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -57.82 -20.76 38.22 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 120.567 -1.333 . . . . 0.0 113.307 168.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 72.0 m -69.02 0.32 4.71 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 125.436 1.494 . . . . 0.0 114.451 170.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 100.32 -76.69 0.44 Allowed Glycine 0 C--N 1.342 0.875 0 C-N-CA 126.36 1.933 . . . . 0.0 110.876 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -73.46 175.53 6.91 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.286 1.034 . . . . 0.0 111.173 172.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.01 142.08 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 120.65 -1.281 . . . . 0.0 111.442 172.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -76.95 -96.28 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.749 1.22 . . . . 0.0 111.142 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -160.66 147.07 15.24 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.633 1.573 . . . . 0.0 111.978 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.48 172.01 19.11 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.968 -1.082 . . . . 0.0 112.185 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -158.26 153.22 25.23 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -178.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 27.2 t -157.28 136.25 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 129.476 3.11 . . . . 0.0 105.674 176.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -132.24 144.27 50.51 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.02 0.528 . . . . 0.0 111.892 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 9.1 mp -64.77 144.07 57.5 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.6 1.16 . . . . 0.0 111.755 175.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -69.79 151.41 45.8 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.864 1.266 . . . . 0.0 111.339 169.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -64.86 -11.31 49.85 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.949 1.261 . . . . 0.0 115.348 -176.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -70.49 -6.45 36.19 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 118.782 1.291 . . . . 0.0 113.151 166.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 85.74 49.19 4.42 Favored Glycine 0 C--N 1.343 0.918 0 C-N-CA 125.481 1.515 . . . . 0.0 112.367 176.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 9.5 p -155.13 143.83 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.922 0.889 . . . . 0.0 112.135 -170.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 38.3 t -68.15 170.34 8.72 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.414 1.086 . . . . 0.0 113.209 176.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 12.1 t -144.15 -25.02 0.54 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -173.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 73.98 -48.25 1.67 Allowed Glycine 0 N--CA 1.475 1.246 0 C-N-CA 125.624 1.583 . . . . 0.0 114.589 177.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 7.8 p -51.07 123.12 8.67 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.542 1.937 . . . . 0.0 112.411 168.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -168.74 -168.6 31.04 Favored Glycine 0 N--CA 1.469 0.894 0 C-N-CA 124.075 0.845 . . . . 0.0 115.177 -174.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 18.7 p -115.56 152.54 32.86 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.259 1.824 . . . . 0.0 111.073 -170.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.5 t -138.99 120.53 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.177 1.391 . . . . 0.0 108.095 -177.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 4.5 t -100.12 108.22 20.31 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.398 1.079 . . . . 0.0 108.849 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.25 162.09 22.45 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -158.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -53.91 -63.51 1.13 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.906 1.282 . . . . 0.0 111.052 174.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -172.32 -176.34 1.57 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.995 2.518 . . . . 0.0 109.533 159.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.5 mp -49.11 -39.08 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 125.605 1.562 . . . . 0.0 113.569 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.25 -42.03 66.06 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 177.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -95.21 -31.43 13.5 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 123.321 0.388 . . . . 0.0 110.617 -174.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.5 tt -55.93 -51.32 68.08 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 125.469 1.508 . . . . 0.0 110.755 175.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -61.92 -46.59 88.69 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.056 0.844 . . . . 0.0 112.516 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -70.45 -32.74 70.43 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 176.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -65.87 -38.37 88.61 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.18 0.992 . . . . 0.0 112.045 171.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -57.74 -40.86 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.653 1.181 . . . . 0.0 112.168 176.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -81.99 -24.57 35.38 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -79.27 -45.09 20.42 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.355 1.062 . . . . 0.0 112.959 -177.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -103.68 -26.18 12.86 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -167.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -65.32 116.26 6.46 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 119.682 1.128 . . . . 0.0 110.023 173.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 99.61 0.55 56.58 Favored Glycine 0 CA--C 1.538 1.486 0 CA-C-O 119.101 -0.833 . . . . 0.0 114.962 -174.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -104.27 151.7 23.09 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.795 1.638 . . . . 0.0 111.63 175.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 26.9 p -111.92 134.11 53.69 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 120.433 -1.417 . . . . 0.0 113.09 -177.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 59.3 mt -145.27 118.71 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.898 1.279 . . . . 0.0 109.604 -176.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 57.15 23.27 8.39 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.636 1.574 . . . . 0.0 114.32 173.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 170.17 -119.84 0.83 Allowed Glycine 0 C--N 1.341 0.839 0 O-C-N 120.992 -1.067 . . . . 0.0 113.029 -177.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -86.03 176.66 7.9 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.355 0.662 . . . . 0.0 111.079 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 9.4 p -57.1 138.45 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 121.655 -0.653 . . . . 0.0 109.335 155.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 1.5 pp -100.48 145.03 28.76 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.831 0.824 . . . . 0.0 111.432 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -126.28 137.9 53.55 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.038 1.735 . . . . 0.0 109.374 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 18.5 t -120.54 132.19 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.36 1.464 . . . . 0.0 109.996 -170.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -131.41 154.72 48.36 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.377 1.871 . . . . 0.0 110.652 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 79.3 p -145.14 167.37 22.9 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 120.599 -1.313 . . . . 0.0 112.754 -172.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt . . . . . 0 CA--C 1.547 0.831 0 C-N-CA 123.904 0.882 . . . . 0.0 111.945 176.319 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 . . . . . 0 N--CA 1.469 0.511 0 CA-C-O 121.148 0.499 . . . . 0.0 112.289 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 21.2 t -126.96 140.01 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 127.33 2.252 . . . . 0.0 108.499 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.4 mp -106.79 131.04 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.736 1.614 . . . . 0.0 107.057 175.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 23.0 m -110.59 126.39 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.617 0.767 . . . . 0.0 109.232 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -148.69 59.64 1.07 Allowed 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 121.64 0.733 . . . . 0.0 112.127 -155.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -171.42 -38.26 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 126.116 1.767 . . . . 0.0 111.285 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -34.29 122.52 0.53 Allowed Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 126.637 1.975 . . . . 0.0 111.517 162.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -86.18 167.13 9.39 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.46 3.44 . . . . 0.0 110.671 175.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -60.53 -4.6 0.94 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -174.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 8.3 t -60.58 -31.05 70.2 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.606 1.163 . . . . 0.0 113.205 169.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 8.8 p -79.73 121.63 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 121.639 0.733 . . . . 0.0 111.511 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -79.15 156.68 28.14 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.965 1.306 . . . . 0.0 110.6 170.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -52.04 -37.92 55.28 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 120.804 -1.185 . . . . 0.0 113.087 178.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -71.42 -38.24 71.41 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.502 -0.749 . . . . 0.0 111.354 178.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.98 -26.36 64.99 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.05 -1.031 . . . . 0.0 112.651 171.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.793 HD21 HG12 ' A' ' 306' ' ' VAL . 1.8 tt -66.95 -46.93 73.22 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.623 0.769 . . . . 0.0 111.367 170.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . 0.469 ' N ' HD23 ' A' ' 277' ' ' LEU . 0.0 OUTLIER -69.26 -28.56 66.42 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.808 1.186 . . . . 0.0 111.218 177.907 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -64.99 -23.17 67.14 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.675 1.19 . . . . 0.0 113.258 173.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 41.3 mt -55.02 -51.33 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 119.226 0.921 . . . . 0.0 110.315 171.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -91.09 -18.73 24.06 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.267 1.027 . . . . 0.0 112.508 -173.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -57.17 -17.86 12.98 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.863 1.665 . . . . 0.0 114.146 176.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -57.17 -14.86 4.56 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.343 1.457 . . . . 0.0 114.146 173.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 9.3 t -66.15 -11.38 48.98 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 171.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 91.23 -3.29 79.79 Favored Glycine 0 N--CA 1.479 1.537 0 C-N-CA 125.488 1.518 . . . . 0.0 114.219 -177.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -138.53 -179.6 5.91 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.971 2.509 . . . . 0.0 108.189 171.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 5.0 p -145.78 143.3 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 120.158 1.345 . . . . 0.0 112.68 164.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -78.77 -94.73 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.529 1.532 . . . . 0.0 112.183 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -170.6 153.47 4.18 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 127.717 2.407 . . . . 0.0 110.072 -167.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.56 170.15 22.82 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.156 -0.965 . . . . 0.0 112.626 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -149.65 143.27 25.4 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.43 1.092 . . . . 0.0 113.314 -177.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 32.2 t -158.66 136.82 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 127.498 2.319 . . . . 0.0 107.999 -171.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -132.67 128.06 36.2 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.998 0.919 . . . . 0.0 110.322 170.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 12.1 mt -75.49 167.68 21.45 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 122.206 1.003 . . . . 0.0 113.631 -169.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.96 151.97 0.86 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 127.842 2.457 . . . . 0.0 113.804 167.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -70.9 -6.93 60.99 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.938 1.256 . . . . 0.0 116.082 -172.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -109.72 0.43 18.92 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.101 1.76 . . . . 0.0 111.83 169.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 95.26 8.6 58.66 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.735 2.112 . . . . 0.0 114.393 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 6.2 t -90.19 58.74 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 118.804 1.302 . . . . 0.0 111.019 -166.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 7.6 t 60.36 -163.48 0.24 Allowed 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 125.598 1.559 . . . . 0.0 114.096 172.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -166.47 143.53 5.02 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 129.041 2.937 . . . . 0.0 108.631 173.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -89.11 -76.9 1.3 Allowed Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.148 0.88 . . . . 0.0 112.086 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 32.2 p -54.92 149.34 11.74 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.372 1.469 . . . . 0.0 113.676 169.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -163.32 -177.46 36.26 Favored Glycine 0 N--CA 1.471 1.028 0 C-N-CA 125.045 1.307 . . . . 0.0 114.664 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 40.6 m -116.38 135.3 53.98 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.503 1.521 . . . . 0.0 108.623 -177.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.793 HG12 HD21 ' A' ' 277' ' ' LEU . 13.2 m -129.93 130.73 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.066 0.946 . . . . 0.0 109.181 178.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 33.0 m -90.52 115.51 27.72 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.953 0.901 . . . . 0.0 108.715 -175.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -83.59 147.54 27.67 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -163.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -49.78 -55.62 13.38 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.95 1.3 . . . . 0.0 112.573 -175.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.59 172.84 4.15 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.85 2.06 . . . . 0.0 110.039 162.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.42 -24.84 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.3 1.04 . . . . 0.0 112.422 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -45.54 69.72 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 169.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -98.18 -20.04 17.52 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.35 0.523 . . . . 0.0 111.947 -175.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -49.3 -52.15 29.5 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.066 1.747 . . . . 0.0 111.117 174.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -67.32 -29.67 69.3 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -70.49 -52.25 23.32 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.314 0.645 . . . . 0.0 110.888 170.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -59.65 -35.9 75.33 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.276 1.43 . . . . 0.0 113.004 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -50.67 -44.38 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.639 1.176 . . . . 0.0 112.393 176.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -90.39 -34.35 15.68 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 177.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -62.43 -40.08 95.4 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.994 -1.066 . . . . 0.0 113.025 -176.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -92.98 -13.39 28.82 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -62.71 115.28 4.17 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.532 -0.73 . . . . 0.0 110.189 169.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 91.93 0.18 72.01 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-O 118.935 -0.925 . . . . 0.0 114.898 -175.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -103.42 135.54 44.85 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.011 1.405 . . . . 0.0 111.5 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 30.1 p -112.82 133.48 54.79 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.411 1.084 . . . . 0.0 112.563 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -144.0 119.65 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.579 1.151 . . . . 0.0 109.015 -170.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 56.94 28.35 14.54 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.447 1.099 . . . . 0.0 113.44 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 149.18 -119.67 1.08 Allowed Glycine 0 C--N 1.343 0.964 0 C-N-CA 124.433 1.016 . . . . 0.0 113.09 -174.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -89.67 175.32 7.3 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.112 0.965 . . . . 0.0 112.239 -169.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.94 137.06 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.161 0.984 . . . . 0.0 110.014 169.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.56 124.57 24.97 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.726 0.81 . . . . 0.0 111.832 -177.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.5 113.43 24.81 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 158.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 91.4 t -105.83 121.22 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.648 1.179 . . . . 0.0 108.609 177.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -140.98 133.69 28.79 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.239 1.416 . . . . 0.0 110.042 175.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 65.2 p -82.9 166.61 18.76 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.377 -0.827 . . . . 0.0 111.811 173.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 86.1 tttt . . . . . 0 CA--C 1.547 0.863 0 O-C-N 121.244 -0.91 . . . . 0.0 111.001 174.712 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.538 0.507 0 CA-C-O 120.999 0.428 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 65.5 t -151.32 146.35 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 126.642 1.977 . . . . 0.0 108.898 -165.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 2.0 mp -131.29 136.99 56.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.026 1.731 . . . . 0.0 107.835 176.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 31.5 m -120.3 124.64 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.809 1.244 . . . . 0.0 108.797 -176.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -143.85 80.0 1.64 Allowed 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -156.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -172.27 -38.82 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.245 1.818 . . . . 0.0 111.105 169.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 59.0 mt -34.82 123.26 0.56 Allowed Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 128.362 2.665 . . . . 0.0 113.132 167.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -85.44 174.89 6.6 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.102 3.201 . . . . 0.0 111.459 173.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -53.87 -12.73 0.59 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.248 1.819 . . . . 0.0 115.832 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 41.2 t -55.3 -30.99 61.26 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.731 1.612 . . . . 0.0 113.746 171.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 8.8 p -91.57 122.62 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 119.318 0.963 . . . . 0.0 110.712 176.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -84.48 158.4 21.02 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.625 1.57 . . . . 0.0 111.147 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -49.85 -34.51 20.19 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 175.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -67.31 -38.31 84.75 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.97 -1.081 . . . . 0.0 111.04 177.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -76.8 -27.42 55.21 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 173.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 3.7 tp -53.6 -51.58 62.57 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 120.218 1.372 . . . . 0.0 109.491 166.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -55.22 -43.97 74.99 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 122.971 0.508 . . . . 0.0 111.067 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.45 -19.83 62.43 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.056 1.343 . . . . 0.0 114.505 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 66.0 mt -58.73 -29.67 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 119.293 0.951 . . . . 0.0 111.526 171.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -123.27 -23.05 4.96 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.54 1.136 . . . . 0.0 113.716 -175.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -65.97 -12.39 54.63 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.34 1.456 . . . . 0.0 113.892 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -60.51 -12.18 9.04 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 177.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 23.6 p -72.62 -8.62 56.16 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 170.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 93.13 13.37 56.28 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.203 1.382 . . . . 0.0 114.509 -177.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -138.45 176.51 8.63 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.417 1.887 . . . . 0.0 111.116 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 6.8 p -145.47 140.58 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 O-C-N 121.184 -0.948 . . . . 0.0 112.633 168.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -95.06 -99.15 0.16 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.103 1.361 . . . . 0.0 110.295 167.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -160.72 154.5 22.48 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.975 1.71 . . . . 0.0 111.959 176.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.04 149.85 21.73 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.119 -0.988 . . . . 0.0 111.894 -170.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -157.32 165.11 36.7 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.539 1.136 . . . . 0.0 113.881 -174.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 8.1 m -141.02 144.93 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 127.222 2.209 . . . . 0.0 110.525 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -108.94 129.3 55.43 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.471 1.109 . . . . 0.0 109.476 171.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -134.66 171.85 13.77 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.602 1.161 . . . . 0.0 113.098 -171.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -68.88 152.6 45.08 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.956 1.302 . . . . 0.0 113.144 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -70.61 -18.31 75.55 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.616 1.103 . . . . 0.0 115.252 -175.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -88.96 0.25 56.8 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 118.824 1.312 . . . . 0.0 112.67 169.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 92.61 10.77 60.04 Favored Glycine 0 N--CA 1.471 1.019 0 C-N-CA 125.004 1.287 . . . . 0.0 115.008 173.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 57.9 t -70.75 116.06 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 118.386 1.093 . . . . 0.0 108.613 172.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 68.5 p -76.69 177.35 7.62 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.063 1.345 . . . . 0.0 114.555 -170.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 21.0 p -145.28 139.48 27.12 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 127.03 2.132 . . . . 0.0 109.884 -170.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -94.74 -34.99 6.02 Favored Glycine 0 N--CA 1.472 1.045 0 C-N-CA 123.391 0.52 . . . . 0.0 113.822 175.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 17.6 t -55.73 111.96 1.04 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.825 1.25 . . . . 0.0 110.293 167.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -142.89 169.22 25.72 Favored Glycine 0 N--CA 1.471 0.981 0 C-N-CA 124.789 1.185 . . . . 0.0 114.919 -165.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 85.7 m -115.73 141.31 48.26 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.414 1.886 . . . . 0.0 109.086 -173.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.34 113.04 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 124.829 1.252 . . . . 0.0 109.613 -170.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 13.6 t -74.34 147.88 41.83 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 113.911 -1.495 . . . . 0.0 110.159 170.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.72 157.46 19.72 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 -169.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -59.2 -53.9 52.99 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 113.974 -1.466 . . . . 0.0 111.519 176.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -172.67 166.19 5.44 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.814 2.846 . . . . 0.0 108.498 171.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 67.5 mt -60.25 -30.57 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.027 0.931 . . . . 0.0 111.603 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.56 -43.38 45.95 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.935 1.294 . . . . 0.0 114.273 171.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -96.33 -22.34 17.26 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 6.0 tt -58.4 -52.19 66.67 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.708 1.203 . . . . 0.0 110.524 177.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -65.79 -28.88 69.34 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -70.16 -51.65 29.63 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.267 1.027 . . . . 0.0 110.978 172.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -61.73 -33.99 75.03 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.785 1.634 . . . . 0.0 113.191 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -56.92 -41.55 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.817 1.247 . . . . 0.0 112.72 177.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -82.61 -29.24 30.29 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 175.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -75.03 -45.44 41.7 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -171.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -100.26 -16.7 17.63 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -172.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . 0.403 ' ND2' ' H ' ' A' ' 333' ' ' VAL . 32.0 t-20 -70.35 118.62 13.39 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.437 -0.789 . . . . 0.0 110.754 178.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 102.24 0.11 50.77 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.68 1.61 . . . . 0.0 114.726 -176.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -105.47 144.24 32.52 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.941 1.371 . . . . 0.0 112.441 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 67.3 m -94.06 125.6 38.79 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.184 -0.948 . . . . 0.0 112.54 -176.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 46.5 mt -138.32 108.36 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.403 1.081 . . . . 0.0 109.427 176.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 59.48 20.31 8.72 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.77 1.628 . . . . 0.0 114.314 177.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . -168.59 -133.21 1.53 Allowed Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.157 1.36 . . . . 0.0 112.406 -176.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 49.4 p30 -98.01 -172.94 2.47 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.599 1.16 . . . . 0.0 110.282 172.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 20.4 m -58.31 131.38 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-N 119.163 0.892 . . . . 0.0 109.353 172.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 2.4 pp -91.26 138.15 31.81 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 122.378 1.085 . . . . 0.0 111.126 178.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -91.48 156.0 18.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 113.925 -1.489 . . . . 0.0 109.998 166.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.403 ' H ' ' ND2' ' A' ' 322' ' ' ASN . 18.6 t -136.93 131.68 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.953 1.701 . . . . 0.0 108.977 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -148.11 143.34 27.07 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.116 1.367 . . . . 0.0 111.366 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 83.5 p -119.09 171.7 8.08 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 120.919 -1.113 . . . . 0.0 112.503 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 52.6 tttm . . . . . 0 CA--C 1.552 1.043 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -164.497 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 . . . . . 0 CA--C 1.551 1.01 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 35.5 m -139.01 152.4 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 120.906 -1.121 . . . . 0.0 110.95 163.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 5.1 mp -118.72 138.84 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 126.024 1.729 . . . . 0.0 108.355 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 20.8 m -112.73 125.57 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.643 1.177 . . . . 0.0 107.95 172.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -142.95 46.47 1.55 Allowed 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -148.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -168.99 -26.36 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 88.1 mt -51.85 144.79 18.51 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 124.338 1.055 . . . . 0.0 111.583 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -79.74 -179.16 5.09 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.497 3.465 . . . . 0.0 111.017 178.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -62.54 -7.49 4.75 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 115.216 1.561 . . . . 0.0 115.216 -176.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 16.4 m -68.96 -17.08 63.89 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.86 1.664 . . . . 0.0 114.589 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 9.9 p -98.98 142.79 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.458 1.103 . . . . 0.0 110.482 175.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -142.53 168.33 19.99 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.722 2.009 . . . . 0.0 110.219 -177.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -46.31 -51.03 15.46 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -171.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -63.59 -36.37 83.59 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.793 0.724 . . . . 0.0 112.226 -178.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.89 -39.95 75.93 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 169.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 6.8 tt -60.06 -35.57 75.44 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.863 0.865 . . . . 0.0 111.698 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -53.79 -52.86 58.94 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.508 0.723 . . . . 0.0 111.306 169.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -62.42 -21.18 65.2 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.605 1.562 . . . . 0.0 113.561 -176.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 28.2 mt -54.9 -29.82 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 124.654 1.182 . . . . 0.0 111.992 171.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -121.29 -27.55 4.84 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.142 1.377 . . . . 0.0 112.577 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.6 -8.93 30.51 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.6 1.56 . . . . 0.0 115.005 -177.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -60.38 -15.48 26.39 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 120.348 -1.47 . . . . 0.0 114.139 172.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 71.3 m -66.37 -5.62 11.43 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 171.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 91.26 5.28 67.65 Favored Glycine 0 N--CA 1.477 1.43 0 C-N-CA 125.35 1.453 . . . . 0.0 114.54 177.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -138.43 179.3 6.55 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.904 2.481 . . . . 0.0 110.719 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.41 144.27 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 121.118 -0.989 . . . . 0.0 112.439 177.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -100.63 -114.0 0.18 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.518 1.527 . . . . 0.0 110.528 172.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -156.59 143.38 18.62 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.645 1.178 . . . . 0.0 113.475 -178.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.3 174.07 15.71 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.594 1.158 . . . . 0.0 112.06 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -159.25 152.0 21.77 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.143 1.377 . . . . 0.0 112.608 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 20.4 t -150.04 140.09 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.225 1.81 . . . . 0.0 108.203 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -132.19 135.75 46.56 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.289 1.035 . . . . 0.0 109.939 173.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 8.7 mt -91.34 158.09 16.74 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.759 0.824 . . . . 0.0 111.705 -169.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -77.86 146.43 35.68 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.706 1.203 . . . . 0.0 112.129 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -66.55 -12.67 59.42 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.095 1.331 . . . . 0.0 115.792 -174.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -74.97 -1.12 21.18 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 119.157 1.478 . . . . 0.0 113.237 166.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 87.85 38.63 7.37 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.094 1.33 . . . . 0.0 113.308 174.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 23.9 m -142.49 143.79 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 125.158 1.383 . . . . 0.0 111.732 -174.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.71 154.46 40.69 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.218 1.007 . . . . 0.0 113.114 -178.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 37.1 p -69.54 -32.14 70.79 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.076 0.951 . . . . 0.0 112.874 173.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 78.29 -61.37 3.86 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.932 1.253 . . . . 0.0 111.641 -176.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 52.2 p -60.07 146.63 42.25 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 122.471 1.129 . . . . 0.0 112.243 161.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -159.37 170.08 35.61 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.569 1.557 . . . . 0.0 113.924 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 99.0 m -119.9 142.49 48.64 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.751 1.62 . . . . 0.0 109.492 -175.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.0 t -133.54 127.62 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.689 1.596 . . . . 0.0 109.059 -170.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 14.9 t -92.92 127.85 38.57 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.916 0.886 . . . . 0.0 109.24 172.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -85.3 163.53 18.55 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -164.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -52.4 -54.44 31.94 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.776 1.23 . . . . 0.0 112.108 175.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -172.35 161.88 5.33 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 129.081 2.952 . . . . 0.0 108.375 170.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.78 -28.01 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.99 0.916 . . . . 0.0 112.02 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.54 -43.44 56.1 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 171.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -102.44 -17.55 15.76 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -176.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 4.1 tt -58.6 -50.66 73.01 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.318 1.047 . . . . 0.0 110.021 174.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -64.98 -28.12 69.3 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 45.4 mtp85 -70.01 -53.33 18.11 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.349 1.06 . . . . 0.0 111.071 169.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -60.02 -36.28 76.9 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.703 1.601 . . . . 0.0 113.264 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -53.34 -46.54 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.826 1.25 . . . . 0.0 112.482 -178.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -85.82 -37.27 19.41 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.168 0.587 . . . . 0.0 112.339 175.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -61.05 -34.42 74.85 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.193 -0.942 . . . . 0.0 113.324 -175.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -97.61 -1.51 43.61 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 175.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -60.03 111.51 1.52 Allowed 'General case' 0 CA--C 1.552 1.038 0 O-C-N 119.576 -1.952 . . . . 0.0 111.891 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 96.44 -0.01 61.36 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.462 1.506 . . . . 0.0 115.499 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.2 169.31 15.38 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 119.137 1.469 . . . . 0.0 114.576 179.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 56.0 p -138.5 124.3 19.86 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.262 1.025 . . . . 0.0 111.833 172.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 10.1 mt -138.28 116.66 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 125.147 1.379 . . . . 0.0 108.77 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 61.98 30.34 17.98 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.42 1.488 . . . . 0.0 113.271 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 173.68 -127.94 1.42 Allowed Glycine 0 C--N 1.342 0.864 0 N-CA-C 115.116 0.806 . . . . 0.0 115.116 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 42.7 p30 -110.27 -177.2 3.19 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.397 1.879 . . . . 0.0 111.376 -171.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 26.6 m -66.12 139.65 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 121.476 -0.765 . . . . 0.0 111.315 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.83 130.22 56.75 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.453 1.501 . . . . 0.0 112.29 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -72.24 154.66 40.88 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.86 148.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 47.1 t -136.45 124.34 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.295 1.438 . . . . 0.0 108.79 -174.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 58.2 mttt -146.28 141.93 27.81 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.613 1.565 . . . . 0.0 111.742 -170.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 30.2 p -89.61 167.34 13.01 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.11 1.364 . . . . 0.0 112.369 173.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 77.9 tttt . . . . . 0 CA--C 1.552 1.023 0 C-N-CA 125.332 1.453 . . . . 0.0 112.351 -173.963 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.913 0 N-CA-C 112.099 -0.4 . . . . 0.0 112.099 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 53.9 p -169.89 152.7 4.52 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.472 1.509 . . . . 0.0 111.403 -175.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 67.99 168.34 0.26 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 127.068 2.147 . . . . 0.0 113.52 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.66 157.87 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 O-C-N 121.257 -0.902 . . . . 0.0 111.495 172.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 3.7 mp -131.86 132.81 61.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 126.166 1.787 . . . . 0.0 107.235 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 36.0 m -104.43 137.27 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.212 1.005 . . . . 0.0 109.254 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -140.15 35.59 1.91 Allowed 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -157.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -160.58 -22.43 0.06 Allowed 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 12.7 mt -47.41 130.67 10.22 Favored Pre-proline 0 CA--C 1.557 1.243 0 O-C-N 120.77 -1.206 . . . . 0.0 111.341 160.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -88.44 170.29 5.66 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 124.82 3.68 . . . . 0.0 111.791 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -61.13 -8.36 3.43 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 9.1 m -68.89 -22.87 64.16 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.474 1.11 . . . . 0.0 113.121 171.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.5 p -108.6 136.69 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 126.882 2.073 . . . . 0.0 109.247 173.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -141.7 174.2 10.79 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.498 1.519 . . . . 0.0 111.447 -167.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -43.48 -50.8 6.95 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -168.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -69.14 -28.47 66.48 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 119.315 0.961 . . . . 0.0 113.014 -175.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -77.48 -40.13 44.06 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 167.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.419 HD23 ' C ' ' A' ' 277' ' ' LEU . 3.9 tt -53.16 -46.03 68.72 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.993 1.317 . . . . 0.0 109.743 175.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -46.15 -54.17 9.13 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.932 0.893 . . . . 0.0 111.586 172.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -61.75 -27.89 69.05 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.881 1.272 . . . . 0.0 113.891 -175.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 23.8 mt -53.79 -27.38 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 124.587 1.155 . . . . 0.0 112.125 172.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -118.26 -29.46 5.53 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.357 1.463 . . . . 0.0 112.309 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.8 -13.61 62.36 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.571 1.548 . . . . 0.0 113.709 176.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -57.9 -17.74 18.57 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 172.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 75.8 m -71.72 -1.85 15.34 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 173.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 89.11 14.25 60.84 Favored Glycine 0 N--CA 1.476 1.334 0 C-N-CA 124.973 1.273 . . . . 0.0 114.63 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -138.54 -178.82 5.47 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 126.811 2.044 . . . . 0.0 109.755 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.36 147.05 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 120.476 -1.39 . . . . 0.0 112.896 169.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -109.31 -114.5 0.3 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.481 1.513 . . . . 0.0 110.205 169.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -158.44 155.11 27.97 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.174 1.39 . . . . 0.0 113.081 175.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.34 171.52 20.02 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.573 1.149 . . . . 0.0 112.54 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -161.63 168.27 23.73 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.559 1.143 . . . . 0.0 113.197 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 11.7 m -140.66 158.74 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 127.951 2.5 . . . . 0.0 109.52 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -128.1 108.14 10.39 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.517 0.727 . . . . 0.0 110.521 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 8.3 mp -70.44 145.6 50.9 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.945 1.298 . . . . 0.0 111.74 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -65.14 159.11 24.19 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.747 0.819 . . . . 0.0 111.269 164.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -62.81 -17.63 58.36 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 124.333 0.968 . . . . 0.0 115.391 -177.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -81.83 -3.25 53.54 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 118.992 1.396 . . . . 0.0 113.675 170.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 84.07 21.91 56.12 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 125.106 1.336 . . . . 0.0 114.928 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 19.9 m -99.43 -6.1 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 -164.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 4.8 t 66.76 -177.11 0.2 Allowed 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 38.1 p -142.87 -35.46 0.41 Allowed 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -164.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 75.02 -57.63 2.71 Favored Glycine 0 N--CA 1.475 1.256 0 C-N-CA 124.547 1.07 . . . . 0.0 111.936 -168.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 19.2 t -40.74 118.1 0.92 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.397 1.879 . . . . 0.0 111.381 158.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -169.98 177.62 43.26 Favored Glycine 0 N--CA 1.473 1.121 0 C-N-CA 124.722 1.153 . . . . 0.0 115.193 -169.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 25.4 p -106.41 142.06 36.7 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.392 1.877 . . . . 0.0 111.497 -169.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 1.7 t -128.3 121.7 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.398 1.479 . . . . 0.0 108.789 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 42.7 m -93.82 109.82 21.49 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.962 1.305 . . . . 0.0 108.572 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.4 162.1 28.14 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -163.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -51.69 -54.86 23.62 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.42 1.088 . . . . 0.0 111.699 173.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -172.56 163.69 5.41 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 129.139 2.976 . . . . 0.0 108.551 171.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 87.8 mt -58.26 -30.74 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.048 0.939 . . . . 0.0 111.74 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.06 -40.21 57.79 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 172.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -102.25 -20.78 14.52 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.377 0.535 . . . . 0.0 112.365 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.6 tt -55.08 -52.35 63.5 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.22 1.408 . . . . 0.0 110.381 174.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -64.04 -30.46 71.53 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 32.4 mtp-105 -70.33 -46.67 63.74 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.557 1.143 . . . . 0.0 111.383 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -69.18 -32.08 71.13 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.31 1.444 . . . . 0.0 113.032 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -57.92 -38.96 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.438 1.095 . . . . 0.0 112.418 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -82.49 -18.79 40.37 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -84.23 -45.91 12.39 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.224 1.01 . . . . 0.0 112.572 -177.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -100.94 -21.14 15.16 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.644 1.349 . . . . 0.0 114.644 -170.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -67.33 111.96 4.3 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.386 0.993 . . . . 0.0 109.919 171.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 99.04 0.34 57.29 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 124.59 1.09 . . . . 0.0 114.88 -171.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -94.22 168.1 11.13 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 118.938 1.369 . . . . 0.0 111.668 173.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 45.6 p -138.42 129.2 26.61 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 120.181 -1.575 . . . . 0.0 112.615 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 11.5 mt -144.63 111.3 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 124.308 1.043 . . . . 0.0 110.099 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 63.07 16.77 9.59 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.771 1.628 . . . . 0.0 114.048 173.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . -159.42 -132.84 1.42 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.969 1.271 . . . . 0.0 113.319 -171.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -95.97 -176.55 3.73 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.933 0.893 . . . . 0.0 110.279 176.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 12.1 p -55.39 131.88 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 121.259 -0.9 . . . . 0.0 108.784 152.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 1.2 pp -103.53 143.22 33.01 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.144 0.978 . . . . 0.0 110.687 -176.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -128.36 141.22 51.49 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.623 1.569 . . . . 0.0 109.33 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 17.3 t -126.66 129.88 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.068 1.347 . . . . 0.0 110.174 -164.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -129.14 169.96 14.12 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.061 1.744 . . . . 0.0 110.822 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 94.5 p -138.38 169.43 17.8 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.885 1.274 . . . . 0.0 111.833 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -74.39 -13.0 60.67 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -176.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 61.68 -144.89 0.43 Allowed 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 126.045 1.738 . . . . 0.0 112.357 170.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 9.5 t -165.85 173.79 10.23 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.379 1.872 . . . . 0.0 111.067 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 59.2 t -145.53 122.24 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 126.22 1.808 . . . . 0.0 108.817 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -160.09 2.32 0.08 Allowed 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -171.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -78.81 -22.29 46.45 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -161.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 18.6 t60 61.86 -179.25 0.12 Allowed 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 126.327 1.851 . . . . 0.0 114.268 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 29.4 m -163.23 114.53 1.45 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.478 2.311 . . . . 0.0 108.763 170.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -115.55 0.07 13.2 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.119 1.367 . . . . 0.0 114.244 -166.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 98.09 63.73 0.87 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.171 1.367 . . . . 0.0 110.234 -165.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -98.25 12.37 34.92 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.441 1.496 . . . . 0.0 113.558 -167.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -157.46 164.24 37.65 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.068 2.147 . . . . 0.0 109.875 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 28.4 m -146.7 166.22 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 127.675 2.39 . . . . 0.0 111.489 -170.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -142.65 45.88 1.6 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.913 1.285 . . . . 0.0 111.631 -173.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 40.4 pt -133.12 149.34 72.45 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 126.054 1.742 . . . . 0.0 111.622 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -75.06 163.99 34.13 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.792 2.995 . . . . 0.0 112.048 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 27.4 ttt -157.22 129.47 7.31 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.097 1.359 . . . . 0.0 110.677 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -165.86 168.47 15.85 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.241 1.816 . . . . 0.0 111.015 -176.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -147.34 113.81 5.97 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.565 1.546 . . . . 0.0 110.5 171.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 56.7 p -115.28 148.38 40.65 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 125.59 1.556 . . . . 0.0 112.241 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.19 139.74 39.45 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.213 2.609 . . . . 0.0 110.926 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 13.0 p -165.55 144.14 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.024 1.33 . . . . 0.0 110.648 -174.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 29.0 m120 . . . . . 0 C--O 1.253 1.27 0 C-N-CA 126.166 1.786 . . . . 0.0 111.726 -178.078 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.818 0 CA-C-O 119.267 -0.74 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 15.5 m 76.38 154.73 0.16 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 127.091 2.156 . . . . 0.0 114.296 175.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 68.68 170.92 0.29 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 126.939 2.096 . . . . 0.0 112.494 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 34.2 m -137.37 151.37 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 120.977 -1.077 . . . . 0.0 112.243 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 3.2 mp -102.04 143.68 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 127.865 2.466 . . . . 0.0 108.305 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 18.9 m -126.83 140.38 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 125.695 1.598 . . . . 0.0 108.622 168.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -145.61 24.99 1.36 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -145.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -161.55 -22.54 0.05 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 84.5 mt -47.7 119.37 6.74 Favored Pre-proline 0 CA--C 1.563 1.453 0 C-N-CA 127.023 2.129 . . . . 0.0 111.585 168.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -89.33 -172.71 0.67 Allowed 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 124.986 3.791 . . . . 0.0 113.375 -176.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -54.27 -29.53 47.38 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -173.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 30.6 m -71.09 -18.06 62.56 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.374 -0.829 . . . . 0.0 112.987 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . 0.263 2.4 p -113.6 60.58 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 127.53 2.332 . . . . 0.0 109.948 176.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -62.52 175.6 0.76 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.733 1.613 . . . . 0.0 111.969 176.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -45.63 -42.25 11.13 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.803 1.641 . . . . 0.0 114.952 -174.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -68.72 -40.03 80.12 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.272 0.942 . . . . 0.0 111.696 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.66 -35.73 75.44 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 172.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.506 HD23 ' C ' ' A' ' 277' ' ' LEU . 2.2 tt -54.74 -51.55 65.29 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.18 0.9 . . . . 0.0 109.229 168.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 4.6 tmmm? -57.2 -35.96 70.26 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.575 0.75 . . . . 0.0 111.905 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -67.57 -23.89 65.45 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 175.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 18.3 mt -58.83 -51.44 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-N 119.38 0.991 . . . . 0.0 110.86 173.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -79.03 -27.5 43.21 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.226 0.61 . . . . 0.0 111.5 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -51.86 -23.27 4.59 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.177 1.391 . . . . 0.0 113.927 173.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -61.59 -13.43 21.87 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 175.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 97.5 m -73.13 -5.58 40.07 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 168.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 96.69 -12.23 66.14 Favored Glycine 0 N--CA 1.476 1.366 0 C-N-CA 126.118 1.818 . . . . 0.0 114.608 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -138.33 172.84 12.3 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.305 2.242 . . . . 0.0 108.98 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 4.8 p -145.3 145.16 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -91.8 -125.39 0.08 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 126.238 1.815 . . . . 0.0 111.807 176.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -153.31 158.01 40.95 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.787 1.635 . . . . 0.0 113.232 -175.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.57 175.96 13.0 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -172.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -159.05 168.19 27.33 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.9 2.08 . . . . 0.0 111.312 176.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 28.7 m -151.01 170.99 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 126.72 2.008 . . . . 0.0 112.722 -171.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -103.71 153.52 20.58 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.489 1.516 . . . . 0.0 112.424 174.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.8 mp -126.71 144.18 51.01 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.115 1.366 . . . . 0.0 111.902 174.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -71.14 160.49 32.77 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.946 0.898 . . . . 0.0 111.304 162.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -66.95 -12.61 60.33 Favored Glycine 0 CA--C 1.534 1.276 0 N-CA-C 115.926 1.13 . . . . 0.0 115.926 -169.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -85.67 -1.36 57.09 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.688 1.195 . . . . 0.0 113.062 172.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.86 15.31 73.18 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.146 1.355 . . . . 0.0 115.131 175.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 97.7 t -81.22 -17.72 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -168.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.4 p 75.98 171.68 0.25 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 127.319 2.248 . . . . 0.0 114.943 176.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 30.3 p -146.26 164.05 33.55 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 127.672 2.389 . . . . 0.0 107.518 172.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -94.7 -16.2 43.24 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.137 0.875 . . . . 0.0 113.862 170.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 8.7 t -55.45 121.7 9.58 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.578 1.151 . . . . 0.0 110.852 166.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 174.86 -160.39 29.43 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.211 0.91 . . . . 0.0 114.46 -171.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 20.1 p -123.55 148.19 46.56 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.845 1.658 . . . . 0.0 110.537 -172.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.9 123.48 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.134 1.774 . . . . 0.0 106.851 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 8.1 t -99.32 110.56 23.06 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.733 1.213 . . . . 0.0 108.255 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.18 165.23 16.71 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -149.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -52.12 -51.57 57.01 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.086 1.354 . . . . 0.0 111.89 174.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -172.55 166.44 5.58 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 129.813 3.245 . . . . 0.0 108.059 171.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.55 -26.82 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 123.863 0.865 . . . . 0.0 111.81 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -30.89 64.85 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 171.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -91.14 -14.48 31.05 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -168.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 10.6 mp -49.52 -49.07 47.48 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.958 0.903 . . . . 0.0 109.311 161.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -61.52 -31.77 71.78 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -172.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -75.21 -56.65 4.52 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.064 1.345 . . . . 0.0 112.039 168.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -65.92 -33.04 74.91 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.967 1.307 . . . . 0.0 114.01 -170.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.18 -27.08 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.594 1.158 . . . . 0.0 111.599 177.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -82.61 -38.82 23.06 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.788 0.835 . . . . 0.0 111.569 170.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -77.32 -41.19 41.56 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -170.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -106.35 -17.33 14.32 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -172.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -54.92 126.24 23.62 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.407 1.003 . . . . 0.0 111.025 167.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 82.77 0.31 90.05 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 119.258 -0.745 . . . . 0.0 114.383 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -97.66 162.59 13.21 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.985 1.314 . . . . 0.0 112.034 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 47.5 p -138.27 128.26 25.53 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.547 1.139 . . . . 0.0 111.468 -176.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 12.2 mt -136.05 112.85 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.038 0.935 . . . . 0.0 109.858 -177.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 56.61 27.54 12.62 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.935 1.694 . . . . 0.0 112.961 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . -176.76 -143.44 4.8 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.428 1.014 . . . . 0.0 113.754 -166.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -93.23 174.96 6.95 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.971 0.908 . . . . 0.0 111.054 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 11.4 p -58.39 141.28 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 121.645 -0.66 . . . . 0.0 110.182 163.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 1.7 pp -122.81 156.26 34.9 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 122.429 1.109 . . . . 0.0 112.804 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -122.83 166.1 15.55 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.707 1.603 . . . . 0.0 110.172 163.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.03 125.64 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 126.824 2.05 . . . . 0.0 107.466 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -141.86 133.7 27.24 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.146 0.578 . . . . 0.0 112.389 -169.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 20.0 p -110.47 153.82 24.51 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.542 1.537 . . . . 0.0 111.997 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -75.82 103.86 6.1 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.208 -0.933 . . . . 0.0 110.908 173.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -166.87 144.42 4.89 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.925 1.69 . . . . 0.0 110.224 -177.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 23.2 t -166.08 153.62 10.18 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.092 0.957 . . . . 0.0 112.217 173.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 14.8 p -170.82 144.88 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 126.93 2.092 . . . . 0.0 109.543 -174.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -155.45 161.79 40.89 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.711 1.204 . . . . 0.0 113.273 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -158.89 137.11 10.64 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.772 1.629 . . . . 0.0 110.664 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -72.56 -31.12 65.0 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -174.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 27.2 t -171.43 143.57 1.83 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.192 1.397 . . . . 0.0 111.837 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -80.0 -10.22 59.75 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.136 0.975 . . . . 0.0 112.866 171.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 88.24 161.19 36.81 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.578 1.561 . . . . 0.0 113.707 -178.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -166.85 138.48 3.38 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.161 1.785 . . . . 0.0 110.731 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -163.59 155.56 17.38 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.999 1.719 . . . . 0.0 110.546 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 10.1 p -170.27 135.42 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 127.977 2.511 . . . . 0.0 109.556 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -156.44 39.64 0.34 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.431 1.093 . . . . 0.0 112.086 -172.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 6.4 pt -129.51 96.9 26.14 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 125.239 1.416 . . . . 0.0 111.529 -172.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -81.36 164.03 19.3 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.895 3.064 . . . . 0.0 111.597 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -157.01 124.62 5.37 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.94 1.296 . . . . 0.0 110.423 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -153.76 146.07 23.9 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.258 1.823 . . . . 0.0 111.226 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -150.53 126.68 10.57 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.036 1.735 . . . . 0.0 109.905 172.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 39.4 m -115.22 146.6 36.71 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 125.018 1.327 . . . . 0.0 111.964 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -72.61 153.45 54.53 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.455 2.77 . . . . 0.0 111.518 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 10.1 p -161.76 143.4 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 125.028 1.331 . . . . 0.0 110.736 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 . . . . . 0 C--O 1.255 1.343 0 C-N-CA 126.83 2.052 . . . . 0.0 112.553 -178.141 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.957 0 CA-C-O 121.029 0.239 . . . . 0.0 112.699 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 18.7 m -169.43 164.27 10.58 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 127.196 2.198 . . . . 0.0 110.155 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -156.75 160.21 39.06 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.042 -1.037 . . . . 0.0 112.923 -171.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 31.1 m -130.99 147.37 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.978 1.711 . . . . 0.0 110.553 173.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.7 mp -97.84 140.91 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 127.461 2.305 . . . . 0.0 107.232 175.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 30.0 m -131.48 120.64 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.608 0.763 . . . . 0.0 110.388 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -147.66 77.93 1.44 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.972 0.909 . . . . 0.0 110.9 -162.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -174.36 -42.21 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 126.383 1.873 . . . . 0.0 110.732 177.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 71.3 mt -34.75 116.97 0.54 Allowed Pre-proline 0 CA--C 1.558 1.271 0 C-N-CA 127.377 2.271 . . . . 0.0 111.582 160.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -89.64 177.92 2.54 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 125.121 3.881 . . . . 0.0 112.641 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -51.36 -26.94 8.54 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 -171.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 5.5 t -76.85 -14.85 59.85 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . 0.259 1.6 p -108.28 79.88 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.938 1.695 . . . . 0.0 108.863 174.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -69.81 179.14 2.32 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.965 2.106 . . . . 0.0 112.546 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -57.05 -37.76 72.27 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 120.6 -1.313 . . . . 0.0 112.689 177.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -65.5 -37.33 86.49 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.239 -0.913 . . . . 0.0 111.321 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -71.12 -38.2 72.31 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 168.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.462 HD23 ' C ' ' A' ' 277' ' ' LEU . 5.4 tt -53.79 -45.67 70.8 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.819 1.248 . . . . 0.0 110.517 176.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -47.76 -51.77 21.1 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.483 0.713 . . . . 0.0 111.706 172.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -64.99 -22.55 67.02 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -174.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 45.0 mt -55.73 -44.98 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.271 1.028 . . . . 0.0 111.509 171.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -104.89 -22.34 13.17 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.181 0.993 . . . . 0.0 113.047 -173.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -64.93 0.15 1.32 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.426 1.89 . . . . 0.0 115.138 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -55.45 -19.05 8.24 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 120.501 -1.374 . . . . 0.0 113.834 168.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 21.8 t -56.54 -20.48 20.76 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.624 1.57 . . . . 0.0 114.072 169.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 92.3 -7.46 78.12 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.919 1.724 . . . . 0.0 113.454 -173.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -138.46 175.87 9.19 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.362 2.665 . . . . 0.0 109.116 174.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.4 p -145.12 145.24 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 120.705 -1.247 . . . . 0.0 113.136 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -79.44 -104.75 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.656 1.582 . . . . 0.0 111.877 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -152.04 146.03 25.25 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.995 1.718 . . . . 0.0 112.253 -175.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.35 166.83 31.33 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.798 0.839 . . . . 0.0 113.254 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -159.82 172.83 16.94 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.942 1.697 . . . . 0.0 111.153 -177.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 4.2 m -142.32 152.07 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.471 1.909 . . . . 0.0 111.753 -177.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -111.18 99.05 7.96 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.108 0.963 . . . . 0.0 109.765 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 8.9 mt -91.33 160.11 15.66 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.943 0.897 . . . . 0.0 112.074 -172.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -80.7 147.18 30.72 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.437 1.095 . . . . 0.0 112.445 -173.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -67.61 -13.12 62.82 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.0 1.286 . . . . 0.0 115.963 -172.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -82.36 -0.13 44.45 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 119.175 1.487 . . . . 0.0 113.152 169.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.84 61.59 1.93 Allowed Glycine 0 C--N 1.341 0.849 0 C-N-CA 125.132 1.349 . . . . 0.0 112.161 176.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 13.6 p -154.29 146.48 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.36 1.064 . . . . 0.0 111.839 -174.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 26.6 t -62.79 161.45 12.56 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.44 1.096 . . . . 0.0 113.932 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 35.9 p -146.09 -27.24 0.43 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 126.846 2.058 . . . . 0.0 114.082 -169.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 78.46 -41.07 2.04 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 126.545 2.022 . . . . 0.0 114.82 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 5.3 p -50.14 132.89 23.75 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.388 1.875 . . . . 0.0 112.828 166.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -172.59 -159.99 20.25 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 124.49 1.043 . . . . 0.0 115.475 -172.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 46.0 p -137.46 155.01 49.8 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.668 1.587 . . . . 0.0 110.638 -173.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.48 119.2 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.593 1.557 . . . . 0.0 107.44 -176.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 44.1 t -108.9 124.81 51.23 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.677 1.191 . . . . 0.0 109.128 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.18 165.63 12.52 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 -144.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -52.75 -53.9 41.43 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.081 170.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -172.91 168.43 4.95 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 129.01 2.924 . . . . 0.0 108.205 165.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 19.5 tt -57.58 -28.3 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.2 -41.38 68.54 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 172.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -94.48 -28.56 15.4 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.179 0.445 . . . . 0.0 111.44 -176.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.1 tt -52.56 -49.01 65.79 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.526 1.531 . . . . 0.0 110.089 169.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -56.69 -35.35 68.37 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -70.71 -55.98 7.43 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.324 0.65 . . . . 0.0 111.381 169.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.72 -35.26 72.4 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.568 1.547 . . . . 0.0 113.712 -174.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.71 -33.43 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.123 0.969 . . . . 0.0 112.291 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -82.58 -42.29 18.48 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.754 0.822 . . . . 0.0 111.711 172.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -64.91 -40.56 95.26 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -174.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -105.95 -10.13 16.76 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -169.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -69.13 116.26 9.37 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 121.096 -1.002 . . . . 0.0 110.542 169.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 93.46 -0.14 67.87 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.817 1.675 . . . . 0.0 114.774 -175.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -80.55 133.98 35.87 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.139 1.375 . . . . 0.0 111.279 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 16.0 p -99.6 126.7 45.64 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.072 -1.643 . . . . 0.0 111.989 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.45 96.84 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.908 0.883 . . . . 0.0 110.058 -171.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 56.84 30.12 17.28 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.279 1.432 . . . . 0.0 113.211 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 178.8 -130.86 1.61 Allowed Glycine 0 C--N 1.342 0.9 0 O-C-N 121.162 -0.961 . . . . 0.0 113.468 -171.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -90.07 178.96 6.05 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.427 0.691 . . . . 0.0 110.562 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 35.2 m -63.6 137.28 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 O-C-N 121.403 -0.811 . . . . 0.0 109.634 162.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 22.7 tp -83.02 118.95 23.87 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.402 1.481 . . . . 0.0 110.181 -175.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -94.43 143.39 26.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.749 0.82 . . . . 0.0 109.721 165.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 19.8 t -136.42 124.9 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.646 1.579 . . . . 0.0 108.418 -171.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -132.75 133.85 43.99 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.545 1.138 . . . . 0.0 111.249 -170.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 34.8 p -83.83 155.95 22.71 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.859 -1.151 . . . . 0.0 111.983 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -72.42 129.94 39.54 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 121.288 -0.882 . . . . 0.0 111.599 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -72.18 137.49 46.96 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.767 0.827 . . . . 0.0 111.166 176.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 12.8 t -167.41 -169.86 1.32 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.683 1.593 . . . . 0.0 111.151 -177.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 16.3 m -143.27 145.41 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 126.975 2.11 . . . . 0.0 110.041 178.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -148.61 151.63 35.35 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.168 1.387 . . . . 0.0 112.654 -171.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -142.73 140.69 31.56 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.917 1.687 . . . . 0.0 110.729 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 30.4 p80 -160.41 168.75 24.51 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.261 1.425 . . . . 0.0 113.224 -173.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 1.4 p 77.89 155.8 0.16 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 128.526 2.73 . . . . 0.0 113.619 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -115.19 -0.34 13.3 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.966 1.306 . . . . 0.0 113.842 -170.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 72.08 -137.97 26.05 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.419 1.009 . . . . 0.0 112.747 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -156.69 135.52 11.74 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.843 1.657 . . . . 0.0 111.146 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -164.46 157.03 16.85 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.843 2.057 . . . . 0.0 109.83 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 12.1 p -165.78 136.15 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 126.933 2.093 . . . . 0.0 110.162 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -166.75 115.1 0.86 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.318 1.847 . . . . 0.0 109.415 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 17.5 tt -69.73 129.69 91.0 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.812 0.845 . . . . 0.0 111.545 -176.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -75.08 158.04 42.11 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.203 2.602 . . . . 0.0 111.693 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 57.6 ttp -159.36 148.14 18.04 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.315 1.446 . . . . 0.0 111.001 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -119.2 146.25 45.35 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.524 1.53 . . . . 0.0 111.433 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -80.32 115.72 20.02 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.602 1.161 . . . . 0.0 111.673 174.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 41.8 p -82.5 153.15 68.06 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 124.925 1.29 . . . . 0.0 112.926 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -72.23 151.71 55.03 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.516 2.811 . . . . 0.0 111.383 177.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 14.6 p -162.79 140.55 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.821 1.249 . . . . 0.0 111.09 -177.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.19 0 C-N-CA 126.007 1.723 . . . . 0.0 110.994 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.895 0 N-CA-C 112.534 -0.227 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 29.1 t -159.71 94.7 1.16 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.643 1.177 . . . . 0.0 110.077 -177.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -166.24 142.91 5.04 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.065 0.946 . . . . 0.0 111.335 -165.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 21.2 m -133.52 156.39 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.605 1.162 . . . . 0.0 110.324 166.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 76.4 mt -106.97 139.17 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 127.276 2.23 . . . . 0.0 107.252 -178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 19.0 m -125.54 118.36 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.317 1.047 . . . . 0.0 108.838 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -143.78 62.41 1.36 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 121.897 0.856 . . . . 0.0 112.33 -151.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -168.21 -25.64 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.533 1.133 . . . . 0.0 113.697 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 23.5 mt -61.13 136.86 94.04 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 125.741 1.616 . . . . 0.0 111.83 175.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -88.52 171.02 5.36 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 124.484 3.456 . . . . 0.0 110.758 173.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -59.98 -5.78 1.11 Allowed 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 6.3 t -59.06 -30.56 68.15 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.824 1.25 . . . . 0.0 112.938 169.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 9.0 p -89.37 123.99 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 170.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -77.92 157.05 29.92 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.724 0.81 . . . . 0.0 110.655 172.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -51.43 -37.72 50.03 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.722 -1.236 . . . . 0.0 113.285 176.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -73.72 -31.09 63.2 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.007 -1.058 . . . . 0.0 112.188 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.85 -32.56 71.02 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.184 -0.947 . . . . 0.0 112.635 167.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.52 HD21 ' CG1' ' A' ' 306' ' ' VAL . 3.1 tt -61.06 -42.44 98.49 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.218 0.917 . . . . 0.0 111.406 169.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -57.17 -46.75 82.52 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 118.785 0.721 . . . . 0.0 110.312 171.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -61.44 -23.1 65.62 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 18.7 mt -51.74 -30.23 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 124.73 1.212 . . . . 0.0 111.83 172.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -116.73 -38.33 3.48 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.275 1.43 . . . . 0.0 110.913 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -5.4 4.43 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.008 1.323 . . . . 0.0 114.142 176.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -55.53 -17.33 5.14 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 120.432 -1.418 . . . . 0.0 113.767 160.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 65.2 m -70.87 -0.72 9.73 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.032 1.333 . . . . 0.0 114.264 168.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 88.31 -58.49 4.18 Favored Glycine 0 N--CA 1.471 1.0 0 C-N-CA 126.589 2.043 . . . . 0.0 111.729 -176.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -70.14 165.21 22.52 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.857 1.263 . . . . 0.0 111.921 175.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.9 p -142.03 142.5 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 120.911 -1.118 . . . . 0.0 112.475 178.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -89.35 -96.01 0.1 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.85 1.26 . . . . 0.0 110.203 167.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -165.31 157.85 15.67 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 127.133 2.173 . . . . 0.0 111.208 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.72 159.61 35.45 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.083 -1.011 . . . . 0.0 113.667 -173.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -161.22 171.67 18.02 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.284 1.434 . . . . 0.0 113.21 -176.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 16.8 m -144.03 160.17 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 128.009 2.523 . . . . 0.0 110.244 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -132.15 99.63 4.78 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.51 0.724 . . . . 0.0 111.428 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.69 170.77 7.74 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.065 1.346 . . . . 0.0 113.338 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -74.85 153.7 38.58 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 122.766 0.426 . . . . 0.0 111.391 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -64.99 -10.84 48.73 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 124.121 0.867 . . . . 0.0 114.873 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 44.5 p30 -74.14 -12.65 60.65 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.859 1.263 . . . . 0.0 114.289 169.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 88.15 12.62 65.32 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 117.226 -1.874 . . . . 0.0 116.613 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 14.6 m -67.73 -17.18 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-N 121.408 2.604 . . . . 0.0 116.297 -172.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 3.7 t 73.54 163.65 0.27 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 126.025 1.73 . . . . 0.0 113.687 -176.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 29.1 p -151.65 136.89 17.52 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.44 1.896 . . . . 0.0 110.089 -171.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -79.98 -35.71 26.93 Favored Glycine 0 N--CA 1.47 0.93 0 O-C-N 123.246 0.341 . . . . 0.0 112.823 173.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 33.9 p -57.05 124.46 18.8 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.057 1.343 . . . . 0.0 111.878 167.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -161.53 -165.83 19.13 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.952 1.263 . . . . 0.0 113.788 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 99.1 m -130.53 138.83 50.4 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.943 1.297 . . . . 0.0 108.656 -175.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.52 ' CG1' HD21 ' A' ' 277' ' ' LEU . 8.4 m -128.45 128.11 67.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 124.442 1.097 . . . . 0.0 109.374 -175.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 36.8 m -79.87 146.93 31.94 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.669 173.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.39 146.89 35.05 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -173.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -49.65 -49.05 48.76 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.148 1.779 . . . . 0.0 112.552 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -172.24 173.31 4.27 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 128.13 2.572 . . . . 0.0 108.466 159.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 15.1 tt -62.27 -24.06 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -177.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.7 -42.69 65.04 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.267 1.427 . . . . 0.0 114.161 168.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -98.32 -20.34 17.25 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -175.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 6.7 tt -60.26 -52.63 64.47 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.838 1.255 . . . . 0.0 111.109 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -73.3 -20.78 60.73 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.017 -1.052 . . . . 0.0 113.247 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -70.66 -44.98 65.95 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.198 0.999 . . . . 0.0 111.682 166.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -73.16 -38.62 66.14 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.783 1.633 . . . . 0.0 113.284 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 2.5 pp -64.09 -22.21 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 121.147 -0.971 . . . . 0.0 113.556 176.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -82.31 -23.23 35.26 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.958 0.903 . . . . 0.0 112.951 169.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -89.44 -47.17 8.18 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.153 1.381 . . . . 0.0 112.968 -175.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -90.56 -30.01 17.5 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -172.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -65.85 118.18 9.31 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 121.245 -0.909 . . . . 0.0 110.28 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 96.69 -1.98 62.04 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.269 0.937 . . . . 0.0 115.265 -173.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -92.16 173.89 7.59 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.05 1.425 . . . . 0.0 111.097 169.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 60.0 p -138.57 129.7 26.99 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 119.83 -1.793 . . . . 0.0 112.395 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 18.9 mt -143.21 116.73 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 124.305 1.042 . . . . 0.0 109.58 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 59.49 18.96 7.39 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 125.633 1.573 . . . . 0.0 114.357 175.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . -177.55 -131.47 1.53 Allowed Glycine 0 CA--C 1.527 0.83 0 O-C-N 120.98 -1.075 . . . . 0.0 114.301 -173.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -94.96 -178.81 4.62 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.448 1.099 . . . . 0.0 110.929 -176.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 10.4 p -61.44 125.52 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 121.513 -0.742 . . . . 0.0 110.714 169.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 88.4 mt -62.9 132.85 53.49 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.174 1.79 . . . . 0.0 111.753 176.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -132.81 120.94 22.24 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.027 1.731 . . . . 0.0 108.19 174.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 15.1 t -129.31 125.38 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.72 1.208 . . . . 0.0 109.915 -160.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -142.94 171.19 14.38 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.447 1.499 . . . . 0.0 111.476 -171.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 90.3 p -145.29 152.75 40.42 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.147 -1.596 . . . . 0.0 112.842 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -78.26 -19.13 54.31 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -142.2 167.81 21.24 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.549 2.34 . . . . 0.0 109.686 175.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 16.9 t -160.04 -170.73 2.96 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.177 1.391 . . . . 0.0 111.379 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 26.2 m -144.49 147.14 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 126.658 1.983 . . . . 0.0 110.701 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -162.87 148.8 12.23 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.36 1.464 . . . . 0.0 112.433 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -158.65 152.26 23.2 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.778 1.631 . . . . 0.0 111.739 175.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -159.33 143.38 15.04 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.328 1.451 . . . . 0.0 112.225 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 19.9 m -155.44 150.05 26.25 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.585 1.554 . . . . 0.0 110.955 -177.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -75.34 -19.12 59.79 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 87.96 170.78 46.31 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.336 1.446 . . . . 0.0 114.464 175.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -164.06 134.12 4.12 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.286 1.835 . . . . 0.0 110.64 -178.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -165.37 162.84 19.8 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.515 1.926 . . . . 0.0 109.957 -177.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 11.8 p -165.24 139.87 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 127.13 2.172 . . . . 0.0 110.318 -177.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -166.03 120.74 1.19 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.483 1.913 . . . . 0.0 109.92 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 7.8 tp -133.46 133.68 22.96 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 125.713 1.605 . . . . 0.0 110.843 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -81.88 174.11 10.53 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.602 2.868 . . . . 0.0 111.897 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 13.0 tpt -153.56 129.3 10.11 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.836 1.254 . . . . 0.0 111.418 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -159.51 8.31 0.11 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.267 2.227 . . . . 0.0 112.18 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -85.92 31.72 0.62 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.422 2.289 . . . . 0.0 113.824 -158.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 25.3 p -63.34 130.24 94.11 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 125.05 1.34 . . . . 0.0 112.348 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.31 156.01 50.95 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.52 2.813 . . . . 0.0 112.162 -176.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 22.1 t 74.49 115.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 127.733 2.413 . . . . 0.0 111.356 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.912 1.685 . . . . 0.0 112.07 -178.024 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.797 0 N-CA-C 112.127 -0.389 . . . . 0.0 112.127 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 59.0 p -143.26 17.98 1.9 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.678 1.191 . . . . 0.0 113.211 -174.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -148.38 141.44 24.91 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.993 -1.067 . . . . 0.0 111.79 -169.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 35.7 m -132.05 159.94 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 126.262 1.825 . . . . 0.0 110.052 170.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 5.0 mp -124.08 130.67 73.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.184 1.794 . . . . 0.0 106.95 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 29.3 m -99.48 138.11 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 170.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -150.01 78.37 1.34 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.053 0.541 . . . . 0.0 112.281 -165.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -176.71 -34.83 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.227 1.411 . . . . 0.0 113.649 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 74.2 mt -62.99 140.5 97.63 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 125.613 1.565 . . . . 0.0 111.711 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -83.1 177.17 6.84 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 124.8 3.667 . . . . 0.0 112.013 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -57.89 -7.42 0.74 Allowed 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 -176.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 4.0 t -62.65 -31.5 72.39 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.217 -0.927 . . . . 0.0 112.318 170.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 3.7 p -84.05 133.06 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.651 0.739 . . . . 0.0 109.915 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -137.71 167.11 22.37 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.53 1.932 . . . . 0.0 109.144 -176.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -43.74 -50.63 7.6 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -168.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -68.5 -36.17 78.52 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.635 -0.666 . . . . 0.0 111.987 -175.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.83 -38.36 76.5 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.483 -0.761 . . . . 0.0 112.977 169.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 8.1 tt -63.08 -37.41 87.09 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.129 0.972 . . . . 0.0 111.531 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -53.3 -53.5 50.0 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.483 0.713 . . . . 0.0 110.606 168.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -60.93 -25.26 66.66 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.139 1.376 . . . . 0.0 113.672 -173.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 29.8 mt -49.83 -40.32 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 124.351 1.06 . . . . 0.0 111.686 171.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -111.5 -31.63 6.96 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.009 1.323 . . . . 0.0 112.215 -175.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -63.24 -2.99 1.6 Allowed 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.698 1.599 . . . . 0.0 113.493 170.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -51.79 -27.7 13.1 Favored 'General case' 0 CA--C 1.55 0.979 0 O-C-N 120.699 -1.251 . . . . 0.0 112.449 160.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 96.5 m -66.95 -1.69 4.36 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 169.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 86.71 -51.03 4.28 Favored Glycine 0 N--CA 1.473 1.148 0 C-N-CA 126.303 1.906 . . . . 0.0 113.059 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -71.79 169.88 14.79 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.65 1.18 . . . . 0.0 111.16 171.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.0 p -139.88 144.14 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 120.59 -1.319 . . . . 0.0 112.925 174.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -101.01 -108.72 0.22 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.671 1.589 . . . . 0.0 110.608 172.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -158.47 149.42 20.55 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.582 1.553 . . . . 0.0 112.267 -176.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.43 175.42 13.72 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.107 -0.996 . . . . 0.0 112.964 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -154.39 153.62 31.9 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -174.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 50.7 t -158.0 135.82 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 129.055 2.942 . . . . 0.0 106.893 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -132.53 146.43 51.9 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.657 0.783 . . . . 0.0 110.667 171.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 4.7 mt -92.75 142.98 26.75 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.458 0.647 . . . . 0.0 111.587 -171.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -72.73 144.06 47.79 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.967 1.307 . . . . 0.0 111.036 171.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -66.91 -9.98 54.57 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.15 1.357 . . . . 0.0 116.209 -171.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -75.4 -2.13 27.14 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 119.321 1.561 . . . . 0.0 113.045 165.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 86.9 44.49 5.71 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.58 1.562 . . . . 0.0 112.48 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 53.9 t -136.47 129.1 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.384 1.073 . . . . 0.0 110.656 -169.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 22.1 m -81.28 141.14 34.38 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -177.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 67.9 p -78.93 104.49 9.6 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.604 0.762 . . . . 0.0 109.102 171.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -69.82 -36.83 74.97 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 111.952 -0.459 . . . . 0.0 111.952 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 27.4 m -66.46 111.22 3.46 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.148 0.979 . . . . 0.0 110.76 161.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -131.65 165.31 23.36 Favored Glycine 0 N--CA 1.474 1.21 0 C-N-CA 124.765 1.174 . . . . 0.0 114.892 -173.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.74 146.02 24.46 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 126.562 1.945 . . . . 0.0 110.902 178.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -140.68 138.91 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.821 1.648 . . . . 0.0 108.259 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 26.9 t -116.33 132.4 56.68 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.127 0.971 . . . . 0.0 110.888 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.63 156.8 16.85 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 -158.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -55.73 -52.72 62.94 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 113.934 -1.484 . . . . 0.0 111.179 171.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -172.9 170.31 4.57 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 129.061 2.944 . . . . 0.0 108.623 170.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 10.7 tp -57.7 -30.87 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.954 0.901 . . . . 0.0 113.323 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -46.66 78.94 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.831 0.852 . . . . 0.0 113.11 171.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -84.43 -25.04 29.29 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 119.581 -0.247 . . . . 0.0 110.819 -175.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 4.9 tt -60.14 -45.64 92.35 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.845 1.258 . . . . 0.0 109.725 171.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -67.27 -25.54 66.11 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 171.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 21.3 mmm-85 -70.33 -43.1 70.97 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.962 1.255 . . . . 0.0 111.649 166.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -68.84 -38.42 79.81 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.675 1.59 . . . . 0.0 113.073 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 2.6 pp -69.56 -19.94 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 171.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -82.41 -42.59 18.4 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.62 1.168 . . . . 0.0 111.879 170.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -76.51 -53.4 8.14 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -105.62 -19.99 13.6 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -159.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -67.43 113.69 5.5 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 119.269 0.94 . . . . 0.0 109.423 172.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 97.65 -0.26 59.47 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.692 1.615 . . . . 0.0 114.962 -171.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -100.38 149.58 23.49 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.966 1.383 . . . . 0.0 111.472 176.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 23.1 p -113.42 128.29 56.4 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.108 0.963 . . . . 0.0 113.269 -173.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 15.2 mt -147.95 122.65 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.754 1.622 . . . . 0.0 107.943 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 59.18 37.66 23.83 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.364 1.065 . . . . 0.0 113.133 -177.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 140.36 -111.13 0.72 Allowed Glycine 0 N--CA 1.47 0.942 0 C-N-CA 124.449 1.023 . . . . 0.0 114.085 171.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -84.58 177.03 8.23 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.52 0.728 . . . . 0.0 111.008 -170.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 17.9 m -63.77 142.59 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 159.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 3.1 pp -99.52 144.86 28.13 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.74 0.781 . . . . 0.0 111.922 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -105.61 165.58 11.06 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.117 1.767 . . . . 0.0 109.205 162.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 26.6 t -136.16 120.3 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.718 1.607 . . . . 0.0 109.204 -174.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -122.69 170.39 10.1 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.239 1.815 . . . . 0.0 110.841 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 32.2 t -145.19 155.63 43.38 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 120.218 -1.551 . . . . 0.0 112.058 177.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -84.69 3.46 37.11 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 125.0 1.32 . . . . 0.0 113.215 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -150.9 177.79 9.78 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.696 1.999 . . . . 0.0 109.622 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 14.9 t -67.86 152.24 45.88 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 120.703 -1.248 . . . . 0.0 113.08 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 45.9 t -142.05 118.74 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 126.635 1.974 . . . . 0.0 107.959 -175.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -162.63 152.27 15.81 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.857 1.263 . . . . 0.0 113.01 -169.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -159.96 127.38 4.6 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.633 1.573 . . . . 0.0 110.155 -177.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 29.4 p80 -169.13 172.56 7.34 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.539 1.536 . . . . 0.0 112.794 -166.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 88.7 p -158.88 165.01 35.16 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.218 1.407 . . . . 0.0 111.758 176.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -79.9 -13.01 59.69 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 79.23 -131.74 10.89 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.47 1.033 . . . . 0.0 111.967 -176.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -158.7 173.64 16.25 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.755 1.622 . . . . 0.0 112.676 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -125.46 25.74 6.97 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.245 1.818 . . . . 0.0 113.912 -174.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 31.2 m -135.04 156.01 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -171.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -132.92 17.77 4.18 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.126 1.77 . . . . 0.0 113.597 -174.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 18.9 tt -60.94 130.19 90.89 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 124.804 1.242 . . . . 0.0 111.939 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.13 128.41 12.99 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.952 2.434 . . . . 0.0 110.237 175.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 53.7 ttm -164.55 139.05 5.4 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.196 1.398 . . . . 0.0 110.695 -173.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -159.37 142.34 14.23 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.99 1.316 . . . . 0.0 111.791 -177.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -80.27 53.34 1.76 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.733 1.613 . . . . 0.0 111.647 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 57.4 p -68.33 149.07 98.2 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.15 1.38 . . . . 0.0 113.631 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -73.2 150.59 47.83 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.581 2.854 . . . . 0.0 111.747 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 8.2 p -149.14 22.36 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 124.331 1.052 . . . . 0.0 112.861 -175.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 . . . . . 0 C--O 1.255 1.343 0 C-N-CA 126.499 1.919 . . . . 0.0 111.552 -177.905 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.921 0 N-CA-C 112.385 -0.286 . . . . 0.0 112.385 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 18.0 t -153.29 33.45 0.46 Allowed 'General case' 0 N--CA 1.48 1.069 0 O-C-N 121.718 -0.872 . . . . 0.0 112.496 -174.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -140.19 157.15 46.05 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.134 0.974 . . . . 0.0 112.017 -172.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 30.1 m -143.26 164.7 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 126.166 1.787 . . . . 0.0 110.624 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.6 mp -116.97 145.85 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 127.437 2.295 . . . . 0.0 107.446 173.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 19.2 m -118.62 146.19 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.43 1.092 . . . . 0.0 110.488 171.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -150.52 153.63 36.17 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.289 1.036 . . . . 0.0 113.135 -163.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 28.1 t30 83.91 -23.03 0.2 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 128.999 2.919 . . . . 0.0 114.259 176.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 47.8 mt -28.91 116.58 0.28 Allowed Pre-proline 0 CA--C 1.563 1.454 0 C-N-CA 126.495 1.918 . . . . 0.0 111.285 144.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -81.81 -175.52 2.61 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 125.107 3.871 . . . . 0.0 112.95 -173.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -61.92 -12.91 20.36 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 -176.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 16.1 m -85.27 -10.04 56.97 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.96 1.304 . . . . 0.0 114.12 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -108.72 127.43 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 126.704 2.002 . . . . 0.0 109.609 177.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -136.74 -177.26 4.66 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.175 2.19 . . . . 0.0 110.407 -173.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -43.76 -51.15 7.46 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.426 1.49 . . . . 0.0 114.595 -176.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -63.47 -38.04 89.61 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.076 0.853 . . . . 0.0 112.293 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.31 -41.66 73.02 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 170.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.459 HD23 ' C ' ' A' ' 277' ' ' LEU . 5.8 tt -55.65 -43.31 76.12 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.89 1.276 . . . . 0.0 110.719 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -46.8 -58.46 3.88 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.321 1.049 . . . . 0.0 111.643 171.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -61.19 -24.19 66.14 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.489 1.515 . . . . 0.0 113.293 -175.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 34.9 mt -52.14 -40.41 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 119.861 1.209 . . . . 0.0 111.185 172.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -102.02 -29.58 11.7 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.867 1.267 . . . . 0.0 111.718 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 23.7 tptt -70.16 -18.09 63.2 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.148 1.379 . . . . 0.0 113.553 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -61.07 -18.73 59.45 Favored 'General case' 0 CA--C 1.551 1.011 0 O-C-N 120.323 -1.486 . . . . 0.0 113.281 168.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 10.4 t -66.18 -11.03 47.04 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 124.709 1.203 . . . . 0.0 113.837 171.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 100.45 -8.94 58.85 Favored Glycine 0 N--CA 1.475 1.272 0 C-N-CA 125.973 1.749 . . . . 0.0 114.099 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -138.47 143.12 39.47 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.943 1.697 . . . . 0.0 109.936 172.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.9 p -89.54 141.26 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.176 0.99 . . . . 0.0 111.301 -177.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -83.52 -128.84 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.206 1.402 . . . . 0.0 110.583 170.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -157.64 162.22 38.67 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 127.457 2.303 . . . . 0.0 110.327 169.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -155.43 165.79 35.54 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.936 -1.103 . . . . 0.0 113.651 -170.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -147.69 137.26 22.58 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.609 1.564 . . . . 0.0 111.822 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 22.6 t -154.9 137.76 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.771 2.028 . . . . 0.0 108.375 -174.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -132.49 123.01 25.77 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.09 0.956 . . . . 0.0 110.097 170.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 18.8 mt -89.63 161.73 15.98 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.677 0.791 . . . . 0.0 112.948 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -74.03 139.04 44.46 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.481 1.112 . . . . 0.0 110.728 177.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -68.8 -8.99 58.46 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 116.59 1.396 . . . . 0.0 116.59 -163.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -78.53 -2.07 36.96 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 118.879 1.34 . . . . 0.0 112.791 166.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 89.03 46.63 4.41 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 125.519 1.533 . . . . 0.0 112.133 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.06 128.81 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.508 1.123 . . . . 0.0 110.896 -168.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 51.8 m -61.22 146.34 48.09 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.026 1.73 . . . . 0.0 114.449 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 29.4 p -84.79 -32.02 23.59 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.12 1.368 . . . . 0.0 112.895 172.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 77.78 -60.81 3.73 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.911 1.243 . . . . 0.0 111.433 -171.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 59.3 p -67.3 154.99 40.02 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.16 1.784 . . . . 0.0 113.393 167.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -167.05 171.31 41.81 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.802 1.192 . . . . 0.0 114.773 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 94.8 m -106.85 146.18 31.25 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.833 1.653 . . . . 0.0 110.092 -174.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 1.1 t -134.6 135.0 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.143 1.777 . . . . 0.0 109.292 -175.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 8.2 m -109.39 119.76 40.45 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.17 1.788 . . . . 0.0 108.347 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.45 164.49 25.4 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -157.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -56.09 -47.0 78.84 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.784 173.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -172.39 162.07 5.32 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 129.746 3.218 . . . . 0.0 108.921 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.56 HD12 ' H ' ' A' ' 311' ' ' ILE . 4.5 mp -62.19 -31.4 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.99 0.916 . . . . 0.0 111.823 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.62 -43.4 62.56 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 177.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -97.91 -14.97 20.36 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -176.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.8 tt -55.41 -51.6 66.32 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.178 1.391 . . . . 0.0 110.828 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -66.91 -29.33 69.18 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 39.1 mtp85 -70.16 -51.05 34.3 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.653 1.181 . . . . 0.0 111.126 170.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -63.07 -32.98 74.48 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.982 1.713 . . . . 0.0 113.524 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -54.83 -39.17 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.213 1.405 . . . . 0.0 112.051 177.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -82.67 -39.19 22.39 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.217 0.607 . . . . 0.0 112.055 174.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -65.51 -49.05 70.41 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -171.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -85.87 -20.84 28.48 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -176.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -67.19 113.69 5.33 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.415 -0.803 . . . . 0.0 110.03 173.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 101.03 0.07 54.86 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.29 0.947 . . . . 0.0 114.864 -173.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -94.21 168.83 10.67 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 118.962 1.381 . . . . 0.0 111.742 172.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 55.3 p -138.22 127.06 23.83 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 120.399 -1.438 . . . . 0.0 112.671 -175.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 22.6 mt -143.53 125.13 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.688 1.195 . . . . 0.0 109.487 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 59.49 20.73 9.16 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.7 1.6 . . . . 0.0 114.217 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 170.78 -118.49 0.75 Allowed Glycine 0 C--N 1.342 0.893 0 O-C-N 121.004 -1.06 . . . . 0.0 114.935 -178.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -96.48 178.13 5.45 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.8 0.84 . . . . 0.0 111.081 -171.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 12.6 p -52.64 137.49 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 O-C-N 121.879 -0.513 . . . . 0.0 109.948 157.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 2.1 pp -112.98 147.53 36.95 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.475 1.11 . . . . 0.0 112.195 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -104.56 157.45 17.16 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.176 1.39 . . . . 0.0 110.475 170.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 16.6 t -133.91 135.64 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.242 1.417 . . . . 0.0 109.313 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -149.29 159.57 44.15 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.819 1.248 . . . . 0.0 111.515 -171.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 23.0 t -144.39 151.7 39.65 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 120.59 -1.319 . . . . 0.0 111.099 172.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -72.73 -28.82 62.88 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -174.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 59.1 -167.12 0.16 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 126.809 2.044 . . . . 0.0 113.004 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 24.9 t -164.75 126.48 2.16 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.712 1.605 . . . . 0.0 110.23 174.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 11.6 p -169.46 141.2 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 125.299 1.44 . . . . 0.0 111.162 -174.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -157.58 129.05 6.82 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.317 1.447 . . . . 0.0 111.718 171.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -165.92 150.09 8.07 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.77 1.628 . . . . 0.0 111.939 -176.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -152.42 152.72 32.35 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.019 1.328 . . . . 0.0 112.66 172.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 34.4 p -163.76 127.71 2.74 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.144 1.778 . . . . 0.0 109.496 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -77.38 -16.76 58.7 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -173.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 79.23 -179.25 53.1 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.205 1.383 . . . . 0.0 115.06 171.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -163.64 132.21 3.78 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.83 2.052 . . . . 0.0 110.071 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -158.23 149.81 21.34 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.674 1.989 . . . . 0.0 110.241 -172.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 14.7 p -159.23 139.65 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 126.164 1.786 . . . . 0.0 110.356 176.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -170.63 128.84 0.8 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.507 2.323 . . . . 0.0 108.873 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 44.6 pt -133.06 151.08 77.25 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 126.018 1.727 . . . . 0.0 111.977 -176.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -73.82 158.24 46.84 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.597 2.865 . . . . 0.0 111.743 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 59.7 ttm -159.55 134.46 8.02 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.276 1.43 . . . . 0.0 110.754 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -80.05 155.32 27.62 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.207 1.403 . . . . 0.0 113.524 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -157.62 115.66 3.11 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.58 1.552 . . . . 0.0 110.447 175.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 73.2 m -115.32 147.26 38.23 Favored Pre-proline 0 N--CA 1.477 0.882 0 C-N-CA 124.979 1.312 . . . . 0.0 112.157 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.35 147.17 52.34 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.467 2.778 . . . . 0.0 111.414 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 14.6 p -164.01 143.18 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 125.172 1.389 . . . . 0.0 110.804 -176.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 5.9 p30 . . . . . 0 C--O 1.254 1.311 0 C-N-CA 126.281 1.832 . . . . 0.0 112.682 -179.48 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.925 0 N-CA-C 112.253 -0.339 . . . . 0.0 112.253 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 5.0 m 66.22 -156.14 0.25 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.392 1.477 . . . . 0.0 112.966 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 71.96 166.8 0.3 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 127.515 2.326 . . . . 0.0 114.016 176.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 35.3 m -134.28 157.72 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.197 0.999 . . . . 0.0 111.454 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 3.8 mp -131.82 140.29 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 126.258 1.823 . . . . 0.0 107.485 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 28.0 m -123.74 125.79 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.796 0.838 . . . . 0.0 109.984 -177.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -142.08 66.84 1.33 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.301 1.44 . . . . 0.0 111.82 -160.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -170.61 -44.67 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.957 1.703 . . . . 0.0 111.069 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 33.1 mt -40.09 119.26 1.45 Allowed Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 126.98 2.112 . . . . 0.0 112.327 165.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -94.06 -174.54 0.39 Allowed 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 124.505 3.47 . . . . 0.0 111.593 -176.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -51.32 -18.23 0.93 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.449 1.9 . . . . 0.0 115.379 177.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 15.8 m -64.68 -21.5 66.75 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.324 1.45 . . . . 0.0 113.879 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 5.4 p -105.72 148.54 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.742 1.217 . . . . 0.0 109.816 169.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -127.26 168.13 15.17 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.171 1.389 . . . . 0.0 111.549 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -54.1 -40.87 67.68 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -167.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -68.98 -37.75 78.94 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.482 -0.761 . . . . 0.0 111.687 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.47 -33.52 73.03 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 171.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 7.2 tt -60.48 -43.39 97.0 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.939 0.79 . . . . 0.0 110.962 172.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.49 -36.44 78.33 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.766 -0.584 . . . . 0.0 111.928 174.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -69.2 -20.06 63.97 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 23.7 mt -54.48 -45.53 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-N 119.604 1.093 . . . . 0.0 112.484 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -103.17 -3.97 25.06 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.662 1.185 . . . . 0.0 112.496 -174.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -61.8 -23.95 66.55 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.818 2.047 . . . . 0.0 115.217 -169.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -76.2 -10.87 59.75 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 14.0 t -79.03 -23.82 44.05 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 174.08 -165.99 37.88 Favored Glycine 0 N--CA 1.473 1.158 0 C-N-CA 124.346 0.974 . . . . 0.0 114.543 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -64.03 105.5 0.88 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.428 1.091 . . . . 0.0 110.087 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 5.3 p -52.94 137.2 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -153.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -73.43 -111.05 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.469 1.508 . . . . 0.0 112.397 -176.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -162.86 161.66 26.04 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.434 1.894 . . . . 0.0 111.091 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.3 168.39 27.14 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.076 -1.015 . . . . 0.0 112.386 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -156.86 153.62 28.52 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.313 1.045 . . . . 0.0 112.118 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 20.1 t -151.66 142.46 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.752 2.021 . . . . 0.0 108.302 -172.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -127.87 152.18 48.15 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.924 0.889 . . . . 0.0 110.861 172.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 15.4 mt -103.62 -157.06 0.59 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.762 1.225 . . . . 0.0 110.655 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -149.9 151.12 32.91 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.026 0.93 . . . . 0.0 111.273 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -63.26 -20.94 63.62 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-O 118.784 -1.009 . . . . 0.0 115.604 -174.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -117.55 -9.8 10.74 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 118.924 1.362 . . . . 0.0 113.962 165.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -70.27 -51.58 21.62 Favored Glycine 0 N--CA 1.47 0.92 0 C-N-CA 124.362 0.982 . . . . 0.0 112.267 169.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 2.8 t 58.94 10.46 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 C-N-CA 127.145 2.178 . . . . 0.0 112.016 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 86.4 p -179.57 153.45 0.56 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 127.94 2.496 . . . . 0.0 110.652 -168.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 5.0 p -152.97 -54.81 0.12 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 125.385 1.474 . . . . 0.0 112.774 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 78.3 -62.9 3.7 Favored Glycine 0 N--CA 1.473 1.111 0 C-N-CA 125.186 1.374 . . . . 0.0 112.023 -176.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 38.3 m -49.48 120.8 4.41 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.73 1.612 . . . . 0.0 112.451 165.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -157.25 -160.82 10.39 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.114 1.34 . . . . 0.0 114.522 -177.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 22.0 p -108.96 145.74 34.97 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.615 1.966 . . . . 0.0 111.149 -173.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.68 127.14 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.915 1.286 . . . . 0.0 109.047 -177.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 19.4 m -85.21 151.84 23.78 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.036 0.934 . . . . 0.0 110.138 171.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.33 157.74 27.51 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 -169.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -57.91 -55.66 32.01 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.608 1.563 . . . . 0.0 111.52 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -172.26 175.35 3.69 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 128.184 2.594 . . . . 0.0 108.975 161.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 74.2 mt -57.05 -35.9 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.241 1.416 . . . . 0.0 111.77 -176.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.39 -50.16 9.34 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.957 1.703 . . . . 0.0 114.874 172.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -95.76 -21.67 18.0 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.333 0.653 . . . . 0.0 112.129 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.0 tt -56.01 -49.4 73.78 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.549 1.14 . . . . 0.0 109.881 170.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -59.87 -33.64 72.08 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -70.51 -53.79 14.8 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.236 0.614 . . . . 0.0 111.267 170.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.52 -37.06 74.85 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.331 1.452 . . . . 0.0 113.602 -176.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.16 -40.17 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.306 1.042 . . . . 0.0 112.071 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -82.54 -38.94 23.04 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.487 0.715 . . . . 0.0 111.776 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -64.46 -47.72 77.94 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.519 1.128 . . . . 0.0 113.403 -173.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -92.54 -18.48 23.08 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -172.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -70.0 116.36 10.28 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.023 -1.048 . . . . 0.0 110.479 175.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 97.72 -5.84 62.29 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.628 1.585 . . . . 0.0 115.139 -174.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -80.09 172.79 13.31 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 118.824 1.312 . . . . 0.0 111.164 170.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 53.8 m -134.56 130.86 37.18 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 120.703 1.592 . . . . 0.0 111.697 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 39.0 mt -145.63 114.62 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.297 1.039 . . . . 0.0 109.159 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 57.1 28.52 15.06 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.439 1.096 . . . . 0.0 113.897 172.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 168.87 -125.52 1.28 Allowed Glycine 0 C--N 1.342 0.909 0 O-C-N 120.825 -1.172 . . . . 0.0 114.33 -177.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -87.35 -178.94 6.3 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.193 0.997 . . . . 0.0 110.824 -176.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 35.1 m -59.87 137.19 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 121.9 -0.5 . . . . 0.0 109.655 161.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 11.1 mp -71.34 128.31 35.47 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.135 1.374 . . . . 0.0 109.476 173.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -106.05 146.28 30.33 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 154.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 14.4 t -136.7 128.76 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.561 1.544 . . . . 0.0 108.938 -172.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -130.03 169.69 14.96 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.77 2.028 . . . . 0.0 110.512 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 32.9 t -138.5 151.66 47.58 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 120.537 -1.352 . . . . 0.0 111.833 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 40.6 tttm -80.13 2.11 25.43 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 -168.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -152.88 121.98 6.6 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.671 1.189 . . . . 0.0 110.91 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 23.3 t -172.93 165.41 5.11 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.679 1.992 . . . . 0.0 110.977 173.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 14.9 p -168.91 -40.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 125.043 1.337 . . . . 0.0 113.871 -176.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -141.63 157.17 45.42 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.495 1.118 . . . . 0.0 113.41 -174.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -120.51 3.38 10.73 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.318 1.447 . . . . 0.0 113.844 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 23.5 t60 58.83 34.35 23.64 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.912 1.685 . . . . 0.0 113.713 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 16.0 m -67.72 -15.92 63.88 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -171.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -83.31 -10.8 58.29 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.741 1.216 . . . . 0.0 113.307 175.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -87.52 141.14 17.14 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.147 1.356 . . . . 0.0 112.63 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -163.34 133.95 4.56 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.61 1.564 . . . . 0.0 111.432 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -166.23 156.81 12.69 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.105 2.162 . . . . 0.0 109.83 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 16.2 m -151.35 149.89 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 127.197 2.199 . . . . 0.0 111.037 -175.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -166.75 118.0 0.94 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.926 1.69 . . . . 0.0 110.222 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 5.3 mp -130.2 108.04 16.37 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 125.259 1.424 . . . . 0.0 108.699 178.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.47 152.69 13.64 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.568 2.845 . . . . 0.0 112.235 -176.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 42.3 tpp 73.38 146.08 0.08 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 128.103 2.561 . . . . 0.0 114.228 174.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -163.3 -41.73 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.007 1.323 . . . . 0.0 114.012 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -118.84 -11.17 9.79 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -160.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 66.0 m -115.52 152.05 46.71 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 124.491 1.116 . . . . 0.0 112.997 -166.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.24 150.84 53.93 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.234 2.623 . . . . 0.0 111.08 174.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 59.9 t -142.68 128.54 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.397 1.479 . . . . 0.0 108.798 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 32.9 m120 . . . . . 0 C--O 1.254 1.291 0 C-N-CA 125.939 1.696 . . . . 0.0 111.61 -174.878 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.938 0 N-CA-C 112.389 -0.284 . . . . 0.0 112.389 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 92.5 p -157.25 33.6 0.28 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.129 0.972 . . . . 0.0 112.723 -171.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -159.74 145.94 16.03 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.771 -1.206 . . . . 0.0 110.972 -170.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 32.6 m -133.24 147.14 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.142 0.977 . . . . 0.0 111.056 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.7 mp -91.57 141.23 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 126.675 1.99 . . . . 0.0 108.606 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 34.7 m -132.84 129.07 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.577 1.151 . . . . 0.0 109.036 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.3 tptm -150.5 50.46 0.88 Allowed 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 -148.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -160.94 -17.68 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 170.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 39.3 mt -54.35 131.96 61.93 Favored Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 125.713 1.605 . . . . 0.0 111.598 168.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -86.09 169.5 8.75 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.312 3.341 . . . . 0.0 111.276 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -55.81 -10.66 0.78 Allowed 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 6.2 t -59.32 -31.21 68.95 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.696 1.198 . . . . 0.0 113.006 171.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.62 116.33 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 169.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -69.36 153.28 43.85 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.562 0.745 . . . . 0.0 110.097 171.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -55.46 -32.67 62.99 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 120.538 -1.351 . . . . 0.0 113.108 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -69.11 -39.57 78.85 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.021 0.929 . . . . 0.0 111.033 175.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.53 -25.51 64.06 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.078 -1.014 . . . . 0.0 113.065 170.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.74 -49.05 64.63 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.258 0.935 . . . . 0.0 111.343 170.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -25.89 68.25 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 119.762 1.165 . . . . 0.0 111.852 174.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -68.93 -21.66 64.19 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 171.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.441 HG23 HD12 ' A' ' 326' ' ' ILE . 30.1 mt -56.97 -51.35 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 CA-C-N 119.696 1.134 . . . . 0.0 111.269 173.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -85.84 -19.55 30.46 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.678 0.791 . . . . 0.0 111.824 -174.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -57.62 -13.98 4.71 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.103 1.761 . . . . 0.0 114.808 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -59.48 -15.32 16.84 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 168.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 83.9 m -68.79 -5.62 21.86 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 168.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.39 -8.58 60.5 Favored Glycine 0 N--CA 1.48 1.575 0 C-N-CA 125.789 1.662 . . . . 0.0 115.666 172.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -138.69 -174.65 3.89 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.823 2.049 . . . . 0.0 108.634 170.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 6.8 p -144.06 144.22 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 121.159 1.799 . . . . 0.0 113.618 172.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -94.81 -121.04 0.1 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.184 1.793 . . . . 0.0 111.189 177.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -143.82 158.55 43.61 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.538 1.935 . . . . 0.0 111.567 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.96 -179.72 8.3 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 120.974 -1.079 . . . . 0.0 113.855 -177.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 8.2 p30 -155.54 173.7 16.32 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.656 1.583 . . . . 0.0 113.781 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 17.2 m -149.92 173.86 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 127.69 2.396 . . . . 0.0 110.075 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -108.22 159.54 16.54 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.674 1.19 . . . . 0.0 111.318 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.3 mp -132.96 134.17 44.15 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.542 1.137 . . . . 0.0 111.347 173.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -66.77 164.27 17.5 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.691 1.196 . . . . 0.0 111.221 165.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -61.97 -19.93 59.5 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.019 0.819 . . . . 0.0 114.669 176.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -79.14 -6.16 55.86 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.917 1.287 . . . . 0.0 113.47 171.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 80.87 14.13 80.12 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.034 1.302 . . . . 0.0 115.135 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 3.7 p -91.11 4.66 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 -165.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 10.9 p 64.87 -179.39 0.18 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 126.992 2.117 . . . . 0.0 116.159 175.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 68.6 p -141.99 156.3 45.45 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 128.368 2.667 . . . . 0.0 108.229 172.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -88.01 -34.31 10.0 Favored Glycine 0 N--CA 1.47 0.947 0 C-N-CA 123.245 0.45 . . . . 0.0 112.203 169.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 18.7 p -56.81 143.04 38.58 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.762 1.625 . . . . 0.0 111.922 163.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 169.55 -153.59 22.09 Favored Glycine 0 N--CA 1.471 0.985 0 C-N-CA 126.172 1.844 . . . . 0.0 112.253 -175.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 17.8 p -125.09 154.97 40.57 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 117.994 0.897 . . . . 0.0 111.357 173.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 13.4 m -123.82 121.96 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 125.222 1.409 . . . . 0.0 107.782 172.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 4.5 m -91.09 120.79 32.34 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.013 1.725 . . . . 0.0 109.356 -175.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.85 157.47 21.99 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -158.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -54.38 -54.03 46.0 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 113.56 -1.655 . . . . 0.0 111.793 172.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -172.68 170.24 4.78 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 129.366 3.067 . . . . 0.0 108.676 171.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 89.5 mt -57.49 -34.32 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 124.864 1.266 . . . . 0.0 112.054 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.14 -40.2 64.07 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.138 1.375 . . . . 0.0 114.433 172.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -89.39 -33.15 16.96 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 119.328 -0.368 . . . . 0.0 110.418 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 6.2 tt -56.64 -52.16 65.94 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.854 1.262 . . . . 0.0 111.378 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -62.3 -47.58 83.66 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.67 -0.644 . . . . 0.0 112.541 -177.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 28.1 ptt85 -70.44 -28.83 65.34 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -74.12 -33.78 63.68 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.502 1.121 . . . . 0.0 112.997 173.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -53.71 -44.04 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.156 1.382 . . . . 0.0 112.3 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -82.75 -17.37 44.47 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -89.07 -48.51 7.36 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.913 0.885 . . . . 0.0 112.671 -171.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -85.32 -21.55 28.89 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -49.8 125.26 11.37 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.885 0.874 . . . . 0.0 110.761 159.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 86.93 0.34 85.74 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 119.141 -0.811 . . . . 0.0 114.757 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -103.69 163.43 12.33 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.139 1.375 . . . . 0.0 112.045 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 34.1 p -138.03 129.35 27.66 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 120.684 -1.26 . . . . 0.0 111.897 -175.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.441 HD12 HG23 ' A' ' 280' ' ' ILE . 11.0 mt -146.71 116.86 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.49 1.116 . . . . 0.0 109.104 -177.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 60.86 25.95 15.84 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.695 1.198 . . . . 0.0 112.792 176.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 178.2 -140.01 4.42 Favored Glycine 0 C--N 1.342 0.888 0 O-C-N 120.931 -1.106 . . . . 0.0 114.474 -170.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -91.42 178.26 6.0 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.399 1.08 . . . . 0.0 110.644 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 11.7 p -59.92 129.19 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 O-C-N 121.642 -0.661 . . . . 0.0 109.308 160.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 1.8 pp -104.37 149.09 25.69 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 122.406 1.098 . . . . 0.0 111.533 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -113.37 163.54 14.72 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.017 1.327 . . . . 0.0 110.092 166.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 24.3 t -135.93 130.52 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 126.561 1.945 . . . . 0.0 107.51 -175.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -135.28 133.94 39.41 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.234 1.014 . . . . 0.0 111.46 -173.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 77.3 p -118.0 167.54 11.35 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.186 1.394 . . . . 0.0 112.894 -171.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -122.22 124.01 42.82 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.081 1.352 . . . . 0.0 110.718 175.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -161.05 -59.8 0.05 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.64 1.176 . . . . 0.0 110.997 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 12.1 t -163.77 -169.8 2.0 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.026 1.33 . . . . 0.0 111.865 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 21.7 m -143.56 149.81 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 127.307 2.243 . . . . 0.0 110.535 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -146.73 156.74 43.4 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.133 1.373 . . . . 0.0 112.749 -170.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -159.48 177.35 11.04 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.901 1.68 . . . . 0.0 112.08 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -116.35 21.13 13.81 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.505 1.522 . . . . 0.0 112.825 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 20.1 m -79.58 71.64 6.19 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.326 1.45 . . . . 0.0 111.674 -176.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -75.42 -10.65 59.64 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.021 1.328 . . . . 0.0 114.214 -175.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 92.04 -2.86 76.26 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.29 1.424 . . . . 0.0 115.107 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -151.51 138.98 19.51 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.257 1.823 . . . . 0.0 110.897 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -164.62 134.18 3.77 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.934 1.693 . . . . 0.0 110.938 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 17.1 m -153.8 154.27 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 126.212 1.805 . . . . 0.0 111.232 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -148.61 106.11 3.66 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.86 1.664 . . . . 0.0 109.652 174.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 7.4 pt -133.33 96.56 17.08 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 125.172 1.389 . . . . 0.0 110.596 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -83.13 147.53 13.02 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.238 2.625 . . . . 0.0 111.806 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -73.39 149.27 42.63 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.558 1.143 . . . . 0.0 111.411 172.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -71.56 133.77 45.99 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.359 0.664 . . . . 0.0 111.994 173.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -151.94 26.46 0.63 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.009 1.724 . . . . 0.0 111.4 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 21.3 t -63.43 128.75 92.97 Favored Pre-proline 0 CA--C 1.55 0.978 0 O-C-N 120.994 -1.066 . . . . 0.0 112.347 -176.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.43 151.31 33.13 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.585 2.857 . . . . 0.0 111.742 -177.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 15.9 m -148.58 144.98 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 125.432 1.493 . . . . 0.0 111.095 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 . . . . . 0 C--O 1.254 1.339 0 C-N-CA 126.291 1.836 . . . . 0.0 111.56 -178.942 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.719 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 73.0 m -146.8 164.79 31.69 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.198 1.399 . . . . 0.0 111.229 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -142.56 160.07 41.0 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.156 0.982 . . . . 0.0 112.156 -170.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 34.7 m -132.86 157.43 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.687 1.195 . . . . 0.0 111.109 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.0 mp -125.17 136.91 59.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 127.044 2.137 . . . . 0.0 107.033 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.93 128.89 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.116 0.967 . . . . 0.0 109.427 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 60.2 mmtt -138.76 73.84 1.45 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.034 1.334 . . . . 0.0 110.784 -161.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -179.13 -32.21 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.554 1.942 . . . . 0.0 113.3 -173.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 89.1 mt -74.07 131.35 81.29 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-O 117.917 -1.04 . . . . 0.0 109.834 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -94.83 -168.88 0.16 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 124.272 3.315 . . . . 0.0 110.759 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -55.59 -13.62 1.68 Allowed 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 50.0 m -60.26 -24.19 64.71 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.386 1.474 . . . . 0.0 113.872 170.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.3 p -103.5 144.57 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.43 1.092 . . . . 0.0 109.893 170.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -135.91 173.56 11.58 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.944 1.698 . . . . 0.0 109.775 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -44.35 -51.28 8.65 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.959 1.303 . . . . 0.0 113.777 -170.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -70.07 -40.82 74.8 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.917 -0.49 . . . . 0.0 111.618 -175.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.25 -33.56 73.45 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.789 0.722 . . . . 0.0 112.82 176.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 8.2 tt -63.1 -45.2 93.2 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.98 0.809 . . . . 0.0 110.409 172.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 3.7 tmmm? -60.69 -37.63 82.27 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.864 -0.523 . . . . 0.0 111.161 174.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -63.68 -25.32 68.16 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 176.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 28.1 mt -55.92 -51.37 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 124.112 0.965 . . . . 0.0 110.609 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -89.0 -26.26 21.56 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.666 0.786 . . . . 0.0 112.343 -175.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 2.9 ttpt -52.7 -22.03 4.71 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.292 1.437 . . . . 0.0 114.356 173.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -61.8 -13.75 26.7 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 120.77 -1.206 . . . . 0.0 113.79 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 79.3 m -71.54 -0.37 10.42 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.968 1.307 . . . . 0.0 114.403 167.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.58 -73.57 0.25 Allowed Glycine 0 N--CA 1.471 1.001 0 C-N-CA 126.393 1.949 . . . . 0.0 111.449 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -73.08 172.3 11.3 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.19 0.996 . . . . 0.0 111.136 170.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.29 142.05 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 O-C-N 120.635 -1.29 . . . . 0.0 113.827 172.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -85.36 -125.56 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.733 1.613 . . . . 0.0 111.415 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -152.1 162.0 41.77 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.4 1.48 . . . . 0.0 112.89 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.6 173.72 16.16 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.11 -0.994 . . . . 0.0 113.641 -173.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -154.87 158.42 39.33 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.799 1.24 . . . . 0.0 113.398 -177.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 21.8 m -151.53 163.45 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 127.486 2.314 . . . . 0.0 110.914 -172.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -131.97 167.46 19.61 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.77 1.228 . . . . 0.0 111.84 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 4.0 mp -129.05 152.68 48.39 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.228 1.411 . . . . 0.0 112.203 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -92.84 153.17 19.0 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.066 1.746 . . . . 0.0 111.487 173.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -68.5 -7.08 52.25 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.801 1.191 . . . . 0.0 114.989 -178.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -74.08 -4.77 37.57 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.31 1.444 . . . . 0.0 112.953 168.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 86.45 38.29 8.37 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.035 1.302 . . . . 0.0 113.392 176.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 30.6 m -142.05 148.41 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.678 1.591 . . . . 0.0 111.143 -174.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 75.0 p -81.1 152.74 27.67 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.924 0.89 . . . . 0.0 113.039 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 39.1 p -76.25 -29.4 57.48 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.858 0.863 . . . . 0.0 112.881 176.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 74.49 -64.26 2.16 Favored Glycine 0 N--CA 1.47 0.926 0 C-N-CA 125.724 1.63 . . . . 0.0 112.207 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 58.1 m -55.0 110.61 0.69 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.427 1.891 . . . . 0.0 111.435 166.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -146.67 -160.11 8.61 Favored Glycine 0 N--CA 1.469 0.851 0 C-N-CA 124.695 1.14 . . . . 0.0 113.897 -173.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 98.0 m -114.89 136.67 52.85 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.526 1.53 . . . . 0.0 109.625 -170.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 1.3 t -120.41 120.23 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 125.751 1.621 . . . . 0.0 107.622 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 42.9 m -88.46 108.04 19.18 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.416 1.086 . . . . 0.0 108.426 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -79.6 162.91 25.02 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 -160.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -53.21 -55.58 23.21 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.625 1.17 . . . . 0.0 111.35 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -172.39 178.82 2.69 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.039 2.535 . . . . 0.0 109.007 154.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 16.7 tt -53.51 -33.31 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.101 1.36 . . . . 0.0 113.488 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.69 -42.72 68.28 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.207 1.403 . . . . 0.0 113.956 173.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -95.26 -24.58 16.72 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.5 tt -58.35 -51.97 67.57 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 125.434 1.493 . . . . 0.0 110.221 175.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -62.21 -33.43 74.54 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -70.33 -42.39 71.97 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.695 1.198 . . . . 0.0 112.036 174.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -72.92 -33.55 66.05 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.432 1.493 . . . . 0.0 113.134 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.44 -37.01 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.833 0.853 . . . . 0.0 112.6 -176.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -82.17 -19.59 39.6 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.855 0.862 . . . . 0.0 113.206 175.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -89.01 -46.09 9.13 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.68 1.192 . . . . 0.0 112.645 -175.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -87.71 -30.71 20.14 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -171.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -65.09 118.84 9.75 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 119.011 0.823 . . . . 0.0 110.324 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 103.42 -7.07 50.45 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 125.644 1.592 . . . . 0.0 115.629 -172.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -93.88 142.92 26.82 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 119.451 1.625 . . . . 0.0 111.78 176.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 11.0 p -111.96 126.64 55.35 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.793 1.237 . . . . 0.0 112.234 -174.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -148.58 103.16 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.113 0.965 . . . . 0.0 109.517 -166.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 57.06 35.89 26.96 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 121.932 0.872 . . . . 0.0 111.462 -172.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 163.31 -148.69 15.47 Favored Glycine 0 C--N 1.343 0.952 0 O-C-N 121.152 -0.968 . . . . 0.0 114.787 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -80.93 174.55 11.51 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.804 1.642 . . . . 0.0 111.066 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 32.8 m -63.37 136.18 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 121.213 -0.929 . . . . 0.0 111.301 175.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 14.6 mt -63.41 122.28 15.86 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.674 0.79 . . . . 0.0 113.001 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -106.04 102.37 11.8 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.36 1.864 . . . . 0.0 107.599 160.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.45 131.69 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.286 1.435 . . . . 0.0 109.698 -171.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -130.0 135.13 47.94 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.978 1.311 . . . . 0.0 110.806 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 50.1 p -97.05 159.0 15.16 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.874 -1.141 . . . . 0.0 112.005 175.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -82.07 97.85 8.36 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 121.286 -0.883 . . . . 0.0 111.079 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.04 174.24 12.53 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.987 1.715 . . . . 0.0 112.087 -175.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 20.3 t -160.94 163.63 31.71 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.478 1.511 . . . . 0.0 111.293 174.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 9.9 p -91.82 -24.23 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.442 1.097 . . . . 0.0 113.614 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 57.27 26.96 12.96 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 125.535 1.534 . . . . 0.0 114.538 174.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -71.18 -21.97 62.09 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -167.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 63.94 175.88 0.17 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 126.473 1.909 . . . . 0.0 114.356 177.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 33.5 t -163.41 140.16 7.17 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.465 1.506 . . . . 0.0 111.152 177.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -84.68 -8.11 58.98 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.401 1.08 . . . . 0.0 113.107 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 84.21 -171.24 47.98 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.177 1.37 . . . . 0.0 114.045 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -150.07 146.63 27.06 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.177 1.791 . . . . 0.0 111.153 -176.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -164.49 158.74 18.61 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.994 2.117 . . . . 0.0 109.697 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 14.9 p -165.36 143.45 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 126.86 2.064 . . . . 0.0 110.606 -175.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -161.83 114.24 1.77 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.311 1.844 . . . . 0.0 109.167 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 40.5 mm -99.1 119.99 59.39 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 124.325 1.05 . . . . 0.0 110.0 -175.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -79.42 163.67 24.42 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.684 2.923 . . . . 0.0 112.106 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 27.8 ttt -158.12 132.92 8.43 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.257 1.423 . . . . 0.0 110.53 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -161.07 158.37 27.64 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.142 1.377 . . . . 0.0 112.171 -178.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -149.05 9.65 0.77 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 128.115 2.566 . . . . 0.0 112.547 177.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 12.7 t -64.3 147.56 96.91 Favored Pre-proline 0 CA--C 1.552 1.023 0 O-C-N 120.663 -1.273 . . . . 0.0 112.304 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.28 -14.16 41.98 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.957 2.438 . . . . 0.0 113.289 164.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 21.6 t 73.49 95.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 126.4 1.88 . . . . 0.0 110.9 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 . . . . . 0 C--O 1.254 1.316 0 C-N-CA 126.653 1.981 . . . . 0.0 111.163 179.346 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.913 0 CA-C-O 121.151 0.306 . . . . 0.0 112.608 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 8.3 m -176.6 98.04 0.05 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 128.288 2.635 . . . . 0.0 109.122 175.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -167.47 153.35 7.63 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.218 -0.926 . . . . 0.0 112.853 -173.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 31.3 m -138.59 147.26 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.45 1.5 . . . . 0.0 111.126 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.4 mp -92.05 137.83 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 126.01 1.724 . . . . 0.0 107.683 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 5.4 m -117.75 118.5 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.417 ' H ' HD11 ' A' ' 331' ' ' LEU . 6.8 tmtt? -139.37 44.75 1.97 Allowed 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -148.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -168.51 -6.65 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 116.623 2.083 . . . . 0.0 116.623 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 68.0 mt -69.84 144.17 93.04 Favored Pre-proline 0 CA--C 1.553 1.079 0 O-C-N 120.532 -1.355 . . . . 0.0 110.103 174.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -90.62 -175.24 0.83 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.3 3.333 . . . . 0.0 110.905 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -56.37 -12.47 1.68 Allowed 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 20.4 m -60.48 -31.05 70.1 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.78 1.232 . . . . 0.0 113.266 171.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.6 p -93.73 142.49 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.503 0.721 . . . . 0.0 109.697 172.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -137.26 168.41 19.69 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.004 1.722 . . . . 0.0 109.09 176.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -50.56 -40.92 53.43 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -167.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -68.64 -39.01 80.94 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.761 -0.587 . . . . 0.0 111.895 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.58 -36.25 76.09 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.382 -0.824 . . . . 0.0 112.715 170.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.453 HD21 HG12 ' A' ' 306' ' ' VAL . 3.3 tt -61.03 -38.27 85.51 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.189 0.996 . . . . 0.0 112.138 176.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -57.84 -46.94 84.02 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 121.537 -0.727 . . . . 0.0 110.947 169.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.29 -17.82 64.82 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 29.3 mt -54.41 -33.45 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.344 1.058 . . . . 0.0 111.803 169.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -118.05 -27.7 6.05 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.171 1.389 . . . . 0.0 112.183 -176.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -64.31 -6.66 7.39 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -52.72 -25.29 10.65 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.198 1.399 . . . . 0.0 113.06 167.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 70.8 m -67.66 -5.17 14.52 Favored 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 172.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 97.06 -12.17 65.59 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 126.436 1.969 . . . . 0.0 115.017 175.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -138.67 172.47 12.83 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.394 1.878 . . . . 0.0 109.659 174.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.1 p -145.34 144.35 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 120.341 -1.474 . . . . 0.0 112.318 173.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -72.57 -79.4 0.08 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.473 1.109 . . . . 0.0 112.077 178.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -178.45 147.01 0.39 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 127.947 2.499 . . . . 0.0 109.813 -167.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.59 166.56 31.79 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.11 -0.994 . . . . 0.0 112.658 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -157.46 165.8 34.71 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.898 1.279 . . . . 0.0 112.496 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 22.7 m -146.37 155.4 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 126.838 2.055 . . . . 0.0 110.793 -174.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -132.0 115.21 15.54 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.875 1.27 . . . . 0.0 108.848 174.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 17.2 mt -96.13 169.1 10.19 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.466 1.106 . . . . 0.0 111.376 -173.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -78.16 144.76 36.11 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.009 0.923 . . . . 0.0 112.119 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -68.44 -12.35 63.58 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.88 1.229 . . . . 0.0 115.795 -173.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -80.81 0.01 36.77 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 119.301 1.551 . . . . 0.0 113.22 168.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 85.81 43.35 6.44 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.575 1.083 . . . . 0.0 113.172 175.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.19 148.9 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.08 1.352 . . . . 0.0 111.89 -177.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 58.5 m -77.79 139.32 39.32 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -169.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 7.9 p -89.22 -26.66 21.1 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.69 1.996 . . . . 0.0 113.529 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 80.27 -54.27 4.52 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.103 1.811 . . . . 0.0 113.067 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 23.4 p -52.34 139.75 23.63 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 122.998 1.38 . . . . 0.0 113.28 163.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -161.23 -171.73 27.63 Favored Glycine 0 N--CA 1.468 0.832 0 C-N-CA 124.831 1.205 . . . . 0.0 114.682 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 26.6 p -123.39 122.41 38.22 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.48 1.512 . . . . 0.0 109.493 -176.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.453 HG12 HD21 ' A' ' 277' ' ' LEU . 19.6 m -112.58 129.73 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 175.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 5.1 m -87.88 150.03 23.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.709 172.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.74 157.44 19.76 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -165.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -53.82 -52.57 59.92 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.743 1.617 . . . . 0.0 111.88 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -172.66 170.36 4.77 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.351 2.66 . . . . 0.0 108.532 162.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.553 HD12 ' H ' ' A' ' 311' ' ' ILE . 4.3 mp -47.1 -38.23 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 125.121 1.368 . . . . 0.0 112.11 175.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.67 -48.99 19.98 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.878 1.671 . . . . 0.0 115.111 173.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -96.39 -21.44 17.77 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 118.749 -0.643 . . . . 0.0 111.993 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.3 tt -57.87 -52.33 65.91 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.234 1.013 . . . . 0.0 110.191 173.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -68.87 -26.61 65.21 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -70.29 -43.36 70.56 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.043 0.937 . . . . 0.0 111.594 169.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -75.24 -30.6 60.57 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.511 1.525 . . . . 0.0 113.675 -177.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.01 -42.28 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.179 0.991 . . . . 0.0 113.12 -172.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -82.77 -37.79 24.09 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.688 0.795 . . . . 0.0 112.449 175.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -57.46 -38.15 74.01 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.198 -0.939 . . . . 0.0 111.997 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -106.31 28.53 7.65 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.322 1.849 . . . . 0.0 112.616 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -89.94 118.75 29.74 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.421 -1.424 . . . . 0.0 110.866 161.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 84.41 -8.67 67.15 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.975 1.274 . . . . 0.0 115.523 172.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . 0.458 ' CE1' HD23 ' A' ' 331' ' ' LEU . 0.2 OUTLIER -60.43 171.55 1.06 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.282 1.833 . . . . 0.0 113.78 168.395 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 73.4 p -138.52 122.25 17.55 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.077 -1.015 . . . . 0.0 112.048 175.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 13.4 mt -135.54 111.3 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.714 1.206 . . . . 0.0 108.878 177.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 65.09 26.6 12.52 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.359 1.464 . . . . 0.0 112.939 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . -179.07 -131.83 1.65 Allowed Glycine 0 CA--C 1.53 1.014 0 N-CA-C 115.707 1.043 . . . . 0.0 115.707 -176.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -98.61 179.28 4.74 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.481 1.513 . . . . 0.0 111.077 -172.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 30.8 m -60.29 132.28 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 162.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . 0.458 HD23 ' CE1' ' A' ' 324' ' ' TYR . 59.7 tp -126.21 117.16 22.5 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.553 0.741 . . . . 0.0 111.147 -165.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -75.67 148.74 38.45 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.147 160.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 96.6 t -136.89 137.69 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 126.074 1.75 . . . . 0.0 108.998 -176.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -144.13 135.74 25.92 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.994 0.918 . . . . 0.0 111.952 -170.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 82.5 p -89.37 161.74 16.17 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 45.0 tttm -86.87 16.36 4.95 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 124.826 1.25 . . . . 0.0 113.219 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -82.02 -26.08 34.1 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -168.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 53.7 m 69.66 164.62 0.26 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 126.647 1.979 . . . . 0.0 114.155 -176.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 15.8 m -148.01 150.95 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 125.794 1.638 . . . . 0.0 111.358 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -147.34 -13.67 0.4 Allowed 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -72.92 128.09 34.46 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.203 -0.936 . . . . 0.0 111.367 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -109.56 -17.15 13.8 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 -170.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 22.9 t -169.73 155.62 5.98 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.622 1.569 . . . . 0.0 111.392 -173.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -88.86 -12.31 42.2 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.671 1.188 . . . . 0.0 113.02 173.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 147.34 173.03 18.12 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.485 1.517 . . . . 0.0 114.237 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -85.62 -8.07 58.47 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.022 1.329 . . . . 0.0 114.141 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -163.71 156.98 18.62 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.916 2.487 . . . . 0.0 109.262 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 15.3 m -152.62 144.77 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 127.022 2.129 . . . . 0.0 111.116 -170.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -81.55 -14.85 56.36 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.941 0.896 . . . . 0.0 113.343 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 5.3 mp -133.06 125.46 19.06 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.456 1.903 . . . . 0.0 107.721 172.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.4 133.31 27.84 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.036 2.49 . . . . 0.0 111.518 -174.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 28.0 ttt -165.21 140.45 5.2 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.041 1.736 . . . . 0.0 110.255 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -159.56 153.21 22.77 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.419 1.487 . . . . 0.0 112.328 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -150.21 18.27 0.85 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.085 1.354 . . . . 0.0 112.718 -175.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 32.5 p -87.33 152.96 53.31 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 125.319 1.448 . . . . 0.0 112.808 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -72.39 149.1 49.97 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.517 2.812 . . . . 0.0 111.315 177.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 11.0 p -163.47 142.77 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.017 1.327 . . . . 0.0 110.75 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 . . . . . 0 C--O 1.253 1.275 0 C-N-CA 124.987 1.315 . . . . 0.0 113.885 -179.095 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.916 0 N-CA-C 112.411 -0.276 . . . . 0.0 112.411 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 57.2 m -137.75 75.89 1.55 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.717 1.207 . . . . 0.0 110.367 -174.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -147.25 154.73 41.36 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.436 1.094 . . . . 0.0 112.084 -173.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 12.1 m -133.94 161.46 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 124.976 1.311 . . . . 0.0 110.963 169.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.97 139.57 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 127.343 2.257 . . . . 0.0 108.368 178.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.57 126.6 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.329 1.051 . . . . 0.0 108.961 175.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -140.15 42.5 1.93 Allowed 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -153.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -158.34 -15.31 0.07 Allowed 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 171.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 16.2 mt -52.29 133.47 42.36 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 125.641 1.577 . . . . 0.0 112.969 173.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -88.24 166.55 6.71 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.929 3.753 . . . . 0.0 110.931 172.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -60.32 -12.48 9.23 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -174.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 16.0 m -61.76 -23.47 66.2 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.289 1.036 . . . . 0.0 112.789 171.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.5 p -115.32 131.51 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 126.936 2.094 . . . . 0.0 108.958 167.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -148.5 178.2 8.82 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.109 1.764 . . . . 0.0 109.224 -171.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -38.87 -50.67 1.73 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.284 1.834 . . . . 0.0 115.932 -162.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -67.35 -44.51 78.86 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.234 0.925 . . . . 0.0 111.886 -176.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.84 -32.0 70.17 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 172.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.496 HD23 ' C ' ' A' ' 277' ' ' LEU . 4.1 tt -58.64 -45.31 89.59 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.257 1.023 . . . . 0.0 109.91 174.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -56.08 -38.3 70.49 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.577 -0.702 . . . . 0.0 112.376 173.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -69.04 -19.95 64.11 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 178.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 29.7 mt -58.19 -30.47 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 124.157 0.983 . . . . 0.0 111.707 170.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -114.19 -26.46 8.03 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.666 1.186 . . . . 0.0 113.434 -175.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 1.8 tmmt? -63.54 -20.73 65.87 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -176.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -75.0 -13.54 60.52 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 171.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 11.2 t -107.08 -33.55 7.43 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.185 1.394 . . . . 0.0 113.301 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -138.03 153.52 22.32 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.843 1.211 . . . . 0.0 114.84 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -69.45 115.25 8.49 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.707 1.203 . . . . 0.0 110.751 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 4.8 p -41.14 132.9 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 -154.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -99.09 -111.76 0.17 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.971 1.708 . . . . 0.0 110.274 174.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 -159.58 155.23 25.91 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.667 1.587 . . . . 0.0 112.456 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.23 171.31 20.44 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.132 -0.98 . . . . 0.0 112.621 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -157.59 165.6 35.1 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.828 1.251 . . . . 0.0 112.814 -173.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 23.1 t -151.01 142.78 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 127.421 2.288 . . . . 0.0 107.387 -177.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -119.52 133.09 55.83 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.224 0.61 . . . . 0.0 110.921 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 11.8 mt -86.34 164.99 16.76 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.981 0.912 . . . . 0.0 111.471 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -64.72 133.33 51.88 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 155.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -67.51 -11.88 60.47 Favored Glycine 0 N--CA 1.475 1.265 0 N-CA-C 117.385 1.714 . . . . 0.0 117.385 -153.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -79.73 0.4 30.7 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 118.556 1.178 . . . . 0.0 112.736 168.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 93.75 33.91 6.83 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 126.356 1.931 . . . . 0.0 113.584 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.32 15.38 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -157.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 21.0 p 73.27 148.0 0.09 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 127.532 2.333 . . . . 0.0 115.484 171.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 11.9 p -159.75 158.05 30.53 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 128.183 2.593 . . . . 0.0 109.022 -177.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -112.82 -50.22 0.56 Allowed Glycine 0 N--CA 1.473 1.137 0 C-N-CA 124.187 0.898 . . . . 0.0 112.844 169.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 69.1 m -44.19 120.82 2.27 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.901 1.68 . . . . 0.0 113.093 170.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -152.01 -168.22 16.05 Favored Glycine 0 N--CA 1.468 0.826 0 C-N-CA 125.047 1.308 . . . . 0.0 114.288 -173.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 30.0 p -122.65 152.75 40.19 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.101 1.76 . . . . 0.0 110.314 -174.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 1.7 t -139.46 126.19 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.353 1.061 . . . . 0.0 108.474 -170.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 19.4 t -92.57 121.0 33.58 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.819 0.847 . . . . 0.0 108.757 172.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.94 155.54 18.65 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -165.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -55.02 -53.83 50.81 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.844 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -172.85 -170.62 0.68 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 128.519 2.728 . . . . 0.0 108.805 145.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.4 mp -55.96 -34.18 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.426 1.49 . . . . 0.0 113.284 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.36 -35.61 60.46 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.293 1.219 . . . . 0.0 114.293 174.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -98.82 -35.57 10.08 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 123.703 0.627 . . . . 0.0 110.127 -173.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.5 tt -51.21 -52.32 45.59 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 126.971 2.108 . . . . 0.0 110.659 174.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -65.15 -25.27 67.67 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 119.13 0.877 . . . . 0.0 113.21 -176.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -70.64 -55.96 7.57 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.917 1.287 . . . . 0.0 110.427 169.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -63.88 -37.2 86.52 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.124 1.37 . . . . 0.0 113.351 -175.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.15 -34.01 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.446 1.098 . . . . 0.0 112.031 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -82.53 -40.82 20.47 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.054 0.942 . . . . 0.0 111.901 173.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.07 -41.69 85.99 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.224 1.01 . . . . 0.0 113.501 -175.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -106.13 -17.53 14.29 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -169.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -66.78 121.05 14.6 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.977 1.262 . . . . 0.0 109.836 168.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 91.41 -1.2 75.89 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 124.193 0.901 . . . . 0.0 114.693 -171.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -97.49 166.75 11.38 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.318 1.447 . . . . 0.0 111.446 175.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 61.7 p -138.43 127.21 23.66 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 120.11 -1.619 . . . . 0.0 112.358 -177.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 16.9 mt -137.47 106.91 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.991 0.917 . . . . 0.0 109.72 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 59.03 25.18 13.54 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.402 1.481 . . . . 0.0 112.996 175.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . -167.29 -140.61 2.94 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.807 1.194 . . . . 0.0 113.808 -169.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -96.2 179.94 4.87 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.891 0.876 . . . . 0.0 111.101 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.53 128.2 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 165.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 16.3 mt -72.37 129.46 38.42 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.042 1.337 . . . . 0.0 112.111 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -112.79 118.84 36.08 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.021 1.728 . . . . 0.0 107.3 163.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 18.0 t -127.25 138.49 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.18 1.392 . . . . 0.0 109.436 -166.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -140.37 139.96 35.44 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.622 1.169 . . . . 0.0 111.521 -177.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 32.4 t -91.15 146.98 23.38 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.27 -0.894 . . . . 0.0 112.594 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -81.09 -6.96 59.42 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.121 0.968 . . . . 0.0 112.877 170.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -144.91 132.65 21.08 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.423 1.489 . . . . 0.0 111.126 -176.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 21.7 t -168.57 161.87 11.73 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.17 0.988 . . . . 0.0 112.273 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 12.9 p -170.99 147.48 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 127.14 2.176 . . . . 0.0 109.565 -172.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -151.82 137.77 18.13 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.271 1.028 . . . . 0.0 113.349 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -163.89 143.79 8.22 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.542 2.337 . . . . 0.0 109.606 174.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -154.35 143.69 21.35 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.166 0.986 . . . . 0.0 113.348 -176.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 13.6 t -164.21 164.13 22.64 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.995 2.118 . . . . 0.0 109.523 174.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -115.11 -61.21 1.78 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.469 1.108 . . . . 0.0 112.197 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 72.92 3.42 59.93 Favored Glycine 0 CA--C 1.536 1.404 0 N-CA-C 116.552 1.381 . . . . 0.0 116.552 170.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -89.13 118.95 29.21 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.661 1.731 . . . . 0.0 112.484 -174.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -165.85 136.87 3.72 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.486 1.914 . . . . 0.0 110.391 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 13.3 p -167.95 141.77 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 125.405 1.482 . . . . 0.0 111.389 -175.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -149.77 106.22 3.51 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.362 1.865 . . . . 0.0 109.186 172.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 39.0 pt -133.63 153.02 79.99 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 125.598 1.559 . . . . 0.0 112.048 -176.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -72.32 157.42 53.49 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.55 2.833 . . . . 0.0 111.263 172.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 97.8 mtp -79.39 143.35 35.14 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.934 0.893 . . . . 0.0 112.498 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -99.77 20.56 13.93 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.004 2.122 . . . . 0.0 113.098 -178.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -78.01 -1.38 31.85 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.207 1.803 . . . . 0.0 115.577 -169.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 19.9 t -63.16 125.6 87.3 Favored Pre-proline 0 CA--C 1.55 0.978 0 O-C-N 121.276 -0.89 . . . . 0.0 111.867 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.39 158.39 32.93 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.552 2.835 . . . . 0.0 112.35 -174.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 14.9 p -162.98 140.05 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.42 1.488 . . . . 0.0 110.397 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 . . . . . 0 C--O 1.254 1.295 0 C-N-CA 125.974 1.71 . . . . 0.0 111.68 -177.783 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.158 0 CA-C-O 119.67 -0.517 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 83.6 p 62.41 5.09 1.48 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 117.869 2.544 . . . . 0.0 117.869 164.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -156.81 159.58 38.39 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 120.338 -1.477 . . . . 0.0 113.286 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.37 149.47 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 126.3 1.84 . . . . 0.0 110.957 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.79 126.41 62.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 126.842 2.057 . . . . 0.0 106.277 172.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 29.5 m -91.44 144.74 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 167.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -144.94 138.21 26.72 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.6 0.76 . . . . 0.0 112.647 -167.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 50.2 t30 96.97 -3.03 0.05 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 129.461 3.104 . . . . 0.0 114.051 175.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 82.6 mt -70.62 133.62 86.68 Favored Pre-proline 0 CA--C 1.556 1.173 0 O-C-N 120.954 -1.091 . . . . 0.0 109.491 165.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -88.95 -168.58 0.35 Allowed 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 124.396 3.397 . . . . 0.0 111.471 -174.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -52.71 -17.09 1.16 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.908 1.683 . . . . 0.0 115.249 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 7.6 t -63.47 -31.25 72.36 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.567 1.147 . . . . 0.0 113.135 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.23 137.32 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 118.712 0.687 . . . . 0.0 110.74 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -145.24 173.0 12.33 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.35 2.26 . . . . 0.0 108.554 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -48.61 -44.38 37.04 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 120.156 1.344 . . . . 0.0 114.135 -166.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -74.7 -23.75 58.65 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -79.85 -37.26 35.37 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.852 1.206 . . . . 0.0 113.166 164.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.48 -48.54 76.91 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.835 0.854 . . . . 0.0 111.044 177.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.28 -30.86 71.43 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.773 -0.579 . . . . 0.0 111.344 -178.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.47 -18.91 63.75 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.011 1.724 . . . . 0.0 114.699 172.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.416 HG23 HD12 ' A' ' 326' ' ' ILE . 56.3 mt -56.78 -42.91 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 119.52 1.055 . . . . 0.0 110.27 168.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.445 ' CE1' HG21 ' A' ' 306' ' ' VAL . 79.0 m-85 -104.96 -9.71 17.73 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -173.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -61.95 -8.56 5.32 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -175.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -57.9 -21.07 41.61 Favored 'General case' 0 CA--C 1.55 0.955 0 O-C-N 120.818 -1.176 . . . . 0.0 112.873 168.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 34.2 t -56.87 -21.85 32.52 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.505 1.522 . . . . 0.0 114.074 167.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.1 -17.37 58.16 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 126.907 2.194 . . . . 0.0 113.794 -176.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -139.35 -172.9 3.46 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.624 1.97 . . . . 0.0 109.875 173.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.41 134.56 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 120.544 -1.348 . . . . 0.0 111.294 167.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -74.25 -72.69 0.26 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.591 1.156 . . . . 0.0 112.674 -172.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -159.13 136.54 9.94 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.049 1.74 . . . . 0.0 110.888 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.45 137.89 11.75 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.326 -0.859 . . . . 0.0 112.459 -154.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -162.53 175.37 11.52 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.399 1.48 . . . . 0.0 112.499 -174.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 17.6 m -145.68 167.03 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 126.59 1.956 . . . . 0.0 110.821 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -132.12 148.11 52.46 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.643 1.577 . . . . 0.0 109.684 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.1 mp -134.88 142.05 46.49 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.642 1.177 . . . . 0.0 111.746 -177.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -79.92 179.75 7.41 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.0 0.92 . . . . 0.0 111.072 170.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -67.68 -17.8 69.46 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 121.105 -0.997 . . . . 0.0 114.589 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -88.61 -0.42 57.25 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.184 1.394 . . . . 0.0 113.569 175.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 72.65 25.07 74.99 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.066 0.841 . . . . 0.0 114.238 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 4.8 p -96.18 12.06 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -163.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 22.7 p 59.97 10.85 2.34 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 127.336 2.254 . . . . 0.0 115.132 -176.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . 0.27 1.1 t 50.47 10.07 0.05 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 129.389 3.075 . . . . 0.0 115.752 176.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 86.44 20.23 55.02 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.552 1.548 . . . . 0.0 114.531 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 95.1 p -164.37 167.99 19.08 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 120.103 1.951 . . . . 0.0 116.027 -172.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -153.78 163.6 30.91 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.303 1.906 . . . . 0.0 112.082 173.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 55.1 m -125.71 130.96 52.56 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 118.367 1.083 . . . . 0.0 110.779 -165.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.445 HG21 ' CE1' ' A' ' 281' ' ' PHE . 21.7 t -135.83 123.77 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.789 0.836 . . . . 0.0 109.455 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 66.2 m -104.07 128.26 51.67 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.077 1.351 . . . . 0.0 109.914 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.27 163.38 13.46 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 -141.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -54.21 -51.45 64.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.324 1.45 . . . . 0.0 111.688 175.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -172.86 167.33 5.16 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 128.7 2.8 . . . . 0.0 108.507 164.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.27 -30.62 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.92 0.888 . . . . 0.0 111.306 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.59 -43.7 46.54 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 171.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -95.72 -26.43 15.7 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 118.13 0.423 . . . . 0.0 111.581 -176.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 4.6 tt -53.87 -48.25 70.24 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.507 1.523 . . . . 0.0 109.973 172.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -57.81 -37.57 74.0 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -70.67 -52.43 21.19 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.515 0.726 . . . . 0.0 111.462 171.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -59.64 -34.72 73.15 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.32 1.448 . . . . 0.0 113.452 -175.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.89 -36.81 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.336 1.055 . . . . 0.0 112.382 176.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -83.66 -43.13 15.91 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.753 0.821 . . . . 0.0 112.268 173.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -58.65 -48.51 80.78 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.337 1.455 . . . . 0.0 113.898 -171.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -93.17 -18.51 22.47 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -174.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -73.74 111.89 9.32 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.598 -0.689 . . . . 0.0 110.558 177.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 101.07 -0.05 54.73 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.731 1.157 . . . . 0.0 114.414 -170.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -103.87 173.81 6.14 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.532 1.533 . . . . 0.0 111.446 174.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 30.5 p -138.03 122.94 18.94 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 120.412 -1.43 . . . . 0.0 111.933 -175.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.416 HD12 HG23 ' A' ' 280' ' ' ILE . 11.7 mt -145.02 115.09 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.636 1.174 . . . . 0.0 108.34 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 63.95 34.88 11.18 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.27 1.028 . . . . 0.0 112.565 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 167.45 -132.24 2.55 Favored Glycine 0 C--N 1.341 0.823 0 O-C-N 121.305 -0.872 . . . . 0.0 115.24 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -97.75 -174.64 2.95 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.516 1.526 . . . . 0.0 110.215 -173.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 55.1 t -58.76 126.12 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 159.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 2.2 pp -103.85 144.16 31.87 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 122.419 1.104 . . . . 0.0 112.006 -177.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -94.05 158.62 15.53 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.497 1.919 . . . . 0.0 109.931 165.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 26.3 t -136.2 132.03 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.303 1.441 . . . . 0.0 108.567 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -132.2 133.81 44.62 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.307 1.443 . . . . 0.0 109.98 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 78.0 p -94.73 154.4 17.32 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.973 -1.079 . . . . 0.0 112.154 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -80.21 70.06 6.76 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.864 0.866 . . . . 0.0 110.955 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -141.03 147.31 38.44 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.955 1.702 . . . . 0.0 111.283 -171.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 23.0 t -160.48 96.16 1.15 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.737 1.215 . . . . 0.0 109.916 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 27.6 m -142.32 14.84 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 124.887 1.275 . . . . 0.0 113.53 -172.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -70.32 149.75 47.05 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -173.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -152.16 129.89 11.61 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.11 1.764 . . . . 0.0 110.622 173.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -77.05 121.76 23.99 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.833 0.853 . . . . 0.0 112.207 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 32.8 t -165.58 141.0 5.05 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.336 1.454 . . . . 0.0 111.03 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -89.12 -14.38 36.34 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.413 1.085 . . . . 0.0 113.219 177.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 74.52 -172.75 52.21 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.987 1.28 . . . . 0.0 113.801 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -162.48 121.74 2.28 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.403 1.481 . . . . 0.0 111.244 178.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -168.64 159.05 9.72 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.261 2.224 . . . . 0.0 109.743 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 11.3 m -150.24 137.67 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 127.21 2.204 . . . . 0.0 110.648 -178.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -170.19 118.17 0.56 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.67 1.988 . . . . 0.0 109.886 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 18.0 tt -133.72 132.98 21.91 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 125.06 1.344 . . . . 0.0 111.255 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.5 154.91 35.94 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 123.217 2.611 . . . . 0.0 111.557 176.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 25.1 ptp -163.99 153.2 13.99 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.396 1.478 . . . . 0.0 112.045 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -162.49 149.69 13.58 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.651 1.58 . . . . 0.0 111.752 -176.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -154.15 66.58 0.72 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.555 1.542 . . . . 0.0 110.233 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 21.9 t -114.88 137.35 22.79 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.824 1.25 . . . . 0.0 112.577 -171.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -78.92 174.31 12.37 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 124.261 3.308 . . . . 0.0 112.515 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 25.1 m -141.28 154.19 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.564 1.546 . . . . 0.0 111.56 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.158 0 C-N-CA 125.854 1.662 . . . . 0.0 111.418 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.004 0 N-CA-C 111.905 -0.478 . . . . 0.0 111.905 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 55.9 p -148.95 26.0 0.9 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.126 0.97 . . . . 0.0 113.165 -169.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -156.15 142.48 18.4 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.765 1.226 . . . . 0.0 110.801 -175.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 29.9 m -135.24 149.97 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 125.15 1.38 . . . . 0.0 111.249 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.74 144.34 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 126.606 1.962 . . . . 0.0 107.848 169.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 17.4 m -138.57 128.63 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.452 1.501 . . . . 0.0 109.432 -177.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -141.3 158.01 44.46 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -159.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 82.35 -26.25 0.14 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 129.847 3.259 . . . . 0.0 113.938 173.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 92.2 mt -28.71 108.67 0.23 Allowed Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 126.664 1.986 . . . . 0.0 111.482 145.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -87.56 -175.64 1.54 Allowed 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.89 3.06 . . . . 0.0 111.692 177.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -56.29 -25.2 47.55 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 16.8 m -67.47 -16.8 64.41 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . 0.262 2.7 p -108.6 85.36 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 126.407 1.883 . . . . 0.0 109.671 176.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -68.19 174.48 3.88 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.877 2.071 . . . . 0.0 113.39 -174.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -54.31 -43.31 71.02 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.85 -1.156 . . . . 0.0 113.573 -177.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -59.5 -45.12 92.61 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.373 0.669 . . . . 0.0 111.388 176.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.37 -32.98 72.39 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 176.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.569 HD21 ' CG1' ' A' ' 306' ' ' VAL . 2.6 tt -62.19 -42.13 98.99 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.299 1.04 . . . . 0.0 111.258 170.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -64.55 -38.67 91.83 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.415 -0.803 . . . . 0.0 111.036 173.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -62.7 -25.21 68.05 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 177.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 30.8 mt -50.34 -51.18 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 124.667 1.187 . . . . 0.0 111.432 175.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -94.33 -29.92 14.78 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.999 0.92 . . . . 0.0 111.19 -176.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -58.35 -20.53 44.32 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -177.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -61.73 -11.42 12.01 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 172.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 7.8 t -65.95 -14.08 60.93 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 124.358 1.063 . . . . 0.0 113.606 168.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.89 -10.1 60.33 Favored Glycine 0 N--CA 1.476 1.363 0 C-N-CA 126.337 1.922 . . . . 0.0 113.718 -177.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 34.5 p-10 -138.63 166.32 24.64 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 128.312 2.645 . . . . 0.0 110.028 173.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.5 p -145.28 140.92 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 120.936 -1.102 . . . . 0.0 111.733 168.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -69.98 -79.61 0.06 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.421 1.088 . . . . 0.0 111.828 -177.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -168.16 149.41 5.11 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 127.433 2.293 . . . . 0.0 110.66 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.14 150.07 21.75 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.95 0.9 . . . . 0.0 112.027 -168.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -170.14 179.84 3.38 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 126.37 1.868 . . . . 0.0 110.731 -176.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -165.21 138.51 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 127.246 2.219 . . . . 0.0 109.78 170.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -76.86 131.25 38.51 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 163.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 14.2 mt -103.25 170.5 7.92 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.633 0.773 . . . . 0.0 112.996 -168.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -51.09 154.67 1.48 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.149 1.779 . . . . 0.0 112.701 165.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -65.41 -15.78 61.86 Favored Glycine 0 CA--C 1.536 1.361 0 N-CA-C 115.983 1.153 . . . . 0.0 115.983 -173.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -88.48 -0.01 56.76 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 119.27 1.535 . . . . 0.0 113.15 169.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.07 21.18 61.47 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.409 1.48 . . . . 0.0 114.566 173.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 63.5 t -86.89 -62.53 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 117.939 0.87 . . . . 0.0 111.938 -167.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 10.3 t -175.05 -174.13 0.74 Allowed 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.051 1.34 . . . . 0.0 111.584 -171.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -161.71 -51.71 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 127.54 2.336 . . . . 0.0 112.106 174.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 87.51 -68.14 3.16 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.807 1.194 . . . . 0.0 112.241 -178.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 34.4 p -61.97 122.54 15.73 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.52 1.128 . . . . 0.0 112.665 172.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -177.54 -141.06 3.95 Favored Glycine 0 N--CA 1.471 1.021 0 C-N-CA 125.41 1.481 . . . . 0.0 113.856 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 8.0 p -130.77 148.81 52.59 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.911 1.685 . . . . 0.0 111.624 -175.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.569 ' CG1' HD21 ' A' ' 277' ' ' LEU . 13.4 m -130.25 147.9 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.004 1.322 . . . . 0.0 110.376 169.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 38.4 m -80.15 155.97 27.2 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.469 169.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.2 159.21 29.13 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 -172.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -58.06 -51.79 68.21 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.781 1.632 . . . . 0.0 112.237 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -172.16 -178.3 2.05 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.8 2.44 . . . . 0.0 109.398 159.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 17.9 tt -56.09 -33.21 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.095 1.358 . . . . 0.0 114.29 -175.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.31 -34.19 72.02 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 175.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.47 -22.2 25.07 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 119.208 -0.425 . . . . 0.0 111.674 -161.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 7.9 mp -50.09 -50.42 48.29 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.636 1.174 . . . . 0.0 109.848 163.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -62.92 -36.05 82.11 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -172.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.34 -51.73 27.86 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.465 1.106 . . . . 0.0 111.839 170.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -67.17 -32.41 73.48 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.48 1.512 . . . . 0.0 113.548 -172.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -62.65 -31.3 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 120.949 -1.094 . . . . 0.0 112.531 -178.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -82.33 -16.16 50.27 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.204 1.002 . . . . 0.0 113.308 174.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -89.0 -42.05 12.0 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.851 1.26 . . . . 0.0 112.438 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -101.48 -21.51 14.75 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -166.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -67.27 115.13 6.59 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 119.145 0.884 . . . . 0.0 110.999 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 91.67 0.3 72.66 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.03 1.3 . . . . 0.0 114.55 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -90.75 130.59 36.72 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.687 1.243 . . . . 0.0 111.23 -178.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 22.5 p -92.26 134.51 34.82 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 120.341 -1.474 . . . . 0.0 113.261 -175.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 49.1 mt -138.16 101.78 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.416 1.087 . . . . 0.0 109.68 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 53.34 38.84 28.79 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.913 1.685 . . . . 0.0 113.224 170.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 168.56 -128.82 1.76 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.017 0.818 . . . . 0.0 112.953 -169.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -90.63 -168.46 2.1 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.62 0.768 . . . . 0.0 110.372 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 34.4 m -68.46 145.89 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 O-C-N 120.896 -1.128 . . . . 0.0 109.587 164.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 42.7 tp -83.84 141.91 31.0 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.281 1.433 . . . . 0.0 109.309 167.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -126.64 154.31 44.17 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.976 0.911 . . . . 0.0 109.376 159.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 41.1 t -136.35 127.94 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.582 1.553 . . . . 0.0 108.838 -169.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -136.04 153.21 51.42 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.901 1.28 . . . . 0.0 112.817 -167.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 89.8 p -82.78 173.97 11.39 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.216 -0.927 . . . . 0.0 112.193 172.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -59.45 165.18 2.95 Favored 'General case' 0 CA--C 1.552 1.022 0 O-C-N 121.629 -0.669 . . . . 0.0 111.996 157.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -64.43 -33.5 76.02 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -170.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 9.4 t -164.23 172.97 12.9 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.502 1.121 . . . . 0.0 112.172 178.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 57.6 t -148.34 126.83 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 127.088 2.155 . . . . 0.0 108.236 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -67.35 131.78 46.39 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.371 0.668 . . . . 0.0 112.639 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -158.25 144.6 17.35 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.301 1.441 . . . . 0.0 111.559 -174.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -158.91 161.0 36.73 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.978 1.311 . . . . 0.0 113.18 -174.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 95.9 p -167.29 -159.72 0.34 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.873 2.069 . . . . 0.0 108.872 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -64.79 -13.75 56.56 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 120.91 -1.119 . . . . 0.0 113.756 167.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 91.81 -6.4 79.58 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.525 1.536 . . . . 0.0 114.689 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -164.21 175.83 9.77 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.774 2.03 . . . . 0.0 111.918 177.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -131.91 28.07 4.54 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.111 1.765 . . . . 0.0 113.247 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 3.5 p -60.48 138.21 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.01 0.924 . . . . 0.0 112.885 -173.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -163.17 112.51 1.32 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.277 1.831 . . . . 0.0 109.668 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 7.7 tp -74.52 131.32 80.24 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.788 0.835 . . . . 0.0 111.413 -175.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.73 161.93 30.26 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 123.197 2.598 . . . . 0.0 111.461 177.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 15.5 tpt -157.57 146.43 19.6 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.887 1.275 . . . . 0.0 111.472 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -163.22 156.23 18.99 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.765 2.026 . . . . 0.0 111.805 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -155.74 111.53 3.05 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.152 1.381 . . . . 0.0 110.742 177.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 69.2 m -115.42 146.8 37.32 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 124.946 1.298 . . . . 0.0 111.627 174.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -77.0 64.4 7.75 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 124.3 3.334 . . . . 0.0 111.652 -176.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 12.9 p -69.71 138.42 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.255 1.422 . . . . 0.0 111.728 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 9.0 t30 . . . . . 0 C--O 1.252 1.228 0 C-N-CA 125.754 1.622 . . . . 0.0 111.921 -177.649 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.914 0 N-CA-C 112.375 -0.29 . . . . 0.0 112.375 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 25.4 m -169.01 170.69 8.75 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 127.135 2.174 . . . . 0.0 110.2 178.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -151.25 137.09 18.07 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 120.719 -1.238 . . . . 0.0 112.683 -175.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 25.7 m -125.47 154.35 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.183 1.393 . . . . 0.0 110.341 165.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.1 mp -115.1 134.24 58.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.998 1.719 . . . . 0.0 107.434 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 20.5 m -105.78 129.65 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.233 1.013 . . . . 0.0 109.968 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -138.95 64.27 1.48 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.318 1.447 . . . . 0.0 111.257 -162.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -169.12 -40.48 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.179 1.792 . . . . 0.0 113.07 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 48.9 mt -57.19 116.58 14.03 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 127.16 2.184 . . . . 0.0 110.221 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -91.25 -170.17 0.33 Allowed 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 124.669 3.579 . . . . 0.0 112.342 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -56.56 -25.77 53.19 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -175.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 15.7 m -72.81 -16.58 61.61 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.441 1.096 . . . . 0.0 113.958 -177.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 1.3 p -108.34 105.67 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.926 2.09 . . . . 0.0 108.047 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -79.63 168.26 19.62 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.537 1.135 . . . . 0.0 111.912 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.7 -36.29 73.99 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 120.894 -1.129 . . . . 0.0 112.62 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -68.77 -32.93 73.03 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.333 -0.854 . . . . 0.0 112.233 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.53 -39.93 77.22 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.461 -0.781 . . . . 0.0 112.438 170.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.48 HD23 ' C ' ' A' ' 277' ' ' LEU . 4.2 tt -54.33 -48.3 71.53 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.938 0.895 . . . . 0.0 109.856 170.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.83 -39.85 68.96 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.387 0.675 . . . . 0.0 112.161 175.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -68.88 -20.73 64.27 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 27.5 mt -60.13 -46.96 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 120.04 1.291 . . . . 0.0 112.259 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -98.43 -9.43 25.18 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.188 0.995 . . . . 0.0 113.429 -173.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -71.58 -0.74 11.38 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 128.23 2.612 . . . . 0.0 115.086 -177.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -61.56 -15.42 38.53 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 120.43 -1.419 . . . . 0.0 114.011 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 63.3 m -68.98 -3.35 12.59 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.678 1.591 . . . . 0.0 114.398 172.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 87.25 -52.99 4.39 Favored Glycine 0 N--CA 1.473 1.103 0 C-N-CA 126.074 1.797 . . . . 0.0 111.456 -176.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -72.16 170.23 14.44 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.31 1.044 . . . . 0.0 111.044 162.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.6 p -145.72 146.35 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.03 0.932 . . . . 0.0 111.827 164.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -77.53 -107.72 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.221 1.408 . . . . 0.0 112.158 177.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -158.38 149.25 20.55 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.3 1.84 . . . . 0.0 111.354 -171.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.31 165.65 34.26 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.478 1.111 . . . . 0.0 111.514 177.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -161.34 166.93 26.74 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.113 1.365 . . . . 0.0 111.619 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 14.8 m -145.48 153.82 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 126.516 1.926 . . . . 0.0 110.97 -171.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -106.45 117.63 34.53 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.344 1.057 . . . . 0.0 108.716 170.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 12.9 mt -89.77 160.22 16.65 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.642 0.734 . . . . 0.0 112.497 -175.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -78.77 137.46 37.75 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.753 1.221 . . . . 0.0 110.616 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -70.2 -8.03 61.14 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 116.488 1.355 . . . . 0.0 116.488 -162.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -79.78 -0.43 34.39 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 118.797 1.299 . . . . 0.0 112.699 166.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 88.55 48.48 3.95 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.429 1.49 . . . . 0.0 111.789 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 39.5 t -132.15 140.54 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.377 1.071 . . . . 0.0 110.78 -170.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 22.2 p -65.28 158.01 27.49 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.457 1.503 . . . . 0.0 114.021 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 21.7 p -139.15 -16.82 1.06 Allowed 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -168.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 67.85 -71.8 0.28 Allowed Glycine 0 N--CA 1.476 1.3 0 C-N-CA 126.26 1.886 . . . . 0.0 113.611 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 49.9 p -36.7 126.94 0.87 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.915 2.486 . . . . 0.0 113.881 167.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 176.34 -165.22 35.49 Favored Glycine 0 N--CA 1.471 1.027 0 N-CA-C 115.256 0.862 . . . . 0.0 115.256 -175.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 16.6 p -100.46 137.53 38.75 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.621 1.968 . . . . 0.0 110.893 -174.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.3 t -119.85 119.52 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.626 1.57 . . . . 0.0 107.111 172.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 53.7 m -93.81 110.16 21.82 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.774 1.229 . . . . 0.0 108.208 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.51 158.28 24.54 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -159.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -51.83 -54.17 31.9 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.675 1.19 . . . . 0.0 111.147 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -172.97 169.3 4.74 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 128.641 2.776 . . . . 0.0 109.272 161.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 19.5 tt -54.35 -29.02 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.325 1.05 . . . . 0.0 113.719 177.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.38 -37.91 62.87 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.17 1.388 . . . . 0.0 114.736 171.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -104.49 -20.88 13.56 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 7.0 tt -55.08 -51.55 66.01 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.332 1.453 . . . . 0.0 111.332 177.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -69.02 -24.16 64.16 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 33.6 mtp-105 -70.36 -44.28 68.45 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.135 0.974 . . . . 0.0 110.773 168.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -68.4 -43.26 77.67 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.215 1.406 . . . . 0.0 113.349 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 2.6 pt -70.96 -16.67 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 177.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -82.05 -40.91 21.35 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.84 0.856 . . . . 0.0 110.831 168.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -70.3 -53.74 15.56 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.451 1.1 . . . . 0.0 113.605 -178.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -90.18 -24.26 21.08 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -163.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -62.72 121.53 13.62 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 119.364 0.984 . . . . 0.0 110.244 173.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 101.82 0.32 52.23 Favored Glycine 0 CA--C 1.538 1.499 0 CA-C-O 118.833 -0.982 . . . . 0.0 115.098 -174.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -108.1 145.34 34.21 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.998 1.399 . . . . 0.0 112.032 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 62.1 m -112.59 129.15 56.47 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 120.779 -1.201 . . . . 0.0 111.974 -174.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 55.5 mt -137.33 106.95 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.298 1.039 . . . . 0.0 109.915 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 56.19 33.31 21.87 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.463 1.505 . . . . 0.0 112.95 170.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 171.78 -135.63 3.5 Favored Glycine 0 C--N 1.341 0.843 0 O-C-N 121.122 -0.986 . . . . 0.0 113.94 -168.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -99.8 165.31 11.64 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.164 0.986 . . . . 0.0 110.78 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 9.0 p -60.12 130.09 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.8 0.84 . . . . 0.0 112.771 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 35.9 mt -57.37 127.97 34.65 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.661 1.584 . . . . 0.0 113.923 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -134.02 122.57 23.2 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.527 2.731 . . . . 0.0 107.33 173.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 13.6 t -136.59 126.57 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.726 1.21 . . . . 0.0 109.476 -162.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -135.33 134.05 39.43 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.729 0.812 . . . . 0.0 111.532 -170.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 95.9 p -82.38 155.28 24.79 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.824 -1.173 . . . . 0.0 113.589 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -78.2 57.69 1.9 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.386 1.474 . . . . 0.0 111.579 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -138.37 -42.02 0.51 Allowed 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -171.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 42.9 m 66.59 20.55 10.78 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 172.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 89.0 t -87.89 125.7 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.149 1.38 . . . . 0.0 109.876 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -148.5 142.25 25.63 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.516 1.526 . . . . 0.0 112.141 -176.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 19.0 m120 65.65 99.23 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 127.734 2.414 . . . . 0.0 112.483 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -157.6 153.45 26.88 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.927 1.291 . . . . 0.0 113.079 -173.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 61.0 p -165.68 154.25 11.47 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.565 1.946 . . . . 0.0 110.845 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -77.9 -28.13 49.72 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -175.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 76.53 175.78 41.25 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.117 1.341 . . . . 0.0 115.003 175.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 33.6 t70 71.24 146.1 0.07 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 128.44 2.696 . . . . 0.0 114.78 175.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -163.48 142.28 8.09 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.669 1.987 . . . . 0.0 110.853 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 14.9 p -167.01 141.58 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.854 1.662 . . . . 0.0 110.655 -176.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 25.7 t70 75.41 123.75 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 128.213 2.605 . . . . 0.0 113.651 175.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 46.2 pt -133.25 148.99 71.31 Favored Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 125.678 1.591 . . . . 0.0 111.593 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.25 141.91 32.98 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.301 2.668 . . . . 0.0 111.235 178.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.86 166.31 15.66 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.607 1.963 . . . . 0.0 111.437 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -162.92 157.32 20.99 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.677 1.591 . . . . 0.0 112.378 -176.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -158.58 111.2 2.29 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.455 1.502 . . . . 0.0 110.445 176.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 66.2 m -115.57 146.4 36.58 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 124.813 1.245 . . . . 0.0 112.151 176.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -72.07 146.75 47.33 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.413 2.742 . . . . 0.0 111.184 177.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 14.6 p -164.26 142.4 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.086 1.354 . . . . 0.0 110.809 -177.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 . . . . . 0 C--O 1.252 1.219 0 C-N-CA 126.244 1.817 . . . . 0.0 111.683 -178.294 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.733 0 N-CA-C 112.323 -0.311 . . . . 0.0 112.323 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 69.2 p -162.13 13.88 0.08 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.553 1.541 . . . . 0.0 113.517 -177.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -139.4 166.68 23.91 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.826 2.05 . . . . 0.0 111.544 -172.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 31.0 m -138.49 153.88 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.568 1.147 . . . . 0.0 110.919 175.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 2.7 mp -103.93 134.32 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 30.7 m -107.36 132.26 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.916 1.286 . . . . 0.0 108.134 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -149.71 55.33 0.95 Allowed 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -154.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -167.58 -24.46 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.337 1.055 . . . . 0.0 113.728 172.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 52.6 mt -47.39 127.02 9.93 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 126.205 1.802 . . . . 0.0 111.311 165.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -82.78 173.28 10.45 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.879 3.053 . . . . 0.0 110.154 172.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -62.61 0.3 0.52 Allowed 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 8.3 t -65.67 -31.11 71.94 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.435 1.094 . . . . 0.0 113.089 171.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 8.0 p -83.24 130.0 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 118.457 0.571 . . . . 0.0 109.801 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -94.08 159.84 14.97 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.753 1.221 . . . . 0.0 111.16 177.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -48.62 -40.88 29.21 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -68.21 -39.35 82.43 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.458 -0.776 . . . . 0.0 111.727 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.42 -32.55 71.59 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.438 -0.789 . . . . 0.0 112.491 172.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.489 HD21 ' CG1' ' A' ' 306' ' ' VAL . 1.9 tt -62.26 -38.96 91.31 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.312 1.045 . . . . 0.0 112.0 171.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -60.5 -48.7 80.62 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.549 -0.719 . . . . 0.0 110.012 171.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -59.7 -24.43 63.96 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.26 1.424 . . . . 0.0 114.171 -175.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 9.1 mt -49.56 -39.86 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 125.117 1.367 . . . . 0.0 111.687 171.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -110.52 -35.19 6.09 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.051 1.34 . . . . 0.0 111.592 -176.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -61.31 -7.17 2.66 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.596 1.558 . . . . 0.0 113.915 174.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -44.95 -31.04 1.14 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.017 1.327 . . . . 0.0 112.955 159.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 83.5 m -64.37 -7.09 8.46 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 176.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 91.18 -3.01 79.74 Favored Glycine 0 N--CA 1.477 1.424 0 C-N-CA 125.678 1.609 . . . . 0.0 114.958 177.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -138.36 178.3 7.24 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.207 2.203 . . . . 0.0 109.496 176.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.11 142.03 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 120.458 -1.402 . . . . 0.0 112.912 177.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -83.65 -106.42 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.256 1.422 . . . . 0.0 110.161 167.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -148.69 147.0 28.39 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.848 1.659 . . . . 0.0 111.834 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.08 148.66 20.58 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.577 1.151 . . . . 0.0 111.628 -176.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -168.27 160.04 11.2 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.843 1.657 . . . . 0.0 110.943 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.68 131.71 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 126.827 2.051 . . . . 0.0 110.271 177.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -75.29 130.33 38.9 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.659 0.783 . . . . 0.0 110.534 167.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 10.4 mt -87.43 153.48 21.4 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.303 0.641 . . . . 0.0 111.392 -178.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -76.81 149.83 36.18 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.867 0.867 . . . . 0.0 112.537 -177.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -67.29 -15.74 66.07 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.801 1.191 . . . . 0.0 115.483 -176.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -81.68 0.16 39.99 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 119.059 1.429 . . . . 0.0 113.193 168.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 85.45 47.35 5.19 Favored Glycine 0 N--CA 1.469 0.889 0 C-N-CA 124.944 1.259 . . . . 0.0 113.402 171.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 35.5 m -137.54 151.18 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.658 1.183 . . . . 0.0 112.24 -176.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 10.9 m -90.04 11.69 19.94 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 -150.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 18.2 p 45.59 80.53 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 127.263 2.225 . . . . 0.0 114.16 167.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -69.36 -47.09 53.67 Favored Glycine 0 N--CA 1.472 1.069 0 O-C-N 121.692 -0.63 . . . . 0.0 113.481 -175.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 5.9 p -60.26 117.69 5.48 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.849 1.259 . . . . 0.0 110.932 164.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -179.13 -160.87 25.7 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.394 0.997 . . . . 0.0 115.336 -173.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 14.2 p -104.77 146.64 28.69 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.152 1.781 . . . . 0.0 112.867 -169.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.489 ' CG1' HD21 ' A' ' 277' ' ' LEU . 0.8 OUTLIER -145.71 137.23 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.314 1.446 . . . . 0.0 109.912 169.054 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 8.7 t -102.29 144.55 30.66 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.86 0.864 . . . . 0.0 110.993 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -104.01 158.76 16.2 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -165.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -57.34 -55.93 28.45 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.145 -1.388 . . . . 0.0 111.152 175.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -172.64 179.78 2.34 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 128.46 2.704 . . . . 0.0 108.521 161.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.23 -25.37 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.637 1.175 . . . . 0.0 112.075 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.18 -33.56 41.28 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 168.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.56 -26.07 9.66 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.315 0.646 . . . . 0.0 112.514 -174.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 6.5 tt -55.05 -49.25 72.07 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.534 1.534 . . . . 0.0 111.041 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -68.82 -30.76 69.38 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.404 -0.81 . . . . 0.0 113.042 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 33.9 mtm180 -69.62 -37.4 76.82 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 121.52 -0.737 . . . . 0.0 111.107 174.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -70.48 -47.89 58.36 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.2 1.4 . . . . 0.0 112.284 174.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 3.5 pt -68.87 -21.65 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -75.38 -31.6 60.54 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 118.822 0.737 . . . . 0.0 112.205 170.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -88.91 -53.1 4.76 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.792 0.837 . . . . 0.0 113.081 -176.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -90.14 -16.98 28.47 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -164.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -71.49 110.2 5.94 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 121.102 -0.999 . . . . 0.0 110.013 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 99.21 0.12 57.14 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 125.193 1.377 . . . . 0.0 114.537 -170.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -98.55 145.67 26.58 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.193 1.397 . . . . 0.0 111.312 175.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 18.7 p -110.19 128.43 55.48 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.25 1.02 . . . . 0.0 113.155 -173.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 18.6 mt -143.9 115.48 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.883 1.273 . . . . 0.0 109.042 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 61.73 25.81 15.6 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.924 1.29 . . . . 0.0 113.449 173.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 173.87 -134.43 2.86 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 120.996 -1.065 . . . . 0.0 114.076 -171.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -86.39 -176.14 5.76 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.824 0.849 . . . . 0.0 109.751 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 19.9 m -58.94 142.84 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 O-C-N 120.981 -1.074 . . . . 0.0 108.687 155.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 3.0 pp -98.43 143.03 29.31 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.773 0.797 . . . . 0.0 111.006 175.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -125.58 137.06 53.9 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.779 1.632 . . . . 0.0 108.953 173.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 12.5 t -118.44 137.19 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.574 1.549 . . . . 0.0 110.026 -165.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -134.81 159.25 41.97 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.755 1.622 . . . . 0.0 112.328 -171.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 35.0 t -114.9 148.25 38.88 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.412 1.085 . . . . 0.0 112.101 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -86.86 -1.06 57.5 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.749 1.22 . . . . 0.0 112.946 172.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -149.72 136.54 19.44 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.708 1.603 . . . . 0.0 111.539 -171.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 98.3 p -169.72 159.56 8.21 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.942 1.297 . . . . 0.0 112.061 172.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 20.1 m -147.92 151.92 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 125.258 1.423 . . . . 0.0 111.739 -176.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -158.0 147.11 19.46 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.451 1.5 . . . . 0.0 112.513 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -162.49 144.4 10.67 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.443 1.897 . . . . 0.0 111.268 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -156.91 148.15 22.09 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.898 1.279 . . . . 0.0 113.065 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 64.0 p -164.45 151.22 11.19 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.554 1.942 . . . . 0.0 110.824 171.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -108.07 -22.85 12.23 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -173.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 71.5 -170.92 47.69 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.48 1.038 . . . . 0.0 114.549 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -164.96 151.66 10.6 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.414 1.886 . . . . 0.0 111.975 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -165.28 158.3 16.18 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.885 2.074 . . . . 0.0 110.097 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 57.8 t -148.13 129.41 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 127.395 2.278 . . . . 0.0 108.758 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -167.37 116.64 0.82 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.313 1.845 . . . . 0.0 109.93 -177.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 35.6 mm -131.51 122.88 19.1 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 125.325 1.45 . . . . 0.0 109.77 -177.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -78.6 143.73 19.27 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.387 2.725 . . . . 0.0 110.905 175.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 24.4 ptp -166.35 151.93 8.46 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.104 1.362 . . . . 0.0 112.431 -175.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -164.09 157.46 18.23 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.181 1.792 . . . . 0.0 111.647 -178.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -143.78 11.09 1.61 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.831 2.052 . . . . 0.0 112.217 176.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 18.8 m -68.62 133.84 90.65 Favored Pre-proline 0 CA--C 1.552 1.026 0 O-C-N 120.589 -1.319 . . . . 0.0 112.712 -176.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.64 -23.9 6.66 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 123.061 2.507 . . . . 0.0 114.297 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 77.35 149.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 127.654 2.381 . . . . 0.0 113.238 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 32.2 m120 . . . . . 0 C--O 1.252 1.207 0 C-N-CA 125.977 1.711 . . . . 0.0 111.916 -176.142 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.839 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 56.2 p -152.35 21.63 0.64 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.121 0.968 . . . . 0.0 113.236 -173.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -162.64 141.98 9.12 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.138 1.375 . . . . 0.0 110.289 -174.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 15.6 m -135.91 156.82 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 125.159 1.384 . . . . 0.0 111.584 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 5.4 mp -116.13 138.32 46.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 126.858 2.063 . . . . 0.0 107.129 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 34.3 m -120.22 129.76 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.28 1.032 . . . . 0.0 109.338 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -146.17 58.5 1.22 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.779 0.8 . . . . 0.0 111.907 -157.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -164.36 -45.14 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.798 1.239 . . . . 0.0 111.471 -176.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 27.7 mt -40.12 117.53 1.32 Allowed Pre-proline 0 CA--C 1.557 1.242 0 C-N-CA 126.099 1.76 . . . . 0.0 111.496 158.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -95.33 -177.95 0.47 Allowed 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.633 3.555 . . . . 0.0 111.703 -176.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -54.44 -14.19 1.16 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.577 1.551 . . . . 0.0 115.16 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 17.1 m -65.91 -21.12 66.42 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.111 1.364 . . . . 0.0 113.987 172.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 8.2 p -101.4 132.84 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 119.428 1.013 . . . . 0.0 110.643 172.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -90.59 157.1 17.68 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.271 1.428 . . . . 0.0 111.373 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -59.59 -31.62 69.63 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 120.478 -1.389 . . . . 0.0 113.213 178.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -68.24 -34.59 76.5 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.282 -0.886 . . . . 0.0 111.042 176.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.94 -38.8 76.27 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 117.733 -1.127 . . . . 0.0 113.098 168.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.495 HD23 ' C ' ' A' ' 277' ' ' LEU . 3.9 tt -53.37 -51.25 63.11 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.84 1.2 . . . . 0.0 109.883 172.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -48.84 -44.52 39.61 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.138 0.975 . . . . 0.0 111.953 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -68.71 -25.49 64.79 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 21.1 mt -53.32 -45.05 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 124.627 1.171 . . . . 0.0 111.377 176.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -98.09 -34.15 10.88 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.449 1.1 . . . . 0.0 111.627 -175.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -61.17 -10.33 6.35 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.611 1.164 . . . . 0.0 113.803 173.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 15.4 tm-20 -52.23 -24.71 7.69 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.638 1.575 . . . . 0.0 113.484 165.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 87.0 m -63.82 -8.21 10.15 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 172.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 88.8 2.28 78.83 Favored Glycine 0 N--CA 1.479 1.516 0 C-N-CA 124.663 1.125 . . . . 0.0 114.777 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -138.39 -177.92 5.06 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 127.237 2.215 . . . . 0.0 108.227 172.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.6 p -132.01 146.75 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 120.828 1.649 . . . . 0.0 114.063 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -106.48 -120.03 0.24 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.27 1.828 . . . . 0.0 110.821 171.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -161.08 156.69 24.92 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.602 1.961 . . . . 0.0 112.733 -174.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.39 164.85 35.9 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.487 1.115 . . . . 0.0 113.174 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -156.64 160.03 39.01 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.279 1.832 . . . . 0.0 110.995 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 3.5 t -151.63 141.58 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.354 1.462 . . . . 0.0 109.555 -172.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -113.06 134.49 54.5 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.463 1.105 . . . . 0.0 109.515 168.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 13.9 mt -98.69 172.59 7.37 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.182 0.993 . . . . 0.0 113.037 -170.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.25 153.72 0.68 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.094 2.158 . . . . 0.0 113.277 165.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -72.09 -3.92 57.87 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.911 1.243 . . . . 0.0 115.808 -172.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -114.65 0.62 13.97 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 126.267 1.827 . . . . 0.0 111.709 168.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 94.84 8.93 58.93 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 126.345 1.926 . . . . 0.0 114.476 176.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 4.8 t -87.58 58.28 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 118.819 1.31 . . . . 0.0 111.074 -171.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 75.6 m 61.1 -168.08 0.18 Allowed 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 126.325 1.85 . . . . 0.0 114.501 170.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -167.04 -45.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 127.249 2.22 . . . . 0.0 112.276 175.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 82.08 -57.14 4.98 Favored Glycine 0 N--CA 1.472 1.042 0 C-N-CA 125.252 1.406 . . . . 0.0 112.051 -176.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 61.9 p -55.57 111.04 0.8 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.715 1.606 . . . . 0.0 112.459 169.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -139.37 -166.35 10.59 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.008 1.29 . . . . 0.0 113.996 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 93.7 m -115.99 141.63 47.87 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.528 1.931 . . . . 0.0 108.934 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 t -129.9 116.11 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 125.446 1.498 . . . . 0.0 107.412 -173.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 46.2 m -101.52 110.25 22.22 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.223 1.409 . . . . 0.0 108.176 -174.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.28 168.65 12.53 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -151.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -53.68 -65.31 0.59 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.847 1.259 . . . . 0.0 111.024 175.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -172.65 -175.73 1.37 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 129.153 2.981 . . . . 0.0 108.005 162.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 16.3 tt -55.14 -37.03 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -175.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -49.63 67.76 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -92.05 -18.82 23.06 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.439 0.296 . . . . 0.0 110.836 -174.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 57.5 tp -66.25 -47.36 73.97 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.462 0.705 . . . . 0.0 111.093 171.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -68.32 -20.87 64.78 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.342 -0.848 . . . . 0.0 113.037 178.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 35.5 mtp85 -70.61 -54.57 11.51 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.36 1.064 . . . . 0.0 111.621 162.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.03 -43.99 82.48 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.026 1.33 . . . . 0.0 113.752 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 2.6 pp -65.38 -21.35 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 177.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -82.6 -46.32 13.46 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.438 1.095 . . . . 0.0 111.199 172.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -71.57 -47.99 51.32 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -176.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -98.39 -22.26 16.16 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -163.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -67.15 120.47 13.78 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.872 -1.142 . . . . 0.0 110.494 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 92.37 -1.0 72.18 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.071 1.319 . . . . 0.0 114.95 -173.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -98.59 139.76 33.83 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.126 1.463 . . . . 0.0 111.328 177.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 23.7 p -103.15 133.99 47.33 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.136 0.975 . . . . 0.0 113.155 -174.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 56.3 mt -144.17 113.59 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.953 1.301 . . . . 0.0 108.763 -176.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 58.07 25.84 12.87 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.806 1.242 . . . . 0.0 113.832 176.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 166.37 -129.63 1.97 Allowed Glycine 0 C--N 1.342 0.905 0 C-N-CA 124.424 1.012 . . . . 0.0 113.194 -176.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -83.76 177.7 8.25 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.889 0.876 . . . . 0.0 111.099 -177.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 32.9 m -62.69 149.83 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 O-C-N 121.55 -0.718 . . . . 0.0 110.739 166.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 10.9 mt -73.35 137.18 44.59 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.186 0.994 . . . . 0.0 111.489 170.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -125.37 108.48 11.72 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.667 1.587 . . . . 0.0 107.747 167.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.84 120.96 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.27 1.428 . . . . 0.0 109.798 -165.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -139.54 162.5 34.93 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.391 1.477 . . . . 0.0 111.859 -171.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 77.8 p -145.19 159.18 43.39 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 120.869 -1.145 . . . . 0.0 113.078 -176.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -83.31 59.57 5.1 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.393 1.077 . . . . 0.0 111.981 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -160.92 149.86 16.61 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.294 1.438 . . . . 0.0 111.523 -172.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 79.2 p -166.68 167.9 14.87 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.58 1.152 . . . . 0.0 112.566 176.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 18.1 m -147.39 152.36 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 125.364 1.466 . . . . 0.0 111.89 -173.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -70.88 153.7 42.48 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.763 1.225 . . . . 0.0 113.918 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -162.33 -176.01 4.86 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.899 1.68 . . . . 0.0 111.337 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 22.7 m80 62.32 24.49 14.58 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 126.211 1.804 . . . . 0.0 114.456 174.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 22.8 t -157.15 32.78 0.29 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.814 1.246 . . . . 0.0 111.661 -168.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -113.31 0.13 14.73 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -156.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 92.9 170.86 40.22 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.278 1.418 . . . . 0.0 115.274 172.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -152.08 155.87 38.77 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.511 2.324 . . . . 0.0 110.307 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -161.95 150.46 15.21 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.869 1.667 . . . . 0.0 111.266 -177.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 14.9 p -164.0 143.29 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 126.633 1.973 . . . . 0.0 110.414 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -161.84 113.91 1.74 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.761 1.625 . . . . 0.0 109.778 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.36 149.06 71.36 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 125.936 1.694 . . . . 0.0 111.851 -176.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -71.76 149.19 53.98 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.217 2.611 . . . . 0.0 110.905 173.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 28.4 ttm -150.84 13.95 0.72 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -172.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -160.82 160.31 30.98 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.933 1.693 . . . . 0.0 111.575 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -156.88 100.48 1.9 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.046 1.738 . . . . 0.0 109.979 177.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 77.6 p -115.17 151.5 45.79 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 125.284 1.434 . . . . 0.0 112.746 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -73.14 148.83 45.08 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.491 2.794 . . . . 0.0 111.501 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 14.9 p -163.61 140.42 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.12 1.368 . . . . 0.0 110.792 -177.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.187 0 C-N-CA 125.799 1.639 . . . . 0.0 111.134 -178.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.986 0 N-CA-C 112.157 -0.377 . . . . 0.0 112.157 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 18.0 m -92.15 -10.56 38.38 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -172.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 71.83 163.61 0.27 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 127.489 2.315 . . . . 0.0 113.025 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 16.1 m -137.03 159.76 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.248 1.019 . . . . 0.0 111.069 173.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.4 mp -131.66 141.47 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 127.249 2.22 . . . . 0.0 107.469 -175.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 19.4 m -129.68 133.43 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.834 0.854 . . . . 0.0 111.086 -174.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -148.57 73.23 1.22 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.863 1.265 . . . . 0.0 112.772 -164.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -169.12 -41.68 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.627 1.571 . . . . 0.0 111.237 171.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 49.6 mt -28.17 110.92 0.24 Allowed Pre-proline 0 CA--C 1.561 1.396 0 C-N-CA 127.159 2.183 . . . . 0.0 111.415 153.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -95.64 -170.64 0.18 Allowed 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 125.238 3.959 . . . . 0.0 112.658 -175.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -58.1 -20.25 38.55 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -173.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 58.8 m -76.93 -11.6 59.83 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 176.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 1.4 p -108.51 145.56 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 126.969 2.107 . . . . 0.0 108.227 167.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -155.59 174.63 14.99 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.678 1.591 . . . . 0.0 109.638 -176.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -41.99 -49.41 4.65 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.817 1.647 . . . . 0.0 114.853 -170.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -68.52 -35.71 77.86 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 118.916 0.78 . . . . 0.0 112.18 -175.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.37 -37.75 74.64 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 168.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 7.8 tt -61.79 -35.3 77.77 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.233 0.613 . . . . 0.0 111.727 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -53.03 -52.39 58.63 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.686 0.676 . . . . 0.0 110.641 170.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -59.63 -27.99 66.82 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.041 1.336 . . . . 0.0 113.331 -175.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 32.9 mt -51.7 -45.7 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.782 1.233 . . . . 0.0 112.082 173.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -106.17 -24.6 12.29 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.164 0.986 . . . . 0.0 112.548 -174.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -64.03 -2.93 2.21 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 126.626 1.97 . . . . 0.0 114.713 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -57.82 -20.76 38.22 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 120.567 -1.333 . . . . 0.0 113.307 168.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 72.0 m -69.02 0.32 4.71 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 125.436 1.494 . . . . 0.0 114.451 170.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 100.32 -76.69 0.44 Allowed Glycine 0 C--N 1.342 0.875 0 C-N-CA 126.36 1.933 . . . . 0.0 110.876 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -73.46 175.53 6.91 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.286 1.034 . . . . 0.0 111.173 172.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.01 142.08 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 120.65 -1.281 . . . . 0.0 111.442 172.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -76.95 -96.28 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.749 1.22 . . . . 0.0 111.142 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -160.66 147.07 15.24 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.633 1.573 . . . . 0.0 111.978 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.48 172.01 19.11 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.968 -1.082 . . . . 0.0 112.185 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -158.26 153.22 25.23 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -178.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 27.2 t -157.28 136.25 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 129.476 3.11 . . . . 0.0 105.674 176.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -132.24 144.27 50.51 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.02 0.528 . . . . 0.0 111.892 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 9.1 mp -64.77 144.07 57.5 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.6 1.16 . . . . 0.0 111.755 175.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -69.79 151.41 45.8 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.864 1.266 . . . . 0.0 111.339 169.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -64.86 -11.31 49.85 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.949 1.261 . . . . 0.0 115.348 -176.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -70.49 -6.45 36.19 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 118.782 1.291 . . . . 0.0 113.151 166.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 85.74 49.19 4.42 Favored Glycine 0 C--N 1.343 0.918 0 C-N-CA 125.481 1.515 . . . . 0.0 112.367 176.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 9.5 p -155.13 143.83 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.922 0.889 . . . . 0.0 112.135 -170.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 38.3 t -68.15 170.34 8.72 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.414 1.086 . . . . 0.0 113.209 176.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 12.1 t -144.15 -25.02 0.54 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -173.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 73.98 -48.25 1.67 Allowed Glycine 0 N--CA 1.475 1.246 0 C-N-CA 125.624 1.583 . . . . 0.0 114.589 177.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 7.8 p -51.07 123.12 8.67 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.542 1.937 . . . . 0.0 112.411 168.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -168.74 -168.6 31.04 Favored Glycine 0 N--CA 1.469 0.894 0 C-N-CA 124.075 0.845 . . . . 0.0 115.177 -174.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 18.7 p -115.56 152.54 32.86 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.259 1.824 . . . . 0.0 111.073 -170.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.5 t -138.99 120.53 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.177 1.391 . . . . 0.0 108.095 -177.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 4.5 t -100.12 108.22 20.31 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.398 1.079 . . . . 0.0 108.849 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.25 162.09 22.45 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -158.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -53.91 -63.51 1.13 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.906 1.282 . . . . 0.0 111.052 174.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -172.32 -176.34 1.57 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.995 2.518 . . . . 0.0 109.533 159.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.5 mp -49.11 -39.08 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 125.605 1.562 . . . . 0.0 113.569 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.25 -42.03 66.06 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 177.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -95.21 -31.43 13.5 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 123.321 0.388 . . . . 0.0 110.617 -174.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 5.5 tt -55.93 -51.32 68.08 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 125.469 1.508 . . . . 0.0 110.755 175.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -61.92 -46.59 88.69 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.056 0.844 . . . . 0.0 112.516 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -70.45 -32.74 70.43 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 176.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -65.87 -38.37 88.61 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.18 0.992 . . . . 0.0 112.045 171.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -57.74 -40.86 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.653 1.181 . . . . 0.0 112.168 176.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -81.99 -24.57 35.38 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -79.27 -45.09 20.42 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.355 1.062 . . . . 0.0 112.959 -177.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -103.68 -26.18 12.86 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -167.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -65.32 116.26 6.46 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 119.682 1.128 . . . . 0.0 110.023 173.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 99.61 0.55 56.58 Favored Glycine 0 CA--C 1.538 1.486 0 CA-C-O 119.101 -0.833 . . . . 0.0 114.962 -174.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -104.27 151.7 23.09 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.795 1.638 . . . . 0.0 111.63 175.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 26.9 p -111.92 134.11 53.69 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 120.433 -1.417 . . . . 0.0 113.09 -177.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 59.3 mt -145.27 118.71 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.898 1.279 . . . . 0.0 109.604 -176.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 57.15 23.27 8.39 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.636 1.574 . . . . 0.0 114.32 173.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 170.17 -119.84 0.83 Allowed Glycine 0 C--N 1.341 0.839 0 O-C-N 120.992 -1.067 . . . . 0.0 113.029 -177.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -86.03 176.66 7.9 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.355 0.662 . . . . 0.0 111.079 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 9.4 p -57.1 138.45 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 121.655 -0.653 . . . . 0.0 109.335 155.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 1.5 pp -100.48 145.03 28.76 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.831 0.824 . . . . 0.0 111.432 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -126.28 137.9 53.55 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.038 1.735 . . . . 0.0 109.374 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 18.5 t -120.54 132.19 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.36 1.464 . . . . 0.0 109.996 -170.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -131.41 154.72 48.36 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.377 1.871 . . . . 0.0 110.652 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 79.3 p -145.14 167.37 22.9 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 120.599 -1.313 . . . . 0.0 112.754 -172.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -69.32 144.96 53.37 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.904 0.882 . . . . 0.0 111.945 176.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -157.3 -60.81 0.09 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.245 1.018 . . . . 0.0 111.34 -173.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 1.4 t 68.62 19.02 8.73 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 164.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 7.9 p -157.54 141.88 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.295 1.438 . . . . 0.0 111.123 -177.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -143.96 155.82 44.19 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.419 1.488 . . . . 0.0 112.595 -173.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -79.05 167.19 21.43 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.263 1.025 . . . . 0.0 113.111 177.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -141.95 168.56 19.47 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.674 1.589 . . . . 0.0 112.81 -175.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 19.4 m 75.84 158.62 0.21 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 127.757 2.423 . . . . 0.0 113.484 -177.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -86.06 -7.63 58.48 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -172.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 95.79 -149.06 19.2 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.221 1.391 . . . . 0.0 113.266 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -158.57 148.98 19.96 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.55 1.54 . . . . 0.0 111.875 -172.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -164.42 149.9 10.31 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.983 2.113 . . . . 0.0 110.617 -177.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 13.4 p -162.46 139.83 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.746 1.618 . . . . 0.0 110.95 -178.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -164.14 114.73 1.27 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.091 1.756 . . . . 0.0 109.91 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 1.8 mp -91.07 126.34 55.56 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 124.411 1.084 . . . . 0.0 108.785 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -73.51 143.17 34.05 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.297 2.665 . . . . 0.0 111.03 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 24.9 ptp -165.04 156.37 14.78 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.405 1.482 . . . . 0.0 112.088 -175.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -161.69 163.71 29.58 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.919 1.688 . . . . 0.0 111.228 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -151.67 104.32 3.03 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.602 1.561 . . . . 0.0 110.259 177.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 46.4 m -66.02 140.2 96.96 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 123.944 0.897 . . . . 0.0 113.033 -177.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -74.54 162.59 37.73 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.593 2.862 . . . . 0.0 111.691 176.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 96.4 t -68.83 -28.25 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.451 0.7 . . . . 0.0 111.812 178.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 8.3 t30 . . . . . 0 C--O 1.254 1.339 0 C-N-CA 126.098 1.759 . . . . 0.0 111.811 179.597 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.906 0 CA-C-O 121.025 0.236 . . . . 0.0 112.591 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 33.3 t -159.09 105.78 1.76 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.869 1.268 . . . . 0.0 110.08 -177.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -158.08 140.53 14.46 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 120.875 -1.14 . . . . 0.0 112.289 -167.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 21.2 t -126.96 140.01 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 127.33 2.252 . . . . 0.0 108.499 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.4 mp -106.79 131.04 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.736 1.614 . . . . 0.0 107.057 175.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 23.0 m -110.59 126.39 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.617 0.767 . . . . 0.0 109.232 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -148.69 59.64 1.07 Allowed 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 121.64 0.733 . . . . 0.0 112.127 -155.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -171.42 -38.26 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 126.116 1.767 . . . . 0.0 111.285 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -34.29 122.52 0.53 Allowed Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 126.637 1.975 . . . . 0.0 111.517 162.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -86.18 167.13 9.39 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.46 3.44 . . . . 0.0 110.671 175.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -60.53 -4.6 0.94 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -174.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 8.3 t -60.58 -31.05 70.2 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.606 1.163 . . . . 0.0 113.205 169.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 8.8 p -79.73 121.63 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 121.639 0.733 . . . . 0.0 111.511 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -79.15 156.68 28.14 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.965 1.306 . . . . 0.0 110.6 170.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -52.04 -37.92 55.28 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 120.804 -1.185 . . . . 0.0 113.087 178.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -71.42 -38.24 71.41 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.502 -0.749 . . . . 0.0 111.354 178.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.98 -26.36 64.99 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.05 -1.031 . . . . 0.0 112.651 171.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.793 HD21 HG12 ' A' ' 306' ' ' VAL . 1.8 tt -66.95 -46.93 73.22 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.623 0.769 . . . . 0.0 111.367 170.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . 0.469 ' N ' HD23 ' A' ' 277' ' ' LEU . 0.0 OUTLIER -69.26 -28.56 66.42 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.808 1.186 . . . . 0.0 111.218 177.907 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -64.99 -23.17 67.14 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.675 1.19 . . . . 0.0 113.258 173.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 41.3 mt -55.02 -51.33 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 119.226 0.921 . . . . 0.0 110.315 171.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -91.09 -18.73 24.06 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.267 1.027 . . . . 0.0 112.508 -173.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -57.17 -17.86 12.98 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.863 1.665 . . . . 0.0 114.146 176.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -57.17 -14.86 4.56 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.343 1.457 . . . . 0.0 114.146 173.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 9.3 t -66.15 -11.38 48.98 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 171.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 91.23 -3.29 79.79 Favored Glycine 0 N--CA 1.479 1.537 0 C-N-CA 125.488 1.518 . . . . 0.0 114.219 -177.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -138.53 -179.6 5.91 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.971 2.509 . . . . 0.0 108.189 171.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 5.0 p -145.78 143.3 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 120.158 1.345 . . . . 0.0 112.68 164.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -78.77 -94.73 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.529 1.532 . . . . 0.0 112.183 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -170.6 153.47 4.18 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 127.717 2.407 . . . . 0.0 110.072 -167.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.56 170.15 22.82 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.156 -0.965 . . . . 0.0 112.626 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -149.65 143.27 25.4 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.43 1.092 . . . . 0.0 113.314 -177.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 32.2 t -158.66 136.82 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 127.498 2.319 . . . . 0.0 107.999 -171.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -132.67 128.06 36.2 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.998 0.919 . . . . 0.0 110.322 170.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 12.1 mt -75.49 167.68 21.45 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 122.206 1.003 . . . . 0.0 113.631 -169.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.96 151.97 0.86 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 127.842 2.457 . . . . 0.0 113.804 167.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -70.9 -6.93 60.99 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.938 1.256 . . . . 0.0 116.082 -172.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -109.72 0.43 18.92 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.101 1.76 . . . . 0.0 111.83 169.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 95.26 8.6 58.66 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.735 2.112 . . . . 0.0 114.393 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 6.2 t -90.19 58.74 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 118.804 1.302 . . . . 0.0 111.019 -166.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 7.6 t 60.36 -163.48 0.24 Allowed 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 125.598 1.559 . . . . 0.0 114.096 172.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -166.47 143.53 5.02 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 129.041 2.937 . . . . 0.0 108.631 173.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -89.11 -76.9 1.3 Allowed Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.148 0.88 . . . . 0.0 112.086 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 32.2 p -54.92 149.34 11.74 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.372 1.469 . . . . 0.0 113.676 169.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -163.32 -177.46 36.26 Favored Glycine 0 N--CA 1.471 1.028 0 C-N-CA 125.045 1.307 . . . . 0.0 114.664 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 40.6 m -116.38 135.3 53.98 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.503 1.521 . . . . 0.0 108.623 -177.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.793 HG12 HD21 ' A' ' 277' ' ' LEU . 13.2 m -129.93 130.73 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.066 0.946 . . . . 0.0 109.181 178.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 33.0 m -90.52 115.51 27.72 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.953 0.901 . . . . 0.0 108.715 -175.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -83.59 147.54 27.67 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -163.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -49.78 -55.62 13.38 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.95 1.3 . . . . 0.0 112.573 -175.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.59 172.84 4.15 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.85 2.06 . . . . 0.0 110.039 162.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.42 -24.84 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.3 1.04 . . . . 0.0 112.422 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -45.54 69.72 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 169.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -98.18 -20.04 17.52 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.35 0.523 . . . . 0.0 111.947 -175.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -49.3 -52.15 29.5 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.066 1.747 . . . . 0.0 111.117 174.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -67.32 -29.67 69.3 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -70.49 -52.25 23.32 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.314 0.645 . . . . 0.0 110.888 170.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -59.65 -35.9 75.33 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.276 1.43 . . . . 0.0 113.004 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -50.67 -44.38 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.639 1.176 . . . . 0.0 112.393 176.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -90.39 -34.35 15.68 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 177.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -62.43 -40.08 95.4 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.994 -1.066 . . . . 0.0 113.025 -176.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -92.98 -13.39 28.82 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -62.71 115.28 4.17 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.532 -0.73 . . . . 0.0 110.189 169.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 91.93 0.18 72.01 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-O 118.935 -0.925 . . . . 0.0 114.898 -175.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -103.42 135.54 44.85 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.011 1.405 . . . . 0.0 111.5 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 30.1 p -112.82 133.48 54.79 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.411 1.084 . . . . 0.0 112.563 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -144.0 119.65 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.579 1.151 . . . . 0.0 109.015 -170.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 56.94 28.35 14.54 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.447 1.099 . . . . 0.0 113.44 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 149.18 -119.67 1.08 Allowed Glycine 0 C--N 1.343 0.964 0 C-N-CA 124.433 1.016 . . . . 0.0 113.09 -174.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -89.67 175.32 7.3 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.112 0.965 . . . . 0.0 112.239 -169.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.94 137.06 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.161 0.984 . . . . 0.0 110.014 169.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.56 124.57 24.97 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.726 0.81 . . . . 0.0 111.832 -177.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.5 113.43 24.81 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 158.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 91.4 t -105.83 121.22 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.648 1.179 . . . . 0.0 108.609 177.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -140.98 133.69 28.79 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.239 1.416 . . . . 0.0 110.042 175.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 65.2 p -82.9 166.61 18.76 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.377 -0.827 . . . . 0.0 111.811 173.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -71.58 94.12 1.28 Allowed 'General case' 0 CA--C 1.547 0.863 0 O-C-N 121.244 -0.91 . . . . 0.0 111.001 174.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -168.49 178.92 4.58 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.477 1.911 . . . . 0.0 110.185 -173.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 12.0 t -161.15 176.76 10.94 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.846 1.258 . . . . 0.0 112.05 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 14.0 p -166.84 146.14 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.303 1.841 . . . . 0.0 110.84 -171.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 35.1 p80 -133.26 8.57 4.0 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.153 1.381 . . . . 0.0 114.548 -173.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -67.35 162.57 22.6 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.86 1.264 . . . . 0.0 113.078 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -147.42 165.3 30.65 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.159 1.784 . . . . 0.0 112.664 -176.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 64.9 p -146.27 20.68 1.38 Allowed 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -165.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -67.14 -23.98 65.85 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -176.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 83.06 168.1 42.49 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.079 1.323 . . . . 0.0 114.593 174.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -160.03 26.48 0.17 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.907 1.683 . . . . 0.0 111.561 -175.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -102.19 7.04 40.99 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -154.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 58.3 t -143.2 126.74 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 126.267 1.827 . . . . 0.0 109.247 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -154.4 35.71 0.42 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.304 1.441 . . . . 0.0 111.516 -175.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 7.9 tp -133.45 138.68 31.86 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 125.854 1.661 . . . . 0.0 110.805 -173.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.31 160.96 41.32 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.015 2.477 . . . . 0.0 111.45 174.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 63.0 ttp -158.11 142.15 15.76 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.741 1.216 . . . . 0.0 111.514 -175.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -157.27 158.5 36.23 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.898 1.679 . . . . 0.0 111.4 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -153.74 1.79 0.25 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.449 2.3 . . . . 0.0 113.285 -176.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 73.3 m -67.33 139.43 94.7 Favored Pre-proline 0 CA--C 1.551 1.009 0 O-C-N 121.021 -1.049 . . . . 0.0 112.442 178.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -76.23 153.11 35.82 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.707 2.938 . . . . 0.0 111.779 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 18.3 m -147.16 149.97 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 125.445 1.498 . . . . 0.0 111.567 -178.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.252 1.226 0 C-N-CA 126.82 2.048 . . . . 0.0 111.858 -177.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.939 0 CA-C-O 121.116 0.287 . . . . 0.0 112.424 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 9.9 p -78.55 62.22 3.09 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.501 1.521 . . . . 0.0 112.788 -177.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.14 138.66 24.1 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.624 1.17 . . . . 0.0 111.029 -173.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 65.5 t -151.32 146.35 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 126.642 1.977 . . . . 0.0 108.898 -165.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 2.0 mp -131.29 136.99 56.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.026 1.731 . . . . 0.0 107.835 176.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 31.5 m -120.3 124.64 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.809 1.244 . . . . 0.0 108.797 -176.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -143.85 80.0 1.64 Allowed 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -156.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -172.27 -38.82 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.245 1.818 . . . . 0.0 111.105 169.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 59.0 mt -34.82 123.26 0.56 Allowed Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 128.362 2.665 . . . . 0.0 113.132 167.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -85.44 174.89 6.6 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.102 3.201 . . . . 0.0 111.459 173.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -53.87 -12.73 0.59 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.248 1.819 . . . . 0.0 115.832 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 41.2 t -55.3 -30.99 61.26 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.731 1.612 . . . . 0.0 113.746 171.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 8.8 p -91.57 122.62 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 119.318 0.963 . . . . 0.0 110.712 176.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -84.48 158.4 21.02 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.625 1.57 . . . . 0.0 111.147 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -49.85 -34.51 20.19 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 175.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -67.31 -38.31 84.75 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.97 -1.081 . . . . 0.0 111.04 177.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -76.8 -27.42 55.21 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 173.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 3.7 tp -53.6 -51.58 62.57 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 120.218 1.372 . . . . 0.0 109.491 166.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -55.22 -43.97 74.99 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 122.971 0.508 . . . . 0.0 111.067 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.45 -19.83 62.43 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.056 1.343 . . . . 0.0 114.505 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 66.0 mt -58.73 -29.67 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 119.293 0.951 . . . . 0.0 111.526 171.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -123.27 -23.05 4.96 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.54 1.136 . . . . 0.0 113.716 -175.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -65.97 -12.39 54.63 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.34 1.456 . . . . 0.0 113.892 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -60.51 -12.18 9.04 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 177.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 23.6 p -72.62 -8.62 56.16 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 170.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 93.13 13.37 56.28 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.203 1.382 . . . . 0.0 114.509 -177.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -138.45 176.51 8.63 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.417 1.887 . . . . 0.0 111.116 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 6.8 p -145.47 140.58 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 O-C-N 121.184 -0.948 . . . . 0.0 112.633 168.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -95.06 -99.15 0.16 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.103 1.361 . . . . 0.0 110.295 167.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -160.72 154.5 22.48 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.975 1.71 . . . . 0.0 111.959 176.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.04 149.85 21.73 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.119 -0.988 . . . . 0.0 111.894 -170.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -157.32 165.11 36.7 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.539 1.136 . . . . 0.0 113.881 -174.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 8.1 m -141.02 144.93 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 127.222 2.209 . . . . 0.0 110.525 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -108.94 129.3 55.43 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.471 1.109 . . . . 0.0 109.476 171.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -134.66 171.85 13.77 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.602 1.161 . . . . 0.0 113.098 -171.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -68.88 152.6 45.08 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.956 1.302 . . . . 0.0 113.144 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -70.61 -18.31 75.55 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.616 1.103 . . . . 0.0 115.252 -175.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -88.96 0.25 56.8 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 118.824 1.312 . . . . 0.0 112.67 169.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 92.61 10.77 60.04 Favored Glycine 0 N--CA 1.471 1.019 0 C-N-CA 125.004 1.287 . . . . 0.0 115.008 173.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 57.9 t -70.75 116.06 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 118.386 1.093 . . . . 0.0 108.613 172.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 68.5 p -76.69 177.35 7.62 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.063 1.345 . . . . 0.0 114.555 -170.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 21.0 p -145.28 139.48 27.12 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 127.03 2.132 . . . . 0.0 109.884 -170.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -94.74 -34.99 6.02 Favored Glycine 0 N--CA 1.472 1.045 0 C-N-CA 123.391 0.52 . . . . 0.0 113.822 175.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 17.6 t -55.73 111.96 1.04 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.825 1.25 . . . . 0.0 110.293 167.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -142.89 169.22 25.72 Favored Glycine 0 N--CA 1.471 0.981 0 C-N-CA 124.789 1.185 . . . . 0.0 114.919 -165.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 85.7 m -115.73 141.31 48.26 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.414 1.886 . . . . 0.0 109.086 -173.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.34 113.04 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 124.829 1.252 . . . . 0.0 109.613 -170.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 13.6 t -74.34 147.88 41.83 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 113.911 -1.495 . . . . 0.0 110.159 170.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.72 157.46 19.72 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 -169.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -59.2 -53.9 52.99 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 113.974 -1.466 . . . . 0.0 111.519 176.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -172.67 166.19 5.44 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.814 2.846 . . . . 0.0 108.498 171.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 67.5 mt -60.25 -30.57 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.027 0.931 . . . . 0.0 111.603 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.56 -43.38 45.95 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.935 1.294 . . . . 0.0 114.273 171.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -96.33 -22.34 17.26 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 6.0 tt -58.4 -52.19 66.67 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.708 1.203 . . . . 0.0 110.524 177.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -65.79 -28.88 69.34 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -70.16 -51.65 29.63 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.267 1.027 . . . . 0.0 110.978 172.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -61.73 -33.99 75.03 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.785 1.634 . . . . 0.0 113.191 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -56.92 -41.55 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.817 1.247 . . . . 0.0 112.72 177.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -82.61 -29.24 30.29 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 175.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -75.03 -45.44 41.7 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -171.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -100.26 -16.7 17.63 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -172.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . 0.403 ' ND2' ' H ' ' A' ' 333' ' ' VAL . 32.0 t-20 -70.35 118.62 13.39 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.437 -0.789 . . . . 0.0 110.754 178.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 102.24 0.11 50.77 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.68 1.61 . . . . 0.0 114.726 -176.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -105.47 144.24 32.52 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.941 1.371 . . . . 0.0 112.441 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 67.3 m -94.06 125.6 38.79 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.184 -0.948 . . . . 0.0 112.54 -176.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 46.5 mt -138.32 108.36 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.403 1.081 . . . . 0.0 109.427 176.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 59.48 20.31 8.72 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.77 1.628 . . . . 0.0 114.314 177.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . -168.59 -133.21 1.53 Allowed Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.157 1.36 . . . . 0.0 112.406 -176.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 49.4 p30 -98.01 -172.94 2.47 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.599 1.16 . . . . 0.0 110.282 172.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 20.4 m -58.31 131.38 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-N 119.163 0.892 . . . . 0.0 109.353 172.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 2.4 pp -91.26 138.15 31.81 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 122.378 1.085 . . . . 0.0 111.126 178.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -91.48 156.0 18.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 113.925 -1.489 . . . . 0.0 109.998 166.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.403 ' H ' ' ND2' ' A' ' 322' ' ' ASN . 18.6 t -136.93 131.68 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.953 1.701 . . . . 0.0 108.977 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -148.11 143.34 27.07 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.116 1.367 . . . . 0.0 111.366 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 83.5 p -119.09 171.7 8.08 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 120.919 -1.113 . . . . 0.0 112.503 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -77.64 -8.43 57.88 Favored 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -164.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -63.46 150.42 43.77 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.334 1.454 . . . . 0.0 113.536 -176.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 19.3 t -159.33 160.31 34.91 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.077 1.751 . . . . 0.0 110.325 173.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.422 HG22 ' H ' ' A' ' 341' ' ' ASN . 12.8 p -164.42 140.52 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.852 1.261 . . . . 0.0 111.284 -171.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -88.01 -7.45 57.04 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.721 1.208 . . . . 0.0 114.223 -176.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . 0.422 ' H ' HG22 ' A' ' 339' ' ' VAL . 4.9 t-20 -152.14 -144.14 0.14 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.243 1.817 . . . . 0.0 110.613 -175.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 35.6 p-80 -154.16 168.51 26.27 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.989 1.316 . . . . 0.0 113.555 -174.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 28.6 t -162.21 151.73 16.0 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.608 1.563 . . . . 0.0 110.874 -177.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -82.5 0.51 42.12 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.464 1.506 . . . . 0.0 112.592 172.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 99.79 10.21 47.26 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.738 1.637 . . . . 0.0 112.376 -162.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -85.02 -18.04 35.67 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.053 2.141 . . . . 0.0 113.737 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -78.33 57.96 2.01 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.708 1.603 . . . . 0.0 111.603 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 28.1 m -143.39 152.44 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 126.535 1.934 . . . . 0.0 111.677 -172.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -153.82 110.43 3.35 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.863 2.065 . . . . 0.0 108.516 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 8.1 tp -133.46 135.74 25.77 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 125.087 1.355 . . . . 0.0 111.141 -176.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -86.08 170.64 8.29 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.742 2.961 . . . . 0.0 111.791 175.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -136.59 144.66 44.24 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.417 1.487 . . . . 0.0 110.911 174.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -147.2 152.59 38.64 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.137 1.775 . . . . 0.0 111.202 -177.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -127.56 9.8 6.59 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.921 1.289 . . . . 0.0 113.678 -170.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 26.8 p -75.46 143.71 76.51 Favored Pre-proline 0 CA--C 1.553 1.068 0 O-C-N 120.794 -1.191 . . . . 0.0 113.059 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.53 157.64 32.44 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.773 2.982 . . . . 0.0 111.767 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 14.7 p -161.87 141.11 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.104 1.361 . . . . 0.0 110.797 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 . . . . . 0 C--O 1.254 1.307 0 C-N-CA 125.971 1.708 . . . . 0.0 111.591 -175.898 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.925 0 N-CA-C 112.655 -0.178 . . . . 0.0 112.655 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 49.0 m 70.91 -55.98 0.63 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.979 2.512 . . . . 0.0 114.534 174.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 63.09 176.65 0.15 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.65 1.98 . . . . 0.0 113.857 172.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 35.5 m -139.01 152.4 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 120.906 -1.121 . . . . 0.0 110.95 163.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 5.1 mp -118.72 138.84 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 126.024 1.729 . . . . 0.0 108.355 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 20.8 m -112.73 125.57 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.643 1.177 . . . . 0.0 107.95 172.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -142.95 46.47 1.55 Allowed 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -148.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -168.99 -26.36 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 88.1 mt -51.85 144.79 18.51 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 124.338 1.055 . . . . 0.0 111.583 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -79.74 -179.16 5.09 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.497 3.465 . . . . 0.0 111.017 178.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -62.54 -7.49 4.75 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 115.216 1.561 . . . . 0.0 115.216 -176.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 16.4 m -68.96 -17.08 63.89 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.86 1.664 . . . . 0.0 114.589 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 9.9 p -98.98 142.79 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.458 1.103 . . . . 0.0 110.482 175.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -142.53 168.33 19.99 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.722 2.009 . . . . 0.0 110.219 -177.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -46.31 -51.03 15.46 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -171.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -63.59 -36.37 83.59 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.793 0.724 . . . . 0.0 112.226 -178.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.89 -39.95 75.93 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 169.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 6.8 tt -60.06 -35.57 75.44 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.863 0.865 . . . . 0.0 111.698 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -53.79 -52.86 58.94 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.508 0.723 . . . . 0.0 111.306 169.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -62.42 -21.18 65.2 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.605 1.562 . . . . 0.0 113.561 -176.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 28.2 mt -54.9 -29.82 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 124.654 1.182 . . . . 0.0 111.992 171.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -121.29 -27.55 4.84 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.142 1.377 . . . . 0.0 112.577 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.6 -8.93 30.51 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.6 1.56 . . . . 0.0 115.005 -177.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -60.38 -15.48 26.39 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 120.348 -1.47 . . . . 0.0 114.139 172.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 71.3 m -66.37 -5.62 11.43 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 171.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 91.26 5.28 67.65 Favored Glycine 0 N--CA 1.477 1.43 0 C-N-CA 125.35 1.453 . . . . 0.0 114.54 177.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -138.43 179.3 6.55 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.904 2.481 . . . . 0.0 110.719 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.41 144.27 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 121.118 -0.989 . . . . 0.0 112.439 177.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -100.63 -114.0 0.18 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.518 1.527 . . . . 0.0 110.528 172.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -156.59 143.38 18.62 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.645 1.178 . . . . 0.0 113.475 -178.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -158.3 174.07 15.71 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.594 1.158 . . . . 0.0 112.06 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -159.25 152.0 21.77 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.143 1.377 . . . . 0.0 112.608 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 20.4 t -150.04 140.09 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.225 1.81 . . . . 0.0 108.203 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -132.19 135.75 46.56 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.289 1.035 . . . . 0.0 109.939 173.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 8.7 mt -91.34 158.09 16.74 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.759 0.824 . . . . 0.0 111.705 -169.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -77.86 146.43 35.68 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.706 1.203 . . . . 0.0 112.129 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -66.55 -12.67 59.42 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.095 1.331 . . . . 0.0 115.792 -174.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -74.97 -1.12 21.18 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 119.157 1.478 . . . . 0.0 113.237 166.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 87.85 38.63 7.37 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.094 1.33 . . . . 0.0 113.308 174.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 23.9 m -142.49 143.79 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 125.158 1.383 . . . . 0.0 111.732 -174.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.71 154.46 40.69 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.218 1.007 . . . . 0.0 113.114 -178.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 37.1 p -69.54 -32.14 70.79 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.076 0.951 . . . . 0.0 112.874 173.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 78.29 -61.37 3.86 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.932 1.253 . . . . 0.0 111.641 -176.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 52.2 p -60.07 146.63 42.25 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 122.471 1.129 . . . . 0.0 112.243 161.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -159.37 170.08 35.61 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.569 1.557 . . . . 0.0 113.924 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 99.0 m -119.9 142.49 48.64 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.751 1.62 . . . . 0.0 109.492 -175.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.0 t -133.54 127.62 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.689 1.596 . . . . 0.0 109.059 -170.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 14.9 t -92.92 127.85 38.57 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.916 0.886 . . . . 0.0 109.24 172.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -85.3 163.53 18.55 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -164.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -52.4 -54.44 31.94 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.776 1.23 . . . . 0.0 112.108 175.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -172.35 161.88 5.33 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 129.081 2.952 . . . . 0.0 108.375 170.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.78 -28.01 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.99 0.916 . . . . 0.0 112.02 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.54 -43.44 56.1 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 171.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -102.44 -17.55 15.76 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -176.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 4.1 tt -58.6 -50.66 73.01 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.318 1.047 . . . . 0.0 110.021 174.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -64.98 -28.12 69.3 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 45.4 mtp85 -70.01 -53.33 18.11 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.349 1.06 . . . . 0.0 111.071 169.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -60.02 -36.28 76.9 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.703 1.601 . . . . 0.0 113.264 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -53.34 -46.54 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.826 1.25 . . . . 0.0 112.482 -178.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -85.82 -37.27 19.41 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.168 0.587 . . . . 0.0 112.339 175.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -61.05 -34.42 74.85 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.193 -0.942 . . . . 0.0 113.324 -175.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -97.61 -1.51 43.61 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 175.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -60.03 111.51 1.52 Allowed 'General case' 0 CA--C 1.552 1.038 0 O-C-N 119.576 -1.952 . . . . 0.0 111.891 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 96.44 -0.01 61.36 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.462 1.506 . . . . 0.0 115.499 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.2 169.31 15.38 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 119.137 1.469 . . . . 0.0 114.576 179.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 56.0 p -138.5 124.3 19.86 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.262 1.025 . . . . 0.0 111.833 172.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 10.1 mt -138.28 116.66 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 125.147 1.379 . . . . 0.0 108.77 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 61.98 30.34 17.98 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.42 1.488 . . . . 0.0 113.271 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 173.68 -127.94 1.42 Allowed Glycine 0 C--N 1.342 0.864 0 N-CA-C 115.116 0.806 . . . . 0.0 115.116 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 42.7 p30 -110.27 -177.2 3.19 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.397 1.879 . . . . 0.0 111.376 -171.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 26.6 m -66.12 139.65 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 121.476 -0.765 . . . . 0.0 111.315 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.83 130.22 56.75 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.453 1.501 . . . . 0.0 112.29 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -72.24 154.66 40.88 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.86 148.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 47.1 t -136.45 124.34 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.295 1.438 . . . . 0.0 108.79 -174.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 58.2 mttt -146.28 141.93 27.81 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.613 1.565 . . . . 0.0 111.742 -170.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 30.2 p -89.61 167.34 13.01 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.11 1.364 . . . . 0.0 112.369 173.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -80.87 58.44 3.38 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.332 1.453 . . . . 0.0 112.351 -173.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -161.23 175.73 12.0 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.937 1.695 . . . . 0.0 112.123 -172.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 23.0 t -155.08 131.45 10.4 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.495 1.118 . . . . 0.0 111.065 176.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 61.4 t -151.13 133.77 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 125.882 1.673 . . . . 0.0 109.318 -172.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -155.01 144.57 21.35 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.863 1.265 . . . . 0.0 112.906 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -163.37 153.76 15.94 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.375 1.87 . . . . 0.0 111.477 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -147.19 147.24 30.29 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.929 1.292 . . . . 0.0 112.768 175.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 33.2 t -162.03 133.28 5.22 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.309 1.844 . . . . 0.0 109.37 171.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -79.47 -15.79 57.18 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.794 0.837 . . . . 0.0 113.162 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 77.94 -37.22 1.7 Allowed Glycine 0 CA--C 1.534 1.273 0 C-N-CA 126.438 1.97 . . . . 0.0 116.066 167.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -165.2 156.72 14.78 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.41 1.484 . . . . 0.0 112.318 -170.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -160.77 153.86 21.48 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.152 2.181 . . . . 0.0 109.731 175.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 14.6 p -167.95 147.53 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 126.569 1.947 . . . . 0.0 111.137 -170.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -158.99 113.02 2.39 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.981 1.713 . . . . 0.0 109.837 177.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' ILE . . . . . . . . . . . . . 8.0 tp -133.48 136.18 26.52 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 125.61 1.564 . . . . 0.0 111.132 -176.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.4 166.51 24.13 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.371 2.714 . . . . 0.0 111.611 176.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' MET . . . . . . . . . . . . . 27.9 ttt -158.55 139.71 13.15 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.015 1.326 . . . . 0.0 111.321 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -146.55 147.43 31.12 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.393 1.877 . . . . 0.0 110.797 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -152.34 30.54 0.54 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.873 1.269 . . . . 0.0 112.444 -172.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 37.4 p -71.02 148.16 94.24 Favored Pre-proline 0 CA--C 1.553 1.07 0 O-C-N 120.793 -1.192 . . . . 0.0 113.176 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -75.73 152.13 37.09 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.623 2.882 . . . . 0.0 111.714 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 15.9 m -147.59 148.46 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.793 1.637 . . . . 0.0 110.722 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 6.4 t30 . . . . . 0 C--O 1.253 1.287 0 C-N-CA 125.786 1.634 . . . . 0.0 111.654 -177.552 . . . . . . . . 0 0 . 1 stop_ save_